Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytoplasmic translation (GO:0002181),-0.6280632343710457,-2.25358288433806,0.0,0.0,0.0,63/91,25.74%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;EIF4A1;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPL28;RPS24;RPS27;RPL14;RWDD1;RPL26;EIF4A2;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;RPL36A;DRG2;FTSJ1;RPS26;RPL35A;RPS29;RPL8;RPL36;TMA7;RPS3;RPL13A
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6132796355892699,-2.171100911329374,0.0,0.0,0.0,60/87,25.74%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;SEC61A1;RPL36A;SEC61B;RPS26;RPL35A;RPS29;RPL8;RPL36;RPS3;RPL13A
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6018557558726856,-2.1570498821368393,0.0,0.0007460129511318145,0.002,68/91,31.89%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;SEC61A1;RPL36A;RPS26;RPL35A;RPS29;RPL8;RPL36;RPS3;RPL13A;TRAM1;RPS2;RPL21;RPL29;SRP14;SEC63;RPL19;RPL23A;RPS21
prerank,muscle contraction (GO:0006936),0.6666381160915925,2.11172274457143,0.0,0.04740639145251209,0.046,20/126,3.94%,SNTB1;ITGA1;GJC1;EDNRA;CALD1;CASQ2;UTRN;DMD;DYSF;KCNJ12;UTS2;MYLK;CACNA1H;VCL;MYH11;ROCK1;TACR2;MYL9;ITGB5;TMOD1
prerank,transition metal ion transport (GO:0000041),0.8010005125508831,2.110192579055307,0.0,0.024150425834298613,0.047,7/35,3.71%,TRPC3;TRPC4;TRPC6;SLC30A10;TRPC1;ATP2C1;ATP7A
prerank,manganese ion transport (GO:0006828),0.9276242861317925,2.1036220886498667,0.0,0.01967812475387294,0.054,6/14,2.39%,TRPC3;TRPC4;TRPC6;SLC30A10;TRPC1;ATP2C1
prerank,embryonic skeletal system development (GO:0048706),-0.685921852469522,-2.0923108703780127,0.0,0.0030773034234187345,0.01,13/35,6.26%,SULF1;COL1A1;PDGFRA;PCSK5;OSR1;KIAA1217;HOXB3;RBP4;WNT9A;HOXA3;SULF2;SIX1;WNT5A
prerank,response to ATP (GO:0033198),0.8932818098932079,2.090570292646753,0.0,0.022361505402128345,0.073,2/18,0.02%,ABCC9;TRPC3
prerank,bone development (GO:0060348),-0.682054369542707,-2.0604249993393093,0.0,0.004699881592130431,0.017,16/39,11.93%,RANBP3L;SULF1;AKAP13;CYP26B1;TGM2;FGFR2;GJA1;LRP6;SKI;SULF2;SFRP4;RPL13;GNAS;NOTUM;MYOC;DYM
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.6399727737546721,2.055030912381141,0.0,0.04150295402635021,0.17,16/142,4.05%,TRPC3;TRPC4;TRPC6;EDNRA;CACNA1C;PLCE1;S1PR3;TBXA2R;ATP1A2;TRPC1;GPER1;CCRL2;ADCY8;ACKR3;ATP2B3;TACR1
prerank,positive regulation of calcium ion transport (GO:0051928),0.7887688239351246,2.036393205749271,0.0018656716417910447,0.052773152749022896,0.239,5/36,1.47%,TRPC3;TRPC6;PDGFRB;CACNB2;MYLK
prerank,protein targeting to ER (GO:0045047),-0.5653951678852925,-2.0324991624017428,0.0,0.006714116560186329,0.031,73/99,32.06%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;CHMP4B;CHMP4A;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;SPCS1;RPS7;RPL38;RPLP0;RPL27;SEC61A1;RPL36A;RPS26;RPL35A;RPS29;RPL8;RPL36;RPS3;RPL13A;EDEM1;RPS2;RPL21;RPL29;SRP14;SEC63;RPL19;RPL23A;GET3;RPS21;SPCS2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5489128194907492,-2.024646565803775,0.0,0.0067141165601863305,0.036,66/110,25.74%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;CTIF;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;SMG6;RPL18;RPS9;UPF3A;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;SMG5;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;PNRC2;UPF2;RPL36A;RPS26;RPL35A;DHX34;HELZ2;RPS29;RPL8;RPL36;RPS3;RPL13A
prerank,sprouting angiogenesis (GO:0002040),-0.6215868780044518,-2.019735092033894,0.0,0.00671411656018633,0.042,26/51,14.62%,ROBO1;EFNB2;NRP1;TEK;CCBE1;RECK;SLIT2;RSPO3;RNF213;THBS1;BMP4;EPHB4;ANGPT1;RAMP2;VEGFD;VEGFC;BMPER;ACVRL1;PTK2B;SEMA3E;AKT1;CDH13;KDR;FLT4;PARVA;ESM1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.6538524595762508,2.018208411454189,0.0,0.07040679700898696,0.335,25/107,6.62%,GRM3;GRM7;PTEN;MEF2C;SLC12A2;CEL;CLSTN1;CDH2;ATP1A2;BEGAIN;LRRC4C;EIF4EBP2;IL1B;GRIK1;NMU;GRM5;RIMS1;CLSTN3;NRG3;RIMS2;ITGB1;GRM1;GRID1;SYN1;CHRNA7
prerank,regulation of heart contraction (GO:0008016),0.662151029324508,2.0138106364241892,0.0015337423312883436,0.06775536136844888,0.356,15/90,3.95%,ABCC9;ACE2;PDE4D;TBX2;CASQ2;ATP2A3;KCNJ12;ATP1A2;TRPC1;CACNA1H;ITPR2;ATP1A4;FXYD2;ATP2B3;ITPR1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7450774014081115,2.011793752516577,0.0,0.06291036853132106,0.364,11/46,5.56%,GRM3;GRM7;MEF2C;CDH2;ATP1A2;NRXN1;CACNG7;GRIK1;GRM5;ATAD1;GRM1
prerank,response to organophosphorus (GO:0046683),0.8905527404121047,1.9991720958313952,0.0,0.07316684567576394,0.438,2/16,0.02%,ABCC9;TRPC3
prerank,regulation of cardiac conduction (GO:1903779),0.7227932904124643,1.9974272986443102,0.0,0.06879212207345665,0.449,15/54,7.48%,ABCC9;ACE2;CASQ2;ATP2A3;ATP1A2;TRPC1;ITPR2;ATP1A4;FXYD2;ATP2B3;ITPR1;ATP1B2;RYR2;ATP2A2;STIM1
prerank,response to purine-containing compound (GO:0014074),0.8813202047415297,1.9834164838394266,0.0,0.08616633414953456,0.553,2/17,0.02%,ABCC9;TRPC3
prerank,cellular calcium ion homeostasis (GO:0006874),0.6165997597498809,1.958852914673039,0.0015313935681470138,0.12990314522836405,0.722,21/133,7.48%,TRPC3;ATP13A5;TRPC4;TRPC6;PTH1R;ATP2A3;TRPC1;GPER1;ATP2C1;STIM2;ADCY8;ATP2B3;ATP13A4;SLC24A4;SLC24A2;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.852905495467467,1.9378557615522805,0.0,0.18010595351028513,0.837,4/15,5.56%,GRM3;GRM7;GRM5;GRM1
prerank,metal ion transport (GO:0030001),0.6478524981402587,1.9303749025464034,0.0,0.19069891806935052,0.867,10/86,3.95%,TRPC3;TRPC4;CACNA1C;ATP2A3;TRPC1;ATP2C1;NDFIP2;CACNG7;CACNA2D1;ITPR1
prerank,amino acid import (GO:0043090),-0.7189230975520597,-1.920853003674334,0.0,0.0466258094457384,0.277,15/21,22.10%,SLC6A13;SLC47A1;SLC1A3;SLC16A2;SLC6A6;SFXN2;SLC22A4;SLC7A5;SLC6A1;SLC25A38;SLC7A1;SLC22A2;SH3BP4;SLC36A1;SLC1A1
prerank,androgen receptor signaling pathway (GO:0030521),-0.834536788218408,-1.9181612591668673,0.0,0.04453697318256932,0.288,6/11,12.24%,ZMIZ1;DDX5;AR;TMF1;KDM3A;PLPP1
prerank,potassium ion import across plasma membrane (GO:1990573),0.7328822105921964,1.9173090343109527,0.0,0.22054034702849082,0.907,9/41,4.90%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;ATP1A4;FXYD2;SLC12A6;ATP1B2
prerank,inorganic ion transmembrane transport (GO:0098660),0.902362585903075,1.9162208594371182,0.0022026431718061676,0.21261845489411912,0.911,3/12,1.67%,ABCC9;KCNJ8;CACNA1H
prerank,chordate embryonic development (GO:0043009),-0.5769501459106267,-1.9089487188137806,0.0,0.05045760324018818,0.34,22/55,11.87%,SULF1;ALDH1A2;COL1A1;CHD7;BMP7;PCSK5;KIAA1217;RBP4;MBNL1;FGFR2;TGFBR1;ADAM10;IGF2;ARNT2;SULF2;WNT5A;HINFP;TBX1;FUT8;FLCN;TGFB1;PTCH1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.7795867372912437,1.9004328783975128,0.0,0.2615302287364477,0.949,11/24,10.19%,PDE4D;PDE3A;RAPGEF2;GPR61;PRKAR1B;PEX5L;PRKAR2B;PRKAR2A;GPR62;CGAS;PRKAR1A
prerank,skin development (GO:0043588),-0.5626039739212696,-1.8946564901288714,0.0,0.057629500474932656,0.414,21/65,14.82%,COL1A2;COL3A1;COL5A2;COL1A1;ERRFI1;CLIC4;COL5A1;ITGA6;ANXA1;ADAM9;ITGA3;LSR;WNT5A;TXNIP;ITGB4;GATA6;WNT16;MET;UGCG;CLDN1;PKD1
prerank,eye morphogenesis (GO:0048592),-0.729370952131437,-1.8921830028834878,0.001976284584980237,0.05629528500463923,0.427,11/19,7.33%,FBN1;COL5A2;EFEMP1;COL5A1;SHROOM2;MFAP5;NKD1;SKI;RARG;FBN2;STAT3
prerank,mesenchymal cell development (GO:0014031),0.8007381781337783,1.8900961973427606,0.00631578947368421,0.2890518803559327,0.965,6/18,2.80%,HEY2;CDH2;HEYL;NOTCH1;TBX20;NRG1
prerank,platelet degranulation (GO:0002576),-0.5041226927776636,-1.889399769193655,0.0,0.054672091990088684,0.444,42/118,18.45%,IGF1;TIMP3;FN1;ABCC4;LHFPL2;LAMP2;SERPING1;VWF;PECAM1;ACTN2;APP;SPARC;PCDH7;ANXA5;THBS1;CLEC3B;ISLR;CD9;VEGFD;VEGFC;IGF2;GAS6;SRGN;TMSB4X;ECM1;PSAP;LGALS3BP;ITGB3;TGFB1;ACTN1;F5;APOOL;SCG3;SERPINE1;APLP2;SYTL4;CD109;CALM1;QSOX1;CYRIB;BRPF3;MAGED2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.730004750188749,1.8837904939305041,0.001893939393939394,0.3017908769071241,0.972,12/35,7.26%,GUCY1B1;PDE4D;CAP2;PDE3A;RAPGEF2;IRAG1;PDE7B;PDE9A;AKAP6;RIMS2;HTR2C;CAP1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.8400232627005798,-1.882470877429753,0.0018281535648994515,0.057592199827376074,0.484,7/11,11.59%,TGFBR3;TGFBR2;TGFBR1;SMAD7;ACVR1;USP15;TGFB1
prerank,cGMP metabolic process (GO:0046068),0.8665249705244289,1.8798483464673181,0.006147540983606557,0.3049257469977844,0.977,4/12,3.73%,GUCY1B1;GUCY1A1;PDE9A;GUCY2D
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8133942448150038,1.8785559740088096,0.007707129094412331,0.29622896065437654,0.98,7/21,6.40%,PDE4D;CACNA1C;CASQ2;DMD;ATP1A2;AKAP6;RYR2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.7968599616314138,1.860654359385421,0.016,0.3618286021937428,0.991,4/17,1.63%,PTEN;MEF2C;PRKG1;GPER1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.7822187069245189,1.8595631190185649,0.006134969325153374,0.3516719416241384,0.992,4/22,2.17%,GRM3;CACNA1C;CAP2;NF1
prerank,proteoglycan metabolic process (GO:0006029),-0.6671510107991555,-1.8532780923025964,0.0,0.08623443456989317,0.644,8/26,8.96%,SULF1;IGF1;CHST11;ADAMTS12;BMPR2;CSGALNACT1;SULF2;FOXL1
prerank,ATP transport (GO:0015867),-0.8373311362144332,-1.8502560605921052,0.0,0.08550624913413768,0.664,5/10,10.65%,CD47;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,skeletal system morphogenesis (GO:0048705),-0.595662811532264,-1.8498370320420416,0.0,0.08137757941929542,0.667,12/42,6.60%,PDGFRA;WWOX;CYP26B1;HOXB3;FGFR2;TGFBR1;LRP6;SKI;HOXA3;SFRP4;SIX1;FBN2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.8228464217743217,1.8498362700413518,0.002105263157894737,0.38705082470435914,0.995,6/17,6.40%,GJD3;GJC1;CACNA1C;ATP1A2;ATP1B2;RYR2
prerank,bone morphogenesis (GO:0060349),-0.7661270782326419,-1.8477761029351598,0.00398406374501992,0.0800982326478369,0.68,6/14,5.90%,CYP26B1;FGFR2;BMPR2;LRP6;SKI;SFRP4
prerank,regulation of bone mineralization (GO:0030500),-0.5498251750743051,-1.8462137322546854,0.0,0.07765994821282188,0.687,25/55,12.78%,BMP6;WNT4;BMP7;OSR1;ENPP1;SGMS2;ANKH;BMPR2;BMP4;ADGRV1;ACVR1;SRGN;BMP2K;FBN2;ANO6;PTK2B;KL;ATRAID;ECM1;NOTUM;P2RX7;TGFB1;TMEM119;S1PR1;CCN1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.6339867931721254,-1.841310110370029,0.0,0.07945037929553823,0.717,12/30,12.55%,TGFBR3;SMAD3;FSTL1;DKK3;SMURF2;SMAD7;ITGA3;LTBP4;SFRP4;FKBP1A;TGFB1;TWSG1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.6338695381998503,1.8376659664046702,0.0015748031496062992,0.4335379862732637,0.997,13/75,4.90%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;TRPV2;ATP1A4;SLC5A1;FXYD2;CACNA2D1;SLC24A2;SLC12A6;ATP1B2
prerank,chemical synaptic transmission (GO:0007268),0.5336392463445441,1.8356336897875993,0.0,0.4278501366940557,0.998,66/284,12.34%,GRM3;GRM7;LIN7A;PTEN;CEL;CACNB2;UTS2;PRKAR1B;RAPSN;PDE7B;SLC1A4;PCDHB11;KCNMB1;NRXN1;CHRNA3;GRIK1;SNAP25;GRM5;RIMS1;KCND2;MINK1;RPS6KA2;SLC12A6;RIT2;SYN2;GABRG2;GRM1;GRID1;ASIC2;HTR1B;GRIA2;CDH8;GABRA2;SYN1;PRKAR2B;SNCA;HTR2C;SLC32A1;OPRK1;CHRNA7;CHRFAM7A;ERC2;RIMBP2;PRKAR2A;KCNQ3;SYT1;SLC5A7;GRM4;PLP1;GRIN2B;CACNA1A;SLC12A5;STXBP2;PRKAR1A;APBA2;DLG2;GAD1;BRSK1;NTSR1;SCN2B;GABRA5;KCNC4;GABRA4;DLGAP2;GRIK5;GRIK2
prerank,cation transport (GO:0006812),0.5676865794340108,1.8353948645573976,0.0,0.4141670250551343,0.998,19/166,5.53%,ABCC9;ANO1;TRPC6;KCNJ8;SLC12A2;NEDD4L;KCNJ12;ATP1A2;KCNG1;KCNMB1;ATP1A4;SLC5A1;KCNQ4;NDFIP2;FGF13;SCN2A;KCNH4;KCNAB3;SCN5A
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.8236709633356517,1.8287961451011194,0.012170385395537525,0.4311298241530344,0.999,4/16,1.22%,CACNA1C;CASQ2;DMD;ATP1A2
prerank,inorganic cation transmembrane transport (GO:0098662),0.5298733092688948,1.8266264293494148,0.0,0.427909767375128,1.0,42/268,9.03%,ABCC9;TRPC3;TRPC4;TRPC6;CACNA1C;KCNJ8;SLC30A10;SLC12A2;ATP2A3;KCNJ12;ATP1A2;TRPC1;KCNG1;CACNA1H;TRPV2;ATP2C1;KCNV2;ATP1A4;KCNQ4;KCND2;SLC24A4;SLC24A2;SCN2A;KCNH4;KCNH8;KCNAB3;SCN5A;ASIC2;KCNQ5;ATP6V0E2;HCN2;SCN8A;ATP2A2;CACNA1D;KCNA4;KCNQ3;SLC9A7;RYR3;HCN3;SLC6A15;SCN9A;PKD2
prerank,renal system development (GO:0072001),-0.5606268032254961,-1.820551362508323,0.0,0.1058490648617254,0.823,15/52,9.11%,SULF1;WNT4;GLI2;PCSK5;GREB1L;RBP4;BMP4;TGFBR1;SULF2;ACE;SIX1;FOXC1;STAT1;STRA6;ARL3
prerank,secondary palate development (GO:0062009),-0.7439844900891917,-1.8192992653002702,0.0018975332068311196,0.103339011404607,0.828,5/14,6.26%,TGFBR3;CHD7;TGFBR2;LEF1;WNT5A
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7796396441175347,1.814977593001647,0.01775147928994083,0.4716113623197262,1.0,6/20,6.59%,CACNA1C;CASQ2;DMD;ATP1A2;RYR2;ATP2A2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.7937633213403469,1.8126797878692364,0.01072961373390558,0.4693120946271686,1.0,6/18,2.51%,IL34;DAAM2;TNFRSF21;NOTCH1;NF1;PTN
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.7514577911464829,-1.8107575632844077,0.0,0.11250807819256675,0.858,8/15,10.62%,NTRK3;F3;VEGFD;VEGFC;IL16;CXCL12;CDH13;KDR
prerank,negative regulation of cell aging (GO:0090344),0.7780051371738332,1.8043919301016973,0.014373716632443531,0.49748250927353166,1.0,4/16,2.56%,SLC30A10;CDK6;AKT3;FOXM1
prerank,digestive tract development (GO:0048565),-0.6180752304317089,-1.8041751955158793,0.0,0.11682562814724214,0.879,15/32,16.39%,CLMP;GLI2;PCSK5;RARB;FGFR2;SMO;STRA6;BBS7;KIT;GLI3;ZIC3;GATA6;PKD1;PKDCC;EPHB3
prerank,diacylglycerol metabolic process (GO:0046339),0.7469257408146666,1.8023429720501298,0.011811023622047244,0.4935052703982654,1.0,4/23,1.88%,DGKB;PLCE1;DGKH;DGKG
prerank,cGMP biosynthetic process (GO:0006182),0.8612617935356653,1.8020385458046277,0.01882845188284519,0.48101514820441105,1.0,3/10,3.73%,GUCY1B1;GUCY1A1;GUCY2D
prerank,prostaglandin metabolic process (GO:0006693),-0.6366579550272871,-1.8013942380810304,0.004140786749482402,0.11637802037656304,0.886,9/26,11.61%,PTGDS;PLA2G4A;PTGIS;PTGS1;DAGLB;ACOX1;TBXAS1;GSTM1;PTGS2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.654551464856587,-1.7984478148371885,0.0021231422505307855,0.11704114299979132,0.898,7/23,4.34%,TGFBR3;SMAD3;DKK3;SMURF2;SMAD7;ITGA3;LTBP4
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.699812788922582,1.7982890956161202,0.018796992481203006,0.48536889781175246,1.0,7/32,6.30%,TRPC3;TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA
prerank,calcium ion transport (GO:0006816),0.5887521631098818,1.7971833023367696,0.0015151515151515152,0.47802854899641717,1.0,21/113,7.48%,TRPC3;TRPC4;TRPC6;CACNA1C;CACNB2;ATP2A3;TRPC1;CACNA1H;TRPV2;ATP2C1;CACNG7;CACNA2D1;STIM2;ITPR1;SLC24A4;SLC24A2;RYR2;ATP2A2;CHRNA7;CACNA1D;STIM1
prerank,extracellular matrix organization (GO:0030198),-0.4323948652696332,-1.7968908931426502,0.0,0.1156186857655896,0.903,110/276,12.53%,FLRT2;ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;COL1A1;ADAMTS6;DCN;ADAMTS2;THSD4;ITGA9;ELN;COL22A1;GSN;COL12A1;LAMA1;COL5A1;VWF;LOXL1;COL6A3;JAM2;PECAM1;APP;ADAMTS9;SPARC;RECK;SH3PXD2A;COL25A1;COL6A1;COL8A2;ITGA6;ADAMTS5;ITGB8;TLL1;VIT;MFAP5;BSG;COL4A5;COL6A2;THBS1;ITGA5;TGFBR1;PLEC;COL11A1;CAPN2;TIMP2;NID2;CDH1;FBLN5;VCAM1;COL23A1;ITGA3;COL4A6;HTRA1;HSPG2;ADAM10;PLOD2;COL13A1;GAS6;BGN;ST7;SERPINH1;ADAMTS1;ITGA11;SPOCK2;NDNF;P4HB;ITGA10;TNC;DDR1;ADAMTS15;ICAM1;FBN2;COL18A1;ADAMTSL1;CYP1B1;CD47;GFOD2;KLK2;CAPNS1;ADAMTSL4;ITGB4;TGFBI;MMP14;COL14A1;ADAM15;CAPN1;DPT;LAMA5;COL15A1;SLC39A8;KDR;COL16A1;LUM;MMP19;ITGB3;ADAMTS14;LAMA3;TGFB1;CTSS;ADAMTS3;F11R;COL20A1;SMOC2;COL9A2
prerank,neurotransmitter secretion (GO:0007269),0.661490535268626,1.7967740065485729,0.0054249547920434,0.467237770770787,1.0,14/44,10.74%,LIN7A;NRXN1;SNAP25;RIMS1;SYN2;RIMS2;SYN1;SNCA;SLC32A1;SYT1;GRM4;STXBP2;GAD1;BRSK1
prerank,collagen fibril organization (GO:0030199),-0.5052434793929806,-1.7961955943798131,0.0,0.1127894408357738,0.905,39/88,12.53%,COL1A2;COL3A1;COL5A2;COL1A1;ADAMTS2;COL22A1;COL12A1;COL5A1;LOXL1;COL6A3;COL25A1;COL6A1;COL8A2;ITGA6;TLL1;COL4A5;COL6A2;TGFBR1;PLEC;COL11A1;COL23A1;COL4A6;PLOD2;COL13A1;SERPINH1;P4HB;COL18A1;CYP1B1;ITGB4;COL14A1;DPT;COL15A1;COL16A1;LUM;ADAMTS14;LAMA3;ADAMTS3;COL20A1;COL9A2
prerank,mesonephros development (GO:0001823),-0.7901276451564575,-1.7936120540532325,0.001996007984031936,0.11279715821113034,0.912,5/11,5.36%,ZBTB16;BMP7;OSR1;BMP4;FGF1
prerank,glutamate receptor signaling pathway (GO:0007215),0.6694376256848005,1.7903779064653613,0.012867647058823529,0.4843158046940967,1.0,6/37,5.80%,GRM3;GRM7;GRIK1;GRM5;GRM1;GRIA2
prerank,respiratory tube development (GO:0030323),-0.6406480835314634,-1.7851482110073142,0.0,0.12258677332469235,0.93,10/28,8.16%,GLI2;PDPN;PCSK5;RBP4;FGFR2;BMP4;ITGA3;FGF1;ABCA3;STRA6
prerank,positive regulation of behavior (GO:0048520),0.8554977448872714,1.7835342360320945,0.01735357917570499,0.505280576066492,1.0,2/10,0.63%,SGIP1;MEF2C
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5553874818889325,1.7832262204839522,0.004484304932735426,0.4947237639064044,1.0,16/140,6.40%,TRPC3;EDNRA;CACNA1C;PLCE1;S1PR3;TBXA2R;GPER1;CCRL2;CACNA2D1;ADCY8;ACKR3;TACR1;GRM1;CXCR2;HTR2C;RYR2
prerank,regulation of multicellular organism growth (GO:0040014),-0.722336914752004,-1.773238020074732,0.00408997955010225,0.14061178483598558,0.955,5/15,13.16%,IGF1;APP;GHR;PTCH1;MFSD2A
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.5852928784783993,-1.7716552071717306,0.006864988558352402,0.13964006058003692,0.959,17/38,16.55%,SMAD3;ROCK2;PTGIS;CAV1;KLF4;KLF2;CD34;DDAH1;P2RX4;CD47;NOS1AP;AKT1;ZC3H12A;PTGS2;HSP90AB1;SIRPA;TLR4
prerank,cGMP-mediated signaling (GO:0019934),0.8232583810496376,1.771289188679589,0.01098901098901099,0.5390826535657854,1.0,4/13,2.42%,GUCY1B1;PDE3A;IRAG1;PDE9A
prerank,signal release from synapse (GO:0099643),0.653785187254054,1.771009400482891,0.010869565217391304,0.5275651162872363,1.0,13/43,10.74%,LIN7A;NRXN1;SNAP25;RIMS1;SYN2;SYN1;SNCA;SLC32A1;SYT1;GRM4;STXBP2;GAD1;BRSK1
prerank,chloride transmembrane transport (GO:1902476),0.654417960482745,1.7707239143962819,0.006980802792321117,0.5170793194623059,1.0,7/48,5.87%,ANO1;ANO4;SLC12A2;SLC5A1;SLC12A6;GABRG2;GABRA2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.6839528890498984,1.7697243816755277,0.020257826887661142,0.5099218307432893,1.0,3/32,0.19%,DLC1;ITGA1;PDGFRB
prerank,respiratory system development (GO:0060541),-0.615610648871406,-1.7675248579475973,0.0022222222222222222,0.1432344866173084,0.962,13/32,13.41%,GLI2;PDPN;CHD7;RBP4;FGFR2;BMP4;ITGA3;FGF1;ABCA3;STRA6;DISP1;ZIC3;SPEF2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.45704513039789785,-1.7674608896785227,0.0,0.13923798866481651,0.962,88/168,24.60%,SAMD4A;RPLP1;RPS14;DDX5;CNOT7;RPL9;TUT4;RPS12;THRAP3;TUT7;RPL41;RPS20;CTIF;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RC3H2;SMG6;RPL18;RPS9;UPF3A;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;ZC3H12A;MTPAP;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;ATM;RPS24;RPS27;RPL14;RPL26;CNOT8;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;XRN1;NBDY;RPL31;CNOT3;SMG5;RPS25;RPL15;RPSA;PNLDC1;RPS7;RPL38;RPLP0;RPL27;AGO1;CNOT11;PNRC2;UPF2;TENT4B;RPL36A;PAN3;RPS26;RPL35A;DHX34;CSDE1;HELZ2;EXOSC7;SAMD4B;RPS29;RPL8;RPL36;POLR2G
prerank,cellular response to BMP stimulus (GO:0071773),-0.525003654647446,-1.767458537963689,0.0,0.1353702667574605,0.962,19/66,9.08%,BMP6;TGFBR3;SMAD3;ADAMTS12;SMAD6;BMP7;BMPR2;BMP4;DDX5;SMAD9;SMAD7;ACVR1;PDCD4;RGMB;ACVRL1;SMURF1;HIVEP1;USP15;TMEM100
prerank,anterograde trans-synaptic signaling (GO:0098916),0.5276508554805874,1.7641138526470757,0.0,0.5245620271593187,1.0,66/224,16.41%,GRM3;GRM7;CEL;CACNB2;UTS2;PRKAR1B;RAPSN;PDE7B;PCDHB11;KCNMB1;NRXN1;CHRNA3;GRIK1;SNAP25;GRM5;KCND2;MINK1;RPS6KA2;SLC12A6;RIT2;SYN2;GABRG2;GRM1;ASIC2;HTR1B;GRIA2;GABRA2;SYN1;PRKAR2B;SNCA;HTR2C;OPRK1;CHRNA7;CHRFAM7A;PRKAR2A;KCNQ3;SYT1;GRM4;PLP1;GRIN2B;CACNA1A;SLC12A5;PRKAR1A;APBA2;DLG2;GAD1;NTSR1;SCN2B;GABRA5;KCNC4;GABRA4;GRIK2;SLC12A4;NLGN3;DLGAP1;CHRNB2;CAMKK2;PCDHB16;GABRB3;CDK5;GRIN2A;HTR4;GRIA1;GRIA4;MAPK1;APBA1
prerank,positive regulation of transporter activity (GO:0032411),0.8079573767077022,1.7621145672634995,0.022123893805309734,0.5230118225202478,1.0,4/13,7.40%,TRPC6;NR1H3;STK39;PDZK1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.7779749060290709,1.761753987115522,0.02092050209205021,0.5138487595530743,1.0,4/17,1.62%,NOTCH3;HEYL;NOTCH1;MAML2
prerank,central nervous system neuron development (GO:0021954),0.7867644940239266,1.7617275410563162,0.024844720496894408,0.5034898302053094,1.0,7/15,9.19%,PTEN;RAPGEF2;MAP2;ATP7A;NTRK2;B4GALT6;ARHGAP35
prerank,skeletal system development (GO:0001501),-0.4576392248931991,-1.7578821226510215,0.0031746031746031746,0.15061396607985553,0.979,40/148,8.80%,BMP6;SULF1;IGF1;FBN1;COL1A2;EXT1;ZBTB16;COL1A1;WWOX;GLI2;AKAP13;CHD7;BMP7;PCSK5;KIAA1217;ITGB8;RBP4;TLL1;SUFU;ANKH;TGM2;NPR3;FGFR2;GJA1;TGFBR1;CREB3L2;TNFRSF11B;COL13A1;PAPSS2;IGF2;TEAD4;SULF2;WNT5A;PRELP;ALPL;EVC;RPL13;GNAS;MMP14;CMKLR1
prerank,visual perception (GO:0007601),-0.5057607221490943,-1.7573847503106066,0.0,0.14735718976829995,0.98,17/84,12.34%,COL1A1;EFEMP1;ABLIM1;ZIC2;DHRS3;EYA4;SLC4A10;COL11A1;ADGRV1;PITPNA;CRYBG3;MYO9A;COL18A1;ATF6;EML2;CRYBB3;OAT
prerank,negative regulation of nuclear division (GO:0051784),-0.77463155082372,-1.7559883467710373,0.0019267822736030828,0.1464767736741505,0.982,4/11,6.19%,BMP7;TOM1L2;BMP4;TOM1L1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.8338022960707989,1.753945785408263,0.015151515151515152,0.5285186524803839,1.0,2/10,0.99%,PDE4D;PDE3A
prerank,calcium ion import (GO:0070509),0.7102539272085828,1.7536689625877053,0.025341130604288498,0.519453385882539,1.0,4/28,1.67%,TRPC4;CACNA1C;CACNB2;CACNA1H
prerank,prostanoid biosynthetic process (GO:0046457),-0.7101783419524907,-1.7494012300887058,0.00392156862745098,0.15506811705463677,0.986,7/15,11.61%,PTGDS;PLA2G4A;PTGIS;PTGS1;DAGLB;TBXAS1;PTGS2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.630800778573721,-1.7438314211521324,0.0,0.16228511002791834,0.992,15/24,19.58%,SEC23A;SEC24D;B2M;SEC31A;TAPBP;ACE;SEC24A;ERAP1;IDE;CALR;PDIA3;HFE;BCAP31;SAR1B;CANX
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.7740473845227359,1.74355157448773,0.026530612244897958,0.5450131739293078,1.0,4/16,1.69%,DLC1;PTEN;ARHGAP6;PHLDB2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.7740473845227359,1.74355157448773,0.026530612244897958,0.5450131739293078,1.0,4/16,1.69%,DLC1;PTEN;ARHGAP6;PHLDB2
prerank,tight junction assembly (GO:0120192),-0.5393524731880884,-1.7413968946987364,0.002331002331002331,0.16292389986325162,0.992,15/49,12.07%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;LSR;PDCD6IP;PARD6G;CLDN11;ACTG1;PARD3;PATJ;F11R
prerank,cAMP-mediated signaling (GO:0019933),0.7081073743717842,1.7412832267744691,0.01761252446183953,0.5447262715958465,1.0,8/24,7.26%,PDE4D;CAP2;PDE3A;RAPGEF2;PDE7B;AKAP6;RIMS2;CAP1
prerank,peptide cross-linking (GO:0018149),-0.6343231660429098,-1.7388859137610133,0.0020491803278688526,0.16459995055495558,0.992,6/25,6.07%,FN1;COL3A1;TGM2;THBS1;ANXA1;NDNF
prerank,BMP signaling pathway (GO:0030509),-0.5164272194244998,-1.7385243073776693,0.0,0.1614948490802394,0.992,18/62,9.08%,BMP6;TGFBR3;SMAD3;SMAD6;BMP7;BMPR2;BMP4;DDX5;SMAD9;SMAD7;ACVR1;PDCD4;RGMB;ACVRL1;SMURF1;HIVEP1;USP15;TMEM100
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.7004862749075524,-1.7361609160591198,0.00749063670411985,0.16238215236302492,0.992,6/15,8.00%,PDGFRA;TGFBR2;FGFR2;TGFBR1;SIX1;TBX1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.6717383240605693,-1.7353954460509748,0.00398406374501992,0.16045765518474286,0.993,7/18,11.61%,PTGDS;PLA2G4A;PTGIS;PTGS1;DAGLB;TBXAS1;PTGS2
prerank,positive regulation of phosphatase activity (GO:0010922),0.743686330846738,1.7327370421688413,0.02663934426229508,0.5744548765959123,1.0,3/21,0.63%,ITGA1;PDGFRB;MEF2C
prerank,membrane lipid biosynthetic process (GO:0046467),-0.532754458694933,-1.7296477796201055,0.002364066193853428,0.16842432817999325,0.994,19/58,14.58%,ST3GAL4;PLPP3;SGMS1;CERT1;SGMS2;ST3GAL2;ELOVL7;ACER2;HACD4;HACD3;ACER3;CSNK1G2;SPNS2;DEGS2;PLPP1;ALDH3A2;SPHK1;SPTLC2;VAPA
prerank,arachidonic acid metabolic process (GO:0019369),-0.5741785436283864,-1.7295880583412515,0.006396588486140725,0.1651253041520825,0.994,11/35,12.26%,PTGDS;PLA2G4A;PTGIS;PTGS1;CYP1B1;DAGLB;GPX4;TBXAS1;MGLL;PTGS2;EPHX2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.6745380389290038,1.7286967444856765,0.022727272727272728,0.5825811057408781,1.0,5/32,1.69%,DLC1;PTEN;ARHGAP6;AJAP1;PHLDB2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.6031369861646676,-1.7264374494331698,0.002066115702479339,0.16840100515242856,0.994,11/30,16.36%,ROBO1;COL3A1;AKAP13;LPAR1;ARHGEF3;ARRB1;F11R;LPAR6;PRAG1;LPAR4;NET1
prerank,negative regulation of cell junction assembly (GO:1901889),0.7153499866738773,1.725850508477372,0.01717557251908397,0.5862794409325733,1.0,7/25,2.62%,DLC1;PTEN;ARHGAP6;PHLDB2;SLIT1;ROCK1;IL1B
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.5557145608137115,-1.724507191178605,0.0,0.16879289032308434,0.995,15/43,13.07%,NFIB;SMAD3;FOXO3;NR3C1;BMP4;KLF4;DDX5;TEAD1;STAT3;HIF1A;GATA2;TGFB1;RELA;PPARA;ATOH8
prerank,substrate-dependent cell migration (GO:0006929),-0.7158411522026817,-1.724487947176488,0.005703422053231939,0.1654832258069454,0.995,10/14,19.66%,NRP1;CD2AP;ANKS1A;SDCBP;VEGFC;ITGA11;EPHA8;OPHN1;NTN1;ITGA2
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.4791173503433157,-1.7233464666080764,0.0,0.16430217928532892,0.995,36/92,13.39%,DOCK5;ANXA3;NRP2;ROCK2;FOXP1;NRP1;CTSH;TEK;SPARC;PLCG1;SASH1;BMPR2;THBS1;BMP4;ANGPT1;RAB11A;FOXC2;ADAM9;FGF1;PRKCE;WNT5A;PTK2B;RHOB;PIK3CB;AKT1;RREB1;HIF1A;ZC3H12A;KDR;ITGB3;PFN1;SMOC2;FLT4;CALR;ATOH8;PLCG2
prerank,regulation of BMP signaling pathway (GO:0030510),-0.4957741191389161,-1.7212670528205471,0.0024875621890547263,0.16563598872535146,0.995,21/73,7.15%,SULF1;ZNF423;FSTL1;SMAD6;CDH5;SKIL;HTRA3;BMPR2;SMURF2;BMP4;FOXD1;SMAD9;SMAD7;ITGA3;SKI;BMPER;SFRP4;ACVRL1;SMURF1;NBL1;VWC2
prerank,positive regulation of blood coagulation (GO:0030194),-0.6873837543167074,-1.7209283867358325,0.009765625,0.16294166207637378,0.995,7/17,15.72%,ST3GAL4;F3;THBS1;THBD;ANO6;USF1;SERPINE1
prerank,calcium ion transmembrane transport (GO:0070588),0.584704050743198,1.7206409196541133,0.008264462809917356,0.599303766504903,1.0,12/86,4.64%,TRPC3;TRPC4;TRPC6;CACNA1C;ATP2A3;TRPC1;TRPV2;ATP2C1;CACNA2D1;ATP2B3;SLC24A4;SLC24A2
prerank,negative regulation of lyase activity (GO:0051350),0.7582504599654963,1.7196875896231605,0.03571428571428571,0.5933151697747084,1.0,1/16,0.04%,GRM3
prerank,lung development (GO:0030324),-0.5939438636808848,-1.7192355526286558,0.0,0.16333614468235108,0.995,11/33,8.16%,ERRFI1;GLI2;PDPN;RBP4;FGFR2;BMP4;ITGA3;RCN3;FGF1;ABCA3;STRA6
prerank,negative regulation of cyclase activity (GO:0031280),0.776003919369507,1.7188351909570923,0.02869757174392936,0.5872131318598903,1.0,1/14,0.04%,GRM3
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.7698095926137192,-1.7181672770141219,0.005415162454873646,0.16265746666641884,0.995,8/11,17.18%,NUPR1;ARHGEF2;BIRC3;SLC25A4;CASP8;YBX3;PELI1;RIPK1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.808617497345551,1.7179143826996237,0.02553191489361702,0.5815750998421078,1.0,2/12,3.74%,ANO1;ADCY8
prerank,sensory perception of light stimulus (GO:0050953),-0.49025725138823395,-1.717805645817805,0.0,0.16051057601193988,0.995,17/87,12.34%,COL1A1;EFEMP1;ABLIM1;ZIC2;DHRS3;EYA4;SLC4A10;COL11A1;ADGRV1;PITPNA;CRYBG3;MYO9A;COL18A1;ATF6;EML2;CRYBB3;OAT
prerank,aorta morphogenesis (GO:0035909),0.7554568770721949,1.715836746040847,0.022267206477732792,0.5816443956758764,1.0,4/17,1.47%,PDGFRB;TBX2;HEY2;MYLK
prerank,mesenchyme morphogenesis (GO:0072132),0.7331742805035469,1.7156268601671794,0.025,0.5734767785414401,1.0,4/17,1.22%,TBX2;HEYL;NOTCH1;TBX20
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.7445607790400257,1.7146359321251514,0.04474708171206226,0.5688487455483924,1.0,7/17,7.39%,CACNA1C;CACNB2;ATP1A2;CACNA2D1;SCN5A;HCN2;CACNA1D
prerank,neuron cell-cell adhesion (GO:0007158),0.7552968647702388,1.714339837233279,0.03483606557377049,0.5613081879094246,1.0,7/14,7.52%,CEL;NRXN1;ASTN1;ASTN2;CNTN4;NINJ2;NRXN3
prerank,potassium ion transmembrane transport (GO:0071805),0.5299539470835867,1.7139234094531035,0.00583941605839416,0.5548228300955953,1.0,30/135,10.27%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;KCNG1;KCNV2;ATP1A4;KCNQ4;FXYD2;KCNE4;KCND2;SLC24A4;SLC24A2;SLC12A6;ATP1B2;KCNH4;KCNH8;KCNAB3;KCNQ5;HCN2;KCNE5;KCNA4;KCNQ3;SLC9A7;HCN3;PKD2;KCNJ3;SLC12A5;KCNJ6
prerank,T cell migration (GO:0072678),0.7770532183460814,1.7136141553550088,0.028017241379310345,0.5478101568184683,1.0,3/13,5.81%,SLC12A2;PIK3CD;CXCL10
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.7418201163118705,-1.713379661088807,0.009140767824497258,0.16594286360391558,0.995,3/12,1.10%,NFIB;EPHA4;GLI2
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4938643704535643,-1.7120148861435698,0.0,0.16580453946087256,0.995,27/73,11.50%,ITGBL1;DAB2;FN1;COL3A1;NRP1;FBLN1;PLPP3;NEDD9;ITGB8;FYB1;ITGA5;SEMA7A;ADAM9;ADAM10;ADAMTS1;ITGA11;ITGA10;PTK2B;PTPRA;CD47;ZYX;ITGB4;ADAM15;LAMA5;COL16A1;ITGB3;LAMA3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.4881590713147991,-1.711329094753201,0.0,0.16432800281056043,0.995,28/75,11.35%,SULF1;DCN;ROCK2;WNT4;TEK;SEMA6A;SPARC;CLDN5;THBS2;PTPRM;THBS1;KLF4;HSPG2;HOXA5;NIBAN2;NPR1;GTF2I;ADAMTS1;FOXC1;STAT1;SERPINF1;SEMA3E;HGS;STAB1;EMILIN1;DAB2IP;PML;ECSCR
prerank,positive regulation of embryonic development (GO:0040019),-0.6557893540290054,-1.7110302079466786,0.007936507936507936,0.16223947229040409,0.995,5/19,7.38%,PLCB1;WNT4;OSR1;NIBAN2;NR2C2
prerank,positive regulation of protein secretion (GO:0050714),-0.4986597868700799,-1.7085327470224814,0.0,0.16456805052628753,0.996,22/69,17.59%,BMP6;IGF1;UNC13B;CD2AP;MCU;MYRIP;RBP4;MYO18A;EZR;TCF7L2;ADAM9;NNAT;GOLPH3;C1QTNF3;MYH10;NLGN2;TGFB1;PPID;PPIA;SYTL4;TLR4;ACSL4
prerank,negative regulation of cellular senescence (GO:2000773),0.7727086309108457,1.7083415838886746,0.031914893617021274,0.5614447853406141,1.0,3/13,2.36%,SLC30A10;CDK6;AKT3
prerank,regulation of DNA binding (GO:0051101),-0.5404601914228068,-1.708229450470971,0.002352941176470588,0.1626841099861021,0.996,18/44,21.26%,IGF1;SP100;LEF1;SKI;SMO;FOXC1;MDFI;CEBPG;TGFB1;NME1;TXN;HMGB2;SIRT2;NFKBIA;E2F1;PLAUR;RSF1;HJURP
prerank,heart morphogenesis (GO:0003007),0.6122978977245528,1.7081081907419189,0.017793594306049824,0.5542801437589587,1.0,8/50,1.88%,DLC1;TBX2;HEY2;HEYL;NOTCH1;TBX20;PTK2;TBX3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.8052927128638299,1.7079623995566926,0.012711864406779662,0.5468729761144508,1.0,2/12,0.33%,GJD3;PDE4D
prerank,eye development (GO:0001654),-0.5159578502098842,-1.7073484229376144,0.004975124378109453,0.162187878157001,0.996,15/54,8.16%,PBX1;FBN1;SMOC1;COL5A2;EFEMP1;LAMA1;COL5A1;SHROOM2;PBX3;RBP4;SKI;RAB3GAP1;FBN2;FOXC1;STRA6
prerank,kidney development (GO:0001822),-0.5129578392957317,-1.7055888517728448,0.002352941176470588,0.1628775814767253,0.996,17/65,9.11%,SULF1;ZBTB16;WNT4;GLI2;CTSH;BMP7;PCSK5;OSR1;GREB1L;BMP4;TGFBR1;SULF2;ACE;SIX1;FOXC1;STRA6;ARL3
prerank,inositol lipid-mediated signaling (GO:0048017),0.6217349299230726,1.7055377248367247,0.016363636363636365,0.549412739206884,1.0,11/50,7.20%,ADAP2;PDGFRB;PLCL1;PLCE1;PIK3CD;PIK3R1;PIK3CA;PITPNM2;OGT;PIK3C2A;IRS1
prerank,lipid phosphorylation (GO:0046834),0.809939827259097,1.7038739466817037,0.02145922746781116,0.5488383039781267,1.0,3/10,1.88%,DGKB;DGKH;DGKG
prerank,response to muscle stretch (GO:0035994),0.7423136703223553,1.7031784188634593,0.032397408207343416,0.5439543401764853,1.0,5/15,6.40%,DMD;CDH2;PTK2;PIK3CA;RYR2
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.5262695208555643,-1.6977285876397221,0.0022675736961451248,0.1758216887099299,0.998,18/47,13.91%,ZBTB16;MEDAG;BMP7;TMEM64;SOX13;SIX1;SYAP1;NOCT;WDFY2;AKT1;CMKLR1;RREB1;CARM1;ZC3H12A;METRNL;PTGS2;ID2;SFRP1
prerank,in utero embryonic development (GO:0001701),-0.6055064085747622,-1.6973161344579437,0.014056224899598393,0.17383215213537145,0.998,12/25,14.82%,CHD7;MBNL1;FGFR2;TGFBR1;ADAM10;IGF2;ARNT2;HINFP;FUT8;FLCN;ZNF568;PKD1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.7076238689592271,-1.697266223564001,0.009174311926605505,0.1714074463012275,0.998,4/13,2.27%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.7787461226426946,1.6965558588590903,0.033482142857142856,0.5640417773431984,1.0,1/13,0.04%,GRM3
prerank,response to cholesterol (GO:0070723),-0.6679164886755036,-1.6963942756317034,0.005639097744360902,0.17072344209923065,0.999,8/17,11.87%,TGFBR2;TGFBR1;LRP6;SMO;GRAMD1C;GRAMD1A;TGFB1;PTCH1
prerank,negative regulation of wound healing (GO:0061045),0.6871389145839848,1.696228763176575,0.025878003696857672,0.557725760069617,1.0,7/28,5.27%,PTEN;SLC12A2;VTN;AJAP1;PHLDB2;FGF2;CLASP2
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.7799494553959516,1.6955025799722263,0.031914893617021274,0.5532589512887638,1.0,3/13,0.73%,GJC1;CACNA1C;CACNB2
prerank,cellular response to interferon-gamma (GO:0071346),-0.470661823430709,-1.6954827999778566,0.0,0.17039468670244304,0.999,28/88,16.89%,DAPK1;SP100;B2M;VCAM1;LGALS9;IRF1;WNT5A;CCL15;ICAM1;IRF2;STAT1;CCL14;CD47;GBP4;PRKCD;IRF9;OAS2;PML;GBP6;CAMK2A;GBP5;CCL25;GBP7;GBP2;CCL13;SIRPA;TLR4;TRIM8
prerank,mesonephric tubule development (GO:0072164),-0.6858237389836535,-1.6944603079868832,0.017045454545454544,0.17016975704303242,0.999,7/15,6.84%,BMP7;OSR1;SLIT2;FGFR2;BMP4;SIX1;FOXC1
prerank,sodium ion homeostasis (GO:0055078),0.719372939697998,1.6935330098825008,0.034623217922606926,0.5538683519862232,1.0,6/21,5.65%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2;TFAP2B
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5767096719232994,-1.6925207987200055,0.004273504273504274,0.1715518948873535,0.999,10/31,10.27%,PDGFRA;OSR1;HOXB3;TGFBR2;FGFR2;TGFBR1;HOXA3;SIX1;TBX1;HOXB9
prerank,retinoic acid metabolic process (GO:0042573),-0.7110987095699839,-1.6918227706215576,0.0078125,0.17047417868911455,1.0,4/14,13.44%,ALDH1A2;CYP26B1;SCPEP1;ADH1A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7720324878258221,1.6914769176394855,0.031180400890868598,0.5546800083594605,1.0,3/14,3.07%,ACE2;ENPEP;ECE1
prerank,response to laminar fluid shear stress (GO:0034616),-0.7603803671916103,-1.6895063651650297,0.0037105751391465678,0.17263142939434042,1.0,6/10,7.48%,ABCA1;SMAD6;KLF4;SMAD7;KLF2;MAP2K5
prerank,cellular response to type I interferon (GO:0071357),-0.5442193277959182,-1.6889297687205822,0.00425531914893617,0.16923696434820543,1.0,19/41,17.63%,SP100;IFITM3;STAT2;IRF1;IRF2;STAT1;IFI27;IFIT2;IRF9;OAS2;IFI35;IFIT3;IFIT1;SAMHD1;IP6K2;IFITM2;GBP2;RNASEL;RSAD2
prerank,type I interferon signaling pathway (GO:0060337),-0.5442193277959182,-1.6889297687205822,0.00425531914893617,0.16923696434820543,1.0,19/41,17.63%,SP100;IFITM3;STAT2;IRF1;IRF2;STAT1;IFI27;IFIT2;IRF9;OAS2;IFI35;IFIT3;IFIT1;SAMHD1;IP6K2;IFITM2;GBP2;RNASEL;RSAD2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.7418483306384025,-1.6878938454056682,0.005639097744360902,0.16879754079342904,1.0,5/12,11.87%,CYP26B1;MBNL1;LRP6;SKI;PTCH1
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.6002691470271022,-1.6837091521059946,0.0064516129032258064,0.17442356653578076,1.0,11/26,10.88%,ST3GAL4;B4GALT1;ST3GAL6;OGN;FMOD;ST3GAL1;ST3GAL2;ST3GAL3;PRELP;LUM;OMD
prerank,placenta development (GO:0001890),0.7843621607139257,1.6833620921663663,0.029661016949152543,0.5813085622056068,1.0,3/12,2.53%,PTK2;NODAL;ADAM19
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7367348290565521,-1.6821485285689426,0.003745318352059925,0.17545941314562882,1.0,7/11,16.28%,DAB2;RSPO3;NKD1;MLLT3;WNT5B;SFRP1;PLEKHA4
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.703448531124684,-1.681743299205467,0.007259528130671506,0.17404948407999687,1.0,6/13,16.85%,NOS3;AKT1;GCH1;PTS;CALM1;FPGS
prerank,regulation of epithelial cell migration (GO:0010632),-0.5209178040056811,-1.680725244138106,0.002336448598130841,0.1737657573951104,1.0,23/51,15.89%,MCC;DOCK5;GLUL;CTSH;PLCG1;MACF1;SASH1;BMPR2;ARSB;RAB11A;PTPRG;BMPER;PRKCE;RREB1;HIF1A;DAB2IP;RHOJ;PFN1;EVL;PLCG2;CORO1C;DUSP10;CEACAM1
prerank,cardiac muscle cell action potential (GO:0086001),0.667218616251128,1.6786311658851547,0.045112781954887216,0.5942234638034575,1.0,8/30,7.39%,CACNA1C;DMD;ATP1A2;FGF12;CACNA2D1;SCN5A;HCN2;CACNA1D
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5731859105813129,1.6784513274072004,0.021311475409836064,0.5876493192492158,1.0,10/75,4.08%,RGS5;RGS4;RGS6;PLCE1;METAP2;GPER1;ROCK1;RGS3;GUCY2D;RGS11
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.5114048872278306,1.6777601468467627,0.00425531914893617,0.5832207850417542,1.0,28/172,9.41%,INPP4B;PIP5K1B;DGKB;PTEN;PIK3CD;PLD1;DGKH;PIK3R1;DGKG;CDS2;PLD6;PIP4K2A;PIK3CA;SLC44A2;FGF2;PITPNM2;CPNE7;INPP5J;PIP4K2C;LIPH;PIK3C2A;ABHD3;PIKFYVE;ACHE;MTMR12;MTMR14;STARD7;MTMR7
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.7083416045354711,1.6774223039177925,0.04263565891472868,0.5777243099290112,1.0,6/21,3.95%,GUCY1B1;GUCY1A1;GUCY2D;ADCY8;ADCY3;ADCY6
prerank,diol metabolic process (GO:0034311),-0.6501495889248442,-1.676645034755828,0.0057692307692307696,0.1787701767041482,1.0,10/19,16.18%,PLPP3;NOS3;NAAA;AKT1;DEGS2;GCH1;PLPP1;SPHK1;PTS;CALM1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.6179243853735593,-1.6761178562912238,0.012474012474012475,0.1779106066831703,1.0,7/23,12.56%,TGFBR3;ADAMTS9;FGFR2;SMAD7;FKBP1A;TGFB1;ID2
prerank,protein O-linked mannosylation (GO:0035269),-0.6434833999684311,-1.6742855071284957,0.016,0.17934950644799316,1.0,5/18,7.53%,TMTC1;LARGE1;TMTC4;TMTC2;RXYLT1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7055374975471951,1.6728197844976964,0.03346456692913386,0.5889062172689086,1.0,4/21,1.44%,PDE4D;PTEN;DMD;NCK2
prerank,vasoconstriction (GO:0042310),0.7647332835852643,1.6724244201804368,0.05183585313174946,0.583556368035307,1.0,2/11,7.15%,EDNRA;PIK3C2A
prerank,cardiac ventricle development (GO:0003231),0.7218076607748478,1.6722927172370825,0.04612159329140461,0.5773636687827668,1.0,4/20,5.53%,HEY2;HEYL;NOTCH1;SCN5A
prerank,leukotriene biosynthetic process (GO:0019370),0.7585700003085007,1.6715652011286468,0.03382663847780127,0.573503215789206,1.0,3/14,1.42%,GGT5;GGT1;GGTA1
prerank,response to interferon-gamma (GO:0034341),-0.49504414321330575,-1.6711341227730865,0.0,0.1840326184212641,1.0,21/67,16.55%,DAPK1;SP100;IFITM3;LGALS9;WNT5A;CCL15;STAT1;CCL14;CD47;GBP4;GBP6;GBP5;GCH1;CCL25;GBP7;IFITM2;GBP2;CXCL16;CCL13;SIRPA;TLR4
prerank,vascular transport (GO:0010232),0.5594852828376871,1.6709130251547422,0.014657980456026058,0.5696390214779449,1.0,15/81,5.05%,ABCC9;KCNJ8;SLC16A12;SLC12A2;SLCO3A1;ATP2A3;ATP1A2;SLC1A5;SLC1A4;ATP1A4;SLC5A1;SLC19A1;SLC27A4;ATP1B2;SLC22A8
prerank,regulation of execution phase of apoptosis (GO:1900117),0.7993724800545002,1.669598360847272,0.029017857142857144,0.5684244422647088,1.0,2/11,0.68%,DLC1;FAP
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.5690583143865935,-1.6694170828407866,0.004357298474945534,0.18497651360389317,1.0,12/35,12.07%,NOTCH2;PDGFRA;NRP1;NTRK3;BAIAP2L1;TEK;BAIAP2;PTK2B;SEMA3E;IQGAP2;ARHGDIA;F11R
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.664364443443363,-1.6677599419728018,0.00784313725490196,0.18582153629312623,1.0,5/17,3.70%,NRP1;NTRK3;BAIAP2L1;TEK;BAIAP2
prerank,negative regulation of chemokine production (GO:0032682),-0.6854363067967657,-1.6662006598609034,0.015180265654648957,0.18688896038836836,1.0,7/14,21.75%,APOD;KLF4;LGALS9;MAP2K5;C1QTNF3;SIRPA;SIGIRR
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.7414937393482642,-1.6638601423270045,0.0054446460980036296,0.18934060164765157,1.0,4/10,6.89%,PODXL;DPP4;PIEZO1;WNK1
prerank,extracellular structure organization (GO:0043062),-0.4157960666376682,-1.661734139823206,0.0,0.19153882520309337,1.0,88/204,12.53%,ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;COL1A1;ADAMTS6;DCN;ADAMTS2;THSD4;ITGA9;ELN;COL22A1;LAMA1;COL5A1;VWF;LOXL1;COL6A3;JAM2;PECAM1;APP;ADAMTS9;SPARC;RECK;SH3PXD2A;COL6A1;COL8A2;ITGA6;ADAMTS5;ITGB8;VIT;MFAP5;BSG;COL4A5;COL6A2;THBS1;ITGA5;TGFBR1;COL11A1;NID2;CDH1;FBLN5;VCAM1;COL23A1;ITGA3;COL4A6;HSPG2;COL13A1;BGN;ST7;ADAMTS1;ITGA11;SPOCK2;NDNF;ITGA10;TNC;DDR1;ADAMTS15;ICAM1;FBN2;COL18A1;ADAMTSL1;CD47;GFOD2;ADAMTSL4;ITGB4;TGFBI;MMP14;COL14A1;ADAM15;LAMA5;COL15A1;SLC39A8;KDR;COL16A1;LUM;MMP19;ITGB3;ADAMTS14;LAMA3;ADAMTS3;F11R;SMOC2;COL9A2
prerank,bicellular tight junction assembly (GO:0070830),-0.5228063003982746,-1.661303682208495,0.01179245283018868,0.19030708403927407,1.0,13/46,12.07%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;PDCD6IP;PARD6G;CLDN11;PARD3;PATJ;F11R
prerank,lipid oxidation (GO:0034440),-0.6888175076831121,-1.6597134533643765,0.014598540145985401,0.19142530149313852,1.0,5/12,20.35%,ADIPOR2;ACOX1;ALOX12;PPARGC1A;ADIPOR1
prerank,B cell homeostasis (GO:0001782),0.779609753060085,1.6593932525420187,0.04525862068965517,0.603551938473712,1.0,2/10,0.75%,MEF2C;DOCK10
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.7051372176057407,-1.6588647513088681,0.003913894324853229,0.19109964015928188,1.0,4/14,4.28%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,external encapsulating structure organization (GO:0045229),-0.41245763109941813,-1.6587210929381035,0.0,0.18928094557972103,1.0,87/205,12.53%,ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;COL1A1;ADAMTS6;DCN;ADAMTS2;THSD4;ITGA9;ELN;COL22A1;LAMA1;COL5A1;VWF;LOXL1;COL6A3;JAM2;PECAM1;APP;ADAMTS9;SPARC;RECK;SH3PXD2A;COL6A1;COL8A2;ITGA6;ADAMTS5;ITGB8;VIT;MFAP5;BSG;COL4A5;COL6A2;THBS1;ITGA5;COL11A1;NID2;CDH1;FBLN5;VCAM1;COL23A1;ITGA3;COL4A6;HSPG2;COL13A1;BGN;ST7;ADAMTS1;ITGA11;SPOCK2;NDNF;ITGA10;TNC;DDR1;ADAMTS15;ICAM1;FBN2;COL18A1;ADAMTSL1;CD47;GFOD2;ADAMTSL4;ITGB4;TGFBI;MMP14;COL14A1;ADAM15;LAMA5;COL15A1;SLC39A8;KDR;COL16A1;LUM;MMP19;ITGB3;ADAMTS14;LAMA3;ADAMTS3;F11R;SMOC2;COL9A2
prerank,transport across blood-brain barrier (GO:0150104),0.5553016341401475,1.6570628875388576,0.016366612111292964,0.6069158296966227,1.0,15/83,5.05%,ABCC9;KCNJ8;SLC16A12;SLC12A2;SLCO3A1;ATP2A3;ATP1A2;SLC1A5;SLC1A4;ATP1A4;SLC5A1;SLC19A1;SLC27A4;ATP1B2;SLC22A8
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6076398150052941,-1.656902152707498,0.012219959266802444,0.19083403928347145,1.0,10/23,14.98%,UACA;BMP7;HDAC7;CCN3;TMSB4X;C1QTNF3;IFI35;ZC3H12A;RELA;PPM1B
prerank,actin filament depolymerization (GO:0030042),-0.7308285793576756,-1.65469704882005,0.009398496240601503,0.19343882693800718,1.0,5/11,13.17%,MICAL3;GSN;MICAL2;DSTN;TWF1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6621156409392113,1.654686206210178,0.04823747680890538,0.6100121449764082,1.0,10/30,7.70%,GJC1;CACNA1C;NEDD4L;FGF12;KCNE4;CACNA2D1;SCN5A;RYR2;CACNA1D;KCNE5
prerank,myelin maintenance (GO:0043217),0.7687827487917673,1.6546320024089298,0.042600896860986545,0.6036644673396067,1.0,2/10,3.42%,PTEN;ABCD2
prerank,peptidyl-arginine modification (GO:0018195),0.7411307450818935,1.652906576572946,0.03837953091684435,0.6047312303472597,1.0,1/15,0.14%,ART3
prerank,nucleotide catabolic process (GO:0009166),-0.6516455010382709,-1.6525319131788638,0.015748031496062992,0.19586300852034969,1.0,12/16,25.02%,XDH;SAMHD1;NT5E;DERA;NUDT3;GDA;GPX1;NT5C1A;PNP;VCP;NT5C2;NT5C
prerank,inorganic anion transmembrane transport (GO:0098661),0.5845893912720956,1.6524431858117496,0.011570247933884297,0.6002110511052117,1.0,8/63,5.87%,ANO1;ANO4;SLC12A2;SLC5A1;XPR1;SLC12A6;GABRG2;GABRA2
prerank,negative regulation of neurogenesis (GO:0050768),0.6531787180993216,1.6496917881588762,0.04847396768402154,0.6050277978302526,1.0,7/34,2.62%,PTEN;RAPGEF2;NOTCH1;LINGO1;NF1;PTN;IL1B
prerank,ureteric bud development (GO:0001657),-0.6456085520447805,-1.6492824786804683,0.015414258188824663,0.20081831282992685,1.0,7/17,6.84%,BMP7;OSR1;SLIT2;FGFR2;BMP4;SIX1;FOXC1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.6340182620366835,1.6486736389977366,0.029143897996357013,0.6029952829921553,1.0,11/37,16.99%,DYNLL1;IFT43;IFT81;IFT20;KIF3A;IFT57;KIF3C;TRIP11;IFT80;TNPO1;TRAF3IP1
prerank,monocyte chemotaxis (GO:0002548),-0.5583707794982343,-1.6482466426504483,0.010438413361169102,0.20067748385445808,1.0,9/32,15.69%,FLT1;IL6R;ANXA1;CCL15;CCL14;RPS19;CCL25;TNFRSF11A;CCL13
prerank,positive regulation of ossification (GO:0045778),-0.5372854273706854,-1.6467950374528046,0.00437636761487965,0.20188229477053596,1.0,20/39,15.76%,BMP6;ZBTB16;WNT4;BMP7;OSR1;BMPR2;BMP4;ADGRV1;ACVR1;WNT5A;FBN2;ANO6;KL;ATRAID;P2RX7;TGFB1;TMEM119;CCN1;PKDCC;BMPR1A
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.6246340213055827,-1.64647744274662,0.01383399209486166,0.2005703829852362,1.0,7/20,11.77%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST3GAL3;FUT8;ST6GALNAC6
prerank,regulation of interleukin-1 production (GO:0032652),-0.6736957240207826,-1.6464085630084575,0.017110266159695818,0.19877953914054916,1.0,6/15,16.55%,FOXP1;ANXA1;GAS6;CEACAM1;SIRPA;TLR4
prerank,cellular sodium ion homeostasis (GO:0006883),0.7472433120795418,1.645205121939939,0.050955414012738856,0.6114274477096237,1.0,5/15,4.90%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2
prerank,neuron projection extension (GO:1990138),-0.5521473129360558,-1.6449690476627967,0.013422818791946308,0.1993810147452096,1.0,5/32,1.93%,AUTS2;ALCAM;NRP2;NRP1;IQGAP1
prerank,potassium ion transport (GO:0006813),0.5168449934114028,1.6448670095740932,0.007518796992481203,0.60675121486276,1.0,23/120,9.41%,ABCC9;KCNJ8;KCNJ12;ATP1A2;KCNG1;KCNMB1;KCNV2;ATP1A4;KCNQ4;KCND2;SLC24A4;SLC24A2;KCNH4;KCNH8;KCNAB3;KCNQ5;HCN2;KCNA4;KCNQ3;SLC9A7;HCN3;PKD2;KCNJ3
prerank,keratan sulfate metabolic process (GO:0042339),-0.5694380751563564,-1.6447960958606715,0.0045662100456621,0.19798036010805845,1.0,13/31,10.88%,ST3GAL4;B4GALT1;ST3GAL6;OGN;FMOD;ST3GAL1;ST3GAL2;HEXA;ST3GAL3;PRELP;HEXB;LUM;OMD
prerank,primary alcohol metabolic process (GO:0034308),-0.5929143981525099,-1.6447705198763962,0.012474012474012475,0.19614811950830063,1.0,8/25,13.44%,IGF1;DHRS3;RBP4;GPD2;NAAA;CYP1B1;ALDH3A2;ADH1A
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.57551896109579,1.6436662343148982,0.011725293132328308,0.6054243418593837,1.0,14/69,7.20%,PDGFRB;PLCL1;PTEN;PLCE1;PIK3CD;PIK3R1;NF1;PIK3CA;MYO16;PITPNM2;OGT;NYAP2;PIK3C2A;IRS1
prerank,phospholipid translocation (GO:0045332),-0.5919243660804182,-1.6415518289362319,0.008849557522123894,0.2009695549626842,1.0,14/28,17.15%,ABCA1;ATP10A;PLSCR2;ANO6;ABCA4;PLSCR4;P2RX7;ATP9A;ATP8A1;MFSD2A;TMEM30A;PLSCR3;ATP11A;ATP11B
prerank,cellular response to zinc ion (GO:0071294),-0.6732575638122136,-1.640875273910902,0.021032504780114723,0.20051363988855528,1.0,13/15,31.15%,P2RX4;MT3;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;ATP13A2;HVCN1;MT2A
prerank,positive regulation of glucose import (GO:0046326),-0.5964690252244181,-1.6408168110079593,0.014084507042253521,0.19878136760366472,1.0,5/21,1.64%,IGF1;SORBS1;OSBPL8;OCLN;RHOQ
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5585771061893547,1.6404642680943011,0.01951219512195122,0.6124927030164745,1.0,10/76,6.60%,ANO1;PLCE1;PTH1R;GRM5;TACR1;GRM1;CXCR2;HTR2C;TRHR;OPRK1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.6141106697891652,-1.6379525871209404,0.020242914979757085,0.20232692533356603,1.0,7/21,11.77%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST3GAL3;FUT8;ST6GALNAC6
prerank,regulation of endothelial cell migration (GO:0010594),-0.46666405391963683,-1.637888562326937,0.0027548209366391185,0.20060966449526427,1.0,38/85,13.07%,ANXA3;NRP2;DCN;ROCK2;FOXP1;GLUL;NRP1;TEK;SP100;APOE;ADAMTS9;SPARC;SLIT2;SASH1;PTPRM;BMPR2;THBS1;BMP4;ANGPT1;FOXC2;FGF1;BMPER;ACVRL1;WNT5A;PTK2B;RHOB;PIK3CB;AKT1;PRCP;DAB2IP;ZC3H12A;KDR;ITGB3;RHOJ;SMOC2;FLT4;CALR;ATOH8
prerank,positive regulation of DNA binding (GO:0043388),-0.5671163437302484,-1.6376994470707338,0.0044444444444444444,0.19919553920829083,1.0,16/31,26.38%,IGF1;SKI;NIBAN2;FOXC1;PINX1;CEBPG;TGFB1;NME1;TXN;HMGB2;SIRT2;PARK7;PLAUR;TRIM6;PRKN;TWIST1
prerank,carnitine shuttle (GO:0006853),-0.7155088828672357,-1.6372372014612155,0.015748031496062992,0.19837616711681486,1.0,7/11,18.87%,PRKAG2;CPT1A;SLC25A20;CPT2;ACACA;PRKAA2;ACACB
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7241144746024213,1.636732348663839,0.03837953091684435,0.6211149278930778,1.0,2/17,0.19%,ITGA1;PDGFRB
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.46942168273548673,-1.6364447320384625,0.0,0.19813575831299127,1.0,36/84,13.47%,ANXA3;NRP2;ROCK2;FOXP1;NRP1;PLPP3;TEK;SPARC;PLCG1;SASH1;NOS3;BMPR2;THBS1;BMP4;ANGPT1;FOXC2;FGF1;WNT5A;MAPK14;PTK2B;RHOB;P2RX4;TMSB4X;PIK3CB;AKT1;HIF1A;ZC3H12A;KDR;GATA2;ITGB3;TGFB1;SMOC2;FLT4;CALR;ATOH8;MET
prerank,inositol phosphate metabolic process (GO:0043647),0.6068448576646263,1.6361097850595383,0.029462738301559793,0.6175249122894549,1.0,8/46,5.66%,INPP4B;PTEN;PLCE1;IMPA2;INPP5A;FGF2;ITPKB;INPP5J
prerank,lymphocyte chemotaxis (GO:0048247),0.625220237476237,1.6354887060928323,0.034926470588235295,0.6139437313944345,1.0,3/34,0.77%,CYP7B1;SLC12A2;PIK3CD
prerank,odontogenesis (GO:0042476),-0.5506354752267341,-1.6354187359553196,0.013071895424836602,0.19838054924176277,1.0,9/35,8.00%,COL1A2;GLI2;OSR1;WNT6;FGFR2;BMP4;LRP6;FOXC1;TBX1
prerank,Notch signaling pathway (GO:0007219),0.5887941233746635,1.6351482042048917,0.011764705882352941,0.609442597896787,1.0,6/59,1.62%,NOTCH3;HEY2;HEYL;NOTCH1;DTX3;MAML2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.7162693556524999,-1.6341756805566543,0.00929368029739777,0.19905896010395907,1.0,10/11,27.55%,FOXO1;CAV1;ATP6V1G1;ATP6V0A2;CCDC115;ATG7;TMEM199;FAS;ATP6AP1;ATP6V0D1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7346951774992814,1.6329538696509562,0.051587301587301584,0.6128740140968233,1.0,6/14,10.19%,RAPGEF2;PRKAR1B;PKIA;PRKAR2B;PRKAR2A;PRKAR1A
prerank,regulation of blood circulation (GO:1903522),0.624886813063051,1.6329477155167802,0.044859813084112146,0.6071712978963694,1.0,6/34,3.07%,ACE2;TBX2;KCNJ12;PER2;CACNA1H;ECE1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.723180074336229,1.6328233876029268,0.06378600823045268,0.6020048535814464,1.0,4/16,3.00%,SOX5;TCF15;PTN;RBM24
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6933944801361256,1.63256897062668,0.033582089552238806,0.5974009516605296,1.0,4/24,4.11%,PDE4D;CASQ2;DMD;AKAP6
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.5110279805646123,1.6323070041942345,0.009174311926605505,0.5929376772428352,1.0,24/119,11.03%,INPP4B;PIP5K1B;PTEN;PIK3CD;PIGU;PIK3R1;PIP4K2A;PIK3CA;FGF2;PITPNM2;ITPKB;SOCS5;PIGO;INPP5J;PIP4K2C;PIK3C2A;PIKFYVE;MTMR12;MTMR14;MTMR7;PIGZ;SOCS6;FIG4;DPM3
prerank,cyclooxygenase pathway (GO:0019371),-0.7223690285123469,-1.6319381074761827,0.011049723756906077,0.20179971885422102,1.0,5/10,11.61%,PTGDS;PTGIS;PTGS1;TBXAS1;PTGS2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.6739515267588462,-1.6315214842744488,0.005905511811023622,0.2009261548381687,1.0,11/15,28.35%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SPHK1;SIRT3;ORMDL3;ORMDL2;RACK1;SPHK2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.5592137032446308,-1.6302107571020932,0.013157894736842105,0.20185024150221192,1.0,14/30,21.77%,FLT1;BMP4;MLLT3;ACE;KIT;KDR;TGFB1;FLT4;SFRP1;LMBR1L;CSF1R;PLEK;FSTL3;SP7
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.639824861083631,-1.6294345489141144,0.012072434607645875,0.2019594977074535,1.0,6/18,11.59%,EGFR;ESR1;BMP4;DDX5;ZC3H12A;TGFB1
prerank,blood vessel diameter maintenance (GO:0097746),0.6264191175117393,1.6289090174927119,0.04059040590405904,0.600255328794429,1.0,7/34,3.95%,ACE2;EDNRA;PER2;GPER1;ROCK1;ECE1;ADCY6
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.43946686031009496,-1.627808716312893,0.0,0.20334448015475434,1.0,29/95,13.00%,TGFBR3;DAB2;LDLRAD4;SMAD3;SMAD6;DKK3;SKIL;CAV1;HTRA3;TGFBR2;SMURF2;THBS1;TGFBR1;SNX6;SMAD7;ITGA3;LTBP4;SKI;SDCBP;SMURF1;PRDM16;FKBP1A;FLCN;EMILIN1;TGFB1;BCL9L;STRAP;PPARA;UBB
prerank,macrophage differentiation (GO:0030225),-0.6996015913787486,-1.6268075452519217,0.0210727969348659,0.20366153565898534,1.0,5/13,10.09%,IL31RA;IL15;BMP4;CSF1;CASP8
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.48127246027989934,-1.6252257178925165,0.0024096385542168677,0.20543178770285958,1.0,15/63,5.30%,IGF1;WWOX;SP100;SH3RF1;CAV1;ITGA6;THBS1;BMP4;TGFBR1;DEPTOR;TCF7L2;ACVR1;CFLAR;AR;TNFSF10
prerank,glycolipid metabolic process (GO:0006664),-0.5134185669657239,-1.6242147765318153,0.011990407673860911,0.20589047679346453,1.0,16/47,15.35%,ST3GAL4;ST3GAL6;ESYT2;ST3GAL2;ST6GALNAC3;SMPD3;HEXA;HEXB;FUCA1;B3GALNT1;PSAP;NAGA;ST6GALNAC6;ESYT3;UGCG;SUMF2
prerank,cellular metal ion homeostasis (GO:0006875),0.5395768076874596,1.6233383461834432,0.022257551669316374,0.6161952401114345,1.0,22/102,8.66%,ATP13A5;PTH1R;SLC12A2;ATP2A3;NEDD4L;ATP1A2;ATP2C1;ATP1A4;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;ATP1B2;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1;STC2;LETM1
prerank,regulation of vasoconstriction (GO:0019229),0.6606560800214523,1.6227229291168965,0.04259634888438134,0.6132197605319939,1.0,5/27,3.07%,ACE2;TBXA2R;SMTNL2;PER2;ECE1
prerank,icosanoid secretion (GO:0032309),-0.7084421579189173,-1.6215510396847543,0.027675276752767528,0.20961760680108615,1.0,4/12,6.54%,ABCC4;ANXA1;ACE;BDKRB2
prerank,ganglion development (GO:0061548),-0.713674043395825,-1.621544811177017,0.009107468123861567,0.20794066594667743,1.0,2/11,1.02%,NRP2;NRP1
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.44167892212742677,-1.6214150284972744,0.002932551319648094,0.20651237086509622,1.0,26/108,11.01%,NXN;SULF1;TRABD2B;WWOX;VGLL4;APP;MDFIC;MACF1;RSPO3;ESR1;FGFR2;NKD1;LRRK2;NFATC1;ITGA3;RNF43;SKI;SULF2;SFRP4;RSPO2;TIAM1;FOXL1;TLE1;FZD7;NOTUM;MDFI
prerank,cation transmembrane transport (GO:0098655),0.6102577546646952,1.6205516739321384,0.051094890510948905,0.6160947814687444,1.0,4/44,1.67%,ABCC9;KCNJ8;ATP1A2;CACNA1H
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.620867566280729,-1.6179609305970186,0.01616161616161616,0.21143299340975222,1.0,10/19,12.42%,ROBO1;DCN;SEMA6A;CCBE1;JCAD;XDH;PIK3CB;DAB2IP;ADAMTS3;SMOC2
prerank,response to interleukin-1 (GO:0070555),-0.4651845104280015,-1.6150893822065593,0.005154639175257732,0.21543746665712463,1.0,22/73,16.31%,ADAMTS12;HDAC4;PTGIS;APP;IL1R1;ANXA1;IRAK2;LGALS9;CCL15;CCL14;CD47;HIF1A;IRAK3;DAB2IP;ZC3H12A;CCL25;RELA;TNFRSF11A;SFRP1;GBP2;CCL13;SIRPA
prerank,striated muscle contraction (GO:0006941),0.589563612294356,1.6145884083994861,0.026402640264026403,0.6340634023954451,1.0,10/53,8.92%,CASQ2;DMD;ATP1A2;RCSD1;PIK3CA;SCN5A;RYR2;MYL3;KCNE5;STAC
prerank,stabilization of membrane potential (GO:0030322),-0.6295542445644199,-1.614208384770473,0.02389705882352941,0.21561509201549278,1.0,2/16,2.80%,KCNK2;KCNK5
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6205565912234032,-1.6141890148605769,0.007707129094412331,0.2139823379098359,1.0,12/20,17.68%,ENTPD1;APP;TXNIP;ANO6;P2RX4;IL18;NT5E;P2RX7;ENTPD5;TXN;HSP90AB1;SUGT1
prerank,sensory perception of smell (GO:0007608),0.7601809178116926,1.612730732384005,0.07191011235955057,0.63569904426285,1.0,3/11,6.85%,ADCY3;SLC24A4;UBR3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.716210165039185,-1.6127126743538271,0.0210727969348659,0.21540696857279729,1.0,5/11,17.18%,EGFR;BMP4;DDX5;TGFB1;RIPK1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7648458615781691,1.6125092951263547,0.06,0.6311219545187361,1.0,3/11,1.01%,MEF2C;PIK3CD;RAPGEF2
prerank,heart contraction (GO:0060047),0.5999384504661709,1.612033289788793,0.033216783216783216,0.6276836665520813,1.0,9/41,7.70%,CASQ2;DMD;ATP1A2;PIK3CA;SCN5A;RYR2;SGCZ;MYL3;KCNE5
prerank,dendrite morphogenesis (GO:0048813),0.6391440468692701,1.6119719151443077,0.04419889502762431,0.6226194751192938,1.0,9/35,4.30%,PTEN;DOCK10;FARP1;BTBD3;SDC2;MAP2;PTN;WASL;MINK1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.5340703941085589,-1.6117439054298701,0.01569506726457399,0.2158435880541719,1.0,9/38,14.61%,BMP6;SASH1;DDX60;USP15;IFI35;PUM1;GBP5;CYBA;CD180
prerank,protein localization to cell surface (GO:0034394),0.6543730650119551,1.6111921352754222,0.047151277013752456,0.620434875052319,1.0,7/26,7.64%,PTPRK;PIGU;JAM3;VCL;GGA3;EMP2;FGF10
prerank,base conversion or substitution editing (GO:0016553),0.7377963920389796,1.610883379235413,0.06622516556291391,0.6164235413132821,1.0,2/11,6.20%,APOBEC1;ADARB2
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7186677483789186,1.6108386320924,0.05672268907563025,0.6114881955931516,1.0,2/16,0.30%,GUCY1B1;GUCY1A1
prerank,neuron projection regeneration (GO:0031102),0.753164741593185,1.610733015428939,0.06652360515021459,0.607033061282167,1.0,4/10,8.94%,RTN4RL1;PTN;DHFR;GAP43
prerank,regulation of biosynthetic process (GO:0009889),0.7766559384721197,1.6106501783697225,0.05829596412556054,0.6023468216449437,1.0,4/11,7.50%,SLC25A33;CCN6;SNCA;PIKFYVE
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.49903334917715386,-1.6103420970028823,0.0045662100456621,0.21705611405975808,1.0,15/51,7.15%,FBN1;FSTL1;SMAD6;SKIL;HTRA3;BMPR2;SMURF2;SMAD9;SMAD7;SKI;BMPER;GREM2;SMURF1;NBL1;VWC2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5847865318972687,1.6092601760793064,0.03529411764705882,0.6026586708712484,1.0,6/55,2.56%,PDGFRB;ACE2;PID1;SLC25A33;CCN6;FOXM1
prerank,polyol metabolic process (GO:0019751),0.5972732602788257,1.6081541506922312,0.03333333333333333,0.6020711098937489,1.0,7/46,5.66%,INPP4B;PTEN;PLCE1;IMPA2;INPP5A;ITPKB;INPP5J
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5954934576934013,1.6080610118469232,0.05018587360594796,0.5976332412275907,1.0,5/35,7.40%,SGIP1;VTN;LDLRAP1;IL4;PPT1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.6378670705783629,-1.6070304389239316,0.028901734104046242,0.22216711065571781,1.0,7/17,10.62%,ROBO1;EFNB2;NRP1;SLIT2;EPHB4;AKT1;KDR
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.7016190689238684,-1.6069203133207404,0.021442495126705652,0.22081983353501708,1.0,5/11,7.78%,SLIT2;RIN3;CCN3;NBL1;DUSP1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6579276959844491,-1.6068023698488838,0.027932960893854747,0.2194594569770708,1.0,7/15,14.53%,EGFR;IGF1R;DDR1;PTK2B;BMX;KDR;MAPK3
prerank,pore complex assembly (GO:0046931),-0.6241421597899456,-1.606240438625124,0.018789144050104383,0.21903375873230732,1.0,8/19,17.49%,AFDN;ADAM10;ANO6;PLEKHA7;GSDMD;P2RX7;NUP98;TPR
prerank,membrane depolarization during action potential (GO:0086010),0.6506153265101722,1.6057965014504834,0.05927342256214149,0.6013567840267365,1.0,10/26,11.06%,CACNA1C;ATP1A2;CACNA1H;SCN2A;SCN5A;HCN2;SCN8A;CACNA1D;SCN9A;SCN2B
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6666218734856323,1.6056427271762654,0.05384615384615385,0.5973399469420014,1.0,9/27,7.09%,PDE4D;CACNA1C;CTNNA3;FGF13;SCN5A;PDE4B;RYR2;ATP2A2;STC1
prerank,protein mannosylation (GO:0035268),-0.5908215491269443,-1.6055416227763613,0.037037037037037035,0.21895480115718752,1.0,5/22,7.53%,TMTC1;LARGE1;TMTC4;TMTC2;RXYLT1
prerank,regulation of necroptotic process (GO:0060544),-0.5840963627772952,-1.6052470101809568,0.02012072434607646,0.21812023271185663,1.0,11/23,17.18%,ARHGEF2;CFLAR;SDCBP;PDCD6IP;BIRC3;SLC25A4;FLOT2;CASP8;YBX3;PELI1;RIPK1
prerank,lipid catabolic process (GO:0016042),0.699076227518237,1.604687059190708,0.04518664047151277,0.596130212167939,1.0,5/18,7.40%,CEL;PLA1A;LIPC;LIPH;PPT1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4988223968875692,1.601050185042159,0.01772525849335303,0.6046687619547121,1.0,18/140,3.88%,DLC1;STARD8;CHN1;PLCE1;ARHGEF17;ARHGAP21;ARHGAP10;KALRN;PLEKHG2;ARHGAP6;ARHGAP32;ARHGEF6;ARHGAP1;FOXM1;STARD13;ARAP2;SH3BP1;RAC3
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.6512824232285195,1.6001275719739647,0.06095238095238095,0.6032727584668734,1.0,3/28,2.83%,NOTCH3;CHAC1;TSPAN15
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.6231722068686197,-1.599787917164211,0.028790786948176585,0.2276485163698415,1.0,5/17,5.90%,SULF1;FSTL1;SLIT2;ITGA3;SFRP4
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4884398275427724,-1.599764592186987,0.0,0.2260577968089213,1.0,12/49,10.32%,IGF1;IL31RA;IL15;IL6R;IL6ST;GHR;PARP9;PARP14;STAT3;KIT;TNFRSF1A;IL18
prerank,negative regulation of cartilage development (GO:0061037),-0.6924005286081869,-1.5982119763930456,0.015151515151515152,0.22750768203354385,1.0,4/13,4.28%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.7340190958292349,1.5977436563727887,0.06183368869936034,0.6072779593387624,1.0,2/13,0.50%,PDE4D;CASQ2
prerank,focal adhesion assembly (GO:0048041),0.6867446115650443,1.597304657560545,0.05555555555555555,0.6042012008892684,1.0,4/21,2.09%,DLC1;PTPRK;PEAK1;FERMT2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7608879228218718,1.5968696652218672,0.06382978723404255,0.5969206559697555,1.0,4/11,5.66%,PTEN;IMPA2;INPP5A;INPP5J
prerank,inositol phosphate dephosphorylation (GO:0046855),0.7608879228218718,1.5968696652218672,0.06382978723404255,0.5969206559697555,1.0,4/11,5.66%,PTEN;IMPA2;INPP5A;INPP5J
prerank,cardiac muscle contraction (GO:0060048),0.6236036641486526,1.5961792870964333,0.04159132007233273,0.5950837288707708,1.0,8/34,7.70%,CASQ2;DMD;ATP1A2;PIK3CA;SCN5A;RYR2;MYL3;KCNE5
prerank,vesicle transport along actin filament (GO:0030050),0.676130576176803,1.5958142759914864,0.0653061224489796,0.5921132182610522,1.0,4/19,8.19%,MYO1B;WASL;ACTN4;MYO6
prerank,cellular protein metabolic process (GO:0044267),-0.3685417192509031,-1.5957317450643678,0.0,0.2313553101420849,1.0,138/396,18.99%,IGF1;FBN1;FN1;FSTL1;IGFBP2;ST3GAL6;CTSH;IGFBP5;PCSK5;APOE;PAPPA;APP;CP;ST3GAL1;CPE;RPLP1;BMP4;RPS14;IGFBP6;YES1;ITIH2;CSF1;IGFBP4;PHKA2;ADAM10;IGFBP3;PLOD2;DENND3;IGF2;GAS6;WWP2;RPL9;VWA1;RPS12;P4HB;SERPIND1;RPL41;RPS20;TNC;CALU;RPL18A;RPS13;RPS19;ABCA3;RPS23;SRBD1;RPS4X;SEPHS1;DUSP12;CST3;MSLN;RPS11;RPL13;RPL18;RPS9;EEF1A1;GOLM1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;RPL37;SFTPA2;SFTPA1;NOTUM;IDE;DAB2IP;PRSS23;ST8SIA2;MXRA8;RPL11;RPS18;CKAP4;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;GATA6;CCN1;RPS24;LMCD1;RPS27;RPL14;SPG7;RPL26;SPP1;MRPS7;MRPS6;F5;UBE2G2;LTBP1;SARS1;MSRB3;RPL10;MRPS18A;RPL7;NEDD8;SCG3;MRPL52;RCN1;RPL10A;MRPL24;HARS1;RPL22;UBA3;RPS15;RPS6;MMP2;FBXL2;DNAJC3;RPL23;RPL17;APLP2;AFG3L2;PDIA6;RPL31;MANBA;RIPK1;RPS25;UBA7;PSEN2;RPL15;RPSA;SPCS1;RPN2;QSOX1;RPS7;RPL38;UBE2M;RPLP0;HSP90B1;RPL27;CSF2RA
prerank,negative regulation of stem cell differentiation (GO:2000737),0.7333653365336334,1.5940898714687537,0.04883227176220807,0.5936577498916117,1.0,6/12,13.28%,NOTCH1;TCF15;N4BP2L2;JAG1;YTHDF2;HNRNPU
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.5146985551815039,-1.5926174302386595,0.015659955257270694,0.23659489906415854,1.0,19/40,15.76%,BMP6;WNT4;BMP7;OSR1;WNT6;BMPR2;BMP4;ADGRV1;ACVR1;FBN2;ANO6;KL;ATRAID;P2RX7;TGFB1;TMEM119;CCN1;PKDCC;BMPR1A
prerank,regulation of focal adhesion assembly (GO:0051893),0.569650426684192,1.5923683927703365,0.03361344537815126,0.5956785589049818,1.0,10/54,2.15%,DLC1;PTEN;LIMS1;ARHGAP6;PTK2;VCL;PHLDB2;PEAK1;FERMT2;ROCK1
prerank,muscle cell differentiation (GO:0042692),0.6294090310284314,1.5919512580537907,0.043233082706766915,0.5929192805433554,1.0,6/32,1.29%,MEF2C;DMD;GLMN;HEY2;SYNE1;RORA
prerank,phosphatidylinositol metabolic process (GO:0046488),0.5148570649817225,1.5918736606441062,0.015220700152207,0.5890083513076668,1.0,20/109,10.75%,INPP4B;PDGFRB;PIP5K1B;PTEN;PIK3CD;PIK3R1;PIP4K2A;PIK3CA;FGF2;PITPNM2;INPP5J;PIP4K2C;PIK3C2A;PIKFYVE;MTMR12;MTMR14;MTMR7;INPP5B;FIG4;PLA2G4E
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7617722827237798,1.5913867293181998,0.061224489795918366,0.5867659017518478,1.0,2/11,3.42%,SLC30A10;ABCD2
prerank,regulation of aerobic respiration (GO:1903715),0.7093459773072183,1.5906302307435864,0.07234042553191489,0.5853496730763796,1.0,3/15,3.71%,CBFA2T3;SLC25A33;ATP7A
prerank,smooth muscle contraction (GO:0006939),0.7284171125548766,1.59014266357896,0.058091286307053944,0.5830091688442902,1.0,6/14,7.15%,EDNRA;MYLK;MYH11;ROCK1;SMTN;PIK3C2A
prerank,regulation of Ras protein signal transduction (GO:0046578),0.5375187448431377,1.5893118737141285,0.02066772655007949,0.5816748302479658,1.0,20/85,9.11%,DLC1;STARD8;EPS8;PLCE1;NOTCH1;SPRY4;FOXM1;CADM4;STARD13;SH3BP1;RALGPS1;PDCD10;EPS8L1;SPRY2;OGT;LZTR1;FGF10;ARHGDIB;LRRD1;LYN
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6459700912128513,1.5888638856516302,0.06049149338374291,0.5790930151363147,1.0,5/25,6.04%,PDE4D;GLMN;IL1B;SPTBN1;PDE4B
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.6369206763552497,-1.5879388636186185,0.02681992337164751,0.2456054707217586,1.0,6/16,9.43%,BMPR2;ACE;DDAH1;PLCB3;KLK2;PRCP
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.6867981528106692,1.5868584608866447,0.05636743215031315,0.5820276800666401,1.0,5/18,4.25%,ITGA4;MEF2C;COL4A3;AKT3;FGF2
prerank,regulation of tissue remodeling (GO:0034103),-0.6043758993750649,-1.5859132366425102,0.03333333333333333,0.2484299772435154,1.0,7/18,15.89%,LEPR;IL15;CST3;IL18;TGFB1;FLT4;CEACAM1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.5978039980937131,1.5855449826255423,0.054003724394785846,0.5828819033638807,1.0,4/33,1.63%,PTEN;MEF2C;PRKG1;GPER1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.6675166857156858,-1.585404808466485,0.022770398481973434,0.2479198958414381,1.0,7/13,16.12%,PTGIS;PARP9;NAMPT;PTGS2;NUDT12;NNMT;PARP16
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.7001586114436403,1.5833000583224883,0.07128309572301425,0.5868136062967056,1.0,4/16,4.11%,TRPC3;ROCK1;PDE9A;AKAP6
prerank,pinocytosis (GO:0006907),0.7583508499440356,1.5831264420167088,0.06873614190687362,0.5834783161894156,1.0,2/10,7.40%,CARMIL1;PPT1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.46011850609889837,-1.5823573208951682,0.004597701149425287,0.2530874139854921,1.0,21/74,10.09%,EYA2;IGF1;EYA1;SH3RF1;ITGA6;EYA4;NOS3;THBS1;BMP4;TGFBR1;TCF7L2;ARHGEF2;ACVR1;CFLAR;AR;TNFSF10;ICAM1;MAP2K5;AKT1;MCL1;CASP8
prerank,heart looping (GO:0001947),0.60955445727559,1.579002616560218,0.058712121212121215,0.5935214302259644,1.0,6/39,3.37%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.6150813636075899,-1.576823959098004,0.023346303501945526,0.2645692373403177,1.0,9/18,16.21%,FN1;SMAD3;ITGB8;CD34;LGALS9;HIF1A;PTGS2;LTBP1;CD200
prerank,ERBB signaling pathway (GO:0038127),0.5523967498147819,1.5760624059211303,0.03442340791738382,0.5995864981824014,1.0,10/64,3.05%,SLC30A10;PLCE1;GAB1;PTK2;PIK3R1;NCK2;BCAR1;ERBB4;NRG1;PIK3CA
prerank,endocardial cushion morphogenesis (GO:0003203),0.6631211775873889,1.5724011976598748,0.06622516556291391,0.6084768906331869,1.0,4/18,1.22%,TBX2;HEYL;NOTCH1;TBX20
prerank,response to nitric oxide (GO:0071731),0.7289532599797894,1.5723334394444548,0.07789473684210527,0.6047820617171238,1.0,1/13,0.12%,GUCY1B1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5035723763087978,-1.572172799146995,0.012738853503184714,0.2742492810950776,1.0,21/48,13.39%,PLCG1;JCAD;HDAC7;NOS3;THBS1;ANGPT1;FOXC2;ANXA1;HDAC9;MAPK14;P2RX4;TMSB4X;AKT1;HIF1A;FGFBP1;KDR;GATA2;TGFB1;PTGS2;RHOJ;SRPX2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.48050624835643935,-1.571951782672835,0.0024330900243309003,0.2730777937376447,1.0,13/56,6.10%,BMP6;DAB2;LDLRAD4;SMAD6;BMP7;BMPR2;BMP4;TGFBR1;SMAD7;ACVR1;SDCBP;BMPER;ACVRL1
prerank,regulation of glucose import (GO:0046324),-0.5281949590771633,-1.5714975007043628,0.015184381778741865,0.27240024873185786,1.0,7/30,2.24%,PRKAG2;IGF1;SORBS1;OSBPL8;OCLN;RHOQ;ENPP1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.644957858078149,-1.5709236439915881,0.025793650793650792,0.27197291765478093,1.0,7/15,15.66%,SDCBP;SMPD3;PDCD6IP;SDC4;HGS;RAB7A;SDC1
prerank,sulfur compound transport (GO:0072348),-0.5528709866470841,-1.5699068908651868,0.0189873417721519,0.2727428193577856,1.0,9/27,13.54%,SLC13A4;SLC6A13;SLC6A6;SLC26A7;ABCG2;SLC5A6;MGST1;SLC35F3;SLC25A19
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.5377659901761755,-1.5695989035309412,0.019027484143763214,0.2718206479651349,1.0,14/33,12.45%,CDH5;TEK;NUPR1;CAST;ANGPT1;TCF7L2;RAMP2;GAS6;YAP1;NDNF;ICAM1;KDR;GATA2;PPARA
prerank,regulation of platelet activation (GO:0010543),-0.5853546223490054,-1.5689191885112341,0.017578125,0.2717280442483102,1.0,5/21,3.29%,PDGFRA;PLA2G4A;APOE;NOS3;THBD
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.4745637409696963,-1.5682159872289876,0.01278772378516624,0.27177917044210714,1.0,12/61,8.37%,AUTS2;NOTCH2;IGF1;ROBO1;COL3A1;AKAP13;LPAR1;ARHGEF3;ARRB1;ALS2;RAPGEF1;PIK3CB
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.4038275828650601,-1.5680821474243993,0.0031746031746031746,0.27037775717476087,1.0,39/151,15.58%,ST3GAL4;LARGE1;PLA2G4A;PLPP3;PAM;PCSK5;APOE;SGMS1;CERT1;SGMS2;ST3GAL2;ELOVL7;ACER2;HACD4;LPCAT3;HACD3;ACER3;CSNK1G2;GSTA4;GOLPH3;GSTM1;SPNS2;MGST1;DEGS2;ALAS1;GCH1;PLPP1;GSTT1;ALDH3A2;MFSD2A;SPHK1;ASL;LPIN3;SPTLC2;GSTM2;VAPA;GCNT1;AKR1A1;TYW5
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5041859221299415,1.5680038840317148,0.021116138763197588,0.6161684144959796,1.0,17/116,6.93%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;NPSR1;PRKAR2B;GPR45;ADCY9
prerank,regulation of angiogenesis (GO:0045765),-0.39366583688730156,-1.567473297778675,0.0,0.27014114260607136,1.0,60/192,11.80%,SULF1;ANXA3;FLT1;CDH5;DCN;ROCK2;GLUL;PTGIS;CTSH;TEK;SEMA6A;SP100;SPARC;F3;PLCG1;CLDN5;ITGB8;SASH1;THBS2;PTPRM;NOS3;THBS1;KLF4;RAMP2;HSPG2;CD34;HOXA5;VEGFD;VEGFC;NIBAN2;FGF1;NPR1;GTF2I;BMPER;ADAMTS1;WNT5A;PRKCB;FOXC1;CYP1B1;STAT1;RHOB;SERPINF1;SEMA3E;HK2;PIK3R6;PLXND1;TIE1;HGS;PPP1R16B;HIF1A;STAB1;ECM1;EMILIN1;DAB2IP;ZC3H12A;KDR;PML;GATA2;ECSCR;RHOJ
prerank,regulation of calcium ion transport (GO:0051924),0.560069166720901,1.567410023242081,0.03904923599320883,0.6141295477254585,1.0,13/54,12.17%,TRPC6;CACNB2;MYLK;EPB41;CACNA2D1;STIM2;STC1;CACNA1D;STIM1;PKD2;CASQ1;PACSIN3;SLC8B1
prerank,myotube cell development (GO:0014904),-0.7032268705068565,-1.5649182204459922,0.025,0.27436258181203077,1.0,4/10,14.31%,IGF1;SKI;SIX1;CAV2
prerank,negative regulation of biosynthetic process (GO:0009890),0.7051581023103768,1.5648307016227858,0.060133630289532294,0.6188419244375336,1.0,3/16,3.42%,SLC30A10;GPER1;ABCD2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.46394223650996375,-1.5647187684375283,0.016867469879518072,0.2731658478762351,1.0,15/66,3.56%,NFIB;TGFBR3;MCC;SULF1;ROBO1;MTSS1;APOE;SPARC;CAV1;NUPR1;XDH;FGFR2;PTPRM;THBS1;B2M
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.46703762184035047,-1.5639840376798684,0.00954653937947494,0.2731374454967982,1.0,23/63,16.89%,TIMP3;LEPR;PTPN3;NUPR1;TIMP2;DAP;RASIP1;STAT3;CST3;ATRAID;AKT1;MCL1;FOXK1;DAPL1;DAB2IP;ZKSCAN3;EIF4G3;MFSD2A;MET;RGP1;WASHC1;TIMP4;SIRT2
prerank,vasculogenesis (GO:0001570),0.6171328212482858,1.5632748681014037,0.07509157509157509,0.6201253299366581,1.0,6/32,2.21%,PDGFRB;GLMN;HEY2;NOTCH1;TBX20;SPRED1
prerank,presynapse assembly (GO:0099054),0.7020844286325562,1.5626555584976334,0.082,0.618267672487096,1.0,3/16,2.44%,PTEN;CEL;LRRTM3
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6034914657439509,-1.56256123028896,0.024714828897338403,0.2747913533277896,1.0,4/18,10.32%,IGF1;IGFBP2;IGF2;IL18
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.634811578271413,-1.5614236286325243,0.030965391621129327,0.2758587585485499,1.0,6/13,19.02%,ENTPD1;ENPP1;ENPP3;ENTPD5;SMPDL3A;ENTPD2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.41838126886852245,-1.5612921251023608,0.003236245954692557,0.274573457632024,1.0,36/128,9.08%,BMP6;TGFBR3;ZMIZ1;COL1A2;COL3A1;SMAD3;SMAD6;CDH5;BMP7;CLDN5;TGFBR2;BMPR2;SMURF2;BMP4;TGFBR1;DDX5;SMAD9;ADAM9;SMAD7;ACVR1;PXN;ID1;PDCD4;RGMB;SKI;APPL2;ACVRL1;SMURF1;PRKCZ;RHOA;HIVEP1;FKBP1A;ZYX;USP15;PARD3;TMEM100
prerank,negative regulation of heart contraction (GO:0045822),0.74636103068717,1.559390137663934,0.08225108225108226,0.6257943677021462,1.0,2/11,1.22%,PDE4D;ATP1A2
prerank,apical junction assembly (GO:0043297),-0.4765685551472717,-1.5592566828005565,0.014563106796116505,0.27785387186522104,1.0,14/53,10.00%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;PDCD6IP;PARD6G;RHOA;CLDN11;PARD3;CTNNA1;PATJ
prerank,cell cycle checkpoint signaling (GO:0000075),-0.6673656464730131,-1.559052564519775,0.020637898686679174,0.27689365131395177,1.0,6/12,17.44%,WEE1;PLK2;CHFR;NABP1;ZW10;PRCC
prerank,inositol phosphate catabolic process (GO:0071545),0.7336419114679471,1.558956720380642,0.08438818565400844,0.6234387706113382,1.0,4/12,5.66%,PTEN;IMPA2;INPP5A;INPP5J
prerank,chloride transport (GO:0006821),0.5340920440020891,1.5588250272149191,0.03257328990228013,0.6200694542145513,1.0,9/74,6.37%,ANO1;ANO4;SLC12A2;SLC5A1;SLC12A6;SLC26A1;GABRG2;GABRA2;TTYH1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5593563981179894,-1.5579384041114226,0.02240325865580448,0.27758342612024317,1.0,6/24,10.77%,IGF1;SORBS1;ENPP1;IGF2;AKT1;PPP1R3B
prerank,cellular response to leucine (GO:0071233),0.7312776581974089,1.5574652728414984,0.09565217391304348,0.6171775490987422,1.0,4/10,12.04%,UBR1;SESN3;MTOR;UBR2
prerank,response to leucine (GO:0043201),0.7312776581974089,1.5574652728414984,0.09565217391304348,0.6171775490987422,1.0,4/10,12.04%,UBR1;SESN3;MTOR;UBR2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.562892911329799,-1.55702759923037,0.030303030303030304,0.27803328832566465,1.0,9/23,16.18%,PRKAG2;CEMIP;BMP7;APP;CALM2;IRGM;TGFB1;SPHK1;CALM1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.5755747161823894,-1.5562392056130554,0.034,0.2781882294770536,1.0,9/20,17.18%,NUPR1;CFLAR;SDCBP;PDCD6IP;BIRC3;FLOT2;CASP8;PELI1;RIPK1
prerank,regulation of interleukin-12 production (GO:0032655),-0.4909306007365357,-1.5557567536294221,0.022727272727272728,0.27775894483149,1.0,15/47,22.30%,PLCB1;FOXP1;THBS1;IL16;LGALS9;MAPK14;CD47;CMKLR1;IRAK3;MAST2;PLCG2;TLR4;SYK;MDK;CCL19
prerank,positive regulation of cell communication (GO:0010647),0.621750120149265,1.5551164414314043,0.06626506024096386,0.6213804344514314,1.0,10/28,12.34%,CLSTN1;NMU;RIMS1;CLSTN3;RIMS2;ANK3;SYT1;KCTD13;WLS;GRIK2
prerank,positive regulation of calcium ion import (GO:0090280),0.7336858077019492,1.5544542353979667,0.08571428571428572,0.6197109603694505,1.0,3/12,9.16%,PDGFRB;STC1;PDGFB
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.36987415631966847,-1.5543275680525337,0.0,0.2798524455779215,1.0,123/306,27.15%,EXT1;ST3GAL4;LARGE1;APOE;RPLP1;ST3GAL2;RPS14;REV1;THRB;RPL9;RPS12;RPL41;RPS20;PTMS;RPL18A;RPS13;RPS19;RPS23;SRBD1;RPS4X;EEF1D;GOLPH3;RPS11;POLR2A;RPL13;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;NR4A2;MMS19;RPL37;RPL11;RPS18;EEF1B2;ALAS1;PWP1;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;POLR2F;MEF2A;RPL28;ATM;RPS24;RPS27;RPL14;RPL26;MRPS7;MRPS6;SARS1;RPL10;MRPS18A;RPL7;RPA1;DTX1;MRPL52;GCNT1;RAD50;DBF4;RPL10A;MRPL24;HARS1;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;EEFSEC;RPS25;POLR2E;RPL15;RPSA;RPS7;RPL38;GAL3ST2;TYMS;RPLP0;RPL27;RFC3;E2F1;RRBP1;RPL36A;THAP1;TOP3A;POLE2;RPS26;MCM8;RPL35A;RMI2;CDC45;FARSB;RPS29;BRCA1;RPL8;RPL36;RPA3;POLR2G;MRPL35;GTPBP2;ING4;PPP5C;RPS3;RRAGC;RPL13A;EPC1;POLA1;ABCF1;B4GALT5;HUS1;ASMT;MRPL34;EXT2;POLD1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5818679315633054,1.5540671440194742,0.048027444253859346,0.6172840324578,1.0,9/48,6.30%,PDE4D;CASQ2;DMD;TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA
prerank,leukotriene metabolic process (GO:0006691),0.6693928296236419,1.55396738914644,0.07172131147540983,0.6139543167224355,1.0,2/19,0.87%,GGT5;GGT1
prerank,positive regulation of axonogenesis (GO:0050772),-0.49543879204547653,-1.5531973514091169,0.023758099352051837,0.280848002819586,1.0,10/43,8.75%,PLXNA2;ROBO1;TIAM2;PLXNA4;SLIT2;MACF1;SEMA7A;RHOA;TIAM1;PLXND1
prerank,calcium ion homeostasis (GO:0055074),0.5135249895572271,1.552752446387998,0.034482758620689655,0.6143047533459042,1.0,18/95,8.35%,ATP13A5;PTH1R;ATP2A3;ATP2C1;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;TFAP2B;SNCA;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1;STC2
prerank,response to calcium ion (GO:0051592),0.5083757756439938,1.5525296657470962,0.027906976744186046,0.611350480790445,1.0,22/102,11.38%,TRPC3;CASQ2;MEF2C;TRPC1;RASGRP2;KCNMB1;ADCY8;PPP3CA;ITPKB;CPNE7;SLC25A13;SCN5A;RYR2;STIM1;SYT1;RYR3;PKD2;HPCA;CPNE4;BRAF;CHP2;SYT2
prerank,determination of heart left/right asymmetry (GO:0061371),0.5966860537560637,1.5525069623515293,0.06463878326996197,0.6078533213810642,1.0,6/42,3.37%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,cellular response to inorganic substance (GO:0071241),0.652597491345446,1.5517439300658498,0.06790123456790123,0.6066766895677081,1.0,1/21,0.12%,GUCY1B1
prerank,lipid modification (GO:0030258),0.5795513553868447,1.5505702843774345,0.05197132616487455,0.6070403333164441,1.0,5/37,3.82%,DGKB;MBOAT2;DGKH;DGKG;PLPPR5
prerank,xenobiotic transport (GO:0042908),-0.6232042126030639,-1.550349077469556,0.02490421455938697,0.28640466177331225,1.0,6/16,7.48%,SLC47A1;GJA1;ABCG2;SLC22A4;SLC7A5;ABCA3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.559533778789841,-1.5491060547972433,0.023504273504273504,0.28779900775320605,1.0,12/25,17.93%,EPHA4;TAF1;PML;PRKCG;RPL11;TRIM39;HSP90AB1;OPHN1;HIPK2;RPL23;HFE;RPS7
prerank,acidic amino acid transport (GO:0015800),-0.596974338972002,-1.5490690914970129,0.035781544256120526,0.2862527990271865,1.0,7/17,16.03%,SLC6A13;SLC1A3;SLC6A6;GJA1;SLC6A1;SLC25A22;ARL6IP5
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6567139009403835,-1.548430599286754,0.02443609022556391,0.2861465439082801,1.0,7/13,19.04%,SP100;MDFIC;APOD;SUFU;TPR;PARK7;CHP1
prerank,regulation of transmembrane transport (GO:0034762),0.6278049439057719,1.5481240186359932,0.07889908256880734,0.611800565399762,1.0,4/31,1.12%,ACE2;KCNJ8;NEDD4L;KCNJ12
prerank,fatty acid transmembrane transport (GO:1902001),-0.587828895925171,-1.5481091545862562,0.02004008016032064,0.2853059474259702,1.0,6/19,9.91%,PRKAG2;SLC2A1;CPT1A;SLC25A20;CPT2;ACACA
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.6584596582857516,-1.5479736688621908,0.03415559772296015,0.2839933771844922,1.0,4/12,8.76%,IGF1;SORBS1;IGF2;AKT1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.58407914048913,1.5475731254928158,0.05442176870748299,0.6100269495303798,1.0,14/41,14.03%,ACE2;GNG2;KCNJ12;KCNMB1;AKAP6;ANK3;PDZK1;KCNE5;STAC;KCNJ3;KCNJ6;PIRT;KCNMA1;ANK2
prerank,actin filament bundle assembly (GO:0051017),0.5955068407348021,1.5470020241612734,0.05304518664047151,0.608293588308473,1.0,4/33,1.13%,MYO1B;EPS8;CALD1;AIF1L
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.49673847414366745,1.5462190699866458,0.025525525525525526,0.6073435117791995,1.0,17/117,6.93%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;NPSR1;PRKAR2B;GPR45;ADCY9
prerank,positive regulation of organelle organization (GO:0010638),-0.5341866450723367,-1.5452607001627798,0.03665987780040733,0.2888624314528313,1.0,17/32,20.13%,ANXA2;ANXA1;SORBS3;RAB3GAP1;IRGM;C2CD5;P2RX7;LMAN1;UVRAG;SURF4;PFDN2;SYNJ1;RAB3GAP2;STX18;ADRB2;PPARGC1A;TMED9
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.49506098755513467,-1.5438985307557496,0.01583710407239819,0.29095123336917944,1.0,16/45,13.44%,SMAD3;BMP7;PTPN3;TOM1L2;BMP4;GAS1;WEE1;TOM1L1;FOXC1;PLK2;CHFR;BTG3;NABP1;TGFB1;TRIM35;ZW10
prerank,amyloid fibril formation (GO:1990000),-0.48350492636849085,-1.5434520413094108,0.0267639902676399,0.29053310422938156,1.0,13/51,8.57%,TSPAN5;SNCAIP;GSN;APP;B2M;HSPG2;ADAM10;IAPP;GGA2;FKBP1A;H3-3A;CST3;TGFBI
prerank,actin filament-based transport (GO:0099515),0.6373801761973592,1.542193015424749,0.10183299389002037,0.616802775265187,1.0,4/21,8.19%,MYO1B;WASL;ACTN4;MYO6
prerank,negative regulation of proteolysis (GO:0045861),-0.5152075387654559,-1.541482428027709,0.02654867256637168,0.29395967704721077,1.0,9/34,9.39%,TIMP3;EPHA4;PTPN3;GAS1;TIMP2;LRRK2;CST3;AKT1;ECM1
prerank,positive regulation of bone mineralization (GO:0030501),-0.5153100095058774,-1.5409797896310595,0.02207505518763797,0.2936696199803238,1.0,18/35,15.76%,BMP6;WNT4;BMP7;OSR1;BMPR2;BMP4;ADGRV1;ACVR1;FBN2;ANO6;KL;ATRAID;P2RX7;TGFB1;TMEM119;CCN1;PKDCC;BMPR1A
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5719599370889759,1.5402129649809766,0.05719557195571956,0.6197714837253891,1.0,8/45,3.05%,SLC30A10;PLCE1;GAB1;PTK2;PIK3R1;NCK2;BCAR1;PIK3CA
prerank,amino acid import across plasma membrane (GO:0089718),-0.5569820222585,-1.5398450799116679,0.04225352112676056,0.294919082094599,1.0,9/24,6.94%,SLC6A13;SLC47A1;SLC1A3;SLC16A2;SLC6A6;SLC7A2;SLC6A9;SLC22A4;SLC7A5
prerank,detection of calcium ion (GO:0005513),0.7136592394816473,1.5388132299660282,0.08552631578947369,0.6210370708046125,1.0,5/13,8.40%,CASQ2;KCNMB1;RYR2;STIM1;SYT1
prerank,ethanol metabolic process (GO:0006067),-0.6717849744142838,-1.5381170853196304,0.017013232514177693,0.297562907765964,1.0,3/12,13.44%,ALDH1A1;SULT1A1;ADH1A
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6481716416689167,1.5377588792773185,0.060903732809430254,0.6209421453928149,1.0,5/24,2.30%,DLC1;ARHGAP6;PIK3R1;PHLDB2;WAS
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.6729358914546072,-1.5375295747746676,0.035849056603773584,0.29735398038522187,1.0,7/11,19.48%,TGFBR2;FGFR2;WNT5A;STAT1;TBX1;CHRD;CTNNBIP1
prerank,heterochromatin organization (GO:0070828),-0.6323234907908075,-1.537218879078779,0.02385685884691849,0.29654014807489626,1.0,7/14,20.13%,MECOM;SETD7;PRDM16;EZH1;SNAI1;SETDB1;HP1BP3
prerank,actin filament bundle organization (GO:0061572),0.5991588409612219,1.5366423817685708,0.046966731898238745,0.6211073087366245,1.0,4/33,1.13%,MYO1B;EPS8;CALD1;AIF1L
prerank,actin filament network formation (GO:0051639),0.7171387391629864,1.536548449684905,0.09071729957805907,0.618033119740215,1.0,3/11,7.03%,CARMIL1;SPIRE1;PLS3
prerank,dendritic spine morphogenesis (GO:0060997),0.6986291680654488,1.5362335900988648,0.0841683366733467,0.6157077333923106,1.0,3/15,3.93%,PTEN;DOCK10;WASL
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6924752550000031,1.536199541264777,0.09312638580931264,0.6125080820567065,1.0,6/13,4.25%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;FGF2
prerank,negative regulation of T cell activation (GO:0050868),0.5850201767490077,1.5361557432954391,0.06093189964157706,0.6093952668978304,1.0,4/35,3.87%,GLMN;TNFRSF21;PTPN22;PAG1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.6465948973593689,-1.5361159754123939,0.04597701149425287,0.29778942373115663,1.0,4/13,8.76%,IGF1;SORBS1;IGF2;AKT1
prerank,translation (GO:0006412),-0.3791365866451898,-1.5356477903916528,0.003663003663003663,0.2973587991291646,1.0,93/208,26.69%,RPLP1;RPS14;LARS2;RPL9;RPS12;RPL41;RPS20;RPL18A;RARS2;RPS13;RPS19;RPS23;SRBD1;RPS4X;EEF1D;RPS11;RPL13;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;RPL37;KARS1;RPL11;RPS18;EEF1B2;CARS1;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RWDD1;RPL26;MRPS7;MRPS6;QARS1;SARS1;RPL10;MRPS18A;RPL7;MRPS24;MRPL52;RPL10A;MRPL24;HARS1;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;EEFSEC;RPS25;MARS2;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;RRBP1;RPL36A;DRG2;FARSA;FTSJ1;RPS26;PPA1;RPL35A;APEH;FARSB;RPS29;TRMT112;RPL8;RPL36;MRPL35;GTPBP2;TMA7;RPS3;RPL13A;ABCF1;ASMT;MRPL34
prerank,axon development (GO:0061564),0.5165928535719986,1.5344914103025773,0.038397328881469114,0.6114063775981504,1.0,21/78,12.83%,GRM7;RTN4RL1;SEMA5A;SVBP;DHFR;NTNG2;RYK;CNTN4;SLITRK5;ANK3;CCK;SLITRK1;MARK2;GAP43;ARHGAP35;PLP1;CTNNA2;BRSK1;PAK3;ZDHHC17;SLITRK2
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.49495700900845124,-1.5335682255576566,0.021897810218978103,0.3006061139499131,1.0,16/43,12.78%,BMP6;IGF1;WNT4;BMP7;IL6R;BMPR2;BMP4;IL6ST;ACVR1;ZHX3;YAP1;FBN2;ATRAID;CCN4;TMEM119;CCN1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6366499028986252,1.533454994074604,0.07214428857715431,0.6115741581154365,1.0,6/26,7.50%,SLC30A10;SLC25A33;CCN6;ABCD2;SNCA;PIKFYVE
prerank,central nervous system myelination (GO:0022010),0.7174762003953413,1.5333906008192246,0.09615384615384616,0.6085624849122382,1.0,4/11,9.77%,PTEN;B4GALT6;TENM4;PLP1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.5207775208971787,-1.532495605407011,0.028077753779697623,0.3016631588877467,1.0,14/33,25.65%,IGF1;IAPP;TFRC;AKT1;FLCN;BNIP3;ADCK1;GPX1;VAT1;PRELID1;TMEM14A;PSMD10;BCL2L1;PRKN
prerank,neural crest cell differentiation (GO:0014033),0.6609049515390799,1.5322325612492271,0.0989247311827957,0.6092585322118315,1.0,3/18,2.80%,MEF2C;CDH2;NRG1
prerank,response to metal ion (GO:0010038),0.5328262337892219,1.531222489624405,0.043859649122807015,0.609318411679286,1.0,6/67,6.30%,TRPC3;NEDD4L;TRPC1;PPP3CA;SLC25A13;SNCA
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5361148522126566,-1.5308968334660022,0.024439918533604887,0.3042399294150754,1.0,5/26,1.64%,IGF1;SORBS1;OSBPL8;OCLN;RHOQ
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6206818249205074,-1.5281148849349973,0.028901734104046242,0.30962806085415984,1.0,6/16,4.69%,IGF1;IGFBP2;IGFBP5;IGFBP6;IGFBP4;IGFBP3
prerank,regulation of keratinocyte migration (GO:0051547),0.7131818769499976,1.5279942262872115,0.07755102040816327,0.6165287178539137,1.0,6/12,12.36%,PTEN;MAPRE2;FGF10;MTOR;MAP4K4;IQSEC1
prerank,nitric oxide metabolic process (GO:0046209),-0.6243090256353314,-1.5278980231724126,0.04911591355599214,0.30857391083276864,1.0,6/14,18.75%,NOS3;CYP1B1;AKT1;GCH1;NOS1;CYB5R3
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7102853813146013,1.5272308790009477,0.10062893081761007,0.6158358587746147,1.0,2/12,1.87%,PTEN;BTRC
prerank,activin receptor signaling pathway (GO:0032924),-0.6229438098040179,-1.5262292028725262,0.04066543438077634,0.31117303986380573,1.0,3/15,4.09%,SMAD3;TGFBR1;ACVR1
prerank,cellular component disassembly (GO:0022411),-0.47528519091354443,-1.5257901568937278,0.02386634844868735,0.3107238613158313,1.0,18/53,15.44%,GSN;ADAMTS5;TLL1;BSG;CAPN2;TIMP2;HTRA1;ADAM10;ADAMTS15;KLK2;CAPNS1;MMP14;ADAM15;CAPN1;MMP19;CTSS;WASHC1;MMP2
prerank,cellular response to heat (GO:0034605),0.590791612099738,1.5254557968521227,0.06204379562043796,0.6182004446279064,1.0,1/35,0.04%,ANO1
prerank,extracellular matrix disassembly (GO:0022617),-0.4758325806449852,-1.5248267228717505,0.026442307692307692,0.31157909097612163,1.0,18/53,15.44%,GSN;ADAMTS5;TLL1;BSG;CAPN2;TIMP2;HTRA1;ADAM10;ADAMTS15;KLK2;CAPNS1;MMP14;ADAM15;CAPN1;MMP19;CTSS;WASHC1;MMP2
prerank,sensory organ development (GO:0007423),-0.46707743989423434,-1.5245223901334357,0.025510204081632654,0.31075000782999745,1.0,13/51,16.97%,PBX1;SMOC1;CHD7;SHROOM2;PBX3;RBP4;FOXC1;STRA6;ATF6;MEIS2;HIPK2;MEIS1;RAB18
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5725531557875301,1.5241343900639859,0.07224334600760456,0.6191581395772165,1.0,8/42,4.30%,LIMS1;ECM2;GCNT2;NOTCH1;PTK2;NF1;CORO2B;MINK1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.7250586361686094,1.5230189488279064,0.07912087912087912,0.6194886163575613,1.0,3/11,3.39%,NR1H3;SCARB1;LDLR
prerank,clathrin coat assembly (GO:0048268),0.6780943267093753,1.5225536536487265,0.07974137931034483,0.6177648209577881,1.0,4/15,10.21%,SGIP1;PIK3C2A;AP2S1;HIP1
prerank,embryonic organ morphogenesis (GO:0048562),-0.48063130213198085,-1.5223264884976857,0.027777777777777776,0.3146179069131979,1.0,17/42,14.68%,FBN1;EFEMP1;PDGFRA;HOXB3;RBP4;MFAP5;FGFR2;ACVR1;HOXA3;RARG;SIX1;FBN2;TBX1;HOXB9;ID2;SOX17;HOXC4
prerank,anion transport (GO:0006820),-0.5148869485090626,-1.5219488488760486,0.025477707006369428,0.313960107209907,1.0,6/33,4.69%,SLC13A4;SLC13A3;SLCO2B1;SLC26A7;ABCG2;SLC22A6
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.43337356321911036,-1.5218819572663207,0.01907356948228883,0.31257757995751956,1.0,27/87,9.05%,TGFBR3;ZMIZ1;COL1A2;COL3A1;SMAD3;SMAD6;CDH5;FMOD;CLDN5;TGFBR2;TGFBR1;SMAD9;ADAM9;SMAD7;ACVR1;PXN;ID1;SKI;APPL2;ACVRL1;SMURF1;PRKCZ;RHOA;FKBP1A;ZYX;USP15;PARD3
prerank,regulation of melanin biosynthetic process (GO:0048021),0.7414673963232228,1.520761541648753,0.09502262443438914,0.6201306162443099,1.0,5/10,12.24%,RAPGEF2;ZEB2;ATP7A;APPL1;OPN3
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6645619405128993,-1.5204235613056265,0.03518518518518519,0.31462085605306633,1.0,7/12,20.50%,PTPN14;BMP4;IFI27;TGFB1;SIRT7;TPR;NUP214
prerank,sphingolipid metabolic process (GO:0006665),-0.4151256154957226,-1.520043395626909,0.0113314447592068,0.31391786152479023,1.0,43/108,24.73%,PLPP3;SGMS1;ESYT2;CERT1;SGMS2;ELOVL7;ST6GALNAC3;ACER2;SMPD3;HACD4;HACD3;HEXA;HEXB;ACER3;CSNK1G2;NSMAF;B3GALNT1;PSAP;SPNS2;DEGS2;ST6GALNAC6;PLPP1;ALDH3A2;ESYT3;PLA2G15;SPHK1;UGCG;SPTLC2;VAPA;SUMF2;SERINC1;ELOVL1;CLN8;NEU3;ORMDL3;GLB1;ENPP2;SUMF1;SGPL1;PPM1L;SPTSSA;ORMDL2;PDXDC1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.4313963504318955,-1.5195198546793942,0.015189873417721518,0.3138330921908883,1.0,30/88,13.07%,SULF1;NRP2;NRP1;TEK;APOE;SPARC;F3;CAV1;XDH;PTPRM;BMPR2;THBS1;BMP4;TGFBR1;ANGPT1;VEGFD;VEGFC;ACVRL1;WNT5A;STAT1;AKT1;TIE1;PPP1R16B;HIF1A;ECM1;CDH13;KDR;ITGB3;FLT4;ATOH8
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6988576551171646,1.5189922210322648,0.08149779735682819,0.6225353657930923,1.0,3/15,2.70%,GGT5;GGT1;CHAC1
prerank,embryonic digit morphogenesis (GO:0042733),0.6712613224622684,1.5187852651184428,0.07171314741035857,0.6201724333048383,1.0,4/18,3.07%,TBX2;MAP3K20;TBX3;ECE1
prerank,response to iron ion (GO:0010039),-0.6651086164527366,-1.518130033223989,0.033271719038817,0.31563952819270785,1.0,4/12,9.24%,BMP6;B2M;ACO1;HIF1A
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6373333222990907,1.517981355124882,0.0931098696461825,0.6196306726616688,1.0,4/20,3.67%,CASQ2;NEDD4L;HECW2;STK39
prerank,endocardial cushion development (GO:0003197),0.6364758462420018,1.5179539256336594,0.07268722466960352,0.6166399917274991,1.0,4/21,1.22%,TBX2;HEYL;NOTCH1;TBX20
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.5955348917851015,-1.5173943342650051,0.026515151515151516,0.3159202671314727,1.0,8/16,14.26%,BMP7;SOX13;SIX1;RREB1;FLCN;METRNL;PTGS2;FTO
prerank,glutathione biosynthetic process (GO:0006750),0.7085331096055505,1.5173091073651948,0.09761388286334056,0.6155157823247409,1.0,2/11,2.70%,GGT1;CHAC1
prerank,B cell receptor signaling pathway (GO:0050853),0.6022131771673542,1.5169540690212209,0.08477842003853564,0.6135517128081728,1.0,4/32,2.48%,MEF2C;PIK3CD;BCAR1;RFTN1
prerank,cell-matrix adhesion (GO:0007160),0.5045401691693352,1.5157015330616268,0.0315955766192733,0.6143639072539696,1.0,12/95,3.63%,DLC1;PTPRK;ITGA1;ITGA4;ITGA7;ECM2;VTN;VCL;PEAK1;FERMT2;CD96;ITGB5
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5134252579835331,-1.5155688743285793,0.032397408207343416,0.3191411125535363,1.0,13/35,12.24%,ZMIZ1;RBFOX2;NR3C1;ESR1;DDX5;NR3C2;AR;YAP1;TMF1;EGLN2;PGR;KDM3A;PLPP1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.581107498695463,1.5149816874673596,0.07692307692307693,0.6135694607874811,1.0,15/39,11.63%,UTRN;DMD;NEDD4L;HECW2;FGF12;FXYD2;STK39;FGF13;ANK3;HECW1;NETO1;SCN2B;RANGRF;FGF11;FGF14
prerank,tube closure (GO:0060606),0.5998652716818457,1.5149006331647268,0.07939508506616257,0.6108217212171374,1.0,3/31,2.41%,DLC1;VASP;GRHL3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.6792754674229498,1.5136085923420022,0.09611451942740286,0.6116823963836546,1.0,6/17,7.70%,KCNJ8;NEDD4L;KCNE4;SCN5A;RYR2;KCNE5
prerank,mesenchyme development (GO:0060485),-0.6254561341028715,-1.5126511624919015,0.026717557251908396,0.32503498725616553,1.0,5/15,3.45%,BMP7;FGFR2;BMPR2;BMP4;TGFBR1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.5776459647725106,1.5123843022776515,0.07664233576642336,0.6125987646592588,1.0,9/39,7.70%,TRPC6;UTRN;NEDD4L;FGF12;FXYD2;STK39;CACNA1D;PDZK1;KCNE5
prerank,regulation of autophagy (GO:0010506),-0.37019215073725736,-1.51204248015595,0.0,0.3250538287999415,1.0,68/216,19.58%,PRKAG2;DAPK1;LEPR;DCN;FOXO1;FOXO3;NUPR1;SNX6;LRRK2;WDR41;ACER2;TPCN1;DAP;RASIP1;SNX32;PLK2;EXOC4;STAT3;CAPNS1;ATP6V1G1;PIK3CB;AKT1;MCL1;EEF1A1;IRGM;CAPN1;FOXK1;DAPL1;FLCN;ATF6;PSAP;GFAP;ATP6V0B;ZC3H12A;ZKSCAN3;PIP4K2B;TRIM27;OPTN;VPS35;ERN1;SH3GLB1;EIF4G3;RAB8A;ATP6V0A1;PRKAG3;ATM;PRKAB1;MET;TICAM1;BNIP3;WASHC1;ATP6V0A2;FBXL2;SREBF1;PRKAA2;GPR137;MTMR3;TRIM8;SIRT2;RRAGB;TRIM14;LAMTOR5;SH3BP4;TMEM59;MT3;PIM2;ATG101;ORMDL3
prerank,nitric oxide biosynthetic process (GO:0006809),-0.6366607067623669,-1.5114102304586887,0.05765407554671968,0.3251732565333844,1.0,6/13,18.75%,NOS3;CYP1B1;AKT1;GCH1;NOS1;CYB5R3
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6337501739212101,-1.5111906415005114,0.03518518518518519,0.32418837334396544,1.0,6/12,10.24%,ADAMTS12;DCN;SEMA6A;XDH;PIK3CB;DAB2IP
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6611126435216237,-1.5110317208644926,0.04681647940074907,0.3230551295140671,1.0,6/11,14.16%,SEMA6A;ADAMTS9;THBS1;KLF2;PIK3CB;CREB3L1
prerank,epithelial cell differentiation (GO:0030855),-0.42691532897652823,-1.5110226451627424,0.008241758241758242,0.321582129544314,1.0,21/88,16.16%,DAB2;MAF;FSTL1;ANXA4;FGFR2;BMP4;ANXA1;CPT1A;CNN3;SIX1;TBX1;AKT1;CTSB;FZD7;KDR;ANXA7;HDAC1;GATA6;BDH2;CASP6;KDM6B
prerank,negative regulation of cellular component movement (GO:0051271),-0.6014277111239795,-1.5109372390572509,0.04660194174757282,0.320273769403927,1.0,7/15,15.08%,TGFBR3;FBLN1;SP100;CD9;CCDC125;ACTN1;FRMD5
prerank,hemopoiesis (GO:0030097),-0.4268564040326047,-1.5106458940153034,0.016129032258064516,0.31952667213164526,1.0,23/87,13.91%,TGFBR3;NOTCH2;ZBTB16;FLT1;MECOM;TEK;MFAP5;TGFBR2;FGFR2;BMP4;ETV6;CD34;WNT5A;KIT;FLCN;KDR;CD164;MKNK2;TGFB1;FLT4;FLT3LG;TAL1;SFRP1
prerank,positive regulation of cell differentiation (GO:0045597),-0.3643962684111685,-1.5103708813604544,0.0,0.31867816834592533,1.0,64/237,12.78%,BMP6;RANBP3L;IGF1;DAB2;PLCB1;SMAD3;ZBTB16;COL1A1;WNT4;BOC;PDPN;MEDAG;PRKCH;BMP7;CCN2;TMEM64;SLC6A6;CDON;IL6R;TGFBR2;BMPR2;BMP4;IL6ST;GJA1;TGFBR1;TCF4;CSF1;ARHGEF2;LEF1;ACVR1;CD34;HOXA5;ZHX3;IGFBP3;SDCBP;AR;YAP1;ACVRL1;NBL1;RHOA;FBN2;MAPK14;FOXC1;SYAP1;VWC2;NOCT;WDFY2;ATRAID;TIAM1;AKT1;CMKLR1;TMEM100;CTNNA1;CCN4;CARM1;IL18;ZC3H12A;KDR;TGFB1;BCL9L;TMEM119;ID2;MEF2A;CCN1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6644481444835855,-1.5097044823325751,0.062135922330097085,0.31889487102566955,1.0,3/10,2.43%,ERRFI1;ENPP1;CAV1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.5648477230792868,-1.5092041601554904,0.045454545454545456,0.3187774656319213,1.0,9/22,10.62%,ROBO1;EFNB2;CDH5;NRP1;SLIT2;EPHB4;ID1;AKT1;KDR
prerank,regulation of muscle contraction (GO:0006937),0.6198080096819788,1.5087305647568425,0.07809523809523809,0.6209461516205417,1.0,4/26,3.41%,PLCE1;ATP1A2;MYL9;CHRNA3
prerank,dendritic cell migration (GO:0036336),0.6770872326526531,1.508453301777679,0.07942973523421588,0.6189158397073605,1.0,2/16,5.78%,EPS8;CXCR2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.44798211320859554,-1.5080796096923612,0.007462686567164179,0.3201565444301577,1.0,13/57,10.32%,IGF1;IL31RA;IL15;IL6R;IL6ST;GHR;PARP9;CNOT7;PARP14;STAT3;KIT;TNFRSF1A;IL18
prerank,primary neural tube formation (GO:0014020),0.6029842458872209,1.5079947727517942,0.07358490566037736,0.6175596893788537,1.0,3/30,2.41%,DLC1;VASP;GRHL3
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6339114936125192,1.5079526530821246,0.06427221172022685,0.6148076474981803,1.0,2/26,3.74%,ANO1;ADCY8
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5854087860266538,1.5068854344630627,0.07476635514018691,0.6154593534278439,1.0,8/33,4.25%,MEF2C;TBXA2R;NOTCH1;RGCC;STARD13;MECP2;PDCD10;FGF2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7131069234872393,1.506300193792605,0.11064718162839249,0.6143865019429952,1.0,5/11,7.70%,CASQ2;NEDD4L;STK39;BIN1;KCNE5
prerank,activation of protein kinase B activity (GO:0032148),-0.5201525623275843,-1.5060089659399392,0.029411764705882353,0.3237459914217146,1.0,13/29,19.09%,IGF1;NTRK3;OSBPL8;GAS6;FGF1;WNT5A;AKT1;IL18;TXN;PPIA;PDPK1;PARK7;MT3
prerank,membrane assembly (GO:0071709),0.5576749768317083,1.5052353644981225,0.07207207207207207,0.6147868259405423,1.0,10/34,11.13%,PTEN;CEL;RFTN1;NRXN1;SPTBN1;ANK3;EMP2;IL1RAPL1;UBXN2B;STX4
prerank,lung epithelium development (GO:0060428),-0.6665697030522137,-1.5051902592948199,0.03977272727272727,0.32423335857164076,1.0,5/10,14.82%,ERRFI1;BMP4;RCN3;STRA6;PKD1
prerank,purine-containing compound catabolic process (GO:0072523),-0.6284189303622569,-1.505103839117148,0.03525046382189239,0.3229901543445092,1.0,9/13,25.02%,XDH;DPYD;NT5E;GDA;GPX1;NT5C1A;PNP;NT5C2;NT5C
prerank,positive regulation of signal transduction (GO:0009967),-0.36695695459189753,-1.504851640852401,0.004016064257028112,0.3221477087054878,1.0,55/238,11.85%,TSPAN5;BMP6;SULF1;IGF1;SORBS1;ROBO1;ZMIZ1;NRP1;NTRK3;PTGIS;VWF;TEK;CCBE1;F3;LIMS2;MACF1;RSPO3;JCAD;SASH1;SHANK3;FGFR2;NOS3;IL6ST;ITGA5;TGFBR1;KAT2B;LRRK2;KLF2;SKI;SMO;IGF2;SLC39A14;GAS6;MN1;FGF1;CCN3;SULF2;YAP1;BMP2K;PRKCZ;RSPO2;PRKCB;PTK2B;STAT3;EVC;TTC23;HIF1A;TRIM16;NLGN2;DAB2IP;VPS35;ITGB3;POGLUT1;ERN1;ADAMTS3
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.5710554650150058,-1.5036680696098654,0.041916167664670656,0.3235458169058679,1.0,8/21,19.09%,IGF1;CTSH;LGALS9;KARS1;KDR;MAPK3;ZFP36L2;MT3
prerank,atrioventricular valve development (GO:0003171),0.6687245991422386,1.5021344563810963,0.09267241379310345,0.6213134018410075,1.0,4/14,1.81%,HEYL;NOTCH1;TBX20;SLIT3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.44506538169383153,-1.5006964356877532,0.012106537530266344,0.3293135533196406,1.0,24/65,13.92%,FBN1;LDLRAD4;SMAD3;SMAD6;SKIL;CAV1;HTRA3;TGFBR2;SMURF2;TGFBR1;SNX6;SMAD7;SKI;SMURF1;FBN2;PRDM16;FKBP1A;EMILIN1;TGFB1;BCL9L;STRAP;PPARA;UBB;LTBP1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6364809845295136,1.500555156765928,0.08731808731808732,0.6233652533333038,1.0,4/20,1.63%,ITGA4;PLA2R1;RGCC;GPER1
prerank,defense response to tumor cell (GO:0002357),0.7200459228718498,1.500541724876477,0.1038961038961039,0.6205683664633559,1.0,2/10,1.51%,DLEC1;RBMS3
prerank,regulation of cell killing (GO:0031341),-0.5975245841833621,-1.4998050923214357,0.05642023346303502,0.33025861890578795,1.0,6/16,13.32%,CD55;CFH;WNT5A;ICAM1;FZD7;CYBA
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5675969377607348,-1.4997423524291902,0.04604051565377532,0.32900643538895513,1.0,5/19,7.48%,APP;KLF4;SLCO1C1;KLF2;MAP2K5
prerank,regulation of feeding behavior (GO:0060259),0.7072651316969584,1.4984403909524315,0.11479028697571744,0.6240701542932807,1.0,1/11,0.11%,SGIP1
prerank,action potential (GO:0001508),0.5576752848773715,1.4984278289041078,0.07360861759425494,0.6213073766730093,1.0,12/44,8.86%,DMD;GPER1;CACNA1H;KCNE4;KCND2;AKAP6;SCN2A;SCN5A;ANK3;SCN8A;KCNE5;SCN9A
prerank,regulation of T cell migration (GO:2000404),-0.5902015968574265,-1.4978574274322463,0.046875,0.3321924002023485,1.0,5/18,6.59%,APP;APOD;LRCH1;CXCL12;RHOA
prerank,artery development (GO:0060840),-0.5509599569079796,-1.4978205706311347,0.05108055009823183,0.3308551220596746,1.0,8/23,8.16%,ROBO1;NRP1;BMPR2;TGFBR1;SMAD7;ACVRL1;TBX1;STRA6
prerank,endocrine system development (GO:0035270),-0.5553155163622792,-1.4975792482001826,0.05165289256198347,0.32995087095772824,1.0,7/21,8.16%,WNT4;GLI2;DKK3;TGFBR1;SIX1;TBX1;STRA6
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.6320778215708245,-1.4973405754109606,0.05566218809980806,0.3292039392714349,1.0,4/12,6.59%,JAM2;APP;CXCL12;RHOA
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.39439572070017326,-1.4967781669668243,0.0031847133757961785,0.32917421247151,1.0,34/136,12.56%,HDAC4;PTGIS;BMP7;SP100;ANXA4;NUPR1;SUFU;ESR1;KLF4;TCF7L2;SMAD7;TAF1;ID1;IRAK2;GAS6;ARRB1;WWP2;DAP;GLIS2;SFRP4;BHLHE40;ID3;CYP1B1;MAP2K5;TMSB4X;CMKLR1;NLRC5;IRAK3;DAB2IP;ZC3H12A;MDFI;CEBPG;PTCH1;ID2
prerank,positive regulation of endocytosis (GO:0045807),0.5559310584309267,1.4966881722777523,0.07992895204262877,0.6238358628148917,1.0,10/45,7.40%,SGIP1;NEDD4L;VTN;LDLRAP1;AXL;GPC3;IL4;CBLL1;SNCA;PPT1
prerank,positive regulation of binding (GO:0051099),-0.41656868774060424,-1.4962655489028216,0.01084010840108401,0.32905866132935996,1.0,30/84,16.89%,IGF1;APOE;APP;CAV1;CLDN5;BMP4;B2M;TCF7L2;LRRK2;TAF1;SKI;PARP9;FOXC1;FKBP1A;AMFR;TIAM1;DTX3L;IDE;CEBPG;RPL11;ADD1;NME1;RAN;MET;TXN;PKD1;HIPK2;HFE;HMGB2;SIRT2
prerank,negative regulation of bone mineralization (GO:0030502),-0.6113841587018279,-1.4961583632516526,0.056795131845841784,0.3278965009464047,1.0,4/13,9.39%,ENPP1;SRGN;PTK2B;ECM1
prerank,negative regulation of angiogenesis (GO:0016525),-0.4259785628622407,-1.4959629720102223,0.013192612137203167,0.3269480785130847,1.0,30/84,11.35%,SULF1;DCN;ROCK2;TEK;SEMA6A;ADAMTS9;SPARC;CLDN5;THBS2;PTPRM;THBS1;KLF4;KLF2;HSPG2;HOXA5;NIBAN2;NPR1;GTF2I;ADAMTS1;FOXC1;STAT1;SERPINF1;SEMA3E;PIK3CB;HGS;STAB1;EMILIN1;DAB2IP;PML;ECSCR
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6139730161131957,1.4953733057760894,0.09126984126984126,0.6250280347452751,1.0,7/25,6.30%,CACNB2;TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA
prerank,regulation of peptide hormone secretion (GO:0090276),0.5203385773600931,1.495349355244502,0.056140350877192984,0.6223455414583453,1.0,18/67,12.84%,CACNA1C;RAPGEF4;PER2;ITPR2;IL1B;FFAR2;GIPR;SNAP25;ITPR1;TFAP2B;HTR2C;RAP1A;CACNA1D;GCK;CACNA1A;SLC8B1;KCNG2;RASL10B
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.6403607829399082,1.494511890842796,0.09183673469387756,0.6220772913443768,1.0,6/20,5.65%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2;TFAP2B
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6780854572936645,-1.494494817252665,0.040740740740740744,0.32808427132579965,1.0,8/10,28.35%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SIRT3;RACK1;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6780854572936645,-1.494494817252665,0.040740740740740744,0.32808427132579965,1.0,8/10,28.35%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SIRT3;RACK1;SPHK2
prerank,artery morphogenesis (GO:0048844),0.60458237601077,1.494479374735371,0.07632093933463796,0.619451132996016,1.0,5/30,2.17%,PDGFRB;TBX2;HEY2;NOTCH1;NF1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5510471847622297,1.4940363496694615,0.07155322862129145,0.6181661630217837,1.0,9/48,7.34%,GUCY1B1;GUCY1A1;GUCY2D;ADCY8;ADCY3;ADCY6;SLC26A1;ADCY9;ADSL
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.638144932030536,1.4937699100227235,0.08076923076923077,0.6162948067020818,1.0,5/22,7.81%,DYNLL1;ROCK1;TESK1;ANKLE2;CDKN1A
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.6547286120724477,1.4929711103622165,0.1183206106870229,0.6159058600089169,1.0,5/18,7.70%,NEDD4L;ATP1A2;STK39;BIN1;KCNE5
prerank,purine nucleotide catabolic process (GO:0006195),-0.6234075347096071,-1.4928451180778208,0.04924242424242424,0.3306398070064423,1.0,9/13,25.02%,XDH;NT5E;HINT1;GDA;GPX1;NT5C1A;PNP;NT5C2;NT5C
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.6160208338961719,1.4923092960200548,0.08445297504798464,0.6151408128491286,1.0,5/27,2.30%,DLC1;ARHGAP6;PIK3R1;PHLDB2;WAS
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.6408422446946793,-1.4920652856107908,0.05851063829787234,0.331192449654969,1.0,6/12,18.65%,CYP26B1;DHRS3;KLF2;TRIM16;CALR;EZH2
prerank,visual system development (GO:0150063),-0.4876437537608386,-1.4918857696640073,0.022988505747126436,0.33026860083644083,1.0,10/37,16.97%,PBX1;SMOC1;PBX3;RBP4;FOXC1;ATF6;MEIS2;HIPK2;MEIS1;RAB18
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.6071058144171096,-1.4890812291903552,0.04431599229287091,0.33596015060629325,1.0,6/15,28.09%,MOXD1;DDC;SAT1;ASMT;SRM;SMOX
prerank,positive regulation of biosynthetic process (GO:0009891),-0.491220940269391,-1.4884342957885723,0.027210884353741496,0.33623540510425576,1.0,12/40,14.16%,SORBS1;WNT4;APOE;VIM;BMP4;RAB27A;AKT1;TGFB1;PPARA;CYBA;PLCG2;CREB3L1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6515336647015936,1.4870123004822882,0.10991379310344827,0.6284199887112605,1.0,3/14,1.63%,ITGA4;RGCC;GPER1
prerank,epithelial structure maintenance (GO:0010669),-0.6617055184308742,-1.4868300196090254,0.05137614678899083,0.3388748543365629,1.0,3/11,12.20%,CXADR;RBP4;STRAP
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.6293721106167467,-1.4867758412203051,0.06607142857142857,0.337628714452744,1.0,5/12,11.79%,CTSH;THRB;LMO2;CTSB;CTSS
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6853786482721796,1.4860281746724948,0.10931174089068826,0.6287364319769926,1.0,2/12,1.34%,IL34;PTK2
prerank,second-messenger-mediated signaling (GO:0019932),0.5034464064555731,1.4853251080242829,0.05756578947368421,0.6281518879037867,1.0,12/82,8.64%,GUCY1B1;GUCY1A1;PLCE1;INPP5A;CCRL2;ACKR3;CXCR2;RYR2;MAFA;CCR9;ACKR2;GPR62
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6205711266111367,-1.484297172628998,0.04007633587786259,0.34244268886679347,1.0,6/13,8.48%,GLUL;NOS3;DDAH1;ALDH4A1;PRODH;GLS
prerank,regulation of ion transmembrane transport (GO:0034765),0.592782045093694,1.4841897295866757,0.09444444444444444,0.6290110674468643,1.0,5/33,4.11%,KCNJ8;CASQ2;NEDD4L;KCNJ12;AKAP6
prerank,substantia nigra development (GO:0021762),0.5563472573510948,1.4840538534273926,0.07861060329067641,0.6267626757363665,1.0,2/37,0.70%,DYNLL1;GNB4
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.39064932027503896,-1.4834513276245962,0.019672131147540985,0.3433350940601625,1.0,37/132,13.84%,IGF1;DAPK1;DCN;VGLL4;FOXO1;APOE;FOXO3;APP;EZR;SNX9;LRRK2;ADAM9;CNOT7;TPCN1;MOV10;TNFRSF1B;PLK2;PRKCD;DAGLB;PIK3CB;DTX3L;IRGM;HIF1A;FLCN;ATF6;ZC3H12A;TRIM27;P2RX7;OPTN;VPS35;SH3GLB1;PPARA;GRSF1;ENTPD5;TICAM1;BNIP3;CNOT8
prerank,regulation of dendrite morphogenesis (GO:0048814),0.5948258195794855,1.4827537316473622,0.08587786259541985,0.628096002284963,1.0,17/32,18.46%,NEDD4L;RAPGEF2;SDC2;HECW2;CHRNA3;CAPRIN2;IL1RAPL1;ADGRB3;HECW1;SARM1;CUX2;LZTS1;CHRNB2;NSMF;GORASP1;GSK3B;KNDC1
prerank,neural tube closure (GO:0001843),0.5766865152325529,1.4821758658632274,0.09380863039399624,0.627242105647801,1.0,3/34,2.41%,DLC1;VASP;GRHL3
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5503210802896441,1.48198799238841,0.07733812949640288,0.6251603258389498,1.0,5/46,2.73%,DGKB;PLD1;DGKH;DGKG;PLD6
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5699515294342703,1.4814851261326456,0.09838998211091235,0.6239754467409893,1.0,11/38,11.06%,CACNA1C;CACNB2;KCNE4;CACNA2D1;CTNNA3;SCN5A;BIN1;CACNA1D;KCNE5;KCNJ3;SCN2B
prerank,glutathione metabolic process (GO:0006749),0.5656864465343374,1.4808539178025935,0.09023941068139964,0.62334227282869,1.0,4/38,4.12%,GGT5;GGT1;CHAC1;GSTT2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5699545304160956,-1.4799361784248513,0.05084745762711865,0.3507945415693052,1.0,3/17,2.43%,PRKAG2;ADIPOR2;CAV1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6598164811909641,-1.4794357171277535,0.06761565836298933,0.3507519205417822,1.0,3/10,5.51%,CD55;TGFBR2;LGALS9
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5567733649460244,1.4781311315957784,0.08224299065420561,0.6287500901589181,1.0,3/47,0.80%,PDGFRB;ACE2;PID1
prerank,axon extension (GO:0048675),-0.526622732559809,-1.4773843662322659,0.03711340206185567,0.3546754453306962,1.0,6/23,5.80%,AUTS2;ALCAM;NRP2;NRP1;SLIT2;MAP1B
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.6276747955220452,-1.4773680139602112,0.060836501901140684,0.35331143643971213,1.0,3/12,6.46%,SORBS1;IGF2;PRKCZ
prerank,carboxylic acid metabolic process (GO:0019752),-0.5089290187294857,-1.4766985329803222,0.041584158415841586,0.353747795988177,1.0,12/33,19.67%,PLA2G4A;PTGIS;DDO;ST3GAL1;SLC2A1;CSGALNACT1;CARNMT1;TBXAS1;PON3;AGXT;CYB5R3;GNE
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5654338479435862,1.4766283390474482,0.09416195856873823,0.6307969021831661,1.0,6/43,3.37%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,glycerolipid metabolic process (GO:0046486),0.7056081639323167,1.4759408846624833,0.1148936170212766,0.6303011866954012,1.0,2/11,1.88%,DGKB;DGKG
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.655285234954804,1.4757909146982748,0.09876543209876543,0.6281447266053535,1.0,10/17,21.14%,KCNG1;KCNE4;AKAP6;ANK3;KCNE5;RNF207;SUMO1;VAMP2;KCNS2;KCNAB1
prerank,blood circulation (GO:0008015),0.5461210825508811,1.4757393295835515,0.0763765541740675,0.6257040092886594,1.0,7/49,3.95%,GUCY1B1;ACE2;GUCY1A1;COL4A3;ADORA2A;ROCK1;ADCY6
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6295969352715616,1.4756217165432197,0.09343936381709742,0.6235039539469235,1.0,7/22,11.85%,PTEN;HEXIM1;CDKN1A;INCA1;NR2F2;LATS2;APC
prerank,activation of adenylate cyclase activity (GO:0007190),0.5733034745100877,1.4755353408196288,0.08442776735459662,0.6212278669320633,1.0,8/35,7.26%,EDNRA;CAP2;GIPR;ADCY8;ADCY3;ADCY6;ADCY9;CAP1
prerank,regulated exocytosis (GO:0045055),-0.3732115247946388,-1.4754285269678793,0.003067484662576687,0.3556889496291596,1.0,42/173,16.18%,IGF1;TIMP3;FN1;ABCC4;LHFPL2;LAMP2;SERPING1;VWF;PECAM1;ACTN2;APP;SPARC;PCDH7;ANXA5;THBS1;CLEC3B;ISLR;CD9;VEGFD;VEGFC;IGF2;GAS6;ARHGAP17;SRGN;TMSB4X;ECM1;PSAP;STX1A;LGALS3BP;ITGB3;TGFB1;ACTN1;RAB11FIP1;F5;APOOL;SCG3;RAB11FIP5;SERPINE1;APLP2;SYTL4;CD109;CALM1
prerank,regulation of exosomal secretion (GO:1903541),-0.5684392826434754,-1.4752096962358532,0.050505050505050504,0.3548172700290595,1.0,8/19,15.66%,SDCBP;SMPD3;PDCD6IP;SDC4;HGS;RAB7A;ATP9A;SDC1
prerank,aggrephagy (GO:0035973),0.6037903082974356,1.4749367029140967,0.07905138339920949,0.6205793716876283,1.0,1/27,0.06%,DYNLL1
prerank,peptide catabolic process (GO:0043171),0.6139707565568239,1.4741800574677182,0.09533073929961089,0.6203332047410905,1.0,6/23,3.21%,ENPEP;GGT5;GGT1;CHAC1;ECE1;ANPEP
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5554295171152981,-1.4735098895981158,0.06554307116104868,0.3577395399365685,1.0,9/18,22.56%,ESR1;KAT2B;RPS13;ZC3H12A;TGFB1;TMBIM6;PTBP3;RPS26;NUDT16
prerank,positive regulation of inflammatory response (GO:0050729),-0.4212003294817814,-1.4729828829961777,0.01366120218579235,0.3577408941420634,1.0,28/86,22.25%,APP;IL15;NUPR1;LBP;IL6ST;PDCD4;IL16;WNT5A;RPS19;CD47;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;KARS1;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;AGT;AGTR1;CD81;MDK;VAMP8;LPL
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.5185999021913317,-1.4729715319097922,0.049484536082474224,0.35639244783904755,1.0,10/26,16.55%,SMAD3;KLF4;KLF2;DDAH1;P2RX4;NOS1AP;AKT1;PTGS2;HSP90AB1;TLR4
prerank,rRNA metabolic process (GO:0016072),-0.37330218646299096,-1.472959637061059,0.0,0.35503276818515,1.0,64/160,24.46%,RPLP1;RPS14;RPL9;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;KRR1;UTP11;RPL27A;RPL12;RPL37;NOP58;RPL11;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RPS27;RPL14;DDX49;RPL26;RPL10;BYSL;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;XRN1;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;ESF1;RPL36A;RRP12;RRP7A;DEDD2;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36
prerank,regulation of protein localization to nucleus (GO:1900180),-0.47282881457474946,-1.472872186351845,0.03981264637002342,0.3539384997493334,1.0,21/43,21.83%,GLUL;BMP4;LIMK2;PARP9;YAP1;MFHAS1;TFRC;AKT1;DTX3L;CTNNA1;CARD10;FLCN;TGFB1;BYSL;TPR;PARK7;LAMTOR5;ORMDL3;CDK5RAP3;SIN3A;EIF2AK3
prerank,cellular response to fatty acid (GO:0071398),0.6802494486679839,1.4700567827454512,0.11713665943600868,0.6299672611128042,1.0,3/12,7.20%,PID1;FFAR2;IRS1
prerank,aorta development (GO:0035904),0.6634841139510035,1.4699594865897847,0.11482254697286012,0.6276910060830445,1.0,7/14,9.83%,PDGFRB;TBX2;TFAP2B;ROBO2;PKD2;JAG1;EFEMP2
prerank,positive regulation of hemostasis (GO:1900048),-0.6618901124834411,-1.4696959395521116,0.07731958762886598,0.35943675723066476,1.0,2/10,3.21%,ST3GAL4;THBS1
prerank,positive regulation of coagulation (GO:0050820),-0.6618901124834411,-1.4696959395521116,0.07731958762886598,0.35943675723066476,1.0,2/10,3.21%,ST3GAL4;THBS1
prerank,embryonic heart tube development (GO:0035050),0.6692472361083046,1.469390900010418,0.09513742071881606,0.626988328148688,1.0,4/14,10.35%,TBX2;TBX20;RYR2;CITED2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5805164817245791,1.4686624751124306,0.0900562851782364,0.626671504778134,1.0,9/35,10.52%,DLC1;TNFAIP1;SPRY4;CUL3;SPRY2;LZTR1;KCTD13;ARHGAP35;ABL2
prerank,NAD biosynthetic process (GO:0009435),-0.5546153886008676,-1.4686597790077425,0.05731225296442688,0.36061895898614016,1.0,11/20,24.30%,PTGIS;PARP9;NAMPT;PTGS2;NUDT12;NMNAT1;NNMT;PARP16;QPRT;NAPRT;KYNU
prerank,regulation of autophagosome maturation (GO:1901096),-0.6208050700426218,-1.4671142670318298,0.06998158379373849,0.36351963026149525,1.0,6/13,18.06%,CLEC16A;IRGM;PHF23;UVRAG;TBC1D25;ADRB2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6587933523485607,1.4661609314470558,0.09829059829059829,0.6310855285370857,1.0,4/15,6.69%,NR1H3;SCARB1;LDLR;SIK1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3803026824924714,-1.4660402571502276,0.002967359050445104,0.3650080298909883,1.0,41/151,9.08%,BMP6;SMAD3;ADAMTS12;EGFR;FLT1;NRP1;WNT4;NTRK3;WWOX;BMP7;SEMA6A;IQGAP1;NR3C1;PLCG1;TGFBR2;BMPR2;BMP4;GAS1;TGFBR1;CLEC3B;MAGI2;KLF4;SMAD9;ANXA1;SMAD7;ACVR1;RAMP2;APPL2;NDNF;ACVRL1;WNT5A;MAPK14;FOXC1;SYAP1;MAP2K5;TBX1;RAPGEF1;EHD1;AKT1;EEF1A1;TMEM100
prerank,amino sugar metabolic process (GO:0006040),-0.6662390461589386,-1.4660368218744892,0.07054673721340388,0.36363064109894677,1.0,6/10,19.67%,ST3GAL1;CSGALNACT1;EXTL2;GFPT2;GFPT1;GNE
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.5818185784431622,1.46575898219919,0.08901515151515152,0.6297628838578776,1.0,9/33,7.20%,PTEN;PIK3CD;PIK3R1;NF1;PIK3CA;MYO16;NYAP2;PIK3C2A;IRS1
prerank,epithelial cell-cell adhesion (GO:0090136),0.6877770424654679,1.4651256198046043,0.11788617886178862,0.629268423770648,1.0,3/11,3.63%,SERPINB8;VCL;ITGB5
prerank,sphingolipid biosynthetic process (GO:0030148),-0.4341982160825542,-1.4648806069002855,0.0175,0.3652210170984564,1.0,22/71,16.94%,LARGE1;PLPP3;SGMS1;CERT1;SGMS2;ELOVL7;A4GALT;ACER2;HACD4;HACD3;ACER3;CSNK1G2;SPNS2;DEGS2;PLPP1;ALDH3A2;SPHK1;SPTLC2;VAPA;ST3GAL5;ELOVL1;CLN8
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5036637745441499,-1.4646812189326741,0.05048543689320388,0.3643393138639938,1.0,11/33,13.07%,SMAD3;FOXO3;NR3C1;KLF4;TEAD1;STAT3;HIF1A;GATA2;TGFB1;RELA;ATOH8
prerank,ruffle organization (GO:0031529),0.6533219236147297,1.4643589834174955,0.1029126213592233,0.6291314205137095,1.0,2/16,1.13%,CARMIL1;AIF1L
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.653025435139938,1.4641605523246704,0.11135371179039301,0.627279078566113,1.0,4/14,5.94%,DMD;FXYD2;ACTN4;ANK3
prerank,positive regulation of lipid transport (GO:0032370),-0.6277022091865421,-1.4637688222513365,0.06433823529411764,0.36519282499192585,1.0,5/12,21.92%,APOE;ABCA3;SPP1;PRELID1;DBI
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7165445728674591,1.4629467476030924,0.10874200426439233,0.6282000511461914,1.0,4/10,3.67%,NEDD4L;ATP1A2;HECW2;STK39
prerank,carboxylic acid transmembrane transport (GO:1905039),0.5450673118957164,1.4628434679926765,0.09892086330935251,0.6261050160064119,1.0,2/40,3.11%,SLC38A11;SLC19A1
prerank,neuronal action potential (GO:0019228),0.6150836085508243,1.4619582122901729,0.11482254697286012,0.6262894358038233,1.0,7/22,8.86%,GPER1;CACNA1H;SCN2A;SCN5A;ANK3;SCN8A;SCN9A
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.519126200264327,-1.4618061418080106,0.055327868852459015,0.36883129899368067,1.0,10/25,16.55%,SMAD3;KLF4;KLF2;DDAH1;P2RX4;NOS1AP;AKT1;PTGS2;HSP90AB1;TLR4
prerank,regulation of nervous system development (GO:0051960),0.5639645839027662,1.4616146901909457,0.09340659340659341,0.6248841911126165,1.0,6/37,2.62%,HEY2;HEYL;PER2;PTN;GBX2;IL1B
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.6695169385825553,-1.461383787515671,0.057803468208092484,0.3686547333509716,1.0,5/10,13.24%,TGFBR2;FGFR2;STAT1;TBX1;CHRD
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.4156754073205403,-1.4612352643203366,0.004962779156327543,0.3676907891871783,1.0,20/86,6.79%,BMP6;IGF1;EGFR;EPHA7;NRP1;PECAM1;APP;IL15;IL6R;ITGA5;PTPRJ;ANGPT1;GHR;ARHGEF2;ACVR1;CNOT7;IGF2;EFNA5;PRKCZ;PTK2B
prerank,inorganic anion transport (GO:0015698),0.5311514896784564,1.4608828430550267,0.07855973813420622,0.6246483247671807,1.0,2/53,0.25%,ANO1;ANO4
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.5426667056755937,-1.46006451298614,0.038535645472061654,0.3694615427006945,1.0,5/22,3.94%,SP100;MDFIC;APOD;SUFU;LRRK2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6291278577019748,-1.4600250442441145,0.06666666666666667,0.36822707391195286,1.0,5/12,18.06%,IGF1R;IRGM;UVRAG;BNIP3;ADRB2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.6091643476712367,1.4599733554396612,0.09210526315789473,0.6249104108159159,1.0,3/27,0.73%,PDE4D;DMD;CACNB2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3276636038710404,-1.459778294210925,0.0,0.36747127728250945,1.0,103/476,13.91%,NFIB;IGF1;ZMIZ1;ZNF423;PLCB1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;COL1A1;WNT4;HDAC4;GLI2;TBL1XR1;CREB5;IL31RA;BMP7;SP100;ELF2;FOXO1;APOE;FOXO3;MDFIC;ZIC2;KAT6B;HIVEP3;ESR1;ELF1;BMP4;ELF4;TGFBR1;KLF4;TCF4;FOXC2;LRP6;NFATC1;CDH1;LEF1;ACVR1;FZD2;KLF2;MLLT3;RGMB;CREB3L2;PARP9;QRICH1;NIBAN2;ARNT2;AR;BRD7;YAP1;GLIS2;THRAP3;ACVRL1;IRF1;TEAD1;SIX1;WNT5A;PRDM16;FOXC1;STAT1;STAT3;HINFP;SFR1;TBX1;FZD4;AKT1;DTX3L;RREB1;HIF1A;TRIM16;FOXK1;MMS19;FZD7;CD38;KARS1;ZKSCAN3;ESRRG;PML;BRCA2;KDM3A;GLI3;TGFB1;NSD1;AHR;HDAC1;ATXN7L3;ZIC3;RELA;PPARA;ID2;GATA6;FBXW11;PRDM11;ATOH8;CLOCK;SPP1;RET;TAL1;SOX17;SFRP1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6214248657304443,1.4590408748458985,0.10392156862745099,0.6252276910435084,1.0,6/20,11.85%,PTEN;HEXIM1;INCA1;NR2F2;LATS2;APC
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.40090556577696296,-1.459008389544852,0.02564102564102564,0.3681533222219988,1.0,33/113,12.65%,BMP6;NOTCH2;IGF1;EGFR;NRP2;NRP1;TEK;TGFA;OSR1;F3;FGFR2;BMPR2;BMP4;TGFBR1;TCF7L2;VEGFD;VEGFC;FGF1;YAP1;WNT5A;STXBP4;TBX1;AKT1;PPP1R16B;RREB1;HIF1A;ECM1;CDH13;FZD7;KDR;ITGB3;NME1;FLT4
prerank,positive regulation of vasoconstriction (GO:0045907),0.6648422565888231,1.459006311574316,0.13053097345132744,0.6229865154459019,1.0,2/13,1.02%,TBXA2R;SMTNL2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5180665351923053,-1.4588947716074006,0.05241090146750524,0.3670708073025541,1.0,7/26,10.24%,EGFR;IQGAP1;PLCG1;FOXC1;SYAP1;EEF1A1;DAB2IP
prerank,regulation of macrophage migration (GO:1905521),-0.6660182065966203,-1.4584390695324334,0.07509157509157509,0.36682022376536644,1.0,7/10,25.68%,CSF1;PTK2B;EMILIN1;CD200;CD81;P2RY12;CD200R1
prerank,negative regulation of programmed cell death (GO:0043069),-0.3366949659593063,-1.4583514079303213,0.0,0.3657019890443936,1.0,75/355,14.19%,NOTCH2;IGF1;DAB2;FSTL1;EGFR;MECOM;SMAD6;FHL2;CTSH;IL31RA;PDPN;TEK;FOXO1;SH3RF1;OSR1;ANXA4;NUPR1;ANXA5;MYO18A;USP47;THBS1;BMP4;IL6ST;IGF1R;ANGPT1;TXNDC5;ANXA1;LEF1;SOCS2;CFLAR;ADAM10;GAS6;NIBAN2;NAA35;ZFAND6;RNF144B;WNT5A;CCND2;PTK2B;PLK2;CARD14;HSPA5;SH3RF2;TFRC;BIRC3;GOLPH3;ERC1;GPX4;TPT1;ERCC5;SON;AKT1;BAG3;MCL1;PRDX2;IFIT3;CD38;GCLC;KDR;ARHGDIA;RAB7A;BNIP3L;HDAC1;RELA;FLT4;GATA6;CBX4;UBB;SPHK1;MET;PIM3;BNIP3;SFRP1;RPL10;HYPK
prerank,phosphatidic acid metabolic process (GO:0046473),0.5337746307628358,1.4583286489124834,0.0824561403508772,0.6226143986957673,1.0,5/48,2.73%,DGKB;PLD1;DGKH;DGKG;PLD6
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.7109354117795613,1.4580639249795366,0.13617021276595745,0.6209848239962051,1.0,2/10,1.47%,CARMIL1;SEMA5A
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.42658379808154323,-1.4578580956484335,0.0267639902676399,0.3654781620751846,1.0,15/66,16.55%,IGF1;FOXP1;APP;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;ZC3H12A;P2RX7;GBP5;GIT1;SIRPA;TLR4
prerank,osteoclast differentiation (GO:0030316),-0.5452420409560079,-1.4576594710899324,0.05389221556886228,0.3646724451689775,1.0,10/22,21.19%,FOXP1;ANXA2;CSF1;SBNO2;MAPK14;TNFRSF11A;SNX10;GLO1;CSF1R;TYROBP
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.7040241010608178,1.4572830138309054,0.11464968152866242,0.620914405112609,1.0,3/10,1.22%,BMP5;NOTCH1;TBX20
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5800695780780643,1.456435367588689,0.10420475319926874,0.6211250561778485,1.0,2/35,0.19%,ITGA1;PDGFRB
prerank,positive regulation of neurogenesis (GO:0050769),-0.43125986082642337,-1.4547269568072483,0.030927835051546393,0.3710763993542601,1.0,13/68,8.75%,PLXNA2;ROBO1;CUX1;TIAM2;PLXNA4;SLIT2;SHANK3;TGM2;RHOA;SERPINF1;OBSL1;TIAM1;PLXND1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6423282596954718,1.454724076582237,0.11324786324786325,0.6235242704849346,1.0,5/17,8.39%,IL34;NOTCH1;PTN;BIN1;TENM4
prerank,cellular response to purine-containing compound (GO:0071415),0.6869012206792279,1.4546081050733912,0.1447661469933185,0.6215679399029697,1.0,3/10,8.62%,CASQ2;RYR2;RYR3
prerank,regulation of cell morphogenesis (GO:0022604),-0.5116745690093506,-1.4537392384117245,0.0511727078891258,0.37231601677071074,1.0,8/30,6.66%,FMNL2;PDPN;SPARC;CAPZB;MACF1;MOV10;EFNA5;MYO9A
prerank,ribosome biogenesis (GO:0042254),-0.3620576007887063,-1.4534178784358427,0.0035211267605633804,0.37185055090487784,1.0,74/187,25.80%,GLUL;RPLP1;RPS14;SDAD1;RPL9;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;NAF1;KRR1;UTP11;RPL27A;RPL12;RPL37;NOP58;RPL11;CUL4A;PAK1IP1;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RAN;RPS27;RPL14;DDX49;RPL26;RPL10;BYSL;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RBIS;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;ESF1;RPL36A;RRP12;RIOK2;RRP7A;URB2;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36;RRS1;RPL13A;FBL
prerank,urogenital system development (GO:0001655),-0.6428128983667614,-1.4525863732951905,0.06641366223908918,0.37273197432156474,1.0,4/11,16.39%,OSR1;ANXA1;EPHB2;EPHB3
prerank,regulation of adaptive immune response (GO:0002819),-0.5692513774603002,-1.4524433954091354,0.05056179775280899,0.3718246339959563,1.0,5/18,12.08%,IL6ST;ADCY7;IRF1;TRIM27;AHR
prerank,cell-substrate junction assembly (GO:0007044),0.5829580074761002,1.452347253850891,0.09532710280373832,0.6256292188047438,1.0,5/33,2.09%,DLC1;PTPRK;LAMC1;PEAK1;FERMT2
prerank,regulation of actin filament-based movement (GO:1903115),0.6920969482777639,1.452216048012428,0.13793103448275862,0.6237380082109013,1.0,4/10,7.09%,PDE4D;SCN5A;PDE4B;STC1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.47505770798699415,1.4520726436587976,0.043478260869565216,0.6219317995951078,1.0,16/107,7.48%,ATP13A5;SLC30A10;PTH1R;ATP2A3;ATP2C1;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1
prerank,Golgi localization (GO:0051645),0.6779634021184563,1.4519508000570975,0.14087759815242495,0.6200223846596484,1.0,4/11,8.17%,ARHGAP21;PDCD10;YWHAZ;HOOK3
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.41328338298129874,-1.4510261778709017,0.025906735751295335,0.374241570434302,1.0,15/76,10.42%,PTGIS;BMP7;ANXA4;KLF4;IRAK2;ARRB1;DAP;CYP1B1;MAP2K5;TMSB4X;CMKLR1;NLRC5;IRAK3;DAB2IP;ZC3H12A
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6520281459568895,-1.4508476360895541,0.07942238267148015,0.3721361271229201,1.0,3/10,7.48%,KLF4;WNK1;MAP2K5
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6520281459568895,-1.4508476360895541,0.07942238267148015,0.3721361271229201,1.0,3/10,7.48%,KLF4;WNK1;MAP2K5
prerank,endothelial cell differentiation (GO:0045446),-0.619789896906086,-1.450319522883535,0.06785714285714285,0.37223852105738914,1.0,7/12,16.16%,FSTL1;BMPR2;ACVRL1;TIE1;KDR;SOX18;KDM6B
prerank,sulfur compound catabolic process (GO:0044273),0.5601009560335616,1.4501106115924463,0.10471204188481675,0.6229432782614206,1.0,8/38,6.35%,CSPG4;GGT5;GGT1;CHAC1;CTH;ACAN;TXN2;GNS
prerank,regulation of postsynapse organization (GO:0099175),-0.5040514162128121,-1.4500154562023373,0.05353319057815846,0.371707384047557,1.0,10/28,15.96%,EPHA4;PDLIM5;SIPA1L1;SHANK3;LRRK2;WNT5A;VPS35;ABHD17C;TANC2;HOMER1
prerank,cellular glucan metabolic process (GO:0006073),-0.6388925862654506,-1.449324753180803,0.09021113243761997,0.3721527906424471,1.0,2/11,1.80%,PRKAG2;PHKB
prerank,peripheral nervous system development (GO:0007422),0.5919582695692687,1.448410492532411,0.11594202898550725,0.6256316408185147,1.0,4/23,6.51%,SERPINI1;NF1;ASIC2;SCN8A
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.6053696221125171,-1.4483656104470672,0.07884615384615384,0.3734420755938797,1.0,4/12,5.73%,IQGAP1;PODXL;MAGI2;PROM1
prerank,positive regulation of angiogenesis (GO:0045766),-0.3959142867088669,-1.4483008739946324,0.016713091922005572,0.37234703067053815,1.0,33/108,11.02%,ANXA3;FLT1;CDH5;PTGIS;CTSH;TEK;F3;PLCG1;ITGB8;SASH1;NOS3;THBS1;ITGA5;KLF4;FOXC2;RAMP2;CD34;VEGFD;VEGFC;FGF1;BMPER;WNT5A;PRKCB;CYP1B1;RHOB;HK2;PIK3R6;TIE1;HIF1A;ECM1;ZC3H12A;KDR;GATA2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5389907863347737,-1.4475332061588653,0.05917159763313609,0.3728542280248599,1.0,7/22,6.32%,TIMP3;PTPN3;APOE;SNX9;TIMP2;ADAM9;TNFRSF1B
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4242719485539827,-1.4474879881583147,0.020356234096692113,0.37171549383182995,1.0,23/76,13.40%,EGFR;NFAT5;UACA;BMP7;APP;DLG1;HDAC7;SASH1;EZR;RASSF2;NR3C2;NOD1;PDCD4;CCN3;LGALS9;RHOA;TMSB4X;C1QTNF3;IFI35;ZC3H12A;TRIP6;RELA;SPHK1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.5126224198983627,-1.4471340394625438,0.05,0.37138969411945094,1.0,10/26,18.75%,NOS3;ACER2;ACER3;CYP1B1;AKT1;GCH1;SPHK1;SPTLC2;NOS1;CYB5R3
prerank,synapse assembly (GO:0007416),0.5062947101940778,1.4469362322598542,0.07679180887372014,0.6276810676361992,1.0,13/67,5.87%,PTEN;ADGRL3;CDH2;FARP1;PCDHB11;LRRTM3;PLXNB1;NRXN1;FGF13;DNER;RYK;GABRG2;GABRA2
prerank,small GTPase mediated signal transduction (GO:0007264),0.46787216887381083,1.4463541591312428,0.07246376811594203,0.6270388934027697,1.0,15/103,5.14%,RAPGEF5;PLCE1;RERG;PLD1;RAPGEF2;ARHGAP32;RASGRP2;ARHGAP1;RASGRP3;NF1;RRAD;FGF2;RIN2;RIT2;SIAH2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6237028158097977,-1.4460814988119903,0.07750472589792061,0.3727691078087289,1.0,5/13,6.60%,FBN1;FSTL1;GREM2;NBL1;FBN2
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.47792856334657197,-1.4454851487129992,0.05228758169934641,0.3730239993600613,1.0,10/39,7.33%,TSPAN5;ROBO1;ZMIZ1;NOS3;IL6ST;KAT2B;CCN3;YAP1;BMP2K;STAT3
prerank,ribosomal small subunit assembly (GO:0000028),-0.5665439172854899,-1.4449366957138907,0.08637236084452975,0.3731199992758621,1.0,9/16,22.27%,RPS14;RPS19;RPS5;RPS27;MRPS7;RPS15;RPSA;RRP7A;RPS27L
prerank,positive regulation of insulin secretion (GO:0032024),0.5616453148016125,1.443895140036765,0.10294117647058823,0.6317204572219705,1.0,3/36,3.74%,ANO1;GPER1;ADCY8
prerank,iron ion homeostasis (GO:0055072),-0.43764409350749467,-1.4438905279892893,0.03015075376884422,0.37454326224523876,1.0,17/58,18.23%,BMP6;CP;SCARA5;B2M;NEO1;ABCG2;TFRC;ATP6V1G1;ACO1;FTL;NEDD8;BDH2;ATP6V0A2;HFE;CYB561A3;FRRS1;FTH1
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.38392867040727086,-1.4437501702167181,0.02023121387283237,0.3737004411018438,1.0,33/112,22.82%,IGF1;FOXP1;APP;LBP;THBS1;PTPRJ;ARHGEF2;CD34;GAS6;LGALS9;WNT5A;STAT3;CD47;IL33;OAS2;IRAK3;ZC3H12A;TRIM27;MAVS;EPHB2;CYBA;PLCG2;ARFGEF2;SIRPA;TLR4;RIPK1;SYK;DICER1;TYROBP;LPL;CCL19;RARA;PTPN6
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6590824241779271,1.4424738800519616,0.13263157894736843,0.6334959169278855,1.0,3/13,4.25%,ITGA4;AKT3;FGF2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5303588992633989,-1.440817887534411,0.07157057654075547,0.3801775868147008,1.0,11/24,4.79%,ROBO1;SMAD6;NRP2;NRP1;SEMA3C;TGFBR2;FGFR2;BMPR2;BMP4;ACVR1;ZFPM2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.486206976710035,-1.4404209867017101,0.042826552462526764,0.3799975771327019,1.0,25/36,35.05%,CSF1;PARP9;GAS6;PARP14;CASP4;WNT5A;IRGM;HIF1A;NLRC5;MAVS;RIPK1;AGPAT2;TRIM6;ZBP1;PRKN;HSPA1B;IL7;LAPTM5;CXCR4;AGPAT1;EDN1;ADAM17;FADD;C1QTNF4;CD74
prerank,positive regulation of autophagy (GO:0010508),-0.4076516841785674,-1.4403766403621387,0.02997275204359673,0.3788727385911723,1.0,29/81,19.70%,DAPK1;DCN;FOXO1;FOXO3;LRRK2;TPCN1;PLK2;PIK3CB;IRGM;FLCN;ATF6;ZC3H12A;KDR;TRIM27;OPTN;BNIP3L;SH3GLB1;LARP1;TICAM1;BNIP3;PRKAA2;TRIM8;PARK7;TRIM14;SH3BP4;TMEM59;PIM2;ORMDL3;IKBKG
prerank,positive regulation of ATPase activity (GO:0032781),0.533806971613442,1.440193378992964,0.08433734939759036,0.6376241537565757,1.0,7/41,9.12%,DYNLL1;FXYD2;ATP1B2;RYR2;MYL3;FGF10;MSH3
prerank,organic acid transport (GO:0015849),-0.4030788166132593,-1.4401828654606275,0.031791907514450865,0.37818087031383957,1.0,20/94,11.28%,SLC7A11;ABCC4;SLC6A13;SLC13A3;PDPN;SLCO2B1;SLC6A6;SLC26A7;SLC6A12;SLCO1C1;ABCG2;SLC7A2;SLC16A1;SLC22A6;SLC7A7;SLC25A17;SLC7A14;SLC5A6;SLC38A5;SLC3A2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5653390687030548,1.4401638705686401,0.11132075471698114,0.6354402297913718,1.0,9/31,17.60%,PTEN;BTRC;MAGEC2;CDC14B;SKP1;BMI1;RAB1A;DCUN1D2;GORASP1
prerank,keratan sulfate catabolic process (GO:0042340),-0.6315760774846111,-1.4401630799009917,0.07528957528957529,0.37698521130527685,1.0,8/11,13.97%,OGN;FMOD;HEXA;PRELP;HEXB;LUM;OMD;GALNS
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6599142794415703,1.4396311268015467,0.13537117903930132,0.6347540050931425,1.0,4/13,16.11%,PIGU;PTPRT;JAK2;MGAT5
prerank,regulation of response to stress (GO:0080134),0.6849763177162365,1.4376558578665568,0.135632183908046,0.6381210078168331,1.0,4/10,14.19%,ADCY8;CORO2B;DYRK3;MLC1
prerank,bile acid biosynthetic process (GO:0006699),0.60009710736224,1.4376452462003468,0.12403100775193798,0.635927050225499,1.0,5/24,6.00%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6
prerank,positive regulation of signaling (GO:0023056),0.5386550696967731,1.4366534451981143,0.10727272727272727,0.6363697560189635,1.0,11/37,12.34%,CLSTN1;ECE1;NMU;RIMS1;CLSTN3;RIMS2;SNCA;SYT1;KCTD13;WLS;GRIK2
prerank,exit from mitosis (GO:0010458),0.6599813173069888,1.436377164356366,0.11727078891257996,0.6350081508545635,1.0,2/12,5.27%,EPS8;CLASP2
prerank,muscle tissue morphogenesis (GO:0060415),0.6213844607128444,1.434803875504639,0.1393939393939394,0.637258334637176,1.0,4/16,1.47%,HEY2;NOTCH1;TBX20;MYLK
prerank,Golgi to plasma membrane transport (GO:0006893),-0.44973537351005655,-1.4345188367693624,0.0405982905982906,0.3903919793407364,1.0,12/47,10.98%,VAMP5;STXBP6;MACF1;KIF13A;VPS35L;GGA2;EXOC4;GOLPH3;EXOC6;ARL3;EXOC5;OPTN
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6272737468807402,-1.4343602856597155,0.07846715328467153,0.38949142408994336,1.0,4/11,6.26%,MECOM;ETV6;CD34;WNT5A
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6467202883710397,1.4337465636687532,0.1341991341991342,0.6379645594629673,1.0,3/18,2.79%,DLC1;TNFAIP1;CUL3
prerank,axoneme assembly (GO:0035082),0.566753721907931,1.4334218146601139,0.09363295880149813,0.6367091411209699,1.0,8/30,8.57%,RSPH6A;SPEF1;TTLL3;JHY;GAS8;RSPH1;LRGUK;CFAP46
prerank,UV protection (GO:0009650),-0.6559363332329846,-1.4333615363522536,0.07289719626168224,0.390903543548885,1.0,5/10,23.71%,SCARA3;ERCC5;MFAP4;GPX1;ERCC2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6241341496878539,1.4333326116677625,0.13247863247863248,0.6347473033432717,1.0,7/16,4.25%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;AKAP6;FGF2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.4784404094688252,-1.433291068491408,0.05360824742268041,0.3897797344994193,1.0,8/37,12.76%,ALCAM;HMCN1;CXADR;VCAM1;ADGRL1;ICAM1;CD164;FAT4
prerank,protein ADP-ribosylation (GO:0006471),0.5891308683218269,1.43256827125989,0.10141987829614604,0.6347483862248893,1.0,2/28,0.90%,ART3;PARP8
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.36804795280651764,-1.431597823811643,0.0064516129032258064,0.39322558542150227,1.0,38/152,16.28%,RNF220;SULF1;LRRK1;LGR4;EGFR;COL1A1;TBL1XR1;CAV1;MACF1;RSPO3;FGFR2;SMURF2;USP47;RNF146;LRRK2;SKI;TNKS2;SULF2;LYPD6;SFRP4;RSPO2;WNK1;USP8;CSNK1G2;USP34;PSME2;TGFB1;WNT5B;PSMB4;SFRP1;PSMB1;PSMD11;PSMD8;PPM1B;GSKIP;PSME3;HHEX;PLEKHA4
prerank,positive regulation of response to wounding (GO:1903036),0.6003942710301091,1.4313503761347381,0.11670020120724346,0.636048846563106,1.0,8/24,7.16%,VTN;PTK2;MYLK;SCARF1;PTN;ITGB1;ARFGEF1;HRAS
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5835691336013111,1.431104379619927,0.10766045548654245,0.6344493650558072,1.0,7/25,8.92%,TRPC6;DMD;STK39;ATP1B2;ANK3;PDZK1;STAC
prerank,positive regulation of lyase activity (GO:0051349),0.6478093629109115,1.4296288910538029,0.1406926406926407,0.6362703727045058,1.0,4/14,7.48%,CACNA1C;NF1;CACNA1D;STIM1
prerank,endothelial cell proliferation (GO:0001935),-0.5558355987231574,-1.4286768327510297,0.07017543859649122,0.39957601374852486,1.0,7/17,6.10%,TEK;DLG1;BMPR2;BMP4;CD34;BMPER;ACVRL1
prerank,regulation of cholesterol transport (GO:0032374),0.6072232401231069,1.4284980039991255,0.12109375,0.6371608074380356,1.0,4/20,6.00%,NR1H3;ARV1;ABCA5;OSBPL6
prerank,regulation of interleukin-4 production (GO:0032673),-0.5346728995772483,-1.428427665072792,0.07186858316221766,0.39893221318870686,1.0,8/21,22.35%,LEF1;LGALS9;PRKCZ;SLC7A5;ZFPM1;CEBPB;SYK;RARA
prerank,regulation of DNA repair (GO:0006282),-0.4566753794924208,-1.427880743287011,0.06359649122807018,0.3991977073279363,1.0,17/44,25.15%,EYA2;EYA1;EGFR;EYA4;PML;CEBPG;POLH;CDK9;SIRT7;NPAS2;BABAM2;RAD52;BABAM1;WRAP53;RNF8;BRCA1;RPS3
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.40564291497173993,-1.4273850497186962,0.03333333333333333,0.39936915228185577,1.0,17/85,6.10%,BMP6;TGFBR3;MCC;IGF1;EGFR;MTSS1;TGFA;OSR1;NUPR1;FGFR2;BMP4;ANGPT1;B2M;TCF7L2;FGF1;YAP1;ACVRL1
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.5634325057752738,-1.4271891008716953,0.06597938144329897,0.3986081763524545,1.0,7/19,10.94%,ELF1;KLF4;PARP9;IRAK2;WNT5A;MAP2K5;MAVS
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5871066232543385,-1.426765353583352,0.08928571428571429,0.3984979969749287,1.0,8/13,12.24%,BMP7;NR3C1;ESR1;BMP4;NR3C2;AR;PGR;PLPP1
prerank,rRNA processing (GO:0006364),-0.36025574249136105,-1.4261204680278061,0.0033003300330033004,0.39894450133379683,1.0,70/172,25.91%,NSA2;RPLP1;RPS14;RPL9;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;KRR1;UTP11;RPL27A;RPL12;RPL37;NOP58;RPL11;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RPS27;RPL14;DDX49;RPL26;RPL10;BYSL;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;NAT10;TFB1M;ESF1;RPL36A;RRP12;RIOK2;MRPL1;RRP7A;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36;RPL13A;FBL;NHP2
prerank,cellular response to amino acid stimulus (GO:0071230),0.5522423876268797,1.425917827602376,0.11070110701107011,0.6421359706615711,1.0,4/33,2.38%,SPAAR;UBR1;CPEB1;SESN3
prerank,glucan biosynthetic process (GO:0009250),0.6586130833431831,1.4254279021644511,0.14255765199161424,0.6392487991989623,1.0,2/12,3.24%,PER2;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.6586130833431831,1.4254279021644511,0.14255765199161424,0.6392487991989623,1.0,2/12,3.24%,PER2;UGP2
prerank,cardiac muscle cell development (GO:0055013),0.6049969732052526,1.42514710983968,0.13373253493013973,0.6379065908061673,1.0,3/20,2.04%,PDGFRB;HEY2;MYH11
prerank,histone H4 deacetylation (GO:0070933),-0.6587085259413301,-1.4251089339293934,0.07664233576642336,0.4005879073704483,1.0,6/10,19.29%,HDAC4;HDAC8;HDAC9;HDAC1;SIRT2;SMARCAD1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5831385259369566,1.4248647000874848,0.10877862595419847,0.6367026740788112,1.0,5/25,5.53%,ITGA4;ITGA7;JAM3;CTNNA3;ITGB1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.586091989527556,-1.4247274685902718,0.0724907063197026,0.40029423054402563,1.0,6/13,11.61%,BMP7;SOX13;SIX1;RREB1;METRNL;PTGS2
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.5224189228407798,-1.4242637180663655,0.0835030549898167,0.40035795974618854,1.0,5/23,15.89%,IGF1;GAS6;ZC3H12A;GIT1;CEACAM1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5528014558215718,-1.4242329321576057,0.0796812749003984,0.39920149243538494,1.0,7/18,20.27%,DDX60;BIRC3;USP15;PUM1;RNF125;NPLOC4;SEC14L1
prerank,cellular response to glucagon stimulus (GO:0071377),0.6172727629649052,1.4238608582021746,0.13293650793650794,0.6374451377982976,1.0,9/17,10.19%,CYSLTR2;PRKAR1B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5020476026704396,-1.42382317832327,0.0736196319018405,0.39906380719026985,1.0,11/28,13.27%,FOXP1;CD55;APPL2;IRF1;ERAP1;BIRC3;RNF135;CASP8;SAMHD1;GATA6;LRP8
prerank,organic hydroxy compound transport (GO:0015850),-0.4777935254426266,-1.4235270248539535,0.06926406926406926,0.3986679395793765,1.0,7/36,8.16%,ABCC4;SLCO2B1;RBP4;SLCO1C1;SLC16A1;NPC2;STRA6
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6599283625935044,1.4226252279633411,0.13245033112582782,0.6387936709874663,1.0,2/12,2.70%,GGT1;CHAC1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5349248867274471,-1.4212921430429468,0.0660377358490566,0.402129585451119,1.0,6/21,8.99%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5349248867274471,-1.4212921430429468,0.0660377358490566,0.402129585451119,1.0,6/21,8.99%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1
prerank,dicarboxylic acid transport (GO:0006835),-0.4952587417671873,-1.4208260264719508,0.056795131845841784,0.4020736040379881,1.0,6/28,4.69%,SLC13A3;SLC1A3;PDPN;SLC26A7;GJA1;SLC22A6
prerank,homotypic cell-cell adhesion (GO:0034109),-0.4785006056460202,-1.4206536893201214,0.049217002237136466,0.4013219884778447,1.0,14/39,14.14%,FN1;PDGFRA;TJP2;PLPP3;MEGF11;ACTG1;CLIC1;PIK3CB;GNAS;ITGB3;ACTN1;MEGF10;ACTB;PPIA
prerank,positive regulation of phosphorylation (GO:0042327),-0.34318647054142126,-1.4205872174251428,0.004166666666666667,0.40025522217305315,1.0,72/240,14.80%,IGF1;DAB2;EPHA4;EPHA3;EGFR;FLT1;LEPR;ROCK2;EPHA7;PDGFRA;NRP1;NTRK3;LMO4;TEK;PECAM1;APP;ITGA6;FGFR2;THBS1;BMP4;EPHB4;IGF1R;ANGPT1;LRRK2;NIBAN1;VEGFD;SDCBP;VEGFC;LIMK2;IGF2;GAS6;ARRB1;AR;FGF1;EFNA5;DDR1;CCND2;CARD14;FNIP1;CCND3;TFRC;TBX1;WDFY2;AKT1;TIE1;KIT;IRGM;HIF1A;EPHA8;FZD7;FLCN;KDR;P2RX7;MAVS;ITGB3;TGFB1;FGFR4;TMEM119;EPHB2;FLT4;CCN1;ENTPD5;KCTD20;CDK2AP1;MET;CCND1;RET;LIMCH1;PPIA;FXR2;MAPK3;RAD50
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.406551671791181,-1.4203586450454264,0.04450261780104712,0.39961879211355483,1.0,21/79,10.24%,SULF1;ADAMTS12;SMAD6;SKIL;SLIT2;HTRA3;BMPR2;SMURF2;THBS1;SMAD9;SMAD7;SKI;NIBAN2;SULF2;BMPER;SMURF1;NBL1;VWC2;HGS;EMILIN1;DAB2IP
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.4134186350776016,-1.420175739067674,0.034482758620689655,0.3988746436825701,1.0,27/69,28.70%,APP;LBP;THBS1;PTPRJ;ARHGEF2;LGALS9;WNT5A;STAT3;IL33;OAS2;MAVS;EPHB2;CYBA;PLCG2;ARFGEF2;TLR4;RIPK1;SYK;TYROBP;LPL;CCL19;SETD4;TWIST1;FZD5;CLU;SPHK2;CCR2
prerank,ceramide metabolic process (GO:0006672),-0.454523228830165,-1.419355131331655,0.05580357142857143,0.3998640653201332,1.0,18/49,24.03%,PLPP3;SGMS1;SGMS2;ST6GALNAC3;ACER2;ACER3;NSMAF;DEGS2;ST6GALNAC6;PLPP1;PLA2G15;SPTLC2;CLN8;ORMDL3;CLN6;SGPL1;SPTSSA;ORMDL2
prerank,cell junction assembly (GO:0034329),0.4576371896806396,1.4190366526742588,0.07919254658385093,0.6463655049448037,1.0,20/100,7.13%,GJC1;PTEN;LIMS1;ADGRL3;CDH2;FARP1;VASP;FERMT2;PCDHB11;NRXN1;SH3BP1;DNER;GJA4;RYK;CDH8;CDH22;FBLIM1;CDH19;CDH7;CDH20
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6607827060069456,1.4188087594459164,0.14754098360655737,0.6449261444386561,1.0,3/12,8.18%,IL1B;CARD9;IL12RB1
prerank,regulation of calcium ion import (GO:0090279),0.609741663648767,1.418336315132685,0.12266112266112267,0.644170563710373,1.0,4/21,9.16%,PDGFRB;STC1;PKD2;PDGFB
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5878025847448969,1.4168454526650163,0.129979035639413,0.6462128818550801,1.0,6/19,4.25%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;FGF2
prerank,regulation of fat cell differentiation (GO:0045598),-0.39934343315635246,-1.4165074272859184,0.027848101265822784,0.40613012267989956,1.0,28/74,19.25%,SMAD3;ZBTB16;MEDAG;TMEM64;FOXO1;ENPP1;ZFPM2;YAP1;WNT5A;SYAP1;NOCT;TRIO;WDFY2;AKT1;CMKLR1;CARM1;ANKRD26;ZC3H12A;GATA2;TGFB1;ID2;SFRP1;FTO;ZFPM1;SIRT2;CEBPB;ZFP36L2;E2F1
prerank,intestinal lipid absorption (GO:0098856),0.6487758275291026,1.4164694272763734,0.16452991452991453,0.6452135561289606,1.0,2/11,3.39%,CEL;LDLR
prerank,negative regulation of reproductive process (GO:2000242),-0.549306163926443,-1.4163585616846617,0.10505836575875487,0.40532625820925255,1.0,6/17,14.41%,SULF1;IGF1;GJA1;DUSP1;CALR;PAEP
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5438865758669442,1.4160885028371526,0.096045197740113,0.6441805003016458,1.0,10/37,9.83%,PTEN;MEF2C;PRKG1;GPER1;LDLRAP1;FGF2;HTR1B;CDKN1A;PDGFB;EFEMP2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6426508180045423,1.4156308756220402,0.12291666666666666,0.6433683729978485,1.0,2/13,1.37%,HEY2;PER2
prerank,negative regulation of blood coagulation (GO:0030195),-0.46382828137915255,-1.4150464091045378,0.06666666666666667,0.40760700162026714,1.0,7/38,4.57%,PDGFRA;SERPING1;APOE;F3;NOS3;THBD;CD34
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5491844165203547,-1.4144359427497604,0.05747126436781609,0.4080024759698943,1.0,6/18,9.92%,MDFIC;APOD;SUFU;MFHAS1;CTNNA1;FLCN
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5677997917279223,-1.4144073233695944,0.06692160611854685,0.4068747994408069,1.0,7/16,16.31%,APOD;PDCD4;APPL2;ADCY7;ZC3H12A;PPARA;SIRPA
prerank,negative regulation of cytokine production (GO:0001818),-0.3634858624325811,-1.4141847327214114,0.013245033112582781,0.40628019818362215,1.0,44/163,17.49%,FN1;LGR4;ANXA4;APOD;HDAC7;THBS1;EZR;KLF4;ANXA1;LEF1;PDCD4;HDAC9;CD34;GAS6;ARRB1;SRGN;LGALS9;APPL2;ADCY7;IKBKE;MAP2K5;TMSB4X;C1QTNF3;CMKLR1;PCBP2;NLRC5;RNF135;IRAK3;ZC3H12A;TRIM27;MAVS;RNF125;PPARA;TWSG1;SSC5D;SARS1;ZFPM1;CEACAM1;CD200;SIRPA;ASB1;TLR4;HOMER3;UBA7
prerank,positive regulation of ruffle assembly (GO:1900029),0.6349257136070307,1.4139739504273243,0.15550755939524838,0.6459370087853522,1.0,3/13,7.16%,EPS8;EPS8L1;HRAS
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5547102775151764,-1.4128034292802356,0.08634538152610442,0.4087556802595247,1.0,3/17,2.78%,BMP6;CD55;SASH1
prerank,negative regulation of potassium ion transport (GO:0043267),0.648910363645888,1.412315383812276,0.1496881496881497,0.6485404477865527,1.0,5/13,7.70%,CASQ2;NEDD4L;STK39;BIN1;KCNE5
prerank,response to alcohol (GO:0097305),-0.5082620283605468,-1.411911784879112,0.07959183673469387,0.4099363108026706,1.0,4/27,3.45%,TGFBR3;SLIT2;TGFBR2;TGFBR1
prerank,response to zinc ion (GO:0010043),-0.5127343187581542,-1.4118524534025276,0.08634538152610442,0.4089047937920713,1.0,16/25,31.15%,PAM;P2RX4;MT3;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H;CRIP1;ATP13A2;HVCN1;KHK;MT2A
prerank,negative regulation of blood pressure (GO:0045776),-0.5983612753998707,-1.4115821244172038,0.07992202729044834,0.408376651012113,1.0,5/13,15.93%,NOS3;BMPR2;PRCP;SCPEP1;NOS1
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.5350627786814024,-1.4115546189388992,0.07916666666666666,0.40725129747719124,1.0,5/21,5.90%,ERRFI1;ROCK2;BMP4;MAFG;SFRP4
prerank,lipoprotein biosynthetic process (GO:0042158),-0.6272870735079922,-1.4114268139014496,0.10218978102189781,0.40640898858860425,1.0,4/11,13.66%,APOE;WIPI2;ATG10;UGCG
prerank,protein O-linked glycosylation (GO:0006493),-0.38481543274684693,-1.4110971355030872,0.022598870056497175,0.4061164764578792,1.0,17/96,11.41%,TMTC1;GXYLT2;ST3GAL4;LARGE1;TMTC4;ST3GAL1;ST3GAL2;EOGT;PLOD2;TMTC2;ST3GAL3;TET3;RXYLT1;ST6GALNAC2;GALNT12;POGLUT1;POGLUT2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4587656176902698,1.4109393003523572,0.05669291338582677,0.6501452014302093,1.0,15/100,4.25%,PDGFRB;PIP5K1B;PTEN;PIK3CD;GAB1;ROR1;PTK2;PIK3R1;GPER1;UNC5B;PIP4K2A;PLXNB1;PIK3CA;NCF1;FGF2
prerank,sulfation (GO:0051923),-0.6239825039646466,-1.4107110900308493,0.07775768535262206,0.4058838700321889,1.0,1/11,0.04%,UST
prerank,positive regulation of ion transport (GO:0043270),0.5117243716988134,1.4106676870045327,0.10193321616871705,0.6488730431280303,1.0,9/48,7.39%,TRPC6;CACNB2;MYLK;STIM2;SCN5A;ANK3;RAB3B;PRSS8;CACNA1D
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5892103274129147,-1.4106180551201513,0.09423076923076923,0.404959263710566,1.0,3/13,6.46%,SORBS1;IGF2;PRKCZ
prerank,neuropeptide signaling pathway (GO:0007218),0.5023518960310986,1.4100724154483961,0.09880749574105621,0.6484020863904437,1.0,9/58,11.05%,CYSLTR2;RAPGEF2;SORCS1;NMU;SORT1;OPRK1;GPR37;NXPH4;NTSR1
prerank,regulation of dendrite development (GO:0050773),0.5591297167269842,1.4094815753636174,0.118491921005386,0.64799576927113,1.0,13/37,10.81%,NEDD4L;BMP5;SDC2;HECW2;MARK1;PTN;CHRNA3;CSMD3;BCL11A;ADGRB3;HECW1;SARM1;VLDLR
prerank,B cell proliferation (GO:0042100),0.6112422509750709,1.4083940650687992,0.12317327766179541,0.6489672242160429,1.0,1/17,0.63%,MEF2C
prerank,Notch signaling involved in heart development (GO:0061314),0.666474732265671,1.408391846346218,0.15463917525773196,0.6469538789089783,1.0,3/11,1.19%,HEY2;HEYL;NOTCH1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.3232190009640299,-1.4082526201222252,0.0,0.4101174043116498,1.0,87/390,10.62%,FLRT2;SULF1;IGF1;SORBS1;PDGFD;EPHA4;PLCB1;EPHA3;EGFR;FLT1;EFNB2;COL1A1;NRP2;MTSS1;ROCK2;EPHA7;PDGFRA;NRP1;NTRK3;IL31RA;RHOQ;TEK;RBFOX2;NEDD9;FOXO1;ELMO1;SIPA1L1;FGFR2;VAV2;ANKS1A;CYFIP2;PTPRJ;EPHB4;IGF1R;MPZL1;SHB;ANGPT1;BAIAP2;YES1;FOXC2;GHR;CSF1;AP3S1;PXN;SOCS2;ATP6V0A4;COL4A6;ARHGEF28;VEGFD;SDCBP;VEGFC;IGF2;SLC39A14;AP2A2;FGF1;SULF2;PTPRG;EFNA5;DDR1;BDKRB2;RHOA;MAPK14;PTK2B;KL;FOXC1;STAT3;NAMPT;EFNB1;ACTG1;RAPGEF1;ARPC2;POLR2A;ATP6V1G1;PIK3CB;TIAM1;AKT1;TIE1;KIT;EFS;FRS2;EPHA8;GRB14;IDE;ATP6V0B;FGFBP1;ARPC1B;KDR
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.47330680938059944,-1.4081779529612897,0.06753812636165578,0.40919879156042965,1.0,12/35,11.70%,PLXNA2;NRP2;NRP1;SEMA3D;SEMA6A;SEMA3C;PLXNA4;SEMA7A;SEMA3E;PLXND1;ARHGDIA;SEMA3B
prerank,regulation of activated T cell proliferation (GO:0046006),-0.49187549266545005,-1.4081302309208152,0.056768558951965066,0.4082023008675189,1.0,5/30,10.32%,IGF1;IGFBP2;IGF2;LGALS9;IL18
prerank,regulation of protein import into nucleus (GO:0042306),-0.4728754448474238,-1.4079536351822322,0.060542797494780795,0.4074952281528472,1.0,12/36,13.01%,SMAD3;MDFIC;APOD;SUFU;BMP4;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,cardiac muscle cell contraction (GO:0086003),0.5995996994573893,1.406357519538938,0.1504950495049505,0.6503559118966331,1.0,6/19,7.39%,CACNA1C;FGF12;PIK3CA;CACNA2D1;SCN5A;CACNA1D
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3917360274714399,-1.4060471210353014,0.019021739130434784,0.4113985909345232,1.0,25/82,9.61%,BMP6;RANBP3L;IGF1;SMOC1;SMAD6;WNT4;BMP7;TMEM64;IL6R;HDAC7;SUFU;FGFR2;BMPR2;BMP4;IL6ST;DDX5;ACVR1;ZHX3;SKI;YAP1;FBN2;NOCT;ATRAID;TWIST2;CCN4
prerank,heart development (GO:0007507),0.4330555632218387,1.406032907491004,0.051209103840682786,0.6492119632772959,1.0,15/150,3.07%,DLC1;ADAP2;CACNA1C;PTEN;PLCE1;TBX2;MEF2C;BMP5;NOTCH1;PTK2;NF1;FGF12;ERBB4;UTY;ECE1
prerank,receptor clustering (GO:0043113),0.5631045494761429,1.405732101417012,0.1171875,0.647961888202339,1.0,4/27,3.96%,ITGA4;PTN;NRXN1;AGRN
prerank,primary miRNA processing (GO:0031053),-0.6376226395700577,-1.4056176656520705,0.08450704225352113,0.4114409360071501,1.0,1/10,0.62%,SMAD3
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.48994298060730035,-1.4050141299825183,0.08668076109936575,0.411865531533125,1.0,9/29,14.82%,IL31RA;IL15;GHR;SOCS2;STAT2;STAT1;STAT3;FER;PKD1
prerank,positive regulation of macroautophagy (GO:0016239),-0.438769519143282,-1.40487385197063,0.05605381165919283,0.4110520853511634,1.0,20/48,19.70%,DCN;HSPB8;RAB3GAP1;VPS13D;SLC25A4;BAG3;IRGM;KDR;PIP4K2B;OPTN;BNIP3L;SH3GLB1;UVRAG;LARP1;BNIP3;SPTLC2;PRKAA2;RAB3GAP2;ADRB2;IKBKG
prerank,regulation of cellular senescence (GO:2000772),0.5684676253761928,1.4033624596446324,0.11509433962264151,0.6522926810896045,1.0,7/28,11.35%,SLC30A10;CDK6;AKT3;NEK6;CGAS;NUAK1;RBL1
prerank,protein localization to cell-cell junction (GO:0150105),-0.5687640320114343,-1.403096390211463,0.09811320754716982,0.4145558345225534,1.0,7/15,13.85%,CDH5;TJP2;LSR;ACTG1;F11R;ARHGEF18;ACTB
prerank,metanephric mesenchyme development (GO:0072075),-0.635133928970073,-1.4028520794389308,0.11320754716981132,0.4140434568945531,1.0,4/10,7.09%,WNT4;OSR1;SIX1;STAT1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.6462033434346037,1.40240905103477,0.14660831509846828,0.6528873641672944,1.0,2/11,1.63%,MEF2C;GPER1
prerank,retinol metabolic process (GO:0042572),-0.5788932855877946,-1.4018761578026009,0.0830188679245283,0.41550316584218283,1.0,4/14,13.44%,DHRS3;RBP4;CYP1B1;ADH1A
prerank,regulation of cell migration (GO:0030334),-0.3245980297444899,-1.4017144267636914,0.0,0.4148133322716048,1.0,89/382,9.92%,PLXNA2;AFDN;SULF1;IGF1;ROBO1;DAB2;PHACTR1;PDGFD;LDLRAD4;EPHA4;DPYSL3;EGFR;FLT1;COL1A1;CDH5;ROCK2;PDGFRA;NTRK3;CTSH;LMO4;CLIC4;PDPN;SEMA3D;IGFBP5;CEMIP;SEMA6A;NEDD9;SEMA3C;PECAM1;FOXO3;PODXL;RECK;PLXNA4;SLIT2;F3;CAV1;ITGA6;MACF1;CLDN5;PODN;SASH1;THBS1;PTPRJ;IGF1R;TGFBR1;MAGI2;SEMA7A;NKD1;ARSB;SRGAP3;SRGAP2;ANXA1;CSF1;ADAM9;SMAD7;CDH1;LEF1;ACVR1;ADAM10;SMO;SDCBP;CXCL12;FGF1;APPL2;SCAI;ACE;ACVRL1;SYNE2;RHOA;PTK2B;CYP1B1;RHOB;STAT3;HSPA5;SH3RF2;SEMA3E;TMSB4X;ACTG1;TBCCD1;TIAM1;MMP14;PLXND1;AKT1;KIT;ADAM15;ZMYND8;TWIST2;CDH13;FLCN
prerank,purine ribonucleotide transport (GO:0015868),-0.5560252043157321,-1.4017083643374084,0.09210526315789473,0.4136735065644802,1.0,5/16,10.65%,ABCC4;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,glucose transmembrane transport (GO:1904659),0.5971335809856158,1.4006583947736653,0.1536643026004728,0.6557460171317709,1.0,7/18,12.50%,SLC5A1;SORT1;PPARD;SLC45A1;SLC2A6;SLC2A3;SLC2A9
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.5218353056136888,-1.40030422247639,0.09765625,0.416281426285163,1.0,7/22,13.00%,MAN1C1;RNF139;RNF103;AMFR;RNF185;EDEM2;UBB
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4021532554111322,-1.4000827878699245,0.04081632653061224,0.41564152788494185,1.0,28/73,28.70%,APP;LBP;THBS1;PTPRJ;ARHGEF2;LGALS9;WNT5A;STAT3;IL33;OAS2;MAVS;EPHB2;CYBA;PLCG2;ARFGEF2;TLR4;RIPK1;SYK;TYROBP;LPL;CCL19;SETD4;TWIST1;BCL10;FZD5;CLU;SPHK2;CCR2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.43653322765500197,-1.39981007837858,0.05668934240362812,0.41524252285291957,1.0,23/50,27.32%,SH3RF1;USP47;THBS1;KLF4;GAS6;FNIP1;MAP2K5;AKT1;DNAJB6;GPX1;PARK7;LAMTOR5;MT3;PLAUR;RFFL;VEGFA;PIH1D1;RPS6KA3;YWHAE;CD44;CDKN2D;PAK2;SFN
prerank,arachidonic acid secretion (GO:0050482),-0.6323627536430481,-1.3997501123277103,0.0975177304964539,0.41310824846366545,1.0,3/10,6.54%,ANXA1;ACE;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.6323627536430481,-1.3997501123277103,0.0975177304964539,0.41310824846366545,1.0,3/10,6.54%,ANXA1;ACE;BDKRB2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5023058160954608,-1.3996443166866324,0.061752988047808766,0.412294452705431,1.0,7/26,9.13%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1;PPP2R1B
prerank,endoderm formation (GO:0001706),0.5522717821868612,1.3967122985759477,0.11153119092627599,0.6647584693739051,1.0,8/35,5.24%,ITGA4;ITGA7;VTN;TBX20;NODAL;MMP15;ITGB5;LAMB1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5503566886327202,-1.3966304399161698,0.0741444866920152,0.41911088903898813,1.0,8/17,13.91%,NPR3;FGFR2;MN1;RHOA;ATRAID;TMEM119;CCN1;SFRP1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5523933735205507,-1.3955252445172242,0.0888030888030888,0.4208486104754475,1.0,2/17,3.14%,PLA2G4A;LPGAT1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.5884844378423932,-1.395143911391193,0.07400379506641366,0.42067549011404126,1.0,3/13,13.81%,BCL2L11;BNIP3L;BNIP3
prerank,regulation of stress fiber assembly (GO:0051492),0.48115903321345715,1.394789770439387,0.08374384236453201,0.6681046882103129,1.0,11/74,3.09%,DLC1;CARMIL1;ARHGAP6;PIK3R1;RGCC;PHLDB2;PPM1E;FERMT2;ROCK1;WAS;LIMK1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5850481400464704,-1.3945587549405762,0.09441233140655106,0.4209478889322227,1.0,9/14,28.63%,LRRK2;CREB3L1;CREB3;TMBIM6;PARK7;XBP1;BCL2L1;PRKN;SYVN1
prerank,negative regulation of nervous system development (GO:0051961),0.6126208553577547,1.394554310116142,0.14285714285714285,0.6666899877873094,1.0,5/17,8.17%,NOTCH1;SLIT1;IL1B;ROBO2;HOOK3
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5954769401495029,1.3943225451567323,0.15476190476190477,0.6653351790408969,1.0,2/20,1.01%,PDE4D;RAPGEF2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6355966871211456,-1.394136950609696,0.11594202898550725,0.42093529415540143,1.0,5/10,25.06%,BMP4;IRF1;GLI3;MDK;LAG3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5156919196422145,-1.3941088492705789,0.06653992395437262,0.4187532697515319,1.0,6/20,15.77%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,positive regulation of glycolytic process (GO:0045821),-0.5156919196422145,-1.3941088492705789,0.06653992395437262,0.4187532697515319,1.0,6/20,15.77%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6405322694114398,1.3940966737000062,0.15885947046843177,0.6639346486474095,1.0,6/12,17.52%,PTEN;B4GALT6;ARHGAP35;EPHB1;CHRNB2;SPTBN4
prerank,protein export from nucleus (GO:0006611),-0.5075057002940434,-1.3937234781248797,0.06889352818371608,0.41861499462373863,1.0,12/27,20.50%,RANBP3L;SMURF1;CCHCR1;DUSP16;TGFB1;RAN;CALR;PKD1;STYX;TPR;CHP1;NUP214
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.43941147469491154,-1.3936230845076991,0.05241090146750524,0.4177314440121617,1.0,16/46,10.32%,IGF1;FOXP1;ELN;IGFBP5;OGN;IL6R;APOD;THBS1;BMP4;TCF7L2;IGFBP3;STAT1;AKT1;CCN4;CDH13;IL18
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.5756341964091082,1.3934371145168531,0.12778904665314403,0.6636921664018842,1.0,10/26,12.17%,ITPR2;ITPR1;FGF2;HTR2C;RYR2;RYR3;LETM1;PKD2;CHERP;SLC8B1
prerank,smooth muscle cell differentiation (GO:0051145),0.6404102283022226,1.3933187805301213,0.1475054229934924,0.6620023248377632,1.0,2/12,0.68%,MEF2C;HEY2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.41862312726076434,-1.3931298618284713,0.05063291139240506,0.4178138784432618,1.0,16/63,8.93%,AUTS2;PHACTR1;NRP1;GSN;NEDD9;MCU;SIPA1L1;CXADR;NRK;EZR;PARVB;ANXA1;RHOA;DTNBP1;KIT;EFS
prerank,regulation of stem cell proliferation (GO:0072091),-0.551104591784785,-1.3928641042435246,0.09262759924385633,0.4175129750098892,1.0,4/17,5.89%,FBLN1;GJA1;YAP1;ACE
prerank,sulfate transport (GO:0008272),-0.5777699609613888,-1.392264051435718,0.10176125244618395,0.41803960656835626,1.0,3/14,2.95%,SLC13A4;SLC26A7;SLC26A2
prerank,negative regulation of synaptic transmission (GO:0050805),0.5776404206283869,1.3921022485439625,0.14227642276422764,0.663334366279231,1.0,5/23,8.10%,PTEN;IL1B;SLC24A2;ATAD1;ACHE
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6272660919858575,-1.3913479136383846,0.09659090909090909,0.4193104562055505,1.0,2/10,1.96%,ABCA1;APOE
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.49425175006179084,1.3905121721452094,0.1168141592920354,0.6659229687914056,1.0,11/57,9.86%,GRM7;ADCY8;ADCY3;ADCY6;HTR1B;OPRK1;ADCY9;GPR37;AKAP12;GRM4;NPY1R
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.47216427426357443,-1.3904328714172964,0.06991525423728813,0.42072185655869343,1.0,15/33,17.84%,GLUL;SEMA6A;ADAMTS9;THBS1;ITGA5;KLF4;KLF2;FGF1;BMPER;PIK3CB;PPP1R16B;RHOJ;CREB3L1;CEACAM1;PDPK1
prerank,cardiac atrium morphogenesis (GO:0003209),0.613261575171087,1.389981653553886,0.15587044534412955,0.6653483457210838,1.0,3/16,1.22%,HEY2;NOTCH1;TBX20
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.3474725667005251,-1.3897041756295359,0.019305019305019305,0.42158542915535685,1.0,45/186,14.36%,NXN;MCC;DAB2;TRABD2B;IGFBP2;BICC1;WWOX;TMEM64;VGLL4;DKK3;APOE;CAV1;RNF213;IGFBP6;NKD1;TCF7L2;TLE4;LRP6;NFATC1;MLLT3;RNF43;IGFBP4;SFRP4;SOX13;PFDN5;WNT5A;SCYL2;AMFR;FZD4;TLE2;TLE1;NOTUM;DAB2IP;ZNRF3;MDFI;PSME2;GLI3;HDAC1;PSMB4;CCDC88C;SOX17;SFRP1;PSMB1;PSMD11;PSMD8
prerank,mitochondrial membrane organization (GO:0007006),-0.4764464646093585,-1.3896635369296628,0.05422993492407809,0.42059311844608765,1.0,15/32,29.59%,MICOS10;MTX2;SLC25A4;SPG7;BNIP3;APOOL;CHCHD6;MICOS13;MAIP1;RCC1L;HSPA9;BCL2L1;TIMM50;DNAJC11;MTX3
prerank,lymphocyte migration (GO:0072676),-0.4698291388808108,-1.3895883164719736,0.05732484076433121,0.41968195428123795,1.0,26/32,52.41%,CCL15;CCL14;CCL25;S1PR1;RET;CCL13;CCL19;CKLF;CCL2;CX3CL1;MYO1G;CCL5;CCL11;ZAP70;ADAM8;CCL4;GATA3;CRTAM;CCL7;CCL8;MSMP;CCR6;CCL1;CCL3;TBX21;XCL1
prerank,phospholipid homeostasis (GO:0055091),-0.6083586638435134,-1.3893439632503775,0.10925925925925926,0.41926802087535076,1.0,3/11,8.29%,ABCA1;RCN3;TLCD2
prerank,embryonic limb morphogenesis (GO:0030326),0.5408686850923408,1.3893328630077082,0.13405797101449277,0.6651343776073068,1.0,5/34,3.07%,CACNA1C;TBX2;MAP3K20;TBX3;ECE1
prerank,muscle organ development (GO:0007517),0.496586072375561,1.3889593821476718,0.10416666666666667,0.6641564993860456,1.0,6/54,1.67%,LAMA2;UTRN;MEF2C;DMD;ITGA7;CACNA1H
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5593494717255829,1.388936868025972,0.13152804642166344,0.6622741285814817,1.0,5/27,6.78%,MAP3K20;MAP3K5;BTRC;TNIP2;KAT7
prerank,response to glucagon (GO:0033762),0.5966526358986547,1.3883371444351238,0.1504950495049505,0.662008104972968,1.0,9/19,10.19%,CYSLTR2;PRKAR1B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.41875649335835124,-1.3878154946496999,0.03617571059431524,0.42212028664606965,1.0,23/57,22.77%,GLUL;SDAD1;RPS19;NAF1;RPL11;CUL4A;PAK1IP1;RPS16;RPS24;RPL14;RPL26;BYSL;RPL7;RPS15;RPS6;EBNA1BP2;RBIS;RPS25;RPS7;RPL38;RIOK2;URB2;RPL35A
prerank,regulation of plasminogen activation (GO:0010755),-0.5954790490281092,-1.3875801577007538,0.09751434034416825,0.42163550372627806,1.0,6/12,19.73%,THBS1;CLEC3B;ENO1;SERPINE1;PLGRKT;SERPINE2
prerank,positive regulation of vasculature development (GO:1904018),-0.3882125451606159,-1.3875338868188758,0.021621621621621623,0.42066166722328485,1.0,32/94,13.40%,ANXA3;FLT1;CDH5;PTGIS;CTSH;TEK;F3;PLCG1;ITGB8;SASH1;NOS3;THBS1;RAMP2;CD34;VEGFD;VEGFC;FGF1;WNT5A;PRKCB;CYP1B1;RHOB;HK2;PIK3R6;TIE1;HIF1A;ECM1;ZC3H12A;KDR;GATA2;SMOC2;GATA6;SPHK1
prerank,response to interferon-beta (GO:0035456),-0.5130666274507931,-1.387505354819661,0.08935361216730038,0.41966400978920665,1.0,11/22,25.16%,IFITM3;IRF1;IKBKE;STAT1;IRGM;UBE2G2;IFITM2;PNPT1;NDUFA13;TRIM6;PLSCR1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6412106633712229,1.3874828964102943,0.15315315315315314,0.6623608669147855,1.0,4/11,9.28%,HEY2;TBX20;SOX4;JAG1
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.48155877708405154,-1.3872668734683238,0.07707509881422925,0.4192295530842994,1.0,9/28,16.31%,PRKAG2;ADIPOR2;TNFRSF1B;CD47;NOS1AP;AVIL;FGFR4;PRKAA2;SIRPA
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.6099309267711088,-1.3866317375543749,0.09900990099009901,0.41973844839315283,1.0,3/11,10.02%,DAB2;EZR;RAB21
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5692155325515253,-1.3860835125948645,0.10074626865671642,0.4201130913126308,1.0,8/15,28.31%,IGF1;AKT1;GPX1;PRELID1;PSMD10;BCL2L1;PRKN;CLU
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.47907653289559177,1.385554719113762,0.1018363939899833,0.6656244350883329,1.0,11/70,5.24%,ITGA4;LAMC3;MEF2C;PIK3R1;LAMC1;PEAK1;FERMT2;RILPL2;ABI2;NTNG2;LAMB1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.31813023588366046,-1.3854060762052967,0.0,0.4207170487416077,1.0,79/348,12.80%,BMP6;AFDN;IGF1;ROBO1;SLC24A3;FN1;SMAD3;CDH5;ROCK2;NTRK3;GSN;CTSH;OCLN;BMP7;OSR1;APP;F3;WNT6;CLDN5;ITGB8;ANXA2;NOS3;BMP4;GJA1;EZR;TGFBR1;FOXD1;ANGPT1;MAGI2;KLF4;CSF1;LEF1;KLF2;RAMP2;CD34;HOXA5;SMO;MED26;GAS6;ARRB1;AR;FGF1;RAB27A;LGALS9;YAP1;MOV10;SFRP4;WNT5A;MAPK14;STAT3;HINFP;SCYL2;MAP2K5;TFRC;ACTG1;DTNBP1;PIK3CB;NOS1AP;AKT1;DTX3L;HGS;IL33;HIF1A;TLE1;EMILIN1;SEC16B;ZC3H12A;P2RX7;GATA2;VPS35;RPL11;TGFB1;FGFR4;EPHX2;TMEM119;EPHB2;ID2;ATM;PRKAB1
prerank,regulation of macroautophagy (GO:0016241),-0.3679011771707567,-1.3853966370973188,0.04120879120879121,0.41966360616608245,1.0,33/105,21.26%,PRKAG2;DCN;SNX6;LRRK2;SNX32;EXOC4;CLEC16A;NRBP2;CAPNS1;ATP6V1G1;AKT1;CAPN1;ATP6V0B;KDR;VPS35;BNIP3L;ERN1;SH3GLB1;ATP6V0A1;PRKAG3;PRKAB1;LARP1;BNIP3;ATP6V0A2;PRKAA2;TBC1D25;QSOX1;RRAGB;LAMTOR5;ATG101;IKBKG;USP36;PRKAG1
prerank,stem cell development (GO:0048864),0.5984596230191199,1.385252119034207,0.15843621399176955,0.6643811268976071,1.0,4/16,11.06%,CDH2;NRG1;KLHL12;SNAI2
prerank,negative regulation of immune response (GO:0050777),0.43352036677827344,1.3850961642586108,0.05377906976744186,0.662836502332004,1.0,19/154,6.93%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;CD300A;NPSR1;PRKAR2B;CACTIN;GPR45;ADCY9
prerank,filopodium assembly (GO:0046847),-0.5624643983667434,-1.3849966106138438,0.10821643286573146,0.4196209244083289,1.0,6/16,10.58%,FGD5;FGD6;EZR;SRGAP2;DNM3;FGD4
prerank,regulation of neurogenesis (GO:0050767),0.49872758553030094,1.3848751574218277,0.11505922165820642,0.6614972772622207,1.0,6/55,2.62%,HEY2;HEYL;NOTCH1;PER2;GPER1;IL1B
prerank,regulation of peptidase activity (GO:0052547),-0.5297843757267333,-1.3843599476615758,0.09580838323353294,0.42014221791495093,1.0,6/19,12.12%,CTSH;CAV1;RCN3;CST3;ECM1;HDAC1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.45478034125959815,-1.3838456002312403,0.0738255033557047,0.4204800270015681,1.0,14/36,19.04%,PDGFD;ERRFI1;EPHA7;ENPP1;RASSF2;TOM1L1;CALM2;TAOK2;RAD50;CALM1;RAP2C;PDGFC;PPP2R5C;CHP1
prerank,supramolecular fiber organization (GO:0097435),-0.32459931978838075,-1.3830430415002026,0.0,0.42163919138899775,1.0,84/333,13.07%,TSPAN5;COL1A2;COL3A1;SNCAIP;COL5A2;COL1A1;ADAMTS2;COL22A1;GSN;COL12A1;RHOBTB1;COL5A1;FIGN;LOXL1;SHROOM2;CD2AP;ELMO1;COL6A3;APP;DLG1;COL25A1;COL6A1;COL8A2;ITGA6;VIM;TLL1;COL4A5;SHROOM3;COL6A2;TGFBR1;PLEC;COL11A1;B2M;CLIP4;ARHGEF2;FBLN5;COL23A1;COL4A6;HSPG2;ADAM10;PLOD2;COL13A1;HDGFL3;ARHGAP17;IAPP;SERPINH1;PGM5;P4HB;SHROOM4;RHOA;COL18A1;CYP1B1;GGA2;FKBP1A;RHOB;H3-3A;FAT1;CST3;ITGB4;TGFBI;TRIOBP;COL14A1;DPT;GFAP;EMILIN1;COL15A1;SPAST;COL16A1;LUM;MAP7D3;MFAP4;ADAMTS14;AVIL;LAMA3;ADAMTS3;COL20A1;MDM2;EVL;ACTN1;COL9A2;TRPV4;CCDC88C;UBB;DNAJB6
prerank,dendritic spine organization (GO:0097061),0.5579617471346923,1.3826230052200175,0.1383177570093458,0.6657413256723559,1.0,4/26,6.62%,PTEN;DOCK10;WASL;CHRNA7
prerank,bile acid metabolic process (GO:0008206),0.5698497249621288,1.3824937109581787,0.1588235294117647,0.6641135778514164,1.0,5/27,6.00%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6
prerank,ketone body metabolic process (GO:1902224),-0.6229944543897069,-1.382335793634861,0.1203883495145631,0.4224101523321917,1.0,4/10,14.75%,ACSS3;HMGCS2;BDH1;BDH2
prerank,prostanoid metabolic process (GO:0006692),-0.5788006764868384,-1.3817163045324816,0.10687022900763359,0.4230342162512053,1.0,6/13,24.76%,PTGS1;ACOX1;GSTM1;PTGR2;PTGES;PTGR1
prerank,regulation of membrane repolarization (GO:0060306),0.6382865727352841,1.3814284733483928,0.15450643776824036,0.6650785847395192,1.0,5/13,7.70%,CASQ2;NEDD4L;CACNA2D1;AKAP6;KCNE5
prerank,lipid translocation (GO:0034204),-0.5169388611912481,-1.3811667147214233,0.07755102040816327,0.4234761167423523,1.0,8/21,17.15%,ABCA1;ATP10A;ABCA4;ATP9A;ATP8A1;TMEM30A;ATP11A;ATP11B
prerank,sphingosine metabolic process (GO:0006670),-0.5558100523304619,-1.3807674725914776,0.11788617886178862,0.42346094998279094,1.0,7/17,14.17%,PLPP3;ACER2;NAAA;ACER3;PLPP1;SPHK1;SPTLC2
prerank,amino acid transport (GO:0006865),0.5022700517306373,1.3805553694242414,0.1273031825795645,0.66540939955067,1.0,3/49,2.19%,SLC38A11;SLC1A5;SLC1A4
prerank,cellular component assembly (GO:0022607),0.3999096681731673,1.3798081592276983,0.03994673768308921,0.6655115289234907,1.0,34/253,7.91%,MYO1B;LIN7A;EPS8;CALD1;LIMS1;AIF1L;LAMC1;VASP;FERMT2;WASF3;WAS;RSPH6A;LRRTM3;SPEF1;WIPF1;SH3BP1;TTLL3;SPTBN1;JHY;RAC3;WASL;RIMS1;PDCD10;GAS8;YTHDF3;ANK3;FBLIM1;YWHAZ;PLS3;RSPH1;LRGUK;DARS1;REC8;TEX12
prerank,regulation of receptor internalization (GO:0002090),-0.45870034669814463,-1.3797935364746032,0.07805907172995781,0.42493510095159376,1.0,16/35,28.11%,RIN3;ANGPT1;MAGI2;SDCBP;ARRB1;SFRP4;SCYL2;ATXN2;ANKRD13D;VEGFA;NTF3;CD63;ANKRD13A;TBC1D5;PICK1;MKLN1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5529650739884759,1.3796146314882431,0.1441947565543071,0.6640960531606624,1.0,10/29,13.89%,PTEN;BMP5;IL17RD;SPRED1;SPRY2;HPN;VASN;FUZ;SPRED2;SFRP2
prerank,protein depolymerization (GO:0051261),-0.48869557092322286,-1.3789387971834637,0.08695652173913043,0.4261881283526712,1.0,3/27,1.88%,MICAL3;GSN;MICAL2
prerank,thyroid hormone generation (GO:0006590),-0.605524593023864,-1.3786932940478231,0.11029411764705882,0.4257730426081527,1.0,2/10,12.81%,CPQ;SLC5A5
prerank,negative regulation of secretion by cell (GO:1903531),0.528100598903368,1.3783381036897908,0.13670411985018727,0.6656380353101535,1.0,5/38,6.30%,GRM7;NOTCH1;RHBDF1;HTR1B;SNCA
prerank,response to thyroid hormone (GO:0097066),-0.573729027069988,-1.3777057270955828,0.12341197822141561,0.4273300334629539,1.0,5/13,11.79%,CTSH;THRB;LMO2;CTSB;CTSS
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.38400582511353787,-1.3776029130547025,0.03067484662576687,0.4265448483667143,1.0,31/95,11.10%,UST;EXT1;CHST11;ST3GAL4;DCN;B4GALT1;ST3GAL6;CEMIP;OGN;FMOD;ST3GAL1;HS3ST3A1;ST3GAL2;ANGPT1;NDST1;CSGALNACT1;HSPG2;CHSY1;BGN;HEXA;SDC4;ST3GAL3;HS6ST1;PRELP;GLCE;HS3ST3B1;LUM;PXYLP1;OMD;CHST15;DSEL
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5225848231597015,-1.3775334806824666,0.11663479923518165,0.4256617926351053,1.0,6/21,6.61%,FOXP1;PRKCH;ELF2;ELF1;SLC39A10;PRKCB
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6130370959990079,1.3774812278863375,0.1595744680851064,0.6660115394837067,1.0,3/16,3.39%,NR1H3;SCARB1;LDLR
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.572429580223491,-1.3773664218729658,0.11752988047808766,0.42505459238071763,1.0,9/14,28.90%,SEMA7A;WNT5A;KIT;MAVS;PLCG2;TICAM1;NR4A3;BCL10;LAPTM5
prerank,embryonic digestive tract development (GO:0048566),-0.5488858780661823,-1.3761488548435037,0.11177644710578842,0.4272821097477015,1.0,9/18,14.90%,PDGFRA;GLI2;PCSK5;RARB;FGFR2;STRA6;GLI3;ID2;PKDCC
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.570930884737677,-1.3751878237693735,0.1111111111111111,0.42889285309648795,1.0,3/12,13.16%,LPCAT3;P4HB;MFSD2A
prerank,ncRNA processing (GO:0034470),-0.34512905103782154,-1.3749048786379297,0.010638297872340425,0.42852181890013236,1.0,74/200,25.83%,SMAD3;RPLP1;RPS14;RPL9;TUT4;TUT7;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;KRR1;UTP11;RPL27A;RPL12;RPL37;KARS1;NOP58;RPL11;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RPS27;RPL14;DDX49;RPL26;SARS1;RPL10;BYSL;INTS11;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;AGO1;ESF1;RPL36A;DICER1;RRP12;RRP7A;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36;INTS5;RPL13A;FBL;POP1
prerank,glycoprotein catabolic process (GO:0006516),-0.5651899640685819,-1.374518540508398,0.0912621359223301,0.42850295842813774,1.0,11/17,33.53%,ADAMTS12;ADAMTS9;STT3B;EDEM2;MANBA;NGLY1;FBXO17;EDEM1;FBXO44;NEU2;FBXO2
prerank,import into cell (GO:0098657),-0.45156206245240643,-1.3736321462669054,0.06178489702517163,0.4297874540461809,1.0,11/41,9.26%,SLC6A13;GLUL;SLC47A1;SLC1A3;SLC16A2;SLC6A6;SLC12A7;SLC39A14;SLC22A4;SLC7A5;SLC5A6
prerank,nucleoside catabolic process (GO:0009164),-0.6035401128210434,-1.3734141961212656,0.11313868613138686,0.42932775043088406,1.0,6/11,18.32%,DPYD;UPP2;UPB1;NT5E;DERA;NT5C1A
prerank,regulation of cartilage development (GO:0061035),0.6135006353770516,1.373109475568635,0.14473684210526316,0.6761842076916937,1.0,3/18,1.50%,SOX5;MBOAT2;TRPS1
prerank,response to cytokine (GO:0034097),-0.3594040459740321,-1.3725819591654076,0.027190332326283987,0.4305501396109205,1.0,27/141,7.33%,TIMP3;DPYSL3;ALDH1A2;AFF3;COL3A1;SMAD3;NFAT5;PTPN14;PTPN13;HDAC4;SP100;APP;IL1R1;IL6R;IL6ST;TIMP2;ANXA1;ADAM9;LEF1;ADAM10;IRAK2;IFITM3;LGALS9;IKBKE;RHOA;STAT1;STAT3
prerank,intracellular lipid transport (GO:0032365),-0.505536936880889,-1.37206161325753,0.11133200795228629,0.43092738734987573,1.0,7/21,9.91%,PRKAG2;CERT1;CPT1A;SLC25A20;NPC2;CPT2;ACACA
prerank,regulation of cation channel activity (GO:2001257),0.4548849016417948,1.3716051615607716,0.10232558139534884,0.6785108871179957,1.0,24/89,12.90%,PDE4D;MEF2C;DMD;CACNB2;KCNG1;FGF12;CACNG7;FGF13;MINK1;ITGB1;GRIA2;ANK3;KCNE5;STAC;NETO1;GRIN2B;HPCA;DLG2;GSG1L;FGF11;FGF14;PIRT;DLG3;JPH4
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5430744232957365,-1.3713755098296712,0.10946196660482375,0.43150677173379764,1.0,11/18,13.39%,JCAD;HDAC7;FOXC2;ANXA1;HDAC9;FGFBP1;KDR;GATA2;PTGS2;RHOJ;SRPX2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.5857744393806693,1.3700998167605831,0.1460446247464503,0.6806591695327733,1.0,4/19,1.81%,HEY2;HEYL;NOTCH1;SLIT3
prerank,negative regulation of cell population proliferation (GO:0008285),0.38809122656335354,1.3696416447538062,0.028500619578686492,0.6799296797892289,1.0,36/351,5.65%,DLC1;PTPRK;ITGA1;PTEN;GLMN;FAP;RERG;CBFA2T3;IGFBP7;RAPGEF2;CDK6;BMP5;NOTCH1;COL4A3;PER2;NCK2;RGCC;CCN6;GPER1;FRK;TBX3;NODAL;TNS2;NF1;ERBB4;IL1B;PLXNB1;ETS1;SH2B3;MYO16;RPS6KA2;GAS8;CD300A;FABP3;TNFRSF8;TFAP2B
prerank,adenine nucleotide transport (GO:0051503),-0.5380922388610309,-1.369590555305542,0.11969111969111969,0.4350736822680869,1.0,5/17,10.65%,ABCC4;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.4829472759099539,-1.3692372250847087,0.10386965376782077,0.4349834154762244,1.0,15/27,22.34%,SLC47A1;SLC1A3;SLC7A2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC25A22;SLC7A1;ARL6IP5;SLC22A2;SLC25A29;SLC1A1;SLC38A1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.613580670416184,-1.3689272043759306,0.12186379928315412,0.43481631289914635,1.0,5/10,21.92%,APOE;ABCA3;TMEM30A;PRELID1;DBI
prerank,positive regulation of heart rate (GO:0010460),0.6158548582379214,1.368110271164767,0.1670061099796334,0.6821068895755628,1.0,3/17,6.59%,PDE4D;RYR2;ATP2A2
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.5075209343425591,-1.3664542320090813,0.09832635983263599,0.44017333520052926,1.0,4/22,12.33%,ALDH1A2;RBP1;CUBN;VKORC1L1
prerank,carnitine metabolic process (GO:0009437),-0.5922508948864864,-1.3662304141467263,0.11731843575418995,0.43971629718654737,1.0,5/12,17.19%,CPT1A;CPT2;TMLHE;ACADL;CPT1C
prerank,cellular iron ion homeostasis (GO:0006879),-0.42010519273548425,-1.366053049565222,0.0725,0.43910004851298967,1.0,23/55,28.78%,BMP6;CP;SCARA5;ABCG2;SLC39A14;TFRC;ATP6V1G1;ACO1;FTL;NEDD8;ATP6V0A2;HFE;CYB561A3;FRRS1;FTH1;NUBP1;CCDC115;TMEM199;SMAD4;ATP6AP1;ALAS2;ATP6V0D1;ATP13A2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.3916027650561562,-1.3658904886716967,0.056790123456790124,0.43850518105012537,1.0,30/77,25.65%,IGF1;SH3RF1;ITGA6;THBS1;BMP4;TGFBR1;TCF7L2;ACVR1;CFLAR;AR;AKT1;MCL1;NR4A2;RELA;QARS1;MAZ;TMBIM6;PSME3;RIPK1;GPX1;PRELID1;PARK7;PLAUR;ZMYND11;NDUFA13;PIH1D1;TMEM14A;PSMD10;BCL2L1;PRKN
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.535063844083451,-1.3653987840475539,0.09819639278557114,0.4388662542164147,1.0,5/18,9.65%,PRKAG2;OCLN;SLC2A1;PRKCB;C2CD5
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6348005472081458,-1.3653307606681657,0.11923076923076924,0.4379490044068644,1.0,5/10,14.34%,TUT4;TUT7;CHFR;UBB;NEDD8
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.43819343555436774,1.3646930368081764,0.0889894419306184,0.6895319267448956,1.0,33/118,13.34%,CHN1;MEF2C;PID1;NEDD4L;CDH2;SDC2;HECW2;PHLDB2;FERMT2;NF1;LRRC4C;CDX1;ETS1;CHRNA3;ABI2;FGF2;TSPAN12;CLASP2;EMP2;ADGRB3;MARK2;HECW1;ARHGAP35;ZMYM3;EPHA2;SARM1;BRSK1;PAK3;PAK1;PPFIA2;PHLDB1;RNH1;LZTS1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5814651836653961,-1.3646100458511772,0.11196911196911197,0.43882333714679184,1.0,5/13,13.39%,SEMA7A;WNT5A;IRAK3;TGFB1;PLCG2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5001372328835828,-1.364591402709855,0.07539682539682539,0.4378634122601578,1.0,10/24,17.31%,EPHA4;APOE;CTSC;TMF1;PTK2B;PSME2;UBB;PKD1;PSME3;GPX1
prerank,cellular potassium ion homeostasis (GO:0030007),0.6305979112950929,1.3644210490406024,0.1721311475409836,0.6884122615985971,1.0,4/13,4.90%,SLC12A2;ATP1A2;ATP1A4;ATP1B2
prerank,gland development (GO:0048732),-0.4126949200166023,-1.3641294783890456,0.0645933014354067,0.43800872291627363,1.0,14/59,8.16%,TGFBR3;WNT4;GLI2;DKK3;CAV1;FGFR2;EZR;TGFBR1;IGSF3;ANXA1;LSR;SIX1;TBX1;STRA6
prerank,regulation of cellular component size (GO:0032535),0.5338174740342135,1.3640870239307354,0.15384615384615385,0.6873630254465275,1.0,2/30,0.42%,EPS8;PTEN
prerank,cellular response to interferon-beta (GO:0035458),-0.5623016403226071,-1.363574796698245,0.1348314606741573,0.4385697370304347,1.0,8/14,23.98%,IRF1;STAT1;IRGM;UBE2G2;IFITM2;PNPT1;NDUFA13;TRIM6
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5605530912988973,1.3626220775749998,0.1465863453815261,0.6895253353369671,1.0,5/23,9.57%,PTEN;INPP5J;MTMR12;MTMR7;INPP5B
prerank,microtubule bundle formation (GO:0001578),0.5111880568399667,1.3625728685498741,0.14136125654450263,0.6877809307706051,1.0,13/42,11.53%,MTCL1;RSPH6A;SPEF1;TTLL3;NCKAP5;JHY;GAS8;TPPP;RSPH1;LRGUK;CFAP46;CCDC66;KIF20A
prerank,regulation of monocyte differentiation (GO:0045655),0.6238502256781149,1.3618086732946317,0.14107883817427386,0.6881021177944572,1.0,2/14,1.10%,IL34;CDK6
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.6173204318668001,-1.3616584568823475,0.1150278293135436,0.4424332794554029,1.0,4/10,10.91%,DCN;LRRK2;KDR;MYOC
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5858106057466547,1.361508259888088,0.15975103734439833,0.6869796602785881,1.0,7/19,9.04%,RAPSN;CHRNA3;CHRNA7;CHRFAM7A;ACHE;SLC5A7;COLQ
prerank,ERBB2 signaling pathway (GO:0038128),0.5297388553416977,1.3612628379976894,0.14522058823529413,0.6857658308455211,1.0,5/31,3.05%,GAB1;PIK3R1;ERBB4;NRG1;PIK3CA
prerank,cellular response to drug (GO:0035690),0.5657026227349269,1.3609703181956696,0.15213358070500926,0.6847724909719151,1.0,5/25,6.04%,MEF2C;PPM1E;IL1B;HTR1B;PDE4B
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.4569037674090881,-1.3609340497525366,0.0835117773019272,0.4432793413688759,1.0,10/33,6.10%,MCC;DCN;SP100;APOE;ADAMTS9;SLIT2;PTPRM;THBS1;PTPRG;ACVRL1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5908175196480834,-1.360862892318536,0.11173184357541899,0.4424287523624553,1.0,5/12,22.25%,FOXP1;KLF4;MAP2K5;TLR4;LPL
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.5094244719665176,-1.360823260636636,0.10121457489878542,0.44152278024819785,1.0,11/21,28.63%,LRRK2;BCL2L11;CREB3L1;CREB3;TMBIM6;PARK7;XBP1;EIF2AK3;BCL2L1;PRKN;SYVN1
prerank,positive regulation of cyclase activity (GO:0031281),0.6203469607443933,1.360713594641088,0.17355371900826447,0.6835591019916728,1.0,4/14,7.48%,CACNA1C;NF1;CACNA1D;STIM1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.44803719612965476,-1.3602910306376532,0.08370044052863436,0.4419972387948869,1.0,13/39,14.82%,NRP1;GLI2;SLIT2;TGFBR2;BMP4;LRP6;RASIP1;SIX1;SEMA3E;TIE1;KDR;MET;PKD1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5372636682721552,1.3600903328675655,0.12195121951219512,0.6834014495296508,1.0,5/32,3.66%,CARMIL1;PLCE1;PIK3R1;PIK3CA;ABI2
prerank,negative regulation of gene expression (GO:0010629),-0.3207144712603578,-1.3599425980479576,0.01015228426395939,0.44185098037155884,1.0,87/302,19.17%,NOTCH2;IGF1;ROBO1;SLC24A3;DAPK1;LGR4;SAMD4A;ROCK2;FOXP1;WNT4;IGFBP5;OCLN;APOE;APP;CLDN5;ITGB8;XDH;ESR1;BMP4;DNMT3A;KLF4;KAT2B;TAF1;HDAC9;RBBP7;CD34;ADAM10;SMO;PARP9;CNOT7;WWP2;SRGN;LGALS9;PARP14;YAP1;MOV10;RNF139;ACVRL1;DDX6;SLC7A5;HINFP;RPS13;PGR;H3-3A;NOCT;IGF2BP2;HIF1A;FLOT2;FLCN;EMILIN1;JARID2;ZC3H12A;KDR;ANXA7;TRIM27;GATA2;ERN1;TGFB1;HDAC1;CPEB3;TWSG1;ID2;NUDT12;CALR;ATOH8;LARP1;CNOT8;SFRP1;CREB3L1;FXR2;TMBIM6;BMPR1A;PRKAA2;ASB1;PPHLN1;PNPT1;TNRC6A;PAIP2B;LSM5;PARK7;EIF4E2;TYMS;EZH2;PTBP3;ZFP36L2;PTRH2;AGO1
prerank,female gamete generation (GO:0007292),0.562422362430272,1.3589582473746853,0.14122137404580154,0.6845128034789086,1.0,6/29,7.87%,DIAPH2;PTN;BCL2L10;FMN2;MEI4;NANOS1
prerank,fatty acid metabolic process (GO:0006631),0.4410074337582149,1.3576149634657249,0.09242424242424242,0.6863178811243553,1.0,15/115,7.28%,GGT5;CEL;GGT1;PER2;ACSF2;ABCD2;SLC27A2;PPARD;BAAT;ACOT12;SLC27A4;PON2;LIPC;LIPH;AOAH
prerank,negative regulation of biomineral tissue development (GO:0070168),0.586949836612171,1.357449167676582,0.166015625,0.6848903456713855,1.0,4/21,2.15%,ASPN;HEY2;NOTCH1;ROCK1
prerank,regulation of establishment of cell polarity (GO:2000114),-0.5491540374517621,-1.3566228147286385,0.1167608286252354,0.4491723493283159,1.0,5/16,6.79%,CDH5;ROCK2;GSN;RAP1B;PTK2B
prerank,regulation of chemokine production (GO:0032642),-0.45299387051339113,-1.3563331082551786,0.07566462167689161,0.44891840302131675,1.0,19/36,33.26%,FOXP1;APP;IL6R;LGALS9;WNT5A;IL33;HIF1A;IL18;TLR4;CSF1R;SIGIRR;LPL;EGR1;IL7;AIF1;HMOX1;TREM2;TLR7;ADAM17
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.4497167177226255,-1.3557351328067178,0.08533916849015317,0.44943541744205506,1.0,14/37,16.55%,APOD;PDCD4;APPL2;ADCY7;MAPK14;STAT3;HIF1A;IL17RA;ZC3H12A;GBP5;PPARA;TICAM1;SIRPA;TLR4
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.5335642434178474,-1.355125887436163,0.10379241516966067,0.4501611695527353,1.0,3/18,2.68%,EPHA4;ROCK2;SLC2A13
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.33889865198718105,-1.3546912364129995,0.018867924528301886,0.45032538928678306,1.0,51/182,14.30%,NOTCH2;IGF1;ROBO1;SLC24A3;ROCK2;FOXP1;WNT4;OCLN;APOE;APP;CLDN5;ITGB8;XDH;RIN3;ESR1;BMP4;KLF4;TAF1;CD34;ADAM10;SMO;SDCBP;PARP9;CNOT7;WWP2;LGALS9;PARP14;YAP1;MOV10;ACVRL1;SLC7A5;HINFP;PGR;NOCT;HIF1A;ATXN2;FLOT2;FLCN;EMILIN1;ZC3H12A;KDR;ANXA7;OPTN;GATA2;TGFB1;HDAC1;ID2;ATOH8;SFRP1;CREB3L1;HSP90AB1
prerank,positive regulation of cell junction assembly (GO:1901890),0.4860345303924096,1.3544149800614775,0.10975609756097561,0.6913244744444305,1.0,8/56,4.35%,ACE2;LIMS1;CLSTN1;FERMT2;ROCK1;NRXN1;CLSTN3;CNTNAP2
prerank,regulation of synapse assembly (GO:0051963),0.5001156264481919,1.3538635931466496,0.13379073756432247,0.6910480368111599,1.0,17/46,15.09%,MEF2C;CLSTN1;SLIT1;LRFN5;NRXN1;CLSTN3;SNCA;ROBO2;IL1RAPL1;SLITRK1;CUX2;IL1RAPL2;EPHB1;SLITRK2;NLGN3;CHRNB2;SYNDIG1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6424565667648721,1.3537916095991016,0.18448637316561844,0.6893647705272088,1.0,3/10,6.04%,CACNB2;CACNA2D1;PDE4B
prerank,regulation of cell adhesion (GO:0030155),-0.3631623852156074,-1.353345682055071,0.027950310559006212,0.45274969026194634,1.0,32/129,13.68%,PLXNA2;PKP4;EPHA4;ROCK2;EPHA7;FBLN1;PODXL;PLXNA4;TGM2;PTPRJ;ANGPT1;ADAM10;CXCL12;P4HB;ACVRL1;EFNA5;PTK2B;STX3;DUSP1;TGFBI;PLXND1;PPP1CB;CDH13;EPHA8;FLCN;IL18;ARHGDIA;CD164;EPHB2;ATM;CHRD;RET
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5839174735021186,1.3533110868749627,0.16996047430830039,0.6887486018266579,1.0,5/18,6.62%,PTEN;NRXN1;RIMS1;RIMS2;CHRNA7
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.5645375258301885,-1.3525241664156693,0.11964285714285715,0.4538116345887266,1.0,8/14,25.02%,DPYD;UPP2;UPB1;NT5E;NT5C1A;ERH;CAD;NT5C
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4815923930988065,-1.351134789506851,0.10887096774193548,0.4566380558274173,1.0,7/24,7.64%,DPYSL3;NRP1;PALM;RHOQ;FNBP1L;ARAP1;DOCK11
prerank,endoderm development (GO:0007492),0.629010087755318,1.3504930819394538,0.19383259911894274,0.6947636908050898,1.0,2/13,1.71%,TBX20;LAMC1
prerank,retinoid metabolic process (GO:0001523),-0.39297623835174655,-1.35029313904591,0.0610079575596817,0.45782479524239844,1.0,14/71,9.48%,ALDH1A1;ALDH1A2;RBP1;APOE;CYP26B1;DHRS3;RBP4;HSPG2;AKR1B1;SDC4;CYP1B1;ABCA4;STRA6;SCPEP1
prerank,pyroptosis (GO:0070269),-0.5540567771231499,-1.3500837399634722,0.11516314779270634,0.457315138755083,1.0,4/15,10.42%,GSDME;CASP4;CASP8;GSDMD
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5967377006749826,-1.3499480965546462,0.14233576642335766,0.4566725790550897,1.0,5/10,23.39%,FN1;GATA6;HSP90AB1;TYROBP;CDH3
prerank,negative regulation of leukocyte activation (GO:0002695),0.5968410104925416,1.3499082684524975,0.163135593220339,0.694436255256428,1.0,5/15,6.03%,GPER1;NR1H3;LRFN5;CD300A;IL4
prerank,cellular amino acid catabolic process (GO:0009063),-0.38027492030858634,-1.3498203621438838,0.05080213903743316,0.4559904251344404,1.0,43/87,36.38%,GLUL;DDO;NOS3;ALDH7A1;IVD;ASPA;DDAH1;CARNMT1;ALDH4A1;PRODH;GLS;BCKDHB;AUH;PIPOX;CARNS1;NOS1;CBS;HOGA1;BCKDK;HNMT;BCKDHA;GCDH;ABAT;AMT;KYNU;HMGCL;AASS;ALDH6A1;MTRR;BLMH;FAH;HYKK;BCAT1;ALDH5A1;ACADSB;GLDC;SHMT1;HGD;IL4I1;HMGCLL1;HAAO;HSD17B10;NOS2
prerank,regulation of protein export from nucleus (GO:0046825),-0.5029539959138816,-1.3497482435759227,0.10700389105058365,0.4551642671195062,1.0,13/23,25.85%,PTPN14;SP100;TCF7L2;GAS6;IFI27;ANP32B;BAG3;SIRT7;TPR;PARK7;YWHAE;XPO4;TP53
prerank,positive regulation of dendrite extension (GO:1903861),0.5900946457453605,1.3495990213910563,0.1644100580270793,0.6934255748346522,1.0,5/17,11.38%,NEDD4L;RIMS1;RIMS2;SYT1;SYT2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6183880427810358,1.3495543180908964,0.17425742574257425,0.6916853807992512,1.0,2/13,2.38%,SPAAR;SESN3
prerank,regulation of dendrite extension (GO:1903859),0.5847762374070673,1.3495318536233616,0.16764132553606237,0.689942590132935,1.0,5/18,11.38%,NEDD4L;RIMS1;RIMS2;SYT1;SYT2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.608092810885732,-1.3493956226838644,0.1264591439688716,0.4550231394133389,1.0,5/10,14.09%,EPHA4;ANXA2;ATRAID;DAB2IP;RGP1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.5277153453301154,1.348356377257287,0.1636029411764706,0.6913360078495708,1.0,3/35,1.42%,GGT5;GGT1;GGTA1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.3986820286595322,-1.3479745046309335,0.0773067331670823,0.45760699083339423,1.0,28/68,30.22%,APP;IL6R;LBP;ARHGEF2;IL16;LGALS9;WNT5A;STAT3;IL33;IL17RA;MAVS;CYBA;PLCG2;TLR4;POU2F2;SYK;TYROBP;XBP1;LPL;RAB7B;IL17D;MYD88;SETD4;TWIST1;BCL10;SPHK2;F2R;AIF1
prerank,positive regulation of cell migration (GO:0030335),-0.3254468497405633,-1.3479239904037668,0.004016064257028112,0.4566960899609633,1.0,74/253,13.68%,IGF1;DAB2;DOCK5;PDGFD;FN1;EGFR;FLT1;COL1A1;CDH5;ROCK2;PDGFRA;NRP1;NTRK3;CTSH;PDPN;SEMA3D;CEMIP;SEMA6A;NEDD9;SEMA3C;PECAM1;PODXL;F3;CAV1;PLCG1;ITGA6;BMPR2;SMURF2;THBS1;IGF1R;TGFBR1;SEMA7A;RAB11A;CSF1;ARHGEF2;ADAM9;LEF1;ACVR1;ADAM10;SMO;SDCBP;CXCL12;FGF1;PRKCE;SYNE2;PTK2B;STAT3;HSPA5;SH3RF2;SEMA3E;ACTG1;TIAM1;MMP14;KIT;RREB1;HIF1A;TWIST2;CCN4;CDH13;DAB2IP;KDR;MYOC;TGFB1;SEMA3B;TRIP6;PFN1;WNT5B;EPHB2;ATM;CCN1;PLCG2;SPHK1;FER;RET
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5571631475612054,-1.3475327084125939,0.12407407407407407,0.4567575454174736,1.0,3/13,6.17%,GLUL;DDO;ASPA
prerank,regulation of cholesterol esterification (GO:0010872),-0.6097492344869192,-1.3474220512726034,0.11299435028248588,0.4560866843967982,1.0,4/10,19.01%,APOE;STARD4;AGT;AGTR1
prerank,positive regulation of cell motility (GO:2000147),-0.33413393188882495,-1.3467687401779518,0.017921146953405017,0.4568353770284729,1.0,75/205,17.56%,IGF1;DAB2;PDGFD;EGFR;FLT1;COL1A1;CDH5;ROCK2;PDGFRA;NTRK3;CTSH;PDPN;SEMA3D;CEMIP;SEMA6A;NEDD9;SEMA3C;PECAM1;PODXL;F3;CAV1;ITGA6;THBS1;IGF1R;TGFBR1;SEMA7A;CSF1;ADAM9;LEF1;ACVR1;ADAM10;SMO;SDCBP;CXCL12;FGF1;SPOCK2;SYNE2;CAVIN1;PTK2B;STAT3;HSPA5;SH3RF2;SEMA3E;ACTG1;TIAM1;MMP14;KIT;TWIST2;CDH13;KDR;MYOC;TGFB1;SEMA3B;TRIP6;WNT5B;EPHB2;ATM;CCN1;SPHK1;FER;RET;MAZ;WASHC1;CLDN1;SNAI1;CXCL16;LAMC2;NTN1;RUFY3;SEMA3G;SEMA6B;CD151;WNT11;PDGFC;ROR2
prerank,glycosphingolipid metabolic process (GO:0006687),-0.43717595875670184,-1.3460087002898422,0.10948905109489052,0.4578065529978513,1.0,19/42,22.79%,LARGE1;ESYT2;ST6GALNAC3;A4GALT;SMPD3;HEXA;HEXB;B3GALNT1;PSAP;ST6GALNAC6;ESYT3;UGCG;SUMF2;ST3GAL5;NEU3;GLB1;ST8SIA5;CLN6;SUMF1
prerank,regulation of metal ion transport (GO:0010959),0.5778911406335153,1.3456947675549686,0.18395303326810175,0.6967798496833605,1.0,4/16,7.48%,SLC30A10;EPB41;CACNA2D1;STIM1
prerank,protein import into peroxisome matrix (GO:0016558),0.6151019040092228,1.345599344429239,0.18105263157894738,0.6952325617735792,1.0,7/12,24.44%,PEX7;PEX5L;PEX1;PEX12;PEX2;PEX5;PEX6
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.503798181959904,-1.3454591559331448,0.08853118712273642,0.45825437126395013,1.0,6/20,14.51%,ZMIZ1;TGFBR1;HIF1A;DNAJB2;HSP90AB1;WASHC1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.5858469848831317,-1.3445911984847485,0.12915851272015655,0.45940389686270566,1.0,5/11,21.24%,LPCAT3;ATL2;BNIP1;STX18;MOSPD3
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.47997158728848416,-1.3438795170375106,0.12317327766179541,0.4603070565040744,1.0,7/25,6.10%,SULF1;ZNF423;CDH5;BMPR2;BMP4;FOXD1;ACVRL1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4587840325307524,1.3437966245468185,0.1070811744386874,0.6981354676722301,1.0,19/75,12.83%,MEF2C;FARP1;BTBD3;SDC2;MAP2;MINK1;NTNG2;RYK;CNTN4;SLITRK5;ANK3;CCK;SLITRK1;CTNNA2;BRSK1;PAK3;RB1;ZDHHC17;SLITRK2
prerank,acylglycerol homeostasis (GO:0055090),0.5714133625802528,1.3435772938065829,0.16463414634146342,0.696883892798773,1.0,4/20,6.95%,RORA;NR1H3;SCARB1;LIPC
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.46028817730482585,-1.3434703086979596,0.1337579617834395,0.4603402656341667,1.0,9/32,15.89%,PRKAG2;SORBS1;APOE;ADIPOR2;AKT1;AVIL;PPARA;PRKAA2;CEACAM1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5629675380597311,1.3430062039912314,0.18012422360248448,0.6965078711500867,1.0,2/21,3.42%,SLC30A10;ABCD2
prerank,regulation of vasculogenesis (GO:2001212),0.6012027840559112,1.3420234136891334,0.17782426778242677,0.697389246214202,1.0,5/14,6.91%,HEY2;RAPGEF2;RIN2;EMP2;RAP1A
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4263035075377971,-1.3417388335293823,0.09425287356321839,0.46400710960917496,1.0,12/45,11.25%,SP100;B2M;VCAM1;IRF1;ICAM1;IRF2;STAT1;PRKCD;IRF9;OAS2;PML;CAMK2A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5829640695732916,-1.3415194228845924,0.13636363636363635,0.46360829520888336,1.0,6/11,25.85%,HSPA5;ATF6;CREB3L1;CEBPB;ATF3;TP53
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.5100200041535444,-1.3414747874007857,0.0945179584120983,0.46271574138381316,1.0,10/21,19.68%,MCU;TGM2;SLC8A3;RAP1GDS1;MCUB;AFG3L2;MICU2;BCAP31;MICU1;MAIP1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.30057729172331266,-1.34136488947131,0.0,0.46205132099480556,1.0,143/572,16.89%,NFIB;BMP6;FOXP2;PRDM6;DAB2;AEBP1;SMAD3;SMARCA2;ZBTB16;FOXP1;WWOX;HDAC4;GLI2;CUX1;FHL2;TBL1XR1;NFIX;WWC2;LCOR;SP100;GLIS3;OSR1;SKIL;FOXO3;NR3C1;DLG1;HDAC8;CAV1;RARB;SUFU;ESR1;FGFR2;SMURF2;BMP4;EZR;RPS14;DNMT3A;KLF4;DDX5;TCF7L2;FOXC2;SMAD7;KLF2;ETV6;TAF1;ID1;HDAC9;THRB;MXI1;SKI;SDCBP;ZFPM2;PARP9;IGF2;GATAD2A;GTF2IRD1;WWP2;AR;RARG;CREM;YAP1;FOXP4;GLIS2;SOX13;BHLHE40;KMT5A;ATXN1;ATN1;PRDM16;ID3;FOXC1;IRF2;GLIS1;CHD3;HIVEP1;STAT1;FNIP1;BPTF;STAT3;NR2C2;MAP2K5;IFI27;KLF10;ZNF219;RTF1;ZBTB18;BAG3;RREB1;IL33;NR4A2;FLCN;BHLHE41;DAB2IP;PRDM5;ZKSCAN3;TGIF1;KLF12;TRIM27;MDFI;GLI3;NSD1;PTCH1;ZMYM5;HDAC1;LRRFIP1;MDM2;RELA;CPEB3;PPARA;ID2;MEF2A;GATA6;CBX4;UBB;CALR;ZGPAT;PPID;MEIS2;EZH1;CCND1;KCNIP3;HDAC5;ZNF568;SARS1;RPL10;ENO1;MAZ;ZBTB4;BEND3;NKX6-1;SNAI1;ZFPM1;YEATS2;RPL23;HHEX;SOX18;PHF21A;HCFC2;MNT;ZFP69;ZNF436;SIRT7;SIRT2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4314180585137802,1.3413462401266278,0.09250398724082935,0.6973693477023748,1.0,12/110,3.95%,S1PR3;PTH1R;ADGRL3;TBXA2R;GNG2;RAPGEF2;UCN2;ADORA2A;GPER1;ADCY8;ADCY3;ADCY6
prerank,regulation of ossification (GO:0030278),-0.44585390321900453,-1.3412719304297278,0.1038135593220339,0.4612910920988806,1.0,14/36,10.12%,ZBTB16;SMAD6;ENPP1;SGMS2;ANKH;BMPR2;BMP4;LRP6;ACVR1;CHSY1;BMP2K;WNT5A;ECM1;NOTUM
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.5077761939193711,-1.3409891113464023,0.134,0.46099998386083374,1.0,3/19,12.68%,IGF1;ZC3H12A;GIT1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.642291800603719,1.3385101118273792,0.18344519015659955,0.7031189337480679,1.0,2/11,4.98%,LIMD1;AJUBA
prerank,regulation of interleukin-2 production (GO:0032663),0.5026898985717438,1.338408477350385,0.1265597147950089,0.7015967955643078,1.0,6/43,6.04%,PDE4D;GLMN;IL1B;SPTBN1;NAV3;PDE4B
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5356490976346779,-1.3381386736121839,0.13111545988258316,0.46711273456199964,1.0,5/16,6.98%,RBFOX2;ESR1;DDX5;AR;EGLN2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.505362942515153,-1.3380780021327947,0.10663983903420524,0.4662533123230819,1.0,13/21,34.04%,FOXP1;PRKCH;SLC39A10;PRKCB;RELA;RAB29;IKBKG;CD81;RPS3;BCL10;KCNN4;NFAM1;CARD11
prerank,positive regulation of T cell migration (GO:2000406),-0.49708117278364206,-1.3375924073492693,0.11787819253438114,0.4666096272126081,1.0,6/20,6.89%,APP;ADAM10;CXCL12;WNT5A;RHOA;WNK1
prerank,erythrocyte differentiation (GO:0030218),-0.42354216380898746,-1.3374783457402144,0.09953703703703703,0.4659096905365894,1.0,22/44,27.92%,TGFBR3;RPS14;MFHAS1;RPS19;KIT;SLC25A38;IKZF1;CEBPG;ALAS1;ID2;TAL1;HIPK2;ZFPM1;PTPN2;CDK5RAP3;VEGFA;LYAR;HSPA9;ACIN1;NCKAP1L;ALAS2;HCLS1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5074446719505457,1.3367365325774034,0.1322463768115942,0.7044044900184949,1.0,5/41,1.22%,MEF2C;HEY2;HEYL;NOTCH1;TBX20
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5628693798862832,1.336508918375444,0.18181818181818182,0.7032023738909098,1.0,3/23,3.58%,CASQ2;ATP1A2;CACNA2D1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.40230339455084707,-1.336453996866899,0.07052896725440806,0.46560671317024355,1.0,32/61,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;SEC23IP;NAPA;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,COPII vesicle coating (GO:0048208),-0.40230339455084707,-1.336453996866899,0.07052896725440806,0.46560671317024355,1.0,32/61,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;SEC23IP;NAPA;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,vesicle coating (GO:0006901),-0.40230339455084707,-1.336453996866899,0.07052896725440806,0.46560671317024355,1.0,32/61,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;SEC23IP;NAPA;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.42885977023382865,-1.3360821203630846,0.08463251670378619,0.4656324823306437,1.0,19/44,27.32%,SH3RF1;USP47;THBS1;CAST;KLF4;GAS6;FNIP1;MAP2K5;AKT1;DNAJB6;GPX1;LAMTOR5;MT3;VEGFA;RPS6KA3;YWHAE;CD44;CDKN2D;SFN
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.4395015654027105,-1.335883011973661,0.08823529411764706,0.465121013664501,1.0,9/36,11.16%,AFDN;VAMP5;MACF1;KIF13A;RILPL1;GGA2;GOLPH3;OPTN;RAB7A
prerank,negative regulation of T cell proliferation (GO:0042130),0.5380669650338648,1.3357484215321436,0.16314779270633398,0.7036141083599717,1.0,2/28,1.05%,GLMN;TNFRSF21
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.5634134499187868,-1.3355661035599316,0.1575984990619137,0.46491260681337837,1.0,4/13,12.45%,NFIB;BMP4;RELA;PPARA
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.4840777879176127,-1.3355346540003128,0.12745098039215685,0.46400128798257645,1.0,9/24,11.02%,CDH5;TEK;ANGPT1;RAMP2;GAS6;NDNF;ICAM1;KDR;GATA2
prerank,neurotransmitter transport (GO:0006836),0.45117220590989554,1.3355220464611142,0.11794019933554817,0.7024855628389022,1.0,19/73,13.14%,LIN7A;ATP1A2;NRXN1;SNAP25;RIMS1;SYN2;GABRA2;SYN1;SLC32A1;SYT1;SLC5A7;SLC6A15;GRM4;STXBP2;GAD1;BRSK1;GLS2;PPFIA2;SLC29A2
prerank,Ras protein signal transduction (GO:0007265),0.4159178035294445,1.33447735159321,0.09145427286356822,0.7034174828294493,1.0,25/137,8.65%,EPS8;PLCE1;RERG;PLD1;RAPGEF2;ARHGAP6;RASGRP2;ARHGAP1;RASGRP3;ROCK1;NF1;WAS;LIMK1;CDC42EP1;ABI2;FGF2;RTKN;EPS8L1;RIT2;HACE1;RAP1A;HRAS;CDKN1A;ARHGDIB;GNA12
prerank,serine family amino acid biosynthetic process (GO:0009070),0.6166145404397071,1.3340527187472195,0.1905697445972495,0.7028299806450655,1.0,5/12,11.73%,GGT1;CTH;SEPHS2;PSAT1;SRR
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.5646171060316288,-1.3335717368921074,0.10940499040307101,0.4682979248488679,1.0,2/13,0.60%,IGF1;PLCB1
prerank,mitochondrion morphogenesis (GO:0070584),0.628597754604131,1.332968474764787,0.175704989154013,0.7038975967153771,1.0,3/11,12.39%,PID1;SUPV3L1;MFF
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6148597919570075,1.3327577333450153,0.19750519750519752,0.7026812373048604,1.0,2/14,0.65%,MEF2C;PRKG1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.43622891429100324,-1.3323357959970572,0.10609480812641084,0.4705932239969986,1.0,21/42,32.01%,REV1;POLH;UBB;RPA1;RFC3;VCP;UBE2L6;POLI;USP43;RFC1;USP10;RPA3;POLA1;CDKN2D;POLD1;ISG15;DTL;WRN;PCNA;PARP10;RFC5
prerank,positive regulation of vascular permeability (GO:0043117),-0.5701527853689703,-1.3311169976541828,0.1442125237191651,0.47272975680845253,1.0,4/12,3.53%,BMP6;TJP2;OCLN;ANGPT1
prerank,purine nucleotide metabolic process (GO:0006163),-0.4855757333152222,-1.3302407137387768,0.10978043912175649,0.4739268284217733,1.0,12/24,25.02%,FHIT;XDH;PRPS2;NT5E;GDA;GPX1;PRPS1;PRPS1L1;NT5C1A;PNP;NT5C2;NT5C
prerank,regulation of amyloid-beta formation (GO:1902003),-0.4566730728263382,-1.3300605691955516,0.09821428571428571,0.47342415247344266,1.0,5/34,2.68%,IGF1;EPHA4;ROCK2;APOE;SLC2A13
prerank,regulation of monooxygenase activity (GO:0032768),-0.4997381829835785,-1.3298254825326856,0.13387423935091278,0.47306720024426724,1.0,8/23,9.96%,EGFR;POR;CAV1;NOS3;DDAH1;NOS1AP;AKT1;LYPLA1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5843531527827137,-1.3289489669631736,0.14015151515151514,0.47437869204630545,1.0,5/11,8.76%,IGF1;PLCB1;IGF1R;GHR;AKT1
prerank,negative regulation of secretion (GO:0051048),0.6539973446143039,1.3289300725407074,0.1939655172413793,0.7111248692510457,1.0,2/10,2.80%,NR1H3;NRG1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5897091334273894,-1.3288965944789208,0.12104283054003724,0.4735367197867773,1.0,7/11,16.21%,THBS1;CD34;LGALS9;PTGS2;GATA6;BMPR1A;CD200
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5148170638498306,1.3285556437745447,0.150278293135436,0.7103972138079531,1.0,12/41,10.52%,ITPR2;TRPV2;CACNA2D1;ITPR1;FGF2;SLC24A2;HTR2C;RYR2;RYR3;PKD2;GRIN2B;CHERP
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.43531135350548505,-1.3284682145835822,0.0975609756097561,0.4736813838229673,1.0,16/37,27.06%,CAV1;NUPR1;GSDME;BCL2L11;BECN1;EIF5A;UBB;BID;BCAP31;RPS7;BBC3;BCL2L1;RPS3;RACK1;TP53;MSX1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5340204577677915,1.328297453369125,0.17647058823529413,0.7093757559875177,1.0,7/26,7.39%,CASQ2;NEDD4L;KCNG1;STK39;ATP1B2;ITGB1;CACNA1D
prerank,negative regulation of B cell proliferation (GO:0030889),0.6256787919994841,1.3280111058159625,0.19703389830508475,0.7083549268680938,1.0,3/11,9.11%,TNFRSF21;CD300A;LYN
prerank,endodermal cell differentiation (GO:0035987),0.5338707642446497,1.3278078192559275,0.16541353383458646,0.7072419629554133,1.0,7/31,5.24%,ITGA4;ITGA7;VTN;NODAL;MMP15;ITGB5;LAMB1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6428712012647161,1.3277793908075988,0.18181818181818182,0.7055660807966131,1.0,4/10,8.97%,NEDD4L;HECW2;STK39;HECW1
prerank,secretory granule organization (GO:0033363),-0.5943548210941949,-1.3275823194237082,0.12897196261682242,0.475022597742601,1.0,3/10,8.10%,ABCA1;SRGN;DTNBP1
prerank,regulation of catabolic process (GO:0009894),0.5919112894320095,1.3271922524772526,0.214,0.705504946014412,1.0,4/18,9.18%,FAP;NEDD4L;ITGB1;ZDHHC2
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5593217947270608,-1.3268535114870006,0.13857677902621723,0.47596619947001223,1.0,2/13,3.24%,GLI2;BMP4
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5412740910620507,-1.3268415199994148,0.12546125461254612,0.4750294675913971,1.0,6/15,12.12%,GLI2;WNT6;LRP6;FOXC1;TBX1;HDAC1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.5240278772822282,-1.3264108025503016,0.12974051896207583,0.47519274140374534,1.0,8/19,16.21%,IGF1;NUPR1;TNFRSF1B;IL33;IL18;PTGS2;SPHK1;CD200
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5089496079931615,-1.326278284843276,0.12549019607843137,0.4745713528323692,1.0,4/19,2.62%,ROCK2;PRKCH;OCLN;CLDN5
prerank,regulation of filopodium assembly (GO:0051489),-0.4291970605607957,-1.325915726658224,0.11062906724511931,0.47463481914951355,1.0,10/38,9.01%,DPYSL3;NRP1;PALM;RHOQ;CAPZB;FNBP1L;ARAP1;DOCK11;PRKCD;PPP1R16B
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5861269206900221,-1.3257387940316097,0.14071294559099437,0.47422590621029387,1.0,5/10,10.24%,DCN;SEMA6A;XDH;PIK3CB;DAB2IP
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6246476280743068,1.3255050455512971,0.1905781584582441,0.7083993373127189,1.0,3/10,7.20%,PTH1R;SNCA;IRS1
prerank,eye photoreceptor cell development (GO:0042462),0.5825042533280302,1.324708740320047,0.19157894736842104,0.708812701945156,1.0,1/15,0.82%,RORB
prerank,acute inflammatory response (GO:0002526),-0.48761987651453814,-1.3245872898628646,0.1293634496919918,0.4762469662494111,1.0,4/23,6.62%,F3;IL6R;LBP;ANO6
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4427940819218668,-1.3243863930829944,0.13771186440677965,0.4757595866804356,1.0,12/36,11.83%,EGFR;APOE;CAV1;NPR3;NOS3;DDAH1;PIK3CB;NOS1AP;AKT1;HIF1A;LYPLA1;GCH1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5759268319609401,1.3240245534459631,0.16432865731462926,0.7089884362541734,1.0,3/19,1.44%,IL34;PTK2;JAM3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4757750158211153,1.323546917922848,0.1482084690553746,0.7084734276018356,1.0,15/54,11.54%,NEDD4L;GNG2;KCNJ12;KCNMB1;STK39;AKAP6;DPP10;KCNAB3;BIN1;CACNA1D;KCNE5;KCNJ3;KCNJ6;KCNIP1;KCNIP4
prerank,protein deacylation (GO:0035601),-0.4945400187877458,-1.3234130922879606,0.14049586776859505,0.4774309920531153,1.0,12/23,21.43%,HDAC4;HDAC7;LYPLA1;NOTUM;HDAC1;ABHD17C;HDAC5;LYPLAL1;SIRT7;SIRT2;SIRT3;SIN3A
prerank,protein N-linked glycosylation (GO:0006487),-0.39175741419403004,-1.3233284651175328,0.08037825059101655,0.4766662510029534,1.0,20/66,19.41%,B4GALT1;MAN1C1;ST3GAL1;STT3A;STT3B;FUT8;MGAT1;SLC39A8;LMAN1;MGAT2;GFPT2;ENTPD5;ALG6;MCFD2;OST4;ASGR1;RPN2;OSTC;GFPT1;DOLPP1
prerank,histone H3 acetylation (GO:0043966),-0.4303487537507186,-1.3231985472655416,0.08803611738148984,0.476052884981431,1.0,23/40,32.81%,KAT6B;KAT2B;LEF1;KAT14;TADA1;MEAF6;TRIM16;TADA2A;BRCA2;YEATS2;BRPF3;PHF14;BRPF1;BRD1;TAF5;SGF29;JADE1;ING4;TAF6L;JADE3;POLE3;NAA60;MAP3K7
prerank,nervous system development (GO:0007399),0.3687154535580496,1.3227808549678526,0.04332129963898917,0.708690381691996,1.0,94/429,13.51%,RAPGEF5;SERPINI1;PTEN;MEF2C;ADGRL3;CDH2;KALRN;DPF3;FARP1;BTBD3;SEMA5A;ST8SIA4;ADORA2A;DPYSL2;TBX3;MERTK;NF1;PCDHB11;LSAMP;GFRA2;ZEB2;PTN;FGF12;ERBB4;GBX2;CHAC1;NRG1;NAB1;LIMK1;NRXN1;TBX6;CHRNA3;GRIK1;AXL;FGF13;FGF2;DNER;ACAN;ROGDI;NAV3;SCN2A;RYK;SREBF2;MYLIP;FEZ2;CNTN4;MOG;RBFOX3;ASIC2;NINJ2;PCDH1;SCN8A;ANKLE2;LIG4;CNTN6;PPT1;IGSF8;NES;ACHE;ROBO2;ITM2B;ADAM23;SLITRK1;PKD2;JAG1;ACTL6B;MARCKS;NCKAP1;GDF11;BTBD6;APBA2;CHERP;TRAK1;SPOCK1;VLDLR;SOX6;AHI1;IL1RAPL2;FGF11;EP300;TRAK2;APC;MYT1L;EPHB1;GFRA1;ARHGAP26;PPP2R5D;ZC4H2;APC2;RPS6KA6;FEZ1;RITA1;NLGN3;DSCAM
prerank,neuron projection development (GO:0031175),0.4106211052365856,1.3227750989309344,0.0824891461649783,0.7069830874042777,1.0,30/168,11.68%,GRM7;FRY;PTEN;DOCK10;RAPGEF2;MAP2;ROCK1;PLXNB1;ATP7A;MYO16;WASL;SVBP;MINK1;CNTNAP2;RYK;LAMB1;CNTN4;NYAP2;TAOK3;MARK2;BLOC1S1;MAP4K4;LYN;TMEM108;PLP1;NCKAP1;PRMT1;PAK3;PAK1;RB1
prerank,axon guidance (GO:0007411),0.3879304692682191,1.3227668477717405,0.08111888111888112,0.7052905225108196,1.0,26/201,5.43%,NOTCH3;CHN1;LAMA2;PIK3CD;GAB1;SH3KBP1;NOTCH1;PTK2;PIK3R1;SEMA6D;SEMA5A;SLIT1;SLIT3;VASP;GFRA2;UNC5B;PLXNB1;PIK3CA;NRXN1;SPTBN1;RYK;SEMA6C;GRB10;SPTB;FEZ2;CNTN4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5008356489863497,1.3227317194059558,0.16042780748663102,0.703685861612017,1.0,3/40,1.34%,PTEN;GLMN;PTK2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.44144316073893625,1.3224885135181723,0.12172573189522343,0.7026479530641273,1.0,12/87,5.84%,DLC1;PDGFRB;EPS8;ROCK1;RND3;GRHL3;PIK3CA;SH3BP1;RAC3;CORO2B;ESAM;TESK1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.36218414590800313,-1.3224213374007212,0.05277777777777778,0.47721132869880134,1.0,30/104,13.24%,LDLRAD4;SMAD3;SMAD6;SKIL;CAV1;HTRA3;TGFBR2;BMPR2;SMURF2;TGFBR1;SNX6;MAGI2;SMAD9;SMAD7;ACVR1;SKI;CCN3;BMPER;SMURF1;NBL1;PRDM16;VWC2;FKBP1A;EMILIN1;TGFB1;BCL9L;STRAP;PPARA;UBB;CHRD
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.6277394770641557,1.322317791991325,0.1915367483296214,0.7014219735273841,1.0,4/10,11.93%,GABRG2;GABRA2;GABRA5;GABRA4
prerank,regulation of T cell cytokine production (GO:0002724),-0.5320049052288781,-1.3213535522491255,0.14312267657992564,0.479065644802415,1.0,4/15,6.32%,CD55;B2M;SMAD7;TNFRSF1B
prerank,acylglycerol metabolic process (GO:0006639),0.49684566859051255,1.3211971649957455,0.14575645756457564,0.7026626954441609,1.0,3/37,1.88%,DGKB;DGKH;DGKG
prerank,cytosolic calcium ion transport (GO:0060401),0.542095870162469,1.321122855434706,0.16768916155419222,0.7011927669131731,1.0,6/28,6.59%,CACNA1C;ATP2A3;CACNA2D1;ATP2B3;RYR2;ATP2A2
prerank,regulation of mitochondrial fusion (GO:0010635),0.6262535865960954,1.321054793483224,0.17647058823529413,0.6997340973762189,1.0,2/11,2.73%,PID1;PLD6
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.474769242200706,-1.320648200532935,0.11037527593818984,0.479929786894144,1.0,8/28,13.00%,NOD1;IRAK2;LACC1;MAP2K6;IRGM;CASP8;RELA;UBB
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.5157363801003665,-1.3197066641681308,0.14531548757170173,0.4814391607966013,1.0,6/18,13.00%,RNF139;RNF103;AMFR;RNF185;EDEM2;UBB
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5161839399981472,1.3183962095092265,0.1743295019157088,0.7051342200861733,1.0,13/34,18.55%,MEF2C;MPP2;CHRNA3;GABRG2;GABRA2;GRIN2B;GABRA5;GABRA4;NLGN3;INSYN2A;GRIN2A;GSK3B;GRID2
prerank,cellular response to alkaloid (GO:0071312),0.5808705906757987,1.318308562443452,0.19747899159663865,0.7037006782001908,1.0,4/17,8.62%,CASQ2;HTR1B;RYR2;RYR3
prerank,limb morphogenesis (GO:0035108),-0.5126456715591801,-1.3181196862828686,0.1483739837398374,0.4848579919129388,1.0,7/20,11.87%,PCSK5;CYP26B1;MBNL1;LRP6;SKI;GLI3;PTCH1
prerank,alcohol catabolic process (GO:0046164),0.6318657920695089,1.3175584343370355,0.1950207468879668,0.7040184288958682,1.0,2/10,2.20%,CEL;SCARF1
prerank,axonogenesis (GO:0007409),0.3839416307879403,1.3170004665758202,0.07901907356948229,0.7038368208359149,1.0,34/237,7.60%,NOTCH3;PTEN;LAMA2;PIK3CD;GAB1;SH3KBP1;NOTCH1;PTK2;PIK3R1;SEMA6D;SEMA5A;SLIT1;SLIT3;VASP;GFRA2;UNC5B;PIK3CA;NRXN1;SPTBN1;NTNG2;RYK;SEMA6C;GRB10;SPTB;FEZ2;CNTN4;SLITRK5;ANK3;B4GALT6;DOK4;SPTA1;CNTN6;NRXN3;CCK
prerank,regulation of smooth muscle contraction (GO:0006940),0.5451339891838012,1.3167984730909899,0.19675456389452334,0.7027216195528514,1.0,3/20,3.64%,PLCE1;CHRNA3;NMU
prerank,COPII-coated vesicle budding (GO:0090114),-0.3877250237115225,-1.3165697079508891,0.06701030927835051,0.4880989557677521,1.0,35/68,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;VAPA;SEC23IP;NAPA;SAR1A;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;SEC31B;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,inhibitory synapse assembly (GO:1904862),0.6233841040913045,1.3162835970534907,0.19419642857142858,0.702348638782492,1.0,4/11,5.87%,PLXNB1;FGF13;GABRG2;GABRA2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5313903444092579,1.3154519318947828,0.16221374045801526,0.7029535606403209,1.0,7/27,9.16%,PDGFRB;RGCC;FGF2;TNKS;CDKN1A;PRKD2;PDGFB
prerank,positive regulation of synapse assembly (GO:0051965),0.5320571309763453,1.3153640123269568,0.16888045540796964,0.7015159520901714,1.0,10/27,15.09%,CLSTN1;NRXN1;AGRN;CLSTN3;IL1RAPL1;CUX2;EPHB1;SLITRK2;NLGN3;SYNDIG1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5164443996120011,-1.3153339006823823,0.14807692307692308,0.4903720398193646,1.0,6/18,16.55%,LBP;THBS1;WNT5A;IL33;KARS1;TLR4
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4881498780100606,-1.3150870830295067,0.12962962962962962,0.4900597408666172,1.0,12/24,22.24%,COL5A1;PDPN;ITGA5;ACVRL1;DDR1;RHOA;CCN1;CEACAM1;CD151;RHOC;TMEFF2;LCP1
prerank,oogenesis (GO:0048477),0.6027263723108726,1.314671266306342,0.2194616977225673,0.7016133425038696,1.0,6/15,18.70%,PTN;FMN2;MEI4;NANOS1;TRIP13;KMT2D
prerank,cytoskeleton organization (GO:0007010),0.4204568172090741,1.3145160188758576,0.10930576070901034,0.7004434746561187,1.0,14/114,4.98%,MAST4;PLCE1;LIMD1;ARHGAP10;SH3KBP1;DPYSL2;MARK1;WASF3;SIPA1;RND3;ABI2;RAC3;FMNL3;AJUBA
prerank,lamellipodium organization (GO:0097581),0.5230639982117088,1.3144536236702433,0.2034548944337812,0.698980190252867,1.0,5/29,5.53%,CARMIL1;ARHGEF6;VCL;SPEF1;ITGB1
prerank,positive regulation of dephosphorylation (GO:0035306),0.5295686033084283,1.3142824527691075,0.1781609195402299,0.6978383977978825,1.0,1/27,0.07%,DLC1
prerank,negative regulation of cell differentiation (GO:0045596),-0.3290346122387783,-1.3141430485989378,0.022222222222222223,0.49150334929479733,1.0,49/181,13.48%,RANBP3L;LDLRAD4;ABCA1;SMAD3;ADAMTS12;EGFR;ZBTB16;COL5A2;SMAD6;EFEMP1;COL5A1;BMP7;TMEM64;FOXO1;OSR1;ENPP1;CAV1;HDAC7;XDH;SUFU;BMP4;TGFBR1;SMAD7;ADGRV1;WNT9A;PDCD4;SKI;ZFPM2;IGF2;YAP1;WNT5A;PTK2B;NOCT;TRIO;TBX1;ANP32B;TWIST2;DAB2IP;ANKRD26;GATA2;ITGB3;TGFB1;PTCH1;PPARA;ID2;CALR;CHRD;PTHLH;MEIS2
prerank,regulation of cytokine production (GO:0001817),0.41681123873785597,1.313751841341665,0.11320754716981132,0.6975508934115376,1.0,12/126,7.25%,ACE2;PLA2R1;GLMN;PIK3CD;AFAP1L2;RGCC;RPS6KA4;CARD9;MOG;SCAMP5;NLRP4;TRAF3
prerank,negative regulation of inflammatory response (GO:0050728),0.40101164006919016,1.3131471659266518,0.0967741935483871,0.6975614933567341,1.0,24/182,7.28%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;RORA;ADORA2A;GPER1;NR1H3;MYH9;PRKAR1B;ADCYAP1R1;GIPR;LRFN5;ADCY8;ADCY3;ADCY6;PPARD;NPSR1;IL4;PRKAR2B;GPR45;ADCY9;AOAH
prerank,plasma membrane tubulation (GO:0097320),-0.5629626542694445,-1.311098800395125,0.14154411764705882,0.49850553224065863,1.0,6/13,17.70%,SNX9;CAVIN2;FNBP1L;CHMP4A;EHD2;MICALL1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5101717488469051,-1.311053896790265,0.1442125237191651,0.4976734473081401,1.0,5/18,6.79%,CDH5;ROCK2;TEK;RAP1B;PTK2B
prerank,modulation by symbiont of host process (GO:0044003),-0.5870338190847351,-1.3103694260523966,0.17475728155339806,0.4985012130364488,1.0,4/10,14.26%,B2M;HGS;UBB;ENO1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5560938097070304,1.309114873051873,0.1797979797979798,0.7063233610715122,1.0,8/24,10.52%,ITPR2;ITPR1;FGF2;HTR2C;RYR2;RYR3;PKD2;CHERP
prerank,response to UV-A (GO:0070141),-0.5460605063700824,-1.3089499950912642,0.15298507462686567,0.5014170570838176,1.0,5/14,15.44%,EGFR;AKT1;PPID;CCND1;MMP2
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.5182185245874245,-1.3083221492454165,0.16699410609037327,0.5021927515028691,1.0,6/17,22.35%,LGALS9;PRKCZ;SLC7A5;CEBPB;SYK;RARA
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.5911943719959449,1.3079481980962289,0.193158953722334,0.7077478005201333,1.0,2/14,1.34%,IL34;PTK2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5448208808145543,1.3074330878020026,0.18875502008032127,0.7075159841036244,1.0,4/20,1.88%,HEY2;HEYL;NOTCH1;TBX3
prerank,regulation of actin filament-based process (GO:0032970),0.4527473049306016,1.3073700928300114,0.14285714285714285,0.7060640225355495,1.0,8/70,3.98%,DLC1;PDGFRB;ROCK1;RND3;GRHL3;SH3BP1;RAC3;CORO2B
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5117234893663726,-1.3070285653659426,0.1527001862197393,0.5045883271395134,1.0,4/16,12.45%,PRKAG2;APPL2;ACADL;PPARA
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.45059642570307457,1.3060074089073836,0.15294117647058825,0.7079540548099973,1.0,12/72,4.25%,PDGFRB;PIK3CD;GAB1;ROR1;PTK2;PIK3R1;GPER1;UNC5B;PLXNB1;PIK3CA;NCF1;FGF2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.574345221674312,1.3058870950127413,0.2,0.7066845566310797,1.0,1/15,0.40%,KCNJ8
prerank,regulation of wound healing (GO:0061041),0.5016245426160513,1.305819721091845,0.14917127071823205,0.7052950640371065,1.0,9/42,7.16%,VTN;AJAP1;PTK2;MYLK;CADM4;FGF2;ITGB1;ARFGEF1;HRAS
prerank,embryonic organ development (GO:0048568),-0.3887143757055641,-1.3056656196158531,0.08148148148148149,0.507200997852234,1.0,25/61,16.16%,PBX1;GLI2;PBX3;PCSK5;RBP4;RARB;TGFBR2;FGFR2;COL13A1;TEAD4;TEAD1;STRA6;KIT;KDR;GLI3;TGFB1;FLT3LG;MFSD2A;TAL1;SOX17;RPL10;PKDCC;ZFPM1;BMPR1A;SOX18
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5342146275009733,1.3055889760982522,0.16820702402957485,0.704292307881622,1.0,9/31,12.56%,LIN7A;MTCL1;SH3BP1;CRB1;MARK2;CAMSAP3;DLG2;PARD3B;DLG3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4804464244535804,-1.30540769214672,0.13429752066115702,0.5058987070554608,1.0,13/23,29.31%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;E2F1;YWHAH;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4804464244535804,-1.30540769214672,0.13429752066115702,0.5058987070554608,1.0,13/23,29.31%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;E2F1;YWHAH;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,peptidyl-amino acid modification (GO:0018193),0.6220970751758591,1.304519310166878,0.1940928270042194,0.7054060548826522,1.0,2/10,3.71%,METAP2;ATP7A
prerank,negative regulation of axonogenesis (GO:0050771),0.5503501529868126,1.3044352881416026,0.20502901353965183,0.7040409175608117,1.0,4/27,4.24%,PTEN;MAP2;LINGO1;FGF13
prerank,cell part morphogenesis (GO:0032990),0.5943465864611565,1.3044001429429968,0.1971252566735113,0.7025371940346689,1.0,3/13,12.39%,PID1;SUPV3L1;MFF
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6115266369685846,1.303694130978535,0.2058165548098434,0.7027769906748537,1.0,2/13,2.21%,PLA2R1;SPRED1
prerank,maintenance of blood-brain barrier (GO:0035633),0.5192696766665696,1.3036685001572208,0.18786692759295498,0.7012608114698773,1.0,8/30,5.53%,LAMA2;SLC12A2;DMD;JAM3;VCL;LAMC1;ESAM;ITGB1
prerank,negative regulation of apoptotic process (GO:0043066),-0.29421549340785963,-1.3033408322851796,0.00684931506849315,0.5105650590047301,1.0,120/444,19.22%,NOTCH2;IGF1;DAB2;FSTL1;EGFR;SMAD6;FHL2;CTSH;IL31RA;PDPN;PRKCH;TEK;FOXO1;SH3RF1;APOE;OSR1;CAV1;ANXA4;NUPR1;RNF213;ANXA5;MYO18A;USP47;THBS1;BMP4;IL6ST;ITGA5;IGF1R;SNX6;ANGPT1;TXNDC5;KLF4;ANXA1;LEF1;SOCS2;CFLAR;ADAM10;GAS6;NIBAN2;NAA35;ZFAND6;YAP1;RNF144B;NDNF;SIX1;WNT5A;CCND2;PTK2B;PLK2;CARD14;FNIP1;MAEA;HSPA5;SH3RF2;MAP2K5;NRBP2;TFRC;BIRC3;TBX1;GOLPH3;PRKCD;ERC1;TPT1;ERCC5;SON;AKT1;BAG3;MCL1;TLE1;PRDX2;IFIT3;NR4A2;CD38;GCLC;ZC3H12A;KDR;TRIM27;ARHGDIA;PRKCG;BNIP3L;FOXQ1;HDAC1;RELA;FLT4;GATA6;CBX4;UBB;DNAJB6;SPHK1;PIM3;BNIP3;SFRP1;QARS1;RPL10;HYPK;MAZ;MAPK3;DNAJC3;TMBIM6;RETREG1;PRKAA2;BNIP1;BID;TCIM;RIPK1;WNT11;GPX1;PSEN2;PRELID1;NFKBIA;ALOX12;PARK7;LAMTOR5;HSP90B1;HMGN5;BABAM2;MT3;PIM2;PTRH2;PPARGC1A
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.40413833249556347,-1.3017705008391294,0.09725685785536159,0.5139733996512522,1.0,26/55,27.22%,WWOX;CAV1;NUPR1;TGFBR1;GSDME;TNFSF10;BCL2L11;BECN1;DAB2IP;PML;TRIM39;BID;BCAP31;RIPK1;AGT;BBC3;TPD52L1;DEDD2;BCL2L1;RPS3;RACK1;TP53;FAS;CRADD;BCL10;PAK2
prerank,regulation of Notch signaling pathway (GO:0008593),0.4410529392165331,1.2999341747771012,0.13556618819776714,0.7090913225534191,1.0,8/76,5.07%,NOTCH3;NOTCH1;MAML2;CHAC1;TSPAN15;CD46;PDCD10;SREBF2
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.4510180201377598,-1.2997927036066326,0.1437007874015748,0.5184121617259605,1.0,14/29,27.00%,TCF7L2;TLE4;LEF1;TRRAP;TLE2;TLE1;BCL9L;HDAC1;PYGO2;SMARCA4;PYGO1;TCF7;CTNNB1;BCL9
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5726557803449948,-1.299136146900909,0.14616755793226383,0.5191324796889968,1.0,4/11,15.89%,SMAD7;AHR;HFE;CEACAM1
prerank,response to retinoic acid (GO:0032526),-0.39055459443618346,-1.298663269563976,0.1,0.5195257101868554,1.0,17/59,13.68%,EPHA3;CTSH;WNT6;RBP4;WNT9A;ACER2;RARG;WNT5A;PTK2B;TBX1;FZD4;TRIM16;FZD7;WNT5B;ATM;GATA6;RET
prerank,secretion (GO:0046903),-0.5338115666389537,-1.2975872850207877,0.1806083650190114,0.5214501905488773,1.0,6/14,16.74%,FBLN5;SLC22A6;NPR1;SLC22A4;TPD52;SLC22A2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3455786123382892,-1.2975636357607832,0.03164556962025317,0.5205002254185495,1.0,24/121,7.33%,BMP6;IGF1;EPHA4;NRP1;IL31RA;NEDD9;PECAM1;IL15;IL6R;IL6ST;ITGA5;PTPRJ;ANGPT1;GHR;ARHGEF2;ACVR1;PARP9;IGF2;GAS6;PARP14;ACE;EFNA5;PTK2B;STAT3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.2827162933391482,-1.2962946508427384,0.0,0.5227614570614287,1.0,185/807,14.51%,BMP6;FOXP2;PRDM6;DAB2;FOXN3;ZNF423;AEBP1;PLCB1;SMAD3;SMARCA2;ZBTB16;MECOM;FOXP1;WNT4;WWOX;HDAC4;GLI2;CUX1;FHL2;TBL1XR1;NFIX;WWC2;BMP7;LCOR;SP100;GLIS3;VGLL4;RBFOX2;DKK3;FOXO1;OSR1;SKIL;FOXO3;MDFIC;ZIC2;NR3C1;DLG1;HDAC8;KAT6B;CAV1;RARB;SUFU;ESR1;FGFR2;SMURF2;USP47;BMP4;EZR;RPS14;SNX6;FOXD1;DNMT3A;KLF4;DDX5;TCF7L2;FOXC2;TFDP2;SMAD7;LEF1;KLF2;ETV6;TAF1;ID1;PDCD4;HDAC9;SBNO2;THRB;MXI1;ZHX3;SKI;SDCBP;ZFPM2;PARP9;CNOT7;IGF2;GATAD2A;GAS6;GTF2IRD1;NIBAN2;WWP2;AR;BRD7;DAP;RARG;SCMH1;CREM;YAP1;FOXP4;GLIS2;SOX13;BHLHE40;PFDN5;KMT5A;ATXN1;IRF1;MIDEAS;WNT5A;ATN1;PRDM16;ID3;FOXC1;IRF2;GLIS1;SFMBT1;CHD3;HIVEP1;STAT1;FNIP1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;IFI27;KLF10;ZNF219;RTF1;ZBTB18;RREB1;TLE2;IL33;CBFA2T2;ZMYND15;RCOR3;TLE1;TWIST2;FOXK1;NR4A2;FLCN;BHLHE41;EHMT1;CD38;PHF10;IKZF1;GCLC;DAB2IP;JARID2;PRDM5;ZKSCAN3;TGIF1;PML;KLF12;TRIM27;MDFI;PATZ1;GLI3;TGFB1;NSD1;ELK3;PTCH1;ZMYM5;AHR;HDAC1;LRRFIP1;MDM2;RELA;CPEB3;PPARA;ID2;MEF2A;GATA6;CBX4;FBXW11;PRDM11;UBB;CALR;ATOH8;ZGPAT;PPID;CLOCK;MEIS2;EZH1;CCND1;KCNIP3;HDAC5;ZNF568;SFRP1;QARS1;SARS1;RPL10;CREB3L1;ENO1;POU2F1;MAZ;ZBTB4
prerank,positive regulation of peptidase activity (GO:0010952),-0.4945279175095525,-1.296151425686924,0.14979757085020243,0.5221557791529036,1.0,11/20,34.23%,CTSH;RCN3;PSME2;PSME3;PRELID1;VCP;NDUFA13;NCSTN;VSIR;APH1A;PINK1
prerank,defense response to symbiont (GO:0140546),0.4358608291076906,1.2961476281098052,0.14146341463414633,0.7176857924888163,1.0,1/92,0.01%,ABCC9
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5562948717481079,1.2960457068756168,0.19560878243512975,0.7163254825177258,1.0,2/21,1.87%,PTEN;BTRC
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.5225265309482506,-1.2953425066848556,0.16022099447513813,0.5232926283296555,1.0,7/16,22.85%,CLEC16A;FLCN;GPR137;SIK3;RRAGB;LAMTOR5;PIH1D1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.5249864930342475,-1.2952694274620422,0.1523809523809524,0.5224992605835073,1.0,6/15,22.49%,ATL2;REEP1;RAB18;ZFYVE27;REEP2;TMEM33
prerank,postreplication repair (GO:0006301),-0.41534562924659263,-1.2949963492576442,0.12529002320185614,0.5222556916017158,1.0,21/45,32.01%,REV1;POLH;UBB;RPA1;RFC3;VCP;UBE2L6;POLI;USP43;RFC1;BRCA1;USP10;RPA3;POLD1;WDR33;ISG15;DTL;UBE2V1;PCNA;PARP10;RFC5
prerank,ion transport (GO:0006811),0.42035931119232534,1.2949941484002385,0.14241960183767227,0.7175117893021723,1.0,12/111,7.11%,ANO1;TRPC6;SLC12A2;ATP1A4;CHRNA3;SLC24A4;SLC24A2;SLC12A6;SLC26A1;SLC32A1;CHRNA7;SLC15A2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5827756136757658,-1.2949270455752022,0.17077464788732394,0.521422861217117,1.0,6/10,25.02%,DPYD;UPP2;UPB1;NT5E;NT5C1A;NT5C
prerank,protein localization to organelle (GO:0033365),-0.34092824998093624,-1.2946770037668403,0.05844155844155844,0.521078785792725,1.0,46/133,24.44%,ZNF423;COL1A1;LAMP2;BMP7;APP;BMP4;TRAM2;RAB11A;LRRK2;SIX1;EHD1;OBSL1;ARL3;TULP3;TOR1AIP1;STX1A;OPTN;VPS35;RPL11;GBP5;MDM2;ALDH3A2;CALR;SNX10;RPA1;SCG3;VAPA;TTC21B;TMEM30A;GBP2;HHEX;LAMP5;MICALL1;RAB6A;GET1;WDR35;FAM83H;CEP68;TULP1;GAK;SEC61B;CNTLN;RIPOR1;WDR83OS;CCDC47;YWHAE
prerank,regulation of mononuclear cell migration (GO:0071675),0.5306704121948561,1.2946492683249335,0.18832391713747645,0.7168544541523003,1.0,3/23,1.34%,IL34;BMP5;PTK2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5098981139917751,1.2943833893565546,0.16036036036036036,0.7158959441614186,1.0,10/33,13.47%,CEL;LRRC4C;EIF4EBP2;GRIK1;NRG3;GRID1;CACNA1A;GRIK5;GRIK2;NLGN3
prerank,dopamine metabolic process (GO:0042417),-0.5167382223793925,-1.2941121744568378,0.1638418079096045,0.521616891670044,1.0,5/18,11.83%,SNCAIP;MOXD1;MAOA;MAOB;GCH1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.46529879640557636,-1.2940064801261413,0.12761904761904763,0.5209161636476394,1.0,6/23,15.77%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,cAMP metabolic process (GO:0046058),0.5861851584223349,1.2939033312154538,0.21021611001964635,0.7155622623380447,1.0,6/13,9.85%,PDE4D;ADCY8;ADCY3;ADCY6;ADCY9;EPHA2
prerank,regulation of mitochondrial fission (GO:0090140),-0.4855072603645907,-1.2936855994947694,0.1510204081632653,0.520812216026361,1.0,13/24,25.65%,DCN;MCU;LRRK2;STAT2;KDR;VPS35;BNIP3;MYO19;CYRIB;DDHD1;INF2;RALBP1;PRKN
prerank,establishment of skin barrier (GO:0061436),-0.5326170939222674,-1.2930096457768983,0.16061185468451242,0.5207079761812544,1.0,9/15,36.35%,LSR;MET;UGCG;CLDN1;ALOX12;HRNR;SFN;ALOXE3;TMEM79
prerank,regulation of water loss via skin (GO:0033561),-0.5326170939222674,-1.2930096457768983,0.16061185468451242,0.5207079761812544,1.0,9/15,36.35%,LSR;MET;UGCG;CLDN1;ALOX12;HRNR;SFN;ALOXE3;TMEM79
prerank,endoplasmic reticulum organization (GO:0007029),-0.37138493377302956,-1.2924893599728118,0.09736842105263158,0.5210956136264017,1.0,33/72,28.14%,APP;TRAM2;LRRK2;SEC31A;LPCAT3;STX1A;SEC16B;LMAN1;ATL2;ALDH3A2;DOP1B;CAV2;VAPA;REEP1;REEP5;BNIP1;RAB18;STX18;GET1;SEC61A1;MOSPD3;GAK;EIF2AK3;SEC61B;REEP2;TMEM33;WDR83OS;CCDC47;SEC31B;ATL3;TRAM1;SEC16A;TLE6
prerank,positive regulation of translational initiation (GO:0045948),0.5665271865817191,1.2923393951463413,0.2043222003929273,0.7179035986630722,1.0,10/18,19.10%,DAZL;RPS6KB2;BOLL;YTHDF3;DDX3X;MTOR;YTHDF2;RPS6KB1;HABP4;POLR2D
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6082324115867245,1.2920680704980438,0.2182952182952183,0.7170746321794081,1.0,3/13,4.39%,NOTCH1;TBX3;SOSTDC1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4001406100857287,1.2916822707685467,0.1006993006993007,0.7164998207080556,1.0,25/163,12.14%,PDE4D;MEF2C;PIK3CD;TNFRSF21;PIK3R1;BTRC;BCAR1;WAS;RFTN1;PTPN22;PIK3CA;PAG1;PSMB11;MOG;PDE4B;PSMF1;RIPK2;CSK;PRKD2;BLNK;EIF2B3;PAK3;PAK1;TEC;PSME4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6120117394207746,1.2913435471316685,0.22103004291845493,0.715870883203245,1.0,2/12,2.62%,GCNT2;IL1B
prerank,amide transport (GO:0042886),-0.45178434932213385,-1.2911341794424702,0.1627450980392157,0.5236927563542977,1.0,7/26,10.88%,PDPN;PLTP;CERT1;ABCG2;SLC5A6;SLC38A5;DISP1
prerank,positive regulation of neuron differentiation (GO:0045666),0.4963287083894063,1.2907301897115433,0.1844484629294756,0.7159793517473967,1.0,6/40,8.37%,MEF2C;HEYL;ZEB1;BRINP1;BEND6;BRINP3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.5133122874156918,1.290055982128465,0.18375241779497098,0.7161865171044441,1.0,4/31,9.11%,GLMN;TNFRSF21;CD300A;LYN
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5599394404300044,1.2895339802733876,0.21443298969072164,0.7159038379817354,1.0,2/16,5.34%,TNFRSF21;TRIB2
prerank,protein autoubiquitination (GO:0051865),-0.38581613885872973,-1.2893205692775442,0.11386138613861387,0.5278256558639419,1.0,16/61,16.97%,RNF220;SH3RF1;RNF213;RNF146;WWP2;SH3RF3;SH3RF2;AMFR;RNF185;DTX3L;MDM2;RNF181;TRIM17;RNF115;RNF187;UBE3D
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5829866436819874,-1.2884209413023668,0.1873767258382643,0.5292754277996977,1.0,6/10,25.85%,MLLT3;ACE;SFRP1;LMBR1L;SP7;TP53
prerank,cellular response to oxygen-containing compound (GO:1901701),0.36765715207347155,1.288412124927169,0.08080808080808081,0.717306755712359,1.0,38/291,9.16%,GUCY1B1;PTPRK;MEF2C;PID1;RORB;SPAAR;GNG2;PDE3A;RAPGEF2;RORA;GPER1;CPEB1;NR1H3;IL1B;FFAR2;NCF1;AXL;NCOA3;ADCY6;AKAP6;BRINP1;CXCL10;TNIP2;PDE4B;CXCL5;HCN2;CACTIN;RAP1A;FAM210B;IRS1;MTOR;BRINP3;RYR3;HCN3;HTRA2;PKD2;LYN;PDGFB
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.5570182939445887,-1.2877725430718412,0.16195856873822975,0.5299821062914241,1.0,3/12,16.55%,RBP4;STRAP;TLR4
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5314500229181296,1.2871932197995628,0.21084337349397592,0.71901657780485,1.0,2/26,1.22%,CASQ2;ATP1A2
prerank,sphingoid metabolic process (GO:0046519),-0.5520557541374452,-1.2860889449970283,0.19180633147113593,0.5335964501738718,1.0,5/12,13.40%,PLPP3;NAAA;DEGS2;PLPP1;SPHK1
prerank,synapse organization (GO:0050808),0.41568674818955925,1.285975547869353,0.12804878048780488,0.7205436078200805,1.0,22/125,8.63%,PTEN;CACNB2;ADGRL3;CDH2;APBB2;FARP1;PCDHB11;LRRC4C;DOK7;LRFN5;NRXN1;RAB39B;GRM5;AGRN;DNER;RYK;ANK3;SNCA;CHRNA7;PPFIBP2;ACHE;SLITRK1
prerank,defense response to protozoan (GO:0042832),-0.5460676919334938,-1.2858846262715313,0.18003913894324852,0.5331404954193713,1.0,8/12,32.87%,GBP4;GBP6;GBP7;GBP2;MYD88;LYST;CD40;BATF2
prerank,regulation of anoikis (GO:2000209),0.5432404713728306,1.2858601622405286,0.20950323974082075,0.7192902815092355,1.0,8/19,12.53%,NOTCH1;PTK2;PIK3CA;ITGB1;SIK1;SNAI2;ANKRD13C;SRC
prerank,positive regulation of protein transport (GO:0051222),-0.3836190632096713,-1.2856302213506008,0.09113300492610837,0.5329170306930461,1.0,19/67,19.90%,BMP6;IGF1;UNC13B;CD2AP;MYO18A;EZR;ADAM9;GOLPH3;MYH10;TGFB1;PPID;PPIA;SYTL4;RUFY3;TPR;OAZ1;RAB29;CHP1;VPS28
prerank,T cell receptor signaling pathway (GO:0050852),0.4042863625322942,1.2852286463594518,0.12517580872011252,0.7194320106684918,1.0,23/138,12.14%,PDE4D;PIK3CD;TNFRSF21;PIK3R1;BTRC;BCAR1;WAS;RFTN1;PTPN22;PIK3CA;PAG1;PSMB11;MOG;PDE4B;PSMF1;RIPK2;CSK;PRKD2;EIF2B3;PAK3;PAK1;TEC;PSME4
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5092790319068288,1.285168348034382,0.1944954128440367,0.71803895162346,1.0,16/32,18.25%,MEF2C;GPER1;CHRNA3;RIMS1;RIMS2;SYN1;VPS18;BAIAP3;MCTP2;PNKD;RAB5A;PREPL;SYT11;FMR1;GSK3B;CPLX1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.4804092074266859,-1.285088399869451,0.14549180327868852,0.5334246299849752,1.0,3/22,2.68%,EPHA4;ROCK2;SLC2A13
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5424565225326288,-1.2848901458062818,0.17407407407407408,0.5329838198194885,1.0,5/13,11.16%,NUPR1;LRRK2;CHMP4B;CHMP4A;PHF23
prerank,motor neuron axon guidance (GO:0008045),0.5684190639106729,1.2847426889128217,0.19956616052060738,0.7175520397576292,1.0,2/15,1.80%,CHN1;SLIT1
prerank,replicative senescence (GO:0090399),0.5948321479475652,1.283744065668228,0.2141280353200883,0.7185528855294572,1.0,1/12,0.58%,PLA2R1
prerank,regulation of multicellular organismal development (GO:2000026),0.5110873589220742,1.2837001529319834,0.20669291338582677,0.7171363329065201,1.0,3/25,2.62%,SPAAR;PTN;GBX2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5373725622627249,1.2835776105191734,0.19631901840490798,0.7159441879907924,1.0,10/22,18.34%,DMD;CACNB2;PDE4B;STAC;HPCA;CBARP;GPR35;FMR1;CACNB4;GNB5
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.4653339467193298,-1.282719769002157,0.14225941422594143,0.5378835357105561,1.0,6/26,10.10%,LGR4;APPL2;IRF1;BIRC3;FLOT2;IRAK3
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.36350856987529845,-1.282405569995568,0.09264305177111716,0.5377410008817851,1.0,14/86,6.10%,BMP6;SULF1;DAB2;ZNF423;CDH5;BMP7;BMPR2;THBS1;BMP4;TGFBR1;FOXD1;ACVR1;SDCBP;ACVRL1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.4161012462265158,-1.2820190690566782,0.14743589743589744,0.5378705730847809,1.0,13/37,16.89%,PRKAG2;CEMIP;BMP7;APP;SMAD7;CALM2;PARD3;IRGM;TGFB1;PPEF2;SPHK1;CALM1;SIRT2
prerank,response to hydroxyurea (GO:0072710),0.6030651286324249,1.2819119991667842,0.2185430463576159,0.7186798331960982,1.0,6/11,19.55%,KAT7;TIMELESS;BLM;FMR1;DDX11;RTF2
prerank,DNA strand elongation (GO:0022616),0.5483791785994665,1.2817018822354904,0.21822033898305085,0.7176785694878766,1.0,5/18,10.98%,DCLRE1B;GINS1;GINS3;GINS4;MCM7
prerank,cortical cytoskeleton organization (GO:0030865),-0.41044482093484286,-1.2793682459002478,0.10297482837528604,0.5440044660284791,1.0,17/41,22.24%,FMNL2;ROCK2;RHOBTB1;RHOQ;DLG1;EZR;RHOA;RHOB;FHOD1;TRPV4;LLGL2;RHOH;RHOC;PPP2R3C;PLEK;RHOBTB2;LCP1
prerank,endothelial cell migration (GO:0043542),-0.4204544579181951,-1.2792491558864123,0.14479638009049775,0.543379556958207,1.0,14/37,9.71%,FSTL1;CDH5;NRP1;DPP4;NOS3;PXN;ID1;CCN3;RHOA;CYP1B1;STAT1;LGALS8;PLXND1;CDH13
prerank,receptor catabolic process (GO:0032801),-0.4597212445661166,-1.2791871775176542,0.14519427402862986,0.5425721053295159,1.0,10/24,13.03%,RNF43;AP2A2;SMURF1;CLTA;BECN1;ZNRF3;TGFB1;SH3GLB1;AP2A1;UVRAG
prerank,positive regulation of nuclear division (GO:0051785),0.530081572452428,1.2788081779324965,0.18789144050104384,0.7235881220629633,1.0,3/25,2.62%,PDGFRB;RGCC;IL1B
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5489398637300775,-1.2786972382646322,0.16634429400386846,0.5429372789045603,1.0,4/12,11.59%,ESR1;STAT3;ZC3H12A;TGFB1
prerank,regulation of developmental growth (GO:0048638),-0.45161345287370525,-1.2785512287433414,0.12527964205816555,0.542364231246854,1.0,6/29,6.23%,IGF1;PLCB1;APOE;APP;GHR;SIX1
prerank,cellular defense response (GO:0006968),0.4886016641386161,1.27816890611545,0.18045112781954886,0.7237425977060555,1.0,8/40,8.20%,NCF2;IL1RL2;ADORA2A;NCF1;ITGB1;CXCR2;KLRG1;CCR9
prerank,regulation of cytoskeleton organization (GO:0051493),0.41909861080796634,1.2780985637750288,0.1456752655538695,0.7223931298110087,1.0,23/108,11.50%,DLC1;PDGFRB;PTK2;PHLDB2;ROCK1;RND3;GRHL3;SPEF1;PLXNB1;SH3BP1;RAC3;CORO2B;SYDE1;TESK1;TPPP;MTOR;CORO1A;MARK2;ARHGAP35;BICD2;CAMSAP3;PAK3;PAK1
prerank,microtubule anchoring (GO:0034453),0.6014786873172546,1.2779125505450653,0.24520255863539445,0.7213737259687351,1.0,5/12,18.98%,CLASP2;BICD2;CAMSAP3;GCC2;BCCIP
prerank,positive regulation of proteolysis (GO:0045862),-0.3914522624494712,-1.277786038614905,0.11435523114355231,0.5434536024773442,1.0,14/55,12.85%,CTSH;CCBE1;APOE;CYFIP2;SNX9;ADAM9;CTSC;RCN3;TNFRSF1B;CASP8;ZC3H12A;TBC1D10A;FGFR4;FBXW11
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.41320338891179226,-1.2774726767301297,0.1341991341991342,0.5433776873434402,1.0,15/39,22.27%,RPS14;RPS19;RPS5;RPS16;RPS24;RPS27;MRPS7;RPS15;RPS6;RPS25;RPSA;RPS7;RIOK2;RRP7A;RPS27L
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5950754253405147,1.2773965877834337,0.21784232365145229,0.7212661464203648,1.0,3/13,6.40%,HEY2;NOTCH1;RYR2
prerank,positive regulation of kinase activity (GO:0033674),-0.34892081933222785,-1.2773447619312819,0.08767123287671233,0.5427224093235269,1.0,31/107,13.68%,PRKAG2;EPHA4;EPHA3;EGFR;FLT1;EPHA7;PDGFRA;NTRK3;LMO4;TEK;IQGAP1;FGFR2;EPHB4;IGF1R;SNX9;RASSF2;CSF1;GAS6;DDR1;PTK2B;ALS2;TIE1;KIT;EPHA8;KDR;FGFR4;EPHB2;FLT4;CCN1;MET;RET
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.46778795396719075,-1.2767849531563147,0.15976331360946747,0.543292972213665,1.0,8/24,15.72%,SLIT2;CXCL12;CCN3;NBL1;ANO6;DUSP1;CREB3;SERPINE1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6144154912328695,1.2766507680911463,0.2320675105485232,0.7217024146423027,1.0,4/12,7.30%,CACNA1C;CTNNA3;RYR2;BIN1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6131575152159296,1.2766182759402538,0.253411306042885,0.7202920408843067,1.0,3/11,7.30%,CACNB2;CACNA2D1;BIN1
prerank,negative regulation of cell cycle (GO:0045786),0.44184787598030123,1.2765482431413382,0.1782178217821782,0.7189991065451903,1.0,17/73,11.85%,PTPRK;PTEN;CDK6;GPER1;SIPA1;RPS6KA2;HEXIM1;BRINP1;NUPR2;BRINP3;INCA1;HTRA2;NR2F2;TAF6;LATS2;RB1;APC
prerank,lamellipodium assembly (GO:0030032),0.5184640830570689,1.2765432536192596,0.22504892367906065,0.7175203972401435,1.0,5/26,5.53%,CARMIL1;ARHGEF6;VCL;SPEF1;ITGB1
prerank,response to ketone (GO:1901654),-0.4691034608769929,-1.2752794898130535,0.16427104722792607,0.5463481999126294,1.0,5/24,5.53%,TGFBR3;SLIT2;CAV1;THBS1;YAP1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3909047491571634,1.2751941115963523,0.12257100149476831,0.7193737955266059,1.0,26/152,9.86%,S1PR3;PTH1R;ADGRL3;TBXA2R;UCN2;ADORA2A;GPER1;GNAZ;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;HTR1B;CXCL10;OPRK1;ADCY9;WASF2;CACNA1D;GPR37;AKAP12;GRK5;ADGRB3;GNA12;ADGRE5;NPY1R
prerank,regulation of cell-cell adhesion (GO:0022407),-0.42160235714203986,-1.2748500582660145,0.1407563025210084,0.5465298887286318,1.0,15/39,16.39%,AFDN;EPHA7;PODXL;DPP4;SMAD7;CDH1;PTPRG;EFNA5;CD47;FLOT2;MDGA1;TGFB1;MEGF10;CEACAM1;EPHB3
prerank,negative regulation of autophagy (GO:0010507),-0.3935984883299436,-1.2734230389052532,0.13114754098360656,0.5494685122432249,1.0,20/54,20.95%,LEPR;NUPR1;LRRK2;DAP;RASIP1;STAT3;NRBP2;AKT1;MCL1;FOXK1;DAPL1;ZKSCAN3;EIF4G3;MET;WASHC1;SIRT2;QSOX1;MT3;USP36;TBC1D14
prerank,signal transduction by p53 class mediator (GO:0072331),-0.44639672055450563,-1.2731626963937506,0.16488222698072805,0.5492510379272808,1.0,4/30,5.04%,PPP1R13B;FHIT;DDX5;ACER2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.40920210866888396,-1.2727754682734762,0.15942028985507245,0.5492931854513768,1.0,9/45,6.10%,BMP6;DAB2;BMP7;BMPR2;BMP4;TGFBR1;ACVR1;SDCBP;ACVRL1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.31116102989326067,-1.2726672901188203,0.029661016949152543,0.5486395228610991,1.0,62/248,16.28%,RNF220;MCC;DAB2;LRRK1;LGR4;EGFR;COL1A1;IGFBP2;BICC1;TBL1XR1;TMEM64;DKK3;APOE;CAV1;FGFR2;SMURF2;USP47;IGFBP6;NKD1;RNF146;TCF7L2;TLE4;LRRK2;LRP6;MLLT3;IGFBP4;TNKS2;LYPD6;SFRP4;SOX13;PFDN5;WNT5A;WNK1;USP8;CSNK1G2;SCYL2;AMFR;FZD4;TLE2;TLE1;USP34;FZD7;NOTUM;DAB2IP;ZNRF3;PSME2;GLI3;TGFB1;HDAC1;PSMB4;CCDC88C;SOX17;SFRP1;PSMB1;PSMD11;PSMD8;PPM1B;SOX7;GSKIP;PSME3;HHEX;PLEKHA4
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.5051482512304377,-1.27244532455076,0.17357001972386588,0.5482322196939852,1.0,9/18,22.83%,ADAMTS9;STT3B;FUCA1;SAMHD1;DERA;NAGA;MANBA;NGLY1;FBXO17
prerank,negative chemotaxis (GO:0050919),-0.4265177296324401,-1.2722805998711966,0.14046121593291405,0.5476976215597896,1.0,14/33,16.62%,ROBO1;EPHA7;SEMA3D;SEMA6A;SEMA3C;SLIT2;SEMA7A;RHOA;SEMA3E;ITGB3;SEMA3B;NTN1;SEMA3G;SEMA6B
prerank,response to growth factor (GO:0070848),-0.4171406887887578,-1.2710699394155962,0.1331877729257642,0.5499703692961815,1.0,13/41,15.93%,TGFBR2;BMPR2;TGFBR1;KLF4;ACVR1;ACVRL1;MAP2K5;AKT1;GATA6;SPHK1;SFRP1;BMPR1A;NOS1
prerank,circulatory system development (GO:0072359),0.40566950387923184,1.2707742021247184,0.13803230543318648,0.7288113586294006,1.0,13/118,3.07%,ADAP2;CACNA1C;PTEN;PLCE1;MEF2C;HEY2;NOTCH1;NF1;FGF12;ERBB4;UTY;PIK3CA;ECE1
prerank,negative regulation of cell migration (GO:0030336),-0.32954660329555896,-1.270572397002215,0.06818181818181818,0.5502694153668525,1.0,28/137,7.29%,AFDN;MCC;SULF1;ROBO1;LDLRAD4;EPHA4;DPYSL3;COL3A1;CLIC4;IGFBP5;FOXO3;RECK;SLIT2;CLDN5;PODN;PTPRJ;GJA1;MAGI2;SRGAP3;SRGAP2;SMAD7;CDH1;IGFBP3;PTPRG;SCAI;ACVRL1;CYP1B1;RHOB
prerank,negative regulation of transport (GO:0051051),0.4672740445447822,1.2705293917176892,0.17428087986463622,0.7279449203117098,1.0,7/51,6.30%,PTEN;DYSF;NR1H3;NRG1;NDFIP2;SCAMP5;SNCA
prerank,protein prenylation (GO:0018342),0.6079516207593854,1.2700522184707344,0.2219679633867277,0.727670992582049,1.0,2/10,3.16%,PTAR1;CHML
prerank,regulation of cell division (GO:0051302),-0.37322068298202904,-1.2699662684727555,0.129973474801061,0.5508924757214386,1.0,32/72,28.48%,FGFR2;RAB11A;KIF13A;MLLT3;FGF1;TXNIP;PLK2;CALM2;BECN1;FLCN;EFHC1;SH3GLB1;GIT1;UVRAG;TAL1;MYO19;CALM1;SIRT2;SMYD5;PLK4;CETN2;CCP110;BCL2L1;RACK1;PLK5;KLHL21;DLL1;FSD1;SFN;KIF18B;TLE6;KLHL9
prerank,ear morphogenesis (GO:0042471),-0.4844570419903547,-1.2699247792786506,0.1807465618860511,0.5500481975986978,1.0,6/20,12.29%,CHD7;OSR1;FGFR2;SIX1;TBX1;EPHB2
prerank,"phagocytosis, engulfment (GO:0006911)",-0.4269750814106224,-1.269588822156821,0.14285714285714285,0.5500333856775101,1.0,5/36,3.21%,GULP1;GSN;RHOBTB1;ELMO1;THBS1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.4656868686877959,-1.2692774342327207,0.162217659137577,0.5499225977001652,1.0,6/25,7.33%,IL31RA;GHR;SOCS2;STAT2;STAT1;STAT3
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.4404727646946828,-1.2683540886933828,0.17255717255717257,0.5515200711484526,1.0,9/31,22.30%,PLCB1;IL16;LGALS9;MAPK14;PLCG2;TLR4;SYK;MDK;CCL19
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4763784379001937,-1.2682196964851502,0.15904572564612326,0.5508954119681214,1.0,4/20,2.33%,FMNL2;ROCK2;RHOQ;DLG1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.4639055535681811,-1.2667314213745233,0.16733870967741934,0.5539692025288697,1.0,6/26,14.71%,ST3GAL4;LARGE1;ST3GAL2;GOLPH3;ALG6;GCNT1
prerank,neurotrophin signaling pathway (GO:0038179),0.5387808467055457,1.2664708454103057,0.23443983402489627,0.7352242575345199,1.0,6/21,10.32%,RAPGEF2;BCAR1;SORT1;NTRK2;RAP1A;DDIT4
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.5318480188574207,-1.2662277720747004,0.17086330935251798,0.5543544395030829,1.0,9/14,33.31%,ENTPD1;ENTPD5;ENTPD2;NUDT16;NUDT1;NUDT18;ENTPD3;NUDT5;NUDT9
prerank,fluid transport (GO:0042044),-0.5526564095390669,-1.2659095663909739,0.2080808080808081,0.5542409968814923,1.0,2/12,15.56%,PDPN;AQP11
prerank,inner mitochondrial membrane organization (GO:0007007),-0.4078597933033955,-1.2658412544686208,0.12751677852348994,0.5534608024444064,1.0,23/47,29.59%,MICOS10;MTX2;ATP5PF;DMAC2L;SPG7;APOOL;CHCHD6;MICOS13;ATP5MF;ATP5MC3;ATP5MC1;TIMM13;AFG3L2;TIMM8B;MAIP1;TIMM9;HSPA9;ATP5MC2;NDUFA13;ATP5F1E;DNAJC11;TIMM10;MTX3
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4841548174366658,1.265436364046967,0.18975332068311196,0.7362928893912106,1.0,5/35,3.58%,PIGU;NOTCH1;ERBB4;CRLF3;SH2B3
prerank,sodium ion export across plasma membrane (GO:0036376),0.5851453227500594,1.2653744563005702,0.22340425531914893,0.7349536317026065,1.0,4/13,4.90%,ATP1A2;ATP1A4;FXYD2;ATP1B2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.487816024643159,-1.264939222870327,0.16532258064516128,0.5549678109699112,1.0,4/18,4.15%,VGLL4;APOE;EZR;CTSC
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5388836328293349,1.2648653727739247,0.2111801242236025,0.7348520049552975,1.0,2/21,0.84%,MBOAT2;PLA1A
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.46796961584463714,1.2645875322168363,0.20967741935483872,0.7341004412555491,1.0,8/46,5.24%,ITGA4;LAMC3;PIK3R1;LAMC1;PEAK1;FERMT2;NTNG2;LAMB1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.37186432525675756,-1.2645124584757712,0.11195928753180662,0.5551766536689708,1.0,21/67,11.21%,SULF1;FLT1;NRP2;ROCK2;NRP1;ELMO1;VAV2;CYFIP2;SHB;BAIAP2;PXN;VEGFD;VEGFC;CLEC14A;RHOA;MAPK14;PTK2B;PIK3CB;DAB2IP;KDR;ITGB3
prerank,positive regulation of immune effector process (GO:0002699),-0.4489445620887903,-1.2644768905257047,0.15289256198347106,0.5543197784215904,1.0,7/27,7.41%,LBP;MYO18A;PTPRJ;DDX60;LGALS9;APPL2;RPS19
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5376211190491932,1.263689676373307,0.2263779527559055,0.7348663338310006,1.0,3/21,2.02%,CSPG4;CHST3;CHST7
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4745002695760437,1.2634284742034894,0.2199248120300752,0.7341087184019285,1.0,10/40,10.93%,SGIP1;VTN;LDLRAP1;WASL;ATAD1;IL4;PPT1;HIP1;DGKD;AHI1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.5094298585990535,-1.2632412898246186,0.1776061776061776,0.5568768397579902,1.0,6/17,7.98%,ANXA4;KLF4;ANXA1;ARRB1;MAP2K5;TMSB4X
prerank,regulation of Rho protein signal transduction (GO:0035023),0.43859241866947546,1.2628121645880555,0.1750841750841751,0.7342015536044069,1.0,9/72,4.92%,DLC1;STARD8;EPS8;TNFAIP1;CUL3;STARD13;PDCD10;EPS8L1;RIT2
prerank,blood vessel morphogenesis (GO:0048514),-0.38631339556246,-1.2625336596055627,0.13380281690140844,0.5578542567743131,1.0,17/54,8.16%,TGFBR3;FLT1;EFNB2;NRP1;LAMA1;CCBE1;CAV1;ITGB8;TGFBR2;TGFBR1;SMAD7;ID1;RAMP2;RASIP1;CYP1B1;TBX1;STRA6
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.35426522964645357,-1.2621917898834971,0.09358288770053476,0.557868612817426,1.0,39/80,33.62%,PLPP3;ERGIC1;COPZ2;TAPBP;KLC1;COPA;RINT1;GOLPH3;ATP9A;UVRAG;ZW10;SURF4;SCYL1;NAPA;RER1;BNIP1;STX18;RAB6A;COPB1;TMED9;TMED2;CENPE;ARFGAP2;PICK1;TMEM115;KIF26A;ERGIC3;ARF4;USE1;KIF4A;ATP9B;TMED10;KIF1C;NBAS;SCFD1;KIF23;KIF18A;KLC2;DNAJC28
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.54124863370134,-1.2613006798938766,0.17296222664015903,0.5593525907581258,1.0,4/12,8.87%,F3;APOD;PTPRJ;HGS
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3949972510999972,1.2612435539122266,0.15313935681470137,0.7365654005669136,1.0,8/138,2.82%,NOTCH3;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.5102376216007617,1.2599727892861743,0.20412371134020618,0.7382903477122053,1.0,3/24,2.80%,MEF2C;CDH2;NRG1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5523775841150966,1.2599521916921967,0.2359081419624217,0.7368552461796865,1.0,5/17,10.02%,WASF3;ABI2;WASF2;CTNNA2;NCKAP1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.49851106746024104,-1.259606849212323,0.19029850746268656,0.563123094027548,1.0,4/16,12.43%,ST3GAL4;NFAT5;RHOA;RELA
prerank,negative regulation of macrophage activation (GO:0043031),0.5557868354338996,1.2593390594484162,0.23492723492723494,0.7369094907145397,1.0,5/16,6.03%,NR1H3;LRFN5;LDLR;TAFA3;IL4
prerank,regulation of interleukin-6 production (GO:0032675),-0.35339024465204183,-1.2590259826164614,0.0987012987012987,0.5636764375622643,1.0,36/96,26.93%,APP;IL6R;LBP;ARHGEF2;IL16;GAS6;ARRB1;LGALS9;WNT5A;STAT3;CD47;C1QTNF3;IL33;IL17RA;IRAK3;ZC3H12A;MAVS;CYBA;PLCG2;CD200;SIRPA;TLR4;POU2F2;SYK;TYROBP;XBP1;LPL;PTPN6;RAB7B;IL17D;MYD88;CD200R1;NCKAP1L;SETD4;TWIST1;BCL10
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5850146497365682,1.2589000944923796,0.23093681917211328,0.7366086017587029,1.0,4/10,17.31%,CPEB1;NCBP2;DHX36;HSF1
prerank,mesenchymal cell differentiation (GO:0048762),0.46548880672113613,1.2588337515700752,0.2018348623853211,0.735321432280131,1.0,7/51,2.15%,LIMS1;MEF2C;HEY2;HEYL;NOTCH1;TBX20;ROCK1
prerank,cell-cell junction assembly (GO:0007043),0.4451487976420119,1.2586990278015537,0.1836007130124777,0.734235789673269,1.0,11/63,7.13%,GJD3;GJC1;CDH2;JAM3;VCL;GJA4;CDH8;CDH22;CDH19;CDH7;CDH20
prerank,leukocyte tethering or rolling (GO:0050901),0.552800915188887,1.2584446059651,0.22532188841201717,0.7334270867044045,1.0,3/17,5.53%,ITGA4;ROCK1;ITGB1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.5324236416120952,-1.2580945055065937,0.21973929236499068,0.5652344413529038,1.0,4/13,20.52%,PLA2G4A;MGLL;ABHD16A;DGAT2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4776516623640923,1.257940175726883,0.18081180811808117,0.7332617695878825,1.0,11/39,17.44%,MYO1B;WASL;ACTN4;MYO6;TRAK1;TRAK2;PPFIA2;RAB1A;NDE1;HTT;HAP1
prerank,aminoglycan catabolic process (GO:0006026),0.5022584697450769,1.2576969227974746,0.2072936660268714,0.7323818952633264,1.0,7/28,6.35%,SDC2;SDC3;HYAL4;AGRN;GPC5;GPC3;GNS
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4183015758771864,-1.25752874381937,0.17197452229299362,0.5657804089457468,1.0,16/34,13.40%,FLT1;NRP1;SEMA6A;GAS1;ANXA1;RAMP2;VEGFD;VEGFC;MAPK14;FOXC1;DAB2IP;KDR;ERN1;RELA;FLT4;SPHK1
prerank,positive regulation of cellular component organization (GO:0051130),-0.3465907698937173,-1.2570590687675631,0.07079646017699115,0.566068041126383,1.0,35/107,20.13%,DAB2;TRABD2B;ATP10A;CDH5;BMP7;APOE;FRMPD4;SHANK3;IGF1R;TGFBR1;ASAP1;ADGRL1;AR;FNIP1;TFRC;BCL2L11;DAB2IP;LMAN1;TGFB1;SH3GLB1;ADD1;TAL1;BNIP3;SURF4;TMEM30A;BID;CD151;GPX1;PARK7;VCP;LRP4;RHOC;NOX1;SYK;TMED9
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.4761767652963427,-1.25705770296143,0.19649805447470817,0.5651123970547338,1.0,10/22,19.61%,GSN;SLIT2;KANK3;TMSB4X;PRKCD;PFN1;TWF1;CYRIB;TMSB10;SSH3
prerank,regulation of histone modification (GO:0031056),-0.5302623740949208,-1.2565792103121303,0.18647166361974407,0.5654853906934598,1.0,5/13,18.15%,IGF2;FLCN;NNMT;CDK9;PARK7
prerank,clathrin-dependent endocytosis (GO:0072583),0.5004832662230085,1.2563117282637826,0.21001926782273603,0.7343695494893816,1.0,1/26,0.11%,SGIP1
prerank,protein polymerization (GO:0051258),0.4564417772470677,1.2558848243206837,0.17900172117039587,0.7339452645804015,1.0,9/55,6.39%,CASQ2;ARHGAP6;WASF3;WAS;CORO7;SPIRE1;WASL;FGF13;TPPP
prerank,regulation of MAPK cascade (GO:0043408),-0.32528376109139534,-1.2557780339223001,0.0664451827242525,0.566726632556854,1.0,39/157,14.53%,TGFBR3;IGF1;FN1;EGFR;FLT1;ROCK2;EPHA7;NTRK3;LPAR1;TEK;IQGAP1;CAV1;JCAD;KSR1;FGFR2;NRK;PTPRJ;IGF1R;GSDME;IGF2;IAPP;DUSP1;TBX1;ADRA1B;TAOK2;KIT;EPHA8;DAB2IP;KDR;P2RX7;MYOC;PPEF2;FLT4;CCN1;PRDM11;PLCG2;RET;CAV2;MAPK3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5753075213210663,-1.2554931676157361,0.20114942528735633,0.5665823690170952,1.0,7/10,37.03%,INO80;SSBP1;DBF4;STOML2;WIZ;ATRX;E2F8
prerank,positive regulation of synaptic transmission (GO:0050806),0.4184450191071302,1.2550440873946898,0.1844331641285956,0.73458118617925,1.0,19/72,11.13%,CLSTN1;GPER1;MPP2;NRXN1;CACNG7;NMU;ADCY8;RIMS1;CLSTN3;SLC24A2;RIMS2;CHRNA7;SYT1;KCTD13;NFATC4;ZDHHC2;GRIN2B;BAIAP3;STX4
prerank,organophosphate ester transport (GO:0015748),0.5268594581663947,1.255021971232421,0.24109014675052412,0.7332214368965903,1.0,3/24,3.39%,PITPNC1;SCARB1;LDLR
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.49667219408574137,-1.2540388184376507,0.21,0.5694622043105512,1.0,8/16,31.51%,APPL2;ACADL;CEACAM1;ERLIN2;BRCA1;SIRT4;TRIB3;APOC1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.32277253633482494,-1.2538737682344665,0.07046979865771812,0.5689452099265793,1.0,56/148,26.75%,PRKAG2;PPP1R13B;TAF1;RBBP7;BRD7;KMT5A;MAP2K6;RPS20;MAPK14;CHD3;AKT1;MEAF6;CCNG1;RPL37;EHMT1;PML;PIP4K2B;RPL11;PAK1IP1;HDAC1;PRKAG3;MDM2;ATM;PRKAB1;RPA1;RAD50;HIPK2;RPS15;TAF4B;RPL23;PRKAA2;TP53RK;PDPK1;PPP2R5C;RFC3;CHD5;TAF9B;CDK5RAP3;RFFL;TOP3A;PRKAG1;BRPF1;TAF5;USP2;RMI2;CHEK2;STK11;TTC5;BRCA1;RPA3;RRS1;L3MBTL1;TP53;HUS1;TAF11;TPX2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5271016160319757,1.2535865351173958,0.21359223300970873,0.7354431140153032,1.0,8/27,13.62%,PTEN;MARK1;NTNG2;IL1RAPL1;CTNNA2;BRSK1;PSEN1;ULK4
prerank,early endosome to Golgi transport (GO:0034498),-0.551316089458813,-1.253236242355071,0.21320754716981133,0.5697611329290111,1.0,7/11,22.31%,TRAPPC10;LMAN1;SURF4;RAB6A;SNX8;TMED9;SNX2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.42803604219824637,1.2528567054937507,0.1890625,0.7358583890247519,1.0,21/75,11.85%,PTEN;SPRY4;PRKAR1B;NF1;IL1B;SH2B3;PKIA;SPRY2;HEXIM1;CD300A;TESK1;UCHL1;PRKAR2B;PRKAR2A;INCA1;NR2F2;LYN;PRKAR1A;LATS2;RB1;APC
prerank,cellular response to organic substance (GO:0071310),-0.338644066782387,-1.2518680412753724,0.10557184750733138,0.5726530370004596,1.0,23/116,7.48%,DPYSL3;SMAD3;NFAT5;PTPN14;PTPN13;IGFBP5;SLIT2;TGFBR2;BMPR2;TGFBR1;CLEC3B;KLF4;LRRK2;GHR;LEF1;ACVR1;SOCS2;RAMP2;ACVRL1;RHOA;CYP1B1;STAT3;MAP2K5
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5396306728680921,1.2514043470894778,0.24285714285714285,0.738078463237686,1.0,3/17,1.19%,HEY2;HEYL;NOTCH1
prerank,metanephros development (GO:0001656),-0.4532875948136359,-1.2510217645309865,0.19305856832971802,0.5740625797057641,1.0,9/26,14.82%,CTSH;BMP7;OSR1;BMP4;FOXD1;SIX1;PTCH1;SOX17;PKD1
prerank,potassium ion homeostasis (GO:0055075),0.5244282726354039,1.250916951777433,0.23679060665362034,0.7378493166101965,1.0,6/23,5.65%,SLC12A2;ATP1A2;ATP1A4;SLC12A6;ATP1B2;TFAP2B
prerank,striated muscle cell differentiation (GO:0051146),0.5614976927310333,1.250738260967661,0.23975409836065573,0.7368538849889009,1.0,5/16,6.69%,MEF2C;NRG1;SORT1;POPDC3;SIK1
prerank,cellular response to cytokine stimulus (GO:0071345),-0.28737757102783656,-1.2506227990685852,0.011976047904191617,0.574225099031829,1.0,100/416,15.89%,DAPK1;COL1A2;DPYSL3;FN1;SMAD3;ADAMTS12;LEPR;NFAT5;PTPN14;PTPN13;ST3GAL6;PTGIS;IL31RA;FOXO1;FOXO3;F3;IL1R1;IL6R;VIM;LBP;IL6ST;PTPRJ;LRCH1;GHR;ANXA1;CSF1;ARHGEF2;LEF1;SOCS2;VCAM1;GSDME;SBNO2;IL16;IRAK2;CXCL12;GAS6;ZFAND6;LGALS9;STAT2;MAOA;GREM2;IRF1;WNT5A;CCL15;TNFRSF1B;ICAM1;RHOA;FOXC1;WNK1;STAT1;STAT3;CCL14;CD47;STX3;GBP4;DUSP1;RAPGEF1;PIK3CB;AKT1;KIT;MCL1;IRGM;HIF1A;TNFRSF1A;BCL2L11;LAMA5;IFIT1;IRAK3;DAB2IP;IL18;STX1A;ZC3H12A;GBP6;GBP5;TGFB1;PTGS2;INPP5D;CCL25;GBP7;RELA;S1PR1;YBX3;FLT3LG;UBB;LRP8;CCND1;FER;OXSR1;UBE2G2;SFRP1;POU2F1;CDK9;CNTFR;IFITM2;GBP2;MMP2;SDC1;CCL13;IL10RB;CDKN1B
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4713683595942056,1.250539753926386,0.20925925925925926,0.7359354148312596,1.0,9/42,9.83%,UTRN;LIMS1;CDK6;FERMT2;ROCK1;RIN2;EMP2;MAP4K4;EFEMP2
prerank,regulation of cell communication (GO:0010646),0.4906503363571681,1.2502610770335856,0.21102661596958175,0.7351802986157445,1.0,10/35,14.03%,CASQ2;IGFBP7;GRK3;RYR2;GRK5;NCLN;TBX18;PTPN1;GRK4;ANK2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.550986132520242,1.2502449200484282,0.26653696498054474,0.733791933045826,1.0,2/17,0.85%,PID1;CBFA2T3
prerank,regulation of myoblast fusion (GO:1901739),-0.5359680729329185,-1.249898999263215,0.19669117647058823,0.5753363781071222,1.0,4/11,15.60%,CFLAR;MAPK14;EHD1;EHD2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5857902830406082,1.2492287315835744,0.24261603375527427,0.7335195404480703,1.0,1/11,0.50%,CASQ2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5857902830406082,1.2492287315835744,0.24261603375527427,0.7335195404480703,1.0,1/11,0.50%,CASQ2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4141351325137462,1.2491520962905724,0.16718266253869968,0.7322940618798724,1.0,17/93,11.50%,PDE4D;PTEN;DMD;NCK2;TNKS1BP1;FNIP2;PDCD10;SPRY2;INPP5J;SNCA;CAPRIN2;RIPK2;PRKD2;CNOT9;DDIT4;BRAF;PAK1
prerank,regulation of programmed cell death (GO:0043067),-0.3230974826830372,-1.2487523755083274,0.05813953488372093,0.5775722881548419,1.0,61/161,28.85%,DAPK1;MECOM;PPP1R13B;STEAP3;ACTN2;TGM2;GAS1;FBXO10;LRRK2;TRIM24;IGFBP3;ACER2;RARG;ACER3;STAT1;BIRC3;ANP32E;TPT1;ANP32B;AKT1;CTSB;BCL2L11;PRDX2;BNIP3L;NME1;ACTN1;ATM;CALR;LRP8;BNIP3;PLSCR3;CASP6;BID;RIPK1;PRELID1;ALK;AGT;VCP;LGALS1;SLK;USP36;LCMT1;OSGIN1;PTPN6;STK26;NTF3;PSMC5;RPS3;PLK5;PRKN;TP53;FAS;CRADD;APAF1;SRA1;DAPK2;ABL1;CLU;NUP62;FANK1;ANP32A
prerank,regulation of apoptotic process (GO:0042981),-0.27297652099838965,-1.2483291364582532,0.0,0.5778248269888153,1.0,135/676,14.32%,NOTCH2;IGF1;DAB2;DAPK1;UNC13B;PAWR;FSTL1;EGFR;SMAD6;FHL2;CTSH;AKAP13;PPP1R13B;IL31RA;TIAM2;PDPN;TEK;STEAP3;FOXO1;SH3RF1;OSR1;FOXO3;ACTN2;ARHGEF3;SLIT2;ANXA4;NUPR1;ITGA6;ANXA5;MYO18A;TGM2;VAV2;STK17B;USP47;THBS1;BMP4;IL6ST;GAS1;IGF1R;RASSF2;ANGPT1;TXNDC5;FBXO10;MCF2L;ANXA1;ARHGEF2;LEF1;SOCS2;CFLAR;TRIM24;HOXA5;ADAM10;IGFBP3;ACER2;GAS6;QRICH1;NIBAN2;TNFSF10;NAA35;IAPP;RARG;ZFAND6;RNF144B;SFRP4;WNT5A;CCND2;ANO6;PTK2B;PLK2;EGLN2;CYP1B1;PTPA;STAT1;CARD14;RHOB;HSPA5;SH3RF2;TFRC;BIRC3;ANP32E;TRIO;GOLPH3;ERC1;IFIT2;ADAMTSL4;ARHGEF1;TPT1;ERCC5;SON;ANP32B;AIFM1;TIAM1;AKT1;BAG3;MCL1;CTSB;UTP11;BCL2L11;PRDX2;EGLN3;IFIT3;FLCN;ATF6;CASP8;CD38;GCLC;DAB2IP;FGD4;KDR;ARHGDIA;BNIP3L;PLEKHG5;HDAC1;NME1;RELA;ACTN1;FLT4;ATM;GATA6;CBX4;TRIM35;UBB;CALR;PPID;ARHGEF18;LRP8;SPHK1;ARHGEF19;PIM3;BNIP3;SFRP1;RPL10;PPIA;HYPK;IP6K2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5570928679939766,-1.248307517156858,0.23699421965317918,0.5769111149477738,1.0,3/10,8.87%,APOD;PTPRJ;HGS
prerank,myoblast differentiation (GO:0045445),-0.515701272816159,-1.2480515165308383,0.1891891891891892,0.576695183882053,1.0,5/14,7.36%,IGF1;MBNL1;DDX5;TCF7L2;HINFP
prerank,amino acid transmembrane transport (GO:0003333),0.4627455235897066,1.247834709237656,0.1917562724014337,0.734176385594278,1.0,1/45,0.03%,SLC38A11
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5124527829180896,-1.2476849184961534,0.21264367816091953,0.5767000712856023,1.0,1/14,0.08%,AUTS2
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5734473709433793,1.2473882538580006,0.2786885245901639,0.7338814303056888,1.0,4/12,14.03%,CASQ2;RYR2;CASQ1;ANK2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5117511244985695,1.2473613498810978,0.22868217054263565,0.7325303599926792,1.0,8/27,7.20%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;PIP4K2C;IRS1
prerank,cellular response to osmotic stress (GO:0071470),0.5250200439617104,1.2466924897997052,0.2446601941747573,0.7327972210838655,1.0,6/21,9.03%,MYLK;RCSD1;STK39;SCN2A;DDX3X;PKD2
prerank,epithelial to mesenchymal transition (GO:0001837),0.46273642543471766,1.246521368410524,0.2032967032967033,0.7318033085841102,1.0,6/47,2.15%,LIMS1;HEY2;HEYL;NOTCH1;TBX3;ROCK1
prerank,establishment of melanosome localization (GO:0032401),-0.470860983469146,-1.2464390743491869,0.19284294234592445,0.5791497968841033,1.0,7/19,20.78%,SHROOM2;RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,positive regulation of DNA repair (GO:0045739),-0.391586526304692,-1.2458832066982886,0.15498938428874734,0.579733178111421,1.0,4/46,3.02%,EYA2;EYA1;EGFR;EYA4
prerank,positive regulation of DNA replication (GO:0045740),-0.4953777708321559,-1.2454347636522978,0.20315581854043394,0.5800569713746064,1.0,2/16,1.10%,EGFR;GLI2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5244184603370492,-1.2453222994509674,0.19662921348314608,0.5794462663532455,1.0,4/15,8.90%,PIEZO2;COL11A1;ADGRV1;KIT
prerank,neuron migration (GO:0001764),0.4553970605718341,1.2447064737083429,0.20695652173913043,0.7349328106129139,1.0,14/48,10.61%,MEF2C;ADGRL3;RAPGEF2;MARK1;ASTN1;FGF13;DNER;ASTN2;NTRK2;TUBB2B;CCK;MARK2;DDIT4;SPOCK1
prerank,Rac protein signal transduction (GO:0016601),0.5306622457250044,1.2444374611227746,0.23877551020408164,0.7342260007975483,1.0,4/18,10.02%,EPS8;ABI2;HACE1;NCKAP1
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4562367818402634,-1.2434989998022865,0.19721115537848605,0.5836328370555413,1.0,10/22,17.39%,PDGFD;RASSF2;ACE;TOM1L1;CALM2;TAOK2;RAD50;CALM1;RAP2C;PDGFC
prerank,regulation of protein phosphorylation (GO:0001932),-0.30381342327635785,-1.2430676804445253,0.06103286384976526,0.583954152445644,1.0,67/256,14.83%,DAB2;FN1;EGFR;LEPR;CDH5;ROCK2;EPHA7;NTRK3;PTPN13;FBLN1;PLPP3;OCLN;BMP7;TEK;PECAM1;APP;SLIT2;XDH;BMP4;ANGPT1;LRRK2;LRP6;NIBAN1;VEGFD;IGFBP3;VEGFC;LIMK2;IGF2;GAS6;ARRB1;FGF1;STAT2;BMPER;EFNA5;CCND2;CARD14;FNIP1;CCND3;TFRC;TBX1;WDFY2;AKT1;IRGM;FLCN;DAB2IP;ZC3H12A;KDR;PML;MAVS;ITGB3;TGFB1;NSD1;TMEM119;EPHB2;FLT4;CCDC88C;CCN1;TWF1;CDK2AP1;CCND1;FER;LIMCH1;NDUFS4;PPIA;FXR2;MAPK3;CORO1C
prerank,adherens junction organization (GO:0034332),0.46035598794955235,1.2425149762578747,0.18702290076335878,0.737524031227267,1.0,14/48,10.27%,CDH2;CDH4;JAM3;VCL;FERMT2;CADM2;CDH8;CDH22;CDH19;CDH7;CDH20;CSK;CDH10;CDH18
prerank,regulation of cholesterol storage (GO:0010885),0.5523617161137153,1.2424867260912802,0.23030303030303031,0.7361729448534167,1.0,5/15,5.47%,NR1H3;SCARB1;PPARD;SREBF2;MSR1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2886553105847373,-1.2423167074727504,0.02040816326530612,0.5850643138513565,1.0,80/348,14.87%,PRKAG2;BMP6;IGF1;DAB2;PDGFD;EGFR;LEPR;ROCK2;NRP1;NTRK3;CEMIP;BMP7;TEK;IQGAP1;PECAM1;APP;IL15;CAV1;IL6R;BMPR2;BMP4;ITGA5;PTPRJ;SNX9;TGFBR1;RASSF2;ANGPT1;LRRK2;GHR;CSF1;ARHGEF2;ACVR1;NIBAN1;VEGFD;SDCBP;VEGFC;LIMK2;IGF2;GAS6;ARRB1;FGF1;ACVRL1;TOM1L1;EFNA5;CCND2;PTK2B;CARD14;CALM2;FNIP1;CCND3;TFRC;ALS2;TBX1;WDFY2;TAOK2;AKT1;IRGM;FLCN;KDR;AKAP9;MAVS;ITGB3;TGFB1;TMEM119;TWSG1;FLT4;CCN1;CDK2AP1;LRP8;PLCG2;SPHK1;CCND1;TXN;LIMCH1;PPIA;HSP90AB1;FXR2;MAPK3;RAD50;CDK9
prerank,negative regulation of innate immune response (GO:0045824),-0.41392365278345844,-1.2420794127383965,0.17154811715481172,0.5847469785594579,1.0,9/34,10.17%,SERPING1;CNOT7;STAT2;RPS19;USP15;USP18;NLRC5;IRAK3;SAMHD1
prerank,regulation of gene expression (GO:0010468),-0.27097083231646507,-1.2419426765177974,0.0,0.5841937509957564,1.0,185/903,13.91%,BMP6;AFDN;BNC2;PRDM6;NOTCH2;IGF1;ROBO1;SLC24A3;FOXN3;ZNF423;FN1;AFF3;SMAD3;SMARCA2;CDH5;EFEMP1;ROCK2;FOXP1;AHNAK;WNT4;NTRK3;GSN;HDAC4;DENND4A;CTSH;WWC2;CHD7;OCLN;BMP7;APOE;OSR1;APP;NFIA;NR3C1;F3;KAT6B;WNT6;CLDN5;ITGB8;XDH;SUFU;MBNL1;ESR1;NOS3;BMP4;GJA1;EZR;PRRX2;TGFBR1;FOXD1;ANGPT1;KLF4;CSF1;CDH1;LEF1;TAF1;RAMP2;SBNO2;CD34;HOXA5;ADAM10;SMO;PARP9;CNOT7;IGF2;MED26;SSBP2;GAS6;TAPBP;GTF2IRD1;ARNT2;RBM20;WWP2;AR;FGF1;RAB27A;CREM;LGALS9;PARP14;YAP1;MOV10;SFRP4;SOX13;BHLHE40;PFDN5;ACVRL1;ATXN1;SIX1;WNT5A;MAPK14;FOXC1;IRF2;SLC7A5;CHD3;STAT3;HINFP;AFF2;NR2C2;PGR;TFRC;NOCT;ZNF219;ACTG1;ERC1;AFF1;DTNBP1;IGF2BP2;POLR2A;ATRAID;TRRAP;GON4L;PIK3CB;NOVA2;NOS1AP;SON;VSX1;AKT1;HGS;RREB1;IL33;REXO4;HIF1A;PCBP2;TLE1;CCN4;CRABP2;CARM1;FLOT2;TULP3;FZD7;FLCN;CASP8;EMILIN1;SEC16B;ZC3H12A;PRDM5;SLC39A8;KDR;ESRRG;PML;ANXA7;TRIM27;P2RX7;GATA2;VPS35;BRCA2;PATZ1;CLK1;RPL11;NFYC;HINT1;PUM1;TGFB1;NSD1;AHR;HDAC1;FGFR4;EPHX2;TMEM119;EPHB2;MBNL2;RELA;GRSF1;ID2;NOVA1;YBX3;SRSF10;ZNF462;ATM;PRKAB1;PRDM11;CALR;GLRX2;ATOH8;TDG;CLOCK;PTHLH;WNT16;TRIM39;PLCG2;LARP1;HDAC5;TICAM1;SOX17;SFRP1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.4636740155302088,-1.241851489274993,0.19230769230769232,0.5834840222369407,1.0,6/20,14.14%,FKBP5;FKBP1A;FKBP4;PPIC;PPID;PPIA
prerank,positive regulation of viral life cycle (GO:1903902),0.5264389874717113,1.2417319905682254,0.24285714285714285,0.7366412497548159,1.0,4/22,8.52%,TMPRSS4;AXL;CHMP2B;TMPRSS2
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.35339417940590384,-1.241599081813837,0.0913978494623656,0.5832525443666193,1.0,35/88,23.51%,TRABD2B;SMAD3;CDH5;BMP7;SDCBP;SMPD3;PDCD6IP;SYNPO2;SDC4;SYNPO;FNIP1;TFRC;HGS;BCL2L11;EMILIN1;DAB2IP;RAB7A;TGFB1;SH3GLB1;PFN1;TAL1;SDC1;BID;TPR;STX18;PARK7;VCP;RHOC;SYK;PLEK;VEGFA;PIH1D1;SLX4;ICE1;ERCC1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.5322694419028853,1.2413742829235344,0.24703557312252963,0.73613907017728,1.0,2/21,1.34%,IL34;PTK2
prerank,regulation of inflammatory response (GO:0050727),-0.31523671558840544,-1.2410555232338438,0.06713780918727916,0.5838053117930142,1.0,45/190,12.45%,ADAMTS12;CDH5;FOXP1;PTGIS;TEK;APOE;CASP12;APP;IL15;IL1R1;SNX6;SEMA7A;KLF4;ANXA1;PDCD4;SBNO2;IL16;LACC1;CCN3;LPCAT3;CASP4;WNT5A;TNFRSF1B;ENPP3;MFHAS1;PIK3AP1;CD47;BIRC3;TMSB4X;PRKCD;DAGLB;C1QTNF3;USP18;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;METRNL;VPS35;MGLL;PTGS2;RELA;PPARA
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.49719207540751575,-1.2409030544858226,0.1937984496124031,0.5832517565897355,1.0,2/17,3.14%,PLA2G4A;LPGAT1
prerank,regulation of macrophage activation (GO:0043030),-0.4307949513733369,-1.2399295554495424,0.16700201207243462,0.5849289898574177,1.0,12/30,16.55%,IL31RA;LBP;MYO18A;THBS1;WNT5A;MFHAS1;IL33;KARS1;ZC3H12A;SPHK1;CD200;TLR4
prerank,negative regulation of cell development (GO:0010721),-0.4386513432230089,-1.239739955710212,0.18789144050104384,0.5845270170157271,1.0,4/25,5.51%,IGF1;FBN1;B2M;APPL2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.47585118924696646,1.239684949241605,0.2230769230769231,0.7390464901784547,1.0,4/38,3.58%,PTEN;PHLPP1;GPER1;SH2B3
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.46317020960704264,1.239447471723429,0.21284403669724772,0.7382407217664303,1.0,8/39,7.15%,PIK3CD;PIK3R1;PIP4K2A;PIK3CA;ITPKB;SOCS5;PIP4K2C;PIK3C2A
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3267225023545187,-1.2387257370603835,0.08978328173374613,0.5863950110080074,1.0,40/138,14.23%,EPHA4;EPHA3;EGFR;FLT1;MTSS1;EPHA7;PDGFRA;NTRK3;IL31RA;TEK;NEDD9;FGFR2;BMPR2;IL6ST;EPHB4;IGF1R;MPZL1;YES1;CSF1;NPR1;PTPRG;DDR1;BDKRB2;PTK2B;TRIO;RAPGEF1;PIK3CB;TIE1;KIT;EFS;FRS2;EPHA8;KDR;FGFR4;EPHB2;FLT4;MET;FER;RET;STYK1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.5307220356417054,-1.2381241865078463,0.2062043795620438,0.5869922547672441,1.0,3/13,13.01%,RHOQ;LRRK2;RAN
prerank,regulation of neuron projection development (GO:0010975),0.38124620153390754,1.2369726963724115,0.16216216216216217,0.7430262555239888,1.0,36/163,11.74%,CHN1;SERPINI1;PTEN;CDH2;RAPGEF2;ROR1;RTN4RL1;PTPN9;MARK1;SCARF1;LRRC4C;PTN;ABI2;PLPPR5;ADCY6;NTNG2;ATP1B2;RIT2;MYLIP;NTRK2;CSMD3;RAP1A;FUT9;IL1RAPL1;MARK2;LYN;ARHGAP35;CTNNA2;TOX;ABL2;SPOCK1;BRSK1;PAK3;PAK1;EP300;PLXNB3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5489913582735144,1.2366605125424797,0.24791666666666667,0.7423835541402173,1.0,3/14,11.11%,LIMS1;EMP2;LOXL3
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5001203111537587,-1.2364672891655475,0.2236842105263158,0.5906303081915008,1.0,3/14,10.10%,THBS1;CMKLR1;IRAK3
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4694949879070071,1.2363573035154134,0.2167577413479053,0.7417800369200372,1.0,3/40,1.57%,PID1;SLC25A33;CCN6
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4257193203611772,1.2358664795448087,0.20098846787479407,0.7415726011279105,1.0,9/64,4.30%,UTRN;CDK6;AJAP1;PTK2;VCL;PEAK1;ROCK1;NF1;MINK1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.4867974374750569,1.2356775078045075,0.2441860465116279,0.7406247185488679,1.0,9/31,11.85%,PTEN;CDK6;MYO16;CDKN1A;PKD2;KANK2;RBL1;RB1;APC
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4805554990245201,1.2355042688875548,0.2262357414448669,0.7396853473932575,1.0,4/34,2.79%,PDGFRB;RGCC;IL1B;CUL3
prerank,regulation of stem cell population maintenance (GO:2000036),0.5428150188786013,1.2353572805676076,0.252465483234714,0.7386615093561232,1.0,4/18,5.75%,NODAL;PTN;NCOA3;CNOT2
prerank,engulfment of apoptotic cell (GO:0043652),-0.49504764895936737,-1.2353208555460395,0.21572212065813529,0.5928471671025637,1.0,5/15,22.19%,RHOBTB1;THBS1;MEGF10;RHOH;RHOBTB2
prerank,chondrocyte differentiation (GO:0002062),-0.4244363907964615,-1.2349995980992976,0.18376068376068377,0.5927705515724826,1.0,9/32,5.48%,NFIB;SULF1;OSR1;BMPR2;BMP4;CREB3L2;SLC39A14;CCN3;SULF2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.26967303955576377,-1.2344751658768585,0.017241379310344827,0.5932519029628324,1.0,250/1082,18.15%,NFIB;AUTS2;BMP6;IGF1;DAB2;ZMIZ1;PBX1;ZNF423;PLCB1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;COL1A1;DCN;NFAT5;WNT4;WWOX;HDAC4;GLI2;TBL1XR1;NFIX;CREB5;IL31RA;CDK8;BMP7;RHOQ;SP100;GLIS3;ELF2;FOXO1;APOE;OSR1;FOXO3;APP;MDFIC;ZIC2;NFIA;NR3C1;HDAC8;KAT6B;HIVEP3;ERG;ITGA6;HOXB3;RARB;MLXIP;ESR1;FGFR2;BMPR2;ELF1;BMP4;ELF4;MEOX2;TGFBR1;KLF4;PLAGL1;KAT2B;TCF4;TCF7L2;FOXC2;TFDP2;MRTFB;LRP6;ARHGEF2;NFATC1;SMAD7;CDH1;LEF1;ACVR1;FZD2;KLF2;MLLT3;SBNO2;THRB;RGMB;HOXA5;CREB3L2;SKI;PCGF5;ZFPM2;PARP9;DCAF6;IGF2;SSBP2;ARRB1;QRICH1;NIBAN2;ARNT2;AR;FGF1;BRD7;RARG;YAP1;TMF1;GLIS2;THRAP3;ACVRL1;IRF1;TEAD1;SIX1;WNT5A;INO80;HLF;TET3;PRDM16;FOXC1;IRF2;GLIS1;LMO2;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;NAMPT;PGR;KLF10;SFR1;TBX1;SSBP3;FZD4;TFCP2;ZBTB18;FIZ1;AKT1;DTX3L;RREB1;IL33;HIF1A;TNFRSF1A;TRIM16;NLRC5;FOXK1;CDH13;NR4A2;MMS19;FZD7;FLCN;ATF6;FOSL2;CD38;PHF10;DAB2IP;IL18;KARS1;ZC3H12A;ZKSCAN3;ESRRG;FHOD1;EIF5A;PML;MAVS;GATA2;BRCA2;CEBPG;KDM3A;GLI3;TGFB1;NSD1;ELK3;BCL9L;AHR;HDAC1;ATXN7L3;ZIC3;RELA;PPARA;ID2;MEF2A;USF1;ZNF462;ATM;GATA6;CCN1;FBXW11;PRDM11;UBB;ATOH8;CLOCK;LPIN3;MET;MEIS2;SPP1;MPND;HDAC5;RET;TAL1;SOX17;HSF2;SFRP1;SMARCC1;POU2F1;MAZ;MAPK3;HOXC4;PKD1;CDK9;HOXB7;HIPK2;DYRK1B;NKX6-1;SNAI1;ZFPM1;CREB3;JUND;SREBF1;SERPINE1;BMPR1A;NOS1;NKRF;CEBPZ;RNF187;HHEX;MEIS1;HMGB2;SOX18;KDM6B;TLR4;RNASEL;USF2;ZMIZ2;SIRT7;JUNB;MYRF;SIRT2;HNRNPAB;ATF1;MED21;RIPK1;WNT11;PTOV1;NFIL3;RAI1;SLC9A1;FZD1;HMGN1;NFKBIA;NFYB;CSRNP3;NPAS2;MAFF;SOX12;CEBPB;KLF15;PARK7
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.501912921712159,-1.2337136239358286,0.2066420664206642,0.5944027736540716,1.0,5/16,16.11%,IGF1R;CLEC16A;IRAK3;BNIP3;TBC1D25
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.4268698024941985,-1.2334663473548806,0.1782608695652174,0.5941102216730907,1.0,6/27,6.76%,IGF1;FN1;PDGFRA;GAS6;WNT5A;S100A6
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5442145767613847,-1.2334197640804965,0.21352313167259787,0.593279549211462,1.0,5/11,16.18%,NOS3;AKT1;GCH1;PTS;CALM1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.40987265279197,-1.2330378756258253,0.18636363636363637,0.5935492185762181,1.0,10/36,16.31%,MECOM;FOXO1;DLG1;EZR;SH3RF2;DUSP1;QARS1;PPIA;DUSP10;SIRPA
prerank,positive regulation of nervous system development (GO:0051962),0.4666388261117757,1.2329638494541293,0.23290203327171904,0.7431688961655636,1.0,13/42,15.29%,CLSTN1;GPER1;NRXN1;CLSTN3;LIG4;IL1RAPL1;CUX2;SPEN;EPHB1;SLITRK2;NLGN3;SYNDIG1;FAIM
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4877186604943593,-1.2329391369985656,0.22593320235756384,0.5929029555116471,1.0,4/18,6.79%,CAMK1D;SLIT2;IL6R;PTK2B
prerank,negative regulation of cell motility (GO:2000146),-0.3351876772164838,-1.2328305914155906,0.10755813953488372,0.5922923789901714,1.0,28/108,9.92%,AFDN;SULF1;ROBO1;LDLRAD4;EPHA4;DPYSL3;CLIC4;FBLN1;IGFBP5;FOXO3;RECK;SLIT2;CLDN5;PODN;PTPRJ;MAGI2;SRGAP3;SRGAP2;SMAD7;CDH1;SCAI;ACVRL1;CYP1B1;RHOB;CCDC125;ADAM15;ZMYND8;FLCN
prerank,protein localization to plasma membrane (GO:0072659),-0.3231503206391739,-1.2327869182936557,0.09480122324159021,0.5914786664490214,1.0,28/129,12.07%,TSPAN5;AFDN;ROCK2;ATP1B3;TTC7B;ACTN2;DLG1;FYB1;BSG;EZR;FCHO2;RAB11A;LRP6;CDH1;EFR3B;RAMP2;GAS6;SMURF1;S100A10;EHD1;TNFRSF1A;KCNB1;C2CD5;FLOT2;SLMAP;RAB8A;PTCH1;F11R
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.32556544774951657,-1.231658463545394,0.11455108359133127,0.593731586636309,1.0,31/129,16.28%,RNF220;LRRK1;LGR4;EGFR;COL1A1;TBL1XR1;CAV1;FGFR2;SMURF2;USP47;RNF146;LRRK2;TNKS2;LYPD6;SFRP4;WNK1;USP8;CSNK1G2;USP34;PSME2;TGFB1;PSMB4;SFRP1;PSMB1;PSMD11;PSMD8;PPM1B;GSKIP;PSME3;HHEX;PLEKHA4
prerank,cellular response to cadmium ion (GO:0071276),-0.45681931584573765,-1.2311524042440871,0.18108651911468812,0.5941270639284671,1.0,12/24,20.00%,EGFR;AKT1;MAPK3;MT3;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H
prerank,synaptic membrane adhesion (GO:0099560),0.5626619002739062,1.231005542068341,0.27310924369747897,0.7466758789044134,1.0,4/14,12.83%,LRRC4C;LRFN5;SLITRK1;SLITRK2
prerank,regulation of tube diameter (GO:0035296),0.5759349591796588,1.230837460180716,0.25386313465783666,0.744342447370087,1.0,3/13,3.95%,ACE2;ROCK1;ADCY6
prerank,vascular process in circulatory system (GO:0003018),0.5759349591796588,1.230837460180716,0.25386313465783666,0.744342447370087,1.0,3/13,3.95%,ACE2;ROCK1;ADCY6
prerank,glucan catabolic process (GO:0009251),-0.4928036932229364,-1.2302998788953792,0.2003780718336484,0.5955118760990004,1.0,7/15,26.97%,PHKB;PHKA2;PYGB;CALM1;GAA;PHKA1;PYGL
prerank,regulation of cellular component movement (GO:0051270),-0.3820868776069283,-1.2298509873323678,0.18095238095238095,0.5957504837927761,1.0,12/49,7.41%,TGFBR3;EGFR;ROCK2;PDPN;SP100;DIAPH1;ARHGAP18;TGFBR1;CD9;ARAP1;RHOA;RPS19
prerank,response to cadmium ion (GO:0046686),-0.4434064955863807,-1.2295467652514256,0.17,0.5957147274646827,1.0,12/26,20.00%,EGFR;AKT1;MAPK3;MT3;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H
prerank,cellular response to virus (GO:0098586),-0.4289334015855064,-1.22954021459005,0.19290465631929046,0.5947982273823283,1.0,8/30,10.79%,GSDME;LGALS9;MAPK14;LGALS8;IRGM;HIF1A;ZC3H12A;EIF5A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4316481743481435,1.2294386876583707,0.19800332778702162,0.746573386645161,1.0,7/67,3.88%,CARMIL1;UTRN;LIMS1;ECM2;CDK6;FERMT2;RAC3
prerank,response to peptide hormone (GO:0043434),-0.3938937811499655,-1.2293059441902838,0.1554054054054054,0.5945437637437706,1.0,10/43,9.53%,TGFBR3;ROCK2;IGFBP5;CAV1;ANXA1;STAT2;STAT1;STAT3;AKT1;TRIM16
prerank,camera-type eye morphogenesis (GO:0048593),0.5806383879839505,1.2290778367764015,0.27391304347826084,0.7461652771038413,1.0,2/10,2.17%,TBX2;NF1
prerank,regulation of lipid kinase activity (GO:0043550),0.5801427592543564,1.2286064512614145,0.2660753880266075,0.7459798202150015,1.0,3/11,11.68%,PIK3R1;RBL1;RB1
prerank,regulation of intracellular signal transduction (GO:1902531),0.34589753406687546,1.2285612610730912,0.0936374549819928,0.7447125319746615,1.0,75/420,12.41%,DLC1;STARD8;CHN1;PIP5K1B;PTEN;ARHGEF17;ARHGAP21;ARHGAP10;KALRN;PLEKHG2;PRDM1;ARHGAP6;ARHGAP32;PHLPP1;ARHGEF6;LBH;ARHGAP1;PRKAR1B;SPRED1;IL1B;PTPN22;PIP4K2A;STARD13;ARAP2;RAC3;TRAF5;AKAP6;MINK1;RIT2;SYDE1;PEX5L;ROS1;PIP4K2C;NTRK2;PRKAR2B;ARHGEF12;TAOK3;ARHGEF26;SOS2;SLC15A2;TRAF3;PAK6;RAD1;STK3;ARHGDIB;MTOR;PRKAR2A;AKAP12;GNA12;ANKRD54;MAP4K4;PRKD2;ARHGEF9;LYN;ARHGAP35;PAK5;INPP5B;AKAP7;ATR;PRKAR1A;TBP;TAF6;DDIT4;KAT6A;ARHGEF7;PAK3;HIPK1;NUAK1;PAK1;EP300;ARHGEF4;WWC1;TTI1;ARHGAP9;ARHGAP26
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3897032203748479,-1.2281163868860294,0.17857142857142858,0.5970221773751956,1.0,17/45,27.56%,APP;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;P2RX7;GBP5;TLR4;TYROBP;LPL;CCL19;EGR1;MYD88;PYDC1;FZD5
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5723791256873032,1.2278851529735713,0.2532188841201717,0.7450282320654074,1.0,7/11,26.81%,MSH3;TIMELESS;BLM;FBXO5;TIPIN;FBH1;SMARCAL1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3816891008133931,-1.22750948731564,0.15714285714285714,0.5977167317806584,1.0,18/51,27.56%,APP;IL16;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;P2RX7;GBP5;TLR4;TYROBP;LPL;CCL19;EGR1;MYD88;PYDC1;FZD5
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.447563720061883,-1.2272282753394352,0.2101010101010101,0.5975894397494407,1.0,8/26,8.76%,PLCB1;EGFR;ANXA1;ADAMTS1;CCND2;CCND3;UBE2E2;AKT1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.4425713999713575,-1.2269163402267584,0.1903765690376569,0.597514671269253,1.0,5/28,2.82%,EPHA4;APOE;APP;SHANK3;ADCY1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.389420521905513,-1.226854983957812,0.16930022573363432,0.596761783317936,1.0,15/47,19.01%,APOE;FOXO3;APP;KLF4;CSF1;AKT1;ATXN2;VPS35;TGFB1;TCOF1;RPL10;GEMIN5;NFKBIA;AGT;AGTR1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5710036049742496,1.2266520046610927,0.2673913043478261,0.7467211305944528,1.0,4/10,10.39%,DGKH;GAP43;PRKD3;DGKD
prerank,wound healing (GO:0042060),-0.3664896386288245,-1.2265846951038506,0.163727959697733,0.5965759326870619,1.0,15/62,11.21%,IGF1;COL3A1;SMAD3;MYOF;PDGFRA;MACF1;TGFBR1;PLEC;CFLAR;FGF1;WNT5A;PRCP;FZD7;PPL;ITGB3
prerank,epithelium development (GO:0060429),-0.3344279416564938,-1.2265131172806658,0.07887323943661972,0.5958250934143509,1.0,27/107,16.16%,ALDH1A2;ERRFI1;WNT4;OSR1;ANXA4;FGFR2;MEOX2;CPT1A;CD34;SMO;RCN3;CNN3;SIX1;STAT1;TBX1;CTSB;KDR;ANXA7;TGFB1;PTCH1;GATA6;MFSD2A;SOX17;BDH2;PKD1;CASP6;SOX18
prerank,regulation of T cell proliferation (GO:0042129),0.42879532949172916,1.2265089828103901,0.1955403087478559,0.7456870877806465,1.0,5/61,2.84%,GLMN;TNFRSF21;NCK2;IL1B;CD46
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.41568024130402886,-1.2260695423989316,0.18461538461538463,0.5961213350547534,1.0,15/36,27.22%,SGMS1;TGFBR1;DEPTOR;NR4A2;DAB2IP;TRIM39;QARS1;PPIA;MAZ;TMBIM6;TPD52L1;RPS3;FAS;CRADD;DAPK2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.46237133963802896,1.2257622060604942,0.21415607985480944,0.7461275441345365,1.0,10/39,10.61%,GCNT2;NOTCH1;AJAP1;SPRY4;CORO2B;ACTN4;AP1AR;MAP4K4;JAG1;SPOCK1
prerank,excitatory postsynaptic potential (GO:0060079),0.5295857100185536,1.2257199194612984,0.24421052631578946,0.7448633653438372,1.0,3/19,3.41%,MEF2C;MPP2;CHRNA3
prerank,defense response to virus (GO:0051607),0.40541779324754246,1.2256936843753725,0.20222929936305734,0.7435908188783692,1.0,1/100,0.01%,ABCC9
prerank,positive regulation of gene expression (GO:0010628),-0.2820751970013013,-1.2253326874683723,0.02666666666666667,0.5972029085523106,1.0,93/442,13.39%,BMP6;AFDN;IGF1;ROBO1;SLC24A3;FN1;SMAD3;EGFR;SAMD4A;CDH5;ROCK2;NTRK3;GSN;CTSH;OCLN;BMP7;OSR1;APP;IL15;F3;WNT6;VIM;CLDN5;ITGB8;NOS3;THBS1;BMP4;GJA1;EZR;TGFBR1;FOXD1;ANGPT1;LARP4B;KLF4;DDX5;KAT2B;CSF1;LEF1;RAMP2;NIBAN1;CD34;HOXA5;SMO;MED26;GAS6;RBM20;AR;FGF1;RAB27A;LGALS9;YAP1;MOV10;SFRP4;WNT5A;MAPK14;STAT3;HINFP;RPS4X;BAZ1B;TFRC;ACTG1;DTNBP1;POLR2A;PIK3CB;C1QTNF3;NOS1AP;AKT1;HGS;UPF3A;IL33;HIF1A;TLE1;EMILIN1;SEC16B;ZC3H12A;P2RX7;GATA2;VPS35;RPL11;ERN1;TGFB1;FGFR4;EPHX2;TMEM119;EPHB2;CPEB3;ID2;POLR2F;ATM;PRKAB1;WNT16;RPL26;PLCG2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5454710773739313,-1.2244928606866161,0.24647887323943662,0.5985772638874014,1.0,7/11,27.84%,GSN;LGALS9;PARK7;PLAUR;PIH1D1;FAS;PRR7
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5032919828988154,-1.2238134469128985,0.22287968441814596,0.5995503255232029,1.0,3/14,11.54%,DDX60;USP15;PUM1
prerank,cristae formation (GO:0042407),-0.4354000020066066,-1.2237399510196836,0.21370967741935484,0.5988126962804219,1.0,10/27,16.08%,ATP5PF;DMAC2L;SPG7;APOOL;CHCHD6;MICOS13;ATP5MF;ATP5MC3;ATP5MC1;AFG3L2
prerank,positive regulation of cell division (GO:0051781),-0.40052402646501345,-1.2233523311998546,0.19724770642201836,0.5990421163419538,1.0,8/38,10.29%,PKP4;FGFR2;CDC14A;FGF1;PRKCE;RHOA;SVIL;SPAST
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.4513742732492443,-1.2229342972505486,0.1958174904942966,0.5992913672796284,1.0,3/23,3.49%,ERRFI1;CAV1;SNX6
prerank,heart trabecula morphogenesis (GO:0061384),-0.47452312049485373,-1.222804583291244,0.20081135902636918,0.5987198123750278,1.0,7/18,7.22%,TGFBR3;BMP7;TEK;ADGRG6;RBP4;TGFBR1;FKBP1A
prerank,organic substance transport (GO:0071702),-0.32175175583680804,-1.2226379450858953,0.09705882352941177,0.5982608784651599,1.0,26/120,13.16%,ABCA1;SLC47A1;SLCO2B1;PLTP;SLCO2A1;CALCRL;ABCG2;ABCA9;RAMP2;SLC22A6;RCN3;TXNIP;SLC22A4;ABCA3;ABCA4;TOM1;CUBN;SPNS2;SLC50A1;SLC22A5;ARRDC1;DISP1;RAB7A;SLC35F3;ATP8A1;MFSD2A
prerank,positive regulation of GTPase activity (GO:0043547),0.36818166092652743,1.2223288447364937,0.16124469589816123,0.7504650376884392,1.0,35/188,10.05%,ARHGAP42;RGS6;TBC1D1;LIMS1;DOCK10;RAPGEF2;RASGRP2;FERMT2;SIPA1;NF1;PLXNB1;SH3BP1;GRTP1;GARNL3;AGRN;TBC1D30;SLC27A4;SYDE1;MAPRE2;ITGB1;TBC1D12;RIC1;ARHGEF26;RAP1A;RUNDC1;HRAS;RGS7;RALGAPA1;TBC1D2B;RAB11FIP2;MTSS2;MAP4K4;TBC1D10C;EPHA2;RGS10
prerank,DNA conformation change (GO:0071103),-0.4828218731796525,-1.2221847432891084,0.20267686424474188,0.5986294061835538,1.0,10/17,31.61%,TOP2B;HHEX;HMGB2;TOP3A;TOP2A;HAT1;ERCC3;ABL1;TOP1;NAA10
prerank,alpha-amino acid catabolic process (GO:1901606),-0.4216051640769822,-1.221832365314645,0.19556451612903225,0.5986617881838684,1.0,14/29,36.32%,DDO;ALDH4A1;PRODH;CBS;HOGA1;KYNU;MTRR;BLMH;FAH;ACADSB;HGD;IL4I1;HAAO;HSD17B10
prerank,glycine transport (GO:0015816),-0.5439328535701834,-1.2214795413145014,0.2536764705882353,0.5987484097253872,1.0,4/10,20.15%,SLC6A9;SLC25A38;SLC38A5;SLC36A1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.46904415631791596,1.2212721772184716,0.23731884057971014,0.7517188703582073,1.0,6/40,7.16%,PDGFRB;EDNRA;ARHGAP6;FGF2;NTRK2;HRAS
prerank,actin filament polymerization (GO:0030041),0.4960636318225028,1.2212222902780203,0.23076923076923078,0.7505116447270732,1.0,6/29,3.93%,ARHGAP6;WASF3;WAS;CORO7;SPIRE1;WASL
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.5595417558606242,1.220477425433031,0.2647702407002188,0.751083221591516,1.0,6/15,17.44%,BCAR1;SORT1;NTRK2;DDIT4;SOS1;HAP1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3563448780011444,-1.2200684808151891,0.14393939393939395,0.6016136670203525,1.0,22/67,14.90%,EPHA4;EPHA3;EGFR;FLT1;EFEMP1;PDGFRA;TEK;IL15;FGFR2;IGF1R;GHR;DDR1;PTK2B;KIT;BMX;KDR;FGFR4;EPHB2;FLT4;FER;MAPK3;PKDCC
prerank,cartilage development (GO:0051216),-0.38389037709266666,-1.2196432723667907,0.1607565011820331,0.601847923397701,1.0,10/49,5.48%,NFIB;SULF1;ZBTB16;OSR1;ITGB8;BMP4;CREB3L2;SLC39A14;CCN3;SULF2
prerank,peptidyl-methionine modification (GO:0018206),0.567946095192092,1.2192803077269974,0.2611464968152866,0.7527764354770106,1.0,4/12,18.38%,METAP2;NAA30;NAA15;METAP1
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3500284395335758,-1.2184209076526193,0.15,0.6042468253533652,1.0,16/79,10.55%,IGF1;CHST11;ST3GAL4;LARGE1;ST3GAL6;BMPR2;ST3GAL2;CSGALNACT1;ST3GAL3;GOLPH3;MGAT1;ST6GALNAC2;FOXL1;B3GALNT1;SERP2;ST8SIA2
prerank,glycoprotein metabolic process (GO:0009100),-0.38084690485571465,-1.2181953689453389,0.15625,0.603951493928616,1.0,20/53,20.12%,ST3GAL4;LARGE1;MAN1C1;ADAMTS9;ST3GAL2;MAN2A1;ST6GALNAC3;STT3B;GOLPH3;FUT8;HIF1A;ST8SIA2;ST6GALNAC6;GCNT1;GANAB;MANBA;PARK7;GAL3ST2;NGLY1;ST8SIA5
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.49244461697544273,-1.2176901545930345,0.24394785847299813,0.604457555411293,1.0,4/15,8.37%,DAB2;BMP2K;SCYL2;PIK3CB
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5270806666473512,-1.2170828595410577,0.24765478424015008,0.6053272486122075,1.0,6/11,25.65%,HIF1A;PARK7;NONO;NR4A3;RACK1;PRKN
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.45503910140660087,-1.2169153482844077,0.218,0.604000382279291,1.0,6/20,15.20%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2;AKR1A1
prerank,glutathione derivative metabolic process (GO:1901685),-0.45503910140660087,-1.2169153482844077,0.218,0.604000382279291,1.0,6/20,15.20%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2;AKR1A1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.2579457412126002,-1.2168560587875155,0.0,0.6032469561806734,1.0,373/1668,18.25%,NFIB;AUTS2;BMP6;TSHZ2;FOXP2;PRDM6;IGF1;DAB2;ZMIZ1;PBX1;PKNOX2;MAF;AEBP1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;SMAD6;DCN;NFAT5;KDM7A;FOXP1;ZKSCAN2;WWOX;HDAC4;GLI2;CUX1;FHL2;TBL1XR1;NFIX;WWC2;CREB5;ZFHX4;CDK8;RHOQ;LCOR;SP100;TGFA;GLIS3;HOXB6;IKZF2;ELF2;FOXO1;PBX3;APOE;OSR1;KLF3;SKIL;FOXO3;APP;ZIC2;NFIA;NR3C1;DLG1;HDAC8;KAT6B;HIVEP3;CAV1;ANXA4;ERG;ITGA6;HOXB3;RARB;MLXIP;SUFU;ESR1;FGFR2;ZIC5;BMPR2;SMURF2;VGLL3;ELF1;BMP4;MAFG;ELF4;MEOX2;ZBTB7C;EZR;PRRX2;RPS14;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;DDX5;KAT2B;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;MRTFB;LRP6;ARHGEF2;NFATC1;SMAD7;LEF1;ACVR1;KLF2;ETV6;TAF1;ID1;HDAC9;SBNO2;THRB;MXI1;HOXA5;ZHX3;CREB3L2;SKI;ZNF23;SP140;PCGF5;SDCBP;ZFPM2;PARP9;DCAF6;IGF2;GATAD2A;HDGFL3;MED26;SSBP2;ARRB1;HOXA3;ZNF697;GTF2IRD1;TEAD4;ARNT2;WWP2;AR;FGF1;BRD7;RARG;CREM;YAP1;STAT2;FOXP4;TMF1;HIF3A;PRRX1;MOV10;GLIS2;SOX13;THRAP3;BHLHE40;KMT5A;ACVRL1;ATXN1;IRF1;TEAD1;MIDEAS;SIX1;WNT5A;BAZ1A;ATN1;INO80;ZNF292;PRKCB;HLF;KDM5B;HOXC6;TET3;PRDM16;MAPK14;ID3;FOXC1;IRF2;GLIS1;LMO2;CHD3;HIVEP1;STAT1;FNIP1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;NAMPT;IFRD1;PGR;IFI27;BAZ1B;KLF10;ZNF219;TBX1;RTF1;SSBP3;ZBTB8A;TFCP2;IRF9;ZBTB18;FIZ1;BAZ2B;BBS7;KIT;FOXL1;LHX6;RREB1;IL33;HIF1A;TADA1;TNFRSF1A;MKX;RCOR3;TWIST2;TADA2A;NLRC5;FOXK1;CDH13;NR4A2;FLCN;ATF6;BHLHE41;FOSL2;PHF10;IKZF1;DAB2IP;HOXB9;TFCP2L1;IL18;ZC3H12A;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;FHOD1;ZFHX2;EIF5A;KLF12;TRIM27;SIX5;MAVS;MDFI;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;KDM3A;GLI3;FOXQ1;TGFB1;NSD1;ELK3;MED27;PTCH1;ZMYM5;BCL9L;AHR;HDAC1;LRRFIP1;ZSCAN22;ATXN7L3;MDM2;ZIC3;RELA;CPEB3;PPARA;CHD2;ID2;MEF2A;USF1;ZNF462;ATM;GATA6;CCN1;CBX4;SP110;UBB;CALR;ATOH8;ZGPAT;PPID;CLOCK;LPIN3;MET;MEIS2;ZNF585A;ZNF585B;EZH1;CCND1;MPND;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;TOX4;RPL10;CREB3L1;SMARCC1;ENO1;SLTM;POU2F1;MAZ;ZBTB4;MAPK3;HOXC4;TTC21B;PKD1;HOXB5;CDK9;HOXB7;HIPK2;PCGF3;BEND3;NKX6-1;SNAI1;ZFPM1;CREB3;YEATS2;JUND;RPL23;SREBF1;SERPINE1;BMPR1A;NOS1;NKRF;CEBPZ;HHEX;MEIS1;HMGB2;SOX18;KDM6B;PHF21A;HCFC2;MNT;TLR4;RNASEL;USF2;ZMIZ2;ZFP69;TNRC6A;ZNF436;SIRT7;JUNB;SIRT2;ATF1;TSHZ1;MED21;RIPK1;FBXL19;PTOV1;NFIL3;PSIP1;RAI1;TPR;SLC9A1;NFKBIA;NFYB;ZFP14;CSRNP3;NPAS2;MAFF;SOX12;NR6A1;CC2D1A;CEBPB;KLF15;PARK7;CIR1;ELP3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5993344423031133,1.216740180587791,0.2780373831775701,0.7576318046399245,1.0,2/10,1.19%,FAP;NOTCH1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5295273495985882,1.2167191856600097,0.23890063424947147,0.7563459752192739,1.0,3/18,5.53%,ITGA4;ROCK1;ITGB1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5142361610620749,-1.215982490402184,0.22563176895306858,0.6047271306312517,1.0,7/13,34.64%,ENPP1;SULT1A1;TPST1;TPST2;SULT4A1;ABHD14B;SULT2B1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.3847044047952848,-1.215957306581491,0.18064516129032257,0.6038997108455355,1.0,14/43,22.82%,IGF1;LBP;CD34;GAS6;LGALS9;IRAK3;ZC3H12A;TRIM27;SIRPA;TLR4;DICER1;CD274;RARA;PTPN6
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.4377920168127261,-1.2157616323544924,0.2405857740585774,0.6035183626053826,1.0,8/26,19.04%,IGF1;FHL2;LMCD1;PLCG2;HOMER3;SLC9A1;EFHB;CHP1
prerank,detection of visible light (GO:0009584),-0.4673089566229989,-1.215713897361012,0.22960151802656548,0.6027468255723821,1.0,5/16,26.06%,ABCA4;RP1;CACNA2D4;TULP1;GNAQ
prerank,epidermal cell differentiation (GO:0009913),-0.3914986554929419,-1.2155795339071196,0.20175438596491227,0.6022186776789614,1.0,15/41,25.94%,CLIC4;ANXA1;ADAM9;WNT5A;TXNIP;HDAC1;GATA6;WNT16;UGCG;GLI1;DSP;ERCC2;USH2A;ERCC3;CTNNB1
prerank,regulation of mitochondrial translation (GO:0070129),0.5194613312761427,1.2155163809026868,0.2608695652173913,0.7580622079467184,1.0,11/21,21.14%,FASTKD2;MRPS27;NSUN3;MALSU1;FASTKD3;MTG2;TRMT10C;RMND1;C1QBP;ALKBH1;TSFM
prerank,limb development (GO:0060173),-0.42695854322196547,-1.2153288215430909,0.19157894736842104,0.6020307912971624,1.0,9/28,11.87%,SMOC1;CHD7;PCSK5;KAT2B;RSPO2;INTU;ZNRF3;GLI3;PTCH1
prerank,glucose import (GO:0046323),0.5511987578249405,1.2150212810648533,0.2662337662337662,0.7579754548211113,1.0,4/13,8.29%,SLC5A1;SORT1;SLC27A4;SLC2A3
prerank,protein deacetylation (GO:0006476),-0.3970959578026008,-1.2146697834122173,0.19130434782608696,0.6028845641342225,1.0,14/41,21.43%,HDAC4;TBL1XR1;HDAC7;HDAC9;MIDEAS;RCOR3;PRDM5;HDAC1;HDAC5;SIRT7;SIRT2;SIRT3;MORF4L2;SIN3A
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.4182494896807873,-1.2145714139176427,0.2024793388429752,0.6022625457946036,1.0,11/33,13.57%,PLCB1;EGFR;ANXA1;ADAMTS1;CCND2;STXBP4;CCND3;UBE2E2;AKT1;PLCG2;CCND1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.43174112177030477,1.21421855134562,0.2170940170940171,0.758705621868362,1.0,17/60,15.03%,PTEN;HEY2;MECP2;MED10;MED13;AGO3;CDKN1A;CCNC;RUNX2;MED1;TNRC6C;MED20;TNRC6B;MED4;ATF7IP;DHX36;MED6
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.36299882323413246,-1.214077399803929,0.1566265060240964,0.6026853506380354,1.0,10/59,5.06%,SDK1;ROBO1;HMCN1;PECAM1;BSG;PTPRM;MPZL2;CDH1;SDK2;PALLD
prerank,positive regulation of protein binding (GO:0032092),-0.36410008153337914,-1.2139855783475455,0.15776699029126215,0.6020390534478975,1.0,20/56,15.72%,APOE;APP;CAV1;CLDN5;BMP4;B2M;TCF7L2;LRRK2;TAF1;FKBP1A;AMFR;TIAM1;DTX3L;IDE;RPL11;ADD1;RAN;PKD1;HIPK2;HFE
prerank,regulation of actin filament depolymerization (GO:0030834),0.5615121142773054,1.2139032012445947,0.2558139534883721,0.7581026108032192,1.0,3/12,3.34%,SEMA5A;PIK3CA;SH3BP1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5210130110237151,-1.213830976482583,0.25092250922509224,0.6015644080918248,1.0,8/12,39.18%,RAB27A;CYBA;PLCG2;TLR4;CD36;TLR6;ZNF205;SLC5A3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4308434696997002,-1.2132936177078368,0.20833333333333334,0.6021213148707883,1.0,10/26,24.17%,PRKAG2;ADIPOR2;LPGAT1;ACADL;PRKAA2;CEACAM1;ERLIN2;ADIPOR1;SLC45A3;BRCA1
prerank,negative regulation of protein processing (GO:0010955),-0.5204206020258517,-1.213268261371984,0.21973929236499068,0.6012995842149056,1.0,6/12,19.73%,THBS1;GAS1;LRRK2;SERPINE1;TMEM59;SERPINE2
prerank,calcium ion import across plasma membrane (GO:0098703),0.5568610249410655,1.21294603920338,0.2698744769874477,0.7592146651822081,1.0,3/14,4.64%,TRPV2;CACNA2D1;SLC24A2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5122142663858917,1.212613134386081,0.26993865030674846,0.7587250881350132,1.0,5/19,8.96%,PLCE1;INPP5A;PPP3CA;GPR62;NFATC4
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.4295020613568432,-1.2119768578140944,0.1910828025477707,0.6038865453348822,1.0,13/27,30.68%,NFAT5;RHOA;CD47;RELA;SIRPA;CYRIB;MDK;NR4A3;ITGB2;CD44;HAS2;CCR2;CCL2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.4320247357538183,-1.2114016348104455,0.20766129032258066,0.6045441013161232,1.0,7/25,20.49%,APP;RIN3;SDCBP;ATXN2;ITGB3;NEU3;ANKRD13D
prerank,positive regulation of macrophage migration (GO:1905523),0.525479575877227,1.211271194161837,0.26810176125244617,0.7607439351397649,1.0,2/19,1.34%,IL34;PTK2
prerank,central nervous system neuron differentiation (GO:0021953),0.4574184042062458,1.2111322737583015,0.25274725274725274,0.7597274217756058,1.0,10/33,12.91%,MAP2;ATP7A;CEND1;RYK;NTRK2;SOX4;MDGA2;TOX;SPOCK1;ZC4H2
prerank,negative regulation of anoikis (GO:2000811),0.527454726601891,1.2108094297884269,0.2838427947598253,0.7591845053030772,1.0,6/14,12.53%,NOTCH1;PTK2;PIK3CA;ITGB1;SNAI2;SRC
prerank,response to lipid (GO:0033993),-0.3265864379745842,-1.2104476597686167,0.11911357340720222,0.6063972817248209,1.0,32/105,16.83%,SMAD6;FOXP1;CTSH;FOXO1;FOXO3;LBP;RBP4;ESR1;NOS3;ANXA1;SOCS2;ACER2;RARG;LGALS9;ALPL;STAT3;NOCT;TRIM16;IRAK3;TGFB1;GCH1;FGFR4;PPARA;GATA6;TNFRSF11A;SPP1;FER;MAPKAPK3;NOS1;HMGB2;TLR4;PELI1
prerank,regulation of cell population proliferation (GO:0042127),0.3271903691912201,1.2099888083940207,0.09121245828698554,0.7598863227324515,1.0,63/691,7.20%,DLC1;PTPRK;ITGA1;PDGFRB;ACE2;PTEN;TBX2;IL34;S1PR3;LIMS1;GLMN;RERG;CBFA2T3;IGFBP7;RAPGEF2;GCNT2;CDK6;BMP5;NOTCH1;COL4A3;SLC25A33;PTK2;NCK2;RGCC;CCN6;GPER1;FRK;TBX3;TNS2;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;CADM4;TBX6;ETS1;MECP2;SH2B3;MYO16;PDCD10;FGF2;SPDYA;RPS6KA2;GAS8;TSPAN31;FABP3;TNFRSF8;TFAP2B;CXCR2;CXCL10;NTRK2;NUPR2;IL4;CXCL5;AGO3;SOX4;CHRNA7;EMP2;CDCA7;HRAS;IRS1
prerank,regulation of neutrophil migration (GO:1902622),0.5673516377732346,1.2084269361514983,0.25877192982456143,0.7624999208084058,1.0,1/10,1.44%,JAM3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.5104897347880444,-1.2082766066203772,0.23540489642184556,0.61040226013245,1.0,3/12,19.04%,FHL2;HOMER3;CHP1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.5104897347880444,-1.2082766066203772,0.23540489642184556,0.61040226013245,1.0,3/12,19.04%,FHL2;HOMER3;CHP1
prerank,fatty acid elongation (GO:0030497),-0.5164696201305231,-1.208274974651757,0.23540856031128404,0.6095202715117432,1.0,3/13,5.61%,ELOVL7;HACD4;HACD3
prerank,atrial septum development (GO:0003283),0.5450814205943404,1.2081953262086256,0.26521739130434785,0.7617548458441394,1.0,2/13,1.22%,HEY2;TBX20
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.33925300678356984,-1.2081717011236568,0.13550135501355012,0.6089157222229451,1.0,24/88,20.55%,DAPK1;SAMD4A;IGFBP5;APOE;CNOT7;RNF139;DDX6;CST3;IGF2BP2;ATRAID;AKT1;DAB2IP;CPEB3;CALR;LARP1;CNOT8;RGP1;FXR2;CLN8;PAIP2B;EIF4E2;TYMS;SERPINE2;CDK5RAP3
prerank,positive regulation of viral genome replication (GO:0045070),-0.4140282738899573,-1.2077037172720455,0.17647058823529413,0.6092809039601114,1.0,13/29,25.11%,CNOT7;HACD3;TOP2B;IFIT1;PPARA;PPID;LARP1;PPIA;DDB1;SRPK1;NR5A2;TOP2A;SRPK2
prerank,peroxisome organization (GO:0007031),0.4845842914768933,1.2076887861046566,0.26003824091778205,0.7617476084221149,1.0,9/25,15.58%,ABCD2;PEX7;PEX1;TMEM135;MFF;PEX3;PEX19;LONP2;PEX12
prerank,peptide biosynthetic process (GO:0043043),-0.3117777627889807,-1.2073339782224246,0.09771986970684039,0.6094228450814344,1.0,63/153,19.07%,PCSK5;RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;SRBD1;RPS4X;RPS11;RPL13;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;MRPS7;MRPS6;SARS1;RPL10;MRPS18A;RPL7;MRPL52;RPL10A;MRPL24;HARS1;RPL22;RPS15;RPS6;CARNS1;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;GGT7
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4710855314658923,1.206220499544517,0.2636363636363636,0.7641292594776209,1.0,4/31,1.19%,LIMD1;RORB;CDK6;NOTCH1
prerank,post-translational protein modification (GO:0043687),-0.2817572267649271,-1.2061933124398012,0.07373271889400922,0.6116955324882734,1.0,98/332,21.65%,FBXL7;FBN1;FN1;FSTL1;ZBTB16;IGFBP5;APOE;APP;CP;BMP4;FBXO10;RAB11A;ITIH2;PTP4A2;CSF1;STT3A;ASB2;SOCS2;SPSB1;IGFBP4;RBBP7;ADAM10;IGFBP3;DCAF6;GAS6;HIF3A;VWA1;P4HB;SERPIND1;TNC;KLHL2;CALU;STT3B;CST3;MSLN;OBSL1;DCAF11;GOLM1;HIF1A;RAB2A;NOTUM;PRSS23;ASB7;MXRA8;KLHL5;PSME2;CUL4A;ASB5;RAB8A;CKAP4;COPS4;PSMB4;CCN1;FBXW11;COPS8;SPP1;ELOB;F5;LTBP1;PSMB1;PSMD11;NEDD8;DDB1;PSMD8;SCG3;NEURL2;RCN1;UBA3;FBXL14;SUMF2;DNAJC3;PSME3;APLP2;PDIA6;ASB1;DCAF4;CCDC8;FBXL19;SPSB4;SPSB2;QSOX1;PSMD4;DCAF8;UBE2M;HSP90B1;PSMA2;FBXO41;ASB6;LGALS1;PSMD3;FAM20C;PSMB7;WSB2;CISH;FSTL3;GAN;ELOC;CUL5
prerank,negative regulation of peptidase activity (GO:0010466),0.4474105923185148,1.2061083884583186,0.25618374558303886,0.7630850107125183,1.0,3/47,1.03%,SERPINI1;SERPINB8;VTN
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.47408025726103764,1.2059045831982347,0.2621359223300971,0.7622400509834519,1.0,9/33,11.85%,PTEN;CDK6;MYO16;CDKN1A;PKD2;KANK2;RBL1;RB1;APC
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4522698079311426,-1.2058846375490986,0.23221757322175732,0.6116767172582083,1.0,6/20,18.53%,IGF1;NIBAN2;FOXC1;TGFB1;PARK7;LAMTOR5
prerank,protein localization to nucleus (GO:0034504),-0.32819886519940367,-1.205876872692856,0.14326647564469913,0.610819902818914,1.0,40/102,31.14%,COL1A1;BMP7;BMP4;APPL2;SIX1;STAT3;AKT1;PINX1;TOR1AIP1;PML;RPL11;IPO7;FAM53C;IPO13;MDM2;RAN;CALR;GBP2;HHEX;NXT2;IPO8;TPR;NUP88;SYK;NUP214;NXT1;YWHAE;RRS1;NUP155;RANBP17;MSX1;EIF4ENIF1;MORC3;CSE1L;NUP62;PTTG1IP;TNPO2;WRN;PAF1;HEATR3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4190399144750035,1.205854533134158,0.210016155088853,0.7610585282251577,1.0,9/60,11.67%,PDGFRB;RGCC;FGF2;TNKS;PARM1;PRKD2;PDGFB;ATR;HNRNPA1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5466511812665573,1.2058316161163443,0.2631578947368421,0.7598052658387119,1.0,3/14,3.05%,PIK3CD;GAB1;PIK3CA
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4357953943165328,1.2057946418539205,0.2288135593220339,0.7585733257098651,1.0,15/59,15.83%,CYP7B1;OSBPL3;PER2;SLC27A2;BAAT;OSBPL6;LIPC;LIPH;SRR;GATM;OSBPL7;GAMT;HSD3B7;MLYCD;ACOX2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.5541636785637037,-1.2052664413797953,0.2344582593250444,0.6116731102841605,1.0,5/10,18.15%,DIP2B;FLCN;PRKAA2;KLF15;PARK7
prerank,anion transmembrane transport (GO:0098656),-0.350513282376117,-1.2047140229223832,0.17016317016317017,0.6123322605886768,1.0,19/67,16.03%,SLC13A4;SLC6A13;SLC13A3;SLC1A3;SLC7A2;SFXN2;SLC6A9;SLC7A5;SLC25A4;SLC5A6;SLC25A38;SLC38A5;SLC39A8;SLC35A2;SLC3A2;SLC25A19;SLC25A22;SLC7A1;ARL6IP5
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.4939575171694797,-1.2047129591073862,0.23540856031128404,0.6114556884310112,1.0,5/15,9.53%,PRKCH;BMP4;SFRP4;FOXC1;TRIM16
prerank,neural crest cell migration (GO:0001755),-0.39752754132039936,-1.2043150029239489,0.18398268398268397,0.6116380372591167,1.0,13/36,16.62%,FN1;NRP1;SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E;TBX1;SEMA3B;RADIL;CORO1C;SEMA3G;SEMA6B
prerank,regulation of lamellipodium organization (GO:1902743),0.5510170329631485,1.204177003968227,0.27405857740585776,0.7613722467955977,1.0,2/14,2.30%,CARMIL1;WAS
prerank,positive regulation of protein modification process (GO:0031401),-0.2968703260404308,-1.2030153438135494,0.09057971014492754,0.6142166172408853,1.0,55/203,14.53%,DAB2;TRABD2B;EGFR;LEPR;CDH5;ROCK2;NTRK3;TEK;PECAM1;APP;BMP4;ANGPT1;LRRK2;NIBAN1;VEGFD;VEGFC;LIMK2;IGF2;GAS6;ARRB1;FGF1;ACE;EFNA5;RAB3GAP1;CCND2;PTPA;CARD14;CALM2;FNIP1;CCND3;TFRC;TBX1;PRKCD;WDFY2;NOS1AP;AKT1;PPP1R16B;IRGM;FLCN;KDR;MAVS;ITGB3;TGFB1;TMEM119;FLT4;CCN1;CDK2AP1;CCND1;ATG10;TXN;NNMT;LIMCH1;PPIA;FXR2;MAPK3
prerank,cellular response to light stimulus (GO:0071482),0.42029911930277536,1.2029620535714307,0.2112,0.7631454508679263,1.0,15/66,17.98%,PTPRK;OPN1MW;OPN1MW3;CASP9;ERCC4;ATR;EP300;RRH;OPN3;PDE6A;DHX36;PARP1;FMR1;RHNO1;SAG
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.479511257019049,-1.2022861092477297,0.2543689320388349,0.615263775685916,1.0,1/16,0.08%,AUTS2
prerank,regulation of neuron projection arborization (GO:0150011),-0.4936649447761159,-1.2014036759790263,0.24907749077490776,0.6166436480776845,1.0,7/15,17.64%,MACF1;MOV10;WNT5A;MYO9A;FZD4;MFSD2A;MAP3K13
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.40027784127836896,-1.2012005476704841,0.20614035087719298,0.6162604403653098,1.0,13/37,27.01%,APOE;RIN3;SDCBP;ATXN2;OPTN;ITGB3;SIRT2;MT3;ANKRD13D;BRCA1;ANKRD13A;PRKN;EDNRB
prerank,cellular response to amyloid-beta (GO:1904646),-0.39797453342280187,-1.2011587399607782,0.2224622030237581,0.6154941596238618,1.0,9/35,6.55%,IGF1;EPHA4;APP;GJA1;IGF1R;SNX6;VCAM1;CASP4;ICAM1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.4954269493128143,1.200819921529917,0.25239005736137665,0.7670426677432607,1.0,3/27,2.02%,CSPG4;CHST3;CHST7
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5764011393436225,1.2004959702597986,0.2875536480686695,0.766489501464789,1.0,2/10,3.58%,PRKG1;SH2B3
prerank,glycogen catabolic process (GO:0005980),-0.48344608559041513,-1.2004701714554364,0.2528957528957529,0.6165192165738663,1.0,9/15,34.05%,PHKB;PHKA2;PYGB;CALM1;GAA;PHKA1;PYGL;RB1CC1;STBD1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4436249557322495,1.2003304476837788,0.2694300518134715,0.7655614535414543,1.0,9/47,10.61%,SERPINI1;SERPINB8;VTN;SERPINA10;BIN1;PCID2;SPOCK3;SERPINA2;SPOCK1
prerank,mitotic DNA replication (GO:1902969),0.5725102318152354,1.1999059976706714,0.30387931034482757,0.7652955739069734,1.0,4/10,10.99%,GINS1;GINS3;MCM6;MCM2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.46287998274406494,-1.1993980915152451,0.24158415841584158,0.6185507042370145,1.0,5/18,17.12%,HDAC7;EZR;CD34;TRIM27;HOMER3
prerank,gene expression (GO:0010467),-0.2832073096274225,-1.1991550860202127,0.06557377049180328,0.6183241046068145,1.0,126/348,26.69%,CELF2;TSPAN5;RBMS2;RPLP1;RPS14;THRB;RPL9;RPS12;ATXN1;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;SRBD1;RPS4X;GOLPH3;RPS11;POLR2A;RPL13;SMG6;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;NR4A2;MMS19;RPL37;NXF1;RPL11;RPS18;PWP1;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;POLR2F;NOVA1;MEF2A;RPL28;RPS24;RPS27;RPL14;RPL26;MRPS7;MRPS6;SARS1;RPL10;MRPS18A;RPL7;DTX1;MRPL52;DNAJB11;RPL10A;MRPL24;AGFG1;NUP98;HARS1;RPL22;RPS15;RPS6;RPL23;RPL17;HHEX;RPL31;RNASEL;SRSF2;SMG5;RPS25;POLR2E;SNRNP40;TPR;RPL15;RPSA;RPS7;SRSF6;RPL38;RPLP0;RPL27;E2F1;NUP88;THOC1;RRBP1;UPF2;RPL36A;MCM3AP;NUP214;THAP1;HNRNPL;DEDD2;RPS26;SRSF5;RPL35A;FIP1L1;NXT1;NUP37;THOC7;FARSB;RPS29;DHX8;RPL8;RPL36;POLR2G;MRPL35;ALKBH5;SRSF11;PPP5C;RPS3;RRAGC;HNRNPF;RPL13A;NUP155;EPC1;ABCF1;DDX54;ASMT;TSPAN33;MRPL34
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4961797365107482,1.1991450431633544,0.2729124236252546,0.7658716385358574,1.0,3/25,5.24%,ACE2;CNRIP1;SOCS5
prerank,O-glycan processing (GO:0016266),-0.36236475477387997,-1.1990943059060395,0.18181818181818182,0.6176194728695292,1.0,7/54,9.97%,GXYLT2;ST3GAL4;ST3GAL1;ST3GAL2;ST3GAL3;ST6GALNAC2;GALNT12
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.46485614545749177,-1.1990286812843611,0.25626204238921,0.6169057550325093,1.0,13/18,36.49%,AKT1;HIF1A;PPIA;PARK7;NONO;PRKN;BAG5;SOD2;HSPB1;PINK1;MAPK7;VNN1;NME5
prerank,regulation of signal transduction (GO:0009966),0.36000869036498423,1.1989587047575418,0.17721518987341772,0.7650438606978656,1.0,18/190,5.32%,RGS5;RGS4;RGS6;PLCE1;IGFBP7;RORA;NCK2;SEMA5A;RGS3;TSPAN15;CD46;GRK3;RGS11;IFT81;TSPAN12;SREBF2;SOCS5;OGT
prerank,triglyceride homeostasis (GO:0070328),0.48575630580330537,1.1989327937836218,0.25656565656565655,0.7638096980938005,1.0,4/26,6.95%,RORA;NR1H3;SCARB1;LIPC
prerank,B cell activation (GO:0042113),0.41698259726683784,1.1986631772070706,0.22549019607843138,0.763161353126355,1.0,3/68,0.77%,ITGA4;MEF2C;PIK3CD
prerank,activation of phospholipase C activity (GO:0007202),0.4828008753402082,1.1986283725281979,0.24329501915708812,0.7619497251577825,1.0,2/29,1.07%,EDNRA;ARHGAP6
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.49397001959902975,1.198436850765711,0.28169014084507044,0.761129645533127,1.0,9/25,18.55%,MEF2C;MPP2;CHRNA3;GRIN2B;NLGN3;INSYN2A;GRIN2A;GSK3B;GRID2
prerank,response to estradiol (GO:0032355),0.48247804749297457,1.198396902829637,0.26744186046511625,0.7599436737911144,1.0,4/31,3.88%,GGT5;GGT1;GPER1;NCOA3
prerank,cholesterol homeostasis (GO:0042632),0.41999583581484146,1.1983034887869077,0.22651006711409397,0.7588838794875281,1.0,9/64,6.95%,CYP7B1;RORA;NR1H3;SCARB1;LDLRAP1;LDLR;FABP3;ABCA5;LIPC
prerank,mucosal immune response (GO:0002385),0.5424080470547699,1.1980799581366264,0.281947261663286,0.7582010981842726,1.0,3/15,6.03%,FFAR2;CAMP;IL4
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.41505569718625546,-1.1977447847046567,0.2396039603960396,0.6194436351855523,1.0,8/29,15.72%,JAM2;CXCL12;GAS6;LGALS9;ANO6;CALR;CREB3;SERPINE1
prerank,negative regulation of bone remodeling (GO:0046851),-0.5335001398925706,-1.1976518163854262,0.25871559633027524,0.6188208995771735,1.0,5/11,22.12%,P2RX7;TMEM119;SFRP1;GPR137;UBASH3B
prerank,regulation of protein dephosphorylation (GO:0035304),0.46068531980347144,1.19753602959843,0.2633587786259542,0.7582497097674165,1.0,1/37,0.07%,DLC1
prerank,negative regulation of cellular process (GO:0048523),0.32783974810059757,1.1970896534011293,0.12055109070034443,0.757992000700816,1.0,49/521,6.56%,DLC1;PTPRK;ITGA1;PTEN;GLMN;RERG;CBFA2T3;APBB2;IGFBP7;RAPGEF2;TNFRSF21;CDK6;DYSF;BMP5;NOTCH1;COL4A3;NCK2;SEMA5A;RGCC;CCN6;GPER1;NR1H3;SLIT3;FRK;MYH9;TNS2;FERMT2;SIPA1;SPEF1;FOXM1;ERBB4;IL1B;PLXNB1;ETS1;CRLF3;SH2B3;MYO16;FGF2;RPS6KA2;BRINP1;GAS8;FABP3;TNFRSF8;TFAP2B;NUPR2;CBLL1;DDX3X;CAPRIN2;SOX4
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.48441301755603183,-1.197081311291443,0.2378167641325536,0.6194765459502621,1.0,3/15,6.23%,BMP4;SMO;SIX1
prerank,protein-containing complex assembly (GO:0065003),-0.28837354024014145,-1.1969366030762343,0.0603448275862069,0.6190097547360723,1.0,66/259,16.08%,AFDN;FBXL7;FN1;OCLN;TGFA;CD2AP;MCU;SEC23A;SEC24D;SLC2A1;SNX9;TCF7L2;TLE4;LRRK2;LEF1;CTSC;SEC31A;ADAM10;CXCL12;TAPBP;REPS2;TRAPPC10;YAP1;TEAD1;ANO6;SEC24A;PTK2B;PLEKHA7;TRRAP;TIAM1;PARD3;TLE2;TNFRSF1A;TLE1;CARD10;CASP8;USO1;SEC16B;GSDMD;ZC3H12A;COL16A1;PML;P2RX7;LMAN1;GPAA1;BCL9L;HDAC1;TRAPPC4;MDM2;TRAPPC3;PPID;SKAP2;SPG7;ZW10;ELOB;F5;GEMIN5;ANKRD28;MCFD2;CLDN1;PYGO2;CAPZA2;HFE;SEC23IP;NAPA;AFG3L2
prerank,regulation of B cell activation (GO:0050864),0.4927759309933733,1.196491375995309,0.2594059405940594,0.7581082213024541,1.0,3/25,6.03%,SH3KBP1;TNIP2;IL4
prerank,regulation of ion transport (GO:0043269),0.4115512913669472,1.1961924316389427,0.23667711598746083,0.7575045960760984,1.0,15/76,11.38%,KCNJ8;NEDD4L;KCNJ12;CLDN10;CHRNA3;NKAIN2;ANK3;SNCA;SIK1;STC1;PDZK1;SYT1;KCNJ3;KCNJ6;SYT2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5486676654371844,-1.1961522223839678,0.27052238805970147,0.6202935284156226,1.0,4/10,16.55%,NAMPT;IL33;KDR;TLR4
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.4897170013714003,-1.1961506572592466,0.26022304832713755,0.619423551517424,1.0,4/15,15.72%,SMAD7;IRAK3;TGFB1;HFE
prerank,epidermis development (GO:0008544),-0.3610424888291632,-1.196126265378961,0.1917808219178082,0.6186328069801561,1.0,20/56,23.46%,SVEP1;CCN2;FGFR2;EMP1;CRABP2;FLOT2;LAMA3;HDAC1;GATA6;ALDH3A2;PTHLH;UGCG;PLOD1;LAMC2;FABP5;EDA2R;KRTDAP;GLI1;EDAR;DSP
prerank,regulation of T cell mediated immunity (GO:0002709),0.582551665349339,1.196069753180043,0.29955947136563876,0.7564998072305605,1.0,2/10,2.62%,WAS;IL1B
prerank,heterocycle biosynthetic process (GO:0018130),-0.5006539088780662,-1.1959203815693389,0.26679841897233203,0.6183012724592104,1.0,9/14,40.49%,GCH1;PYCR2;NOXRED1;GPHN;PYCR1;MOCS2;ALOX5;NFS1;PYCR3
prerank,actin filament organization (GO:0007015),0.3732642547373719,1.195804671751001,0.18041958041958042,0.755896402477332,1.0,26/151,10.80%,MYO1B;EPS8;CARMIL1;MPRIP;BCAR1;RND3;WAS;CORO7;SH3BP1;ABI2;RAC3;SPIRE1;WASL;TMOD1;TMOD3;EMP2;PLS3;SPTA1;MYO6;CORO1A;MARCKS;ERMN;HIP1;LMOD1;ARPC4;GAS2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.48728083523277743,1.1955794554325543,0.26425855513307983,0.7551625482237291,1.0,8/28,7.20%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;PIP4K2C;IRS1
prerank,regulation of cytokinesis (GO:0032465),-0.3464959695955024,-1.1954079472137646,0.17647058823529413,0.6188911981496708,1.0,18/78,16.18%,PKP4;RAB11A;KIF13A;CDC14A;PRKCE;RHOA;PLK2;CALM2;ZFYVE19;BECN1;SVIL;FLCN;SPAST;SH3GLB1;GIT1;UVRAG;MYO19;CALM1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.4796390670424003,-1.1943205771354624,0.23905109489051096,0.6208341629070666,1.0,5/15,22.25%,OSBPL8;PPARA;PLIN2;OSBPL11;LPL
prerank,regulation of double-strand break repair (GO:2000779),0.44738455818991824,1.1942803691310577,0.2555147058823529,0.7571992040881891,1.0,12/39,17.61%,WAS;FOXM1;SPIRE1;FMN2;DEK;SLF2;TIMELESS;OTUB1;PPP4C;MRNIP;RPA2;DDX11
prerank,positive regulation of secretion by cell (GO:1903532),-0.3395586092599866,-1.194259381347915,0.1655011655011655,0.6201424874104878,1.0,20/70,15.91%,BMP6;IGF1;UNC13B;CD2AP;MYO18A;EZR;ADAM9;RAB27A;P2RX4;GOLPH3;DTNBP1;MYH10;KCNB1;STX1A;TGFB1;GRK2;PPID;PPIA;EDN3;SYTL4
prerank,phosphorylation (GO:0016310),0.33284903379992514,1.194179356842084,0.13447432762836187,0.7562090037143765,1.0,74/384,11.80%,DGKB;LIMD1;PRKG1;MAP3K20;PIK3CD;CDK6;DGKH;MAP3K5;SNRK;PEAK1;PKN1;FRK;DGKG;MARK1;PRKAR1B;HUNK;MERTK;NUAK2;ROCK1;AKT3;FNIP2;PIK3CA;LIMK1;RPS6KA4;GRK3;CDK15;CDC42BPA;STK39;STK38L;JAK1;MINK1;RYK;TESK2;TRIB2;ROS1;NEK1;TTBK1;TAOK3;SIK1;YWHAZ;PAK6;LMTK3;STK3;STK24;MTOR;GRK5;ACVR2B;MARK2;CSK;MAP4K4;XYLB;PRKD2;LYN;PDGFB;GK;CSNK1E;MAP4K1;BIRC6;PAK5;COQ8A;MAPK10;NEK6;GNPTG;DGKD;DYRK3;BRSK1;PAK3;HIPK1;BRAF;NUAK1;LATS2;PAK1;TEC;NLK
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4801414113009212,1.1939615808744877,0.2575452716297787,0.7554871622468998,1.0,4/27,4.25%,PDGFRB;PTK2;AGAP2;FGF2
prerank,regulation of protein kinase B signaling (GO:0051896),0.36603915458374037,1.193894935741172,0.17251051893408134,0.7543936600327544,1.0,20/193,5.97%,PDGFRB;PTEN;PIK3CD;GAB1;GCNT2;PHLPP1;PTK2;PIK3R1;SEMA5A;GPER1;FERMT2;ERBB4;NRG1;PIK3CA;SH2B3;AXL;FGF2;SPRY2;ITGB1;NTRK2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.2513924491481682,-1.193836984289379,0.0,0.6204114507426141,1.0,386/1646,19.36%,NFIB;TSHZ2;BNC2;FOXP2;IGF1;ZMIZ1;PBX1;PKNOX2;FOXN3;ZNF423;MAF;PLCB1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;SMAD6;COL1A1;EFEMP1;NFAT5;KDM7A;FOXP1;ZKSCAN2;WNT4;HDAC4;DENND4A;GLI2;CUX1;TBL1XR1;NFIX;WWC2;CREB5;IL31RA;CHD7;ZFHX4;BMP7;LCOR;SP100;TGFA;GLIS3;VGLL4;RBFOX2;DKK3;HOXB6;IKZF2;ELF2;FOXO1;PBX3;APOE;OSR1;KLF3;FOXO3;MDFIC;ZIC2;NFIA;NR3C1;KAT6B;HIVEP3;ANXA4;ERG;HOXB3;MLXIP;SUFU;ESR1;ZIC5;SMURF2;USP47;VGLL3;ELF1;BMP4;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;TGFBR1;SNX6;FOXD1;TBX15;KLF4;PLAGL1;DDX5;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;LRP6;NFATC1;SMAD7;CDH1;LEF1;ACVR1;FZD2;KLF2;ETV6;ID1;MLLT3;PDCD4;HDAC9;SBNO2;MXI1;RGMB;HOXA5;ZHX3;CREB3L2;ZNF23;SP140;PCGF5;ZFPM2;PARP9;CNOT7;IGF2;GATAD2A;HDGFL3;MED26;SSBP2;GAS6;ARRB1;HOXA3;ZNF697;GTF2IRD1;TEAD4;QRICH1;NIBAN2;ARNT2;WWP2;AR;BRD7;DAP;SCMH1;CREM;YAP1;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;PFDN5;KMT5A;ACVRL1;ATXN1;IRF1;TEAD1;MIDEAS;SIX1;WNT5A;BAZ1A;CDK17;ZNF292;PRKCB;HLF;KDM5B;HOXC6;PRDM16;MAPK14;ID3;FOXC1;IRF2;GLIS1;SFMBT1;CHD3;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;IFRD1;PGR;BAZ1B;KLF10;SFR1;ZNF219;TBX1;ERC1;POLR2A;FZD4;ZBTB8A;TRRAP;GON4L;TFCP2;IRF9;ZBTB18;VSX1;BAZ2B;AKT1;DTX3L;BBS7;KIT;FOXL1;LHX6;RREB1;TLE2;REXO4;HIF1A;CBFA2T2;TADA1;MKX;ZMYND15;RCOR3;TRIM16;TLE1;TWIST2;TADA2A;FOXK1;CRABP2;CARM1;NR4A2;MMS19;TULP3;FZD7;ATF6;BHLHE41;EHMT1;FOSL2;CD38;PHF10;IKZF1;GCLC;DAB2IP;HOXB9;TFCP2L1;JARID2;KARS1;PRDM5;ZKSCAN7;ZKSCAN3;SLC39A8;TGIF1;ESRRG;ZFHX2;PML;KLF12;SIX5;GATA2;BRCA2;CEBPG;PATZ1;ZSCAN25;NFYC;HINT1;BACH2;KDM3A;GLI3;FOXQ1;TGFB1;NSD1;ELK3;MED27;AHR;HDAC1;LRRFIP1;ZSCAN22;ATXN7L3;MDM2;ZIC3;RELA;PPARA;CHD2;ID2;MEF2A;SRSF10;USF1;GATA6;CBX4;FBXW11;PRDM11;SP110;CALR;GLRX2;ATOH8;ZGPAT;CLOCK;MEIS2;SPP1;ZNF585A;ZNF585B;HDAC5;RET;ZNF568;TAL1;SOX17;RFX2;HSF2;SFRP1;QARS1;DACH2;TOX4;CREB3L1;SMARCC1;ENO1;SLTM;POU2F1;MAZ;ZBTB4;HOXC4;TTC21B;HOXB5;HOXB7;HIPK2;DYRK1B;PCGF3;SOX7;WWP1;NKX6-1;SNAI1;CREB3;YEATS2;JUND;SREBF1;CDKN1B;NOS1;NKRF;L3MBTL2;RNF187;HHEX;MEIS1;HMGB2;SOX18;HCFC2;MNT;USF2;ZMIZ2;ZFP69;ZNF436;JUNB;MYRF;SIRT2;HNRNPAB;ASCC1;ATF1;TSHZ1;TCIM;MED21;FBXL19;WNT11;NFIL3;PSIP1;RAI1;ACTR8;FZD1;NFYB;ZFP14;CSRNP3;NFXL1;NPAS2;MAFF;SOX12;RRP8;NR6A1;CC2D1A;RHOH;CEBPB;KLF15;BASP1;CIR1;ELP3;PCGF6;POU5F2;TYMS;AGT;EZH2;PLAG1;YAF2;ZSCAN2;BRF2;SBNO1;ATF7;HMGN5;MT3;PIM2;SCML4;PPARGC1A;E2F1;ZFX;ETV4;IRF2BPL;THOC1;ZFP57
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.47226035866023236,1.1937434229005697,0.24660194174757283,0.7534985996551627,1.0,15/35,18.08%,PCDHB11;ATP2C1;CDH8;CDH22;CDH19;CDH7;CDH20;CDH10;CDH18;CDH12;PCDHB16;PCDHGB4;CDH6;PCDHGC3;DCHS1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4448217524381024,-1.193543318543827,0.2318840579710145,0.6203268649962338,1.0,5/21,5.39%,BMP6;DAB2;BMP4;TGFBR1;CCN3
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5594357338803885,1.1929502660169855,0.26200873362445415,0.7541832139925073,1.0,1/13,0.21%,CSPG4
prerank,cardiac cell development (GO:0055006),0.5546233904974207,1.192753959821422,0.2737306843267108,0.7534194342162227,1.0,3/11,9.28%,NOTCH1;MYH11;JAG1
prerank,cellular response to nutrient levels (GO:0031669),-0.3529613067760392,-1.1926954835226635,0.18377088305489261,0.621799208038301,1.0,24/62,25.26%,LAMP2;FOXO1;BMPR2;LRRK2;WIPI2;FNIP1;CLEC16A;KLF10;KCNB1;FLCN;PPARA;MFSD2A;SFRP1;SREBF1;PRKAA2;RRAGB;ZFYVE1;FAM107A;XBP1;LPL;STK26;RIPOR1;ATG7;RRAGC
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5479315499751649,1.1925621590022912,0.2717391304347826,0.7526111631963224,1.0,1/11,0.83%,NEDD4L
prerank,renal absorption (GO:0070293),-0.5370979785596988,-1.1922591058047718,0.25760286225402507,0.6221438034758807,1.0,3/10,10.37%,GSN;WNK4;KCNQ1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5413587279470307,1.1914866780785518,0.2860169491525424,0.7540050345799751,1.0,4/14,4.19%,TBXA2R;NOTCH1;STARD13;PDCD10
prerank,histone deubiquitination (GO:0016578),-0.4661780823972911,-1.1914849624469916,0.2378167641325536,0.6234687158230747,1.0,6/18,20.82%,USP15;TRRAP;ATXN7L3;USP49;USP22;USP36
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5203788268566671,-1.1913679493445333,0.26014760147601473,0.6229537871431814,1.0,7/11,25.35%,PDPN;RREB1;CORO1C;ENPP2;ARPIN;KANK1;CD44
prerank,organic anion transport (GO:0015711),-0.3454946452563701,-1.1909994954851666,0.17616580310880828,0.6231086036620741,1.0,16/76,10.69%,ABCC4;SLCO2B1;SLC16A2;SLC26A7;SLCO2A1;SLC4A10;SLCO1C1;ABCG2;SLC22A6;ABCC6;SLC25A17;SLC25A4;SLC39A8;MGST1;SLC25A24;SLC35A2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4468802112994652,-1.1901995228769338,0.22474226804123712,0.6243588928797881,1.0,4/19,7.04%,LBP;LGALS9;PRKCE;PIK3AP1
prerank,sterol homeostasis (GO:0055092),0.41746566484929937,1.1901851582663665,0.22750424448217318,0.755865728298836,1.0,9/65,6.95%,CYP7B1;RORA;NR1H3;SCARB1;LDLRAP1;LDLR;FABP3;ABCA5;LIPC
prerank,establishment of epithelial cell polarity (GO:0090162),-0.45214839998879386,-1.1900699639377368,0.2622309197651663,0.6238479430827508,1.0,8/19,16.57%,MYO18A;EZR;RHOA;MYO9A;GOLPH3;PARD3;OPHN1;CYTH1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.49145213086284123,1.1893104026332975,0.25274725274725274,0.7566694967189994,1.0,4/28,3.95%,ATP2A3;MAP3K5;CHAC1;ITPR1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.36377385564069686,1.1891712570241442,0.20699708454810495,0.7557707305737801,1.0,21/151,7.64%,PDGFRB;SLC30A10;RAPGEF2;GCNT2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;ERBB4;PTPN22;ACKR3;FGF2;SPRY2;CARD9;NTRK2;HTR2C;CHRNA7;RAP1A;HRAS;FGF10
prerank,positive regulation of receptor internalization (GO:0002092),-0.4486533511796886,-1.1889907712992738,0.23293172690763053,0.6258254484120749,1.0,5/22,7.40%,ANGPT1;MAGI2;ARRB1;SFRP4;SCYL2
prerank,sensory perception of chemical stimulus (GO:0007606),0.5199058048286771,1.188405902138261,0.2860215053763441,0.7564147038107961,1.0,3/15,6.85%,ADCY3;SLC24A4;UBR3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5049048110424439,-1.188394364299793,0.265625,0.6265372885013748,1.0,3/13,5.61%,ELOVL7;HACD4;HACD3
prerank,modified amino acid transport (GO:0072337),0.5365557376488672,1.188281034523796,0.2816326530612245,0.7554640073192147,1.0,3/15,3.11%,SLC16A12;SLC1A4;SLC19A1
prerank,chromatin organization (GO:0006325),-0.3186345894786149,-1.1881942339909133,0.10979228486646884,0.6261894750501269,1.0,33/132,20.44%,SMARCA2;MECOM;HDAC4;HDAC8;ESR1;SETD7;KAT2B;BAZ1A;INO80;KDM5B;PRDM16;BPTF;BAZ1B;BAZ2B;TADA2A;EHMT1;JARID2;HDAC1;EZH1;MPND;HDAC5;SMARCC1;SNAI1;HMGB2;KDM6B;HCFC2;HMGN1;EZH2;SMARCAD1;SETDB1;HP1BP3;RSF1;MCM3AP
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.48201998968375703,1.1880022344329888,0.2771317829457364,0.7548968335055516,1.0,2/29,1.77%,MBOAT2;NR1H3
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.3887349119261043,-1.187838577406735,0.20905172413793102,0.626312570751955,1.0,10/42,16.55%,IL6R;LBP;RPS19;IRGM;GSDMD;OPTN;SERPINE1;HMGB2;MR1;TLR4
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5591029480604384,1.1873074077462877,0.2891832229580574,0.7554506607201623,1.0,1/11,0.50%,IL34
prerank,regulation of cardiac muscle contraction (GO:0055117),0.46399560036808374,1.1869932220395436,0.2730696798493409,0.7549794215477157,1.0,6/34,7.09%,PDE4D;SCN5A;PDE4B;RYR2;ATP2A2;STC1
prerank,cellular protein-containing complex assembly (GO:0034622),0.36889892013469294,1.1866404561872572,0.18857142857142858,0.7545501651933552,1.0,13/159,7.30%,SGIP1;CASQ2;DMD;HIGD1B;NCK2;IMMP2L;NRG1;CHRNA3;PSMG3;CENPW;SNCA;PIK3C2A;BIN1
prerank,calcium ion transport into cytosol (GO:0060402),0.5189913786704696,1.1865934339539137,0.28,0.7534528910526161,1.0,4/21,9.81%,CACNA1C;CACNA2D1;RYR2;GRIN2B
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4756083594632546,-1.185900707560396,0.24727272727272728,0.6307722947627147,1.0,7/16,11.83%,APOE;NPR3;PIK3CB;NOS1AP;AKT1;HIF1A;GCH1
prerank,negative regulation of binding (GO:0051100),-0.3413599165447642,-1.1855892110195434,0.18037135278514588,0.6306964471372848,1.0,27/81,22.97%,DAB2;ARHGAP28;SP100;CAV1;LRRK2;LEF1;SMO;PRKCD;IFIT2;AKT1;IFIT1;MDFI;DNAJB2;ACTB;ZFPM1;TMBIM6;MITD1;STYX;NFKBIA;EFHB;PARK7;E2F1;CTNNBIP1;RSF1;BAG2;PLN;CFHR2
prerank,positive regulation of innate immune response (GO:0045089),-0.4130991395023622,-1.1854883001439511,0.23516483516483516,0.6301329503002849,1.0,7/30,11.55%,LBP;WNT5A;RPS19;IFI35;NLRC5;MAVS;GBP5
prerank,keratinocyte differentiation (GO:0030216),-0.4131700380246267,-1.1851911040389678,0.2389558232931727,0.630077971099699,1.0,7/29,13.66%,CLIC4;ANXA1;ADAM9;WNT5A;TXNIP;WNT16;UGCG
prerank,epithelial cell morphogenesis (GO:0003382),-0.4684511696974331,-1.1850701756131266,0.259047619047619,0.6295518151818915,1.0,6/17,13.47%,COL22A1;RILPL1;COL18A1;COL15A1;CCDC88C;MET
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5600762185107426,1.1850117568942862,0.2760084925690021,0.7560623025219194,1.0,6/10,16.38%,MAPRE2;FGF10;MTOR;MAP4K4;IQSEC1;EPB41L4B
prerank,negative regulation of receptor binding (GO:1900121),0.5588951063736096,1.1847898008417697,0.3008849557522124,0.7553946611068173,1.0,2/10,6.59%,ATP2A3;ATP2A2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.4701159588219648,-1.184324830203255,0.225,0.630757999098916,1.0,4/17,5.67%,PODXL;FOXC2;ADAM9;PIEZO1
prerank,metal ion homeostasis (GO:0055065),0.45394377390047674,1.1835812666148657,0.2698706099815157,0.7569990532141242,1.0,10/40,13.23%,SLC12A2;SLC12A6;TFAP2B;ANK3;SNCA;LETM1;COX11;SLC12A5;FAM20A;SLC12A4
prerank,ether lipid metabolic process (GO:0046485),-0.4956130067634966,-1.1832975023928325,0.26383763837638374,0.6327599972029803,1.0,4/14,11.23%,AGMO;NCEH1;PLA2G6;LIPE
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.48027663321873376,-1.183247732961838,0.2652671755725191,0.6320430686374232,1.0,5/16,6.70%,RANBP3L;PLCB1;BOC;IGFBP3;MAPK14
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.29605872148748535,-1.1830805591563909,0.10040160642570281,0.6316955395013506,1.0,69/234,19.22%,ANXA3;SMAD3;HDAC4;CAMK1D;PLPP3;PRKCH;APP;ZIC2;CAV1;ADCY1;ESR1;NOD1;LRP6;ARHGEF2;FZD2;CFLAR;TAF1;SMO;IRAK2;AR;LGALS9;WNT5A;IKBKE;PRKCZ;PRKCB;CARD14;STAT3;TFRC;ERC1;FZD4;AKT1;KIT;FLOT2;IRAK3;IL18;TRIM27;MAVS;CEBPG;CAMK2A;RELA;TNFRSF11A;UBB;LRP8;CLOCK;PLCG2;SPHK1;FER;HDAC5;TICAM1;PPIA;HIPK2;NKX6-1;CD200;TLR4;TRIM8;RIPK1;FZD1;MAP3K13;NFKBIA;EDA;PARK7;STK36;TRIM14;ALK;LAMTOR5;AGT;TRIM41;EDA2R;PPARGC1A
prerank,cellular response to ATP (GO:0071318),-0.4859772207509878,-1.1830765795454008,0.25486381322957197,0.6308551300761309,1.0,6/14,25.05%,TAF1;P2RX4;P2RX7;P2RY1;HSP90B1;P2RY12
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.3499126664806928,-1.1828937466173108,0.20531400966183574,0.6305252197959889,1.0,20/61,24.71%,PRKAG2;CAV1;PSME2;FGFR4;PPARA;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;ODC1;OAZ1;PSMD4;PSMA2;PSMD3;PSMB7;AZIN1;PSMC2;PSMC5;PSMD10
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5372627375553878,1.182831009329416,0.3031578947368421,0.757643638769945,1.0,3/12,5.94%,DMD;ATP1B2;ANK3
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4893205046411324,1.182688146413789,0.29365079365079366,0.7568135223522248,1.0,4/24,3.66%,PLCE1;PIK3R1;PIK3CA;ABI2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.39103783552187305,-1.182589889837481,0.2199074074074074,0.630529041835982,1.0,17/38,26.22%,NDUFV3;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA11;NDUFA4;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,negative regulation of viral genome replication (GO:0045071),-0.391181779128666,-1.1822999801986787,0.22058823529411764,0.6304666750334286,1.0,22/40,36.96%,IFITM3;OAS2;IFIT1;MAVS;IFITM2;RNASEL;RSAD2;SETDB1;MPHOSPH8;SRPK1;INPP5K;TRIM6;SRPK2;PLSCR1;ISG15;ILF3;BST2;PARP10;OASL;FAM111A;ISG20;PROX1
prerank,regulation of protein processing (GO:0070613),-0.4401302421266434,-1.1815378181897753,0.2693877551020408,0.6316646867981295,1.0,4/21,5.88%,CCBE1;GAS1;LRRK2;RNF139
prerank,regulation of myotube differentiation (GO:0010830),-0.4364193627370301,-1.1814614222256816,0.24242424242424243,0.6310414551731696,1.0,11/24,13.65%,HDAC4;HDAC9;CCN3;PIEZO1;MAPK14;MMP14;DMPK;BHLHE41;HDAC1;TMEM119;HDAC5
prerank,long-chain fatty acid transport (GO:0015909),-0.40780045462017644,-1.1814519451719283,0.23593073593073594,0.630211667675303,1.0,10/30,18.87%,PRKAG2;APOE;CPT1A;SLC25A20;CPT2;ACACA;MFSD2A;PRKAA2;FABP5;ACACB
prerank,positive regulation of metabolic process (GO:0009893),-0.32207880993807964,-1.1813482677368092,0.14730878186968838,0.6296623577019841,1.0,35/103,20.99%,LEPR;CAMK1D;ADIPOR2;CAV1;GJA1;IGF1R;APPL2;PRDM16;CPT2;GNAS;CMKLR1;ACACA;EHMT1;IL18;ESRRG;ACADL;KDM3A;UCP2;PRKAB1;BEND3;KDM6B;CNOT3;FABP5;MFAP2;PDGFC;DYNC1H1;ADRB2;CEBPB;GADD45G;ACACB;PPARGC1A;SYK;ADIPOR1;ALMS1;DECR1
prerank,Rho protein signal transduction (GO:0007266),0.42493776417741286,1.1806477124600203,0.25506756756756754,0.7605183708518486,1.0,9/53,4.60%,EPS8;ARHGAP6;ARHGAP1;ROCK1;WAS;LIMK1;CDC42EP1;RTKN;EPS8L1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.4645277643437276,-1.1803676697394991,0.24165029469548133,0.6316050423938879,1.0,5/18,7.33%,IL6R;IL6ST;YAP1;STAT1;STAT3
prerank,brain morphogenesis (GO:0048854),0.5667673135695052,1.1803264994231435,0.31140350877192985,0.76002298826467,1.0,1/12,0.42%,PTEN
prerank,camera-type eye development (GO:0043010),-0.42685774014152045,-1.1802521662904857,0.26403326403326405,0.6310583234660108,1.0,9/25,8.16%,FBN1;EFEMP1;LAMA1;SHROOM2;SKI;RAB3GAP1;FBN2;CYP1B1;STRA6
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4378896377602317,-1.1797614741563225,0.2525458248472505,0.6314845660615196,1.0,4/23,2.83%,CAMK1D;MCU;SLIT2;DPP4
prerank,cellular response to oxygen levels (GO:0071453),-0.5372930542917962,-1.1792730763756525,0.27106227106227104,0.631897770571118,1.0,7/10,27.55%,ATP6V1G1;ATP6V0A2;CCDC115;TMEM199;PICK1;ATP6AP1;ATP6V0D1
prerank,sodium ion import across plasma membrane (GO:0098719),0.5265365480819899,1.1792705479813195,0.2888402625820569,0.7613708028503772,1.0,4/17,8.34%,SLC12A2;SLC5A1;HCN2;SLC9A7
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.38035124834177225,-1.1791991232252281,0.2203023758099352,0.6312473292651677,1.0,8/41,10.89%,IGF1;LBP;CD34;GAS6;LGALS9;IRAK3;ZC3H12A;TRIM27
prerank,selective autophagy (GO:0061912),0.42645029951884694,1.1791617400895649,0.2516891891891892,0.7603878820741026,1.0,1/56,0.06%,DYNLL1
prerank,regulation of viral genome replication (GO:0045069),-0.3616453137572199,-1.1791021365850165,0.21709006928406466,0.6306401683657951,1.0,30/56,36.96%,CNOT7;IFITM3;HACD3;OAS2;IFIT1;MAVS;PPARA;PPID;LARP1;PPIA;DDB1;IFITM2;RNASEL;RSAD2;SRPK1;NR5A2;TRIM6;SRPK2;PLSCR1;ISG15;ADARB1;ILF3;BST2;PARP10;OASL;FAM111A;PPIE;RAD23A;ISG20;PROX1
prerank,metal ion export (GO:0070839),0.4682162197074844,1.1786293381713155,0.2591170825335892,0.7604061857001461,1.0,7/31,7.70%,ATP1A2;ATP1A4;FXYD2;KCNE4;ATP7A;ATP1B2;KCNE5
prerank,histone modification (GO:0016570),-0.32492760090215966,-1.178122790399304,0.1540785498489426,0.6323823334183268,1.0,28/109,21.43%,EYA2;EYA1;HDAC4;TBL1XR1;KAT6B;EYA4;HDAC9;MIDEAS;BAZ1B;PRKCD;TRRAP;RCOR3;CARM1;EHMT1;PRDM5;NSD1;HDAC1;ATXN7L3;HDAC5;SIRT7;SIRT2;PARK7;EZH2;MT3;USP22;MORF4L2;USP36;SIN3A
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5424262600163936,1.176894005020973,0.2832618025751073,0.7633176061150606,1.0,1/12,0.88%,APOBEC1
prerank,regulation of insulin secretion (GO:0050796),0.3827253545194388,1.1768531237966677,0.24191063174114022,0.7622117256236731,1.0,14/101,7.39%,CACNA1C;RAPGEF4;PER2;GPER1;ITPR2;IL1B;GIPR;SNAP25;ITPR1;TFAP2B;SOX4;RAP1A;IRS1;CACNA1D
prerank,cellular senescence (GO:0090398),0.4850906083295435,1.1765267808651532,0.2795275590551181,0.7618370596224381,1.0,5/27,10.84%,TBX2;TBX3;HRAS;CDKN1A;KAT6A
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5307623223311062,-1.1765068386696285,0.2725563909774436,0.6359419965980543,1.0,3/10,18.15%,BMP4;FZD7;BASP1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.43724276296656983,1.1764440630707256,0.2478920741989882,0.7608442253201639,1.0,9/47,6.21%,CARMIL1;LIMS1;PTK2;SPRY4;FERMT2;RAC3;ACTN4;TESK1;AP1AR
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3544646928436716,-1.176441821090282,0.1922141119221411,0.6352926062538613,1.0,8/55,7.76%,IGF1;IGFBP2;IL15;IL6ST;ANXA1;VCAM1;IGF2;TFRC
prerank,regulation of macrophage differentiation (GO:0045649),0.5225214142083224,1.1759673809956352,0.29958677685950413,0.7608025050242359,1.0,1/15,0.50%,IL34
prerank,muscle tissue development (GO:0060537),-0.4987443855084436,-1.1759242541834718,0.2894736842105263,0.6358495729451219,1.0,7/13,11.87%,BMP4;SMO;PGM5;CSRP2;STRA6;POGLUT1;PTCH1
prerank,pharyngeal system development (GO:0060037),-0.4658205438751382,-1.1754945191655954,0.2780952380952381,0.6361957165903038,1.0,7/15,15.76%,BMP7;BMPR2;BMP4;TGFBR1;TBX1;PTCH1;BMPR1A
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4505978220863959,-1.1751837868326818,0.245136186770428,0.6361507649257948,1.0,6/19,14.16%,WNT4;VIM;BMP4;EMILIN1;TGFB1;CREB3L1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.4922249433318697,-1.1749990482069248,0.2786259541984733,0.6358147804844695,1.0,6/13,27.52%,PRKCD;TGFB1;SYK;TYROBP;ITGB2;ITGAM
prerank,regulation of cellular respiration (GO:0043457),0.5143276926880973,1.1745467677981583,0.2748414376321353,0.7631152027193747,1.0,3/17,6.03%,CBFA2T3;NOA1;IL4
prerank,regulation of neuron differentiation (GO:0045664),0.4037839526327926,1.174286206859926,0.247244094488189,0.7625827991710308,1.0,12/76,9.43%,MEF2C;HEYL;ZEB1;ZFHX3;ROCK1;MOSMO;BRINP1;CNTN4;BIN1;BEND6;BRINP3;MED1
prerank,thymus development (GO:0048538),-0.4909686229387879,-1.1739025119935314,0.2638623326959847,0.637929184983583,1.0,4/13,16.39%,TGFBR1;SIX1;TBX1;EPHB3
prerank,pulmonary valve development (GO:0003177),-0.4643750510490336,-1.173889067037184,0.26136363636363635,0.6371297699123954,1.0,11/18,9.40%,NOTCH2;ROBO1;SMAD6;SLIT2;NOS3;BMPR2;BMP4;NFATC1;TNFRSF1B;STRA6;TNFRSF1A
prerank,error-prone translesion synthesis (GO:0042276),-0.4387344082532637,-1.1737103510163611,0.27037773359840955,0.6367220537910037,1.0,13/21,36.71%,REV1;POLH;UBB;RPA1;RFC3;POLI;POLE2;RFC1;RPA3;PCNA;RFC5;MAD2L2;PRIMPOL
prerank,macrophage migration (GO:1905517),-0.4852738885362191,-1.173653462589784,0.2826923076923077,0.6360345516595683,1.0,8/13,38.70%,P2RX4;P2RY12;EDNRB;CCR2;CKLF;CCL2;CXCL17;CCL5
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.558977285718266,1.1731403063967627,0.3304535637149028,0.764169047242413,1.0,5/10,9.02%,VTN;IL1B;GRB10;ARNT;PRKD2
prerank,calcium ion import into cytosol (GO:1902656),0.5387693599480503,1.172570917681224,0.2928870292887029,0.7642945580354364,1.0,3/15,4.64%,TRPV2;CACNA2D1;SLC24A2
prerank,ceramide catabolic process (GO:0046514),-0.47922456316248807,-1.1724620730896775,0.27079303675048355,0.6385335212702532,1.0,5/14,11.64%,ACER2;HEXA;HEXB;ACER3;NAGA
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3750844546278877,1.171401006604515,0.23372781065088757,0.7658913431815091,1.0,16/124,9.77%,FRY;CARMIL1;RAPGEF2;MAP2;ROCK1;CNTNAP2;RYK;ATP1B2;LAMB1;CNTN4;BLOC1S1;FAM161A;PKD2;LYN;TMEM108;PLP1
prerank,ventricular septum morphogenesis (GO:0060412),-0.4194325033071314,-1.1708128789369903,0.23417721518987342,0.6420253596789387,1.0,10/27,4.79%,TGFBR3;ROBO1;SLIT2;TGFBR2;BMPR2;BMP4;TGFBR1;SMAD7;ACVR1;ZFPM2
prerank,neuron projection morphogenesis (GO:0048812),0.3673557178179061,1.1704749290260448,0.23564954682779457,0.7669487026909941,1.0,30/137,12.16%,PTEN;DOCK10;FARP1;BTBD3;SDC2;MAP2;ROCK1;PLXNB1;ATP7A;MYO16;WASL;MINK1;CNTNAP2;NTNG2;RYK;CNTN4;SLITRK5;NYAP2;ANK3;TAOK3;CCK;SLITRK1;MAP4K4;CTNNA2;NCKAP1;BRSK1;PAK3;PAK1;ZDHHC17;EPHB1
prerank,positive regulation of developmental process (GO:0051094),-0.2946303418935633,-1.1702159913700607,0.11986301369863013,0.6428300348283953,1.0,50/164,22.59%,PLCB1;ZBTB16;DCN;BMP7;CCN2;SLC6A6;APOE;MCU;SHANK3;BMPR2;SMURF2;BMP4;GJA1;FOXD1;ACVR1;ADGRL1;NIBAN2;AR;WNT5A;NR2C2;TFRC;FZD4;RREB1;DAB2IP;KDR;VPS35;TMEM119;CPEB3;LRP8;SHLD1;BNIP3;HSP90AB1;KMT5C;CORO1C;EDN3;BMPR1A;TAPT1;MAP3K13;CEBPB;BASP1;ALK;ZDHHC15;TRPM4;NUMA1;ENPP2;MDK;XBP1;SRF;VEGFA;DDHD1
prerank,regulation of JNK cascade (GO:0046328),-0.3219391122021513,-1.1701537737138374,0.17391304347826086,0.6421425315081025,1.0,18/101,10.24%,TGFBR3;PLCB1;EGFR;MECOM;CCN2;SH3RF1;APP;IGF1R;RASSF2;SDCBP;PTK2B;SH3RF3;MFHAS1;SH3RF2;TAOK2;TNFRSF19;FZD7;DAB2IP
prerank,negative regulation of chemotaxis (GO:0050922),-0.39962390222256683,-1.1700810345925416,0.23922413793103448,0.6415076784301148,1.0,7/31,3.63%,ROBO1;SEMA3D;SEMA6A;SEMA3C;SLIT2;THBS1;SEMA7A
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5145539696198119,1.169792965851744,0.3184713375796178,0.7673744169100223,1.0,4/17,2.62%,S1PR3;VCL;ROCK1;IL1B
prerank,histone H3-K36 demethylation (GO:0070544),-0.5258552575623299,-1.1696311008348195,0.29182156133828996,0.6418730264827679,1.0,1/10,0.92%,KDM7A
prerank,organelle transport along microtubule (GO:0072384),0.46646474361933304,1.1694790110944018,0.2744360902255639,0.7669836379485466,1.0,10/31,17.44%,ARHGAP21;BICD2;UXT;TRAK1;TRAK2;COPG2;RAB1A;NDE1;HTT;HAP1
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.49285547523822776,-1.169209334916349,0.2527881040892193,0.6421127704333467,1.0,4/14,6.72%,SEC23A;SEC24D;SEC31A;SEC24A
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.45051667108967275,-1.168927380242273,0.250501002004008,0.6420609200855201,1.0,2/19,0.11%,BMP6;AFDN
prerank,proteolysis (GO:0006508),0.33935144030835707,1.1688668758878682,0.19790301441677588,0.7672149168667494,1.0,23/252,6.32%,ENPEP;GGT5;TMPRSS4;FAP;NAALAD2;GGT1;CPM;METAP2;TMPRSS7;USP25;ADAM19;ATG4A;ECE1;MMP15;ANPEP;TASP1;SVBP;CTSF;ACAN;PSMB11;OGT;DESI1;DESI2
prerank,cardiac muscle tissue development (GO:0048738),0.43138771766004824,1.1686262127671754,0.266173752310536,0.766631450506381,1.0,9/50,6.97%,TBX2;HEY2;BMP5;NOTCH1;TBX20;NRG1;SCN5A;SIK1;SGCZ
prerank,negative regulation of transposition (GO:0010529),-0.4561858600717804,-1.1683744069271722,0.26145038167938933,0.6427884691843158,1.0,5/16,19.72%,TUT4;MOV10;TUT7;SIRT7;SMYD5
prerank,pancreas development (GO:0031016),-0.5046338928801514,-1.1677691016622362,0.2820976491862568,0.6436238768356684,1.0,4/12,15.34%,TCF7L2;ZIC3;MET;NKX6-1
prerank,cellular response to peptide (GO:1901653),-0.3575823472133724,-1.1676553241278333,0.21875,0.6431174805402361,1.0,13/56,6.55%,IGF1;EPHA4;APP;CAV1;VIM;GJA1;IGF1R;SNX6;NOD1;ARHGEF2;VCAM1;CASP4;ICAM1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5685992365456995,1.1675226798438665,0.31543624161073824,0.7680533260429105,1.0,2/10,3.42%,NR1H3;ABCD2
prerank,carbohydrate homeostasis (GO:0033500),-0.3448030150003923,-1.1674922945537618,0.20243902439024392,0.6427362431422129,1.0,18/67,20.35%,LEPR;MCU;ADIPOR2;RBP4;IGF1R;TCF7L2;APPL2;STAT3;KCNB1;FGFR4;USF1;RPS6;PRKAA2;BACE2;PARK7;PTPN2;TENT4B;ADIPOR1
prerank,oligosaccharide metabolic process (GO:0009311),-0.3637573993941664,-1.1674917277363612,0.22972972972972974,0.6419115423405221,1.0,15/46,20.12%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST6GALNAC3;ST3GAL3;FUT8;ST8SIA2;NAGA;ST6GALNAC6;MANBA;MAN2C1;MAN2B2;NEU3;ST8SIA5
prerank,positive regulation of reproductive process (GO:2000243),0.4674488623710501,1.1674813145848115,0.28125,0.7669671471707796,1.0,5/31,5.02%,PDE3A;CACNA1H;TACR2;TACR1;SYDE1
prerank,positive regulation of viral process (GO:0048524),-0.34948057564043034,-1.1673867392715747,0.22278481012658227,0.6413604539563528,1.0,22/60,25.11%,MDFIC;CNOT7;HACD3;POLR2A;IFIT1;RAB7A;PPARA;POLR2F;PPID;LARP1;PPIA;DDB1;KPNA6;CDK9;POLR2E;RSF1;SRPK1;NR5A2;NELFCD;POLR2G;TBC1D20;SRPK2
prerank,melanosome localization (GO:0032400),-0.4276319401897501,-1.1664992329065555,0.26785714285714285,0.6430129514654517,1.0,7/21,20.78%,SHROOM2;RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,mRNA splice site selection (GO:0006376),-0.39463836190829743,-1.166245816944342,0.2543478260869565,0.6428788098428859,1.0,10/30,27.11%,CELF2;LUC7L;SRSF10;PSIP1;SRSF6;SRSF5;SF3A3;CELF5;PUF60;SNRPC
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.42955114491164537,-1.16612225118688,0.2612244897959184,0.6423858375389186,1.0,11/27,25.77%,GAS6;ARRB1;C1QTNF3;IRAK3;ZC3H12A;CD200;SIRPA;TLR4;PTPN6;CD200R1;NCKAP1L
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3569779923631067,1.1657386117019668,0.21407185628742514,0.7700267205613274,1.0,8/166,2.82%,NOTCH3;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3271489485987267,-1.165665831758295,0.17079889807162535,0.6428587963430343,1.0,30/91,20.00%,BMP6;APP;CP;SCARA5;ABCG2;SLC39A14;ATOX1;SLC39A13;SLC39A10;TFRC;ATP6V1G1;ACO1;FTL;SLC39A8;NEDD8;ATP6V0A2;HFE;CYB561A3;SLC30A1;FRRS1;FTH1;MT3;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H
prerank,acute-phase response (GO:0006953),-0.49877810413340395,-1.1651097161921131,0.2829827915869981,0.6435375101206995,1.0,5/12,25.16%,IL6R;LBP;CEBPB;SIGIRR;PLSCR1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5227920982602166,1.1647434914526478,0.2982832618025751,0.7711652839880981,1.0,4/13,9.94%,CHST3;CHST7;CHST2;CHST5
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.5090837428774949,-1.1646941150683168,0.2706766917293233,0.6437540573985194,1.0,7/11,34.91%,P4HB;PARK7;STK26;PRKN;LANCL1;PINK1;MMP3
prerank,P-body assembly (GO:0033962),0.552985096592237,1.1644915037251495,0.3235908141962422,0.7705747239720625,1.0,2/12,5.17%,LIMD1;LSM3
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.47918350350386757,1.164472261183297,0.3029126213592233,0.7694308908265853,1.0,5/27,5.53%,UTRN;NEDD4L;FGF12;FXYD2;SCN5A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5041114212604547,-1.1640608364252347,0.2767857142857143,0.6445637319109159,1.0,5/11,31.27%,LGALS9;TWSG1;CD274;CBFB;VSIR
prerank,regulation of axon regeneration (GO:0048679),0.5374046542643683,1.1634734984406774,0.31069958847736623,0.7706172604307575,1.0,4/12,8.02%,RTN4RL1;SCARF1;PTN;STK24
prerank,glycosaminoglycan catabolic process (GO:0006027),0.42364442166006167,1.163167627336206,0.2638888888888889,0.7701494228380065,1.0,11/55,6.35%,CSPG4;SDC2;CEMIP2;SDC3;HYAL4;AGRN;FGF2;ACAN;GPC5;GPC3;GNS
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5016538329382811,1.1630714049554451,0.29774127310061604,0.7692097999859587,1.0,7/20,13.07%,LIMD1;AJUBA;AGO3;TNRC6C;EIF6;TNRC6B;CELF1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.48325924440409485,1.1629543265541016,0.29366602687140114,0.768352250322059,1.0,3/24,5.46%,COX4I2;PID1;SLC25A13
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.468397338012948,-1.162943662849636,0.28627450980392155,0.6466425093692374,1.0,4/16,6.23%,BMP4;FOXD1;FGF1;SIX1
prerank,striated muscle tissue development (GO:0014706),0.4685447332093504,1.1628441924414057,0.28680688336520077,0.7674250492982133,1.0,6/29,7.45%,TBX2;MEF2C;BMP5;POPDC3;SGCZ;IGSF8
prerank,cardiac muscle cell differentiation (GO:0055007),0.49016155086103735,1.162199345232546,0.294478527607362,0.7678144517912167,1.0,4/21,6.69%,MEF2C;MYH11;NRG1;SIK1
prerank,superoxide anion generation (GO:0042554),0.530220032283003,1.1621210301507978,0.2936344969199179,0.7668269963151256,1.0,3/13,9.84%,NCF2;NCF1;NOX3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4837453329563396,1.1612464185370035,0.30134357005758156,0.7676789635754766,1.0,3/24,5.53%,ITGA4;ROCK1;ITGB1
prerank,canonical Wnt signaling pathway (GO:0060070),-0.3504285487441976,-1.1609193585927942,0.20930232558139536,0.6512224438493925,1.0,21/68,13.91%,WNT4;PLPP3;WNT6;CAV1;TCF7L2;LRRK2;LRP6;LEF1;FZD2;WNT9A;RARG;SFRP4;WNT5A;SCYL2;FZD4;NR4A2;FZD7;BCL9L;WNT5B;WNT16;SFRP1
prerank,negative regulation of phosphorylation (GO:0042326),0.4010150768464854,1.1606683737993064,0.25736434108527134,0.7678602144402962,1.0,7/85,3.06%,DYNLL1;PTEN;PID1;CBFA2T3;ROCK1;PRR5L;CADM4
prerank,ovarian follicle development (GO:0001541),-0.4902299185904344,-1.1599773246110774,0.29734848484848486,0.6529428715136169,1.0,7/13,28.26%,KIT;EIF2B2;CEBPB;VEGFA;EIF2B5;FOXL2;EIF2B4
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.32981160942991483,-1.1599611518276285,0.18586387434554974,0.6521645218794322,1.0,24/80,19.74%,EPHA4;SAMD4A;ROCK2;VIM;SLC2A13;THBS1;LARP4B;NIBAN1;SMPD3;NSMAF;RPS4X;PRKCD;PLA2G6;UPF3A;TNFRSF1A;RELA;CPEB3;RPL26;FXR2;ELAVL1;SIRT3;ZCCHC4;NAT10;METTL5
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.29800101236570015,-1.1597785606735618,0.13167259786476868,0.6518945991150656,1.0,37/161,14.36%,MCC;DAB2;IGFBP2;BICC1;TMEM64;DKK3;APOE;CAV1;IGFBP6;NKD1;TCF7L2;TLE4;LRP6;MLLT3;IGFBP4;SFRP4;SOX13;PFDN5;WNT5A;SCYL2;AMFR;FZD4;TLE2;TLE1;NOTUM;DAB2IP;ZNRF3;PSME2;GLI3;HDAC1;PSMB4;CCDC88C;SOX17;SFRP1;PSMB1;PSMD11;PSMD8
prerank,purine ribonucleotide catabolic process (GO:0009154),0.4793962533099913,1.1594986984608744,0.29902912621359223,0.7695794967180647,1.0,2/21,2.42%,PDE4D;PDE9A
prerank,ameboidal-type cell migration (GO:0001667),0.4181608396854245,1.1588185938872166,0.2838063439065108,0.7700059403999348,1.0,9/51,7.87%,ITGA4;SEMA6D;SEMA5A;PKN1;ERBB4;SEMA6C;GPC3;PDLIM1;NANOS1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.4696451598836502,-1.1587269929383806,0.2867647058823529,0.6539411065096463,1.0,4/14,11.08%,ATP1B3;ACTN2;AKAP9;LRRC38
prerank,negative regulation of protein catabolic process (GO:0042177),-0.38003495792467623,-1.1586399651436363,0.24735729386892177,0.6533549440589557,1.0,15/40,22.15%,TIMP3;EGFR;PTPN3;TIMP2;CST3;ATRAID;IRAK3;DAB2IP;PRKCG;RGP1;TIMP4;SIRT2;SNX3;CDK5RAP3;AZIN1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.44623290698351725,1.1582759745629942,0.27893738140417457,0.7700911218467867,1.0,4/34,4.25%,PDGFRB;PTK2;PIK3R1;FGF2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3392208944351561,-1.1581889553592832,0.19839142091152814,0.6537511617668078,1.0,30/72,30.77%,ELF1;CFLAR;IRAK2;GAS6;STAT1;BIRC3;USP18;TNFRSF1A;CASP8;IRAK3;SPHK1;HSP90AB1;VRK2;RNASEL;RIPK1;AGPAT2;PTPN2;IKBKG;SYK;SIGIRR;PTPN6;CBFB;ZBP1;RACK1;LIFR;TAX1BP1;IL7;SOCS1;TRADD;AGPAT1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.4911563756970564,-1.1580652375287965,0.27485380116959063,0.6532750958764945,1.0,9/14,29.65%,SUFU;TMSB4X;MDFI;PKD1;NFKBIA;PSMD10;G3BP2;NFKBIE;KEAP1
prerank,regulation of RNA metabolic process (GO:0051252),-0.35063630532612317,-1.157569839661311,0.18858560794044665,0.65371962148975,1.0,15/59,12.59%,AHNAK;MBNL1;RBM20;TNFRSF1B;AFF2;IGF2BP2;RC3H2;NOVA2;SON;OAS2;PCBP2;CLK1;MBNL2;GRSF1;NOVA1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5727885663599963,1.1572787896522285,0.3205944798301486,0.7713022044649539,1.0,3/10,5.22%,PID1;IL1B;GRB10
prerank,regulation of cell death (GO:0010941),-0.3177664914081828,-1.1568061912825192,0.19008264462809918,0.6549170007804337,1.0,33/94,19.09%,BMP7;CCN2;RRAS2;BMP4;SRGAP2;LRRK2;RILPL1;ACER2;CCN3;TNFRSF1B;ACER3;PRODH;CCN4;BECN1;ZC3H12A;SLC25A24;CHMP4B;VPS35;BNIP3L;CCN1;UBB;WNT16;BNIP3;CDKN1B;PARP16;CCN5;WNT11;NPAS2;SRSF6;PARK7;RAB29;CHP1;MT3
prerank,positive regulation of cilium assembly (GO:0045724),0.49968231584082384,1.1565999959998932,0.29957805907172996,0.7718398083570358,1.0,9/18,18.60%,ARHGAP35;FUZ;CEP120;KCTD17;CEP135;HTT;HAP1;MARK4;SEPTIN9
prerank,transport along microtubule (GO:0010970),0.5344209748512921,1.1560552323586093,0.32098765432098764,0.7719393119818326,1.0,5/13,16.41%,ARHGAP21;DYNC1I2;CAMSAP3;COPG2;APBA1
prerank,regulation of neuron migration (GO:2001222),-0.4242737663342704,-1.155909843333957,0.26260504201680673,0.6565348676754799,1.0,5/26,4.01%,PHACTR1;COL3A1;SEMA6A;SRGAP2;ARHGEF2
prerank,iron ion transmembrane transport (GO:0034755),-0.5232922786153593,-1.1557978077194615,0.2870544090056285,0.6559932769591645,1.0,3/10,10.60%,SCARA5;SLC39A14;SLC39A8
prerank,positive regulation of locomotion (GO:0040017),0.4611133848680356,1.1557698337726083,0.31781376518218624,0.7714296942492799,1.0,1/27,0.19%,PDGFRB
prerank,mitochondrial genome maintenance (GO:0000002),0.5517115142721729,1.1555690319581169,0.3282608695652174,0.7707609208423781,1.0,2/11,2.36%,SLC25A33;AKT3
prerank,positive regulation of cell killing (GO:0031343),-0.4950813628973885,-1.1552633514177035,0.28286852589641437,0.6565944400348719,1.0,5/13,19.93%,WNT5A;FZD7;CYBA;NOX1;SYK
prerank,calcium import into the mitochondrion (GO:0036444),-0.5371650459323053,-1.1551051193175927,0.2880143112701252,0.6562287557323023,1.0,6/10,19.68%,MCU;MCUB;AFG3L2;MICU2;MICU1;MAIP1
prerank,negative regulation of cell adhesion (GO:0007162),-0.33691921871560576,-1.154167453211154,0.2169811320754717,0.6579652841793736,1.0,22/72,12.29%,PLXNA2;FBLN1;SEMA6A;PODXL;PLXNA4;ANGPT1;CDH1;ADAM10;ACER2;ACVRL1;RHOA;CYP1B1;DUSP1;FZD4;TGFBI;PLXND1;CDH13;FZD7;ARHGDIA;CD164;TGFB1;EPHB2
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2649762547165544,-1.1538517074670993,0.06818181818181818,0.6579750616074008,1.0,119/428,21.45%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;CTSC;VPS35L;ADAM10;SDCBP;CRISPLD2;CD93;AP2A2;PGRMC1;RAB27A;BRI3;SNAP23;FGL2;PYGB;TNFRSF1B;RHOA;ANO6;MAPK14;NPC2;HEXB;STOM;CD47;CST3;TOM1;PRKCD;FUCA1;NHLRC3;EEF1A1;CTSB;PGLYRP1;PRCP;STK10;CAPN1;PLEKHO2;FTL;PSAP;IQGAP2;GSDMD;MGST1;COTL1;TMC6;RAB7A;YPEL5;DERA;ATP6V0A1;CTSS;TCIRG1;DNASE1L1;CKAP4;ATP8A1;NBEAL2;CYBA;PSMB1;GALNS;PPIA;PSMD11;SURF4;HSP90AB1;VAPA;TMEM30A;DNAJC3;S100A11;NIT2;CEACAM1;SIRPA;UBR4;MANBA;ATP11A;RAP2C;RAB18;FABP5;ATP11B;VAT1;GAA;DYNC1H1;QSOX1;LRG1;ACTR10;FTH1;RAB6A;PSMA2;CANT1;CYB5R3;PNP;AGPAT2;VCP;APRT;PLAUR;ORMDL3;COPB1;GLB1;SYK;CREG1;PSMD3;CYBB;RAB24;PSMB7;TYROBP;DSN1;VAMP8
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.49582076712048,-1.1537534723565475,0.304029304029304,0.6573919014351427,1.0,6/13,28.72%,TGFBR2;GLI3;PNP;CBFB;NCKAP1L;SOCS1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5027255917206133,-1.1535390289550491,0.3050847457627119,0.6571730026178071,1.0,5/12,17.23%,HSPA5;INSIG2;GPAA1;RER1;TAPT1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.4673739801539663,-1.1530650283034891,0.2920892494929006,0.6576710415446537,1.0,5/15,7.22%,MAGI2;SMAD7;ACVR1;SKI;FKBP1A
prerank,sodium ion transport (GO:0006814),0.3907081410274199,1.1528560087641855,0.2708333333333333,0.7760545408437295,1.0,17/85,9.03%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;SLC5A1;FGF13;SLC24A4;SLC24A2;SCN2A;SCN5A;ASIC2;HCN2;SCN8A;HCN3;SLC6A15;SCN9A;PKD2
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5173547424617089,-1.1525665604552107,0.3198458574181118,0.6582357915917658,1.0,3/10,10.32%,ROCK2;IL15;IL18
prerank,regulation of B cell differentiation (GO:0045577),-0.4630160671203885,-1.152360072059885,0.29458917835671344,0.6580346651244829,1.0,8/17,25.77%,MMP14;ID2;SFRP1;ZFP36L2;PPP2R3C;SYK;XBP1;NCKAP1L
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4716703365860685,1.152336062745282,0.3065134099616858,0.7761685200154989,1.0,5/24,5.38%,LIMS1;PIK3R1;FERMT2;ROCK1;MAPRE2
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.501712489415187,-1.1521006436629735,0.30458715596330277,0.6578879811919042,1.0,5/12,12.09%,GMDS;CSGALNACT1;FUT8;EXTL2;GFPT2
prerank,GTP metabolic process (GO:0046039),-0.47473602178931934,-1.1511004583422284,0.3069852941176471,0.6597931950574876,1.0,3/15,13.01%,RHOQ;LRRK2;RAN
prerank,aortic valve morphogenesis (GO:0003180),0.45450915932123565,1.1510908682092207,0.2962264150943396,0.7780284230691279,1.0,6/30,2.15%,HEY2;HEYL;NOTCH1;TBX20;SLIT3;ROCK1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.34204782491384106,1.1509499032516677,0.21727395411605938,0.7771661339990412,1.0,12/198,4.57%,INPP4B;PTEN;PLCE1;LIMD1;IMPA2;PIK3CD;INPP5A;PIP4K2A;PIK3CA;PLPPR5;PPP3CA;ITPKB
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4633251721833033,-1.1506101089968888,0.2801556420233463,0.6602518173957832,1.0,4/15,5.98%,APOE;APP;IAPP;PFDN5
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3935457844756864,-1.1505496141477471,0.24750499001996007,0.6595847782847415,1.0,18/32,13.65%,JCAD;HDAC7;THBS1;MEOX2;KLF4;FOXC2;ANXA1;HDAC9;RHOA;MAP2K5;CARD10;FGFBP1;KDR;GATA2;PTGS2;RHOJ;SRPX2;HDAC5
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.39433311229672546,-1.1500109062653623,0.27056277056277056,0.6602228381593146,1.0,6/31,7.22%,TGFBR3;FGFR2;TGFBR1;SMAD7;ZFPM2;FKBP1A
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.4656293150555011,-1.1499883404120936,0.2998102466793169,0.6594722411281296,1.0,3/15,3.30%,IGF1;ROCK2;IL6ST
prerank,regulation of innate immune response (GO:0045088),-0.3554306066585628,-1.1488765612207954,0.2400990099009901,0.6615464356740647,1.0,15/57,16.61%,PARP9;APPL2;IRF1;ERAP1;BIRC3;USP18;IFI35;RNF135;CASP8;IRAK3;SAMHD1;GBP5;LRP8;HSP90AB1;RNASEL
prerank,ceramide transport (GO:0035627),-0.49903308998876916,-1.1488624041403448,0.3047619047619048,0.6607658866443016,1.0,3/12,10.07%,PLTP;CERT1;PSAP
prerank,positive regulation of cellular metabolic process (GO:0031325),0.38466434396721466,1.1485518673669142,0.28013029315960913,0.7818180367480412,1.0,9/98,6.30%,PDGFRB;ACE2;PID1;NR1H3;ECE1;PPARD;ATAD1;IL4;SNCA
prerank,I-kappaB phosphorylation (GO:0007252),-0.5147550873992705,-1.1479898860130673,0.3236434108527132,0.6622485716066283,1.0,7/10,43.72%,ERC1;DAB2IP;TLR4;TLR7;MAP3K7;TLR2;TLR3
prerank,negative regulation of insulin secretion (GO:0046676),-0.4418198410997247,-1.1477383555189475,0.30039525691699603,0.6621681177958988,1.0,9/17,29.25%,CCN3;KCNB1;PIM3;SFRP1;MIDN;SIRT4;PRKN;ADRA2A;CHGA
prerank,regulation of sensory perception of pain (GO:0051930),-0.5092921806869827,-1.1476169558966498,0.28544776119402987,0.6616806958758475,1.0,4/11,11.08%,CCN3;TMEM100;ZFHX2;MGLL
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.44219729403357483,-1.1471030036180243,0.297029702970297,0.662249343298086,1.0,8/18,13.65%,HDAC4;CCN3;FRS2;FZD7;BHLHE41;HDAC1;TMEM119;HDAC5
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.43620513462495736,-1.146992709424874,0.2791164658634538,0.6617330239248687,1.0,3/19,6.17%,DDO;ALDH7A1;ASPA
prerank,regulation of B cell apoptotic process (GO:0002902),-0.4901333045291758,-1.146919341006737,0.3049907578558225,0.6611213058405209,1.0,2/12,7.17%,FOXP1;FNIP1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.3337094223135428,-1.146736446435811,0.19621749408983452,0.6607898094070137,1.0,22/75,11.21%,NRP2;NRP1;TEK;F3;PLCG1;JCAD;BMPR2;BMP4;TGFBR1;VEGFD;VEGFC;IGF2;WNT5A;AKT1;PPP1R16B;HIF1A;ECM1;CDH13;FGFBP1;KDR;GATA2;ITGB3
prerank,regulation of endopeptidase activity (GO:0052548),0.41075368013710695,1.1465730570613981,0.29739130434782607,0.7854382558305198,1.0,3/59,1.03%,SERPINI1;SERPINB8;VTN
prerank,protein catabolic process (GO:0030163),-0.3497852544863663,-1.145761199500017,0.2388758782201405,0.6625912298336795,1.0,24/59,25.65%,LAMP2;APOE;ADAMTS9;TRIM24;DENND3;STT3B;IDE;DAB2IP;UBE2G2;DDB1;CEACAM1;MANBA;CLN8;RIPK1;VCP;NGLY1;TPP1;CLN6;CLN5;CLPX;FBXO17;CHEK2;CTSD;PRKN
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.46997576012687836,-1.1455821564599993,0.2950191570881226,0.6622682500121246,1.0,8/14,24.02%,AKT1;NNMT;DDB1;PPARGC1A;PTPN2;ARPP19;AKT2;SLC45A3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3724913665979116,1.1454167481762372,0.26198083067092653,0.7870123544240033,1.0,16/102,8.25%,CYSLTR2;SLC30A10;SLC25A33;PIK3R1;GPER1;CPEB1;PRKAR1B;RAB8B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;IRS1;GOT1;PRKAR2A
prerank,activation of protein kinase activity (GO:0032147),-0.309186306658387,-1.1451834698027694,0.19883040935672514,0.6625367210739637,1.0,27/106,14.14%,IGF1;NTRK3;ADCY5;OSBPL8;ADCY1;TGFBR2;NRK;ANGPT1;GHR;GAS6;FGF1;ADCY7;TOM1L1;WNT5A;PTK2B;CARD14;PRKCD;PRRC1;TAOK2;AKT1;CARD10;IL18;ITGB3;COPS8;PRKACB;TXN;PPIA
prerank,positive regulation of interferon-gamma production (GO:0032729),0.41781227444185953,1.1451617756698482,0.313458262350937,0.7865044253008587,1.0,5/48,8.18%,PDE4D;IL1B;PTPN22;PDE4B;IL12RB1
prerank,macromolecule catabolic process (GO:0009057),-0.4135749766570828,-1.1448790432074145,0.30039525691699603,0.6625176842028118,1.0,12/26,22.40%,TRIM24;SMURF1;BECN1;IDE;TGFB1;SH3GLB1;UVRAG;CLN8;TPP1;CLN6;CLN5;CLPX
prerank,regulation of defense response (GO:0031347),-0.3298449229643068,-1.1445486131208358,0.23383084577114427,0.6626284346972459,1.0,26/76,13.27%,ADAMTS12;FOXP1;APOE;CASP12;IL1R1;SEMA7A;ANXA1;SBNO2;LACC1;APPL2;CASP4;IRF1;WNT5A;PIK3AP1;ERAP1;BIRC3;TMSB4X;DAGLB;USP18;RNF135;CASP8;SAMHD1;MGLL;PTGS2;RELA;LRP8
prerank,negative regulation of immune effector process (GO:0002698),-0.47803221394476936,-1.1441218551087133,0.32941176470588235,0.6629224965801505,1.0,5/13,13.59%,CD55;ENPP3;RPS19;CD47;FER
prerank,response to interleukin-4 (GO:0070670),-0.5068538034337311,-1.1437504036459056,0.30275229357798167,0.663098555072828,1.0,4/10,24.39%,LEF1;XBP1;SHPK;TCF7
prerank,glucose homeostasis (GO:0042593),-0.3242745563372622,-1.1437412602572063,0.19843342036553524,0.6623194548524921,1.0,22/83,20.35%,LEPR;FOXO1;MCU;ADIPOR2;RBP4;IGF1R;TCF7L2;APPL2;STAT3;HK2;HIF1A;KCNB1;FOXK1;FGFR4;USF1;RPS6;PRKAA2;BACE2;PARK7;PPARGC1A;PTPN2;ADIPOR1
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.25599619394791023,-1.1434804885918048,0.050359712230215826,0.6622133701301886,1.0,143/532,20.35%,COL1A2;FN1;PLCB1;LEPR;IL31RA;SP100;FOXO1;FOXO3;ADIPOR2;IL15;F3;IL1R1;IL6R;VIM;LBP;ANXA2;IL6ST;PTPRJ;B2M;MAP3K14;RAP1B;NOD1;GHR;ANXA1;CSF1;SOCS2;VCAM1;PDCD4;PITPNA;TNFRSF11B;IL16;IRAK2;CXCL12;IFITM3;APPL2;YAP1;STAT2;MAOA;GREM2;P4HB;IRF1;CCL15;TNFRSF1B;ICAM1;MAP3K8;PTK2B;FOXC1;IRF2;STAT1;CARD14;STAT3;CCL14;STX3;TALDO1;IFI27;BIRC3;TMSB4X;PRKCD;RAPGEF1;IFIT2;PIK3CB;IRF9;AKT1;KIT;MCL1;IL33;HIF1A;OAS2;TNFRSF1A;BCL2L11;IL17RA;IFI35;IFIT3;LAMA5;IFIT1;IRAK3;SAMHD1;IL18;STX1A;EIF5A;PML;PSME2;CAMK2A;TGFB1;PTGS2;INPP5D;CCL25;RELA;S1PR1;PSMB4;FBXW11;FLT3LG;TNFRSF11A;UBB;LRP8;CCND1;FER;UGCG;PSMB1;PPIA;PSMD11;IP6K2;PSMD8;POU2F1;MAPK3;CNTFR;IFITM2;GBP2;MMP2;SDC1;CCL13;IL10RB;PSME3;CEACAM1;CDKN1B;JAGN1;RNASEL;PELI1;JUNB;TRIM8;RIPK1;CSF3R;TRAF3IP2;RSAD2;NFKBIA;MAP3K3;EDA;PSMD4;RPLP0;HSP90B1;PSMA2;IL17RE;CSF2RA;MT3;EDA2R;IL20RB;NDN;CANX;IKBKG;SYK;PSMD3;CSF1R;ADIPOR1
prerank,regulation of neurotransmitter transport (GO:0051588),0.5126057535691175,1.1432515171819513,0.34419551934826886,0.7900752555352989,1.0,3/16,6.12%,MEF2C;RIMS1;SYN1
prerank,epiboly involved in wound healing (GO:0090505),-0.45912222986597445,-1.1431733401500253,0.3087121212121212,0.6622136656049483,1.0,10/16,25.35%,PDPN;DDR1;RHOA;CCN1;CEACAM1;CD151;RHOC;TMEFF2;LCP1;CD44
prerank,neutrophil degranulation (GO:0043312),-0.2639740560772527,-1.142806726305271,0.07471264367816093,0.6624018053588305,1.0,118/425,21.45%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;CTSC;VPS35L;ADAM10;SDCBP;CRISPLD2;CD93;AP2A2;PGRMC1;RAB27A;BRI3;SNAP23;FGL2;PYGB;TNFRSF1B;RHOA;ANO6;MAPK14;NPC2;HEXB;STOM;CD47;CST3;TOM1;PRKCD;FUCA1;NHLRC3;EEF1A1;CTSB;PGLYRP1;PRCP;STK10;CAPN1;PLEKHO2;FTL;PSAP;IQGAP2;GSDMD;MGST1;COTL1;TMC6;RAB7A;YPEL5;DERA;ATP6V0A1;CTSS;TCIRG1;DNASE1L1;CKAP4;ATP8A1;NBEAL2;CYBA;PSMB1;GALNS;PPIA;PSMD11;SURF4;HSP90AB1;VAPA;TMEM30A;DNAJC3;S100A11;NIT2;CEACAM1;SIRPA;UBR4;MANBA;ATP11A;RAP2C;RAB18;FABP5;ATP11B;VAT1;GAA;DYNC1H1;QSOX1;LRG1;ACTR10;FTH1;RAB6A;PSMA2;CANT1;CYB5R3;PNP;AGPAT2;VCP;APRT;PLAUR;ORMDL3;COPB1;GLB1;CREG1;PSMD3;CYBB;RAB24;PSMB7;TYROBP;DSN1;VAMP8
prerank,positive regulation of protein processing (GO:0010954),-0.4417668504954617,-1.1427424022564112,0.3239130434782609,0.6617880889490325,1.0,4/19,5.46%,GSN;CCBE1;CLEC3B;LPCAT3
prerank,cellular response to interleukin-1 (GO:0071347),-0.2925759491783983,-1.142522426676897,0.15822784810126583,0.6615372465560144,1.0,45/143,24.89%,PLCB1;ADAMTS12;PTGIS;IL1R1;NOD1;IRAK2;CCL15;MAP3K8;CCL14;CD47;HIF1A;IRAK3;DAB2IP;ZC3H12A;PSME2;CCL25;RELA;PSMB4;FBXW11;UBB;SFRP1;PSMB1;PSMD11;PSMD8;MAPK3;GBP2;CCL13;PSME3;SIRPA;PELI1;NFKBIA;MAP3K3;PSMD4;PSMA2;IKBKG;PSMD3;PSMB7;CCL19;PSMC2;GBP3;USP10;PSMC5;EGR1;PSMD10;MYD88
prerank,diterpenoid metabolic process (GO:0016101),-0.34883360022096566,-1.1424776311890417,0.25,0.6608926060195198,1.0,10/55,8.16%,ALDH1A1;RBP1;APOE;DHRS3;RBP4;HSPG2;AKR1B1;SDC4;ABCA4;STRA6
prerank,cellular response to catecholamine stimulus (GO:0071870),0.46380365286138214,1.1422526231532544,0.31094049904030713,0.7913149689842487,1.0,6/23,6.89%,GNG2;ADCY6;PDE4B;SNCA;RYR2;GABPA
prerank,cellular response to hydroxyurea (GO:0072711),0.544483150834031,1.1419765464496816,0.3244444444444444,0.7908411496093745,1.0,5/10,19.55%,TIMELESS;BLM;FMR1;DDX11;RTF2
prerank,negative regulation of TOR signaling (GO:0032007),0.44321411425941715,1.1419580354369336,0.32541133455210236,0.7897360247562839,1.0,9/36,14.30%,SPAAR;UBR1;SESN3;AKT1S1;NPRL3;DDIT4;UBR2;NPRL2;PRKAA1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.47284061860265597,-1.1417104084432819,0.3081395348837209,0.6621550418588852,1.0,5/14,13.61%,ADAM10;WNT5A;PTK2B;WNK1;OXSR1
prerank,cellular response to unfolded protein (GO:0034620),-0.3999102090702775,-1.1411884412999287,0.2911392405063291,0.6627769340061883,1.0,11/26,28.08%,HSPB8;HSPA5;BAG3;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;HSPA9;PRKN;HSPA1B
prerank,sensory perception of taste (GO:0050909),0.5404247555696282,1.1410858201339085,0.3282937365010799,0.790641098816386,1.0,3/10,12.31%,TAS1R1;ASIC2;ASIC3
prerank,myeloid cell development (GO:0061515),-0.4425309098650817,-1.140874896192057,0.2761904761904762,0.6628111924248705,1.0,5/18,11.70%,FOXP1;APP;ANXA2;KIT;ALAS1
prerank,glycine metabolic process (GO:0006544),0.5315435579782262,1.1406618567384887,0.33916849015317285,0.7904864293540763,1.0,5/12,15.53%,BAAT;GCSH;GLYAT;GCAT;DLD
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.2564149240633273,-1.140604939002263,0.07575757575757576,0.6627029971033694,1.0,140/509,19.80%,IGF1;PDGFD;FN1;EGFR;FLT1;DCN;ROCK2;NFAT5;PDGFRA;NTRK3;AKAP13;LPAR1;OSBPL8;VWF;TEK;TGFA;IQGAP1;APP;F3;CAV1;NUPR1;JCAD;SASH1;KSR1;ESR1;TGM2;FGFR2;THBS1;PTPRJ;GJA1;IGF1R;TGFBR1;ANGPT1;MAP3K14;NR3C2;TCF7L2;NOD1;ADGRV1;CFLAR;PDCD4;GSDME;IGF2;DDX60;GAS6;TNFSF10;FGF1;IAPP;LGALS9;WNT5A;RPS20;IKBKE;RHOA;PRKCB;KL;PLK2;MFHAS1;PIK3AP1;FNIP1;FKBP1A;P2RX4;TFRC;BIRC3;EEF1D;TBX1;GOLPH3;USP15;PIK3CB;ADRA1B;NOS1AP;KIT;TNFRSF19;FRS2;ECM1;TNFRSF1A;BCL2L11;IFI35;CDH13;BECN1;EPHA8;FLCN;RPL37;CASP8;DAB2IP;IL18;KDR;TRIM27;MYOC;MAVS;PUM1;TGFB1;TNFAIP8L3;TRIP6;PLEKHG5;FGFR4;RELA;FLT4;FLT3LG;WNT16;PLCG2;SPHK1;MET;RET;TICAM1;TXN;HSP90AB1;CAV2;MAZ;VAPA;RPS15;RPL23;TLR4;PELI1;BID;TRIM8;BCAP31;TCIM;RIPK1;WNT11;PDGFC;TRAF3IP2;ROR2;MAP3K3;PDPK1;ADRB2;CC2D1A;RRAGB;PARK7;TRIM14;LAMTOR5;AGT;CANT1;MST1R;BBC3;PIK3R5;PIM2;EDA2R;LGALS1;CHD5;IKBKG;RHOC
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.516108999697962,-1.1403168308921217,0.31464737793851716,0.6626854308931018,1.0,7/10,40.85%,ABCA3;MFSD2A;MTMR3;MTMR1;PHB2;MTMR4;GNB3
prerank,regulation of secretion by cell (GO:1903530),0.40953587818289655,1.1401355022690656,0.27712854757929883,0.7905469880240692,1.0,12/54,11.13%,MEF2C;RAB8B;RHBDF1;RIMS1;RIMS2;RAB3B;SYN1;RIC1;LGI3;SYT1;STXBP5L;STX4
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4380259112052042,-1.139616499783226,0.28402366863905326,0.6637617047065819,1.0,8/20,15.76%,GLI2;ACVR1;ACVRL1;NBL1;MDFI;PTCH1;SFRP1;BMPR1A
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5300917933039605,1.1394861235494391,0.3227848101265823,0.7909800613786296,1.0,2/12,0.65%,MEF2C;PRKG1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.4777005898832828,-1.1382120462069532,0.3193430656934307,0.6666796887983911,1.0,6/14,19.93%,CD55;TGFBR2;LGALS9;IL18;CD81;SYK
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5158160687628012,1.1381476239998554,0.33126293995859213,0.7930806588345737,1.0,6/14,16.52%,FASTKD2;MRPS27;FASTKD3;TRMT10C;RMND1;C1QBP
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.44012834849883337,-1.1379627888509694,0.30357142857142855,0.666526374758174,1.0,8/21,20.47%,PLTP;APOE;CAV1;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4913752980001322,1.1371069608707767,0.31222707423580787,0.7943901976243438,1.0,3/17,11.86%,COX4I2;COX4I1;COX5A
prerank,folic acid-containing compound metabolic process (GO:0006760),0.47699003396913087,1.1371001818989102,0.3114754098360656,0.7932534097140338,1.0,4/19,7.43%,SLC19A1;DHFR;GGH;MTHFD2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5495967807552402,1.1369990084775294,0.3470225872689938,0.7923669430491841,1.0,1/10,0.56%,SOX5
prerank,positive regulation of cell projection organization (GO:0031346),-0.312013614548125,-1.1367865646341302,0.21921921921921922,0.6687966425356763,1.0,24/115,9.29%,PLXNA2;ROBO1;DPYSL3;EPHA3;NTRK3;CUX1;CAMK1D;TIAM2;APOE;PLXNA4;SLIT2;ITGA6;MAGI2;ARSB;NDNF;WNT5A;RHOA;PTK2B;RAPGEF1;FZD4;OBSL1;TIAM1;PLXND1;CBFA2T2
prerank,energy reserve metabolic process (GO:0006112),-0.44023078052955994,-1.1367173359380358,0.30078125,0.6681946403114205,1.0,3/19,1.80%,PRKAG2;LEPR;PHKB
prerank,cellular response to interleukin-6 (GO:0071354),-0.4159419886546541,-1.1365750520566185,0.31020408163265306,0.6677853996689097,1.0,8/26,7.33%,ST3GAL6;PTGIS;IL6R;IL6ST;SBNO2;YAP1;STAT1;STAT3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.3153606108250802,-1.1363898096212515,0.20728291316526612,0.6674904748708994,1.0,36/93,23.63%,PLCB1;CCN2;SH3RF1;APP;SASH1;XDH;RASSF2;SDCBP;PTK2B;SH3RF3;MFHAS1;SH3RF2;TAOK2;TNFRSF19;FZD7;DAB2IP;ZC3H12A;RELL1;FLT4;WNT16;SPHK1;MAPK8IP1;HIPK2;ARL6IP5;MAP3K4;RIPK1;GADD45G;EDA2R;TPD52L1;CCL19;VEGFA;EDAR;KLHDC10;SEMA4C;GADD45B;DUSP15
prerank,generation of neurons (GO:0048699),0.3437026817684822,1.1362179353747532,0.2534435261707989,0.7930837309268056,1.0,30/190,12.05%,MEF2C;HEY2;ADGRL3;HEYL;RAPGEF2;CDK6;PER2;MARK1;IL1B;ASTN1;FGF13;DNER;RYK;ASTN2;TAFA3;NTRK2;TUBB2B;CCK;FUT9;IL1RAPL1;MARK2;RNF112;LHX4;RUNX2;DDIT4;SPOCK1;BRSK1;WNT3;YTHDF2;MYT1L
prerank,transition metal ion homeostasis (GO:0055076),-0.4043451515678341,-1.136122310917797,0.2631578947368421,0.6674003004972825,1.0,8/28,19.09%,CP;B2M;NEO1;SLC39A14;FTL;BDH2;HFE;MT3
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4684751000215054,-1.1358545978925096,0.3107344632768362,0.6672748344952593,1.0,4/14,16.74%,MOXD1;DAGLB;NOS1;SLC22A2
prerank,triglyceride metabolic process (GO:0006641),-0.36202979740980523,-1.1354261316842496,0.2737819025522042,0.6676041004810781,1.0,4/48,3.14%,APOE;AGMO;CAV1;LPGAT1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.48550681260037565,-1.1353464492314749,0.327683615819209,0.6670195375654278,1.0,7/12,31.51%,ACADL;CEACAM1;ERLIN2;BRCA1;PIBF1;TRIB3;APOC1
prerank,regulation of axonogenesis (GO:0050770),0.4145979816744735,1.135222362759539,0.29931972789115646,0.7941977074577591,1.0,16/51,11.74%,CHN1;PTEN;CDH2;LINGO1;LRRC4C;PLXNB1;METRN;NTRK2;ROBO2;SLITRK1;MARK2;ARHGAP35;BRSK1;PAK3;PAK1;PLXNB3
prerank,intracellular protein transport (GO:0006886),-0.2698704951917739,-1.1350623285537615,0.1308411214953271,0.667015508270892,1.0,122/304,29.60%,RANBP3L;LAMP2;KIF13B;ARL4A;SGSM2;TBC1D22A;SNX9;SNX6;ARHGEF2;KIF13A;TLK1;SEC31A;COPZ2;RABGAP1L;APPL2;STX7;SMURF1;USP6NL;TBC1D8B;GGA2;STAT3;STX3;COPA;ARFIP2;CCHCR1;EHD1;TBC1D8;RASSF9;AP3B1;AKT1;BAG3;C2CD5;AP4M1;RAB21;STX1A;USO1;STX6;VPS35;LMAN1;RAB7A;RPL11;TBC1D10A;TGFB1;IPO7;FAM53C;IPO13;AP2A1;SCFD2;RAN;CALR;EVI5;ARL5A;SURF4;TBC1D2;PKD1;SEC23IP;NAPA;TBC1D25;RAB3GAP2;NXT2;IPO8;RAB18;HOMER3;TBC1D13;TPR;AP4E1;SAR1A;RAB29;RAB6A;STX2;RAB32;HPS4;CHP1;SAR1B;NUP88;SNX8;RABL3;MAIP1;YWHAH;VPS26C;ARFIP1;VPS28;SYK;TMED9;NUP214;TBC1D14;RAB24;AP3D1;TMED2;WDR11;ACD;NXT1;AP4B1;LTBP2;AKT2;XPO4;TBC1D22B;STX17;TBC1D5;SEC31B;NUP155;ARL4D;TBC1D4;PICK1;RANBP17;TBC1D17;EIF4ENIF1;TBC1D16;RAB19;STX19;SEC16A;CSE1L;PREB;EIF2D;NUP62;ARF4;PTTG1IP;LAPTM5;CTTN;RAB22A;TMED1;TNPO2
prerank,negative regulation of cell death (GO:0060548),-0.32408451356388723,-1.134992337268057,0.1994535519125683,0.6664578682641875,1.0,30/88,19.70%,MECOM;BMP7;CCN2;BMP4;SRGAP2;LRRK2;CSF1;CD34;CCN3;TNFRSF1B;AKT1;CCN4;BECN1;CHMP4B;CHMP4A;VPS35;BNIP3L;CCN1;WNT16;BNIP3;PARP16;CD200;CCN5;WNT11;NPAS2;SRSF6;PARK7;MT3;PPARGC1A;IKBKG
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.38131902553601965,-1.1346385310527225,0.26789366053169733,0.6665983037650103,1.0,8/35,3.21%,SULF1;FLT1;APOE;SPARC;CAV1;XDH;PTPRM;THBS1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.4810550300340791,-1.1344840981740543,0.3160919540229885,0.6662357015175481,1.0,4/13,3.45%,BMP6;DAB2;BMP4;TGFBR1
prerank,regulation of cell aging (GO:0090342),0.5438140285523433,1.1340791509632637,0.34303534303534305,0.7957420981990259,1.0,5/11,20.79%,FOXM1;NEK6;NUAK1;RSL1D1;NEK4
prerank,cell projection assembly (GO:0030031),-0.4232018864848933,-1.1337918697380553,0.2814498933901919,0.6672290274621999,1.0,6/22,18.11%,GSN;RHOQ;PARVB;RHOJ;PARVA;RHOH
prerank,cellular component maintenance (GO:0043954),-0.4895914372653083,-1.1332498595970837,0.30474452554744524,0.6678526792156781,1.0,3/12,14.79%,IGF1R;ITGA3;CLDN1
prerank,cellular protein catabolic process (GO:0044257),-0.34343382211493484,-1.1330456387254466,0.23728813559322035,0.6675718579626039,1.0,19/59,13.89%,ADAMTS12;CTSH;CAPN2;CTSC;DENND3;AP2A2;CLTA;CTSB;CASP8;IDE;DAB2IP;RAB7A;BNIP3L;CTSS;TCIRG1;MDM2;AP2A1;BNIP3;UBE2G2
prerank,cellular response to alcohol (GO:0097306),-0.3640587537390323,-1.1328952549312636,0.2841163310961969,0.667187715093235,1.0,15/42,13.91%,ADCY5;ADCY1;LRP6;CDH1;SMO;GRAMD1C;GRAMD1A;ADCY7;GOLPH3;ADAM15;CTNNA1;PTCH1;AHR;LARP1;SFRP1
prerank,response to amyloid-beta (GO:1904645),-0.36109614557265546,-1.1327092343722263,0.29515418502202645,0.6668979314865819,1.0,9/44,6.55%,IGF1;EPHA4;APP;GJA1;IGF1R;SNX6;VCAM1;CASP4;ICAM1
prerank,N-glycan processing (GO:0006491),0.496979265185034,1.1327027808089043,0.32941176470588235,0.7979153859408696,1.0,3/18,2.99%,PRKCSH;ST8SIA4;ST8SIA1
prerank,neutrophil mediated immunity (GO:0002446),-0.26246741173902,-1.1326542664555486,0.08333333333333333,0.666267797309815,1.0,119/432,21.45%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;CTSC;VPS35L;ADAM10;SDCBP;CRISPLD2;CD93;AP2A2;PGRMC1;RAB27A;BRI3;SNAP23;ACE;FGL2;PYGB;TNFRSF1B;RHOA;ANO6;MAPK14;NPC2;HEXB;STOM;CD47;CST3;TOM1;PRKCD;FUCA1;NHLRC3;EEF1A1;CTSB;PGLYRP1;PRCP;STK10;CAPN1;PLEKHO2;FTL;PSAP;IQGAP2;GSDMD;MGST1;COTL1;TMC6;RAB7A;YPEL5;DERA;ATP6V0A1;CTSS;TCIRG1;DNASE1L1;CKAP4;ATP8A1;NBEAL2;CYBA;PSMB1;GALNS;PPIA;PSMD11;SURF4;HSP90AB1;VAPA;TMEM30A;DNAJC3;S100A11;NIT2;CEACAM1;SIRPA;UBR4;MANBA;ATP11A;RAP2C;RAB18;FABP5;ATP11B;VAT1;GAA;DYNC1H1;QSOX1;LRG1;ACTR10;FTH1;RAB6A;PSMA2;CANT1;CYB5R3;PNP;AGPAT2;VCP;APRT;PLAUR;ORMDL3;COPB1;GLB1;CREG1;PSMD3;CYBB;RAB24;PSMB7;TYROBP;DSN1;VAMP8
prerank,negative regulation of dephosphorylation (GO:0035305),-0.44985343183793514,-1.1324135964973494,0.30952380952380953,0.6661312830989031,1.0,8/18,23.86%,MFHAS1;PTPA;SH3RF2;PPP1R16B;CHP1;ARPP19;SH2D4A;INPP5K
prerank,MAPK cascade (GO:0000165),0.324814866189017,1.132332943731698,0.23717948717948717,0.7976933022029771,1.0,55/295,13.55%,PDGFRB;MEF2C;MAP3K20;RAPGEF2;MAP3K5;PTK2;PIK3R1;BTRC;RASGRP3;IL17RD;NF1;SPRED1;GFRA2;ERBB4;IL1B;CUL3;NRG1;PIK3CA;IL2RA;RBX1;SPTBN1;RASAL2;JAK1;FGF13;FGF2;MINK1;RIT2;PSMB11;SPTB;TNIP2;TAOK3;PSMF1;SPTA1;HRAS;IRS1;FGF10;PPP1CC;MAP4K4;PDGFB;GRIN2B;DLG2;RGL3;BRAF;KBTBD7;PAK1;RASGEF1A;PSME4;RGL1;GFRA1;DLG3;FGFR3;RASA3;NRG4;SYNGAP1;RASA1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.4624512046076313,-1.132271190854299,0.3154981549815498,0.6657311770560552,1.0,4/15,6.32%,APOE;SNX9;ADAM9;TNFRSF1B
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.44993580641431535,-1.1316960351995204,0.30148619957537154,0.6664988247711678,1.0,5/17,15.34%,BMP4;SFRP4;TMEM100;ATOH8;NKX6-1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3529340411525493,-1.1315144704081184,0.24708624708624707,0.6662102162382502,1.0,20/51,14.78%,ROCK2;NRP1;LPAR1;CCN2;TGFBR1;SORBS3;PXN;ARHGEF10L;SYNPO2;SYNPO;RHOA;CD47;S100A10;FHOD1;MYOC;PFN1;EVL;SFRP1;LIMCH1;ARHGEF15
prerank,regulation of microglial cell activation (GO:1903978),0.5101192191297242,1.131441462866639,0.32793522267206476,0.798707863298948,1.0,3/15,6.28%,LDLR;TAFA3;TTBK1
prerank,detection of mechanical stimulus (GO:0050982),0.49239907576523256,1.1313955644018439,0.32842105263157895,0.7976744727322557,1.0,2/19,1.34%,CDH2;PTK2
prerank,bile acid and bile salt transport (GO:0015721),-0.4187160090414865,-1.131209367363337,0.28600405679513186,0.6662110519088419,1.0,3/24,3.90%,ABCC4;SLCO2B1;SLCO1C1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.45348510916474183,1.1311148469574261,0.3182674199623352,0.7971658201380688,1.0,7/26,10.95%,PTEN;NRXN1;RIMS1;RIMS2;CHRNA7;TMEM108;CUX2
prerank,histone mRNA catabolic process (GO:0071044),-0.4618262807358089,-1.130800061835632,0.3207171314741036,0.6665170727725132,1.0,6/15,20.22%,TUT4;TUT7;MTPAP;ATM;XRN1;TENT4B
prerank,Wnt signaling pathway (GO:0016055),-0.31912552361292934,-1.1303685894830982,0.26256983240223464,0.6668854153720245,1.0,27/92,13.91%,NXN;WNT4;PLPP3;WNT6;CPE;TCF7L2;LRRK2;LRP6;LEF1;FZD2;WNT9A;RARG;SFRP4;WNT5A;CSNK1G2;FZD4;USP34;NR4A2;FZD7;VPS35;BCL9L;WNT5B;CCDC88C;UBB;WNT16;PLCG2;SFRP1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4658806574127433,-1.1299361097907432,0.30784708249496984,0.6664954135602855,1.0,2/14,3.98%,SLCO2B1;ABCG2
prerank,heme catabolic process (GO:0042167),-0.4658806574127433,-1.1299361097907432,0.30784708249496984,0.6664954135602855,1.0,2/14,3.98%,SLCO2B1;ABCG2
prerank,regulation of hydrolase activity (GO:0051336),-0.3278007185004017,-1.1298858453974154,0.2474747474747475,0.6658832129632523,1.0,20/71,13.19%,PLXNA2;EPHA4;EPHA3;FGD5;FGD6;SIPA1L1;PLXNA4;CHN2;CAV1;VAV2;RASIP1;EFNA5;RAB3GAP1;PLXND1;DAB2IP;ADAP1;FGD4;CAMK2A;FBXW11;TDG
prerank,positive regulation of transferase activity (GO:0051347),-0.29442326100486377,-1.1295336064263197,0.19936708860759494,0.6660611043204981,1.0,39/142,18.97%,EPHA4;EPHA3;EGFR;FLT1;EPHA7;PDGFRA;NTRK3;LMO4;TEK;FGFR2;EPHB4;IGF1R;KLF4;IGF2;DDR1;TIE1;DTX3L;KIT;NAF1;EPHA8;KDR;TGFB1;FGFR4;EPHB2;FLT4;MET;RET;HSP90AB1;MAPK3;RAD50;SERINC1;CD200;MAP3K4;EPHB3;ROR2;ARRDC4;ALK;MST1R;RFC3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3566717399859908,-1.1292872965378111,0.23569794050343248,0.6659354946642105,1.0,18/49,27.22%,SGMS1;CAV1;NUPR1;GSDME;P4HB;MCL1;BCL2L11;BECN1;BID;BCAP31;BBC3;PLAUR;EIF2AK3;NDUFA13;BCL2L1;RACK1;TP53;DAPK2
prerank,chromatin remodeling (GO:0006338),-0.3192436934435392,-1.1289055859338168,0.233983286908078,0.6661959524578945,1.0,28/100,22.86%,SMARCA2;HDAC4;ESR1;KAT2B;BAZ1A;INO80;KDM5B;CHD3;BPTF;BAZ1B;BAZ2B;TADA2A;JARID2;HDAC1;EZH1;MPND;HDAC5;ACTB;SMARCC1;KDM6B;HCFC2;ACTR8;SMARCAD1;RSF1;CHRAC1;MBD2;PIH1D1;SMARCA4
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.46401674564908024,1.1284435748686568,0.32388663967611336,0.8023154142263664,1.0,5/23,9.95%,SLC12A2;SLC12A6;TFAP2B;SLC9A7;SLC12A5
prerank,stress-activated MAPK cascade (GO:0051403),0.4014872725892911,1.128198010950552,0.30377668308702793,0.8017387785564003,1.0,7/61,7.59%,MAP3K20;MAP3K5;ARHGEF6;BTRC;MINK1;TNIP2;RIPK2
prerank,oxoacid metabolic process (GO:0043436),-0.40454291015134386,-1.127187506253094,0.2786885245901639,0.6699864055059519,1.0,9/27,25.87%,DDO;ENPP1;SULT1A1;TPST1;AGXT;TPST2;PPA1;SULT4A1;GRHPR
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.46685227919339656,-1.1266898991633052,0.34150943396226413,0.6705577345882372,1.0,6/15,28.70%,CD55;GLI3;PNP;SYK;HSPH1;CCR2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.512226942401415,1.1265949810007243,0.32978723404255317,0.8044242858076428,1.0,6/14,19.05%,WAS;FANCB;TIMELESS;PARP1;MRNIP;FUS
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4632602385755339,1.1265828984988162,0.3203125,0.8033032198632803,1.0,3/22,3.49%,NOTCH1;ERBB4;CRLF3
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.47817132114209027,-1.1264941999319247,0.33948339483394835,0.6702875443533609,1.0,5/11,26.44%,KCNJ2;KCNQ1;ATP1A1;YWHAE;KCNH2
prerank,organelle organization (GO:0006996),0.3139613841277132,1.126478605726051,0.2503037667071689,0.8024009925899693,1.0,64/388,11.77%,MAST4;PLCE1;LIMD1;ARHGAP21;ARHGAP10;SH3KBP1;SYNE1;SLC25A33;DPYSL2;MARK1;WASF3;SIPA1;ABCD2;PTCD2;TMCC1;TOR1B;ABI2;SORT1;ATP7A;MREG;WASL;COG7;FMNL3;CENPW;FANCG;PEX7;AJUBA;ATP8B2;COG1;CLASP2;FAF2;YTHDF3;ESRRA;CHMP2B;ARFGEF1;HACE1;GABPA;LIG4;BIN1;PAK6;PIKFYVE;VPS18;BLZF1;PEX1;TFAM;RAB38;FAM161A;RNF112;MIA3;PKD2;ZMYM3;TMED7;PAK5;VPS11;UBXN2B;TMED4;KIF3A;DYRK3;TMEM135;ARHGEF7;STX4;KIF5C;PACSIN3;YTHDF2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3566735435767594,-1.1264521328461252,0.2681818181818182,0.6696593733254631,1.0,25/46,36.58%,PIEZO2;MAP3K14;MAP3K1;PIEZO1;IRF1;TNFRSF1A;CASP8;F11R;BNIP3;MAPK3;TLR4;SLC9A1;MYD88;FAS;CRADD;BCL10;CD40;LTBR;KCNK4;TLR7;FADD;CHEK1;TNFRSF10B;AQP1;TLR5
prerank,regulation of cytoplasmic translation (GO:2000765),0.5094469972475012,1.1262665603429327,0.3374485596707819,0.8017090238206022,1.0,6/14,16.88%,CPEB1;RBM24;CPEB4;DHX36;FMR1;PKM
prerank,response to tumor necrosis factor (GO:0034612),0.37444936578447263,1.1262461342256942,0.2828438948995363,0.8006131448501076,1.0,5/91,1.63%,GGT5;PID1;GGT1;TNFRSF21;GPER1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3837267090691387,-1.1262344556744905,0.28663793103448276,0.6694759175324954,1.0,13/31,29.31%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;E2F1;YWHAH;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,regulation of extracellular matrix organization (GO:1903053),0.503223124496867,1.1260245620071085,0.33476394849785407,0.7999828557611415,1.0,5/15,11.68%,FAP;NOTCH1;RIC1;EFEMP2;RB1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.3509662738399345,-1.1259609888017998,0.27710843373493976,0.6694489314686313,1.0,23/54,35.93%,CFLAR;GAS6;CASP4;BIRC3;TNFRSF1A;CASP8;SPHK1;RIPK1;PTPN2;IKBKG;SYK;RFFL;RACK1;PRKN;PYDC1;TAX1BP1;HSPA1B;LAPTM5;TRADD;SPATA2;ADAM17;FADD;PELI3
prerank,nerve growth factor signaling pathway (GO:0038180),0.5399744946055034,1.1258692075645913,0.3422222222222222,0.7992147935578613,1.0,2/10,6.91%,RAPGEF2;RAP1A
prerank,regulation of protein localization to centrosome (GO:1904779),0.5382509992794258,1.1258185291426728,0.35698924731182796,0.7982031206498872,1.0,4/10,18.48%,UBXN2B;APC;GSK3B;MARK4
prerank,negative regulation of macroautophagy (GO:0016242),-0.39970258556066973,-1.125467432266904,0.281437125748503,0.6699884863513832,1.0,8/26,11.16%,NUPR1;LRRK2;CLEC16A;NRBP2;AKT1;CHMP4B;CHMP4A;PHF23
prerank,lymphocyte proliferation (GO:0046651),0.4668834191974289,1.1253028454602978,0.32748538011695905,0.7981912468877277,1.0,1/22,0.63%,MEF2C
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.49909293106773883,1.125241961094335,0.32007952286282304,0.7972028279285209,1.0,2/19,2.35%,NDST3;EXTL3
prerank,regulation of AMPA receptor activity (GO:2000311),0.4561218248269007,1.1250446698494418,0.32688588007736946,0.7964985295138917,1.0,3/25,4.30%,MEF2C;CACNG7;MINK1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5101884288448459,1.1248591519414433,0.3407079646017699,0.7958617248007633,1.0,3/13,8.40%,CACNA1H;SCAMP5;SYT1
prerank,monocarboxylic acid transport (GO:0015718),-0.3504398700184406,-1.1247771424506052,0.2675438596491228,0.6709939225222413,1.0,11/51,6.18%,ABCC4;SLC6A13;SLCO2B1;SLC16A2;SLC6A12;SLCO2A1;SLCO1C1;ABCG2;SLC16A1;SLC16A6;SLC16A11
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.40845933060678213,-1.1241135567310283,0.30265848670756645,0.6720211106668457,1.0,5/24,9.53%,ERRFI1;ROCK2;PRKCH;FOXC1;TRIM16
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.40595511445106813,-1.1237913980473706,0.3184713375796178,0.6721315669364858,1.0,6/26,17.57%,EPHA4;ROCK2;STAT3;PSME2;PSME3;PRELID1
prerank,embryonic eye morphogenesis (GO:0048048),-0.4900232902169057,-1.1236940477297064,0.3371868978805395,0.6716185547626898,1.0,6/11,6.60%,FBN1;EFEMP1;MFAP5;LRP6;RARG;FBN2
prerank,positive regulation of cholesterol transport (GO:0032376),-0.40473645681930737,-1.1236798081254902,0.3067484662576687,0.6709012924287538,1.0,9/27,20.47%,PLTP;APOE;CAV1;LPCAT3;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3749679955160492,-1.1234282113086431,0.29930394431554525,0.6708250834057633,1.0,12/37,18.15%,FHIT;TAF1;SDCBP;PML;RPL11;TRIM39;HSP90AB1;HIPK2;RPL23;HFE;RPS7;PARK7
prerank,glycogen metabolic process (GO:0005977),-0.3997814355815976,-1.1231946451815322,0.3086680761099366,0.6706685768262978,1.0,4/27,6.28%,PRKAG2;PHKB;PHKA2;PYGB
prerank,positive regulation of phagocytosis (GO:0050766),-0.35714713013638955,-1.1221591532878767,0.29333333333333333,0.6727102711557883,1.0,13/47,13.32%,CAMK1D;IL15;MYO18A;PTPRJ;GAS6;RAB27A;APPL2;ANO6;CD47;GATA2;C4B;CALR;CYBA
prerank,positive regulation of T cell activation (GO:0050870),-0.3332985196033901,-1.1220939905394114,0.25510204081632654,0.6721267244863658,1.0,19/62,22.30%,ZMIZ1;IL15;IL6ST;ANXA1;VCAM1;LGALS9;CD47;TFRC;FLOT2;SLC7A1;SIRPA;CYRIB;RHOH;PNP;CD81;MDK;CD274;XBP1;CCL19
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.4750685089902298,-1.1220709441826784,0.3479923518164436,0.6714329587400818,1.0,1/13,0.32%,ZMIZ1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.44280111397841965,-1.1219672601609496,0.3235867446393762,0.6709360101773074,1.0,2/17,2.01%,CAMK1D;MCU
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4447043290010188,1.1208234892726336,0.325187969924812,0.804173829604124,1.0,3/30,2.02%,CSPG4;CHST3;CHST7
prerank,response to fatty acid (GO:0070542),0.4905394057290203,1.120765098976312,0.35129740518962077,0.8032089426079205,1.0,3/17,7.20%,PID1;FFAR2;IRS1
prerank,regulation of B cell proliferation (GO:0030888),0.426706588499997,1.1206441135746052,0.31899641577060933,0.8023571583789089,1.0,4/44,6.03%,MEF2C;TNFRSF21;CD300A;IL4
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5017799015708136,-1.1206222893370028,0.3079777365491651,0.6736709499896305,1.0,4/10,28.72%,SH3RF1;CBFB;NCKAP1L;SOCS1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.4991714392001986,-1.1205055398169954,0.3358070500927644,0.6732375560206777,1.0,4/10,8.76%,THBS1;CTTNBP2NL;PRKCB;AKT1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.39280586087820163,-1.120335751324182,0.2936344969199179,0.6729223946203398,1.0,15/27,39.15%,MAP3K1;IRAK2;IRAK3;UBB;TLR4;MYD88;MAP3K7;CD36;LY96;TLR6;TLR1;TLR5;TAB2;CD14;TLR2
prerank,neurogenesis (GO:0022008),0.43063221716073896,1.120203369479325,0.3244274809160305,0.8022280887055093,1.0,12/43,14.08%,CDK6;BTBD3;CHAC1;ROGDI;RYK;BTBD6;TRAK1;SPOCK1;TRAK2;EPHB1;RITA1;SIX4
prerank,negative regulation of developmental process (GO:0051093),0.38942004640623434,1.1201502951594398,0.3067993366500829,0.8012449516359706,1.0,6/69,2.56%,TBX2;HEY2;CDK6;NOTCH1;ROCK1;FOXM1
prerank,negative regulation of viral life cycle (GO:1903901),-0.45368504925585157,-1.1198760229485576,0.3315018315018315,0.6733618402088133,1.0,7/15,22.67%,GSN;LY6E;IFITM3;PPIA;IFITM2;SNX3;TRIM11
prerank,response to acidic pH (GO:0010447),-0.46851387099611047,-1.1189191143734791,0.3499005964214712,0.6751645409702388,1.0,6/13,24.98%,CTSS;RAB11FIP5;SLC9A1;CHP1;GPR4;PKD1L3
prerank,cytoplasmic microtubule organization (GO:0031122),-0.34614322992538316,-1.1186043280041806,0.2505800464037123,0.6752722730407401,1.0,15/54,20.68%,FIGN;DLG1;EZR;CLIP4;RAB11A;LIMK2;RHOA;SPAST;TRPV4;CCDC88C;TUBGCP5;DYNC1H1;CHP1;SLK;NUMA1
prerank,import into nucleus (GO:0051170),-0.3233468695036674,-1.1185796499415686,0.2663316582914573,0.6746159513803202,1.0,29/73,29.60%,APPL2;STAT3;GEMIN7;AKT1;BACH2;IPO7;FAM53C;IPO13;RAN;GEMIN5;SNRPF;NXT2;IPO8;SNRPD1;SNRPD2;TPR;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;SNRPB;EIF4ENIF1;SNRPE;CSE1L;NUP62;PTTG1IP;TNPO2
prerank,regulation of secretion (GO:0051046),0.5064719588814353,1.1183101014786136,0.3422131147540984,0.8044870126174194,1.0,4/13,8.19%,NRG1;OPRK1;FGF10;MYO6
prerank,regulation of actomyosin structure organization (GO:0110020),-0.4682892407769314,-1.118293213370394,0.33201581027667987,0.6746012335641317,1.0,5/13,10.75%,ROCK2;AKAP13;ASAP3;ACTG1;FHOD1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.45424206465799144,1.1181938897764345,0.3333333333333333,0.8036431878134718,1.0,2/28,1.34%,PTEN;PTK2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5008578848468079,1.118116005429611,0.3474576271186441,0.8026995606583944,1.0,4/15,9.94%,CHST3;CHST7;CHST2;CHST5
prerank,glycerophospholipid metabolic process (GO:0006650),0.3815231057552819,1.1180185226756905,0.313893653516295,0.8018145398510698,1.0,10/75,10.75%,PDGFRB;PLA1A;DGKH;GPCPD1;CPNE7;ABHD3;PLAAT1;GDPD1;PIGZ;PLA2G4E
prerank,peptide metabolic process (GO:0006518),0.3870073588698521,1.1178323918269795,0.30634920634920637,0.8011369579010624,1.0,6/75,4.12%,ENPEP;DMD;GGT1;CPM;ANPEP;GSTT2
prerank,embryonic hemopoiesis (GO:0035162),-0.48195454804651233,-1.1171886106945663,0.35660377358490564,0.6766870333159223,1.0,6/12,15.40%,TGFBR2;KIT;KDR;FLT3LG;TAL1;ZFPM1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.48713155720506207,-1.116150002596134,0.32447817836812143,0.678726131452656,1.0,6/12,8.76%,PLCB1;SLIT2;CCN3;NBL1;DUSP1;AKT1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.47924163129505803,1.11584116712056,0.34274193548387094,0.8047003270221549,1.0,1/22,0.16%,PTPRK
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.4751330880352512,-1.115447391639452,0.349146110056926,0.6798209942738497,1.0,4/12,9.84%,ROCK2;APOE;FKBP1A;FLOT2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.45323274210582265,-1.1151714044221517,0.32741617357001973,0.6797635427331253,1.0,6/15,22.25%,PRKCH;CSF1;IL18;AGT;AGTR1;LPL
prerank,regulation of chondrocyte differentiation (GO:0032330),0.48580723188823816,1.115157442153965,0.35728542914171657,0.8052669228479242,1.0,3/24,1.50%,SOX5;MBOAT2;TRPS1
prerank,negative regulation of GTPase activity (GO:0034260),-0.4018140467118221,-1.115073136711619,0.33070866141732286,0.6792744022218795,1.0,10/22,24.09%,LRCH1;LRRK2;WNK1;CPEB2;DAB2IP;F11R;GMIP;SH3BP4;TMED2;RDX
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.5032176143332288,-1.1149360377430622,0.33646616541353386,0.6788676775291189,1.0,4/10,20.81%,PLA2G4A;PLA2G6;PLA2G15;ENPP2
prerank,nuclear migration (GO:0007097),-0.4700594003344324,-1.1148602244616415,0.3231939163498099,0.6783313570059464,1.0,6/13,23.08%,CLMN;SYNE3;SYNE2;FBXW11;DYNC1H1;PAFAH1B1
prerank,synaptonemal complex organization (GO:0070193),0.49672112194339746,1.1146272113578626,0.36026200873362446,0.8042272177395401,1.0,5/15,17.01%,REC8;TEX12;TRIP13;STAG3;SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.49672112194339746,1.1146272113578626,0.36026200873362446,0.8042272177395401,1.0,5/15,17.01%,REC8;TEX12;TRIP13;STAG3;SYCP2
prerank,ventricular septum development (GO:0003281),-0.3717928523730235,-1.1141386609740016,0.2958963282937365,0.6794476911323358,1.0,9/37,4.79%,TGFBR3;ROBO1;SLIT2;TGFBR2;BMPR2;TGFBR1;SMAD7;ACVR1;ZFPM2
prerank,regulation of ruffle assembly (GO:1900027),0.44721041604986256,1.1140184431973763,0.3241650294695481,0.8044602460117621,1.0,3/23,7.16%,EPS8;EPS8L1;HRAS
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.35910821035684165,1.113727648458207,0.3027950310559006,0.8040495080452227,1.0,13/108,6.87%,DLC1;ATP2A3;MAP3K5;COL4A3;GPER1;NODAL;GRAMD4;BCL2L10;CARD9;SNCA;DDX3X;BCL2L13;CASP9
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.38119314282955774,-1.1134577392474132,0.30752688172043013,0.68038469324369,1.0,13/31,28.08%,HSPB8;HSPA5;BAG3;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;HSPA9;DNAJB12;PRKN;ATXN3;HSPA1B
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.48760373851252636,-1.1128353709214789,0.3388581952117864,0.681217799942063,1.0,4/11,10.42%,ANXA1;SMAD7;RC3H2;ZC3H12A
prerank,eosinophil migration (GO:0072677),-0.4620460062179785,-1.1128329750133978,0.34476190476190477,0.6797320674232694,1.0,11/14,52.24%,CCL13;CCL2;CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.4620460062179785,-1.1128329750133978,0.34476190476190477,0.6797320674232694,1.0,11/14,52.24%,CCL13;CCL2;CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,regulation of protein metabolic process (GO:0051246),-0.35443706729023733,-1.1123757628097268,0.3056234718826406,0.6801448994350794,1.0,14/44,14.34%,ROCK2;APOE;APP;KLF4;KLF2;LTBP4;ACE;FKBP1A;MAP2K5;HGS;VPS35;MDM2;HSP90AB1;NEDD8
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.36577291645368726,-1.1121222490641858,0.27654867256637167,0.680114597498758,1.0,12/41,20.20%,PLA2G4A;PTGS1;CYP1B1;DAGLB;GPX4;ACOX1;MGLL;GSTM2;ELOVL1;GPX1;ALOX12;EPHX1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3505494342209692,1.1109194646739877,0.28364688856729375,0.8094705010827558,1.0,15/150,5.53%,PDGFRB;PIK3CD;GAB1;GCNT2;PTK2;PIK3R1;SEMA5A;FERMT2;ERBB4;NRG1;PIK3CA;AXL;FGF2;SPRY2;ITGB1
prerank,positive regulation of exocytosis (GO:0045921),-0.37446089317229575,-1.1106770147470064,0.3333333333333333,0.6832083417306143,1.0,16/35,30.45%,SDCBP;SMPD3;PDCD6IP;RAB27A;SDC4;HGS;RAB7A;SDC1;SYTL4;RAB2B;EXPH5;RAB3D;ATP6AP1;RAB3A;ATP13A2;CADPS2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.4025467786964705,-1.1103256892632032,0.3286852589641434,0.6834319725400559,1.0,7/25,13.39%,CD55;B2M;LACC1;WNT5A;SLC7A5;KIT;PLCG2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3929845176994686,1.1103012625849729,0.30220713073005095,0.8098464912209374,1.0,12/65,10.90%,ITGA1;SH3KBP1;AFAP1L2;GPER1;RHBDF1;SPRY2;EPN1;MVB12A;CNOT9;HIP1;DGKD;ARHGEF7
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.44469051368291884,-1.110286559750265,0.3377862595419847,0.6827857152839033,1.0,5/16,14.16%,WNT4;VIM;BMP4;TGFB1;CREB3L1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3880860073171959,-1.110207347989336,0.2903885480572597,0.6822442505992524,1.0,11/29,29.08%,SMAD3;TUT4;TUT7;PUM1;SNIP1;AGO1;DICER1;ZC3H7B;ZC3H7A;SMAD2;AGO2
prerank,intermediate filament organization (GO:0045109),-0.43516060118768896,-1.1101362398618393,0.32815533980582523,0.6816638665750666,1.0,6/17,28.88%,VIM;GFAP;DNAJB6;BFSP1;DSP;BFSP2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.43106942270148074,-1.110118321071042,0.3215686274509804,0.6809718686261144,1.0,2/18,2.01%,CAMK1D;MCU
prerank,endothelial tube morphogenesis (GO:0061154),-0.4986893085708489,-1.1099481307286847,0.33211678832116787,0.6806681168234403,1.0,4/10,7.29%,BMP4;ACVRL1;RHOA;RHOB
prerank,insulin receptor signaling pathway (GO:0008286),-0.32531188123292143,-1.109714762614816,0.2644230769230769,0.6805176160503865,1.0,22/69,15.25%,SORBS1;RHOQ;FOXO1;IGF1R;BAIAP2;FOXC2;AP3S1;ATP6V0A4;IGF2;SLC39A14;NAMPT;ATP6V1G1;AKT1;C2CD5;GRB14;IDE;ATP6V0B;ATP6V0A1;TCIRG1;FER;CAV2;ATP6V0A2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.49291923609873817,-1.109336686990376,0.35,0.6807339951560737,1.0,1/11,0.32%,ZMIZ1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.41205216657748,1.1089628353609493,0.3262411347517731,0.8120214129869938,1.0,14/44,15.83%,CYP7B1;OSBPL3;PER2;SLC27A2;BAAT;OSBPL6;SQLE;PSAT1;DHCR7;TM7SF2;OSBPL7;HSD3B7;HMGCR;ACOX2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4619817826493942,1.1089095259196133,0.3428030303030303,0.8110413859874736,1.0,7/25,11.15%,CACNA1C;CTNNA3;FGF13;RYR2;ATP2A2;TBX18;RANGRF
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3865527978877863,1.10870716522669,0.3270868824531516,0.8103907446674248,1.0,14/69,14.08%,SLC30A10;MEF2C;AGAP2;UNC5B;NTRK2;LIG4;PPT1;NFATC4;CPEB4;SET;KDM2B;RASA1;MAG;SIX4
prerank,positive regulation of cytokinesis (GO:0032467),-0.37472586860636187,-1.1083417967328906,0.28635346756152125,0.6825825151767256,1.0,6/32,10.29%,PKP4;CDC14A;PRKCE;RHOA;SVIL;SPAST
prerank,steroid biosynthetic process (GO:0006694),0.3963309807310051,1.108274166836433,0.3193979933110368,0.8103430756273681,1.0,17/56,15.83%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6;SQLE;LSS;DHCR7;STAR;TM7SF2;PRLR;SRD5A1;CYP11B1;OSBPL7;HSD3B7;HMGCR;ACOX2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3905923069412419,-1.1080358049550456,0.30390143737166325,0.6826356502251437,1.0,8/26,11.88%,ROCK2;ASAP3;SHANK3;SYNPO2;SYNPO;ACTG1;FHOD1;PFN1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3343762316071376,1.1080258966260659,0.27945205479452057,0.8098513572277274,1.0,15/190,3.95%,PDE4D;PTEN;LIMD1;PDE3A;PHLPP1;RORA;UBR1;GPER1;DGKG;NF1;SPRED1;SH3BP1;SH2B3;BCL2L10;ITPR1
prerank,positive regulation of response to stimulus (GO:0048584),-0.3624259743226933,-1.1079288304094232,0.2995391705069124,0.6821641304021067,1.0,9/40,17.63%,IL15;B2M;WNT5A;PRKCD;MAVS;YPEL3;FXR2;HOMER1;RSAD2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.38309545853855825,-1.1077533023819188,0.29473684210526313,0.6819080341502196,1.0,9/27,19.01%,ABCA1;PRKCH;CSF1;IL18;ITGB3;PPARA;NFKBIA;AGT;AGTR1
prerank,regulation of superoxide anion generation (GO:0032928),-0.45476582158217926,-1.1075818293747626,0.3339805825242718,0.6816524886429602,1.0,6/14,27.52%,PRKCD;TGFB1;SYK;TYROBP;ITGB2;ITGAM
prerank,response to lipopolysaccharide (GO:0032496),0.3449483468311603,1.1075086987318212,0.30447330447330445,0.8099398187183318,1.0,15/138,6.43%,GGT5;MEF2C;GGT1;NR1H3;SCARB1;IL1B;PTPN22;AXL;CXCL10;OTUD5;TNIP2;PDE4B;CXCL5;SNCA;CACTIN
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2981433511809166,-1.1073032126024183,0.23809523809523808,0.6816102380116836,1.0,43/113,25.85%,UNC13B;TRABD2B;ABCA1;CDH5;ESR1;RAP1B;ASAP1;PIEZO1;RASIP1;FNIP1;TFRC;ERCC5;BCL2L11;DAB2IP;CUL4A;GBP5;TGFB1;SH3GLB1;ATM;TAL1;DDB1;RPA1;TLR4;BID;PARK7;VCP;RHOC;SYK;PLEK;LCP1;VEGFA;PIH1D1;ICE1;ERCC1;PSMC2;ERCC2;PSMC5;RPA3;MYD88;RPS3;RACK1;ERCC3;TP53
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.36883961582446384,-1.1071776914283815,0.3020833333333333,0.6811994740083752,1.0,13/32,19.26%,IGF1;APP;NUPR1;TMSB4X;HIF1A;P2RX7;PPARA;ENTPD5;ENO1;BEND3;PRKAA2;PPARGC1A;VCP
prerank,actin crosslink formation (GO:0051764),0.5091046413365073,1.1069992297133098,0.35667396061269147,0.8100365581661216,1.0,1/12,0.31%,EPS8
prerank,negative regulation of cell projection organization (GO:0031345),0.41458112632804556,1.1069565665654266,0.3292035398230089,0.8090380501497969,1.0,7/48,5.16%,PTEN;RAPGEF2;RTN4RL1;PTPN9;ADCY6;SPRY2;MYLIP
prerank,triglyceride catabolic process (GO:0019433),0.4944387053537622,1.1066035889907984,0.3689516129032258,0.8087935012783695,1.0,3/19,6.96%,FABP3;LIPC;LIPH
prerank,apoptotic cell clearance (GO:0043277),-0.3828772049689919,-1.1061839585263442,0.3121272365805169,0.6831103864452241,1.0,6/30,5.09%,RHOBTB1;TGM2;THBS1;TXNDC5;ANXA1;GAS6
prerank,regulation of fibrinolysis (GO:0051917),0.5104272709220866,1.1058784346822566,0.35053763440860214,0.8094464993685219,1.0,1/13,0.68%,FAP
prerank,negative regulation of protein binding (GO:0032091),0.37932822239591674,1.105572890567974,0.32593856655290104,0.8091100718395867,1.0,11/71,9.33%,ITGA4;ATP2A3;MAP2;ROCK1;GNL3L;TTBK1;ATP2A2;CDKN1A;NES;PDGFB;CSNK1E
prerank,cellular response to copper ion (GO:0071280),-0.43921213291182026,-1.1054884845820503,0.3551912568306011,0.6841941166861254,1.0,9/16,20.00%,MT3;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H
prerank,regulation of fibroblast proliferation (GO:0048145),-0.3449015775391301,-1.1051366137278802,0.29453681710213775,0.684294142766199,1.0,15/45,19.25%,IGF1;FN1;PDGFRA;SKI;GAS6;WNT5A;S100A6;DAB2IP;SPHK1;SFRP1;NDUFS4;PDGFC;FTH1;AGT;E2F1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3400231332097484,-1.10506902196643,0.27684964200477324,0.6837531491188473,1.0,23/52,29.31%,PPP1R13B;NPEPPS;TFDP2;CASP8;SH3GLB1;TOMM7;SAE1;PPP3CC;LEPROT;BID;BBC3;HPS4;E2F1;YWHAH;USP36;BAP1;YWHAE;TP53;SFN;FZD5;TFDP1;RHOU;NMT1
prerank,cellular response to interleukin-12 (GO:0071349),-0.3542770647131656,-1.1046344883093666,0.2984054669703872,0.6841113919668759,1.0,8/48,7.61%,PLCB1;ANXA2;RAP1B;PDCD4;PITPNA;P4HB;CD47;TALDO1
prerank,negative regulation of phagocytosis (GO:0050765),0.4890182246677738,1.1046196098200407,0.33675564681724846,0.810225029600327,1.0,3/17,6.72%,DYSF;CD300A;APPL1
prerank,regulation of striated muscle contraction (GO:0006942),0.45565370246549425,1.1042193846646853,0.32879377431906615,0.8100972875534551,1.0,4/27,7.50%,DMD;ATP1A2;RYR2;MYL3
prerank,positive regulation of neuron projection development (GO:0010976),0.3723944382703539,1.104211816709318,0.3252032520325203,0.8090247997851314,1.0,22/85,11.74%,SERPINI1;RAPGEF2;BMP5;ROR1;SCARF1;PTN;PLPPR5;ATP1B2;RIT2;NTRK2;CAPRIN2;RAP1A;FUT9;MARK2;LYN;ARHGAP35;TOX;ABL2;VLDLR;CUX2;EP300;PLXNB3
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.42838942110299727,-1.1041659942905728,0.3235867446393762,0.6845452219765383,1.0,6/19,20.30%,ENPP1;SLC26A2;PAPSS2;SULT1A1;TPST1;TPST2
prerank,cardiac myofibril assembly (GO:0055003),0.5041263225030168,1.1035824978387974,0.37259100642398285,0.8094094491858085,1.0,1/15,0.19%,PDGFRB
prerank,maintenance of protein localization in organelle (GO:0072595),-0.4288999991457275,-1.1034388216348816,0.33852140077821014,0.6856860060644108,1.0,9/19,34.51%,HSPA5;HK2;AKT1;PML;TAPT1;HK1;MORC3;PINK1;BCL3
prerank,extracellular transport (GO:0006858),-0.4811862734255825,-1.1034022413469118,0.35,0.6850529790085575,1.0,9/12,39.68%,WWP2;ARRDC1;SPEF2;ROPN1L;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,renal water homeostasis (GO:0003091),0.46194817430010604,1.1033327962481523,0.3479923518164436,0.8089527047829308,1.0,10/23,10.19%,PRKAR1B;ADCY8;ADCY3;ADCY6;TFAP2B;PRKAR2B;ADCY9;PRKAR2A;RAB11FIP2;PRKAR1A
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.4366754438009179,-1.10322621887245,0.3440643863179074,0.6847661599100415,1.0,4/18,14.53%,DAB2;EZR;RAB21;MAPK3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.35477926181066755,-1.103224140453894,0.31941544885177453,0.6840451715206821,1.0,11/40,8.71%,DAB2;SMAD3;COL1A1;PDPN;TGFBR2;TGFBR1;TCF7L2;LEF1;SDCBP;FOXC1;TIAM1
prerank,protein glycosylation (GO:0006486),-0.29441399695247966,-1.1031746397139737,0.21944444444444444,0.6834598047347114,1.0,35/125,20.99%,ST3GAL4;LARGE1;B4GALT1;ST3GAL6;MAN1C1;ST3GAL1;ST3GAL2;EOGT;STT3A;PLOD2;ST3GAL3;TET3;STT3B;FUT8;MGAT1;ST6GALNAC2;B3GALNT1;SERP2;ST8SIA2;SLC39A8;POGLUT1;MGAT2;GFPT2;ENTPD5;ALG6;PLOD1;AQP11;ST3GAL5;RPN2;GFPT1;DOLPP1;ST8SIA5;PLOD3;B3GALNT2;MOGS
prerank,neuron development (GO:0048666),0.343626388797046,1.103163451573241,0.29505813953488375,0.808275072257677,1.0,20/141,9.77%,FRY;MEF2C;RAPGEF2;MAP2;ETV1;ROCK1;ATP7A;CNTNAP2;RYK;LAMB1;CNTN4;NTRK2;B4GALT6;PPT1;TENM4;BLOC1S1;LYN;TMEM108;ACTL6B;PLP1
prerank,brain development (GO:0007420),0.3365780671484398,1.102558829894028,0.28720238095238093,0.808592035340961,1.0,24/136,10.89%,PTEN;ADGRL3;PCDH18;CDH2;RAPGEF2;ZFHX3;NF1;HESX1;COL4A1;TMX2;UGP2;JHY;CNTNAP2;ROGDI;CNTN4;PPT1;NCOA6;NES;ROBO2;UFM1;GRIN2B;CTNNA2;DDIT4;SOX6
prerank,nuclear membrane organization (GO:0071763),0.4706018417014075,1.102326297731822,0.34911242603550297,0.8080376376434409,1.0,6/19,16.33%,GPER1;TOR1B;UBXN2B;EMD;DCTN1;TOR1A
prerank,toxin transport (GO:1901998),-0.4992640235891445,-1.1022053449326574,0.35500878734622143,0.6852417403949913,1.0,4/10,18.30%,ANTXR2;ADAM10;SLC22A2;RAB29
prerank,renal filtration (GO:0097205),-0.4939574688320222,-1.1015391334205848,0.3533834586466165,0.6861957380739993,1.0,5/10,6.49%,SULF1;ITGA3;CD34;SULF2;TBC1D8B
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4787175156063055,1.099683003830484,0.3603238866396761,0.8131205391354988,1.0,4/18,8.13%,NAALAD2;SLC25A13;MSRA;GOT1
prerank,membrane lipid catabolic process (GO:0046466),-0.48443247589311117,-1.0993816482427299,0.36466165413533835,0.691192039584425,1.0,6/10,24.73%,CYP1B1;FUCA1;NAGA;ENPP2;SGPL1;PDXDC1
prerank,gliogenesis (GO:0042063),0.47725926716285794,1.0992361901865846,0.3476482617586912,0.8130965799805778,1.0,3/15,4.29%,CDH2;CDK6;METRN
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5280944291314088,1.099064525740288,0.3588621444201313,0.8124358290428841,1.0,3/10,9.22%,OGT;ZNF692;SDHAF3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.37418189031366256,1.0987683844882858,0.3074380165289256,0.8120221890324725,1.0,11/74,5.27%,PTEN;GCNT2;BMP5;RGCC;PHLDB2;FERMT2;IL17RD;SPRED1;IL1B;SPRY2;CLASP2
prerank,phosphatidylserine metabolic process (GO:0006658),0.4349633028013934,1.0986610299162514,0.3645224171539961,0.8112076178079439,1.0,2/32,0.84%,MBOAT2;PLA1A
prerank,phospholipid dephosphorylation (GO:0046839),0.41672215539739643,1.098097669178934,0.32967032967032966,0.81143221379602,1.0,13/37,19.66%,PTEN;PLPPR5;INPP5J;MTMR12;MTMR7;INPP5B;SACM1L;MTMR11;PLPPR2;PIP4P1;PLPPR1;SGPP1;TPTE
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.37667739939925005,-1.0980496844536671,0.3346774193548387,0.6938688515882108,1.0,11/30,18.79%,STT3A;STT3B;FUT8;MGAT1;LMAN1;MGAT2;MCFD2;OST4;ASGR1;RPN2;OSTC
prerank,positive regulation of actin filament polymerization (GO:0030838),0.41714543860538367,1.09727144433179,0.3500897666068223,0.8122600339989652,1.0,9/44,10.59%,CARMIL1;NCK2;VASP;CDC42EP1;SPIRE1;BIN1;NCKAP1;LMOD1;ARPC4
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.34695039507754477,-1.0966005160244792,0.3235294117647059,0.6968386575697887,1.0,13/50,13.40%,EGFR;NFAT5;APP;SASH1;NR3C2;NOD1;PDCD4;LGALS9;RHOA;IFI35;TRIP6;RELA;SPHK1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.49436811169710093,1.0965492183542689,0.35802469135802467,0.8127954059988021,1.0,2/16,1.99%,CLDN10;CLDN15
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.37234234593641546,-1.096123043408682,0.31096196868008946,0.697316543041944,1.0,15/34,19.25%,SMAD3;FOXO1;ENPP1;ZFPM2;YAP1;WNT5A;TRIO;FLCN;ANKRD26;GATA2;TGFB1;ZFPM1;SIRT2;ZFP36L2;E2F1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3714972510749868,1.0957117328626371,0.33499170812603646,0.8136215993337889,1.0,13/82,16.52%,DYNLL1;PRKAR2B;CSNK1E;DYNC1I2;CEP41;DYRK3;TUBB4A;DCTN1;DCTN3;CEP76;KCNH5;CEP135;NDE1
prerank,protein localization to membrane (GO:0072657),0.3281988655233045,1.0949815986716567,0.30193905817174516,0.8142565561810033,1.0,35/187,11.69%,LIN7A;ITGA4;CACNB2;RAPGEF2;FERMT2;ROCK1;RFTN1;PTN;RAB8B;TSPAN15;NRXN1;SPTBN1;AGRN;FGF13;MAP7;CLASP2;DPP10;ANK3;RAB3B;EMP2;RAP1A;PDZK1;RAB38;EHD3;ZDHHC2;NKD2;EPHA2;TSPAN17;DLG2;ARL5C;NPC1;BRAF;NDC1;KCNIP4;PPIL2
prerank,response to chemokine (GO:1990868),0.48591111749817717,1.0946430287930462,0.36477987421383645,0.8139694168775043,1.0,3/13,3.67%,SLC12A2;SH2B3;STK39
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.42832556445662756,-1.0939986022194648,0.344106463878327,0.7020869232923825,1.0,5/17,14.16%,WNT4;VIM;BMP4;TGFB1;CREB3L1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3643519164341037,1.0938316315601593,0.319935691318328,0.8148108318630707,1.0,16/94,16.52%,DYNLL1;PRKAR2B;SCLT1;CSNK1E;DYNC1I2;CEP41;AHI1;NPHP4;CEP97;TUBB4A;TCTN3;DCTN1;DCTN3;CEP76;CEP135;NDE1
prerank,T cell mediated immunity (GO:0002456),-0.4619583926047119,-1.0938150829741127,0.3393829401088929,0.7018205088515975,1.0,2/13,2.13%,CTSH;CD55
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.34752789588452865,-1.093690212670025,0.3263888888888889,0.7013853906623219,1.0,16/46,12.98%,ALDH1A1;ZNF423;LGR4;IL15;ADAMTS5;NPR3;FOXC2;ID1;ACOT11;MAP2K6;LNPEP;NOVA2;FLCN;IP6K1;NOVA1;PGAM5
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5065372029141388,1.0932108474797795,0.36486486486486486,0.8151933871199365,1.0,2/12,5.14%,PARP8;TNKS
prerank,plasma membrane repair (GO:0001778),0.5000321753361638,1.0923944586431558,0.3660531697341513,0.816027456269942,1.0,2/13,1.97%,DYSF;MYH9
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3192015410464314,-1.0920470739315888,0.2967581047381546,0.7049693225407675,1.0,16/66,13.01%,SMAD3;CDH1;LIMK2;PARP9;YAP1;TFRC;PRKCD;AKT1;DTX3L;BAG3;PINX1;CARD10;ZC3H12A;MAVS;TGFB1;RAN
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.42100571279998544,-1.0915633091379475,0.3346153846153846,0.7055135971007953,1.0,10/21,22.45%,IGF1;IGFBP5;GJA1;ADAMTS1;ERN1;MMP2;BMPR1A;P2RY6;DNMT1;NR4A3
prerank,regulation of inclusion body assembly (GO:0090083),-0.48298913543168887,-1.0912209810109712,0.3641732283464567,0.7056782571854897,1.0,4/11,15.71%,SNCAIP;DNAJB2;DNAJB6;DNAJA4
prerank,positive regulation of cell population proliferation (GO:0008284),0.30516481685514957,1.0911389926821886,0.2867383512544803,0.8179826937775502,1.0,47/423,7.93%,PDGFRB;PTEN;TBX2;IL34;S1PR3;MEF2C;PID1;GCNT2;CDK6;BMP5;NOTCH1;TBX20;SLC25A33;RBPMS2;PTK2;GPER1;LAMC1;TBX3;NODAL;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;TBX6;MECP2;PDCD10;FGF2;SPDYA;LAMB1;SCN5A;TSPAN31;TFAP2B;CXCR2;NTRK2;IL4;CXCL5;SOX4;CHRNA7;EMP2;LIG4;HRAS;IRS1;FGF10;CDKN1A;NES
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.43161770611969164,1.090396382483952,0.3443223443223443,0.8186596950208288,1.0,5/34,5.84%,CARMIL1;LIMS1;FERMT2;RAC3;TESK1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.3357247724283312,-1.0897741483318086,0.3090128755364807,0.7087911187510232,1.0,10/48,10.17%,ROBO1;SLIT2;CNOT7;GAS6;PARP14;STAT2;USP18;NLRC5;IRAK3;SAMHD1
prerank,photoreceptor cell development (GO:0042461),0.4873454500813001,1.0896556228454812,0.37719298245614036,0.8192763860372868,1.0,1/14,0.82%,RORB
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.42152565419826543,-1.0895978532773298,0.35496957403651114,0.7085415858779428,1.0,6/17,18.27%,APOE;FGF1;LPCAT3;RAN;SREBF1;ERLIN2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.37870352006506663,-1.0894924458754627,0.32599118942731276,0.7080636305185506,1.0,11/32,25.85%,PPP1R13B;FHIT;DDX5;PML;HINT1;HIPK2;RRP8;RPS27L;STK11;TMEM109;TP53
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.45637688502559526,1.0889987037367583,0.36134453781512604,0.8196868497075385,1.0,7/21,13.12%,SPEF1;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3161984776767559,1.0889748771427428,0.2977602108036891,0.8186774829732419,1.0,25/259,6.91%,DYNLL1;CARMIL1;RAPGEF2;AIF1L;NOTCH1;ARHGEF6;MYLK;VCL;DZIP1L;IFT43;RILPL2;SPEF1;RAB8B;TTLL3;CYS1;MINK1;TTC36;IFT81;CCDC57;IFT20;ITGB1;NEK1;SCLT1;EMP2;RAP1A
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4303536328819728,1.0886053534536244,0.34765625,0.8184824096468514,1.0,5/29,9.16%,PDGFRB;PTK2;FGF2;IRS1;PDGFB
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.388437225381015,-1.0882626715641157,0.3512396694214876,0.7105399964101394,1.0,10/24,21.88%,DNMT3A;RBBP7;H3-3A;JARID2;TRIM27;PPHLN1;EZH2;SMYD5;MPHOSPH8;DNMT1
prerank,response to gamma radiation (GO:0010332),0.4503909122230725,1.0882068380256529,0.35645472061657035,0.8183705353074333,1.0,8/24,17.89%,MAP3K20;LIG4;HRAS;ATR;FANCD2;PRKAA1;HSF1;TLK2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4479129456325102,-1.0879425586394982,0.373046875,0.7106705875719448,1.0,10/15,43.78%,MDM2;TAF9B;CD44;PRKN;PTTG1IP;KDM1A;CD74;MUC1;TAF9;MIF
prerank,aortic valve development (GO:0003176),0.41977787717446513,1.087770457896253,0.34888059701492535,0.8182833780203124,1.0,6/34,2.15%,HEY2;HEYL;NOTCH1;TBX20;SLIT3;ROCK1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.47691256848176256,1.0873946334651021,0.3702213279678068,0.8180744752681076,1.0,3/14,4.76%,ZEB1;SPRED1;SPRY2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4646463766236756,-1.086533625608262,0.3690248565965583,0.7135233496362429,1.0,4/13,16.55%,NAMPT;IL33;KDR;TLR4
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.45803344344010677,-1.0865036608108676,0.3653483992467043,0.7128619036807397,1.0,4/13,10.62%,NRP1;TGFBR2;SEMA3E;KDR
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.41873481223416265,1.086499349684241,0.3634651600753296,0.8190100025788916,1.0,10/32,13.12%,MAP2;SPEF1;FGF13;NAV3;CLASP2;SNCA;CAMSAP3;APC;TUBB4A;APC2
prerank,negative regulation of cell activation (GO:0050866),-0.4453372397468099,-1.0860921358350064,0.36528028933092227,0.7131558448916225,1.0,4/14,3.29%,PDGFRA;APOE;NOS3;THBD
prerank,regulation of smooth muscle cell migration (GO:0014910),0.45689184782580217,1.0859929954272627,0.3641732283464567,0.8190880393532863,1.0,2/20,1.03%,PDGFRB;VTN
prerank,regulation of receptor binding (GO:1900120),0.5044212845612907,1.0858785218939906,0.3681917211328976,0.818298027957419,1.0,2/10,6.59%,ATP2A3;ATP2A2
prerank,serine family amino acid metabolic process (GO:0009069),0.4745698906879021,1.0853822553871855,0.3586744639376218,0.818387183650441,1.0,6/16,12.63%,CTH;BAAT;SEPHS2;GLYAT;SRR;DAO
prerank,cellular response to organonitrogen compound (GO:0071417),0.3534789050597925,1.085207654717118,0.3307453416149068,0.817722454398315,1.0,14/99,9.03%,MEF2C;SPAAR;PDE3A;RAPGEF2;CPEB1;AKAP6;GABRG2;HTR1B;HCN2;RAP1A;MTOR;RYR3;HCN3;PKD2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3789966663859156,-1.0851962930499175,0.34623655913978496,0.7147608899092965,1.0,13/29,25.23%,CNOT7;STAT2;WNT5A;USP18;NLRC5;SAMHD1;MAVS;HSP90AB1;RNASEL;PTPN2;PTPN6;TRIM6;ZBP1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.48516058835043036,-1.0847588709157363,0.3663551401869159,0.7151972047571608,1.0,3/10,10.03%,SETD7;KMT5A;EHMT1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4701944217277403,-1.084380630245699,0.3709677419354839,0.715444954618668,1.0,7/12,24.86%,ACTG1;LAMA5;LAMA3;ACTB;VANGL2;ZDHHC7;SCRIB
prerank,platelet aggregation (GO:0070527),-0.3748747108966085,-1.0843789234712258,0.34408602150537637,0.7147108803089625,1.0,10/33,14.14%,FN1;PDGFRA;ACTG1;CLIC1;PIK3CB;GNAS;ITGB3;ACTN1;ACTB;PPIA
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.48844894000226546,-1.0839500695859006,0.3740875912408759,0.7150880940139773,1.0,5/10,27.30%,CSGALNACT1;PXYLP1;DSEL;XYLT1;B3GAT3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.45201906392713515,1.0834901909824168,0.3705179282868526,0.8206568743638516,1.0,5/20,11.99%,BMP5;GPER1;SIK1;PRMT3;ERLIN1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.40608287483827227,1.0834720914649145,0.34600760456273766,0.8196421300825325,1.0,6/39,6.03%,ITGA4;SEMA5A;RGCC;GPER1;TNIP2;IL4
prerank,positive regulation of growth (GO:0045927),-0.316951611395414,-1.0833376954479548,0.28674698795180725,0.7159599464255384,1.0,14/64,13.91%,PLCB1;EGFR;USP47;TGFBR1;ADAM10;SDCBP;INO80;H3-3A;MMP14;AKT1;MFSD2A;DDX49;SPHK1;SFRP1
prerank,defense response to bacterium (GO:0042742),-0.29495966680660823,-1.083254687664672,0.2740112994350282,0.715441032760226,1.0,23/105,16.55%,ANXA3;IL6R;LBP;NOD1;RPS19;GBP4;PRKCD;PLA2G6;IRGM;STAB1;OAS2;PGLYRP1;GSDMD;MAVS;GBP6;OPTN;RPL39;GBP7;GBP2;SERPINE1;HMGB2;MR1;TLR4
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.3015794309254165,-1.0828309634004747,0.2955145118733509,0.7157679265790537,1.0,31/90,20.99%,LEPR;ADIPOR2;CAV1;GJA1;IGF1R;APPL2;PRDM16;CPT2;GNAS;CMKLR1;EHMT1;IL18;ESRRG;ACADL;KDM3A;UCP2;PRKAB1;KDM6B;CNOT3;FABP5;MFAP2;PDGFC;DYNC1H1;ADRB2;CEBPB;GADD45G;PPARGC1A;SYK;ADIPOR1;ALMS1;DECR1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4302669219473211,1.0825843329496414,0.34807692307692306,0.8206523022647824,1.0,8/32,11.08%,TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA;PKD2;CASQ1
prerank,positive regulation of heart contraction (GO:0045823),0.47580235139702354,1.082577233866325,0.38028169014084506,0.8196160565664209,1.0,3/19,6.59%,ATP1A2;RYR2;ATP2A2
prerank,inner ear morphogenesis (GO:0042472),-0.4037031057302386,-1.0825340651625195,0.34575569358178054,0.7158051828837471,1.0,6/22,12.29%,CHD7;FGFR2;SIX1;TTC39C;TBX1;EPHB2
prerank,positive regulation of double-strand break repair (GO:2000781),0.4141446951798819,1.0822903907592643,0.3799621928166352,0.819251019582642,1.0,15/39,19.05%,WAS;FOXM1;SPIRE1;FMN2;FANCB;SLF2;TIMELESS;SETMAR;PRKDC;SHLD3;KMT5B;PARP1;MRNIP;DDX11;FUS
prerank,negative regulation of MAPK cascade (GO:0043409),-0.3020249173103845,-1.082243614127095,0.32625994694960214,0.7158159109670389,1.0,28/87,16.55%,TIMP3;FBLN1;BMP7;SEMA6A;FOXO1;APOE;DLG1;CAV1;BMP4;PTPRJ;EZR;DUSP1;PRKCD;PIK3CB;FLCN;IRAK3;EMILIN1;DAB2IP;P2RX7;PPEF2;EPHB2;DUSP7;QARS1;PPIA;CNKSR3;DUSP10;SIRPA;TLR4
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5102760110854317,1.081277105342565,0.3565217391304348,0.8183831190089885,1.0,6/11,25.58%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5102760110854317,1.081277105342565,0.3565217391304348,0.8183831190089885,1.0,6/11,25.58%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,coenzyme A biosynthetic process (GO:0015937),0.5102760110854317,1.081277105342565,0.3565217391304348,0.8183831190089885,1.0,6/11,25.58%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,regulation of cell development (GO:0060284),0.4234668598267672,1.081181739073384,0.36666666666666664,0.8175548917919364,1.0,4/36,2.62%,HEY2;HEYL;PER2;IL1B
prerank,regulation of neuroblast proliferation (GO:1902692),0.4830587627579269,1.0810156021857098,0.36886993603411516,0.8168518342026184,1.0,3/15,4.97%,NF1;PTN;TAFA3
prerank,muscle cell development (GO:0055001),0.42759791762055377,1.0808566109880489,0.3559633027522936,0.8161790153163294,1.0,4/30,2.04%,DMD;HEY2;DYSF;MYH11
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4937339555492578,-1.08072766748875,0.3655536028119508,0.7189987039178318,1.0,1/10,2.26%,ST3GAL1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4316644704824929,1.0804342154334536,0.3698630136986301,0.8161455075088158,1.0,2/27,2.21%,PLA2R1;SPRED1
prerank,positive regulation of macrophage activation (GO:0043032),-0.4216252522370198,-1.0803074841323619,0.3977272727272727,0.7192896195100403,1.0,5/17,10.34%,LBP;THBS1;WNT5A;IL33;KARS1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3656219037592589,1.0801950090734072,0.33278418451400327,0.8156716652492388,1.0,10/80,4.60%,EPS8;PLCE1;PIK3R1;PIK3CA;CDC42EP1;ABI2;PLPPR5;WASL;AGRN;EPS8L1
prerank,positive regulation of actin nucleation (GO:0051127),0.5117366927191214,1.0796184059754836,0.3968957871396896,0.8159245685192101,1.0,4/11,10.02%,WASF3;ABI2;WASF2;NCKAP1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.5067501608467544,1.0793595750779124,0.39330543933054396,0.8154669244954786,1.0,2/11,8.18%,CARD9;IL12RB1
prerank,protein localization to cilium (GO:0061512),-0.3669473894560131,-1.0792231290521144,0.36542669584245074,0.7213329929631468,1.0,13/32,29.53%,ZNF423;EHD1;ARL3;TULP3;SNX10;TTC21B;RAB29;WDR35;TULP1;TMEM107;BBS9;IFT122;ATP6V1D
prerank,development of primary male sexual characteristics (GO:0046546),-0.3703616592893459,-1.0791509772173233,0.34146341463414637,0.7208019894045687,1.0,6/34,12.78%,WNT4;LHFPL2;AR;WNT5A;KIT;GATA6
prerank,response to glucocorticoid (GO:0051384),-0.38604452850104354,-1.0790603267810155,0.3581780538302277,0.7202972439589809,1.0,5/26,9.52%,NR3C1;SLIT2;ANXA1;ADAM9;BCL2L11
prerank,ether lipid biosynthetic process (GO:0008611),-0.48410060294868157,-1.0789356097127816,0.3815028901734104,0.7198849714909485,1.0,1/10,1.12%,PLA2G4A
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.40407837984529327,-1.0783680530050967,0.37453183520599254,0.7205788575433035,1.0,8/19,21.82%,ZMIZ1;GAS6;MMP14;RHOH;PPP2R3C;SYK;MDK;XBP1
prerank,monocyte differentiation (GO:0030224),-0.49401374971646417,-1.078253106432436,0.36624775583482944,0.7201602943665981,1.0,3/10,4.16%,IL31RA;BMP4;PIR
prerank,regulation of lipid storage (GO:0010883),-0.41151380742658006,-1.077752847574715,0.35080645161290325,0.7207647429537433,1.0,9/22,30.55%,IKBKE;ZC3H12A;ITGB3;FTO;NFKBIA;PTPN2;LPL;C3;HILPDA
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.44301375878113214,-1.0776663739692758,0.37924528301886795,0.7202295899906626,1.0,5/15,15.89%,EGFR;CDH13;RHBDF2;FER;CEACAM1
prerank,skeletal muscle organ development (GO:0060538),-0.3836524441488757,-1.077657787282313,0.3611111111111111,0.7195272169369059,1.0,9/26,10.88%,LARGE1;CAV1;CFLAR;MYL6;SIX1;STRA6;ZBTB18;SVIL;DISP1
prerank,central nervous system development (GO:0007417),0.3125743150305977,1.0770989313771895,0.30148048452220727,0.8197722226436583,1.0,44/250,11.11%,SERPINI1;PTEN;ADGRL3;PCDH18;CDH2;ADORA2A;TBX3;ZFHX3;NF1;HESX1;COL4A1;TMX2;UGP2;TBX6;GRIK1;JHY;CNTNAP2;DNER;ACAN;ROGDI;CNTN4;MOG;ASIC2;TPPP;SOX4;ANKLE2;LIG4;CNTN6;PPT1;NCOA6;NES;ROBO2;ADAM23;PKD2;UFM1;MARCKS;GRIN2B;NCKAP1;DDIT4;SPOCK1;SOX6;AHI1;IL1RAPL2;LOXL3
prerank,extracellular matrix assembly (GO:0085029),0.4417955505714375,1.0769529185282456,0.3614457831325301,0.8190782261318074,1.0,6/23,5.24%,TNXB;MYH11;ATP7A;PXDN;NTNG2;LAMB1
prerank,regulation of microtubule nucleation (GO:0010968),0.5136170499851552,1.0766378599367878,0.3855421686746988,0.8187288751416634,1.0,5/10,13.86%,MECP2;ARHGEF7;RANGRF;PAK1;DCTN1
prerank,positive regulation of cell cycle process (GO:0090068),0.35844624634798516,1.0762141724937804,0.3425324675324675,0.8186530229856162,1.0,12/91,10.17%,PDGFRB;MAP3K20;RGCC;IL1B;CUL3;OPN1MW;CSPP1;PCID2;PDGFB;CDC14B;UBXN2B;NUSAP1
prerank,iron ion transport (GO:0006826),-0.3412369772721802,-1.0759251942284231,0.35697940503432496,0.723289851064472,1.0,14/47,18.23%,STEAP3;CP;SCARA5;ATP6V0A4;SLC39A14;TFRC;ATP6V1G1;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2;HFE;REP15;FTH1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.4789999829487823,-1.0758455373900988,0.39517625231910947,0.7227503606698481,1.0,5/10,19.36%,DNMT3A;PCGF5;IGF2;PCGF3;ZFP57
prerank,innate immune response in mucosa (GO:0002227),0.524757864006218,1.0758443538714646,0.3951965065502183,0.8185132305427707,1.0,2/10,6.03%,CAMP;IL4
prerank,positive regulation of vasculogenesis (GO:2001214),0.5143339070801181,1.0754380920812237,0.3920704845814978,0.8183782841121737,1.0,3/10,6.91%,RAPGEF2;RIN2;RAP1A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.3064514419706072,-1.0753926030413594,0.31496062992125984,0.7231971994166524,1.0,13/80,8.76%,DAPK1;EPHA7;UACA;SH3RF1;USP47;THBS1;KLF4;NOD1;GAS6;TNFSF10;FNIP1;MAP2K5;AKT1
prerank,regulation of fibroblast migration (GO:0010762),0.4595225586496863,1.0753078053169673,0.37601626016260165,0.8176353984792469,1.0,7/20,10.90%,PTK2;PRR5L;FGF2;ITGB1;APPL1;GNA12;ARHGEF7
prerank,atrial septum morphogenesis (GO:0060413),0.509357621107525,1.0752610393965674,0.37333333333333335,0.8167094299335531,1.0,2/10,1.22%,HEY2;TBX20
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4103418632630762,-1.0752162508382372,0.3493282149712092,0.7229397823522492,1.0,6/20,17.00%,TGM2;RAP1GDS1;PML;TMCO1;SELENOK;BCAP31
prerank,negative regulation of defense response (GO:0031348),-0.31056657278865785,-1.0749794674483575,0.29292929292929293,0.7227994267995536,1.0,17/77,12.45%,CDH5;PTGIS;TEK;APOE;KLF4;CCN3;LPCAT3;ENPP3;MFHAS1;PRKCD;C1QTNF3;PCBP2;TNFRSF1A;IRAK3;METRNL;VPS35;PPARA
prerank,regulation of phosphorylation (GO:0042325),0.34372570825205806,1.0748057527778097,0.32595870206489674,0.8168470411399744,1.0,25/120,11.84%,DYNLL1;GLMN;PTK2;ROCK1;FNIP2;CADM4;GRM5;NUP43;OGT;SLC2A6;TESK1;IL4;ANKLE2;EMP2;CDKN1A;NUP35;LYN;GCK;PRKRIP1;MCM7;SEC13;EIF6;NDC1;EP300;BTBD10
prerank,negative regulation of developmental growth (GO:0048640),0.441030263104934,1.0746318185102797,0.3793103448275862,0.8162351978874085,1.0,10/30,16.81%,PTEN;MAP2;FGF13;CDKN1A;WWC1;FGFR3;MAG;TRIM46;RNF6;SLC6A4
prerank,negative regulation of receptor internalization (GO:0002091),-0.45531468791755186,-1.0744346365849224,0.3775700934579439,0.7234788387170207,1.0,3/12,9.79%,RIN3;SDCBP;ATXN2
prerank,regulation of protein ubiquitination (GO:0031396),-0.29263150463184623,-1.074333060027593,0.31085043988269795,0.7230073721277138,1.0,43/108,28.93%,NXN;HDAC8;CAV1;SASH1;TGFBR1;ANGPT1;LRRK2;SMAD7;ARRB1;FKBP1A;SH3RF2;BIRC3;AKT1;PINX1;IVNS1ABP;PRKCG;PHF23;DNAJB2;FANCI;UBB;SPHK1;HSP90AB1;WASHC1;SIRT7;PARK7;CHP1;VPS28;CDK5RAP3;UBXN1;FAM107A;BAG2;BRCA1;PSMD10;RPS3;CENPX;PRKN;BAG5;BCL10;PRR7;HSPA1B;PTTG1IP;LAPTM5;ISG15
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4107506600802404,1.0742780757601829,0.35902255639097747,0.8160804875370494,1.0,6/36,4.25%,MEF2C;NOTCH1;RGCC;MECP2;SVBP;FGF2
prerank,plasma membrane invagination (GO:0099024),-0.3767346605100853,-1.074172920437725,0.39387755102040817,0.7226891419857685,1.0,5/29,6.59%,GULP1;GSN;ELMO1;SNX9;RHOA
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.4405815975740952,1.0735862393478792,0.3671875,0.8166667136008815,1.0,6/25,13.06%,AFAP1L2;GPER1;CNOT9;HIP1;DGKD;BCAR3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.38354916605382355,1.0735298788050691,0.3462897526501767,0.8157733367271388,1.0,8/54,4.25%,MEF2C;RGCC;NF1;AKT3;SH3BP1;ETS1;MECP2;FGF2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.404714887449219,1.073460277555887,0.35514018691588783,0.8149211201286578,1.0,9/43,7.20%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;OGT;PIP4K2C;IRS1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3305208837901364,-1.0731665630602496,0.357630979498861,0.7245329619150115,1.0,11/56,8.76%,PLCB1;EGFR;RAB11A;ANXA1;ADAMTS1;CDC16;CCND2;CCND3;RAD51B;UBE2E2;AKT1
prerank,triglyceride biosynthetic process (GO:0019432),-0.417988643700871,-1.0720991529472075,0.36470588235294116,0.7266083587258657,1.0,2/18,3.14%,AGMO;LPGAT1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.46117274076237125,-1.0717229354626898,0.39783001808318263,0.7268205496010887,1.0,3/12,5.43%,GSN;LY6E;IFITM3
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4752667318607679,-1.071644086111525,0.411660777385159,0.7263110187356586,1.0,4/11,17.17%,ITM2A;NECAB1;ITM2C;BACE2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.39332742715548596,-1.0716285966268038,0.36134453781512604,0.7256218057579241,1.0,9/24,12.65%,SULF1;CCBE1;IL6ST;SULF2;CYP1B1;HIF1A;TGFB1;PTGS2;FLT4
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.40159602906117065,-1.0714303503866833,0.38188976377952755,0.7254284504887359,1.0,5/20,10.32%,CD55;IL1R1;B2M;PRKCZ;IL18
prerank,carboxylic acid transport (GO:0046942),-0.3327383953358914,-1.0712277998712425,0.3333333333333333,0.7252041184093283,1.0,18/55,15.94%,SLC6A13;SLC13A3;SLC16A2;SLC6A6;SLC6A12;SLC16A1;SLC16A6;SLC16A11;SLC6A9;SLC7A5;PSAP;SLC38A5;SLC3A2;SLC38A6;SLC16A13;LLGL2;SLC66A1;SLC7A1
prerank,peptidyl-asparagine modification (GO:0018196),-0.36509262095643313,-1.0711904846731635,0.3682092555331992,0.7245661978062014,1.0,11/31,18.79%,STT3A;STT3B;FUT8;MGAT1;LMAN1;MGAT2;MCFD2;OST4;ASGR1;RPN2;OSTC
prerank,regulation of protein secretion (GO:0050708),0.33843795549386324,1.0711008059802718,0.3441358024691358,0.8194655604025871,1.0,18/119,9.87%,CACNA1C;SLC12A2;RAPGEF4;PER2;ITPR2;IL1B;GIPR;RHBDF1;SNAP25;ITPR1;FRMD4A;TFAP2B;RAP1A;CACNA1D;ACHE;GCK;MYOM1;CACNA1A
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.42792849348309714,-1.0708508950394415,0.3797709923664122,0.7247422661785146,1.0,5/16,10.45%,DPYSL3;DPYD;UPP2;UPB1;NT5E
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.43134303551093367,-1.0708393551819542,0.39365671641791045,0.7240569412227554,1.0,5/15,21.19%,ADAM9;MAPK14;EHD1;EHD2;TYROBP
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.425309171807936,1.0706338720630655,0.369140625,0.8194587281894791,1.0,8/29,17.01%,MEI4;MEIOB;REC8;TEX12;FANCD2;TRIP13;STAG3;SYCP2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4331035520838947,-1.0705241198653186,0.4061302681992337,0.7241260616936487,1.0,5/16,11.02%,JCAD;THBS1;PPP1R16B;FGFBP1;GATA2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.25431978098693525,-1.0704935409632548,0.26666666666666666,0.7235062456639035,1.0,91/327,21.06%,BNC2;ZMIZ1;FOXN3;ZNF423;SMARCA2;EFEMP1;DENND4A;WWC2;CHD7;NFIA;NR3C1;KAT6B;SUFU;ESR1;PRRX2;TGFBR1;SBNO2;IGF2;SSBP2;GTF2IRD1;ARNT2;CREM;SOX13;BHLHE40;PFDN5;ACVRL1;ATXN1;SIX1;FOXC1;IRF2;CHD3;STAT3;HINFP;NR2C2;ZNF219;ERC1;POLR2A;TRRAP;GON4L;VSX1;RREB1;REXO4;HIF1A;CRABP2;CARM1;TULP3;FZD7;SLC39A8;ESRRG;PML;BRCA2;PATZ1;NFYC;HINT1;NSD1;AHR;RELA;SRSF10;CALR;GLRX2;CLOCK;SOX17;ZBTB4;HOXB7;SOX7;SOX18;HCFC2;ASCC1;NFIL3;ACTR8;NFYB;NFXL1;SOX12;RHOH;CEBPB;EZH2;PLAG1;YAF2;SBNO1;ATF7;HMGN5;PPARGC1A;E2F1;NONO;HP1BP3;NAB2;NFATC2;NIF3L1;THAP1;TEAD2;LMX1B
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.391677850382961,-1.0697650102217975,0.36147186147186144,0.7246569385904588,1.0,3/24,2.53%,EPHA7;FOXO3;NUPR1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.4237497484662375,-1.069243472320637,0.39728682170542634,0.7253103501743368,1.0,4/16,8.37%,AUTS2;ARHGAP17;ALS2;PIK3CB
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.3848594438783951,-1.0691061317442299,0.373134328358209,0.7249467899814824,1.0,10/26,14.01%,SULF1;CCBE1;IL6ST;SULF2;CYP1B1;HIF1A;TGFB1;PTGS2;FLT4;SARS1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.33406004547884544,-1.068986397318086,0.34146341463414637,0.724533994913811,1.0,12/47,16.31%,ROCK2;WNT4;PTGIS;CAV1;CD34;C1QTNF3;ZC3H12A;ACADL;PGP;SNAI1;CEACAM1;SIRPA
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4561675220490665,1.0687114347385445,0.3739495798319328,0.8228856647667773,1.0,5/17,15.98%,FERMT2;N4BP2L2;KAT7;HNRNPU;CCNE1
prerank,regulation of cell differentiation (GO:0045595),0.32761936190934604,1.068703890900265,0.3490427098674521,0.8218783119665225,1.0,17/148,7.30%,MBOAT2;HEY2;CDK6;PTK2;TRPS1;PHLDB2;ZFHX3;ROCK1;NF1;NR1D2;HEMGN;MOSMO;CLASP2;TFAP2B;SIK1;EMP2;BIN1
prerank,heme biosynthetic process (GO:0006783),-0.3904208856937881,-1.0681595351366335,0.36610878661087864,0.7259951833960183,1.0,13/22,33.86%,ABCG2;PGRMC1;SLC25A38;ALAS1;PPOX;CPOX;COX10;ALAS2;UROS;TSPO;HMBS;ABCB6;COX15
prerank,regulation of cilium movement (GO:0003352),-0.4860973429616141,-1.0680189164247325,0.4010889292196007,0.7256641552929968,1.0,6/10,39.28%,CFAP43;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3480434431911569,1.0678665340056128,0.3483483483483483,0.8227253912645904,1.0,12/101,7.16%,PDGFRB;IL34;RAPGEF2;RGCC;FERMT2;IL1B;PDCD10;FGF2;SPDYA;SNCA;DDX3X;HRAS
prerank,protein insertion into membrane (GO:0051205),-0.3704787983394359,-1.0676694458813067,0.389010989010989,0.7257864812965283,1.0,12/32,24.11%,EGFR;APP;TRAM2;STX1A;ALDH3A2;VAPA;REEP1;GET1;MAIP1;SEC61B;WDR83OS;CCDC47
prerank,catecholamine metabolic process (GO:0006584),-0.4465485756855052,-1.067641079200125,0.3844731977818854,0.7251489150093996,1.0,1/14,0.58%,SNCAIP
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4389914661886303,1.0673925861522642,0.38910505836575876,0.8227344452019514,1.0,7/23,14.92%,NOTCH1;ERBB4;CRLF3;IL4;PRLR;OCIAD1;JAK2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.2345738005174492,-1.0670174760766307,0.10344827586206896,0.7259829084355077,1.0,191/834,18.15%,NFIB;AUTS2;BMP6;IGF1;DAB2;ZMIZ1;PBX1;SMAD3;SMARCA2;EGFR;DCN;NFAT5;WWOX;HDAC4;GLI2;TBL1XR1;NFIX;CDK8;RHOQ;GLIS3;FOXO1;MICAL2;OSR1;FOXO3;APP;NFIA;NR3C1;HDAC8;KAT6B;ERG;ITGA6;HOXB3;RARB;MLXIP;ESR1;FGFR2;BMPR2;ELF1;BMP4;ELF4;MEOX2;KLF4;PLAGL1;KAT2B;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;MRTFB;LRP6;ARHGEF2;NFATC1;SMAD7;LEF1;ACVR1;KLF2;SBNO2;THRB;HOXA5;SKI;PCGF5;ZFPM2;DCAF6;IGF2;SSBP2;ARRB1;ARNT2;AR;FGF1;RARG;YAP1;TMF1;GLIS2;THRAP3;ACVRL1;IRF1;TEAD1;SIX1;WNT5A;INO80;HLF;TET3;FOXC1;IRF2;GLIS1;LMO2;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;NAMPT;PGR;KLF10;TBX1;SSBP3;TFCP2;ZBTB18;FIZ1;PLXND1;RREB1;IL33;HIF1A;TNFRSF1A;NLRC5;CDH13;NR4A2;FLCN;ATF6;FOSL2;PHF10;DAB2IP;IL18;ZC3H12A;FHOD1;EIF5A;MAVS;GATA2;CEBPG;GLI3;TGFB1;ELK3;BCL9L;AHR;HDAC1;ZIC3;RELA;PPARA;MEF2A;USF1;ZNF462;ATM;GATA6;CCN1;UBB;ATOH8;CLOCK;LPIN3;MET;MEIS2;MPND;HDAC5;TAL1;SOX17;HSF2;POU2F1;MAPK3;HOXC4;PKD1;CDK9;HOXB7;HIPK2;NKX6-1;ZFPM1;CREB3;JUND;SREBF1;SERPINE1;BMPR1A;NOS1;NKRF;CEBPZ;HHEX;MEIS1;HMGB2;SOX18;KDM6B;TLR4;RNASEL;USF2;ZMIZ2;SIRT7;JUNB;SIRT2;ATF1;MED21;RIPK1;PTOV1;SLC9A1;NFKBIA;NFYB;CSRNP3;NPAS2;MAFF;SOX12;CEBPB;KLF15;PARK7
prerank,neutrophil activation (GO:0042119),-0.4563202551975802,-1.0667909484495277,0.38666666666666666,0.7258352872287166,1.0,4/12,21.19%,IL15;PRKCD;SYK;TYROBP
prerank,pulmonary valve morphogenesis (GO:0003184),0.4667106915386442,1.066751179211842,0.37336244541484714,0.8231658914388017,1.0,4/17,1.22%,HEY2;HEYL;NOTCH1;TBX20
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4776028435112662,-1.0666032545102107,0.40373831775700936,0.7255909384680972,1.0,2/11,1.06%,AFDN;TJP2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.45056742742656286,1.066373734196058,0.38209606986899564,0.8230047415814263,1.0,2/20,2.70%,GGT1;CHAC1
prerank,cellular response to estrogen stimulus (GO:0071391),-0.4397209403741457,-1.0661070947789482,0.366412213740458,0.7261510905726456,1.0,8/14,29.32%,TRIM24;AR;SFR1;SFRP1;NCOA4;RARA;SRA1;SERPINB9
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.40685469273713737,1.0660471867729848,0.3684210526315789,0.82272846746455,1.0,4/39,5.98%,ITGA1;SH3KBP1;SPRY2;EPN1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3890867307858057,-1.0659412282800917,0.3582995951417004,0.725155367030524,1.0,6/23,15.05%,DAB2;THBS1;SDCBP;FLCN;HSP90AB1;HIPK2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3890867307858057,-1.0659412282800917,0.3582995951417004,0.725155367030524,1.0,6/23,15.05%,DAB2;THBS1;SDCBP;FLCN;HSP90AB1;HIPK2
prerank,positive regulation of protein import (GO:1904591),-0.3735990079442121,-1.0658516203544415,0.3722334004024145,0.7246798359311221,1.0,10/30,17.87%,SMAD3;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN;TPR;PDCD5
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4783202264654287,1.0656734393907759,0.3962655601659751,0.8225737451560312,1.0,2/16,3.71%,SLC25A33;ATP7A
prerank,regulation of lamellipodium assembly (GO:0010591),0.41661221267213366,1.0654388875675804,0.38878504672897196,0.8220517409729463,1.0,9/34,11.74%,PLCE1;PIK3R1;WAS;PIK3CA;ABI2;WASF2;EPHA2;NCKAP1;PLXNB3
prerank,histone acetylation (GO:0016573),-0.30989632152082985,-1.0653143241515428,0.3357664233576642,0.7253736251764573,1.0,26/69,25.98%,KAT6B;KAT2B;LEF1;KAT14;TRRAP;TADA1;MEAF6;TRIM16;TADA2A;BRCA2;BEND3;YEATS2;NAA40;BRPF3;CHD5;MORF4L2;BRPF1;BRD1;TAF5;HAT1;SGF29;BRD8;JADE1;ING4;ATF2;EPC1
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.33223538967894894,-1.0649751994690655,0.3333333333333333,0.7255607978358981,1.0,12/50,10.98%,NXN;HDAC8;CAV1;SMAD7;TAF1;ARRB1;SH3RF2;AKT1;DTX3L;PINX1;IVNS1ABP;PRKCG
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.2491517148725209,-1.0649460362293754,0.24102564102564103,0.7249143617585132,1.0,98/366,21.06%,BNC2;FOXN3;ZNF423;SMARCA2;EFEMP1;DENND4A;WWC2;CHD7;FOXO3;APP;NFIA;NR3C1;KAT6B;SUFU;ESR1;PRRX2;TGFBR1;SBNO2;IGF2;SSBP2;GTF2IRD1;ARNT2;CREM;SOX13;BHLHE40;PFDN5;ACVRL1;ATXN1;TOM1L1;SIX1;FOXC1;IRF2;CHD3;STAT3;HINFP;NR2C2;ZNF219;ERC1;POLR2A;TRRAP;GON4L;VSX1;RREB1;REXO4;HIF1A;CRABP2;CARM1;ATXN2;TULP3;FZD7;SLC39A8;ESRRG;PML;BRCA2;PATZ1;NFYC;HINT1;NSD1;AHR;RELA;TCOF1;SRSF10;CALR;GLRX2;CLOCK;SOX17;RPL10;GEMIN5;ZBTB4;HOXB7;SOX7;SOX18;HCFC2;SMC3;ASCC1;NFIL3;ACTR8;NFYB;NFXL1;SOX12;RHOH;CEBPB;EZH2;PLAG1;YAF2;SBNO1;ATF7;HMGN5;PPARGC1A;E2F1;RABL3;NONO;HP1BP3;NAB2;NFATC2;THAP1;TEAD2;LMX1B
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2700547579257177,-1.0647507675817507,0.28619528619528617,0.724691419689789,1.0,62/171,27.74%,SMAD3;IQGAP1;PTPN3;APP;GAS1;SDCBP;CDC16;FOXC1;MAEA;OBSL1;BTG3;PSME2;ANAPC4;TGFB1;MDM2;SMOC2;PSMB4;TRIM35;SPHK1;MEIS2;PIM3;TAL1;PSMB1;PSMD11;CAV2;DDB1;PSMD8;CDK9;EIF4EBP1;PSME3;CDKN1B;RNF40;CCDC8;ANAPC16;PSMD4;FZR1;PSMA2;PIM2;USP22;PSMD3;CDC27;CDK5RAP3;THAP1;PSMB7;ANAPC5;CUL9;CDKN1C;USP2;PSMC2;ERCC2;TMEM8B;PSMC5;CDK11B;PSMD10;SCRIB;L3MBTL1;ERCC3;ANGEL2;SRA1;NEK7;PSMD7;MKI67
prerank,cellular response to interleukin-4 (GO:0071353),-0.4790046778294244,-1.0644761129945293,0.4045368620037807,0.7246732652352542,1.0,4/10,24.39%,LEF1;XBP1;SHPK;TCF7
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3426319959610572,-1.0644175854441822,0.36302895322939865,0.7241387596783597,1.0,7/46,7.61%,PLCB1;ANXA2;RAP1B;PDCD4;PITPNA;P4HB;TALDO1
prerank,sterol transport (GO:0015918),0.45890607801062777,1.0641191588542755,0.38650306748466257,0.8240412048084901,1.0,5/19,10.78%,LDLRAP1;ARV1;LDLR;MSR1;NPC1
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2910674120312909,-1.0639678807829114,0.34110787172011664,0.7245934360042154,1.0,34/110,19.90%,ROCK2;FOXO1;APOE;APP;SMURF2;NKD1;KLF4;CSF1;KLF2;WWP2;SMURF1;WNT5A;SLC6A9;PLK2;EGLN2;MAP2K5;AKT1;IDE;DAB2IP;IL18;RAB7A;ASB5;TGFB1;DDB1;PAEP;WWP1;CDKN1B;NFKBIA;OAZ1;FZR1;AGT;AGTR1;VCP;VPS28
prerank,lipoprotein catabolic process (GO:0042159),-0.4537037350501318,-1.0638912924040762,0.38644688644688646,0.7240654970855666,1.0,8/11,28.98%,APOE;LYPLA1;NOTUM;ABHD17C;LYPLAL1;LYPLA2;CTSD;ABHD17A
prerank,positive regulation of protein catabolic process (GO:0045732),-0.29658166527268953,-1.0636808884039226,0.31216931216931215,0.7238956265032932,1.0,19/84,11.46%,VGLL4;FOXO1;APOE;SMURF2;EZR;SNX9;NKD1;ADAM9;WWP2;SMURF1;WNT5A;TNFRSF1B;PLK2;EGLN2;IDE;DAB2IP;VPS35;RAB7A;ASB5
prerank,receptor-mediated endocytosis (GO:0006898),0.33990613159761823,1.0634423644116575,0.3630952380952381,0.8245642263966109,1.0,22/132,10.81%,SGIP1;COLEC12;IGF2R;SCARB1;SCARF1;LDLRAP1;LDLR;GRK3;ACKR3;LRP1B;AP1G1;MSR1;ITGB1;CXCR2;SNCA;PPT1;PIKFYVE;AP2S1;TMEM108;AP2B1;RABEPK;VLDLR
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.41944615975538097,-1.0632951285042824,0.4069767441860465,0.7241676039563976,1.0,12/18,34.23%,DCN;MCU;KDR;VPS35;BNIP3;DDHD1;RALBP1;PRKN;RALA;DNM1L;MIEF2;PINK1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3636391380484125,1.0632247487752229,0.3643926788685524,0.8240679466346686,1.0,7/73,6.87%,DLC1;ATP2A3;COL4A3;BCL2L10;SNCA;BCL2L13;CASP9
prerank,anterior/posterior axis specification (GO:0009948),0.4897072923980359,1.0625572396487586,0.401330376940133,0.8246442652017903,1.0,4/15,15.64%,TBX3;CDX1;WLS;TASOR
prerank,cellular response to glucose starvation (GO:0042149),-0.34190500048401457,-1.0624606502107052,0.36343115124153497,0.7256113076294057,1.0,15/41,21.83%,PRKAG2;FOXO3;ITFG2;HSPA5;BECN1;ZC3H12A;SH3GLB1;PRKAG3;PRKAA2;MTMR3;RRP8;KPTN;PRKAG1;XBP1;EIF2AK3
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.37687444427215455,-1.0620699987895559,0.3838383838383838,0.7259321059137638,1.0,8/28,13.01%,SMAD3;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,positive regulation of protein depolymerization (GO:1901881),0.5205464779011941,1.0617884766918269,0.410752688172043,0.8253620735874155,1.0,3/11,11.94%,SEMA5A;NES;CFL2
prerank,inflammatory response (GO:0006954),0.3179372754756534,1.0616713628741148,0.3388203017832647,0.8246204137807227,1.0,20/195,9.31%,GGT5;PIK3CD;TBXA2R;AFAP1L2;ADORA2A;IL1B;CD96;CCRL2;IL2RA;ADCY8;TACR1;CXCR2;CXCL10;IL4;CXCL5;KLRG1;RIPK2;NFATC4;IL22;ADGRE5
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4739320981306153,1.0605141446630173,0.40969162995594716,0.826273402799802,1.0,3/13,10.49%,RCL1;TBL3;NOP14
prerank,regulation of microtubule-based movement (GO:0060632),0.49411039044915805,1.060429971353989,0.3900862068965517,0.8254574468029403,1.0,1/11,1.46%,MAP2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.45400565617462785,-1.0594551134645867,0.40304182509505704,0.7318809935851561,1.0,3/12,5.98%,APOE;IAPP;PFDN5
prerank,activation of protein kinase A activity (GO:0034199),0.45966287473626977,1.0593322552250724,0.39015151515151514,0.8270305077079779,1.0,8/16,10.19%,PRKAR1B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,dermatan sulfate metabolic process (GO:0030205),0.4926191330485592,1.058344852823218,0.39789473684210525,0.828260402347022,1.0,1/13,0.21%,CSPG4
prerank,regulation of lymphocyte differentiation (GO:0045619),0.46165836971944424,1.0579801588741442,0.3888888888888889,0.8281174737867611,1.0,1/18,1.07%,PRDM1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4543634432004802,1.057825822254399,0.3939393939393939,0.8274784492385167,1.0,4/15,9.02%,NOTCH1;SEMA5A;FGF2;PRKD2
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.30653402756678316,-1.057797013155581,0.36220472440944884,0.7354514154069092,1.0,14/78,8.76%,SORBS1;DAB2;EPHA3;EGFR;PRKCH;RHOQ;DLG1;ITGA3;AR;STX7;PRKCE;STX3;MMP14;AKT1
prerank,mitotic cell cycle phase transition (GO:0044772),0.3137335395773368,1.0577079903779971,0.35802469135802467,0.8267707509403336,1.0,35/203,16.52%,DYNLL1;EPS8;CDK6;BTRC;FOXM1;CUL3;CRLF3;PPP2R2A;SPDYA;CCDC57;AJUBA;CLASP2;PRKAR2B;CDKN1A;NES;CSNK1E;DYNC1I2;CEP41;TACC3;BRSK1;LATS2;RB1;TUBB4A;PPP1R12A;CDK14;DCTN1;EIF4E;ANAPC7;CCNH;SKP1;DCTN3;CEP76;CCNE1;CEP135;NDE1
prerank,positive regulation of cell cycle (GO:0045787),-0.3182555072632666,-1.0576898059847633,0.337468982630273,0.7350171964106109,1.0,19/62,15.89%,EGFR;APP;NUPR1;FGFR2;LRP6;CCND2;CCND3;AKT1;RPS15A;MDM2;SMOC2;CALR;SPHK1;MEIS2;CCND1;TAL1;PKD1;EIF4EBP1;CDKN1B
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4435838795981743,1.0573473277173808,0.4048964218455744,0.8265902149121503,1.0,4/25,9.20%,NDST3;B3GALT1;FUT9;B3GNT8
prerank,positive regulation of B cell activation (GO:0050871),0.3829167060392476,1.057170838780704,0.3648881239242685,0.8259725827686971,1.0,4/50,6.03%,MEF2C;SH3KBP1;TNIP2;IL4
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4961324010474126,1.0571142526235735,0.3979381443298969,0.8251067201729636,1.0,1/12,0.21%,CSPG4
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.44417825107806075,1.0552618537698777,0.3861788617886179,0.8282852111080853,1.0,4/20,6.87%,BCL2L10;IL4;APPL1;CASP9
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.34549992217931513,1.055190497640393,0.3682588597842835,0.8274669713293696,1.0,8/112,2.09%,PTPRK;SOX5;LIMS1;MEF2C;PDE3A;GCNT2;PTK2;FERMT2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.2735256704476909,-1.0550204530390075,0.3090909090909091,0.7412168446807698,1.0,41/149,19.70%,PRKCH;APP;CAV1;NOD1;ARHGEF2;CFLAR;IRAK2;AR;LGALS9;WNT5A;PRKCZ;PRKCB;CARD14;STAT3;TFRC;ERC1;FLOT2;IRAK3;IL18;TRIM27;CAMK2A;RELA;TNFRSF11A;UBB;CLOCK;SPHK1;FER;TICAM1;PPIA;TLR4;TRIM8;RIPK1;MAP3K13;NFKBIA;EDA;TRIM14;ALK;LAMTOR5;AGT;EDA2R;IKBKG
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3790066707412423,1.0541434242482521,0.3879310344827586,0.828987658757377,1.0,17/59,15.03%,PTEN;MECP2;MED10;MED13;AGO3;CDKN1A;CCNC;RUNX2;MED1;MITF;TNRC6C;MED20;BCLAF1;THRA;TNRC6B;MED4;MED6
prerank,AMP metabolic process (GO:0046033),-0.44445602150854163,-1.0535680716650082,0.416988416988417,0.7442883362496129,1.0,5/13,20.92%,AMPD3;XDH;NT5E;NT5C1A;ADSS1
prerank,estrogen metabolic process (GO:0008210),-0.43623457585070646,-1.0535623707193689,0.42057761732851984,0.7435943440520602,1.0,4/15,18.71%,CYP1B1;SULT1A1;HSD17B7;HSD17B8
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.31099218395913586,1.0534076889174815,0.35859269282814615,0.8296723737749003,1.0,25/214,7.16%,PDGFRB;PTEN;SLC30A10;RAPGEF2;GCNT2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;SPRED1;ERBB4;IL1B;PTPN22;ACKR3;FGF2;SPRY2;CARD9;ROS1;NTRK2;HTR2C;CHRNA7;YWHAZ;RAP1A;HRAS
prerank,activation of GTPase activity (GO:0090630),0.3522126688828736,1.0529848892022096,0.3804878048780488,0.8296289692747717,1.0,16/89,9.85%,ARHGAP42;TBC1D1;SIPA1;GRTP1;GARNL3;TBC1D30;SLC27A4;SYDE1;TBC1D12;ARHGEF26;RUNDC1;RALGAPA1;TBC1D2B;MTSS2;TBC1D10C;EPHA2
prerank,negative regulation of protein depolymerization (GO:1901880),0.4195913983522821,1.052774556277785,0.38767395626242546,0.8291154624017913,1.0,8/24,13.12%,SPEF1;PIK3CA;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,zinc ion transmembrane transport (GO:0071577),0.4404369037302401,1.052589414612152,0.3801980198019802,0.828553014459109,1.0,1/22,0.46%,SLC30A10
prerank,translesion synthesis (GO:0019985),-0.3430324471414325,-1.0522855672174924,0.4,0.7461013515104168,1.0,20/42,32.01%,REV1;POLH;UBB;RPA1;NPLOC4;RFC3;VCP;UBE2L6;POLI;USP43;POLE2;RFC1;USP10;RPA3;POLD1;ISG15;DTL;PCNA;PARP10;RFC5
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.3227704847988692,-1.052248926518803,0.38317757009345793,0.7454888034375641,1.0,5/53,3.83%,EYA2;EYA1;EGFR;EYA4;DDX5
prerank,cellular response to organic cyclic compound (GO:0071407),0.32544847540513516,1.0521864500289966,0.36022253129346316,0.8285047027021506,1.0,22/141,9.43%,MEF2C;GNG2;PDE3A;RAPGEF2;ATP1A2;RORA;GPER1;IL1B;ADCY8;ADCY3;NCOA3;ADCY6;AKAP6;GABRG2;HCN2;RAP1A;FAM210B;RYR3;HCN3;PKD2;PDGFB;MED1
prerank,response to estrogen (GO:0043627),-0.3587759493454158,-1.0515391448436078,0.3649193548387097,0.7466420408992592,1.0,13/31,30.35%,CAV1;ESR1;TRIM24;AR;SFR1;SFRP1;NCOA4;RARA;BRCA1;KRT19;SRA1;SERPINB9;RBBP5
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.3161692430777248,-1.0510494159385397,0.33910891089108913,0.7471910926223626,1.0,16/64,17.81%,PLA2G4A;CPT1A;CYP1B1;CPT2;DAGLB;GPX4;ACOX1;MGLL;ACADL;PTGS2;EPHX2;GSTM2;ELOVL1;GPX1;ACSL4;ALOX12
prerank,cellular response to ketone (GO:1901655),-0.3470592584740706,-1.0509851150237293,0.40176600441501104,0.7466565841865817,1.0,11/35,13.91%,ROCK2;ADCY5;NR3C1;ADCY1;AR;GOLPH3;ADAM15;AHR;SPP1;LARP1;SFRP1
prerank,negative regulation of vascular permeability (GO:0043116),-0.4500258571981455,-1.0507822032921583,0.4137323943661972,0.7464353103337734,1.0,6/12,6.45%,SLIT2;CLDN5;PTPRJ;ANGPT1;RAMP2;DDAH1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.4484432543587605,-1.0504833775987348,0.424860853432282,0.7464824247993371,1.0,5/12,29.52%,AKT1;PPP1R3B;PPP1R3F;INPP5K;KHK
prerank,somite development (GO:0061053),-0.4685130473148723,-1.0502432378857682,0.4007352941176471,0.7463731076235331,1.0,3/11,11.87%,MEOX2;SMO;PTCH1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3400572499261468,-1.0491994167543983,0.3738738738738739,0.7482859370546224,1.0,7/41,7.45%,AFDN;PLPP3;BMP7;PODXL;SMAD7;PIEZO1;CD47
prerank,stress fiber assembly (GO:0043149),-0.42694498887250365,-1.0491810452674772,0.38104089219330856,0.7468963500558169,1.0,6/15,7.88%,SORBS1;PHACTR1;FAM171A1;ARRB1;RHOA;ZYX
prerank,contractile actin filament bundle assembly (GO:0030038),-0.42694498887250365,-1.0491810452674772,0.38104089219330856,0.7468963500558169,1.0,6/15,7.88%,SORBS1;PHACTR1;FAM171A1;ARRB1;RHOA;ZYX
prerank,cellular response to acid chemical (GO:0071229),0.41733541660359164,1.0491805192531458,0.38740458015267176,0.8343279983916294,1.0,2/27,1.65%,SPAAR;CPEB1
prerank,positive regulation of viral transcription (GO:0050434),-0.3899546750587524,-1.04892151674458,0.39361702127659576,0.7468371923237703,1.0,10/25,30.31%,MDFIC;POLR2A;POLR2F;CDK9;POLR2E;RSF1;NELFCD;POLR2G;CTDP1;SUPT4H1
prerank,intestinal absorption (GO:0050892),-0.4416742566514129,-1.0488693585414708,0.38817005545286504,0.7462420836810906,1.0,4/13,13.66%,TJP2;KCNQ1;F11R;UGCG
prerank,cell chemotaxis (GO:0060326),0.3707692147661938,1.0485819312145805,0.38860971524288107,0.8346898531558206,1.0,12/60,12.16%,PDGFRB;SEMA5A;BCAR1;CCRL2;ACKR3;CXCR2;CCR9;ACKR2;PDGFB;EPHA2;PLXNB3;EPHB1
prerank,regulation of potassium ion transport (GO:0043266),0.41374168235383657,1.0485668108126496,0.39879759519038077,0.8337325287778621,1.0,8/31,11.54%,CASQ2;DPP10;KCNAB3;ANK3;CACNA1D;KCNE5;KCNIP1;KCNIP4
prerank,neural crest cell development (GO:0014032),0.3870778551471723,1.0485122440544545,0.3981981981981982,0.8328793358702477,1.0,6/44,4.83%,CDH2;SEMA6D;SEMA5A;ERBB4;NRG1;SEMA6C
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.376540913884758,-1.0482053855472016,0.396,0.7472632858734117,1.0,6/24,7.65%,NRP1;SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.40315792863740263,-1.047902673732656,0.39919354838709675,0.7473858418859887,1.0,7/20,24.75%,ADAM9;ADAM10;TGFB1;RELA;PSEN2;MBTPS1;NCSTN
prerank,reverse cholesterol transport (GO:0043691),-0.4386308664426034,-1.0477638002082201,0.40037593984962405,0.7470458921410739,1.0,2/13,1.96%,ABCA1;APOE
prerank,C-terminal protein amino acid modification (GO:0018410),-0.46259652954007346,-1.0477384306813082,0.41030534351145037,0.7464071913725928,1.0,6/11,30.75%,FOLH1;LCMT1;ATG7;ATG12;AGBL1;ICMT
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.27872185196891436,-1.0476147758866825,0.34890965732087226,0.7460157796169372,1.0,42/124,21.25%,PLCB1;WNT4;SMURF2;TCF7L2;NFATC1;LEF1;FZD2;AP2A2;MOV10;SFRP4;SMURF1;WNT5A;RHOA;PLCB3;FZD4;TIAM1;FZD7;PSME2;CAMK2A;PFN1;AP2A1;PSMB4;CCDC88C;ARHGEF19;SFRP1;PSMB1;PSMD11;PSMD8;FZD8;PSME3;CALM1;TNRC6A;WNT11;ROR2;FZD1;PSMD4;PSMA2;AGO1;PSMD3;PPP3CB;PSMB7;VANGL2
prerank,icosanoid metabolic process (GO:0006690),0.4088535187749449,1.0475320238287085,0.35797665369649806,0.8340703742685708,1.0,2/40,0.87%,GGT5;GGT1
prerank,positive regulation of cellular process (GO:0048522),0.28710689135081396,1.047350821763793,0.3712035995500562,0.833451678151327,1.0,52/565,7.78%,TRPC3;PDGFRB;PTEN;TBX2;IL34;S1PR3;IL15RA;GCNT2;COLEC12;BMP5;NOTCH1;SLC25A33;PTK2;GPER1;TBX3;ZFHX3;MERTK;PABIR1;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;TBX6;ETS1;MECP2;AKAP6;PPP3CA;PDCD10;FGF2;CIDEB;SPDYA;ACTN4;TSPAN31;TFAP2B;CXCR2;NTRK2;IL4;CXCL5;DDX3X;TPPP;RYR2;SOX4;CHRNA7;SUPV3L1;EMP2;HRAS;IRS1;RIPK2;FGF10;NCMAP
prerank,positive regulation of hydrolase activity (GO:0051345),0.3278495632623916,1.0471032616354388,0.3788546255506608,0.8330490728332556,1.0,20/137,8.82%,RGS6;LIMS1;DOCK10;RAPGEF2;RASGRP2;MTCL1;FERMT2;NF1;PLXNB1;SH3BP1;AGRN;TBC1D30;MAPRE2;ITGB1;RIC1;RAP1A;HRAS;RGS7;RAB11FIP2;MAP4K4
prerank,histone H3-K9 demethylation (GO:0033169),-0.4584221273525455,-1.0468321479728182,0.40860215053763443,0.7473174141188077,1.0,2/11,11.47%,KDM7A;KDM3A
prerank,digestive tract morphogenesis (GO:0048546),-0.43982381687119915,-1.0466844859557878,0.4115384615384615,0.7469894023313327,1.0,7/14,16.39%,PDGFRA;FGFR2;STRA6;BBS7;ID2;SOX17;EPHB3
prerank,zinc ion transport (GO:0006829),0.44800686818730295,1.046431842380154,0.411522633744856,0.8335397663265515,1.0,1/21,0.46%,SLC30A10
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3856505326854854,-1.0462768264447004,0.40425531914893614,0.7473188263544006,1.0,4/22,5.80%,AEBP1;AKAP13;APOE;MAP1B
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.418115339305403,-1.0461443533843675,0.4090019569471624,0.7469290888494223,1.0,5/16,17.83%,PHKB;PHKA2;PYGB;CALM1;GAA
prerank,negative regulation of response to wounding (GO:1903035),0.45498152479049914,1.0460663902345853,0.4142857142857143,0.8333183754181633,1.0,3/19,4.25%,AJAP1;RTN4RL1;FGF2
prerank,mitotic cytokinesis (GO:0000281),-0.3303112162194979,-1.0459890383891053,0.40097799511002447,0.7466108171714242,1.0,18/47,19.80%,ROCK2;SNX9;PDCD6IP;USP8;RHOB;MYH10;SON;ARL3;TTC19;SPAST;EFHC1;CHMP4B;EFHC2;MITD1;KLHDC8B;STAMBP;CIT;RHOC
prerank,peptidyl-proline modification (GO:0018208),-0.3752454058670054,-1.0456387472155702,0.3881856540084388,0.7468742761696433,1.0,9/25,22.83%,FKBP5;FKBP1A;FKBP4;PPIC;PPID;PPIA;FKBP7;PPIL1;FKBP10
prerank,postsynaptic membrane organization (GO:0001941),0.45075367567754215,1.045635615028125,0.3905325443786982,0.8332766087954658,1.0,2/17,3.15%,CEL;NRXN1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.48391253437579435,1.0455143600416381,0.4153846153846154,0.832586719867047,1.0,1/11,0.63%,MEF2C
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.43618507991789696,-1.0453150258384822,0.4165067178502879,0.7470255478070089,1.0,4/15,5.81%,ITGA5;KLF4;FGF1;BMPER
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.29349842076122157,-1.045252838665556,0.3681462140992167,0.7464828059491078,1.0,15/84,14.50%,IGF1;DAPK1;SAMD4A;IGFBP5;APOE;CNOT7;RNF139;DDX6;IGF2BP2;CPEB3;CALR;SPHK1;LARP1;CNOT8;FXR2
prerank,negative regulation of JNK cascade (GO:0046329),-0.35401884103962056,-1.0452263811403408,0.3761467889908257,0.7458474820937815,1.0,11/31,27.71%,MECOM;PDCD4;SH3RF2;MAPK8IP1;DUSP10;SIRPA;ZMYND11;HIPK3;PRKN;AIDA;DACT1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.40408998148160147,-1.0450541494664178,0.4158215010141988,0.745575850585799,1.0,6/18,14.09%,VGLL4;EZR;ATRAID;DAB2IP;VPS35;RGP1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3711991582750224,-1.0444706329459332,0.391304347826087,0.746298829453144,1.0,4/26,3.49%,ERRFI1;TGFA;APP;SNX6
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.4075781760728433,-1.0443958903557051,0.42588726513569936,0.7458091434699072,1.0,5/18,21.45%,FBN1;TCTA;GPR137;TLR4;FSTL3
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3303869291799759,1.044258666145914,0.3831360946745562,0.834383180796069,1.0,15/125,11.00%,DYNLL1;RMDN1;MECP2;NUP43;TNKS;CLASP2;CENPP;PPP1CC;DYNC1I2;NEK6;NUSAP1;TACC3;TUBG2;XPO1;SEC13
prerank,calcium-mediated signaling (GO:0019722),0.3482587730685822,1.0440746563393855,0.3818770226537217,0.8337954466174349,1.0,11/93,8.21%,CACNA1C;PLCE1;CCRL2;ACKR3;GRM5;PPP3CA;CXCR2;RYR2;ATP2A2;CCR9;ACKR2
prerank,catecholamine biosynthetic process (GO:0042423),-0.4551690440522608,-1.0436749809436394,0.4033457249070632,0.7469769004506926,1.0,3/11,17.95%,MOXD1;GCH1;DDC
prerank,regulation of immune response (GO:0050776),-0.27643750181675264,-1.043651618451384,0.38819875776397517,0.746335711646219,1.0,20/135,10.17%,COL1A2;COL3A1;COL1A1;FOXP1;CXADR;IL15;CLEC2D;B2M;VCAM1;CD34;APPL2;ADCY7;IRF1;ICAM1;FKBP1A;ERAP1;BIRC3;RNF135;CASP8;SAMHD1
prerank,regulation of protein kinase activity (GO:0045859),0.33455484421572235,1.0434054324671413,0.3808,0.8343080287047027,1.0,16/106,9.49%,PLCE1;RAPGEF2;PTK2;PPM1E;NF1;SPRED1;AGAP2;SPDYA;TRIB2;DBNDD2;SNCA;RAP1A;AKT1S1;CDKN1A;ANKRD54;TARBP2
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3177980298016354,-1.0433810576852716,0.39485981308411217,0.746354583230931,1.0,8/56,3.02%,EPHA4;EPHA3;EGFR;FLT1;EFEMP1;PDGFRA;TEK;FGFR2
prerank,cardiac conduction system development (GO:0003161),-0.38422277795787846,-1.0429772583055894,0.38289205702647655,0.7466868703943914,1.0,4/24,3.37%,NOTCH2;GJB6;BMP4;GJA1
prerank,sodium ion transmembrane transport (GO:0035725),0.35492430846149575,1.0429337948224269,0.37766830870279144,0.8344339755183245,1.0,18/84,9.03%,SLC12A2;ATP1A2;ATP1A4;SLC5A1;FXYD2;SLC24A4;SLC24A2;SCN2A;ATP1B2;SCN5A;ASIC2;HCN2;SCN8A;SLC9A7;HCN3;SLC6A15;SCN9A;PKD2
prerank,regulation of sodium ion transport (GO:0002028),-0.35417194364439036,-1.0428308269403284,0.39285714285714285,0.7463838698845693,1.0,15/34,21.00%,SNTA1;DLG1;WNK4;WNK1;GPD1L;P2RX4;AHCYL1;SLMAP;P2RX7;ATP1A1;CNKSR3;NOS1;YWHAH;NKAIN4;SCN3B
prerank,cellular response to estradiol stimulus (GO:0071392),-0.40275841513833377,-1.042814780732671,0.41683778234086244,0.7457174660393344,1.0,3/18,2.97%,EGFR;LCOR;ESR1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.37234902234956824,-1.042565821944218,0.42071881606765327,0.7456586991717797,1.0,11/29,18.55%,WWOX;CAV1;THBS1;TNFSF10;PPP2R1B;PML;RET;SFRP1;BID;RIPK1;AGT
prerank,negative regulation of DNA binding (GO:0043392),0.41441486508681935,1.0424080641625841,0.3843283582089552,0.8346318122281832,1.0,3/28,5.14%,HEY2;PER2;TNKS
prerank,protein homotetramerization (GO:0051289),-0.32214007904500797,-1.0421514252158046,0.3808353808353808,0.7460299532874449,1.0,10/49,11.55%,ALDH1A2;KCNJ2;B2M;APPL2;SSBP1;UPB1;GLS;ACACA;SAMHD1;GBP5
prerank,regulation of NMDA receptor activity (GO:2000310),-0.36192325874167997,-1.0420433019687179,0.395112016293279,0.7456361313930225,1.0,9/32,12.29%,DAPK1;ACTN2;APP;DLG1;SLC6A9;PTK2B;CAPN1;CAMK2A;EPHB2
prerank,myofibril assembly (GO:0030239),0.3941603740146498,1.04202100378062,0.3852596314907873,0.8345115279344092,1.0,3/42,5.36%,PDGFRB;TMOD1;TMOD3
prerank,regulation of myoblast differentiation (GO:0045661),0.41334249126144057,1.0415891877135213,0.391304347826087,0.8344624966899717,1.0,5/32,4.39%,MEF2C;NOTCH1;TBX3;RBM24;SOSTDC1
prerank,cellular protein localization (GO:0034613),0.2993048096510464,1.0415795856216357,0.3732484076433121,0.8335024396106046,1.0,43/285,11.87%,PTPRK;TBC1D1;DMD;HEY2;PIGU;JAM3;VCL;FERMT2;STX16;GRTP1;COG7;CNTNAP2;COX18;TBC1D30;ESAM;GAS8;GGA3;ARL4C;DNAJC27;TBC1D12;RIC1;EMP2;RUNDC1;FGF10;RAB28;MYO6;TBC1D2B;RAB38;TBC1D10C;TMED7;TMED4;BICD2;STXBP2;ARL5C;AHI1;SEC13;STX4;ARFRP1;WLS;AXIN2;ERP29;COPB2;TBC1D9B
prerank,regulation of cell cycle (GO:0051726),0.30532197906470737,1.0413537571745284,0.37844940867279897,0.8330517215759315,1.0,39/271,11.89%,PTPRK;FAP;MAP3K20;APBB2;CDK6;NOTCH1;AFAP1L2;PER2;RGCC;GPER1;TBX3;SIPA1;FOXM1;CRLF3;RPS6KA2;BRINP1;NUPR2;SIK1;HRAS;BIN1;FGF10;CDKN1A;GRK5;RNF112;HTRA2;PKD2;TTLL12;CDC14B;NEK6;TAF6;CITED2;ASAH2;WDR12;SETMAR;RPRD1B;EP300;RB1;APC;SND1
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.4659099090545661,-1.0408078566901962,0.4275092936802974,0.748072279361819,1.0,4/10,13.61%,ADAM10;WNT5A;WNK1;OXSR1
prerank,positive regulation of chemokine production (GO:0032722),-0.3361829071791436,-1.0407298372676819,0.40492170022371365,0.747563107913387,1.0,9/44,10.94%,APP;IL6R;LGALS9;WNT5A;IL33;HIF1A;IL17RA;IL18;MAVS
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3615572125509336,-1.0406800617365648,0.41629955947136565,0.746993691976282,1.0,3/29,2.98%,NOTCH2;IGF1;TGM2
prerank,positive regulation of response to external stimulus (GO:0032103),-0.28072053656223256,-1.040449972042576,0.3772455089820359,0.7468377098944546,1.0,33/128,19.01%,BMP6;APP;IL15;SASH1;THBS1;THBD;PDCD4;IL16;DDX60;WNT5A;CD47;STX3;USP15;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;OPTN;PUM1;GBP5;TGFB1;USF1;CYBA;CD180;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;AGT;AGTR1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2830168830026116,-1.0403855351093696,0.3799392097264438,0.7463290232239683,1.0,39/110,28.76%,TRABD2B;ABCA1;CDH5;GSN;APOE;IAPP;PRKCZ;FNIP1;HSPA5;TFRC;IRGM;BCL2L11;GFAP;DAB2IP;TGFB1;SH3GLB1;TAL1;NAPA;BID;PARK7;SAR1A;SAR1B;VCP;RHOC;SYK;LCMT1;HJURP;VEGFA;PIH1D1;ICE1;HCK;RPS3;RACK1;AIDA;BIK;CLU;PREB;SLF1;MPP7
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.47398695679381664,-1.0402481529866499,0.41889483065953653,0.7453124015738264,1.0,6/10,35.71%,ASCC3;FTO;ASCC1;ALKBH5;ASCC2;MGMT
prerank,DNA dealkylation (GO:0035510),-0.47398695679381664,-1.0402481529866499,0.41889483065953653,0.7453124015738264,1.0,6/10,35.71%,ASCC3;FTO;ASCC1;ALKBH5;ASCC2;MGMT
prerank,regulation of acrosome reaction (GO:0060046),0.49987863932303134,1.0400955381399786,0.42921348314606744,0.834913087304294,1.0,2/10,5.06%,CACNA1H;SERPINA10
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4483720799544213,-1.0400509293803537,0.4272030651340996,0.7450873169811942,1.0,6/12,13.65%,HDAC4;CCN3;BHLHE41;HDAC1;TMEM119;HDAC5
prerank,regulation of cell motility (GO:2000145),-0.27773683323140996,-1.0398896131612811,0.39263803680981596,0.744833769370348,1.0,19/121,8.76%,PLXNA2;EGFR;ROCK2;LMO4;FBLN1;PLXNA4;MACF1;DIAPH1;ARHGAP18;FGF1;SPOCK2;CAVIN1;RHOA;RHOB;TMSB4X;TBCCD1;CCDC125;PLXND1;AKT1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3194426433234302,-1.0396380947584232,0.4052132701421801,0.7447744047681951,1.0,14/51,14.56%,BMP7;GAS7;NRK;SRGAP2;LRRK2;NBL1;ALS2;TRIO;DTNBP1;TAOK2;DAB2IP;DCLK1;UBB;ANKRD27
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3750961913786951,-1.0396244830740717,0.4158215010141988,0.7441211528799332,1.0,7/25,13.57%,SLIT2;CAPZB;LIMK2;YAP1;PRKCD;EVL;TCHP
prerank,cell differentiation in hindbrain (GO:0021533),0.48340655207651473,1.0392788407973037,0.422680412371134,0.8357219175047975,1.0,2/11,4.05%,ATP7A;CEND1
prerank,regulation of phagocytosis (GO:0050764),0.37813943228400027,1.0389721360212503,0.39092495636998253,0.8354424443333263,1.0,5/53,2.62%,IL15RA;DYSF;SCARB1;MERTK;IL1B
prerank,cell proliferation in forebrain (GO:0021846),0.5053318909042562,1.0385575121660895,0.40976645435244163,0.8353999304615194,1.0,4/10,19.42%,HOOK3;AKNA;CEP120;DOCK7
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.31076617773316906,-1.0384253214163308,0.3968668407310705,0.7465659469453143,1.0,21/65,24.71%,FBXL7;FHL1;USP47;CHFR;ZFYVE19;PINX1;PSME2;NABP1;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;CDK5RAP3;PSMB7;PSMC2;PSMC5;PSMD10
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.4046016429343192,-1.0383792532297305,0.44081632653061226,0.7460129511318143,1.0,5/18,21.55%,NR3C1;ANXA1;BCL2L11;ZFP36L2;FAM107A
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.42750003157293526,-1.0383567482258893,0.4346153846153846,0.7453839732399885,1.0,12/14,42.35%,RELA;RAB29;IKBKG;CD81;RPS3;BCL10;KCNN4;CARD11;TRAT1;CD226;TESPA1;LCK
prerank,sterol metabolic process (GO:0016125),-0.3147256558277784,-1.038300733987323,0.3830275229357798,0.7448187150006029,1.0,11/60,12.16%,PRKAG2;ABCA1;APOE;CYP26B1;LBR;LIPA;CYP27A1;CYP1B1;OSBPL1A;INSIG2;STARD3
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.36415447796669265,-1.0382957789283358,0.4346076458752515,0.7441458692678554,1.0,14/29,26.62%,LIMA1;SLIT2;SHANK3;KANK3;PRKCD;FKBP4;PFN1;TWF1;CYRIB;SSH3;ARPIN;KANK1;PRKN;SMAD4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.2892020361334448,-1.0382368043693213,0.3810810810810811,0.743610420859185,1.0,14/87,14.53%,FLRT2;RBFOX2;FGFR2;FGF1;NDNF;KL;TBX1;POLR2A;FRS2;FGFBP1;FGFR4;POLR2F;SFRP1;MAPK3
prerank,cellular response to insulin stimulus (GO:0032869),-0.27561549705565946,-1.0380605483143515,0.38095238095238093,0.7433695149297463,1.0,31/124,14.31%,SORBS1;RHOQ;FOXO1;ENPP1;IGF1R;BAIAP2;KAT2B;FOXC2;AP3S1;ATP6V0A4;HDAC9;IGF2;SLC39A14;SYAP1;CPEB2;NAMPT;ATP6V1G1;AKT1;C2CD5;GRB14;IDE;ATP6V0B;INSIG2;RAB8A;ATP6V0A1;TCIRG1;USF1;LPIN3;FER;HDAC5;CAV2
prerank,regulation of GTPase activity (GO:0043087),0.3128262568993951,1.03796429702408,0.38189533239038187,0.8357426298167118,1.0,22/177,7.65%,CHN1;RGS6;LIMS1;PRKG1;DOCK10;RAPGEF2;PTK2;RASGRP2;FERMT2;NF1;PLXNB1;SH3BP1;AGRN;TBC1D30;MAPRE2;ITGB1;NTRK2;ARFGEF1;RIC1;RAP1A;HRAS;RGS7
prerank,negative regulation of ossification (GO:0030279),0.4395459556771302,1.0378299018793242,0.4123134328358209,0.835049444692122,1.0,2/23,1.19%,MEF2C;NOTCH1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3385658517980706,-1.0373728211564792,0.4342379958246347,0.7444269071589972,1.0,10/39,12.45%,BMP6;PODXL;KLF4;CDH1;FXYD5;WNK1;MAP2K5;AKT1;TGFB1;PPARA
prerank,positive regulation of cell adhesion (GO:0045785),-0.3021051874609204,-1.0369649911835819,0.3925925925925926,0.744765625645547,1.0,19/74,13.68%,AFDN;EPHA4;VIT;TGM2;PTPRJ;FOXC2;ADAM9;SMAD7;CXCL12;NDNF;P4HB;CD47;STX3;FBLN2;FLCN;ATM;CHRD;MEGF10;RET
prerank,cholesterol efflux (GO:0033344),-0.3930712832735157,-1.0369572359261379,0.4314516129032258,0.7441030355682285,1.0,3/20,6.78%,ABCA1;APOE;NPC2
prerank,regulation of interleukin-8 production (GO:0032677),-0.3035126055086803,-1.0363878536699773,0.3888888888888889,0.7448857785581098,1.0,19/69,18.53%,F3;ANXA4;LBP;KLF4;NOD1;ANXA1;ARRB1;LGALS9;STAT3;MAP2K5;TMSB4X;MAVS;RELA;SSC5D;SERPINE1;TLR4;RIPK1;PARK7;LAMTOR5
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.31743746840152326,-1.0358551015079747,0.4009546539379475,0.7455469475913667,1.0,17/55,24.71%,FBXL7;FHL1;USP47;PINX1;PSME2;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;PSMB7;PSMC2;PSMC5;PSMD10
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3156399699053556,1.03523116644036,0.39691444600280507,0.8399425560555477,1.0,27/166,9.26%,PDGFRB;PTH1R;PLD1;RGCC;NR1H3;SCARB1;ZEB2;IL1B;LDLR;ATP7A;FGF2;FABP3;YTHDF3;SNCA;DDX3X;SOX4;APPL1;KAT7;IRS1;NMD3;MTOR;EIF3C;ARNT;PRKD2;PKD2;PDGFB;GCK
prerank,antibacterial humoral response (GO:0019731),0.46498940280030165,1.034955025216523,0.42733188720173537,0.8395803877176036,1.0,8/16,24.36%,WFDC3;CAMP;RNASE6;DMBT1;SLPI;JCHAIN;ANG;RNASE7
prerank,establishment of vesicle localization (GO:0051650),-0.40455586844546476,-1.0347672484647599,0.41865079365079366,0.7475731354900679,1.0,4/18,5.45%,RAB11A;LIMK2;RAB27A;CCDC186
prerank,RNA interference (GO:0016246),0.44547558423778433,1.034719044515464,0.3902439024390244,0.8391376456234442,1.0,5/17,13.07%,CLP1;AGO3;TARBP2;TSN;CELF1
prerank,icosanoid biosynthetic process (GO:0046456),-0.4728206970196688,-1.034716910409328,0.42723880597014924,0.7470089902218813,1.0,1/10,1.12%,PLA2G4A
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.3493951484966769,-1.0346713484423409,0.3917748917748918,0.7464468842549319,1.0,10/36,18.15%,NRP1;TGFA;SHANK3;TAF1;HIF1A;HDAC1;EPHB2;HFE;ADRB2;PARK7
prerank,regulation of chromatin organization (GO:1902275),-0.4310937191768844,-1.0342001859206635,0.4288461538461538,0.7468637981785269,1.0,3/14,5.02%,TLK1;MLLT3;IGF2
prerank,motile cilium assembly (GO:0044458),0.483972390555815,1.0340052641896473,0.4256198347107438,0.8397715392139768,1.0,1/12,2.33%,RSPH6A
prerank,DNA biosynthetic process (GO:0071897),-0.41495138024743106,-1.0334710028712235,0.4505703422053232,0.7480127929152153,1.0,8/16,30.13%,POLH;PPIA;TYMS;RFC3;POLA1;CDKN2D;POLD1;WRN
prerank,cellular response to starvation (GO:0009267),-0.26578222033292076,-1.0332553935033066,0.34539473684210525,0.7478523287656232,1.0,49/147,26.47%,PRKAG2;LAMP2;FOXO1;FOXO3;BMPR2;LRRK2;DAP;WIPI2;FNIP1;ITFG2;HSPA5;CLEC16A;KLF10;ATP6V1G1;BECN1;DAPL1;FLCN;ATP6V0B;ZC3H12A;SH3GLB1;TCIRG1;PRKAG3;PPARA;MFSD2A;SFRP1;MAPK3;SREBF1;PRKAA2;MTMR3;GABARAPL1;RRP8;RRAGB;CEBPB;LAMTOR5;ZFYVE1;KPTN;PRKAG1;XBP1;EIF2AK3;ATP6V1F;STK26;RIPOR1;ATG7;RRAGC;TP53;ATF2;FAS;EIF2AK4;PICK1
prerank,pentose-phosphate shunt (GO:0006098),-0.4518698082664856,-1.0331546046249174,0.4368029739776952,0.7474402236495313,1.0,6/11,23.00%,TALDO1;DERA;PGD;RPIA;PGLS;SHPK
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.47223765281692964,-1.031962954008971,0.4467713787085515,0.7497420050298161,1.0,3/10,8.00%,RARB;RARG;TBX1
prerank,negative regulation of organelle assembly (GO:1902116),-0.3488777132398605,-1.0316970590809438,0.42410714285714285,0.7497450357781353,1.0,10/35,16.06%,NUPR1;KAT2B;LRRK2;LIMK2;YAP1;CHMP4B;CHMP4A;PHF23;TCHP;NBDY
prerank,negative regulation of response to external stimulus (GO:0032102),0.3396557544382533,1.0314940946293294,0.3978328173374613,0.8443581066020754,1.0,12/105,7.28%,PTEN;AJAP1;RORA;RTN4RL1;GPER1;NR1H3;LRFN5;PPARD;FGF2;IL4;CACTIN;AOAH
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.44024382949683083,1.0311972201473756,0.4129032258064516,0.8440418248464245,1.0,4/18,10.98%,GINS1;GINS3;GINS4;MCM7
prerank,negative regulation of cell growth (GO:0030308),-0.272560430591961,-1.0310614524659938,0.3761194029850746,0.7506864632850951,1.0,28/121,14.32%,SMAD3;SMARCA2;VGLL4;FHL1;ENPP1;SLIT2;BMPR2;PTPRJ;GJA1;RBBP7;CCN3;NPR1;ACVRL1;NDRG3;OSGIN2;DIP2B;ADAM15;FLCN;ULK2;PML;DNAJB2;TGFB1;PRDM11;TCHP;SOX17;SFRP1;ENO1;IP6K2
prerank,organic cation transport (GO:0015695),-0.3948620257643861,-1.0309591578218091,0.4069097888675624,0.750256151822779,1.0,8/19,20.27%,SLC47A1;SLC22A4;SLC22A5;SLC25A19;SLC22A2;SLC25A26;SLC25A29;SEC14L1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.41560298303012,-1.0306464454750075,0.4227941176470588,0.7503674911750996,1.0,9/16,30.28%,CAV1;PARP14;HGS;LEPROT;PTPN2;ADIPOR1;PIBF1;SOCS1;INPP5F
prerank,connective tissue development (GO:0061448),-0.35576376295056156,-1.0297927044817654,0.42701525054466233,0.7518311141881909,1.0,7/35,7.50%,SULF1;ZBTB16;ITGB8;CREB3L2;SULF2;SLC39A13;NAMPT
prerank,T cell homeostasis (GO:0043029),-0.46670432435825016,-1.0296696616787322,0.4388349514563107,0.7514833776373511,1.0,10/10,53.37%,AKT1;PPP2R3C;NCKAP1L;FAS;FADD;JAK3;ZC3H8;FOXP3;RIPK3;PMAIP1
prerank,sulfur compound biosynthetic process (GO:0044272),0.3383751830334823,1.0294864317454124,0.4137426900584795,0.8469502231626393,1.0,13/104,7.23%,CSPG4;GGT5;GGT1;CHST3;GGTA1;CHST7;CHAC1;CTH;ACAN;SLC26A1;B4GALT6;TPK1;CHST2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4581907611486558,1.0294027342230254,0.4199134199134199,0.8461798560595167,1.0,2/16,1.91%,PDGFRB;BCAR1
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.36443575791156124,-1.0291096085762115,0.41929499072356213,0.7521769333658295,1.0,8/26,11.83%,POR;APOE;NPR3;PIK3CB;NOS1AP;AKT1;HIF1A;GCH1
prerank,regulation of protein sumoylation (GO:0033233),-0.4079538805397319,-1.0290917118797416,0.43453510436432635,0.7515545226723966,1.0,2/17,1.09%,ZMIZ1;HDAC4
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3569117860463766,1.0289759553985052,0.40558292282430214,0.8461931369418578,1.0,11/70,13.44%,MBOAT2;NR1H3;SLC44A2;LIPC;ABHD3;PLAAT1;ACHE;STARD7;PLA2G4E;CHKB;ABHD4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.43138739218864336,-1.0288612745516563,0.44299065420560746,0.7514776965399709,1.0,10/13,28.17%,SEC16B;EDEM2;TMEM30A;TM9SF4;BCAP31;SAR1A;SAR1B;CD81;SEC16A;EDEM1
prerank,dephosphorylation (GO:0016311),0.3184963976498247,1.028855342569248,0.3988183161004431,0.8454857080937935,1.0,11/147,4.74%,PTPRK;PTEN;PTPN9;PPM1E;BTRC;PTPN22;SSH2;PLPPR5;PPP3CA;PPP2R2A;PTPN4
prerank,multivesicular body organization (GO:0036257),-0.35489603042078766,-1.0287851874630372,0.4130879345603272,0.7510002848046674,1.0,6/31,10.72%,RAB11A;PDCD6IP;RAB27A;HGS;CHMP4B;CHMP4A
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.438511963510578,1.0285718807262105,0.4186046511627907,0.8451689233096843,1.0,8/21,21.29%,MED13;MED1;MITF;BCLAF1;MED4;DHX36;MED30;MED16
prerank,neural tube development (GO:0021915),-0.4201852165175223,-1.0285103058123795,0.4324817518248175,0.7509881502048367,1.0,4/15,14.82%,ALDH1A2;TGFB1;PTCH1;PKD1
prerank,positive regulation of protein polymerization (GO:0032273),0.35902237605785103,1.0283972641381043,0.40381558028616854,0.8446162420597101,1.0,11/65,11.50%,CARMIL1;NCK2;VASP;CDC42EP1;NAV3;TTBK1;TPPP;BIN1;NCKAP1;LMOD1;PAK1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.44334071401187525,-1.0283425801859516,0.4499054820415879,0.7507850339773922,1.0,7/13,23.89%,IL6ST;STAT1;STAT3;OAS2;CANX;TYK2;CRLF1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.39494571568193315,-1.0280058929383702,0.43887775551102204,0.7509809311282578,1.0,2/19,2.01%,CAMK1D;MCU
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5064444326887144,1.0276300045035536,0.4309978768577495,0.8453535352241409,1.0,3/11,5.97%,COLEC12;RFTN1;TNIP2
prerank,regulation of protein binding (GO:0043393),-0.2789723737702232,-1.0274363380418055,0.3879310344827586,0.7516765936122848,1.0,34/114,18.15%,DAB2;HDAC4;APP;CAV1;CLDN5;BMP4;B2M;TCF7L2;LRRK2;TAF1;FKBP1A;AMFR;PRKCD;IFIT2;TIAM1;AKT1;DTX3L;IFIT1;IDE;RPL11;DNAJB2;ADD1;RAN;HDAC5;ACTB;PKD1;HIPK2;ZFPM1;TMBIM6;HFE;MITD1;STYX;EFHB;PARK7
prerank,response to amino acid (GO:0043200),0.4000395322896442,1.0267155328088227,0.42463235294117646,0.8464371660536142,1.0,2/31,1.65%,SPAAR;CPEB1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4353795669794796,-1.026712987656091,0.4538878842676311,0.7527859109595365,1.0,5/13,14.54%,APP;SHANK3;ADCY1;EPHB2;SHISA7
prerank,regulation of protein polymerization (GO:0032271),0.4097274465666348,1.0259880599121298,0.4388888888888889,0.8471188762847005,1.0,9/35,13.98%,PLEKHG2;MAP2;ESAM;TTBK1;TPPP;CAMSAP3;PAK3;RASA1;ABITRAM
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.49494006615711705,1.0255504286733836,0.4376321353065539,0.8471259093946444,1.0,3/10,9.11%,RAPGEF2;AXL;LYN
prerank,cellular response to gamma radiation (GO:0071480),0.45032502091758225,1.0254690409748597,0.42105263157894735,0.8463743593891103,1.0,3/17,10.13%,MAP3K20;HRAS;ATR
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.31546946066064097,-1.0249381685051806,0.41379310344827586,0.7565727212753508,1.0,9/52,14.50%,CELF2;RBFOX2;MBNL1;DDX5;THRAP3;NOVA2;MBNL2;NOVA1;FXR2
prerank,cholesterol transport (GO:0030301),0.38268266327817213,1.024629753430907,0.39233576642335766,0.8473627831444065,1.0,7/45,6.95%,CEL;SCARB1;LDLRAP1;LDLR;MSR1;ABCA5;LIPC
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3778417615344581,-1.0243777903096012,0.44693877551020406,0.757195844560302,1.0,4/22,12.45%,SORBS1;APOE;AKT1;PPARA
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.4415071565253403,-1.0240785451910868,0.43037974683544306,0.7572618317509473,1.0,8/12,43.78%,RPL26;TAF9B;CD44;KDM1A;CD74;MUC1;TAF9;MIF
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.39971280826030126,-1.0240418358868877,0.4326923076923077,0.7566698057667657,1.0,8/18,21.19%,LBP;SBNO2;ENPP3;IFI35;KARS1;PLCG2;SYK;TYROBP
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.4510051264013353,1.0236713667397364,0.4222689075630252,0.8486009170199454,1.0,4/16,13.00%,NCBP2;CACTIN;PRPF39;DDX23
prerank,response to muramyl dipeptide (GO:0032495),-0.43127286444311186,-1.0234742678159061,0.4269449715370019,0.7573706176939436,1.0,3/12,4.01%,VIM;NOD1;ARHGEF2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4840884179103839,1.0233517431148653,0.4551422319474836,0.8484081485756205,1.0,2/10,1.54%,NOTCH1;RGCC
prerank,T-helper cell differentiation (GO:0042093),-0.4135454306088914,-1.0231518854274755,0.421259842519685,0.7574749639474754,1.0,4/14,16.10%,FOXP1;LEF1;ZFPM1;TMEM98
prerank,regulation of MAP kinase activity (GO:0043405),0.34129062206985195,1.0230278367705747,0.40610687022900765,0.8481754333234462,1.0,12/92,6.01%,PDGFRB;IL34;SPRY4;NF1;IL1B;SH2B3;PDCD10;FGF2;SPRY2;TRIB2;CD300A;UCHL1
prerank,pigment granule transport (GO:0051904),-0.3953030720947971,-1.022417225686315,0.44731610337972166,0.7580217790796797,1.0,6/18,20.78%,RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,melanosome transport (GO:0032402),-0.3953030720947971,-1.022417225686315,0.44731610337972166,0.7580217790796797,1.0,6/18,20.78%,RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.41162319070858927,1.0222677238107925,0.4553734061930783,0.8489556870537452,1.0,14/37,19.44%,PHLDB2;ROCK1;CLASP2;MAPRE2;TPPP;MARK2;BICD2;CAMSAP3;PHLDB1;PRKAA1;CDK2AP2;TRAF3IP1;GSK3B;STMN4
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.4687809256704911,-1.0222178246661102,0.45353159851301117,0.7578423023834483,1.0,2/10,15.89%,LGALS9;CEACAM1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4232388008393017,1.022007091380465,0.4217557251908397,0.8485989845104084,1.0,7/24,9.02%,VTN;IL1B;CADM4;GRB10;TMEM204;ARNT;PRKD2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4355253428632853,1.0219821096454116,0.42998027613412226,0.8476866879351161,1.0,3/22,4.80%,PLA2R1;SPRED1;HEXIM1
prerank,autonomic nervous system development (GO:0048483),-0.40508986184838935,-1.0216141948479376,0.44403669724770645,0.7586862745034931,1.0,2/17,1.02%,FN1;NRP1
prerank,endothelial cell development (GO:0001885),0.4144839870505721,1.0213939322424184,0.4389312977099237,0.8480638611687626,1.0,2/25,1.01%,PDE4D;RAPGEF2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3560080220730978,-1.0204474855690617,0.44782608695652176,0.7608937037316194,1.0,8/29,19.70%,IKBKE;BIRC3;CASP8;UBB;TICAM1;TLR4;RIPK1;IKBKG
prerank,monocarboxylic acid catabolic process (GO:0072329),0.43282933069236157,1.020409851251541,0.39959016393442626,0.849379822747851,1.0,2/21,4.23%,CEL;PPARD
prerank,negative regulation of protein kinase activity (GO:0006469),-0.28713368626172076,-1.020272187751442,0.3944723618090452,0.7606519751133495,1.0,37/88,29.20%,PRKAG2;PTPRB;CAV1;DEPTOR;LRP6;SLC8A3;DTNBP1;AKT1;DAB2IP;TRIM27;CEP85;QARS1;PPIA;CORO1C;GSKIP;DUSP10;CEACAM1;CDKN1B;PDPK1;PARK7;CHP1;TRIB1;CDK5RAP3;UBASH3B;CDKN1C;INPP5K;SH3BP5;PYDC1;GNAQ;PAK2;SFN;TRIB3;ABL1;PPM1F;PTPRQ;ADARB1;DUSP26
prerank,sister chromatid segregation (GO:0000819),-0.3504889005649291,-1.0200122608426967,0.4376321353065539,0.7606453214561285,1.0,21/31,37.97%,INO80;TOP2B;NCAPG2;RAN;ZW10;SMC4;CENPK;SMC1A;DSN1;TOP2A;SPAG5;KIF18B;KIFC1;NSL1;NDC80;CDCA8;SGO1;KIF18A;PLK1;KLHL22;ESPL1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.2950008166075798,-1.019583021189706,0.42326732673267325,0.7610386107518597,1.0,11/72,14.53%,FLRT2;RBFOX2;FGFR2;FGF1;KL;POLR2A;FRS2;FGFBP1;FGFR4;POLR2F;MAPK3
prerank,regulation of hippo signaling (GO:0035330),0.4532171815899254,1.0194297459928596,0.45962732919254656,0.8505805248343833,1.0,3/17,4.98%,LIMD1;SCHIP1;AJUBA
prerank,positive regulation of dendrite development (GO:1900006),0.48664677724268113,1.0193261902893798,0.42386831275720166,0.84987442930059,1.0,2/10,2.51%,BMP5;PTN
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.3813869162520209,-1.0192700717568395,0.4311023622047244,0.7611507152497015,1.0,3/21,4.13%,CAV1;LRP6;FZD2
prerank,axonal transport (GO:0098930),-0.3391107871055941,-1.019229566828429,0.42887029288702927,0.7605752812692854,1.0,12/36,23.08%,AP3S1;KIF1B;DTNBP1;AP3B1;HIF1A;RAB21;SPAST;FBXW11;BLOC1S6;DYNC1H1;AP3D1;PAFAH1B1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.4075076663530338,-1.019091361158365,0.4367816091954023,0.7595560309828219,1.0,5/15,21.46%,AP3S1;DTNBP1;AP3B1;BLOC1S6;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.4075076663530338,-1.019091361158365,0.4367816091954023,0.7595560309828219,1.0,5/15,21.46%,AP3S1;DTNBP1;AP3B1;BLOC1S6;AP3D1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.38990063326280716,-1.018922840768591,0.4564796905222437,0.7592894971315363,1.0,7/19,19.85%,MAOB;ACOX1;PRDX2;CYBA;GPX1;PARK7;NOX1
prerank,regulation of glycolytic process (GO:0006110),-0.3050571576099715,-1.018813834805136,0.39841688654353563,0.7588862472977331,1.0,5/68,2.53%,PRKAG2;IGF1;HDAC4;APP;NUPR1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4333686963477854,1.0178996051538165,0.4268292682926829,0.8520944181098442,1.0,1/23,0.56%,MBOAT2
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3537319743829437,-1.0178082956193824,0.44166666666666665,0.76077069289738,1.0,6/30,10.98%,VAMP5;MACF1;KIF13A;GGA2;GOLPH3;OPTN
prerank,negative regulation of signal transduction (GO:0009968),0.29896982485581525,1.0177645439735297,0.4293193717277487,0.8514391781836625,1.0,26/249,6.76%,NOTCH3;PTEN;PID1;BMP5;SPRY4;BTRC;TNS2;IL1B;CHAC1;TSPAN15;PIP4K2A;CADM4;FGF2;SOSTDC1;SPRY2;SLC27A4;MOSMO;SIAH2;GRB10;SOCS5;GPC3;PIP4K2C;SNCA;CACTIN;APPL1;KCTD6
prerank,response to organic cyclic compound (GO:0014070),0.3768445132873396,1.0177179776258685,0.40754039497307004,0.8506047118967007,1.0,4/52,4.37%,GGT5;GGT1;IL1B;DHFR
prerank,cytoplasmic translational initiation (GO:0002183),-0.398705626067268,-1.0175816839043603,0.47572815533980584,0.7606534552977762,1.0,10/17,37.97%,EIF4A1;EIF2S2;DENR;EIF4A2;EIF2D;EIF3D;DHX29;RBM4;EIF4B;EIF3I
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.46683990706415734,-1.01756613920281,0.47093023255813954,0.7600340853749207,1.0,4/10,31.89%,ALDH7A1;HNMT;SMOX;DMGDH
prerank,sympathetic nervous system development (GO:0048485),-0.4203246170252136,-1.0173646320602054,0.4581005586592179,0.7598747310457769,1.0,2/15,1.02%,NRP2;NRP1
prerank,cellular glucose homeostasis (GO:0001678),-0.3281266249550923,-1.0164683979048708,0.4189189189189189,0.7614200372633628,1.0,10/41,11.52%,UNC13B;FOXO1;IGF1R;SLC39A14;GAS6;HK2;HIF1A;KCNB1;FOXK1;ERN1
prerank,negative regulation of DNA replication (GO:0008156),0.46301375835841485,1.016403438157017,0.4190064794816415,0.852571158384683,1.0,5/13,17.26%,ATR;WAPL;CDAN1;RAD17;TERF1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4915802656438526,1.0162223203034861,0.4587737843551797,0.8520181784377088,1.0,2/10,2.78%,NR1H3;PTPN22
prerank,lymphocyte differentiation (GO:0030098),0.3591316955897952,1.0157661475721715,0.4288135593220339,0.8521121513718618,1.0,10/68,6.78%,ITGA4;PIK3CD;PTPN22;AXL;GPR89A;GPR89B;ITGB1;IL4;SOX4;KAT7
prerank,muscle cell migration (GO:0014812),-0.4558066904201,-1.0154516652690324,0.47026022304832715,0.763256052744887,1.0,5/10,13.37%,CCN3;SIX1;DDR1;ITGB3;MEGF10
prerank,GPI anchor metabolic process (GO:0006505),0.4000335239688484,1.0153011213612089,0.4267515923566879,0.8522556077114991,1.0,6/26,16.63%,PIGU;PIGO;PIGZ;DPM3;PIGH;PGAP1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3763496858181469,1.0151246031495411,0.4386873920552677,0.8516889353417243,1.0,10/48,10.95%,CARMIL1;LIMS1;FERMT2;RAC3;TESK1;CAPRIN2;IL1RAPL1;DOCK1;ARHGEF7;CUX2
prerank,positive regulation of JNK cascade (GO:0046330),-0.2959952070856774,-1.0150848755308326,0.42455242966751916,0.7634936123065728,1.0,18/70,15.05%,PLCB1;CCN2;SH3RF1;APP;RASSF2;SDCBP;PTK2B;SH3RF3;MFHAS1;SH3RF2;TAOK2;TNFRSF19;FZD7;DAB2IP;FLT4;WNT16;MAPK8IP1;HIPK2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.35024652834396347,1.0149435883920634,0.43934426229508194,0.8511473188366121,1.0,12/76,9.73%,PTEN;CBFA2T3;PTK2;PABIR1;RBX1;SOCS5;TRIB2;RCHY1;ZER1;DET1;CSNK1E;NKD2
prerank,regulation of protein kinase A signaling (GO:0010738),0.43370273452692015,1.0148082276490547,0.4171539961013645,0.8504919989515933,1.0,7/20,10.19%,PRKAR1B;AKAP6;PRKAR2B;PRKAR2A;AKAP12;AKAP7;PRKAR1A
prerank,hemidesmosome assembly (GO:0031581),-0.4470918254116449,-1.0146505235642294,0.45588235294117646,0.7638961789842721,1.0,6/11,17.17%,ITGA6;PLEC;ITGB4;LAMA3;LAMC2;CD151
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.36487912636103753,-1.0141675381653787,0.4411764705882353,0.764426378529885,1.0,14/24,33.86%,ABCG2;PGRMC1;SLC25A38;ALAS1;PPOX;SUCLA2;CPOX;COX10;ALAS2;UROS;TSPO;HMBS;ABCB6;COX15
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.43333466924980624,-1.0134578751405,0.46923076923076923,0.7655044822221934,1.0,4/12,16.27%,ESR1;ZC3H12A;TGFB1;ELAVL1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4672922708272978,1.0131659832082063,0.4407894736842105,0.8532121436424822,1.0,2/12,5.19%,RMDN1;CHAMP1
prerank,protein localization to vacuole (GO:0072665),-0.42132813686943615,-1.013145099196668,0.45038167938931295,0.7655684545446574,1.0,5/13,19.80%,SH3GLB1;LAMTOR5;SH3BP4;CD81;KPTN
prerank,fatty acid oxidation (GO:0019395),-0.3094822086844341,-1.012684529885198,0.42995169082125606,0.7660347363276369,1.0,17/57,20.99%,ADIPOR2;CPT2;SLC25A17;ACOX1;ECI2;ACADL;ALDH3A2;AUH;BDH2;ACAD10;ECHDC2;ACADS;ALOX12;ILVBL;PPARGC1A;ADIPOR1;DECR1
prerank,negative regulation of type I interferon production (GO:0032480),-0.3331502660230253,-1.0125981409734246,0.4245689655172414,0.7655836804991685,1.0,16/40,28.93%,IKBKE;PCBP2;NLRC5;RNF135;MAVS;RNF125;PPM1B;SIRPA;UBA7;NPLOC4;UBE2L6;RNF216;REL;PTPRS;TAX1BP1;ISG15
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.43691789467326303,1.0121781372744239,0.47184466019417476,0.8544289209115469,1.0,2/21,2.35%,NDST3;EXTL3
prerank,positive regulation of programmed cell death (GO:0043068),-0.24333034733640596,-1.0117523608373127,0.40404040404040403,0.7671071771989819,1.0,64/272,17.87%,DAPK1;UNC13B;PAWR;AKAP13;TIAM2;FOXO1;FOXO3;ARHGEF3;SLIT2;ITGA6;TGM2;VAV2;STK17B;BMP4;RASSF2;MCF2L;LRRK2;ARHGEF2;HOXA5;IGFBP3;QRICH1;TNFSF10;IAPP;RARG;SFRP4;ANO6;CYP1B1;PTPA;RHOB;TRIO;IFIT2;ADAMTSL4;ARHGEF1;AIFM1;TIAM1;UTP11;BCL2L11;FLCN;ATF6;CASP8;DAB2IP;FGD4;BNIP3L;PLEKHG5;ATM;TRIM35;UBB;PPID;ARHGEF18;ARHGEF19;BNIP3;SFRP1;IP6K2;RASGRF2;RPS6;ARL6IP5;NET1;BID;GNA13;RIPK1;STPG1;PSEN2;CSRNP3;PDCD5
prerank,establishment of protein localization to organelle (GO:0072594),-0.29479843395143723,-1.0103543296126403,0.41604010025062654,0.7698302366939428,1.0,35/72,37.21%,LAMP2;RAB11A;APPL2;STAT3;HK2;AKT1;IPO7;FAM53C;IPO13;RAN;NXT2;IPO8;TPR;LAMP5;NUP88;SYK;NUP214;ZDHHC15;NXT1;NUP155;RANBP17;EIF4ENIF1;HK1;CSE1L;NUP62;PTTG1IP;TNPO2;HEATR3;RALA;IPO4;PINK1;PHB2;FAM53B;SPRN;NUP153
prerank,cellular response to reactive oxygen species (GO:0034614),0.3629575613389328,1.0100090106757373,0.4304857621440536,0.8583727941441184,1.0,3/59,3.22%,PTPRK;MAP3K5;NCF1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3884961386078374,1.0095290897242937,0.423728813559322,0.8585131716126759,1.0,1/33,0.50%,IL34
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4184734835117496,1.0092354103412895,0.4294117647058823,0.8581794123864381,1.0,2/25,1.37%,HEY2;PER2
prerank,anterior/posterior pattern specification (GO:0009952),-0.3070587661100724,-1.0091715696501389,0.44717444717444715,0.7721398321677612,1.0,17/53,16.05%,HOXB6;PCSK5;HOXB3;BMPR2;TGFBR1;HOXA5;SKI;HOXA3;BHLHE40;HOXC6;TBX1;BHLHE41;HOXB9;HOXC4;HOXB5;HOXB7;HHEX
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.32533040014950126,-1.009074016954573,0.45,0.7717265821743419,1.0,10/40,16.46%,LBP;GBP4;PGLYRP1;GSDMD;GBP6;RPL39;GBP7;GBP2;HMGB2;MR1
prerank,ephrin receptor signaling pathway (GO:0048013),0.34524889079093823,1.00901803963016,0.450920245398773,0.8576928827803803,1.0,25/82,13.55%,CHN1;KALRN;PTK2;SDC2;NCK2;ROCK1;WASL;ARPC5;ANKS1B;HRAS;AP2S1;LYN;GRIN2B;EPHA2;AP2B1;ARPC4;ARHGEF7;PAK3;EPHA10;PAK1;EPHB1;SRC;PSEN1;ARPC1A;RASA1
prerank,ncRNA 3'-end processing (GO:0043628),0.4490874806271492,1.0089512270760093,0.4329268292682927,0.8568879723929862,1.0,3/14,14.01%,INTS6L;SSB;INTS12
prerank,glycerol metabolic process (GO:0006071),0.477784043937168,1.008176058594571,0.4298642533936652,0.8576724714349935,1.0,3/10,9.26%,COQ2;GOT1;GK
prerank,negative regulation of response to stimulus (GO:0048585),0.3581761446722983,1.0079913859902232,0.42439862542955326,0.8571508289359072,1.0,6/60,5.24%,SLC30A10;CDK6;NR1H3;AKT3;SH2B3;SOCS5
prerank,protein kinase B signaling (GO:0043491),0.4261730393322348,1.0079171898753538,0.4600389863547758,0.8563716900380823,1.0,2/23,2.62%,PTEN;IL1B
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4577193702809434,-1.0078331729849188,0.48375451263537905,0.7733763977502022,1.0,5/10,20.58%,NFAT5;NFATC1;PPP3CC;PPP3CB;NFATC2
prerank,calcineurin-mediated signaling (GO:0097720),-0.4577193702809434,-1.0078331729849188,0.48375451263537905,0.7733763977502022,1.0,5/10,20.58%,NFAT5;NFATC1;PPP3CC;PPP3CB;NFATC2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4674160770109944,1.0077578648849423,0.44372294372294374,0.855824232134323,1.0,6/10,24.79%,DERL3;UBAC2;INSIG1;ERLEC1;OS9;YOD1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.27612011157086425,-1.0076029683154584,0.4447592067988669,0.7732655361254411,1.0,34/104,28.18%,KSR1;LRP6;SLC8A3;CCND2;RHOA;CALM2;SYAP1;CCND3;AKT1;HGS;IRGM;CCNG1;DAB2IP;PPEF2;UVRAG;CCND1;ACTB;CDKN1B;PARP16;CALM1;ADRB2;EZH2;TRIB1;CSF1R;CDK5RAP3;PIH1D1;CCNF;SERTAD1;CDK7;CDC25A;CDKN2D;TRIB3;ABL1;RPTOR
prerank,negative regulation of histone methylation (GO:0031061),-0.4465024297004522,-1.0075613540430413,0.4606741573033708,0.7726978279792427,1.0,6/10,38.25%,JARID2;DNMT1;BRCA1;AASS;KDM1A;PHF1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.3106297376229582,-1.0075502612834897,0.45202020202020204,0.7720589935094101,1.0,14/59,17.71%,ROCK2;MAP3K14;IRAK2;BIRC3;ERC1;AKT1;TNFRSF1A;DAB2IP;RELA;UBB;TICAM1;TLR4;RIPK1;NFKBIA
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.46609286034395925,1.0073660484851272,0.4411134903640257,0.8557804326643069,1.0,5/13,11.21%,UBA2;DESI1;DESI2;UBA1;UBA6
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.3192156786390475,-1.0071013397080186,0.4255813953488372,0.7725373935827212,1.0,12/47,16.03%,TGFBR3;EGFR;FOXO1;IGF1R;LGALS9;TAOK2;DAB2IP;MAPK8IP1;QARS1;PPIA;MAPK3;ARL6IP5
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.28179987915168875,1.0059302752627948,0.4569377990430622,0.8580519746476509,1.0,25/417,3.40%,PTPRK;KCTD1;TBX2;LIMD1;LIMS1;HEY2;RORB;CBFA2T3;HEYL;ZEB1;DPF3;NOTCH1;TBX20;PER2;LBH;BTRC;TBX3;FOXM1;NRG1;NR1D2;NAB1;CBX5;PHC3;PHC2;MECP2
prerank,negative regulation of cation channel activity (GO:2001258),0.41189716495300477,1.0054514937351844,0.43313373253493015,0.8581979990805744,1.0,1/26,0.50%,CASQ2
prerank,axonal fasciculation (GO:0007413),-0.4405938852230281,-1.0054503334027995,0.5038167938931297,0.7759574375343417,1.0,2/12,0.65%,EPHA4;EPHA3
prerank,fibrinolysis (GO:0042730),-0.43184442455335503,-1.0052276299840248,0.46124031007751937,0.775843880321674,1.0,9/13,52.36%,SERPINE1;PLAUR;HRG;PLAT;PLG;SERPINB2;CPB2;GP1BA;F2
prerank,sphingoid biosynthetic process (GO:0046520),-0.44784561605793405,-1.0049130831817523,0.4789272030651341,0.7753043296181059,1.0,4/11,14.17%,ACER2;ACER3;SPHK1;SPTLC2
prerank,sphingosine biosynthetic process (GO:0046512),-0.44784561605793405,-1.0049130831817523,0.4789272030651341,0.7753043296181059,1.0,4/11,14.17%,ACER2;ACER3;SPHK1;SPTLC2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.4381383366290681,1.0047392201282974,0.4817987152034261,0.8588932430265763,1.0,3/19,2.15%,LIMS1;FERMT2;ROCK1
prerank,toll-like receptor signaling pathway (GO:0002224),-0.2844210333699695,-1.0043315512629316,0.43902439024390244,0.7761040530145185,1.0,21/84,19.70%,SCARA3;LBP;MAP3K1;IRAK2;LGALS9;PIK3AP1;BIRC3;CTSB;SFTPA2;SFTPA1;CASP8;IRAK3;CTSS;UBB;PLCG2;TICAM1;MAPKAPK3;TLR4;RIPK1;HSP90B1;IKBKG
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4166878767976938,1.0042563767914625,0.4222689075630252,0.8580809635139669,1.0,5/22,13.17%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC21;ZDHHC23
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4166878767976938,1.0042563767914625,0.4222689075630252,0.8580809635139669,1.0,5/22,13.17%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC21;ZDHHC23
prerank,negative regulation of hippo signaling (GO:0035331),0.4728723350517903,1.003971751631529,0.44742268041237115,0.8577679235510269,1.0,2/12,4.98%,LIMD1;AJUBA
prerank,negative regulation of complement activation (GO:0045916),-0.4554649941124154,-1.0036233964530226,0.48722627737226276,0.7771757150183116,1.0,2/10,2.13%,SERPING1;CD55
prerank,negative regulation of lipid storage (GO:0010888),-0.3768409244804679,-1.0034924310890438,0.44291338582677164,0.7768114465588732,1.0,6/19,19.45%,ABCA1;OSBPL8;ITGB3;PPARA;NFKBIA;PTPN2
prerank,regulation of neuron apoptotic process (GO:0043523),0.3320970082217144,1.003431952296008,0.43569131832797425,0.8580085369536989,1.0,19/96,14.08%,SLC30A10;MEF2C;NF1;AGAP2;UNC5B;TFAP2B;NTRK2;LIG4;AKT1S1;PPT1;NFATC4;GRM4;TRIM2;CPEB4;SET;KDM2B;RASA1;MAG;SIX4
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3541680919247805,1.0033125928264093,0.4507512520868113,0.8573173437534858,1.0,7/66,7.16%,PDGFRB;IL34;MAP3K5;PDCD10;FGF2;TAOK3;HRAS
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.43451189471489343,1.003222830650427,0.4288577154308617,0.8565763410239956,1.0,6/17,13.99%,PDCD10;CARD9;TAOK3;LYN;SCIMP;STK25
prerank,protein dephosphorylation (GO:0006470),0.3119475881119041,1.0027649917220738,0.4413075780089153,0.8567275327425846,1.0,11/135,4.74%,PTPRK;PTEN;PTPN9;PPM1E;BTRC;TNS2;PTPN22;SSH2;PPP3CA;PPP2R2A;PTPN4
prerank,regulation of protein modification process (GO:0031399),-0.31587249949906626,-1.0026055723567182,0.44680851063829785,0.7783176014696361,1.0,15/50,14.87%,FN1;CDH5;KAT2B;IGF2;STAT2;FNIP1;PPP1R16B;FLCN;PML;CCDC88C;FER;ATG10;NDUFS4;CORO1C;CDK9
prerank,negative regulation of ion transport (GO:0043271),0.4149100877593252,1.0024440734861089,0.4589178356713427,0.856503613287007,1.0,4/24,7.09%,CASQ2;HTR1B;SNCA;STC1
prerank,regulation of actin filament polymerization (GO:0030833),0.3513453020370339,1.0017256607852896,0.43322475570032576,0.8572431448935266,1.0,12/69,10.91%,CARMIL1;PLEKHG2;NCK2;VASP;SSH2;CDC42EP1;ESAM;ARFGEF1;BIN1;NCKAP1;LMOD1;PAK3
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.32896417528662614,-1.001616463502933,0.45353982300884954,0.7801443145369826,1.0,18/40,28.31%,IGF1;TNFSF10;AKT1;BCL2L11;BNIP3;PLSCR3;BID;GPX1;PRELID1;PDCD5;BBC3;PLAUR;PSMD10;BCL2L1;PRKN;TP53;BIK;CLU
prerank,negative regulation of neuron death (GO:1901215),0.33243735443919153,1.001193090194625,0.4416,0.8575087922661081,1.0,19/93,14.08%,SLC30A10;MEF2C;AGAP2;UNC5B;INPP5A;NTRK2;SNCA;LIG4;PPT1;NFATC4;HTRA2;CPEB4;BTBD10;SET;KDM2B;RASA1;TRAF2;MAG;SIX4
prerank,peroxisomal membrane transport (GO:0015919),0.39450880804245075,1.0011179684771936,0.43100189035916825,0.8567349844525743,1.0,8/27,15.58%,RAB8B;ABCD2;ATAD1;PEX7;PEX1;PEX3;PEX19;PEX12
prerank,cellular response to hexose stimulus (GO:0071331),-0.36121901135091694,-1.0007648498224955,0.43887775551102204,0.7816622117216869,1.0,6/23,11.52%,UNC13B;IGF1R;SLC39A14;GAS6;KCNB1;ERN1
prerank,cellular lipid catabolic process (GO:0044242),0.4007461980947257,1.0006717420327569,0.42641509433962266,0.8567995938472353,1.0,3/27,7.28%,CEL;PPARD;AOAH
prerank,lysosome localization (GO:0032418),0.3772049363465519,1.0001114295612024,0.44150943396226416,0.857099448713595,1.0,2/37,1.97%,PIK3CD;MYH9
prerank,regulation of myelination (GO:0031641),0.4023845617473847,0.9999175056809598,0.4326923076923077,0.8566529566940846,1.0,6/25,10.51%,TNFRSF21;PTN;TPPP;NCMAP;TENM4;NKX6-2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.453236373438409,-0.999620533381426,0.49536178107606677,0.7838474166292023,1.0,3/10,10.42%,SMAD7;RC3H2;ZC3H12A
prerank,lytic vacuole organization (GO:0080171),-0.3410844259483752,-0.9991292971546295,0.4639830508474576,0.7843708201008842,1.0,12/32,27.23%,ABCA1;ARSB;LRRK2;ZKSCAN3;GAA;HPS4;TPP1;CLN6;CLN5;MBTPS1;ACP3;MYO7A
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.3465525875349738,-0.99910539708475,0.4766146993318486,0.7837629163359672,1.0,8/30,19.70%,IKBKE;BIRC3;CASP8;UBB;TICAM1;TLR4;RIPK1;IKBKG
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.32889147109823424,-0.9990985470267928,0.4618556701030928,0.7831171296287558,1.0,12/38,17.31%,SP100;NOS3;THBS1;ARHGEF2;CFLAR;TNFSF10;ICAM1;CASP8;SFRP1;SERPINE1;RIPK1;GPX1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.408154847112731,-0.9990317064982093,0.46564885496183206,0.7826165823505892,1.0,8/15,24.89%,STAT3;HIF1A;IL17RA;GBP5;TICAM1;TLR4;IL17D;MYD88
prerank,positive regulation of cellular respiration (GO:1901857),-0.44005696756753393,-0.9988061829888969,0.4658040665434381,0.7824977852028956,1.0,8/11,34.23%,NUPR1;IL10RB;PRELID1;PARK7;VCP;IFNAR1;IFNLR1;PINK1
prerank,phospholipid metabolic process (GO:0006644),-0.2977310276567803,-0.9984498392437658,0.4576719576719577,0.7827228473159352,1.0,28/71,34.98%,PLA2G4A;PLPP3;AGPAT4;SMPD3;GPX4;PIP4K2B;TNFAIP8L3;PLPP1;PLA2G15;PGP;PLCD1;CLN8;AGPAT2;ENPP2;LPL;PLPPR4;PLPP2;PLBD2;PLA2G4F;MBOAT1;SMPD1;AGPAT1;ANGPTL3;LGALS13;FITM2;FADS1;ABHD12;PLA2G5
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.395002017366754,-0.9980285790625426,0.482897384305835,0.7832133315208397,1.0,7/16,17.23%,LRRK2;HSPA5;SEC16B;BCAP29;VAPA;BCAP31;TAPT1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.455978769125141,0.9980207777068081,0.44989339019189767,0.8599309839278579,1.0,1/15,0.21%,CSPG4
prerank,steroid catabolic process (GO:0006706),-0.45214335027929453,-0.9978830899654004,0.4864864864864865,0.7828986919921886,1.0,10/10,54.82%,SPP1;YWHAH;HSD17B14;HSD17B11;HSD11B1;CYP27B1;CYP24A1;FGF23;CYP19A1;HSD17B6
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.4200151624691881,-0.9977024943704073,0.4700374531835206,0.78268090416023,1.0,3/12,8.01%,DPYSL3;DPYD;CTPS1
prerank,cellular response to lipid (GO:0071396),0.30031817142147393,0.9976279126816835,0.44157608695652173,0.8598913398324303,1.0,27/191,9.45%,MEF2C;PID1;RORB;ATP1A2;RORA;GPER1;NR1H3;IL1B;FFAR2;ADCY8;ADCY3;AXL;NCOA3;ADCY6;BRINP1;CXCL10;TNIP2;PDE4B;CXCL5;CACTIN;FAM210B;IRS1;BRINP3;HTRA2;LYN;MED1;MAP4K1
prerank,natural killer cell mediated immunity (GO:0002228),-0.4032527811015643,-0.9974415834953687,0.48872180451127817,0.7826286002872394,1.0,10/15,48.69%,CEBPG;ULBP1;RAET1E;TUBB4B;LYST;PLEKHM2;KIF5B;SLAMF7;KLRD1;KLRK1
prerank,regulation of translational initiation (GO:0006446),0.35382404870733314,0.9971986409602566,0.43283582089552236,0.8598823930793614,1.0,10/63,6.30%,NCK2;EIF4EBP2;EIF4EBP3;DAZL;RPS6KB2;MTIF2;BOLL;YTHDF3;NCBP2;DDX3X
prerank,adipose tissue development (GO:0060612),-0.43799842854572907,-0.9969628909420604,0.49074074074074076,0.7830967709983121,1.0,5/11,21.82%,NAMPT;SPTLC2;DYRK1B;DGAT2;XBP1
prerank,cellular response to leucine starvation (GO:1990253),0.48055615367168336,0.9967101472032116,0.46284501061571126,0.8600177640465223,1.0,3/10,16.48%,SESN3;MTOR;IMPACT
prerank,transferrin transport (GO:0033572),-0.34007044709679624,-0.9959990010578595,0.4533898305084746,0.7848103342683905,1.0,16/33,29.53%,STEAP3;ATP6V0A4;TFRC;ATP6V1G1;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2;HFE;REP15;MCOLN1;ATP6V1F;ATP6AP1;ATP6V0D1;ATP6V0C;ATP6V1D
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3117401356433168,0.9959546158833,0.43243243243243246,0.8607714268793062,1.0,23/128,16.52%,DYNLL1;BTRC;FOXM1;PPP2R2A;CCDC57;AJUBA;PRKAR2B;CDKN1A;NES;CSNK1E;DYNC1I2;CEP41;BRSK1;TUBB4A;PPP1R12A;CDK14;DCTN1;CCNH;SKP1;DCTN3;CEP76;CEP135;NDE1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3495450119223555,-0.9958225589674278,0.4870259481037924,0.784594494768923,1.0,8/29,16.20%,APOE;APP;SLC4A10;RAB3GAP1;CAMK2A;EPHB2;SHISA7;MCTP1
prerank,establishment of protein localization to membrane (GO:0090150),-0.29137789987228213,-0.9950880054910922,0.4751131221719457,0.7857641571976273,1.0,16/66,17.70%,AFDN;EGFR;SYNE3;RAB11A;SDCBP;RAB3GAP1;NACA;TAOK2;PARD3;ZDHHC24;REEP1;AQP11;FRMPD1;RAB3GAP2;BID;MICALL1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.43604179324407666,0.9949231812471295,0.4555084745762712,0.8622043405315134,1.0,5/15,14.09%,HECW2;NEK6;TACC3;PTTG1;ANAPC7
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.37795514663753343,0.9948385670552878,0.45960502692998206,0.8614575870686423,1.0,5/43,5.98%,ITGA1;SH3KBP1;SPRY2;SOCS5;EPN1
prerank,positive regulation of wound healing (GO:0090303),0.37906590549542235,0.9947116846263757,0.4342857142857143,0.8608104324453267,1.0,8/36,8.15%,VTN;PTK2;MYLK;FERMT2;ITGB1;ARFGEF1;HRAS;MTOR
prerank,regulation of chemotaxis (GO:0050920),0.385106338303088,0.9944367776233365,0.4581673306772908,0.8605211066108301,1.0,1/30,0.19%,PDGFRB
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.38072509689029355,-0.9942685343828147,0.47701149425287354,0.7871103724107272,1.0,8/20,19.68%,MCU;SLC8A3;MCUB;SPG7;AFG3L2;MICU2;MICU1;MAIP1
prerank,hexose transmembrane transport (GO:0008645),0.4203387449524698,0.9942423914510732,0.45067264573991034,0.8600500846937227,1.0,6/21,12.50%,SLC5A1;PPARD;SLC45A1;SLC2A6;SLC2A3;SLC2A9
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3090694519379295,-0.9941007706014542,0.46318289786223277,0.7868574731311768,1.0,11/54,11.30%,NXN;HDAC8;CAV1;SMAD7;ARRB1;SH3RF2;AKT1;PINX1;IVNS1ABP;PRKCG;RPL11
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2604105977325713,-0.9940258585960279,0.4755700325732899,0.7863873846576326,1.0,41/132,27.77%,CELF2;RPS14;LUC7L;RPS19;GEMIN7;EIF2S2;DENR;NAF1;RPL11;RPS5;STRAP;RPL24;SRSF10;RPS27;MRPS7;RAMAC;RPL10;GEMIN5;HSP90AB1;RPS15;SNRPF;SNRPD1;SNRPD2;RPSA;SRSF6;RPL38;RPLP0;DICER1;SRPK1;RRP7A;RPS27L;SRSF5;WDR77;CELF5;RRS1;SRPK2;PUF60;PRPF19;SNRPC;SNRPB;SNRPE
prerank,protein targeting to lysosome (GO:0006622),-0.37957380956077597,-0.9938969600592155,0.4911242603550296,0.7860352338769564,1.0,9/20,30.52%,LAMP2;HGS;AP4M1;RAB7A;ZFYVE16;NCOA4;CLU;LAPTM5;NEDD4
prerank,positive regulation of defense response (GO:0031349),-0.2809069812785995,-0.9938320832493981,0.4746666666666667,0.7855291635114736,1.0,29/89,25.23%,APP;IL15;PDCD4;IL16;WNT5A;CD47;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;OPTN;GBP5;CYBA;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;NPAS2;AGT;AGTR1;MDK;LPL;POLR3D;GPR4;PLSCR1;ZBP1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.42849429689662333,-0.9937982646248447,0.5046904315196998,0.7849640587792871,1.0,2/13,3.49%,ERRFI1;SNX6
prerank,positive regulation of T cell differentiation (GO:0045582),-0.3288433461134003,-0.9932102760011026,0.4698544698544699,0.7857657189525892,1.0,10/36,21.82%,ZMIZ1;GLI2;LEF1;GLI3;DUSP10;SOX12;RHOH;PNP;MDK;XBP1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.32624638274396023,-0.9928164659200802,0.464818763326226,0.7860765865549926,1.0,10/39,10.24%,SNCAIP;ROCK2;APOE;EZR;RAP1B;RAPGEF1;TIE1;IRGM;GFAP;DAB2IP
prerank,regulation of cellular pH (GO:0030641),-0.35123421469603655,-0.9927915422918987,0.4702127659574468,0.7854816404967611,1.0,9/29,19.04%,SLC9A2;SLC4A10;LACC1;SLC9A9;TM9SF4;SLC9B1;SLC9A1;SLC4A2;CHP1
prerank,membrane repolarization (GO:0086009),0.45227351754043266,0.9926681231631689,0.4530612244897959,0.8625593825884474,1.0,4/15,7.70%,ATP1A2;KCNE4;ATP1B2;KCNE5
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.29740064264284377,-0.9925738143515078,0.47058823529411764,0.7853651343040177,1.0,14/56,12.53%,ROCK2;SNX9;PDCD6IP;RHOA;USP8;RHOB;MYH10;SON;ARL3;TTC19;SPAST;EFHC1;CHMP4B;EFHC2
prerank,protein processing (GO:0016485),0.3218782706652488,0.9924956482713654,0.446676970633694,0.8620388758162938,1.0,6/102,3.07%,TMPRSS4;GGT1;CPM;METAP2;ADAM19;ECE1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.28063566881467134,-0.992420299819611,0.4574468085106383,0.7850634059184953,1.0,29/88,18.23%,CLINT1;STXBP6;APP;GOLGB1;VPS13A;TXNDC5;VPS35L;DNAJC6;ARRB1;SNAP23;EXOC4;DTNBP1;EXOC6;HGS;CLTA;ARL3;AP4M1;FTL;EXOC5;PUM1;AP2A1;AP1B1;MON2;DOP1B;NAPA;ARFGEF2;BLOC1S6;AP4E1;FTH1
prerank,apoptotic process (GO:0006915),0.2979056324728803,0.9921380276239917,0.4649859943977591,0.8619189015570841,1.0,36/203,12.77%,DLC1;FAP;TNFRSF21;TNFAIP1;ARHGEF6;ADORA2A;FASTKD2;IL1B;PIK3CA;IL2RA;AKAP1;PRUNE2;BCL2L10;PPARD;CIDEB;SCN2A;OGT;BCL2L13;CASP9;LIG4;PAK6;CDIP1;STK3;MTOR;BNIP2;PAK5;NCKAP1;HIP1;DDIT4;MCM2;IFT57;EP300;BCLAF1;MRPS30;FAM162A;YARS1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2703730490329934,-0.9915328112886893,0.4547945205479452,0.7865533554312572,1.0,30/101,19.74%,SAMD4A;VGLL4;VIM;THBS1;CYFIP2;EZR;LARP4B;KLF4;CSF1;NIBAN1;RPS4X;AKT1;UPF3A;CASP8;VPS35;TBC1D10A;TGFB1;FGFR4;CPEB3;FBXW11;RPL26;ATG10;FXR2;ELAVL1;NFKBIA;AGT;ZCCHC4;AGTR1;NAT10;METTL5
prerank,positive regulation of vacuole organization (GO:0044090),-0.4458345798015165,-0.9913890108737117,0.4890909090909091,0.786245559813053,1.0,5/10,16.80%,ANXA2;RAB3GAP1;PIP4K2B;SH3GLB1;RAB3GAP2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.45203538051039327,0.9913353896937531,0.45614035087719296,0.8627872474610113,1.0,7/14,15.63%,AK1;AK8;NMNAT3;AK7;AK5;AK3;AK4
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.4153765431571691,-0.9911257116518278,0.4962962962962963,0.7862468423019084,1.0,4/12,22.00%,AR;TGFB1;AP2A1;TMEFF2
prerank,nucleosome assembly (GO:0006334),-0.3433019242304266,-0.9910435710232557,0.4794816414686825,0.785816301887534,1.0,17/31,36.43%,KAT6B;UBN1;H3-3A;ANP32B;HMGB2;RSF1;NAP1L2;BRD2;HAT1;ASF1A;CHAF1A;NAA60;SPTY2D1;IPO4;ATRX;ASF1B;GRWD1
prerank,positive regulation of cell death (GO:0010942),-0.30352502753286137,-0.990958888826204,0.4748201438848921,0.7853911148545545,1.0,9/59,8.23%,EFNB2;SLC6A13;SLC6A6;BMP4;LRRK2;ACER2;RARG;WNT5A;PRODH
prerank,sphingolipid catabolic process (GO:0030149),-0.40315500556937706,-0.9908047267367841,0.4659090909090909,0.7851001359172756,1.0,8/15,25.61%,ACER2;ACER3;SPHK1;SMPDL3A;ENPP2;SGPL1;PDXDC1;GLA
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.44856897038614135,0.9907893798659767,0.4645030425963489,0.8631040489746857,1.0,5/13,14.56%,KPNA4;NUP35;CBLB;KPNA1;RANBP2
prerank,positive regulation of potassium ion transport (GO:0043268),0.38466974898397216,0.9906502114702622,0.4635879218472469,0.8625011903053494,1.0,7/38,10.27%,GNG2;KCNJ12;KCNMB1;AKAP6;KCNE5;KCNJ3;KCNJ6
prerank,modulation by host of viral genome replication (GO:0044827),-0.4225369055166199,-0.9905784845807938,0.4837476099426386,0.785004170256057,1.0,7/13,26.14%,IFI27;ZC3H12A;VAPA;FBXL2;TBC1D20;PRKN;EIF2AK4
prerank,positive regulation of histone methylation (GO:0031062),-0.3610041380218228,-0.9900094726796359,0.49166666666666664,0.7857784032651596,1.0,1/24,0.08%,AUTS2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.41375517351588886,-0.9896536995101578,0.490234375,0.7859465311741971,1.0,3/14,5.48%,SULF1;THBS1;SULF2
prerank,hippo signaling (GO:0035329),-0.3495742632588239,-0.9895009653860152,0.46943231441048033,0.7856486623475836,1.0,4/26,6.20%,TJP2;TEAD4;YAP1;TEAD1
prerank,negative regulation of leukocyte migration (GO:0002686),0.4817292268604234,0.9893824562710726,0.48306997742663654,0.8643643160221048,1.0,2/10,5.44%,BMP5;CD300A
prerank,liver development (GO:0001889),-0.3377899593527836,-0.9891051546403758,0.47046843177189407,0.7859338768509201,1.0,4/32,4.43%,TGFBR3;WNT4;ANXA1;LSR
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.2498807257628366,-0.9889579485164249,0.4452054794520548,0.7856466573282391,1.0,35/170,16.99%,PRDM6;IGF1;AFF3;ROCK2;FOXP1;APOE;APP;CDH1;TAPBP;HINFP;AFF2;AFF1;IGF2BP2;ATRAID;NOVA2;HIF1A;PCBP2;ZC3H12A;PRDM5;TRIM27;AHR;NOVA1;YBX3;ZNF462;PRDM11;PTHLH;TRIM39;TRIM17;EDN3;RNF187;KDM6B;MTMR3;SIRPA;CAVIN4;HNRNPAB
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.402515292700109,-0.9885263386059312,0.4697855750487329,0.7860051445911708,1.0,5/13,16.05%,NIBAN2;HGS;EMILIN1;DAB2IP;HHEX
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.43114376974862634,0.9883902698619584,0.4775510204081633,0.8655879818469753,1.0,2/17,1.03%,PDGFRB;VTN
prerank,cranial nerve development (GO:0021545),-0.4337726497173878,-0.988307594963943,0.49444444444444446,0.7858997769189955,1.0,1/11,1.45%,CHD7
prerank,phosphate ion homeostasis (GO:0055062),-0.439428591969392,-0.988188974293488,0.4871287128712871,0.785528631385824,1.0,3/10,12.18%,ENPP1;SFRP4;FGFR4
prerank,positive regulation of MAPK cascade (GO:0043410),0.28699357874771386,0.9881675493916922,0.46774193548387094,0.8651744035212612,1.0,27/245,7.16%,PDGFRB;SLC30A10;IL34;RAPGEF2;GCNT2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;ROCK1;ERBB4;PTPN22;ACKR3;PDCD10;FGF2;PELI2;RYK;SPRY2;RIT2;CARD9;NTRK2;HTR2C;TAOK3;CHRNA7;RAP1A;HRAS
prerank,positive regulation of cellular component movement (GO:0051272),-0.3533679812674228,-0.9880263933076602,0.48484848484848486,0.7852610786766925,1.0,12/24,26.38%,PDPN;TGFBR1;SPOCK2;CAVIN1;RPS19;NTN1;CSF1R;CCL19;VEGFA;STK11;AKT2;TWIST1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.31345396162560274,-0.9879446064566608,0.46021505376344085,0.7848203243532527,1.0,14/45,21.13%,EGFR;BMP4;DDX5;RBM20;POLR2A;ERN1;TGFB1;RELA;GRSF1;PNPT1;SIRT7;RIPK1;ZC3H18;RIOK2
prerank,epithelial cell migration (GO:0010631),0.382458784239747,0.9878552688533722,0.4506517690875233,0.8649261168914151,1.0,8/37,7.87%,FAP;PKN1;ROCK1;ZEB2;PIK3CA;STARD13;TESK1;NANOS1
prerank,protein transport (GO:0015031),-0.23183866332082856,-0.9877693401023536,0.5050505050505051,0.7846208043189363,1.0,93/332,22.33%,ABCA1;VAMP5;LAMP2;STEAP3;APOE;MACF1;ARL4A;SGSM2;TBC1D22A;SNX9;SNX6;CALCRL;ARHGEF2;KIF13A;TLK1;ATP6V0A4;SEC31A;RAMP2;COPZ2;RABGAP1L;RCN3;STX7;USP6NL;TBC1D8B;TXNIP;PRKCB;GGA2;STX3;COPA;ARFIP2;TFRC;TOM1;GOLPH3;ATP6V1G1;EHD1;TBC1D8;AP3B1;AP4M1;RAB21;ATP6V0B;TMEM167A;STX1A;USO1;STX6;ARRDC1;OPTN;VPS35;RAB7A;TBC1D10A;RAB8A;ATP6V0A1;TCIRG1;AP2A1;UNC119B;SCFD2;EVI5;ARL5A;TBC1D2;ATP6V0A2;HFE;SEC23IP;NAPA;ARL6IP5;TBC1D25;RAB3GAP2;RAB18;TBC1D13;REP15;ARRDC4;SAR1A;RAB29;RAB6A;STX2;HSP90B1;RAB32;PPY;SAR1B;SNX8;RABL3;CANX;YWHAH;VPS26C;ARFIP1;TMED9;MCOLN1;TBC1D14;RAB24;AP3D1;ATP6V1F;TMED2;TANGO2;WDR11;ACD
prerank,negative regulation of cellular component organization (GO:0051129),0.34100592832249416,0.9872279599436697,0.4765751211631664,0.865420762689883,1.0,7/74,6.30%,CARMIL1;FAP;WASL;SACS;SPRY2;SCAMP5;DDX3X
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.3917623038884319,-0.9872115394507651,0.4618249534450652,0.7853360887178056,1.0,5/16,14.40%,PARP9;DTX3L;PARP3;SHLD1;KMT5C
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3303758472675239,0.987011722629436,0.46353322528363045,0.8641169410898353,1.0,10/78,11.89%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;AP2B1;KIF3A;SEC13;KIF3C
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3303758472675239,0.987011722629436,0.46353322528363045,0.8641169410898353,1.0,10/78,11.89%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;AP2B1;KIF3A;SEC13;KIF3C
prerank,nitrogen compound transport (GO:0071705),-0.2580715609627435,-0.9869912695894245,0.4918032786885246,0.7851877958445042,1.0,36/141,20.27%,SLC7A11;SLC6A13;PDPN;SLC6A6;CERT1;SLC6A12;CALCRL;ABCG2;SLC7A2;RAMP2;RCN3;TXNIP;SLC7A7;SLC22A4;SLC7A5;TOM1;CUBN;SLC7A14;SLC22A5;SLC38A5;ARRDC1;RAB7A;SLC3A2;SLC35F3;TMEM30A;SLC7A1;ARL6IP5;SLC22A2;SLC52A3;ATP11B;ARRDC4;HSP90B1;SLC43A1;SLC25A29;SLC36A1;SEC14L1
prerank,cellular response to chemokine (GO:1990869),0.35993195448845133,0.9869216638927066,0.46099290780141844,0.8633973717608383,1.0,6/46,6.11%,SLC12A2;SH2B3;STK39;ACKR3;CXCL10;CXCL5
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.29156871602786266,-0.986278223868336,0.4961439588688946,0.7863300062101255,1.0,15/71,14.35%,ADAMTS12;CTSH;CAPN2;CTSC;PDCD6IP;CHFR;CTSB;CASP8;IDE;CHMP4B;CTSS;MDM2;UBB;NEDD8;DDB1
prerank,nucleic acid-templated transcription (GO:0097659),-0.3188610217670238,-0.98622906866145,0.48717948717948717,0.7858069167078257,1.0,15/42,25.98%,THRB;POLR2A;NR4A2;MMS19;PWP1;POLR2F;MEF2A;DTX1;POLR2E;E2F1;THAP1;POLR2G;PPP5C;RRAGC;EPC1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.44282692048167294,-0.9861734322452164,0.4954128440366973,0.7853075377158788,1.0,5/10,20.68%,PRKCH;FOXC1;TRIM16;ETV4;NUMA1
prerank,sulfur amino acid catabolic process (GO:0000098),0.4737960106606922,0.9860788499716969,0.47474747474747475,0.8643046628857912,1.0,2/10,5.21%,CTH;TXN2
prerank,lipoxygenase pathway (GO:0019372),-0.4100590107610941,-0.9860284615326851,0.48623853211009177,0.7850400858038816,1.0,5/14,17.81%,GPX4;PTGS2;PON3;GPX1;ALOX12
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.35655641882976413,-0.985872332906692,0.4781659388646288,0.7848104925381476,1.0,11/27,25.91%,RNASE4;NYNRIN;ZC3H12A;ERN1;XRN1;TOE1;DICER1;NUDT16;ZC3H12B;POP1;NHP2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.38492000582464747,0.98564955457468,0.4516728624535316,0.8643296047769049,1.0,7/33,13.06%,AFAP1L2;GPER1;NCF1;CNOT9;HIP1;DGKD;BCAR3
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.40618318183797353,0.9855337912813321,0.4816326530612245,0.8636838826647363,1.0,5/24,7.40%,MTCL1;SLC51B;ANK3;HRAS;PDZK1
prerank,regulation of DNA metabolic process (GO:0051052),-0.31470353800481765,-0.9854668891371741,0.47835497835497837,0.7851603911407792,1.0,12/44,20.59%,HDAC8;TOM1L1;SMG6;POLH;MPV17;CDK9;WDR18;SIRT7;SMG5;SMARCAD1;THOC1;MPHOSPH8
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4564985450116411,0.9853997812985519,0.42795698924731185,0.8630581403948032,1.0,3/12,16.08%,GNL3L;CCT7;CCT3
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.4125395714378365,-0.9853839980627878,0.48846153846153845,0.7847287755366636,1.0,5/14,14.73%,EZR;RHOA;MYO9A;PATJ;OPHN1
prerank,neuron differentiation (GO:0030182),-0.2531595777165227,-0.9850588006539109,0.47003154574132494,0.7849115475035837,1.0,26/165,13.66%,PBX1;WNT4;GLI2;PBX3;WNT6;DTNB;TGFBR1;LRP6;FZD2;WNT9A;WNT5A;HS6ST1;WNK1;NRBP2;FZD4;VSX1;LHX6;NR4A2;FZD7;WNT5B;ITM2C;ID2;ATOH8;WNT16;MET;UGCG
prerank,regulation of intracellular transport (GO:0032386),-0.32757112740949157,-0.9848774935337263,0.49122807017543857,0.784701000823132,1.0,14/38,22.24%,GAS1;LRRK2;RNF139;NDEL1;RINT1;ATP9A;TTC21B;REEP5;DYNC1H1;DYNLT2B;DNAJC30;NUP214;NUMA1;LCP1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3784030620750361,0.9847388760218885,0.46605504587155966,0.863560850576711,1.0,4/38,3.81%,IL34;NCK2;DOK7;GRM5
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3854288131210503,-0.9842324528963168,0.49122807017543857,0.7855798175598572,1.0,10/17,35.05%,MDM2;SNAI1;RFFL;PSMD10;CD44;PRKN;TWIST1;PTTG1IP;KDM1A;CD74
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4438403799271019,-0.9841619292511048,0.5062611806797853,0.785132005256789,1.0,2/10,16.38%,ADGRV1;WHRN
prerank,protein homooligomerization (GO:0051260),-0.2619350318833241,-0.9841530544581473,0.49719101123595505,0.7845170210402309,1.0,27/114,16.56%,ALDH1A2;RNF213;KCNJ2;SCARA5;B2M;CLYBL;PDCD6IP;APPL2;SSBP1;UPB1;ALS2;EHD1;GLRA3;GLS;RNF135;ACACA;SAMHD1;SPAST;GSDMD;DISP1;GBP5;ATL2;NINJ1;BEND3;AQP11;ELAVL1;PNPT1
prerank,protein acetylation (GO:0006473),-0.33976388263403634,-0.9841314260389454,0.48358862144420134,0.783929331419951,1.0,11/30,24.92%,FOXO1;KAT2B;NAA35;CLOCK;SPHK1;NAA40;NAT10;NAT9;NAA80;HAT1;ING4
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.42696678049665626,-0.9836233960330533,0.4942084942084942,0.7844833590769612,1.0,5/12,27.39%,SMO;SIX1;AGT;VEGFA;GDNF
prerank,membrane lipid metabolic process (GO:0006643),-0.36500277794420943,-0.9835146845292292,0.5,0.7841039740601746,1.0,5/22,16.00%,ST3GAL6;AGMO;CYP1B1;SPHK1;SERINC1
prerank,vasculature development (GO:0001944),0.43575955686291407,0.9834959543658757,0.4746450304259635,0.8653437694461462,1.0,2/16,3.05%,PDGFRB;PIK3CA
prerank,muscle filament sliding (GO:0030049),0.37532850652132427,0.9824448315825062,0.4863013698630137,0.8657929517322641,1.0,3/38,7.50%,DMD;TMOD1;MYL3
prerank,actin-myosin filament sliding (GO:0033275),0.37532850652132427,0.9824448315825062,0.4863013698630137,0.8657929517322641,1.0,3/38,7.50%,DMD;TMOD1;MYL3
prerank,cell cycle G2/M phase transition (GO:0044839),0.30822840797118606,0.9822137215284813,0.4516616314199396,0.8654185295666058,1.0,23/129,16.52%,DYNLL1;BTRC;FOXM1;PPP2R2A;CCDC57;AJUBA;PRKAR2B;CDKN1A;NES;CSNK1E;DYNC1I2;CEP41;BRSK1;TUBB4A;PPP1R12A;CDK14;DCTN1;CCNH;SKP1;DCTN3;CEP76;CEP135;NDE1
prerank,protein polyglutamylation (GO:0018095),0.4658946092629849,0.9820285259414524,0.47912524850894633,0.8649115469177333,1.0,6/11,20.78%,TTLL11;CEP41;TPGS1;CFAP20;TTLL5;TTLL7
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.41834506024965573,0.9819881386081212,0.44537815126050423,0.86410221785151,1.0,5/18,9.02%,CRTC1;RPS6KA4;ADCY8;CRTC3;PRKD2
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3612623925575274,-0.9817574096717488,0.486815415821501,0.7876585059692695,1.0,4/22,14.59%,BMP7;B2M;CALR;DTX1
prerank,protein phosphorylation (GO:0006468),0.27059658229338,0.9814115808384452,0.5177304964539007,0.8644810143799002,1.0,78/478,11.80%,PDGFRB;MAST4;PRKG1;MAP3K20;PIK3CD;CDK6;MAP3K5;PTK2;SNRK;PEAK1;PKN1;FRK;MARK1;PRKAR1B;HUNK;MERTK;NUAK2;ROCK1;AKT3;FNIP2;ERBB4;LIMK1;RPS6KA4;GRK3;CDK15;ABI2;CDC42BPA;STK39;STK38L;JAK1;RPS6KB2;MINK1;CSNK1G1;RYK;RPS6KA2;TESK2;TNKS;TRIB2;ROS1;NEK1;NTRK2;TTBK1;TAOK3;SIK1;YWHAZ;PAK6;LMTK3;STK3;STK24;MTOR;GRK5;ACVR2B;MARK2;CSK;MAP4K4;PRKD2;LYN;PDGFB;CSNK1E;MAP4K1;BIRC6;PAK5;COQ8A;MAPK10;NEK6;ATR;DYRK3;ABL2;BRSK1;PAK3;HIPK1;BRAF;NUAK1;LATS2;PRKX;PAK1;TEC;NLK
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.3170267741349662,-0.98109989353479,0.475,0.788598660552623,1.0,6/39,9.97%,MCU;MYRIP;RBP4;TCF7L2;NNAT;NLGN2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.38755500637988194,0.981060143045588,0.47358834244080145,0.864332876010225,1.0,7/36,14.26%,MAP3K20;RAD1;TIMELESS;ATR;SETMAR;RAD17;ATRIP
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3670216278980068,-0.9809277413616836,0.4989384288747346,0.7884056338197384,1.0,5/24,13.00%,NOD1;IRAK2;MAP2K6;CASP8;UBB
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3271573527738815,0.9807945905524279,0.4669887278582931,0.8640070731612043,1.0,10/79,11.89%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;AP2B1;KIF3A;SEC13;KIF3C
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.354813551353282,-0.9807578196676703,0.505091649694501,0.7881948697198631,1.0,8/23,20.55%,WEE1;PLK2;CHFR;ZFYVE19;NABP1;ZW10;PRCC;CDK5RAP3
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.354360560114434,0.9806042897163881,0.47424511545293074,0.86351244531315,1.0,14/52,11.15%,PIK3R1;EPB41L2;PTPN9;GPER1;EPB41;SPTBN1;DPP10;ITGB1;EFCAB7;STAC;NKD2;EPHA2;STX4;RANGRF
prerank,retina homeostasis (GO:0001895),-0.36075374986955433,-0.9803338671836007,0.47470817120622566,0.7885624400121822,1.0,8/23,23.39%,B2M;ACTG1;POC1B;ACTB;POTEF;WHRN;TULP1;CDH3
prerank,regulation of gastrulation (GO:0010470),0.4380078962006088,0.9803008460295316,0.4865979381443299,0.863291222279558,1.0,4/14,13.10%,PHLDB2;CLASP2;TENM4;PHLDB1
prerank,positive regulation of organelle assembly (GO:1902117),-0.3215563000472341,-0.9802669525518661,0.5277777777777778,0.7880842974519836,1.0,17/44,22.51%,ASAP1;SDCBP;PDCD6IP;SDC4;RAB3GAP1;PIP4K2B;SH3GLB1;SDC1;G3BP1;RAB3GAP2;TAPT1;DYNC1H1;STX18;NUMA1;PLK4;LCP1;CCP110
prerank,negative regulation of multicellular organismal process (GO:0051241),0.2948561276857581,0.9802387296217923,0.47218453188602444,0.8625519795997124,1.0,14/199,3.10%,PLCL1;PTEN;MEF2C;HEY2;BMP5;NOTCH1;RGCC;NR1H3;NODAL;IL17RD;ROCK1;SPRED1;IL1B;RPS6KA4
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.40848795991709536,-0.9798324699693798,0.47522935779816516,0.7884954778678678,1.0,8/12,35.85%,LRRK2;CLN6;CCDC115;CLN5;TMEM199;TMEM165;CLN3;ATP6AP2
prerank,macrophage activation (GO:0042116),-0.32812115107141504,-0.979553529997788,0.4768611670020121,0.7885326909019905,1.0,5/34,4.90%,FOXP1;APP;LBP;SBNO2;CD93
prerank,cell-cell junction organization (GO:0045216),0.33033193445155273,0.979491486486453,0.46140939597315433,0.8632496155678141,1.0,11/79,7.13%,GJC1;LIMS1;CDH2;CDH4;CADM2;GJA4;CDH8;CDH22;CDH19;CDH7;CDH20
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.43174850066535597,-0.9791465333957764,0.4919499105545617,0.7888466778777636,1.0,8/11,41.74%,P2RX4;CDH13;PLCG2;TREM2;P2RX3;TRAT1;CCL4;NEUROD2
prerank,microvillus organization (GO:0032528),0.4487719533022053,0.9791125663487199,0.4697986577181208,0.8631724564240225,1.0,4/13,8.82%,RAPGEF2;MINK1;RAP1A;MAP4K4
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.43107623980854054,0.9788499617823239,0.4690082644628099,0.8628635922429543,1.0,7/18,12.34%,SLC1A4;GRIK1;GRID1;GRIA2;CDH8;GRIK5;GRIK2
prerank,positive regulation of B cell proliferation (GO:0030890),0.392775731785442,0.978610368760011,0.46904315196998125,0.862519655165197,1.0,2/29,6.03%,MEF2C;IL4
prerank,membrane organization (GO:0061024),0.29096673345576823,0.9780240270275308,0.4821192052980132,0.8628971112617043,1.0,47/227,15.41%,SGIP1;DYSF;SH3KBP1;IGF2R;FNBP1;LDLRAP1;ATP2C1;LDLR;SPTBN1;TMCC1;TOR1B;WASL;RIMS1;COX18;SYNGR1;ARPC5;ANK3;EPN1;CHMP2B;HACE1;SGCZ;PIK3C2A;BIN1;PPT1;SYT1;AP2S1;AP2B1;UBXN2B;HIP1;CPTP;ARPC4;NPC1;SYP;SYT2;KIF20A;EMD;DVL2;SERP1;VTI1B;ARPC1A;FCHO1;ANK2;VPS33B;RAB5A;MYADM;CHMP3;PLEKHA3
prerank,cellular protein modification process (GO:0006464),0.2588328312625574,0.9780228642905746,0.5326902465166131,0.8620175319043707,1.0,129/982,11.24%,ART3;PTPRK;PTEN;PRKG1;CEL;MAP3K20;PIK3CD;PIGU;PARP8;CDH2;PRKCSH;IGFBP7;GCNT2;CDK6;MAP3K5;SDC2;METAP2;ST8SIA4;SNRK;PTPN9;MFGE8;LAMC1;PEAK1;PPM1E;PKN1;FRK;WSB1;BTRC;MARK1;USP25;PRKAR1B;HUNK;MERTK;NUAK2;PTAR1;ROCK1;AKT3;FNIP2;PTPN22;CUL3;SSH2;CTH;ST8SIA1;LIMK1;RPS6KA4;MMP15;CHML;RBX1;GRK3;CDK15;CDC42BPA;STK39;STK38L;COG7;JAK1;PPP3CA;MINK1;PPP2R2A;PTPN4;RYK;EPAS1;PSMB11;TESK2;SERPINA10;TNKS;SPARCL1;LAMB1;SOCS5;GPC3;TRIB2;ROS1;NEK1;TTBK1;ATE1;ASB8;TAOK3;MSRA;SIK1;PSMF1;KCTD6;YWHAZ;B3GALT1;PAK6;LMTK3;UBE2E1;PTPRT;STK3;STK24;PPP1CC;MTOR;GRK5;STC2;FUT9;ACVR2B;HLCS;RAB38;MARK2;CSK;MAP4K4;MIA3;PRKD2;LYN;PDGFB;ANO8;B3GNT8;OARD1;CSNK1E;MTMR7;MAP4K1;BIRC6;CDC14B;PAK5;COQ8A;MAPK10;NEK6;CHST5;BTBD6;SOCS6;DYRK3;ABL2;GAD1;BRSK1;NPC1;PAK3;HIPK1;BRAF;NUAK1;LATS2;KBTBD7
prerank,"transcription, DNA-templated (GO:0006351)",-0.2394147133945245,-0.9778658434823998,0.5354609929078015,0.7912203780083463,1.0,64/207,26.26%,MAF;NFIX;GLIS3;FOXO3;TSC22D1;DDX5;PIR;TAF1;MLLT3;TRIM24;THRB;NOCT;RTF1;POLR2A;IRF9;RREB1;PMF1;NR4A2;MMS19;IVNS1ABP;PWP1;POLR2F;MEF2A;POLR3GL;EAF1;ELOB;DTX1;CDK9;TAF4B;GTF3C2;MNT;GTF3C5;POLR2E;TBPL1;BRF2;E2F1;GTF3C1;TAF9B;TEFM;POLRMT;UBTF;TCEA1;RSF1;TTF1;THAP1;NFE2L3;MRPL12;ELOC;XBP1;NELFCD;CEBPD;TAF5;HSF2BP;HIPK3;CBFB;ERCC2;POLR2G;PPP5C;RRAGC;CDK7;ERCC3;TP53;EPC1;TAF11
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2952569664444207,-0.9770809349463582,0.49635036496350365,0.7925232990702805,1.0,13/56,18.59%,LBP;NOD1;IRAK2;LACC1;CTSB;SFTPA2;SFTPA1;CTSS;UBB;PLCG2;MAPKAPK3;TLR4;HSP90B1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.30479127663732747,-0.9768162586455039,0.49767441860465117,0.7925123329019403,1.0,18/49,24.09%,LRCH1;LRRK2;SLC39A14;WNK1;CPEB2;SH3RF2;CST3;ECM1;DAB2IP;CAMK2A;F11R;GMIP;NOS1;SH3BP4;CHP1;TMED2;SH2D4A;RDX
prerank,myoblast fusion (GO:0007520),-0.4195318373064657,-0.9764634596632612,0.49803149606299213,0.7927531412662172,1.0,7/12,19.75%,JAM2;ADAMTS5;CD9;ADAMTS15;PTGFRN;NOS1;CD81
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.4142369043147677,-0.9763193685747033,0.4990328820116054,0.7924439019947171,1.0,4/12,15.54%,CLCN2;LPCAT3;RAN;SREBF1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.45802333850826976,0.9762141726747726,0.47639484978540775,0.8650562055530943,1.0,4/12,10.99%,GINS4;MCM6;MCM7;MCM2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.43271494374345393,-0.975434042503579,0.5108695652173914,0.7939599369910082,1.0,7/11,33.33%,LRP6;WNT5A;NR4A2;FZD1;CTNNB1;LMX1A;WNT2
prerank,necroptotic process (GO:0070266),-0.3843037183861776,-0.9748761765374717,0.49603174603174605,0.794603003144171,1.0,5/16,17.18%,ITPK1;PGAM5;TICAM1;TLR4;RIPK1
prerank,Golgi inheritance (GO:0048313),0.4511307098713811,0.9745714866026329,0.4639830508474576,0.8678151489142307,1.0,3/11,13.99%,PDCD10;YWHAZ;STK25
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4582456842796172,0.9744815834135383,0.45670995670995673,0.8671236173018882,1.0,3/11,9.11%,JAK1;ANK3;LYN
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4320459003661955,-0.9743283256399023,0.497196261682243,0.7952941618241992,1.0,2/10,7.42%,QRICH1;HSPA5
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.37841076797272777,-0.9742819811079937,0.51340206185567,0.7947616849923167,1.0,8/18,29.25%,CCN3;KCNB1;SFRP1;MIDN;SIRT4;PRKN;ADRA2A;CHGA
prerank,protein autophosphorylation (GO:0046777),-0.2525927270759912,-0.97412009321108,0.5469255663430421,0.7944779351359608,1.0,47/157,21.23%,DAPK1;EPHA4;EGFR;FLT1;PDGFRA;TEK;FGFR2;STK17B;EPHB4;IGF1R;LRRK2;TAF1;DDR1;PTK2B;TAOK2;AKT1;KIT;STK10;EPHA8;BMX;ULK2;KDR;CAMK2A;MKNK2;ERN1;FGFR4;FLT4;ATM;PIM3;FER;OXSR1;MAPK3;MAPKAPK3;VRK2;EPHB3;RIPK1;MAP3K13;MAP3K3;PDPK1;ALK;PIM2;FES;SLK;CSF1R;RIOK2;PASK;CAD
prerank,RNA metabolic process (GO:0016070),0.3082681559837016,0.9740957075832427,0.45975232198142413,0.8670595238298219,1.0,30/127,15.02%,RBPMS;APOBEC1;FASTKD2;ELAVL4;CLP1;PCBP3;NCBP2;ADARB2;AGO3;DDX3X;HNRNPR;SUPV3L1;XRN2;PAPOLA;RBMS1;RNASE6;POLR2C;PCBP1;HNRNPA1;SND1;HNRNPUL1;LAGE3;PABPC4;FASTKD1;HNRNPU;RNASEH1;LSM8;HNRNPC;HNRNPH2;DHX36
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3977959451528942,0.9738841828197797,0.46322067594433397,0.866630140906615,1.0,4/27,8.11%,PER2;CRTC1;SIK1;PPP1CC
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.46287481702835653,0.9737742393648329,0.49375,0.8659600801644922,1.0,1/10,2.01%,DCLRE1B
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3783251439793068,0.9737368378876332,0.4925373134328358,0.8651616546258015,1.0,16/31,26.75%,PEX7;PEX1;GRPEL2;TOMM40L;TIMM23;TOMM40;PEX12;PEX2;TOMM70;DNAJC19;PEX5;PAM16;PEX6;TIMM17A;DNLZ;TIMM17B
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3629674231266604,-0.9736262671180094,0.4989648033126294,0.7950187557170315,1.0,6/22,3.02%,FLT1;PDGFRA;NTRK3;PLCG1;ESR1;FGFR2
prerank,response to molecule of bacterial origin (GO:0002237),0.3386313113016971,0.9732616104693936,0.4600326264274062,0.8652910256341385,1.0,6/69,6.30%,GGT5;GGT1;IL1B;PTPN22;OTUD5;SNCA
prerank,sterol biosynthetic process (GO:0016126),-0.3332305904070531,-0.9727495975654661,0.5089285714285714,0.7964916771079806,1.0,2/33,3.11%,PRKAG2;LBR
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.4712605699661573,0.9725333678370265,0.49107142857142855,0.865963329221053,1.0,3/10,7.70%,KCNE4;ANK3;KCNE5
prerank,regulation of interferon-gamma production (GO:0032649),0.3359158935364152,0.9722597129575569,0.4867109634551495,0.8656303795753807,1.0,6/71,8.18%,PDE4D;IL1B;PTPN22;AXL;PDE4B;IL12RB1
prerank,gene silencing by miRNA (GO:0035195),0.3822435226986579,0.971454513481816,0.47653429602888087,0.8665006546235473,1.0,7/32,12.88%,LIMD1;AJUBA;AGO3;TARBP2;TNRC6C;EIF6;TNRC6B
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3502081266856546,-0.971422722701009,0.48330058939096265,0.7989683068684156,1.0,4/24,13.21%,PLA2G4A;LPGAT1;ABCA3;PLA2G15
prerank,cholesterol metabolic process (GO:0008203),0.3419825609128239,0.9713056889055436,0.49409780775716694,0.8659819025251759,1.0,13/68,13.32%,CEL;SCARF1;LDLRAP1;ARV1;PPARD;ABCA5;IL4;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;CYP11B1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.29556113192156497,-0.9712757637790301,0.5371702637889688,0.7986918942568911,1.0,14/65,10.80%,FOXP1;IL31RA;IL15;TGFBR2;BMP4;CSF1;LEF1;PIR;SBNO2;LGALS9;MAPK14;KIT;CASP8;PML
prerank,response to exogenous dsRNA (GO:0043330),0.41971350018669384,0.9710875481933938,0.4767676767676768,0.8655913322762652,1.0,2/18,2.48%,COLEC12;RFTN1
prerank,protein import (GO:0017038),-0.2780736635321105,-0.971066835163042,0.5025641025641026,0.7985873257521728,1.0,32/84,29.60%,LAMP2;APOE;APPL2;STAT3;SLC25A17;AKT1;IPO7;PXMP2;FAM53C;IPO13;ALDH3A2;RAN;ACBD5;GDAP1;PXMP4;NXT2;IPO8;TPR;TOMM22;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;EIF4ENIF1;PEX26;CLU;CSE1L;NUP62;PTTG1IP;TNPO2
prerank,lipid transport (GO:0006869),0.32295302503399564,0.9710274587192143,0.5088852988691438,0.8648457462722124,1.0,11/97,6.57%,PITPNC1;SLCO3A1;SCARB1;SLC51B;LDLR;ABCD2;PPARD;SLC27A4;FABP3;ABCA5;PRELID3A
prerank,regulation of muscle cell differentiation (GO:0051147),0.37593897669524234,0.9708518964823383,0.46653543307086615,0.8643518213467107,1.0,2/31,0.93%,MEF2C;CDH2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.29152252042325877,-0.9704251827608803,0.5199063231850117,0.7994413219721518,1.0,36/62,37.09%,LRRK2;ARHGEF2;CXCL12;TPT1;AKT1;MCL1;MDM2;YBX3;PPIA;CREB3L1;ENO1;SNAI1;CREB3;TMBIM6;PARK7;PLAUR;XBP1;NDUFA13;BCL2L1;PRKN;BAG5;CDKN2D;SOD2;CLU;SYVN1;PTTG1IP;HSPB1;HYOU1;RTKN2;PINK1;MAPK7;EPO;VNN1;PPIF;NME5;HERPUD1
prerank,UV-damage excision repair (GO:0070914),-0.4149451188454827,-0.9703689616461109,0.5179584120982986,0.7989275551739203,1.0,5/12,26.02%,INO80;DDB1;ERCC1;ACTR5;POLA1
prerank,regulation of nervous system process (GO:0031644),-0.3870807658793118,-0.9696383727980635,0.5,0.8000483880244833,1.0,4/18,4.79%,ROCK2;APP;NOS3;SLC8A3
prerank,regulation of osteoclast differentiation (GO:0045670),-0.3271503901095375,-0.9693917536480506,0.4979166666666667,0.799992654067349,1.0,8/33,22.12%,FBN1;CSF1;TCTA;GPR137;TLR4;CEBPB;FSTL3;UBASH3B
prerank,regulation of mitotic nuclear division (GO:0007088),0.3480229559390117,0.9692866082227667,0.49466192170818507,0.8668604999502133,1.0,3/55,2.62%,PDGFRB;RGCC;IL1B
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.36544843997228565,0.9690771244122893,0.47942754919499103,0.8664418784529649,1.0,9/41,13.17%,IL34;DOK7;NCF1;GRM5;NTRK2;PDGFB;SRC;DLG3;PTPN1
prerank,acylglycerol biosynthetic process (GO:0046463),0.40342340456040027,0.9690120121832373,0.4725490196078431,0.8657172708464823,1.0,1/23,0.48%,PLCE1
prerank,protein-containing complex subunit organization (GO:0043933),0.3114541994576834,0.9688693612891642,0.5069337442218799,0.8651688846401495,1.0,7/109,3.97%,LIN7A;LAMC1;WASF3;WAS;WIPF1;WASL;RIMS1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.4266022169237221,-0.9687575401783293,0.5234521575984991,0.8008534541765968,1.0,3/11,7.33%,IL6ST;STAT1;STAT3
prerank,response to unfolded protein (GO:0006986),-0.29652817444602414,-0.9675202952118853,0.5111111111111111,0.8032119915271249,1.0,18/48,28.08%,SERPINH1;HSPB8;STT3B;HSPA5;BAG3;DAB2IP;OPTN;ERN1;DNAJB2;HSP90AB1;TMBIM6;DNAJB5;HSPA13;HSPA9;HSPB2;PRKN;HSPH1;HSPA1B
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3950029708220801,-0.9674622781498602,0.5,0.8027114074244447,1.0,5/14,26.61%,ACOX1;ECI2;ACOX3;AMACR;CROT
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4525121182465402,0.9669382202374546,0.5147392290249433,0.8684698345510804,1.0,5/12,22.72%,KAT7;WRNIP1;BLM;METTL4;TIPIN
prerank,positive regulation of hormone secretion (GO:0046887),-0.3810146299461636,-0.9665452182326764,0.517175572519084,0.8042643251787868,1.0,10/17,39.36%,C1QTNF3;SPP1;EDN3;HFE;VAMP8;GRP;SNX4;EDN1;NMB;SOX11
prerank,innate immune response (GO:0045087),0.28487383958873413,0.9663126897966992,0.526685393258427,0.8689197990750388,1.0,26/217,9.51%,PIK3CD;COLEC12;NCF2;PTK2;FRK;NCF1;MID2;AKAP1;ANKHD1;WFDC3;CARD9;CAMP;TRIM43;TRIM62;CXCL10;IL4;SNCA;DDX3X;RIPK2;RNASE6;ALPK1;CORO1A;ZDHHC1;TIFA;LYN;CR2
prerank,protein destabilization (GO:0031648),-0.3277762968958926,-0.9661961904717249,0.509594882729211,0.8044850229717666,1.0,9/32,14.46%,GSN;CTSH;RNF139;IRGM;MDM2;CCDC88C;FBXW11;SOX17;SERF2
prerank,protein deubiquitination (GO:0016579),-0.2338351425563204,-0.9661825482485835,0.569672131147541,0.803890339374761,1.0,79/242,27.57%,SMAD3;ESR1;SMURF2;USP47;TGFBR1;KAT2B;SMAD7;USP46;AR;USP12;INO80;RHOA;USP8;BIRC3;USP15;TRRAP;USP18;HGS;IL33;HIF1A;FOXK1;BECN1;USP34;ZC3H12A;USP35;USP11;USP5;PSME2;MINDY1;ATXN7L3;MDM2;USP49;PSMB4;UBB;INO80D;ACTB;PSMB1;PSMD11;NEDD8;PSMD8;PSME3;RIPK1;ACTR8;NFKBIA;ADRB2;PSMD4;STAMBP;PSMA2;BABAM2;VCP;TAF9B;IKBKG;USP22;SNX3;PSMD3;USP36;PSMB7;BABAM1;CCP110;BAP1;USP2;PSMC2;BRCA1;USP10;PSMC5;PSMD10;SUDS3;ACTR5;PRKN;ABRAXAS2;TP53;CDC25A;MINDY2;SMAD4;SENP8;INO80E;ATXN3;ENY2;PSMD7
prerank,response to ionizing radiation (GO:0010212),-0.27768221774077306,-0.9661564476875143,0.5183374083129584,0.8033089174922855,1.0,23/70,26.24%,EYA1;ANXA1;INO80;MAPK14;RHOB;EEF1D;NHEJ1;NABP1;ATM;CLOCK;XRCC4;INIP;NET1;BABAM2;IKBIP;BABAM1;RAD51;STK11;RNF8;BRAT1;BRCA1;TP53;HUS1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.335163968854239,0.966052797904542,0.47487844408427876,0.868629884949896,1.0,6/63,7.64%,MEF2C;NCK2;IL1B;CD46;IL4;FGF10
prerank,steroid metabolic process (GO:0008202),0.33366221039770744,0.9660184160467628,0.48599670510708404,0.8678477929694353,1.0,10/72,13.32%,CYP7B1;RDH5;ARV1;BAAT;NPC1;LSS;STAR;PRLR;SRD5A1;CYP11B1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.33561863704221384,-0.9660136773729974,0.4968017057569296,0.8030257592969081,1.0,5/31,3.94%,EPHA4;PDLIM5;SIPA1L1;SHANK3;LRRK2
prerank,positive regulation of chemotaxis (GO:0050921),0.36227501915412413,0.9660017556308199,0.4953271028037383,0.8670199958967594,1.0,4/43,4.25%,PDGFRB;SEMA5A;PTN;FGF2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.3408545037925205,0.9656953166639936,0.5008183306055647,0.8667631307685294,1.0,15/62,12.88%,MEF2C;CDK6;MYL9;HOXA9;AGO3;LYN;KMT2B;CNOT4;PRMT1;TNRC6C;EIF6;EP300;RBM15;CTR9;TNRC6B
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.441576137807649,0.9655814479338477,0.47288503253796094,0.8661409826367626,1.0,5/12,15.79%,HOOK3;BICD2;KIF3A;DCTN1;CEP19
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.4469572650830327,0.964880298927955,0.4731182795698925,0.8668110815527287,1.0,2/12,4.99%,IL1B;CARD9
prerank,nucleosome organization (GO:0034728),-0.29640469286775967,-0.9647800179048708,0.507537688442211,0.80537489527272,1.0,26/55,36.77%,KAT6B;INO80;BPTF;H3-3A;ANP32E;ANP32B;SMARCC1;HMGB2;CTCF;RSF1;MCM3AP;NAP1L2;BRD2;SMARCA4;RNF8;ASF1A;CHAF1A;SMARCD2;POLE3;PAF1;NAA60;SPTY2D1;ZNHIT1;ATRX;GRWD1;SRCAP
prerank,regulation of dendritic spine development (GO:0060998),0.4109746522503426,0.9642567206295491,0.47534516765285995,0.8672977598707511,1.0,1/19,0.63%,MEF2C
prerank,modification-dependent protein catabolic process (GO:0019941),-0.2429649342091179,-0.9641982827883927,0.5266903914590747,0.8062113360781877,1.0,54/193,21.82%,FBXL7;RNF213;SMURF2;FBXO10;RNF146;ASB2;TAF1;RNF43;SPSB1;RNF130;RNF19A;ARRB1;RNF144B;TTC3;SMURF1;CDC16;AMFR;RC3H2;CHFR;RNF185;DTX3L;KCTD10;ZNRF3;ARRDC1;UBE4B;ANAPC4;RNF125;MDM2;WDR81;UBB;UBE2G2;PSMD11;NEDD8;DDB1;FBXL14;ANKIB1;RNF40;UBR4;SPSB4;SPSB2;ANAPC16;FZR1;NPLOC4;RNF217;PSMD3;CDC27;RNF144A;UBE2L6;RFFL;RNF126;ANAPC5;ELOC;RBBP6;XBP1
prerank,regulation of membrane depolarization (GO:0003254),-0.372558434575506,-0.9641917412711202,0.516504854368932,0.8055939337206783,1.0,5/18,7.02%,PTPN3;FHL1;LRRK2;SMAD7;GPD1L
prerank,growth hormone receptor signaling pathway (GO:0060396),0.4568881609942754,0.9641827023835193,0.49898580121703856,0.8665917462970686,1.0,6/14,14.92%,PTK2;PIK3R1;LYN;PRLR;PTPN1;JAK2
prerank,microvillus assembly (GO:0030033),0.43498262787664943,0.9641375451309809,0.49448123620309054,0.8658295108334969,1.0,4/14,8.82%,RAPGEF2;MINK1;RAP1A;MAP4K4
prerank,regulation of RNA splicing (GO:0043484),-0.28488240120623476,-0.9637104408644578,0.5144230769230769,0.8061315974840539,1.0,23/69,26.65%,AHNAK;MBNL1;RBM20;AFF2;RPS13;POLR2A;SON;CLK1;ERN1;MBNL2;GRSF1;SRSF10;TMBIM6;AHNAK2;PTBP3;HNRNPL;SRPK1;RPS26;ZNF326;SRPK2;HNRNPF;CLK3;CWC22
prerank,regulation of intracellular pH (GO:0051453),-0.3276778102526642,-0.9632152340167434,0.5108695652173914,0.806690326367352,1.0,10/34,19.85%,SLC9A2;SLC4A10;LRRK2;SLC9A9;TM9SF4;SLC9B1;SLC9A1;SLC4A2;CHP1;NOX1
prerank,cellular respiration (GO:0045333),0.3650448530125912,0.9631822268765111,0.4664310954063604,0.8670799918270109,1.0,11/41,18.71%,COX4I2;UQCRFS1;SLC25A13;BLOC1S1;UQCRC2;ETFB;ETFA;MTFR1;ETFDH;OXA1L;NDUFA5
prerank,chromatin assembly (GO:0031497),-0.3176287415656684,-0.963083458660663,0.5187637969094923,0.8063541911720702,1.0,16/38,32.00%,KAT6B;H3-3A;ANP32B;EZH1;HMGB2;CTCF;RSF1;NAP1L2;BRD2;ASF1A;CHAF1A;TP53;POLE3;PAF1;NAA60;SPTY2D1
prerank,sensory perception of sound (GO:0007605),0.3227657042021693,0.963031014115405,0.5055467511885895,0.8665231535299207,1.0,3/88,1.30%,GRM7;COL4A3;ROR1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.430802105178438,-0.9627542412430641,0.5383211678832117,0.8064875373552874,1.0,4/10,14.73%,EZR;RHOA;MYO9A;OPHN1
prerank,regulation of steroid metabolic process (GO:0019218),0.39643097820355605,0.9623855063742114,0.4826923076923077,0.8670510206691101,1.0,6/23,17.84%,RORA;ARV1;STAR;ASAH1;RORC;FMO5
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.32678498812264495,-0.962121867893124,0.5062240663900415,0.8073926237427297,1.0,11/33,16.85%,GLUL;DDAH1;ALDH4A1;PRODH;GLS;DGLUCY;GCLC;SLC39A8;OAT;NIT2;FPGS
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.38875741526178137,-0.9620860933430203,0.5257352941176471,0.806834845435683,1.0,9/15,27.91%,SMAD7;DTX3L;RPL11;RPL23;RPS7;PARK7;BAG2;BAG5;ABL1
prerank,response to copper ion (GO:0046688),-0.3635334224969815,-0.9611184648891005,0.5116731517509727,0.8085840600162723,1.0,9/20,20.00%,MT3;MT1G;MT1F;MT1E;MT1B;MT1A;MT1X;MT1M;MT1H
prerank,cellular response to retinoic acid (GO:0071300),-0.31345557249439254,-0.9610023653526825,0.4965986394557823,0.8082189764977219,1.0,11/42,13.68%,EPHA3;WNT6;WNT9A;WNT5A;PTK2B;TBX1;FZD4;FZD7;WNT5B;ATM;RET
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.3632206581977058,0.9607763479876644,0.4965635738831615,0.8696095859553213,1.0,8/44,10.27%,GNG2;KCNJ12;KCNMB1;AKAP6;ATP1B2;KCNE5;KCNJ3;KCNJ6
prerank,regulation of lymphocyte migration (GO:2000401),-0.43036878036188225,-0.9606045923175706,0.5407801418439716,0.8085342398014935,1.0,3/10,9.46%,JAM2;AKT1;STK10
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.46729839408619833,0.960291584387042,0.5108225108225108,0.8698096335027875,1.0,5/10,26.78%,PDE6A;SAG;CNGB1;PDE6B;GNB1
prerank,cellular response to glucose stimulus (GO:0071333),-0.3268454606878956,-0.9600945120458277,0.4925373134328358,0.8090754288051356,1.0,8/30,15.77%,UNC13B;IGF1R;SLC39A14;GAS6;KCNB1;ERN1;RAB11FIP5;PRKAA2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.43471303165679476,0.9597038527739845,0.49377593360995853,0.8701952288438488,1.0,3/14,8.74%,IL1B;FFAR2;OSMR
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.38954684829696895,0.9596565936573339,0.48747591522157996,0.8694435020100597,1.0,2/25,0.66%,PTH1R;GLMN
prerank,negative regulation of lipid metabolic process (GO:0045833),0.4063486491627454,0.9595788275186388,0.48897795591182364,0.8687776863212183,1.0,2/22,2.62%,GPER1;IL1B
prerank,protein localization to cell periphery (GO:1990778),0.29804029852884206,0.9594855321227175,0.5147492625368731,0.8681351448335359,1.0,21/133,10.43%,LIN7A;CACNB2;RAPGEF2;ROCK1;RAB8B;TSPAN15;SPTBN1;FGF13;MAP7;CLASP2;DPP10;ANK3;RAB3B;EMP2;RAP1A;PDZK1;EHD3;ZDHHC2;NKD2;EPHA2;TSPAN17
prerank,lysine catabolic process (GO:0006554),-0.4114576245229188,-0.9593169604004597,0.5325443786982249,0.8096466385928086,1.0,5/12,28.69%,ALDH7A1;PIPOX;GCDH;AASS;HYKK
prerank,lysine metabolic process (GO:0006553),-0.4114576245229188,-0.9593169604004597,0.5325443786982249,0.8096466385928086,1.0,5/12,28.69%,ALDH7A1;PIPOX;GCDH;AASS;HYKK
prerank,positive regulation of apoptotic process (GO:0043065),0.27696267836485217,0.9591180204053008,0.5548469387755102,0.8680214116607134,1.0,31/293,9.08%,DLC1;ARHGEF17;FAP;MAP3K20;KALRN;PLEKHG2;MAP3K5;ARHGEF6;GPER1;NF1;RYBP;RPS6KA2;SLC27A4;ITGB1;TNFRSF8;TFAP2B;SNCA;DDX3X;ARHGEF12;SOX4;ARHGEF26;SIK1;CASP9;SOS2;BIN1;RNPS1;STK3;TNFAIP8;HTRA2;ARHGEF9;CCAR2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.43150636978594187,-0.9591075451251911,0.5379061371841155,0.8094819722381996,1.0,2/10,2.81%,APP;SHANK3
prerank,error-free translesion synthesis (GO:0070987),-0.36154211713945045,-0.9582423317317712,0.5436507936507936,0.8109201291530967,1.0,12/22,32.01%,REV1;POLH;UBB;RPA1;NPLOC4;RFC3;VCP;RFC1;RPA3;POLD1;PCNA;RFC5
prerank,cellular response to sterol (GO:0036315),-0.401281875477055,-0.9580011078036955,0.5441176470588235,0.8108622955512471,1.0,6/13,11.87%,LRP6;SMO;GRAMD1C;GRAMD1A;INSIG2;PTCH1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.43390067619334605,-0.9576729601277065,0.5231053604436229,0.8109883099630798,1.0,3/10,10.32%,LGALS9;PRKCZ;IL18
prerank,regulation of acute inflammatory response (GO:0002673),0.4120481718432157,0.9574932480327698,0.5151515151515151,0.8705763744720997,1.0,3/18,8.74%,FFAR2;IL4;OSMR
prerank,regulation of protein targeting to membrane (GO:0090313),0.379500303742038,0.9574786978057135,0.50390625,0.8697534903123296,1.0,5/28,7.40%,MTCL1;SLC51B;ANK3;HRAS;PDZK1
prerank,regulation of phospholipase C activity (GO:1900274),0.4314740010463426,0.95678873563938,0.48254620123203285,0.8703868083516332,1.0,3/15,7.16%,PDGFRB;FGF2;HRAS
prerank,cellular response to calcium ion (GO:0071277),0.33347465765844325,0.9553839114705714,0.47863247863247865,0.872715127547463,1.0,14/67,11.38%,MEF2C;RASGRP2;ADCY8;ITPKB;CPNE7;SCN5A;SYT1;RYR3;PKD2;HPCA;CPNE4;BRAF;CHP2;SYT2
prerank,regulation of cation transmembrane transport (GO:1904062),0.3815642959489286,0.9553144927851096,0.4883268482490272,0.8720069935710045,1.0,11/29,13.72%,FGF12;DPP10;KCNAB3;SCN5A;CACNA1D;PDZK1;KCNE5;KCNIP1;RANGRF;KCNIP4;SLC30A5
prerank,transepithelial transport (GO:0070633),0.42956209176909294,0.9552978581661034,0.5112107623318386,0.871196396669901,1.0,1/15,0.64%,SLC12A2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.38583238462237945,-0.9551085206844163,0.523719165085389,0.8163636469108188,1.0,5/17,16.55%,CD55;STAT3;IL18;BACH2;TLR4
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.37031125449105107,-0.954199117314663,0.5262135922330097,0.8179157910458903,1.0,4/18,13.81%,SLC25A4;CAMK2A;SPG7;BNIP3
prerank,cell junction organization (GO:0034330),0.3268442900673555,0.9540330173310899,0.5065359477124183,0.8731509655376005,1.0,13/71,7.88%,LIMS1;APBB2;VASP;FERMT2;RAB8B;SH3BP1;RAB39B;GRM5;AGRN;SNCA;CHRNA7;FBLIM1;PPFIBP2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.3032261927533601,-0.9539472669903432,0.5294117647058824,0.8179288302277068,1.0,11/46,13.01%,SMAD3;TCF7L2;CDH1;GAS6;PRKCD;ANP32B;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,regulation of proteolysis (GO:0030162),-0.2977989022424115,-0.9538334424627741,0.53125,0.8175547290376899,1.0,14/48,19.73%,CAV1;CYFIP2;LTBP4;RNF139;CST3;AKT1;CASP8;TBC1D10A;FGFR4;FBXW11;NEDD8;CLN8;PLAUR;SERPINE2
prerank,double-strand break repair (GO:0006302),-0.24374410037896652,-0.9537903090490237,0.5521885521885522,0.8170301030040837,1.0,49/158,26.31%,EYA1;PARP9;INO80;POLM;RAD51B;BAZ1B;SFR1;ERCC5;DCLRE1C;DTX3L;PARP3;NHEJ1;SAMHD1;BRCA2;NABP1;AP5Z1;ATM;XRCC4;RPA1;RAD50;PAXX;HMGB2;CYREN;ACTR8;BABAM2;VCP;SMARCAD1;PIAS4;RECQL;RAD52;UBXN1;BABAM1;RAD51C;MCM8;BAP1;SLX4;RAD51;ERCC1;CHEK2;RNF8;BRCA1;RPA3;ZSWIM7;PPP5C;RAD54B;ACTR5;POLA1;HUS1;APLF
prerank,endodermal cell fate commitment (GO:0001711),-0.425905294585427,-0.9537504701198128,0.5246800731261426,0.8164873049000685,1.0,2/10,13.79%,RTF1;SOX17
prerank,regulation of biomineral tissue development (GO:0070167),0.38339166085087417,0.9534936735562947,0.5067437379576107,0.8734565134842486,1.0,3/26,2.15%,HEY2;NOTCH1;ROCK1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.40132841237176076,0.9531109280925644,0.5095057034220533,0.8734273495448361,1.0,9/24,17.73%,TTLL3;TTLL11;NAA11;CEP41;TPGS1;CFAP20;PARP1;TTLL10;TTLL5
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3790391289808588,-0.9528260415913222,0.5527831094049904,0.8179876829270665,1.0,9/16,34.56%,ATP5PF;DMAC2L;ATP5MF;ATP5MC3;ATP5MC1;ATP5MC2;ATP5F1E;STOML2;ATP5MG
prerank,endochondral bone morphogenesis (GO:0060350),0.45160795735237164,0.9524754841826639,0.4745098039215686,0.8739415247336375,1.0,1/11,0.63%,MEF2C
prerank,GPI anchor biosynthetic process (GO:0006506),0.37519233309984085,0.9523898038478384,0.5264270613107822,0.8732806139394054,1.0,7/30,16.63%,PIGU;PIGO;PIGZ;DPM3;PIGH;PIGX;PGAP1
prerank,phagosome acidification (GO:0090383),-0.34231170511900877,-0.9515935003020145,0.5254237288135594,0.8203179085369252,1.0,16/26,39.23%,ATP6V0A4;ATP6V1G1;ATP6V0B;RAB7A;ATP6V0A1;TCIRG1;ATP6V0A2;ATP6V1F;ATP6V0D1;ATP6V0C;ATP6V1D;RAB20;ATP6V1E1;ATP6V0D2;ATP6V1G2;RAB39A
prerank,organelle assembly (GO:0070925),0.2691844925489459,0.9514767968022836,0.5745721271393643,0.8743318247433381,1.0,47/384,11.81%,DYNLL1;LIMD1;STARD9;NOTCH1;DZIP1L;IFT43;RILPL2;CDS2;RAB8B;TTLL3;CYS1;TMOD1;TTC36;IFT81;CCDC57;CENPW;TNKS;LSM3;IFT20;TMOD3;MAPRE2;YTHDF3;NEK1;RBM14;ATG16L1;CHMP2B;DDX3X;SCLT1;ATP2A2;CORO1A;RAB38;FAM161A;EHD3;MVB12A;CDC14B;TP53INP2;NEK6;UBXN2B;KIF3A;CEP41;LMOD1;SQLE;POGZ;AHI1;CCDC66;YTHDF2;CFAP20
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4128681010724687,-0.9514118201783665,0.5434380776340111,0.8201138437116212,1.0,7/12,31.77%,HSPA5;CHMP4B;CHMP4A;SEC61A1;SEC61B;SEC63;GET3
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.40773234338513975,0.9513103713708403,0.5206286836935167,0.873836494339256,1.0,4/21,2.15%,PTK2;VCL;PEAK1;ROCK1
prerank,negative regulation of viral process (GO:0048525),-0.2888597273245825,-0.9509154404915349,0.5642201834862385,0.8206437771189261,1.0,28/57,33.45%,IFITM3;STAT1;OAS2;IFIT1;PML;TRIM27;MAVS;TRIM35;PPIA;IFITM2;RNASEL;TRIM8;RSAD2;TRIM14;SRPK1;TRIM11;TRIM6;SRPK2;PLSCR1;ISG15;ILF3;ZFP36;BST2;TRIM21;PARP10;OASL;TRIM13;FAM111A
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.39116421021880643,-0.9507725735208398,0.524904214559387,0.8203521103577894,1.0,5/15,10.17%,CNOT7;STAT2;USP18;NLRC5;SAMHD1
prerank,membrane protein proteolysis (GO:0033619),-0.3173211934777097,-0.9505073682167483,0.5421940928270043,0.8203460136528199,1.0,10/37,17.55%,CTSH;ADAM9;ADAM10;ERAP1;TGFB1;RELA;RET;AFG3L2;BACE2;PSEN2
prerank,amyloid-beta metabolic process (GO:0050435),-0.37438829787079936,-0.9503605553848996,0.5305719921104537,0.8200970716224321,1.0,6/16,24.75%,ACE;IDE;BACE2;PSEN2;APEH;NCSTN
prerank,regulation of transport (GO:0051049),-0.31084049354261756,-0.9493074661293623,0.5,0.8219690743631433,1.0,8/36,16.03%,LEPR;NRP1;RAB11A;LRRK2;ACTG1;ACTB;REEP5;ARL6IP5
prerank,regulation of integrin activation (GO:0033623),0.4312207829386238,0.9492692422576315,0.49356223175965663,0.877385810469468,1.0,3/15,6.84%,JAM3;FERMT2;FBLIM1
prerank,regulation of mRNA metabolic process (GO:1903311),0.44873169958349723,0.9491518531314551,0.5180467091295117,0.8767708379819182,1.0,2/11,4.16%,PTCD2;SRPK3
prerank,regulation of chromatin binding (GO:0035561),-0.4294444813367436,-0.9487479758495092,0.5495495495495496,0.8226540718563983,1.0,2/10,8.84%,PARP9;DTX3L
prerank,protein localization to centrosome (GO:0071539),-0.37095852222332837,-0.9481464604641907,0.5491329479768786,0.8234022342019992,1.0,7/17,30.06%,GOLGB1;SNX10;CEP192;C2CD3;PIBF1;SPAG5;DCTN2
prerank,gas transport (GO:0015669),0.46427788081642535,0.9479519502842887,0.49473684210526314,0.87852672526005,1.0,1/10,3.54%,MB
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4051552370170425,-0.9477041003250911,0.5476635514018692,0.8238164555065627,1.0,7/13,37.09%,CAV1;RNF185;BCAP31;ATXN3;USP13;RNFT1;HERPUD1
prerank,Golgi organization (GO:0007030),0.3091905332954745,0.9476229906855589,0.5294117647058824,0.8783357575951665,1.0,31/112,17.74%,ARHGAP21;SYNE1;STX16;COG7;PDCD10;ATP8B2;COG1;CLASP2;VTI1A;ARFGEF1;HACE1;YWHAZ;BLZF1;TMED7;UBXN2B;TMED4;ARHGEF7;VPS51;GCC2;TRIP11;VTI1B;STK25;TJAP1;VMP1;RAB1A;PRKD1;HTT;CSNK1A1;GORASP1;GOLGA8B;GOLGA5
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.33760048706916873,0.9475940165189248,0.5256849315068494,0.8775543142189152,1.0,11/57,9.81%,MAP3K5;GPER1;NODAL;GRAMD4;CIDEB;CARD9;TTBK1;DDX3X;RIPK2;HTRA2;GRIN2B
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3537216429562857,0.9475712038219126,0.4910071942446043,0.8767648976484207,1.0,5/44,3.09%,CARMIL1;RGCC;PPM1E;FERMT2;LIMK1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3139869760875219,-0.9474202291892595,0.5776255707762558,0.8239051948976397,1.0,15/42,29.02%,SMARCA2;INO80;CHD3;ANP32E;HDAC1;ACTB;SMARCC1;ACTR8;SMARCAD1;MBD2;SMARCA4;RNF8;ACTR5;SMARCD2;SMARCA1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4432338484907129,0.9472765684886135,0.5170212765957447,0.876545185193188,1.0,1/12,1.09%,COLEC12
prerank,negative regulation of establishment of protein localization (GO:1904950),0.44924422967103994,0.9472581455633652,0.4957446808510638,0.8757496564688529,1.0,2/10,3.98%,NDFIP2;CORO2B
prerank,protein modification process (GO:0036211),-0.2750929357801402,-0.9471141675563183,0.5631868131868132,0.8240236962743289,1.0,24/76,24.89%,ST3GAL6;ST3GAL1;CPE;YES1;PHKA2;PLOD2;WWP2;SEPHS1;DUSP12;ST8SIA2;NEDD8;UBA3;FBXL2;MANBA;UBA7;RPN2;UBE2M;UBE2L6;PHEX;LCMT1;BAP1;AKT2;LOX;UBL4A
prerank,Rap protein signal transduction (GO:0032486),0.45681690529881863,0.9464151802699161,0.536036036036036,0.8766887265084876,1.0,2/10,6.91%,RAPGEF2;RAP1A
prerank,regulation of translation (GO:0006417),-0.24143959860606626,-0.9464035469277575,0.5892857142857143,0.8250630099764594,1.0,52/173,26.14%,DAPK1;SAMD4A;IGFBP5;FOXO3;APP;VIM;THBS1;LARP4B;NIBAN1;CNOT7;RNF139;CTIF;DDX6;RPS4X;IGF2BP2;UPF3A;ATXN2;EIF4G3;CPEB3;TCOF1;CALR;RPL26;LARP1;EIF4A2;CNOT8;RPL10;GEMIN5;FXR2;EIF5B;ELAVL1;EIF2B2;PAIP2B;EIF4E2;TYMS;ZCCHC4;EIF1B;NAT10;METTL5;PASK;EIF2AK3;RPS27L;MIF4GD;CSDE1;SAMD4B;MTRF1;RPS6KA3;EIF3B;RPS3;MTG1;RACK1;RPL13A;EIF2AK4
prerank,stem cell differentiation (GO:0048863),-0.31041342005532585,-0.9462477152788774,0.5278396436525612,0.8248128435248413,1.0,10/39,14.15%,OSR1;FGFR2;LRP6;MLLT3;ACE;KIT;JARID2;PUM1;SFRP1;PSMD11
prerank,rRNA transcription (GO:0009303),-0.3790955857004603,-0.9462003621141765,0.5365384615384615,0.8243099364511169,1.0,6/17,19.54%,CAVIN1;TCOF1;GTF3C2;GTF3C5;SIRT7;GTF3C1
prerank,response to glucose (GO:0009749),-0.2958959479740178,-0.9461766584430393,0.5102974828375286,0.8237447754782841,1.0,6/46,5.09%,UNC13B;THBS1;IGF1R;TCF7L2;SLC39A14;GAS6
prerank,genitalia development (GO:0048806),-0.4135397272373474,-0.9458442919977033,0.5610687022900763,0.8238850733702814,1.0,4/12,14.82%,CHD7;WNT5A;STRA6;PKD1
prerank,regulation of mRNA catabolic process (GO:0061013),-0.25128464218551,-0.9457121603429705,0.577922077922078,0.8235421770144457,1.0,37/121,24.71%,SAMD4A;VIM;CNOT7;MOV10;PRKCD;IGF2BP2;RC3H2;AKT1;ZC3H12A;PSME2;PUM1;PSMB4;UBB;CNOT8;PSMB1;PSMD11;PSMD8;FXR2;EXOSC5;PSME3;XRN1;ELAVL1;PNPT1;PSMD4;PSMA2;CSDC2;ZFP36L2;PSMD3;NUP214;PSMB7;PCBP4;TNFSF13;PSMC2;EXOSC7;SAMD4B;PSMC5;PSMD10
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3566575369741604,-0.9453969412477986,0.5585215605749486,0.8236518274526227,1.0,5/22,12.56%,SLC16A2;LRRK2;APPL2;GATA2;ID2
prerank,histone deacetylation (GO:0016575),-0.3055405524700716,-0.9453838271940254,0.5474137931034483,0.8230608630744854,1.0,14/43,21.43%,HDAC4;TBL1XR1;HDAC8;HDAC9;MIDEAS;RCOR3;PRDM5;HDAC1;HDAC5;SIRT7;SIRT2;SMARCAD1;MORF4L2;SIN3A
prerank,mitochondrion transport along microtubule (GO:0047497),-0.39697340121437563,-0.9453550215849298,0.5479204339963833,0.8225013366251712,1.0,3/13,13.00%,HIF1A;SPAST;UBB
prerank,regulation of cell cycle process (GO:0010564),-0.25712833238529736,-0.9449754372004977,0.5710227272727273,0.8227624244474595,1.0,34/104,28.48%,RAB11A;KIF13A;PLK2;CALM2;OBSL1;BECN1;FLCN;SH3GLB1;GIT1;UVRAG;CEP85;SFRP1;CAV2;DBF4;MYO19;CALM1;CCDC8;DYNC1H1;NUMA1;PLK4;CUL9;CETN2;CCP110;NUDT16;RMI2;BCL2L1;L3MBTL1;PLK5;KLHL21;CTNNB1;FSD1;SPAG5;MKI67;KLHL9
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.39981411933129374,0.9449023268296867,0.5009633911368016,0.8790337817825752,1.0,4/23,4.11%,MEF2C;NRG1;RBM24;AKAP6
prerank,DNA damage checkpoint signaling (GO:0000077),0.39028441194870694,0.9447936297167155,0.5124760076775432,0.878415675162088,1.0,5/28,14.26%,MAP3K20;RAD1;ATR;RAD17;ATRIP
prerank,regulation of blood coagulation (GO:0030193),0.3799632832176104,0.9446522925673577,0.48565965583174,0.8778467313628092,1.0,2/27,1.03%,FAP;VTN
prerank,positive regulation of multicellular organismal process (GO:0051240),0.2697115874241245,0.944239591928076,0.5822622107969152,0.877907994402211,1.0,26/308,6.25%,SOX5;PLA2R1;GLMN;PIK3CD;TBXA2R;GCNT2;SMTNL2;PER2;RGCC;NODAL;FERMT2;TRPV2;ROCK1;PTN;IL1B;NCOA3;G0S2;PPARGC1B;FGF2;EPAS1;CARD9;SYDE1;GRB10;OGT;IL4;SCAMP5
prerank,neuron apoptotic process (GO:0051402),0.41212913764246223,0.944024816442832,0.511578947368421,0.8775201999468484,1.0,3/19,6.90%,TNFRSF21;SCN2A;LIG4
prerank,cellular response to fluid shear stress (GO:0071498),0.42947378097986616,0.9440215319889558,0.5243128964059197,0.8766906148486765,1.0,3/12,9.03%,MEF2C;SREBF2;PKD2
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.34236880630428507,-0.944003820592495,0.5463320463320464,0.8244504808983179,1.0,5/22,13.40%,IL15;SLC7A5;IL18;TGFB1;SPHK1
prerank,cellular response to dsRNA (GO:0071359),0.41893167301623097,0.9430415795498984,0.5142857142857142,0.8779528162384711,1.0,1/15,1.09%,COLEC12
prerank,L-amino acid transport (GO:0015807),-0.33089002557087,-0.9430321178841964,0.5316973415132924,0.8261063574756241,1.0,10/28,22.10%,SLC1A3;SLC7A2;SLC7A5;SLC38A5;SLC3A2;SLC25A22;SLC7A1;ARL6IP5;SLC36A1;SLC1A1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3911500309787315,0.9429819187335143,0.512720156555773,0.8772471861689176,1.0,4/28,10.44%,MAP2;CLASP2;MAPRE2;CAMSAP3
prerank,lysosome organization (GO:0007040),-0.3137947699664089,-0.9428445815674001,0.5328947368421053,0.8259378352636169,1.0,13/36,27.23%,ABCA1;ARSB;LRRK2;ZKSCAN3;GAA;HPS4;TPP1;CLN6;CLN5;MBTPS1;TMEM165;ACP3;MYO7A
prerank,synaptic vesicle cycle (GO:0099504),0.3786020846461383,0.9427422864237401,0.5100401606425703,0.8769517962554214,1.0,10/30,18.25%,SNAP25;RIMS1;SNCA;SLC32A1;BRSK1;RAB5A;SYNDIG1;CDK5;VAMP2;CPLX1
prerank,positive regulation of cation channel activity (GO:2001259),-0.3032719938495422,-0.9426192580803109,0.5458422174840085,0.8258566212429794,1.0,11/40,18.45%,ACTN2;SHANK3;CALM2;TMSB4X;LRRC38;CTSS;EPHB2;GSTM2;CALM1;ADRB2;P2RY6
prerank,melanosome organization (GO:0032438),-0.33576406498752387,-0.9425499362722759,0.5355086372360844,0.8253819727885311,1.0,9/26,21.46%,SHROOM2;KIF13A;DTNBP1;AP3B1;BLOC1S6;RAB29;RAB32;HPS4;AP3D1
prerank,regulation of platelet aggregation (GO:0090330),0.4160947366738944,0.9423136357565393,0.4948665297741273,0.8770110078925615,1.0,2/17,3.58%,PRKG1;SH2B3
prerank,negative regulation of protein phosphorylation (GO:0001933),0.29544884568404417,0.9422918111858156,0.5369030390738061,0.8762241108431243,1.0,17/150,6.43%,PDE4D;PTEN;DMD;PID1;NCK2;PPM1E;NF1;SPRED1;PRR5L;CADM4;SPRY2;TRIB2;INPP5J;TESK1;DBNDD2;SNCA;CACTIN
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.39659016807003933,-0.9404632069135458,0.55893536121673,0.8296777972576155,1.0,8/13,35.05%,MDM2;SNAI1;PSMD10;CD44;TWIST1;PTTG1IP;KDM1A;CD74
prerank,regulation of cell size (GO:0008361),0.38983489077924854,0.9393675543103375,0.5088757396449705,0.8815945993398103,1.0,3/23,8.15%,PTEN;AKT1S1;MTOR
prerank,positive regulation of DNA metabolic process (GO:0051054),0.32524630808975785,0.9393309845936193,0.511437908496732,0.8808370947864481,1.0,9/61,10.14%,PDGFRB;RGCC;MECP2;FGF2;FGF10;EYA3;PRKD2;PDGFB;TOX
prerank,protein targeting to peroxisome (GO:0006625),0.36935323366422046,0.9391871592605153,0.5087040618955513,0.8802989184649725,1.0,9/29,15.58%,RAB8B;ABCD2;ATAD1;PEX7;PEX1;PEX3;PEX19;LONP2;PEX12
prerank,lipid homeostasis (GO:0055088),-0.2887843411043418,-0.9390579737935879,0.5496688741721855,0.8322957858919952,1.0,15/57,21.82%,ABCA1;RBP1;APOE;RCN3;TLCD2;ACOX1;USF1;ADCK1;ACOX3;PRKAA2;USF2;CLN8;ORMDL3;DGAT2;XBP1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4263172909779404,0.9386946598422264,0.47551020408163264,0.8804783460217651,1.0,2/13,6.03%,PID1;IL4
prerank,cellular zinc ion homeostasis (GO:0006882),0.3741579856028028,0.9385833706602996,0.5250501002004008,0.8798704444810431,1.0,1/26,0.46%,SLC30A10
prerank,programmed necrotic cell death (GO:0097300),-0.3659232379691371,-0.9384537117671939,0.5663157894736842,0.8331133337168956,1.0,10/18,38.60%,ITPK1;PGAM5;TICAM1;TLR4;RIPK1;DNM1L;LY96;PPIF;CD14;CYLD
prerank,regulation of vasculature development (GO:1901342),0.38141199372624013,0.9384271689113056,0.5126705653021443,0.8793465437950072,1.0,6/26,9.85%,NF1;ETS1;FGF2;TSPAN12;EMP2;EPHA2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3220772994304102,0.9382634396809758,0.5314091680814941,0.8788650192675739,1.0,16/78,15.98%,PTEN;RGCC;SPDYA;HEXIM1;CDKN1A;INCA1;PKD2;NR2F2;PDGFB;CCNYL1;LATS2;APC;CCNH;BLM;GTF2H1;CCNE1
prerank,homologous chromosome segregation (GO:0045143),0.40417676703730443,0.9379044899433475,0.5452631578947369,0.8787911295261858,1.0,5/20,12.97%,FMN2;MEI4;MEIOB;PTTG1;FANCD2
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2836808550516185,-0.9378075025694557,0.5639269406392694,0.833969225271973,1.0,20/54,31.36%,NSA2;SDAD1;RPL11;PAK1IP1;RPL24;RPL14;RPL26;RPL10;RPL7;RPL10A;EBNA1BP2;RPLP0;MRPL1;RPL35A;RRS1;NHP2;MAK16;RPF1;HEATR3;RPL23A
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.4148696937899423,0.9376399298111487,0.488659793814433,0.8784990329832113,1.0,3/15,7.20%,LDLRAP1;PPARD;IRS1
prerank,negative regulation of neuron projection development (GO:0010977),0.34313350636115,0.9373441059626976,0.5218855218855218,0.878276550311051,1.0,6/56,5.16%,PTEN;RTN4RL1;PTPN9;LINGO1;ADCY6;MYLIP
prerank,positive regulation of axon extension (GO:0045773),-0.34933048736423317,-0.9367053587340635,0.5546719681908548,0.8359260218389779,1.0,10/22,22.32%,NRP1;MACF1;SEMA7A;NTN1;RUFY3;MAP3K13;ZFYVE27;MEGF8;DBN1;VEGFA
prerank,response to insulin (GO:0032868),-0.2682265733089983,-0.936371709547342,0.5882352941176471,0.8361042439339171,1.0,17/80,13.65%,SORBS1;RHOQ;FOXO1;ENPP1;KAT2B;HDAC9;SLC39A14;SYAP1;CPEB2;AKT1;C2CD5;INSIG2;RAB8A;USF1;LPIN3;FER;HDAC5
prerank,homeostasis of number of cells (GO:0048872),0.42319551195130467,0.9360019271061016,0.49369747899159666,0.8802969476400302,1.0,2/12,4.99%,NOTCH1;CARD9
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3258582905076869,-0.9349171235300048,0.5662393162393162,0.8388949239664241,1.0,8/30,21.54%,CD34;LGALS9;PRKCZ;STAT3;PLCG2;TLR4;SYK;CD274
prerank,protein lipidation (GO:0006497),0.327930217550599,0.9348792261715411,0.5128205128205128,0.8818528665920616,1.0,13/59,14.23%,PIGU;ZDHHC14;PIGO;ZDHHC1;ZDHHC2;PIGZ;ZDHHC16;DPM3;ZDHHC17;ZDHHC21;ZDHHC23;HHAT;PIGH
prerank,regulation of rRNA processing (GO:2000232),-0.3732344284823028,-0.9348632365587792,0.550561797752809,0.8383940350304288,1.0,6/16,24.10%,KAT2B;SIRT7;USP36;RIOK2;NUDT16;TRMT112
prerank,fatty acid catabolic process (GO:0009062),0.32296288018977437,0.9347729243650873,0.5180921052631579,0.8812566395057212,1.0,8/67,8.24%,CEL;ABCD2;SLC27A2;PPARD;HADHB;SLC27A4;ABHD3;ECI1
prerank,photoperiodism (GO:0009648),0.378278121450604,0.9347246383710416,0.5,0.8805297953464422,1.0,4/28,8.11%,PER2;CRTC1;SIK1;PPP1CC
prerank,tetrahydrofolate metabolic process (GO:0046653),0.44676296750257694,0.9345571083562033,0.5201793721973094,0.8800558019398752,1.0,2/10,7.43%,DHFR;MTHFD2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.317073253800789,0.934539881313448,0.529505582137161,0.8792711426029989,1.0,3/85,1.30%,GRM7;COL4A3;ROR1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3987940501215286,-0.9340811276674686,0.5443037974683544,0.8389468858564609,1.0,1/12,0.24%,IGF1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3987940501215286,-0.9340811276674686,0.5443037974683544,0.8389468858564609,1.0,1/12,0.24%,IGF1
prerank,protein localization to cell junction (GO:1902414),0.3995064667938187,0.9338876574198286,0.5102040816326531,0.8798785900928834,1.0,6/22,15.16%,JAM3;FERMT2;JAK1;KIF3A;NPHS1;CGNL1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.4098758113475066,-0.93365568685549,0.5586080586080586,0.8393190133337218,1.0,7/11,43.78%,TAF9B;CD44;KDM1A;CD74;MUC1;TAF9;MIF
prerank,phospholipid biosynthetic process (GO:0008654),-0.3067734637286551,-0.9336193106068871,0.5488069414316703,0.8387774576026943,1.0,3/36,2.90%,SGMS1;AGPAT4;SGMS2
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4022108821384095,-0.9335817427050979,0.5542635658914729,0.8382417293963471,1.0,7/13,29.65%,SUFU;MDFI;PKD1;NFKBIA;DBN1;NFKBIE;KEAP1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.35425882016034543,-0.9333369212666641,0.58298755186722,0.8381254934896175,1.0,8/20,16.62%,SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E;SEMA3B;SEMA3G;SEMA6B
prerank,regulation of axon guidance (GO:1902667),-0.4220576201757439,-0.9333113510920087,0.5563636363636364,0.8375760198137518,1.0,2/10,11.43%,NRP1;ZSWIM6
prerank,JNK cascade (GO:0007254),0.3612511740934633,0.933237358157637,0.5303571428571429,0.8803812450951283,1.0,5/40,9.85%,MAP3K5;ARHGEF6;MINK1;RIPK2;MAPK10
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.3137540552292662,-0.9330158420708209,0.5613305613305614,0.8376056508433695,1.0,7/32,14.12%,FOXO3;APP;PRKCD;ATXN2;TCOF1;RPL10;GEMIN5
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3502613521817812,-0.9328526100719704,0.5467479674796748,0.8373642382248976,1.0,3/20,5.48%,SULF1;THBS1;SULF2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2985371945663413,0.9324237573509154,0.5555555555555556,0.8812328949811595,1.0,17/117,11.98%,GGT5;GGT1;PER2;SLC16A3;ACSF2;PPARD;BAAT;ACOT12;SLC27A4;AOAH;HLCS;MCCC1;ACOT2;NPC1;PDHX;GLYAT;GATM
prerank,peptidyl-serine modification (GO:0018209),0.28464660958718285,0.9322784028799258,0.5626740947075209,0.8807120621854745,1.0,30/166,11.27%,MAST4;PKN1;MARK1;ROCK1;AKT3;RPS6KA4;STK39;STK38L;RPS6KB2;CSNK1G1;RPS6KA2;TNKS;TTBK1;MBOAT4;GALNT13;GALNT1;MTOR;MARK2;PRKD2;NAA11;PDGFB;CSNK1E;MAP4K1;NEK6;ATR;DYRK3;BRSK1;HIPK1;LATS2;PRKX
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.26931589965158453,-0.9310544430412907,0.5829268292682926,0.8409018545902763,1.0,15/72,13.17%,CDH5;APOE;LIMA1;SLIT2;SHANK3;ARHGEF2;KANK3;HDGFL3;IAPP;PFDN5;PRKCD;EMILIN1;EML2;PFN1;TWF1
prerank,positive regulation of cell development (GO:0010720),0.37086521394443356,0.931046127700059,0.5159474671669794,0.8824387708137789,1.0,2/31,1.63%,PDE3A;GPER1
prerank,hyaluronan metabolic process (GO:0030212),0.3830854830476781,0.9306447619667549,0.5104364326375711,0.8824816115339674,1.0,4/23,4.25%,CEMIP2;IL1B;HYAL4;FGF2
prerank,regulation of protein catabolic process (GO:0042176),-0.25576408823445773,-0.9305900334470278,0.5840220385674931,0.8413602336371291,1.0,29/99,20.02%,EGFR;FOXO1;SMURF2;NKD1;WWP2;SMURF1;WNT5A;PLK2;EGLN2;HGS;EEF1A1;IRAK3;GFAP;IDE;DAB2IP;PRKCG;RAB7A;ASB5;MDM2;DDB1;WWP1;CDKN1B;SIRT2;ODC1;OAZ1;FZR1;VCP;VPS28;SNX3
prerank,Golgi to lysosome transport (GO:0090160),0.4323676419220335,0.9302860815862315,0.508695652173913,0.8823987320922313,1.0,4/11,12.86%,SORT1;AP1G1;EHD3;ANKFY1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.22794130827281714,-0.9299848905245973,0.7307692307692307,0.8421107896952116,1.0,53/208,19.80%,AKAP13;LPAR1;ESR1;GJA1;MAP3K14;NOD1;CFLAR;TNFSF10;ZFAND6;LGALS9;WNT5A;IKBKE;RHOA;PRKCB;PLK2;STAT1;FKBP1A;TFRC;BIRC3;EEF1D;TNFRSF19;ECM1;TNFRSF1A;TLE1;CASP8;DAB2IP;ZC3H12A;TRIM27;MAVS;OPTN;PLEKHG5;RELA;TRIM39;PLCG2;TICAM1;VAPA;PPM1B;PELI1;TRIM8;RIPK1;TRAF3IP2;MAP3K3;PDPK1;CC2D1A;RHOH;TRIM14;LAMTOR5;CANT1;PIM2;EDA2R;LGALS1;IKBKG;RHOC
prerank,transcription by RNA polymerase II (GO:0006366),0.2670571268797068,0.9297328822898613,0.6,0.8827125285630938,1.0,50/305,16.46%,NOTCH3;SOX5;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2;PPARD;CLP1;ESRRA;NCBP2;LSM10;PAPOLA;NR2C1;DEK;POLR2C;PCID2;MED1;RNMT;PAX5;TBP;TAF6;MAML3;SYMPK;MED20;RPRD1B;DRAP1;THRA;CTR9;TRIP11;EAF2;PHAX;INTS1;GTF2H5;INTS12;TRIP13;CCNH;MED4;SNAPC2;RORC;MAML1;RXRB;GTF2H1;TAF5L;PARP1;GTF2E1;NFX1;HDAC10
prerank,protein mono-ADP-ribosylation (GO:0140289),0.4387831712842627,0.9295060614248648,0.5310344827586206,0.8823613336079488,1.0,1/11,0.90%,PARP8
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3201146145019338,-0.9294782934254546,0.5692640692640693,0.8426183028370346,1.0,6/29,12.46%,TGFBR3;FGFR2;SMAD7;FKBP1A;TGFB1;S1PR1
prerank,protein kinase A signaling (GO:0010737),-0.38794283662196577,-0.9294069679741482,0.5695732838589982,0.8421788388791603,1.0,8/12,41.91%,EZR;PRKACB;LCP1;RDX;PRKACA;RAB13;TCP11X2;TCP11
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4098367486598922,0.9293029100823547,0.5383064516129032,0.8819676437165087,1.0,2/15,4.23%,NR1H3;PPARD
prerank,regulation of mRNA polyadenylation (GO:1900363),0.40602743601776303,0.9290798646956315,0.5269461077844312,0.8816003816716687,1.0,6/17,18.90%,CPEB1;NCBP2;CPSF6;CTR9;HSF1;CPSF7
prerank,glial cell development (GO:0021782),0.3844946390911538,0.929068356301693,0.5298804780876494,0.8808064465273748,1.0,4/25,6.56%,CDK6;NF1;TPPP;SOX4
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3759959973442236,0.9290196943454613,0.5234521575984991,0.8801016886755821,1.0,3/28,7.64%,SH3KBP1;TNIP2;FGF10
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.41740844118794623,-0.9284763803080615,0.5910714285714286,0.843694160276154,1.0,7/10,35.09%,AKT1;TICAM1;TLR4;MYD88;TREM2;CD36;TLR6
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4137260144339539,0.9281850036965988,0.5572354211663066,0.8810623263234962,1.0,2/18,9.11%,BCAR1;LYN
prerank,response to prostaglandin E (GO:0034695),0.45523950602318275,0.9278694799733971,0.5431034482758621,0.8809458554980598,1.0,2/10,3.95%,GNG2;ADCY6
prerank,hydrogen peroxide catabolic process (GO:0042744),0.43354240312123554,0.9277792695790186,0.5150214592274678,0.8803229588137438,1.0,2/11,7.33%,PXDN;GPX3
prerank,negative regulation of platelet activation (GO:0010544),-0.37314592722457623,-0.9271293659091004,0.5862745098039216,0.8462142696206769,1.0,6/16,8.03%,PDGFRA;APOE;NOS3;THBD;CD9;PRKCD
prerank,T cell activation involved in immune response (GO:0002286),-0.4001603762677098,-0.927015396507806,0.5419847328244275,0.845875073673598,1.0,4/12,26.14%,ICAM1;MDK;LCP1;EIF2AK4
prerank,regulation of intracellular protein transport (GO:0033157),-0.3202566490340098,-0.9270104631760091,0.5543933054393305,0.8452589028071635,1.0,16/32,28.78%,PTPN14;BMP4;NDEL1;IFI27;TGFB1;RUFY3;SIRT7;TPR;OAZ1;RAB29;LCP1;RIPOR1;ICE1;ZFAND1;B3GAT3;ATP13A2
prerank,smoothened signaling pathway (GO:0007224),-0.31439534813888215,-0.9268482543789575,0.5413043478260869,0.8449912678142096,1.0,9/32,22.44%,GLI2;SMO;GLI3;PTCH1;HIPK2;EVC2;STK36;GLI1;TMEM17
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.3828189361570127,-0.9267445377421847,0.5736137667304015,0.8445826002625124,1.0,8/15,25.85%,TCF7L2;GAS6;ANP32B;BAG3;TPR;YWHAE;XPO4;TP53
prerank,dicarboxylic acid metabolic process (GO:0043648),0.33172790885383796,0.926661882557523,0.5531135531135531,0.8817695980515721,1.0,6/52,9.22%,GGT1;SLC19A1;DHFR;MTHFD2;GOT1;SDHAF3
prerank,angiogenesis involved in wound healing (GO:0060055),-0.40935296654677056,-0.9262849151173688,0.5781544256120528,0.8449588416997662,1.0,7/11,11.21%,ADIPOR2;CD34;NDNF;PRCP;KDR;GATA2;ITGB3
prerank,protein-containing complex disassembly (GO:0032984),-0.2790187254154168,-0.9261835957210144,0.6161137440758294,0.8445689698592169,1.0,11/54,21.45%,LAMP2;CAV1;LRP6;FZD2;WIPI2;UVRAG;RPL23;GABARAPL1;FZD1;VCP;VAMP8
prerank,positive regulation of protein deacetylation (GO:0090312),-0.38255159227252306,-0.9255436129756203,0.5504587155963303,0.8453944198031663,1.0,4/14,23.38%,SAP30BP;FNTA;NNMT;CTBP1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2548107089173409,-0.9255073272864413,0.5956284153005464,0.8448563686470475,1.0,15/98,10.09%,SORBS1;EPHA3;EGFR;PPP1R13B;PRKCH;CEMIP;DLG1;TFDP2;ITGA3;PRKCE;STX3;AKT1;KCNB1;C2CD5;CASP8
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.38980709622251014,0.9254123208642652,0.5261044176706827,0.8836262108527361,1.0,5/21,7.70%,KCNE4;CACNA2D1;SCN5A;CACNA1D;KCNE5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.40161727567725913,-0.9249259835523741,0.5799256505576208,0.8455477240207655,1.0,5/12,22.09%,WNK1;AKT1;PPARA;MDK;ASS1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3123477504898456,-0.9248210442130668,0.5698924731182796,0.8451495088331578,1.0,9/31,24.96%,CNOT7;EDC3;DDX6;CNOT8;EXOSC5;LSM5;EXOSC7;POLR2G;LSM7
prerank,peptidyl-serine phosphorylation (GO:0018105),0.28310906101566014,0.9247574399649099,0.5682758620689655,0.8841455345684575,1.0,31/153,13.45%,MAST4;PKN1;MARK1;ROCK1;AKT3;RPS6KA4;STK39;STK38L;RPS6KB2;CSNK1G1;RPS6KA2;TNKS;TTBK1;PIKFYVE;MTOR;MARK2;PRKD2;PDGFB;CSNK1E;MAP4K1;NEK6;ATR;DYRK3;BRSK1;HIPK1;LATS2;PRKX;NLK;PRKDC;RPS6KA6;MKNK1
prerank,cilium organization (GO:0044782),0.27908390846684145,0.9245804412711971,0.5805084745762712,0.8837069627520513,1.0,22/209,11.23%,DYNLL1;NOTCH1;DZIP1L;IFT43;RILPL2;RAB8B;TTLL3;CYS1;TTC36;IFT81;CCDC57;IFT20;NEK1;SCLT1;FAM161A;EHD3;PKD2;CDC14B;KIF3A;CEP41;AHI1;CCDC66
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.28083102946825955,0.9236334850969052,0.6008344923504868,0.884856883811059,1.0,29/184,16.52%,DYNLL1;HECW2;RGCC;BTRC;CUL3;PSMB11;PRKAR2B;APPL1;PSMF1;UBE2E1;CSNK1E;DYNC1I2;CDC14B;NEK6;CEP41;PSME4;TUBB4A;ANAPC2;DCTN1;ANAPC7;SKP1;DCTN3;MAD2L1;CEP76;KCNH5;XPC;PSMB5;CEP135;NDE1
prerank,smooth muscle tissue development (GO:0048745),0.447630941992724,0.9235691256421568,0.5411255411255411,0.8841747442058576,1.0,2/10,2.17%,MYLK;NF1
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.24085462494140045,-0.9235605279755507,0.6412698412698413,0.8473445485307702,1.0,57/144,28.13%,SMAD3;PPP1R13B;CEMIP;NPEPPS;TCF7L2;TFDP2;CDH1;GAS6;PRKCD;ANP32B;BAG3;KCNB1;C2CD5;CASP8;SEC16B;ZC3H12A;MAVS;TGFB1;SH3GLB1;TOMM7;SAE1;RAN;TMEM30A;PPP3CC;TM9SF4;RUFY3;LEPROT;BID;TPR;OAZ1;SAR1A;RAB29;BBC3;HPS4;CHP1;SAR1B;E2F1;CD81;YWHAH;USP36;BAP1;RIPOR1;ICE1;AKT2;ITGB2;YWHAE;XPO4;ZFAND1;AKAP5;TP53;B3GAT3;SFN;ITGAM;FZD5;HCLS1;SEC16A;TFDP1
prerank,cellular response to ionizing radiation (GO:0071479),0.3463775115898598,0.9233182234957352,0.5166374781085814,0.8838824656653992,1.0,13/47,17.89%,MAP3K20;TNKS1BP1;LIG4;HRAS;CDKN1A;RAD1;ATR;TANK;NIPBL;BLM;HSF1;RHNO1;TLK2
prerank,regulation of vacuole organization (GO:0044088),0.3954779758790766,0.9230118342387275,0.5292887029288703,0.8837152260534444,1.0,9/20,18.63%,IFT20;TBC1D12;PIKFYVE;NPRL3;NPRL2;UBQLN2;RAB5A;RAB1B;ENO2
prerank,cilium assembly (GO:0060271),0.26635274531369857,0.922512895845959,0.5971316818774446,0.8839370103041285,1.0,54/296,17.76%,DYNLL1;NOTCH1;DZIP1L;IFT43;RILPL2;RSPH6A;RAB8B;TTLL3;CYS1;JHY;TTC36;IFT81;CCDC57;GAS8;IFT20;NEK1;PRKAR2B;SCLT1;RSPH1;LRGUK;CFAP46;FAM161A;EHD3;CSNK1E;DYNC1I2;CDC14B;KIF3A;CEP41;AHI1;IFT57;NPHP4;CCDC66;CFAP20;KIF3C;CEP97;FUZ;TUBB4A;TRIP11;TCTN3;DCTN1;CEP126;IFT80;DCTN3;MAK;CEP76;CEP19;CEP135;RAB1A;NDE1;TNPO1;TRAF3IP1;CEP162;TTC8;PTPDC1
prerank,regulation of actin nucleation (GO:0051125),-0.4002395849520181,-0.9218879269696277,0.5827205882352942,0.8503618552563104,1.0,5/12,26.47%,GSN;ARFIP2;ARFIP1;ARPIN;PICK1
prerank,establishment of endothelial barrier (GO:0061028),0.3693039506316544,0.9215491276874155,0.5329457364341085,0.8850822831066177,1.0,2/29,1.01%,PDE4D;RAPGEF2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.41466072546245175,-0.9211623969877697,0.5824175824175825,0.8513503084716931,1.0,4/10,27.50%,HK2;GFPT2;GFPT1;HK1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.31855009865537065,-0.9209651397082207,0.5595744680851064,0.8511608220356537,1.0,8/29,24.96%,CNOT7;EDC3;DDX6;CNOT8;EXOSC5;LSM5;EXOSC7;LSM7
prerank,positive regulation of bone resorption (GO:0045780),-0.4073939530026668,-0.9202578017581651,0.572463768115942,0.8521029387977728,1.0,8/11,40.75%,TNFRSF11A;SPP1;SYK;ATP6AP1;PRKCA;DEF8;MC4R;ADAM8
prerank,folic acid metabolic process (GO:0046655),0.39437726298195974,0.9202508091379201,0.5324947589098532,0.8869875932022601,1.0,3/18,7.43%,SLC19A1;DHFR;MTHFD2
prerank,positive regulation of immune system process (GO:0002684),0.39892139375179053,0.9201908632261719,0.5219298245614035,0.8862974505000212,1.0,1/16,0.77%,PIK3CD
prerank,plasma membrane organization (GO:0007009),-0.2807366547218016,-0.9199254461712316,0.5889423076923077,0.8522533933175027,1.0,19/61,18.44%,MYOF;COL5A1;SNX9;CAVIN2;FNBP1L;PLSCR2;A4GALT;ANO6;TLCD2;PLSCR4;CHMP4A;P2RX7;UGCG;EHD2;AHNAK2;PLSCR3;SYTL4;MICALL1;STX2
prerank,protein modification by small protein removal (GO:0070646),-0.22233938563067002,-0.9198262920655378,0.7291666666666666,0.8518539481707952,1.0,79/252,26.95%,SMAD3;ESR1;SMURF2;USP47;TGFBR1;KAT2B;SMAD7;USP46;AR;USP12;INO80;RHOA;USP8;BIRC3;USP15;TRRAP;USP18;HGS;IL33;HIF1A;FOXK1;BECN1;USP34;ZC3H12A;USP35;USP11;USP5;PSME2;SENP3;MDM2;COPS4;USP49;PSMB4;UBB;COPS8;INO80D;ACTB;PSMB1;PSMD11;NEDD8;PSMD8;PSME3;RIPK1;ACTR8;NFKBIA;ADRB2;PSMD4;STAMBP;PSMA2;BABAM2;VCP;TAF9B;IKBKG;USP22;SNX3;PSMD3;USP36;PSMB7;BABAM1;CCP110;BAP1;USP2;PSMC2;BRCA1;USP10;PSMC5;PSMD10;COPS7A;SUDS3;ACTR5;PRKN;ABRAXAS2;TP53;CDC25A;SMAD4;SENP8;INO80E;COPS2;ATXN3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.43682830600452,0.9197291522302771,0.5434782608695652,0.8856207007802704,1.0,2/11,4.10%,IL2RA;JAK1
prerank,cellular response to interleukin-2 (GO:0071352),0.43682830600452,0.9197291522302771,0.5434782608695652,0.8856207007802704,1.0,2/11,4.10%,IL2RA;JAK1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.4039140292835532,-0.9197068254974923,0.5846422338568935,0.8514968357827236,1.0,8/11,37.68%,PPHLN1;TPR;SETDB1;MPHOSPH8;DNMT1;SIRT6;SETDB2;TRIM28
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.305519110616618,-0.9196674062285699,0.611353711790393,0.8509561962409743,1.0,9/36,8.24%,PLCB1;TCF7L2;NFATC1;LEF1;FZD2;MOV10;WNT5A;PLCB3;FZD4
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.41186550519694115,-0.9196331642328669,0.5932835820895522,0.850413076933978,1.0,6/10,35.16%,HDAC5;PIH1D1;BRCA1;SMAD4;SPHK2;CHEK1
prerank,mammary gland development (GO:0030879),-0.34775768333294166,-0.9195503156283608,0.573469387755102,0.84996794999953,1.0,3/21,2.43%,WNT4;GLI2;CAV1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.37630386031556806,0.9194677845147582,0.5099601593625498,0.8853292341340334,1.0,7/23,18.38%,METAP2;GUCY2D;PDE6A;GRK4;GUCY2F;SAG;METAP1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3844403834670863,0.9193572060684633,0.5221774193548387,0.8847431255558453,1.0,9/22,17.44%,AKAP6;RYR2;STAC;PKD2;CASQ1;ANK2;VMP1;HTT;HAP1
prerank,regulation of cellular component organization (GO:0051128),0.29012096568157286,0.9189222128191491,0.5921450151057401,0.8848104445622826,1.0,28/135,14.56%,PLCE1;RAPGEF2;RASGRP2;BCAR1;ROCK1;STK38L;NRG3;RIT2;ROS1;RAP1A;MTOR;AP2S1;PAK5;ALKBH4;ERMN;HIP1;NCLN;CAMSAP3;ABL2;SPOCK1;PACSIN3;SLITRK2;PTPN1;HNRNPU;TRAF2;URI1;RAB5A;ANKRA2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.28118249590759814,0.9184070651864807,0.5852272727272727,0.8850724421656777,1.0,24/159,8.63%,ADGRL3;CDH2;CDH4;CLDN10;CLDN15;PCDHB11;LRRC4C;ATP2C1;LRFN5;IGSF11;CNTN4;ITGB1;CDH8;CDH22;CRB1;CDH19;CDH7;CDH20;CNTN6;PTPRT;ROBO2;TENM4;IL1RAPL1;SLITRK1
prerank,negative regulation of cell division (GO:0051782),-0.4003176453539403,-0.9183000668513494,0.580896686159844,0.8521541067019276,1.0,2/11,8.52%,TXNIP;ZFYVE19
prerank,glial cell differentiation (GO:0010001),-0.3264582151459805,-0.918135204670383,0.5893909626719057,0.8519171562961495,1.0,4/28,7.33%,NFIB;ADGRG6;SLC8A3;STAT3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4375572276237405,0.9175790390050802,0.5440528634361234,0.885960816697293,1.0,2/11,3.80%,MERTK;AXL
prerank,receptor metabolic process (GO:0043112),-0.27879230436054214,-0.9175427181474137,0.6013667425968109,0.8526300467737762,1.0,17/53,19.93%,CAV1;CALCRL;RAMP2;CD9;DNM3;SMURF1;TFRC;BECN1;TGFB1;SH3GLB1;GRK2;UVRAG;PHETA1;ARFGEF2;REP15;CD81;SYK
prerank,actomyosin structure organization (GO:0031032),0.31840596367387797,0.9175308570515532,0.5646687697160884,0.8852401461041112,1.0,17/75,11.08%,TNFAIP1;EPB41L2;MYH9;ROCK1;CUL3;EPB41;ITGB5;CDC42BPA;TMOD1;PDCD10;TMOD3;ITGB1;PDLIM1;KCTD13;ALKBH4;LMOD1;CASQ1
prerank,negative regulation of B cell activation (GO:0050869),0.3915630832403957,0.9173780129119169,0.5313131313131313,0.8847320505856668,1.0,3/21,9.11%,TNFRSF21;CD300A;LYN
prerank,regulation of cell junction assembly (GO:1901888),0.37505148281117295,0.9171276305267445,0.5603112840466926,0.8844416146774822,1.0,3/27,2.15%,MEF2C;RAPGEF2;ROCK1
prerank,zinc ion homeostasis (GO:0055069),0.3623062853077187,0.9170783494816946,0.5540275049115914,0.8837630536634978,1.0,1/28,0.46%,SLC30A10
prerank,regulation of viral entry into host cell (GO:0046596),0.3611143515544203,0.9169180804609887,0.5326923076923077,0.8833359726034974,1.0,4/30,8.52%,TMPRSS4;MID2;TRIM62;TMPRSS2
prerank,cellular response to UV (GO:0034644),0.3167535993084657,0.9168112190724081,0.5657686212361331,0.8827386738665898,1.0,20/76,21.77%,PTPRK;CASP9;CDKN1A;ERCC4;ATR;EP300;OPN3;DHX36;PARP1;XPC;IMPACT;FMR1;RHNO1;MMP1;SDE2;DDB2;CREBBP;HYAL1;EIF2S1;CERS1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.41293572356268105,-0.9167831353452186,0.5992647058823529,0.8537385243546389,1.0,4/10,22.10%,SLC1A3;SLC25A22;ARL6IP5;SLC1A1
prerank,mitochondrion localization (GO:0051646),0.3909301882625299,0.9163825991591272,0.5329218106995884,0.8828282041759545,1.0,6/19,17.44%,MARK1;MARK2;TRAK1;TRAK2;MFN1;HAP1
prerank,regulation of microtubule depolymerization (GO:0031114),0.3747895916181139,0.9162642902181494,0.5369261477045908,0.8822831586879352,1.0,7/25,13.12%,SPEF1;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3408562209315869,0.9160637414621874,0.5682210708117443,0.8818838802231814,1.0,11/49,12.88%,MEF2C;MYL9;AGO3;KMT2B;CNOT4;PRMT1;TNRC6C;EIF6;EP300;RBM15;TNRC6B
prerank,positive regulation of cartilage development (GO:0061036),0.3956935858315383,0.9159601514464579,0.5268389662027833,0.8812988729055954,1.0,1/17,0.56%,SOX5
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.3584655843029601,-0.915369292769442,0.5875251509054326,0.8562736653090967,1.0,3/17,3.26%,OSR1;CAV1;MAFG
prerank,protein ubiquitination (GO:0016567),-0.20621905995041603,-0.9152875362880167,0.8389261744966443,0.8558189010188282,1.0,113/471,21.98%,RNF220;FBXL7;PDZRN3;SH3RF1;RNF213;SASH1;HERC6;NPEPPS;SMURF2;FBXO10;RNF38;RNF146;ZNRF1;ASB2;TAF1;RNF43;TRIM24;SPSB1;RNF19A;ARRB1;TNKS2;WWP2;RNF144B;HIF3A;RNF139;SMURF1;CDC16;KLHL2;SH3RF3;SH3RF2;RNF103;AMFR;UBE2E2;LNPEP;RTF1;RC3H2;NHLRC3;CHFR;MKRN2;RNF185;DTX3L;HIF1A;KCTD10;RNF135;MGRN1;ZNRF3;ARRDC1;TRIM27;USP5;PSME2;UBE4B;CUL4A;ASB5;RNF125;MDM2;TRIM63;PSMB4;UBE2Q2;FBXW11;TRIM35;BRAP;UBB;RNF181;TRIM39;ELOB;UBE2G2;PSMB1;PSMD11;NEDD8;DDB1;PSMD8;DTX1;TRIM17;RNF115;WWP1;FBXL14;ANKIB1;FBXL2;PSME3;RNF187;ASB1;RNF40;PELI1;UBE3D;FBXL19;SPSB4;SPSB2;ANAPC16;ARRDC4;PSMD4;LONRF1;TRIM14;TRIM47;PSMA2;TRIM41;FBXO41;VCP;USP22;RNF217;PSMD3;CDC27;RNF144A;UBE2L6;RMND5A;RNF126;PSMB7;GAN;ELOC;CUL5;RBBP6;RNF182;CUL9;DZIP3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.35252945509358524,-0.9139312228492076,0.5596868884540117,0.8582391412607387,1.0,4/19,10.62%,PTPRJ;VCAM1;ADGRL1;KDR
prerank,negative regulation of microtubule polymerization (GO:0031115),0.44155068660639807,0.9138602583367823,0.5287610619469026,0.8847560453745368,1.0,4/12,12.86%,MAP2;SNCA;ARHGEF7;TUBB4A
prerank,histone H3 deacetylation (GO:0070932),-0.38223012099524395,-0.91350201420843,0.5799256505576208,0.8585826782538514,1.0,7/15,19.29%,HDAC4;HDAC8;HDAC9;HDAC1;SIRT7;SIRT2;SMARCAD1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3894882935226598,-0.9132615811513339,0.6149425287356322,0.8585078090984977,1.0,7/13,24.27%,ABCA1;CD9;CDH13;CD81;SYK;LPL;ITGB2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3706416041719616,-0.9129501274507708,0.5942307692307692,0.8585684660174695,1.0,5/16,19.90%,TMEM50A;CHMP4B;CHMP4A;LEPROT;VPS28
prerank,regulation of isotype switching (GO:0045191),-0.37439203038728813,-0.9127831177951476,0.5930018416206262,0.8583178812465861,1.0,4/14,14.40%,TFRC;PARP3;SHLD1;KMT5C
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2610958010220573,-0.912752248616485,0.6388888888888888,0.8577696857814314,1.0,13/76,13.40%,HDAC4;CAV1;ANGPT1;LRRK2;SMAD7;FKBP1A;BIRC3;ZC3H12A;PHF23;FANCI;SAE1;UBB;SPHK1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.41530179721503874,-0.9124252751401991,0.583941605839416,0.8578898109366353,1.0,3/10,10.10%,KLF4;MAP2K5;IRAK3
prerank,heterochromatin assembly (GO:0031507),-0.35206531679177944,-0.9123012250350744,0.5784114052953157,0.857544851972864,1.0,7/20,22.14%,H3-3A;HDAC1;EZH1;BEND3;SIRT2;RRP8;MBD2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.4085438801594954,0.9122215244153457,0.5179704016913319,0.8872772593364108,1.0,2/16,6.03%,PID1;IL4
prerank,regulation of embryonic development (GO:0045995),-0.30284963547921745,-0.9120403874222838,0.5813953488372093,0.8575219577381564,1.0,7/34,13.79%,PLCB1;NIBAN2;NR2C2;EHMT1;POGLUT1;TDG;SOX17
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.41077916784945334,0.9119181658204941,0.5341614906832298,0.8870777133518362,1.0,4/15,9.33%,DAAM2;SPEF1;GPC3;CSNK1E
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.25135989966326894,0.9117793032621192,0.6731875719217492,0.8865686266227174,1.0,81/497,14.21%,PTPRK;KCTD1;TBX2;LIMD1;LIMS1;HEY2;RORB;CBFA2T3;HEYL;ZEB1;DPF3;NOTCH1;TBX20;PER2;LBH;BTRC;TBX3;FOXM1;NRG1;NR1D2;NAB1;CBX5;PHC3;PHC2;MECP2;PPARD;DHFR;PHC1;HEXIM1;TFAP2B;IL4;ARID5A;DDX3X;SFPQ;CBX3;KAT7;CDKN1A;NANOS1;TRIM33;MYB;NR2F2;RUNX2;CCAR2;PDGFB;MTERF3;CNOT9;TIMELESS;PSPC1;ATR;EID1;RLIM;CITED2;NKX6-2;MALSU1;WAPL;KAT6A;SFMBT2;LOXL3;SAMD13;RB1;RBM15;SPEN;BCLAF1;RCOR1;FOXS1;THRA;SET;TRAF6;CRY1;CDAN1;TSC22D4;DMAP1;CNOT10;PAIP2;LSM14A;NIPBL;SFRP2;CIART;SIX4;PUS7;RAD17
prerank,positive regulation of transmembrane transport (GO:0034764),-0.38332026582495604,-0.9117011318593295,0.5926605504587156,0.8576411942448401,1.0,5/13,22.45%,ANO6;C2CD5;P2RX7;AZIN1;NR4A3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.3370756103184784,-0.9113352349864254,0.5846774193548387,0.8578925725777423,1.0,2/20,1.64%,DAB2;RHOQ
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.29631427308127917,0.9111808331503833,0.5809379727685325,0.8869869129738178,1.0,17/100,10.68%,GLMN;CBFA2T3;PABIR1;RBX1;RYBP;SOCS5;OGT;TRIB2;DESI1;RCHY1;ZER1;GNA12;CCAR2;DET1;CSNK1E;NKD2;XPO1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.37661960260550753,-0.9109850246942927,0.6166328600405679,0.8580613552779436,1.0,8/14,39.05%,HSPA5;BCL2L11;DAB2IP;TMEM33;BFAR;FICD;BAX;UFL1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.28338408363002116,-0.9108332323377593,0.6226415094339622,0.8577916324824472,1.0,5/49,7.42%,LDLRAD4;SMAD6;IAPP;PRKCZ;HSPA5
prerank,cellular response to radiation (GO:0071478),0.35104986995303195,0.9107957394206366,0.5529197080291971,0.8869975882233188,1.0,10/40,14.32%,TNKS1BP1;OPN1MW;OPN1MW3;LIG4;CDKN1A;RAD1;RRH;OPN3;TANK;BLM
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.37071975738376883,-0.9102468896122115,0.5857418111753372,0.8585157294122284,1.0,8/15,30.32%,CNOT7;CPEB3;TNRC6A;TENT4B;POLR2G;EIF4ENIF1;AGO2;ZFP36
prerank,regulation of kinase activity (GO:0043549),0.30126770227396993,0.909794142598488,0.5884244372990354,0.8882421203329562,1.0,19/89,13.28%,PDGFRB;PLCE1;ROR1;MERTK;ERBB4;AXL;RYK;ROS1;NTRK2;EMP2;ANKRD54;EPHA2;EPHA10;RBL1;RB1;EPHB1;FGFR3;NPRL2;HNRNPU
prerank,fat cell differentiation (GO:0045444),-0.28264290737489406,-0.9097925799500377,0.6090047393364929,0.8588976894399395,1.0,13/57,13.23%,SMAD6;OSBPL8;FOXO1;KLF4;TCF7L2;PRDM16;ERAP1;C1QTNF3;BBS7;NR4A2;METRNL;WNT5B;TMEM120B
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.37901504280785864,-0.9094753130608387,0.5925925925925926,0.8589768368063765,1.0,4/14,25.84%,GAS6;PTPN2;RFFL;PYDC1
prerank,receptor internalization (GO:0031623),-0.28567352366758775,-0.9088220034153836,0.6225596529284165,0.8597868882529012,1.0,8/44,7.76%,CAV1;CALCRL;RAMP2;CD9;DNM3;ARRB1;SCYL2;TFRC
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3085904100918425,0.9080654390813389,0.5772870662460567,0.8909589748467915,1.0,14/86,11.94%,CARMIL1;NCK2;SEMA5A;VASP;LIMK1;CDC42EP1;NAV3;BIN1;EFEMP2;NCKAP1;LMOD1;PAK1;RB1;CFL2
prerank,response to nutrient levels (GO:0031667),0.39425765448330163,0.908052683415781,0.5542635658914729,0.8901919986190734,1.0,4/17,17.37%,UCN2;MTOR;PRKAA1;RPS6KB1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.36201159661996957,0.9072811871297154,0.5343228200371057,0.8900897752428387,1.0,7/29,15.91%,ACSF2;BAAT;ACOT12;ACOT2;GLYAT;MLYCD;ACOT7
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.36201159661996957,0.9072811871297154,0.5343228200371057,0.8900897752428387,1.0,7/29,15.91%,ACSF2;BAAT;ACOT12;ACOT2;GLYAT;MLYCD;ACOT7
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3139000332811771,0.9072076461467132,0.5900826446280992,0.8894353373601045,1.0,10/74,12.14%,LIMD1;NOTCH1;RBX1;EPAS1;PSMB11;PSMF1;ARNT;CITED2;EP300;PSME4
prerank,regulation of trophoblast cell migration (GO:1901163),0.40800205031154013,0.9069782670745956,0.5540275049115914,0.8891268183135569,1.0,4/14,8.06%,NODAL;SYDE1;YTHDF3;ARHGDIB
prerank,heart process (GO:0003015),-0.3719075832730347,-0.9062698413971259,0.619140625,0.8648374551569421,1.0,2/14,5.89%,SGCD;ACE
prerank,natural killer cell activation (GO:0030101),0.37287250838135527,0.9060475315753764,0.5271629778672032,0.890264110350935,1.0,4/23,10.14%,PIK3CD;AXL;KAT7;TOX
prerank,cellular response to hormone stimulus (GO:0032870),0.3138018180350564,0.9059552387619217,0.5993265993265994,0.8896604220355209,1.0,10/69,9.43%,MEF2C;ATP1A2;GPER1;CACNA1H;SLIT3;NCOA3;ARID5A;ROBO2;GCK;MED1
prerank,protein alkylation (GO:0008213),0.37321018482131413,0.9051751253402562,0.555984555984556,0.8904529709363661,1.0,7/22,16.76%,METTL21A;EEF1AKMT1;PRMT1;METTL22;PRMT3;FAM98A;SNRPD3
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3222980239866956,0.9050704602040609,0.5716814159292035,0.8898747222516992,1.0,18/57,16.78%,MEF2C;BEGAIN;CACNG7;MINK1;GRIA2;NETO1;GRIN2B;DLG2;GSG1L;DLGAP2;DLG3;NPTXR;DLGAP1;SHISA8;GRIN2A;GRIA1;GRIA4;SHISA6
prerank,protein localization to lysosome (GO:0061462),-0.3180831848571377,-0.9046303707847558,0.6158940397350994,0.8679884751352568,1.0,12/28,30.52%,HGS;AP4M1;RAB7A;ZFYVE16;LAMTOR5;SH3BP4;CD81;KPTN;NCOA4;ATP13A2;LAPTM5;NEDD4
prerank,negative regulation by host of viral process (GO:0044793),-0.4161569330580064,-0.9045288755183539,0.6159554730983302,0.86759115204381,1.0,4/10,26.14%,ZC3H12A;VAPA;PRKN;EIF2AK4
prerank,cell projection organization (GO:0030030),-0.31305065980817526,-0.9043437360521691,0.6203090507726269,0.8673866416285192,1.0,3/30,3.44%,GSN;RHOQ;PARVB
prerank,positive regulation of JUN kinase activity (GO:0043507),0.38183981140079076,0.9043422819411557,0.5538461538461539,0.8905502149283477,1.0,7/23,15.59%,MAP3K5;TAOK3;PAK1;TRAF6;DVL2;TRAF2;DVL3
prerank,long-chain fatty acid import into cell (GO:0044539),0.4287040979419995,0.9039503824863755,0.5075593952483801,0.8905181118289068,1.0,5/10,21.36%,SLC27A2;SLC27A4;SPX;RPS6KB1;ACSL1
prerank,regulation of TORC1 signaling (GO:1903432),0.3482429734321315,0.903625296120887,0.564638783269962,0.89035975151113,1.0,2/33,2.38%,SPAAR;SESN3
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3679039264127887,-0.9035515317767508,0.575984990619137,0.8685383743674894,1.0,3/14,14.40%,TFRC;SHLD1;KMT5C
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3422359104165495,0.9026571670841264,0.5862068965517241,0.8915733339062348,1.0,5/43,5.75%,PDGFRB;RBPMS2;LDLRAP1;FGF2;HTR1B
prerank,regulation of protein acetylation (GO:1901983),0.4298521333733004,0.902460100065056,0.5558139534883721,0.891223609823053,1.0,8/12,29.89%,DDX3X;FAM161A;GSK3B;CAMK1;TERF2IP;RAPGEF3;CEP295;SIRT1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.25817722827489353,-0.9024010217111414,0.6740196078431373,0.8704523373330632,1.0,29/80,22.31%,SGSM2;SNX6;TRAPPC10;SNX32;ERC1;VPS50;STX6;TRIM27;VPS35;LMAN1;RAB7A;TBC1D10A;EVI5;RGP1;SURF4;WASHC1;PHETA1;HEATR5A;RAB29;RAB6A;VPS52;SNX8;SNX3;SPAG9;TMED9;TBC1D14;RNF126;CLN5;SNX2
prerank,diol biosynthetic process (GO:0034312),-0.3732987480072738,-0.9022719439712358,0.5953307392996109,0.870073572739051,1.0,5/15,14.17%,ACER2;ACER3;GCH1;SPHK1;SPTLC2
prerank,phospholipid transport (GO:0015914),0.33324850036306614,0.9021504289145149,0.570446735395189,0.8910744951967834,1.0,5/52,6.57%,PITPNC1;SCARB1;LDLR;ATP8B2;PRELID3A
prerank,regulation of response to external stimulus (GO:0032101),0.28722660129411454,0.9019718729077476,0.5835913312693498,0.8906337829355839,1.0,8/121,3.73%,ACE2;GGT1;SPAAR;IL1RL2;METAP2;PTPN22;NR1D2;GUCY2D
prerank,RNA polyadenylation (GO:0043631),-0.3235764404006517,-0.9018793723464822,0.6270161290322581,0.869633735619883,1.0,12/26,31.08%,APP;AHCYL1;MTPAP;GRSF1;PNPT1;PAPOLB;TENT4B;FIP1L1;CPSF2;WDR33;PAF1;CPSF1
prerank,mRNA polyadenylation (GO:0006378),-0.3235764404006517,-0.9018793723464822,0.6270161290322581,0.869633735619883,1.0,12/26,31.08%,APP;AHCYL1;MTPAP;GRSF1;PNPT1;PAPOLB;TENT4B;FIP1L1;CPSF2;WDR33;PAF1;CPSF1
prerank,cellular amide metabolic process (GO:0043603),-0.2483168531029936,-0.9018022387118925,0.6639344262295082,0.869183783661413,1.0,25/102,20.03%,AEBP1;PLPP3;PCCA;ST3GAL1;CPE;SMPD3;ACOT11;NAAA;NSMAF;PCCB;CPXM2;SLC5A6;CPXM1;ALDH1L1;PLPP1;PLA2G15;NNMT;ACOT6;ACOT9;FPGS;CLN8;NIT1;ORMDL3;GNE;CPD
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.37409469101410164,-0.9016777914257081,0.5953307392996109,0.8688412736595631,1.0,5/13,21.19%,GPD1L;STX3;HSP90AB1;TM9SF4;TYROBP
prerank,myelination (GO:0042552),0.3324350463408509,0.9011635714767344,0.581081081081081,0.8914624381728765,1.0,7/46,6.51%,TNFRSF21;NF1;ABCD2;SCN2A;B4GALT6;TPPP;SCN8A
prerank,regulation of transferase activity (GO:0051338),-0.360122833990984,-0.9010798225529324,0.6138059701492538,0.8695489790487391,1.0,5/17,19.15%,SMG6;PINX1;NLRC5;ATM;PPP1R3F
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.2532992724022924,-0.9010239538513745,0.6711229946524064,0.8690514982335252,1.0,31/85,24.71%,SMURF2;MAGI2;FZD2;AP2A2;SMURF1;WNT5A;RHOA;FZD4;TIAM1;FZD7;PSME2;PFN1;AP2A1;PSMB4;ARHGEF19;PSMB1;PSMD11;PSMD8;PSME3;WNT11;ROR2;FZD1;PSMD4;PSMA2;PSMD3;PSMB7;VANGL2;AP2M1;PSMC2;PSMC5;PSMD10
prerank,myotube differentiation (GO:0014902),0.4051761143151105,0.9009340861155606,0.5694444444444444,0.8911360281178919,1.0,3/17,3.70%,MEF2C;CACNA1H;SORT1
prerank,positive chemotaxis (GO:0050918),-0.36271900101995774,-0.9003658083667544,0.5996055226824457,0.8697962237343778,1.0,3/17,3.53%,NRP1;PTPRJ;ANGPT1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.27198603566146096,-0.9003510582495882,0.6541353383458647,0.8685973333346139,1.0,18/56,26.22%,NDUFV3;DMAC2;NDUFAF5;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA11;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.27198603566146096,-0.9003510582495882,0.6541353383458647,0.8685973333346139,1.0,18/56,26.22%,NDUFV3;DMAC2;NDUFAF5;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA11;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.33979633524425845,-0.8998832805871168,0.6101010101010101,0.8690058842186792,1.0,6/23,17.81%,GPX4;GSTM1;PTGS2;EPHX2;GSTM2;ALOX12
prerank,response to cAMP (GO:0051591),-0.2999012479231976,-0.89895112071708,0.6495726495726496,0.8704162943894759,1.0,10/37,14.05%,IGFBP5;EZR;RAP1B;STAT1;RAPGEF1;KCNQ1;AKAP9;AHR;SLC5A5;NDUFS4
prerank,granulocyte differentiation (GO:0030851),0.37950989491836484,0.8985302029383837,0.5384615384615384,0.8952558149089148,1.0,4/18,11.62%,CBFA2T3;CDKN1A;DEK;EP300
prerank,positive regulation of protein kinase activity (GO:0045860),0.27696089795455575,0.8985190494215073,0.6446043165467625,0.8944994124136213,1.0,29/148,13.17%,IL34;RAPGEF2;PTK2;AGAP2;DOK7;GRM5;PDCD10;MINK1;SPDYA;TTBK1;SNCA;DDX3X;TAOK3;EMP2;RAP1A;PAK6;CDKN1A;STK3;MARK2;MAP4K4;PDGFB;PAK5;PAK3;ETAA1;PAK1;SRC;DLG3;TRAF6;PTPN1
prerank,neutrophil chemotaxis (GO:0030593),0.325031987587934,0.8983852048913465,0.5798611111111112,0.8939824396124438,1.0,6/53,7.50%,PIK3CD;CXCR2;CXCL10;PDE4B;CXCL5;PIKFYVE
prerank,positive regulation of neuron death (GO:1901216),-0.2823971505631001,-0.8981275278462474,0.6244343891402715,0.8716321276898552,1.0,5/46,6.26%,EFNB2;EPHA7;FOXO3;NUPR1;WNT5A
prerank,regulation of cellular protein localization (GO:1903827),0.33834719902662763,0.8977443480353183,0.5856643356643356,0.894448477762088,1.0,12/45,17.56%,MAP2;GPC5;GPC3;CSNK1E;CCDC66;PTPN1;PRKAA1;TRIM46;DVL3;PARP1;TOR1A;TRIM67
prerank,cellular response to oxidative stress (GO:0034599),0.2883672868195237,0.8975580717480108,0.605925925925926,0.8940247140393651,1.0,12/118,9.03%,PTPRK;PLA2R1;NCF2;PRR5L;NCF1;SOD3;SNCA;MSRA;GPX3;ARNT;HTRA2;PKD2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3054935383672943,-0.8973972698012991,0.6098562628336756,0.8726585489090399,1.0,13/35,16.35%,DLG1;SASH1;XDH;EZR;LGALS9;MFHAS1;DUSP1;DAB2IP;ZC3H12A;RELL1;SPHK1;DUSP10;MAP3K4
prerank,polarized epithelial cell differentiation (GO:0030859),-0.38040744650194463,-0.8972707140840966,0.6224299065420561,0.8723302487264626,1.0,7/13,28.85%,EZR;RHOA;MYO9A;OPHN1;ZDHHC7;SCRIB;RAP2A
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3012863996011668,0.8972618410602998,0.6291600633914421,0.8938219855204685,1.0,14/87,12.14%,PTEN;CDK6;RGCC;RBX1;MYO16;PSMB11;PSMF1;CDKN1A;PKD2;KANK2;RBL1;RB1;APC;PSME4
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3239973922441525,0.8964728589528027,0.5825082508250825,0.8946896849363808,1.0,8/54,6.35%,GCNT2;SDC2;SDC3;HYAL4;AGRN;GPC5;GPC3;GNS
prerank,regulation of leukocyte migration (GO:0002685),-0.3521369232978939,-0.8960768431070838,0.6282527881040892,0.8742918551450547,1.0,8/16,38.15%,ANXA1;RHOH;CD81;VEGFA;NCKAP1L;HMOX1;BST1;RAC2
prerank,histone H2A acetylation (GO:0043968),-0.36072375760959907,-0.8956174600584161,0.6153846153846154,0.8746488177848665,1.0,7/16,28.35%,TRRAP;MEAF6;NAA40;MORF4L2;BRD8;EPC1;SPHK2
prerank,spliceosomal complex assembly (GO:0000245),-0.2836686127431768,-0.8954777820098415,0.6332574031890661,0.8743261257794842,1.0,14/46,27.77%,CELF2;LUC7L;SRSF10;SNRPD1;SNRPD2;SRSF6;SRPK1;SRSF5;SF3A3;CELF5;SRPK2;PUF60;PRPF19;SNRPE
prerank,vitamin transport (GO:0051180),-0.31075238302330976,-0.895368788188095,0.6353944562899787,0.8739652203975876,1.0,10/29,25.92%,PDPN;ABCG2;CUBN;SLC5A6;SLC35F3;SLC52A3;SLC19A2;SLC52A1;CD320;SLC25A32
prerank,negative regulation of telomere maintenance (GO:0032205),-0.36658580221056036,-0.8952685314705503,0.6231060606060606,0.8735732798033554,1.0,7/15,23.51%,TNKS2;SMG6;PINX1;ATM;RAD50;SLX4;ERCC1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4229110209105338,0.8952648720169868,0.5295404814004376,0.8963294585768129,1.0,3/12,6.28%,IL1B;TAFA3;TTBK1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.3813338547226048,0.8951606310469599,0.5501022494887525,0.8957645073758361,1.0,2/22,2.62%,GCNT2;IL1B
prerank,regulation of ATP metabolic process (GO:1903578),0.32404263223020746,0.8949274279166817,0.594306049822064,0.8954543202591466,1.0,12/54,11.71%,SLC25A33;ATP7A;NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;EIF6;NDC1;EP300;ATP5IF1
prerank,endomembrane system organization (GO:0010256),0.27043305325054984,0.8947531397778204,0.6513888888888889,0.8950155592105988,1.0,45/178,17.74%,ARHGAP21;DYSF;SYNE1;SPTBN1;TMCC1;TOR1B;COG7;SYNGR1;ATP8B2;COG1;CLASP2;ANK3;CHMP2B;ARFGEF1;HACE1;VPS18;BLZF1;HOOK3;RNF112;MIA3;TMED7;VPS11;UBXN2B;TMED4;AKTIP;ARHGEF7;SYP;VPS51;PLEKHJ1;WASHC5;TRIP11;USP50;SERP1;TJAP1;VPS33B;VMP1;RAB1A;TOR1A;PRKD1;HTT;CSNK1A1;DNM1;GORASP1;GOLGA8B;GOLGA5
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.252710278223455,-0.894188266078198,0.6821705426356589,0.8752828108096617,1.0,12/84,15.04%,CELF2;RBFOX2;MBNL1;DDX5;THRAP3;NOVA2;SON;MBNL2;NOVA1;SRSF10;FXR2;NUP98
prerank,regulation of exocytosis (GO:0017157),0.3233360637599625,0.8938328404827878,0.5619546247818499,0.8961838587951918,1.0,17/46,18.99%,RAB8B;CLASP2;RIMS2;RAB3B;SNCA;LGI3;SYT1;IL1RAPL1;STXBP5L;STX4;RAB5A;CHMP3;HAP1;VAMP2;CPLX1;STXBP5;CADPS
prerank,negative regulation of axon extension (GO:0030517),0.34965434574839116,0.8937273454279261,0.5636363636363636,0.8956241013836682,1.0,4/30,4.83%,SEMA6D;MAP2;SEMA5A;SEMA6C
prerank,histone H2A ubiquitination (GO:0033522),0.3903351479699626,0.8935350958080079,0.5695238095238095,0.8952096077319145,1.0,8/17,21.96%,RYBP;UBR2;KDM2B;SKP1;TRIM37;UBE2B;DDB2;UBE2A
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3928211715022528,0.8934735738352498,0.582,0.8945640788831888,1.0,3/17,6.95%,NR1H3;SORT1;LIPC
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.31224754121554954,-0.8933462807579698,0.616557734204793,0.8765473678681729,1.0,7/31,22.38%,RBP4;TFRC;EPHB2;SHLD1;KMT5C;XBP1;CLCF1
prerank,positive regulation of integrin activation (GO:0033625),-0.3943214835856548,-0.8928975281272914,0.6330275229357798,0.876876843243013,1.0,3/11,6.16%,RAP1B;PIEZO1;RASIP1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.40881736998100754,0.8926654567133362,0.5536105032822757,0.8954266977731633,1.0,1/12,0.82%,RORB
prerank,organonitrogen compound catabolic process (GO:1901565),0.3243721249646915,0.8926161817315954,0.5806451612903226,0.8947472790091542,1.0,8/57,8.15%,ENPEP;CTH;ANPEP;TXN2;LIPC;PPT1;TRHDE;MTOR
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.43298634948434606,0.8925400705265649,0.5725646123260437,0.894116192925101,1.0,2/10,7.30%,ATP1A2;BIN1
prerank,melanocyte differentiation (GO:0030318),0.43209517762430655,0.8924685804895516,0.5666666666666667,0.8934684311823243,1.0,2/11,3.79%,MEF2C;MREG
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.42948377809224225,0.892192896428546,0.5690866510538641,0.8932477941701469,1.0,4/10,14.37%,BEGAIN;DLGAP2;NPTXR;DLGAP1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.43317193340439997,0.8916153491029631,0.5446808510638298,0.8936220451757505,1.0,4/10,17.06%,CCAR2;ETAA1;CRY1;RPA2
prerank,regulation of dephosphorylation (GO:0035303),-0.359021211256155,-0.891603688030102,0.6078431372549019,0.8790444131145989,1.0,6/15,23.86%,SMG6;PPP1R16B;MTMR3;SMG5;CDK5RAP3;INPP5K
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.43102075069822676,0.8914351569613181,0.5675057208237986,0.8932005757291481,1.0,6/10,22.22%,CBARP;GPR35;FMR1;GNB5;CALM3;DRD2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.32934513395298814,-0.8910238575393682,0.6212424849699398,0.8796860034997501,1.0,4/22,6.94%,LACC1;WNT5A;TNFRSF1B;SLC7A5
prerank,positive regulation of cell growth (GO:0030307),-0.24597046175339943,-0.8909534110332443,0.7216216216216216,0.8791966801054006,1.0,20/96,16.43%,IGF1;EGFR;MACF1;USP47;TGFBR1;SEMA7A;ADAM10;SDCBP;SMURF1;INO80;H3-3A;MMP14;AKT1;MFSD2A;DDX49;SPHK1;SFRP1;CXCL16;NTN1;RUFY3
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.40466074109506245,0.8908771054149816,0.5502092050209205,0.8936050135893759,1.0,3/13,11.13%,AP1G1;IL4;STX4
prerank,copper ion transport (GO:0006825),-0.3868663138295141,-0.89083570367222,0.5989110707803993,0.8788359533543475,1.0,2/11,5.22%,STEAP3;ATOX1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3683682523185634,0.8907395880063675,0.6060037523452158,0.8931012210706689,1.0,8/28,13.98%,PLEKHG2;WAS;SH3BP1;ESAM;ARHGAP35;PAK3;RASA1;ABITRAM
prerank,hepaticobiliary system development (GO:0061008),-0.3457778648577226,-0.8907158597442089,0.621031746031746,0.8784773005292613,1.0,3/20,4.43%,TGFBR3;WNT4;LSR
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.41363424702433954,0.8906355480448717,0.5743801652892562,0.8925421983021884,1.0,1/12,0.75%,DOCK10
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2262675227607661,-0.8905360185692808,0.7552447552447552,0.8782390449576315,1.0,40/158,19.80%,AKAP13;LPAR1;GJA1;MAP3K14;NOD1;CFLAR;TNFSF10;LGALS9;IKBKE;RHOA;PRKCB;PLK2;FKBP1A;TFRC;BIRC3;EEF1D;TNFRSF19;ECM1;TNFRSF1A;CASP8;TRIM27;MAVS;PLEKHG5;RELA;TICAM1;VAPA;PELI1;TRIM8;RIPK1;TRAF3IP2;MAP3K3;CC2D1A;TRIM14;LAMTOR5;CANT1;PIM2;EDA2R;LGALS1;IKBKG;RHOC
prerank,vesicle organization (GO:0016050),-0.2814008976074406,-0.8904668400385574,0.6591422121896162,0.8777787285000401,1.0,14/46,19.11%,CAV1;FNBP1L;CD34;SRGN;USP8;ALS2;ALS2CL;CAV2;SNX10;PHETA1;ARFGEF2;ZFYVE16;SAR1A;SAR1B
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2636543344364609,-0.8903768585689594,0.6666666666666666,0.8773550522708005,1.0,13/59,15.07%,ROCK2;TGFBR2;TGFBR1;LRRK2;ACVR1;TAF1;WNK1;PRKCD;AKT1;CAMK2A;OXSR1;HIPK2;DYRK1B
prerank,protein deneddylation (GO:0000338),-0.39241671194584876,-0.8902537368458358,0.6112185686653772,0.8769874890616547,1.0,4/10,26.75%,COPS4;COPS8;COPS7A;COPS2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.42032689978301835,0.8892708552553288,0.5395833333333333,0.8944655905242004,1.0,2/12,2.06%,HEYL;NODAL
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.40565642877715363,0.8886459922645905,0.5720823798627003,0.895014075670051,1.0,5/14,18.54%,ADK;ADSL;PPAT;IMPDH2;RFK
prerank,negative regulation of metabolic process (GO:0009892),0.32501913475399263,0.8881541293946792,0.5913793103448276,0.8952044499067435,1.0,4/54,2.62%,PLCL1;NOTCH1;NR1H3;IL1B
prerank,regulation of interleukin-13 production (GO:0032656),0.39923991013555893,0.8878857333547809,0.5410821643286573,0.8949579893218249,1.0,2/13,6.03%,TNFRSF21;IL4
prerank,male gonad development (GO:0008584),-0.3020010675391041,-0.8877707893322441,0.6293103448275862,0.881644305056879,1.0,11/34,29.06%,WNT4;AR;WNT5A;KIT;GATA6;NCOA4;CSDE1;COL9A3;ADAM21;BIK;WNT2B
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.2937041055225491,-0.8871314999875901,0.6378132118451025,0.8824135842881965,1.0,13/38,24.22%,ESR1;STAT1;TLE1;CASP8;DAB2IP;ZC3H12A;TRIM39;PPM1B;RIPK1;RHOH;ZMYND11;MAPKBP1;USP10
prerank,negative regulation of protein polymerization (GO:0032272),-0.3136733254821628,-0.8869025909397217,0.6045627376425855,0.8822890721787856,1.0,7/27,13.17%,CDH5;SLIT2;KANK3;PRKCD;EML2;PFN1;TWF1
prerank,positive regulation of lipid storage (GO:0010884),0.37243876784708285,0.8867360774212077,0.5662650602409639,0.8964335376396964,1.0,4/21,9.23%,SCARB1;SREBF2;MSR1;VSTM2A
prerank,neuron remodeling (GO:0016322),-0.4037372061650032,-0.8863296174647873,0.6224299065420561,0.8829024286421097,1.0,3/10,9.74%,APP;ANKS1A;EPHA8
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.3971541349482457,0.8860506928687717,0.5630252100840336,0.8970243353712445,1.0,3/15,6.95%,SCARB1;ABCA5;LIPC
prerank,inositol phosphate biosynthetic process (GO:0032958),0.41887567744209464,0.8857772527097487,0.5531914893617021,0.8968288933951936,1.0,4/11,15.48%,FGF2;ITPKB;IPMK;IPPK
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4390987256202324,0.8857561148396234,0.5711252653927813,0.8953371378656093,1.0,1/10,0.85%,CBFA2T3
prerank,negative regulation of glycolytic process (GO:0045820),0.4390987256202324,0.8857561148396234,0.5711252653927813,0.8953371378656093,1.0,1/10,0.85%,CBFA2T3
prerank,actin polymerization or depolymerization (GO:0008154),0.32493359881438766,0.8856283647038872,0.5763888888888888,0.8948327808599768,1.0,7/50,3.93%,ARHGAP6;WASF3;WAS;CORO7;ABI2;SPIRE1;WASL
prerank,response to reactive oxygen species (GO:0000302),0.32317250272043685,0.8855819670794235,0.6042780748663101,0.8941511515338738,1.0,3/54,4.19%,PTPRK;NCF1;PDCD10
prerank,regulation of microtubule-based process (GO:0032886),0.3469288863076302,0.8854996162491432,0.5831775700934579,0.8935710800370014,1.0,15/36,18.48%,PHLDB2;ROCK1;CLASP2;TPPP;MARK2;BICD2;CAMSAP3;APC;PHLDB1;PRKAA1;MAP10;CDK2AP2;TRAF3IP1;GSK3B;MARK4
prerank,signal peptide processing (GO:0006465),-0.384597800315756,-0.8854637498391713,0.6193078324225865,0.8842108113137308,1.0,4/11,24.36%,PCSK5;SPCS1;CLN5;SEC11C
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.33102333093289593,-0.8854149657372097,0.625,0.883688161696795,1.0,7/21,21.41%,SMO;EVC;TTC23;SFRP1;STK36;TXNDC15;GLI1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.40930207047498235,0.8851931189866448,0.5749440715883669,0.8933826081102749,1.0,6/12,25.78%,FADS2;ELOVL2;HSD17B4;ACSL1;ABCD1;ELOVL5
prerank,negative regulation of lymphocyte activation (GO:0051250),0.38241417267313815,0.8850077861757215,0.5843373493975904,0.8929704614637762,1.0,2/21,3.87%,PTPN22;PAG1
prerank,regulation of primary metabolic process (GO:0080090),-0.23430454633151024,-0.8848343601132902,0.7542087542087542,0.8843257236549731,1.0,38/126,24.71%,ROCK2;TBL1XR1;APOE;CHD9;CARM1;ACACA;PSAP;PSME2;NFYC;TNFAIP8L3;FGFR4;PLPP1;PPARA;ID2;PSMB4;PRKAB1;PSMB1;PSMD11;IDI1;PSMD8;SREBF1;PSME3;ZFP69;ODC1;NFYB;OAZ1;PSMD4;PSMA2;ACACB;PSMD3;ADIPOR1;PSMB7;SIN3A;AZIN1;PSMC2;HELZ2;PSMC5;PSMD10
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.40612264129654924,0.8845294516387613,0.5765957446808511,0.893166700675104,1.0,2/14,4.99%,IL1B;CARD9
prerank,regulation of cholesterol efflux (GO:0010874),-0.3063367577678471,-0.8842420784561622,0.6298568507157464,0.8849460691212279,1.0,8/30,20.47%,PLTP;APOE;CAV1;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.26994029332344904,-0.8841527882986677,0.639344262295082,0.8845320142205104,1.0,17/52,24.96%,SAMD4A;CNOT7;TUT4;TUT7;EDC3;DDX6;RC3H2;CNOT8;EXOSC5;CNOT3;PNLDC1;LSM5;CNOT11;PAN3;EXOSC7;SAMD4B;LSM7
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.36284236744334425,-0.8840243693996059,0.6083650190114068,0.8842062849998888,1.0,6/15,25.83%,NYNRIN;ZC3H12A;DICER1;NUDT16;ZC3H12B;POP1
prerank,protein maturation (GO:0051604),0.29089591626629596,0.8838895268940428,0.5972850678733032,0.8936256392224984,1.0,8/95,5.32%,TMPRSS4;CPM;METAP2;ADAM19;TSPAN15;ECE1;TASP1;OGT
prerank,positive regulation of dendritic spine development (GO:0060999),-0.33517254993791956,-0.8834845196387913,0.6165413533834586,0.8847291963422506,1.0,4/20,13.27%,APOE;SHANK3;CPEB3;LRP8
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.3295696171071348,-0.8834522503263591,0.6247544204322201,0.8841881981512185,1.0,3/22,5.73%,CD55;B2M;STX7
prerank,regulation of lipid metabolic process (GO:0019216),-0.2446156572826248,-0.8830617865134823,0.7111716621253406,0.8844430420157084,1.0,14/88,12.56%,PRKAG2;TBL1XR1;CHD9;CAV1;NPC2;CARM1;ACACA;PSAP;NFYC;TNFAIP8L3;FGFR4;PLPP1;PPARA;ID2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.39504519440959324,0.8822767968651183,0.5819327731092437,0.8960219239306608,1.0,2/15,5.27%,FAP;CLASP2
prerank,regulation of telomere capping (GO:1904353),-0.3240450871957777,-0.8820344730934832,0.6265306122448979,0.8860961138365216,1.0,6/23,16.35%,TNKS2;SMG6;ATM;MAPK3;RAD50;MAP3K4
prerank,regulation of protein localization (GO:0032880),-0.2685676271959424,-0.8819497631393682,0.6571428571428571,0.8856729213370088,1.0,11/58,14.66%,AFDN;DLG1;RABGAP1L;USP8;FKBP1A;STX6;TRIM27;ITGB3;DNAJB6;HSP90AB1;TRIM17
prerank,ncRNA export from nucleus (GO:0097064),0.3409908272269956,0.8819321936198794,0.5959409594095941,0.8959585504572559,1.0,11/36,17.70%,NUP43;NOL6;NCBP2;SSB;NUP35;SEC13;NDC1;PHAX;RANBP2;TSC1;NUP133
prerank,cochlea morphogenesis (GO:0090103),0.43201234513913356,0.881659477992056,0.6058700209643606,0.895738772488684,1.0,5/10,20.13%,MYO3B;TBX18;HPN;PAX2;HOXA1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3045719489156451,0.8814426436591094,0.6132231404958678,0.8953939600269253,1.0,6/76,3.29%,CARMIL1;NCK2;SEMA5A;VASP;LIMK1;CDC42EP1
prerank,ribosome assembly (GO:0042255),-0.27460705533832414,-0.881053980853235,0.668235294117647,0.886999603286832,1.0,14/47,22.27%,RPS14;RPS19;RPL11;RPS5;RPL24;RPS27;MRPS7;RPL10;RPS15;RPSA;RPLP0;MPV17L2;RRP7A;RPS27L
prerank,carbohydrate derivative transport (GO:1901264),-0.3407486873581991,-0.8809241733547911,0.6489563567362429,0.8866505604838052,1.0,6/18,14.56%,PLTP;LBP;NPC2;MFSD2A;SLC25A19;SLC29A1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.40581723650108403,0.8804702702854064,0.5906183368869936,0.8965321935477107,1.0,3/12,13.32%,CACNA1H;STAR;CYP11B1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.42147878483555096,0.8804551759495632,0.5735607675906184,0.89504798269722,1.0,11/11,57.88%,CCT7;CCT3;LARP7;DKC1;TCP1;CCT6A;CCT4;MEPCE;CCT8;CCT2;CCT5
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.42147878483555096,0.8804551759495632,0.5735607675906184,0.89504798269722,1.0,11/11,57.88%,CCT7;CCT3;LARP7;DKC1;TCP1;CCT6A;CCT4;MEPCE;CCT8;CCT2;CCT5
prerank,response to steroid hormone (GO:0048545),-0.307286214186369,-0.8801766297861692,0.6381578947368421,0.8875584829622437,1.0,8/31,13.64%,NR3C1;CAV1;THBS1;AR;YAP1;TGFB1;ATP1A1;ATP1A3
prerank,mitochondrial transport (GO:0006839),-0.272586788159367,-0.8800398695811134,0.6774941995359629,0.8872257426515556,1.0,19/53,24.76%,MTX2;SLC25A4;SLC25A24;TOMM7;STARD3;SPG7;BNIP3;GDAP1;TIMM13;BCAP31;TOMM22;TIMM8B;TOMM34;TOMM5;MAIP1;TIMM9;TMEM14A;TIMM44;BCL2L1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4077519117009629,0.8798498940106954,0.5601659751037344,0.8947317889514136,1.0,3/12,6.21%,SPRY4;ACTN4;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4077519117009629,0.8798498940106954,0.5601659751037344,0.8947317889514136,1.0,3/12,6.21%,SPRY4;ACTN4;AP1AR
prerank,T cell activation (GO:0042110),0.308158683623446,0.8798436210562501,0.6304347826086957,0.893990436559879,1.0,8/69,6.56%,PIK3CD;NCK2;PTPN22;PPP3CA;GPR89A;GPR89B;IL4;SOX4
prerank,proteasome assembly (GO:0043248),-0.38244270052086693,-0.8796481380399296,0.6218637992831542,0.8874464154418762,1.0,4/11,24.71%,POMP;PSMD11;PSMD4;PSMD10
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.32057167202594056,0.8794273715617253,0.6123893805309735,0.8940967242760781,1.0,13/52,11.15%,PIK3R1;PTPN9;GPER1;ATP2C1;SPTBN1;DPP10;ITGB1;STAC;ZDHHC2;NKD2;EPHA2;STX4;RANGRF
prerank,DNA methylation (GO:0006306),-0.31664334279642764,-0.8791634991303003,0.6203319502074689,0.8878910505652468,1.0,8/23,27.28%,DNMT3A;GATAD2A;EHMT1;BEND3;ZFP57;DNMT1;PICK1;MTRR
prerank,negative regulation of cholesterol transport (GO:0032375),0.4200540192036561,0.8789362489085075,0.558695652173913,0.8942561110693829,1.0,1/10,5.07%,SREBF2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3047141113406605,-0.8787405943650393,0.6468172484599589,0.8881748836851762,1.0,10/32,24.17%,FOXN3;RINT1;TAOK2;ATM;TRIM39;FZR1;BABAM2;CDK5RAP3;BABAM1;BRCA1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.31695995287103496,0.8780115392426854,0.6075268817204301,0.8953111903896238,1.0,3/51,2.51%,IL34;PTK2;PTN
prerank,multivesicular body assembly (GO:0036258),-0.30420026206006423,-0.877890683789889,0.6550308008213552,0.8893226034281743,1.0,5/30,10.72%,RAB11A;PDCD6IP;HGS;CHMP4B;CHMP4A
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.32913776012390544,-0.8778419555712175,0.6428571428571429,0.8888105971756766,1.0,14/23,27.43%,ENPP1;SUFU;GLIS2;TULP3;MGRN1;GLI3;PTCH1;VCP;MEGF8;RACK1;RFX4;GPR161;PTCH2;IFT122
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.37136521475703516,-0.8775251971243688,0.6351606805293005,0.8888603410564166,1.0,5/13,16.56%,CNOT7;MOV10;ZC3H12A;CNOT8;PNPT1
prerank,regulation of protein localization to membrane (GO:1905475),0.3534191968915838,0.877498264403459,0.5855130784708249,0.8955681781115911,1.0,9/28,13.37%,LDLRAP1;SPTBN1;GPC5;GPC3;APPL1;PDZK1;ZDHHC2;NECAB2;VTI1B
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.30174992642385595,0.8770657371713027,0.6310517529215359,0.8956638077399162,1.0,16/67,16.85%,TBC1D1;PLD1;WAS;IFT20;MYO10;TBC1D2B;GAP43;TBC1D10C;EPHA2;TBC1D9B;TBC1D19;ABITRAM;RAB5A;TBC1D10B;FSCN1;FMR1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3140027065585519,-0.8769285550293536,0.6483050847457628,0.8894292048031048,1.0,2/24,1.64%,DAB2;RHOQ
prerank,cognition (GO:0050890),-0.2867808792513749,-0.8767908787588556,0.6681318681318681,0.8891238697603037,1.0,6/42,8.16%,ST3GAL4;CHD7;APP;SOBP;SHROOM4;STRA6
prerank,histone H4-K16 acetylation (GO:0043984),0.37649028745673974,0.8760305124442225,0.5908141962421712,0.8969461573545877,1.0,8/19,19.14%,OGT;KAT7;KANSL3;KANSL1;KMT2A;MSL2;MCRS1;WDR5
prerank,mesoderm development (GO:0007498),0.37907577276067117,0.8757901882418232,0.5708154506437768,0.8966556414108297,1.0,3/18,3.37%,TBX3;TCF15;TBX6
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2780304952990085,-0.8755763921944005,0.6746724890829694,0.8910040707125315,1.0,18/46,29.72%,HK2;AIFM1;AKT1;TOMM7;GDAP1;DNAJC15;TIMM13;BCAP31;TOMM22;TIMM8B;TOMM34;TOMM5;TIMM9;TIMM44;HK1;TIMM50;TIMM10;TSPO
prerank,positive regulation of leukocyte migration (GO:0002687),0.35914997717447233,0.8755568328272727,0.5834970530451866,0.8963656104686474,1.0,4/27,8.99%,JAM3;PTN;IL4;MIA3
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4157932398067781,0.875153271072431,0.5783664459161147,0.8963916235075228,1.0,4/11,13.27%,SIK1;GCK;EP300;CRY1
prerank,cellular response to cAMP (GO:0071320),0.3437715594813229,0.8748726389892336,0.5852713178294574,0.896188015069205,1.0,6/30,9.03%,RAPGEF2;AKAP6;HCN2;RAP1A;HCN3;PKD2
prerank,regulation of establishment of protein localization (GO:0070201),0.3984647874642625,0.8744291854035574,0.5763097949886105,0.8962759479809003,1.0,3/13,16.21%,CORO2B;CEP120;CEP135
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.3360856190183664,-0.8742982648682301,0.6417322834645669,0.8930679438009121,1.0,2/19,1.96%,IGF1;APOE
prerank,positive regulation of catalytic activity (GO:0043085),-0.2871183268503444,-0.8740406215912301,0.651685393258427,0.8929836299212183,1.0,14/37,27.91%,CAV1;IGF2;MAPK14;SSBP1;NHEJ1;FGFR4;XRCC4;MAPK3;PSEN2;MT3;MSH6;NCSTN;B3GAT3;ABL1
prerank,protein stabilization (GO:0050821),-0.2254979970813163,-0.8740108074141149,0.7714285714285715,0.8924340662578905,1.0,56/168,28.91%,IGF1;EPHA4;ATP1B3;LAMP2;PLPP3;RASSF2;SMAD7;TAF1;STXBP4;PRKCD;BAG3;IRGM;FLOT2;RAB21;RPL11;PFN1;WDR81;CALR;TRIM39;SOX17;HYPK;HSP90AB1;PARVA;RPL23;SUGT1;RPS7;PARK7;HPS4;CHP1;MT3;PIM2;PPARGC1A;RABL3;GET1;TAF9B;USP36;TYROBP;BAG2;TMEM88;IFT46;MCM8;USP2;CHEK2;ZSWIM7;CDK7;PRKN;GNAQ;BAG5;MSX1;CRTAP;SEC16A;HSPA1B;MORC3;CLU;SYVN1;BAG1
prerank,female gonad development (GO:0008585),-0.3390338680249344,-0.8737574530267549,0.6330645161290323,0.892339592592365,1.0,8/19,28.26%,KIT;EIF2B2;CEBPB;VEGFA;EIF2B5;FOXL2;COL9A3;EIF2B4
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3831465928005254,-0.873493213117351,0.6190476190476191,0.892276586648032,1.0,4/11,13.61%,ADAM10;WNT5A;WNK1;OXSR1
prerank,cell junction maintenance (GO:0034331),-0.3639142132030543,-0.8734240294250497,0.631163708086785,0.8918325126613553,1.0,8/14,36.88%,NLGN2;CLDN1;CSF1R;CBLN2;F2R;PRTN3;CBLN1;PARD6A
prerank,negative regulation of growth (GO:0045926),0.27645083637989204,0.8731880272121475,0.6646971935007385,0.8979435507535984,1.0,7/121,3.49%,TMPRSS4;RERG;APBB2;NOTCH1;SLIT3;SIPA1;CRLF3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4016950521941612,0.8730342073005694,0.5627615062761506,0.8975004885901813,1.0,4/11,22.70%,IL4;JAK2;HDAC2;TAF7
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.2565040528699562,-0.8729749317989026,0.7184986595174263,0.8921493059986653,1.0,13/73,14.30%,EGFR;NTRK3;APP;CAV1;GAS6;FNIP1;TFRC;AKT1;IRGM;AKAP9;TGFB1;TXN;HSP90AB1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.36110246142232405,-0.8726388206548177,0.6420454545454546,0.8922520850032213,1.0,5/14,22.35%,PRKCZ;IL18;RSAD2;CD81;RARA
prerank,cellular response to nitrogen compound (GO:1901699),-0.32717904375578666,-0.8726000869857882,0.6309751434034416,0.8917121263138295,1.0,1/20,0.88%,ROCK2
prerank,protein import into mitochondrial matrix (GO:0030150),0.37372828178155093,0.8719875222272718,0.5639412997903563,0.898783935734316,1.0,10/18,26.75%,GRPEL2;TOMM40L;TIMM23;TOMM40;TOMM70;DNAJC19;PAM16;TIMM17A;DNLZ;TIMM17B
prerank,regulation of presynapse organization (GO:0099174),0.38749536880613267,0.8716210321691514,0.5846774193548387,0.897989106390385,1.0,6/18,12.83%,LRFN5;SNCA;IL1RAPL1;SLITRK1;IL1RAPL2;SLITRK2
prerank,regulation of presynapse assembly (GO:1905606),0.38749536880613267,0.8716210321691514,0.5846774193548387,0.897989106390385,1.0,6/18,12.83%,LRFN5;SNCA;IL1RAPL1;SLITRK1;IL1RAPL2;SLITRK2
prerank,response to progesterone (GO:0032570),-0.343344115147827,-0.8712503599868576,0.638671875,0.8939814967895929,1.0,4/18,11.59%,CAV1;THBS1;YAP1;TGFB1
prerank,neutral amino acid transport (GO:0015804),-0.3006580580185342,-0.8709821084367728,0.636734693877551,0.893907734980581,1.0,11/28,22.34%,SLC6A6;SLC6A9;SLC7A5;SLC38A5;SLC3A2;SLC38A6;LLGL2;SLC43A1;SLC36A1;SLC1A1;SLC38A1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.25175245788254286,-0.8709153238505516,0.7368421052631579,0.8934415418319644,1.0,35/85,28.31%,DAB2;NUPR1;LRRK2;SMAD7;TAF1;RNF19A;RNF144B;SH3RF2;RNF185;BBS7;DAB2IP;USP5;ECSCR;DNAJB2;MDM2;ELOB;ANKIB1;SIRT2;TRIB1;VCP;RNF217;RNF144A;BAG2;DDA1;RNF19B;PSMC2;PSMC5;PSMD10;RACK1;PRKN;ATXN3;CEBPA;TRIB3;HSPA1B;CLU
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.20393738606092,-0.8702523794096385,0.9207920792079208,0.8941740626797969,1.0,86/341,21.82%,FBXL7;TBL1XR1;RNF213;SMURF2;FBXO10;RNF146;ZNRF1;ASB2;TAF1;RNF43;SPSB1;RNF130;RNF19A;ARRB1;WWP2;RNF144B;TTC3;SMURF1;TOM1L1;CDC16;MAEA;AMFR;IFI27;RC3H2;NHLRC3;DCAF11;CHFR;RNF185;DTX3L;KCTD10;PCBP2;ZNRF3;ARRDC1;PML;PSME2;UBE4B;ANAPC4;CUL4A;RNF125;MDM2;WDR81;PSMB4;FBXW11;CLOCK;UBE2G2;PSMB1;PSMD11;NEDD8;DDB1;PSMD8;RNF115;WWP1;FBXL14;ANKIB1;PSME3;RNF187;RNF40;UBR4;PELI1;SIRT2;UBE3D;FBXL19;SPSB4;SPSB2;ANAPC16;PSMD4;FZR1;PPP2R5C;PSMA2;NPLOC4;VCP;RNF217;VPS28;PSMD3;CDC27;RNF144A;UBE2L6;RFFL;RMND5A;RNF126;PSMB7;UBXN1;ANAPC5;ELOC;RBBP6;XBP1
prerank,negative regulation of viral transcription (GO:0032897),0.3875144512851848,0.8702149403063869,0.5758928571428571,0.9000848664911703,1.0,3/13,5.49%,MID2;HEXIM1;TRIM62
prerank,determination of bilateral symmetry (GO:0009855),0.3725584353968401,0.86953179449156,0.6174089068825911,0.90068589613219,1.0,3/24,10.35%,NOTCH1;PKD2;CITED2
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3462969740921451,-0.8695286620967942,0.6556420233463035,0.8950636038935883,1.0,10/17,39.33%,BID;BBC3;BCL2L1;SFN;TIMM50;SOD2;CLU;DNM1L;BAX;GGCT
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.364831235715751,0.8689216150931065,0.6115537848605578,0.9011165093557029,1.0,9/26,14.45%,HEYL;NODAL;CNOT2;VPS18;CNOT9;VPS11;KANK2;CRY1;STRN3
prerank,actin filament capping (GO:0051693),0.381800709500716,0.8684313237424481,0.5886075949367089,0.900607691211869,1.0,1/18,0.31%,EPS8
prerank,barbed-end actin filament capping (GO:0051016),0.381800709500716,0.8684313237424481,0.5886075949367089,0.900607691211869,1.0,1/18,0.31%,EPS8
prerank,cell differentiation in spinal cord (GO:0021515),0.42799107114972906,0.8682616582050411,0.6134453781512605,0.90020852518009,1.0,4/10,12.91%,SOX4;MDGA2;SOX6;ZC4H2
prerank,cellular copper ion homeostasis (GO:0006878),-0.357449312802413,-0.8682036207887196,0.6440677966101694,0.8971817966601767,1.0,2/14,5.22%,APP;ATOX1
prerank,negative regulation of protein modification process (GO:0031400),0.29735396433525185,0.8681967501134484,0.6236044657097288,0.8995917483553205,1.0,5/79,3.06%,PTEN;DMD;PID1;PRR5L;CADM4
prerank,response to hydrogen peroxide (GO:0042542),-0.2748148440996924,-0.867798036882157,0.6790697674418604,0.89738681837459,1.0,13/45,18.15%,ANXA1;ADAM9;CYP1B1;RHOB;PRKCD;RELA;GLRX2;SIRPA;NET1;RIPK1;GPX1;OSER1;PARK7
prerank,basement membrane organization (GO:0071711),0.39020553167955935,0.8677346542737091,0.588865096359743,0.8996987763292567,1.0,5/14,5.24%,NID1;COL4A1;PXDN;NTNG2;LAMB1
prerank,protein secretion (GO:0009306),-0.25888027803353,-0.866538217187283,0.6967592592592593,0.8993140637299442,1.0,8/56,11.75%,ABCA1;STEAP3;PCSK5;ANXA1;RCN3;GOLPH3;TMEM167A;RAB8A
prerank,sodium-independent organic anion transport (GO:0043252),0.41241852294564907,0.8663517038229115,0.5717299578059072,0.9016136892700715,1.0,2/10,4.44%,SLCO3A1;SLCO5A1
prerank,DNA alkylation (GO:0006305),-0.3295026935945358,-0.866064948681725,0.6550308008213552,0.8991018246580686,1.0,4/19,15.23%,DNMT3A;GATAD2A;EHMT1;BEND3
prerank,DNA methylation or demethylation (GO:0044728),-0.3295026935945358,-0.866064948681725,0.6550308008213552,0.8991018246580686,1.0,4/19,15.23%,DNMT3A;GATAD2A;EHMT1;BEND3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.37226165147732715,0.8660086757864414,0.5596707818930041,0.9015195373793516,1.0,9/18,18.00%,RIMS1;RIMS2;SYN1;RAP1A;VPS18;RAB5A;PREPL;FMR1;GSK3B
prerank,SNARE complex assembly (GO:0035493),-0.3858020601777461,-0.8654345219278532,0.6511194029850746,0.8997430682340118,1.0,3/10,21.45%,STXBP6;UVRAG;VAMP8
prerank,protein tetramerization (GO:0051262),-0.2558495469362409,-0.8653602273316584,0.7383419689119171,0.8992795477220289,1.0,18/67,20.76%,ALDH1A2;KCNJ2;B2M;APPL2;SSBP1;UPB1;GLS;ACACA;SAMHD1;GBP5;KCNC3;PKD1;HOMER1;HSD17B8;ACACB;TRPM4;FARSA;MCOLN1
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.250949382260679,-0.8651815406693475,0.7300469483568075,0.8990221719265115,1.0,18/68,24.88%,RHOQ;ENPP1;AMPD3;LRRK2;ACOT11;SULT1A1;HINT1;RAN;PTHLH;ACOT6;ACOT9;TPST1;TPST2;ADSS1;DBI;NT5C2;OXSM;SULT4A1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.40219012862053727,0.8649748286103284,0.5767634854771784,0.9028256607683556,1.0,3/11,8.02%,MAP3K5;PDCD10;STK24
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3624383392977727,0.8646994443801498,0.6252465483234714,0.9026366693247824,1.0,13/24,23.20%,GNL3L;TNKS;ERCC4;HNRNPA1;SRC;HNRNPU;HNRNPC;PARP1;PIF1;TERF1;TINF2;CTC1;EXOSC10
prerank,protein localization to Golgi apparatus (GO:0034067),-0.30945790629539605,-0.8642597986792193,0.6632231404958677,0.9002956781347105,1.0,11/27,23.22%,VPS13A;GOLPH3;VPS13D;OBSL1;OPTN;GBP5;ARL5A;RAB6A;ZDHHC15;GAK;RIPOR1
prerank,T cell differentiation (GO:0030217),0.33524917936478293,0.8642161490734085,0.6349809885931559,0.9028420200624434,1.0,6/40,6.90%,PIK3CD;PTPN22;GPR89A;GPR89B;SOX4;LIG4
prerank,apoptotic mitochondrial changes (GO:0008637),-0.29179594094962547,-0.8634910144253984,0.6547368421052632,0.9012928053248822,1.0,14/32,28.31%,HK2;IFIT2;VPS35;CAMK2A;BNIP3;BID;BBC3;BCL2L1;NDUFS1;BIK;SFN;TIMM50;SOD2;CLU
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.36373970855685356,0.8634786242222879,0.5935613682092555,0.9035184586832746,1.0,8/20,18.01%,CHRNA3;AGRN;CHRNA7;RGS10;CHRNB2;RGS8;CHRM3;CHRM2
prerank,negative regulation of translational initiation (GO:0045947),0.39352065417804727,0.8624996425232757,0.6025641025641025,0.9046824092507781,1.0,2/13,2.94%,EIF4EBP2;EIF4EBP3
prerank,negative regulation of protein metabolic process (GO:0051248),-0.2761927498382922,-0.8624722513923474,0.7217194570135747,0.9027508251391682,1.0,10/48,14.66%,EGFR;APOE;IAPP;PFDN5;FLOT2;IRAK3;PRKCG;ITGB3;HSP90AB1;PFDN2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3265320036537259,0.8618370532108285,0.6245551601423488,0.9052303368866693,1.0,4/46,4.76%,PTEN;GPER1;SPRED1;SPRY2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.3815536481835644,-0.861790116495549,0.6204933586337761,0.9035814360889505,1.0,3/10,20.27%,RNF125;NPLOC4;SEC14L1
prerank,protein complex oligomerization (GO:0051259),-0.2420499365422542,-0.8616415293780402,0.7558441558441559,0.9032881444902093,1.0,22/85,17.51%,MCU;RNF213;PDCD6IP;UPB1;ALS2;EHD1;GLRA3;RNF135;SPAST;GSDMD;ZC3H12A;ATL2;TMEM120B;KCNC3;NINJ1;CLDN1;BEND3;AQP11;HOMER1;ELAVL1;PNPT1;SLC9A1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.34965621428128824,0.8615420302486057,0.6282306163021869,0.9050613614916375,1.0,13/27,24.87%,RIMS1;RIMS2;SYT1;SYT2;SYT12;SYT11;VAMP2;SYT13;SYT3;ARL8B;VAMP7;SYT6;SYT10
prerank,response to interleukin-6 (GO:0070741),-0.3913024148575191,-0.8609812413461114,0.6325411334552102,0.9040217049971933,1.0,3/10,4.49%,ST3GAL6;PTGIS;SBNO2
prerank,chromatin assembly or disassembly (GO:0006333),-0.3865486382588452,-0.8606520304810149,0.6751824817518248,0.9040827174738982,1.0,1/11,2.35%,HDAC8
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3268168394968749,0.8598711444756365,0.664323374340949,0.9075146583238142,1.0,8/44,6.01%,SPRY4;NF1;IL1B;PTPN22;SH2B3;SPRY2;CD300A;UCHL1
prerank,regulation of cellular metabolic process (GO:0031323),0.32100518186073856,0.8598406302056335,0.6078098471986417,0.9068242118720478,1.0,2/45,2.56%,PID1;FOXM1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3804932132943515,0.8597553250000828,0.5831663326653307,0.9062392211330085,1.0,3/14,5.50%,ELAVL4;DAZL;BOLL
prerank,regulation of cellular localization (GO:0060341),-0.2723825224097063,-0.8595133239270449,0.7216981132075472,0.9057684431645503,1.0,6/46,7.03%,GSN;ADCY5;LRRK2;PARD6G;EFNA5;STXBP4
prerank,monosaccharide transmembrane transport (GO:0015749),0.37552567580740787,0.859205161488557,0.6145374449339207,0.9065955699703572,1.0,5/16,16.93%,SLC5A1;SLC2A6;SLC2A9;SLC23A2;SLC23A1
prerank,negative regulation of RNA splicing (GO:0033119),-0.33231765537627156,-0.8591057409068726,0.649402390438247,0.9059731482494646,1.0,7/19,21.95%,RPS13;SRSF10;TMBIM6;SRSF6;PTBP3;PCBP4;RPS26
prerank,positive regulation of cytokine production (GO:0001819),0.2463453914060722,0.8589963781919686,0.7462311557788944,0.9062637403535863,1.0,14/292,3.57%,PDE4D;PLA2R1;GLMN;PIK3CD;RORA;AFAP1L2;RGCC;NODAL;RFTN1;IL1B;PTPN22;CD46;FFAR2;SPTBN1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.3023920739730986,-0.8589691705720055,0.6850220264317181,0.9056327040963158,1.0,10/26,22.35%,FBN1;TCTA;C1QC;ZFPM1;GPR137;CEACAM1;TLR4;PTPN2;FSTL3;RARA
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.35162499785088386,0.8588111304883159,0.6337209302325582,0.9059011555455555,1.0,13/29,20.39%,CNOT2;KCTD6;VPS18;UFM1;CNOT9;VPS11;KANK2;PAK1;STRN3;CNOT1;DDRGK1;KMT2D;WBP2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3378189586462049,0.8585462244927367,0.608286252354049,0.9056671481095955,1.0,3/30,2.06%,HEYL;PKN1;NODAL
prerank,mononuclear cell differentiation (GO:1903131),-0.31531964691982045,-0.8584697995575207,0.6895874263261297,0.905999228568003,1.0,4/24,5.09%,IL31RA;BMP4;PIR;GAS6
prerank,regulation of endocytosis (GO:0030100),0.307531903156322,0.8581333776183506,0.6554054054054054,0.9057241659387094,1.0,15/61,14.52%,NEDD4L;ROCK1;RIT2;GPC3;CBLL1;SCAMP5;SNCA;AP2S1;HIP1;ABL2;PACSIN3;SRC;PTPN1;ABCA7;RAB5A
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4072098868297184,0.8580103479915907,0.5850202429149798,0.9052198755026515,1.0,1/11,1.19%,NOTCH1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.37802263512404644,0.8578924033077713,0.5878661087866108,0.9047171284900225,1.0,5/18,16.21%,CORO2B;CEP120;CCT7;CCT3;CEP135
prerank,regulation of lipid catabolic process (GO:0050994),0.3652002129372729,0.8576869155451403,0.6036217303822937,0.9043688636976813,1.0,7/19,23.39%,IL1B;RARRES2;PRKAA1;LONP2;PDE3B;TYSND1;ABCD1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3020691277746491,-0.8576846659447339,0.6917808219178082,0.9069716161791778,1.0,12/30,28.90%,FHIT;SDCBP;RPL11;TRIM39;HSP90AB1;HFE;STYX;PARK7;UBXN1;BAG5;EIF3H;USP14
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.39836653303478076,-0.8569426265289226,0.6773584905660377,0.9078296017095938,1.0,3/10,8.76%,APOD;LRCH1;AKT1
prerank,water transport (GO:0006833),-0.37235343629744244,-0.8568403470739517,0.6388349514563106,0.9074267005067703,1.0,1/12,1.41%,PDPN
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2997772116809486,-0.8567318012588971,0.665948275862069,0.9070191018884515,1.0,7/26,20.68%,OCLN;AKAP9;TRPV4;MET;TOGARAM1;FES;NUMA1
prerank,myelination in peripheral nervous system (GO:0022011),-0.3667160410773835,-0.8566498921709784,0.6615969581749049,0.9065836425213163,1.0,6/13,20.39%,ADGRG6;SKI;PARD3;MYOC;SIRT2;DICER1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.3629849687716331,-0.8555732161192432,0.6596153846153846,0.9081253502581708,1.0,6/13,25.47%,LRRK2;MET;TXN;PARK7;NR4A3;RACK1
prerank,ganglioside biosynthetic process (GO:0001574),-0.3459122938618231,-0.8551878434391805,0.6558704453441295,0.9082921679742306,1.0,5/15,11.77%,ST3GAL1;ST3GAL2;ST6GALNAC3;ST8SIA2;ST6GALNAC6
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3737769835398538,-0.8550168393280652,0.6134122287968442,0.9080312978456707,1.0,5/11,27.52%,MAVS;TICAM1;TYROBP;ITGB2;ITGAM
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.31155638053091156,-0.8545999553690162,0.7012448132780082,0.9082829447633456,1.0,5/26,13.00%,NOD1;IRAK2;MAP2K6;CASP8;UBB
prerank,mitotic cytokinetic process (GO:1902410),-0.32405722937822523,-0.8542716274037229,0.6737451737451737,0.9082943602900538,1.0,6/20,17.90%,PDCD6IP;RHOA;CHMP4B;CHMP4A;MITD1;KLHDC8B
prerank,regulation of cell projection organization (GO:0031344),-0.3675988649707611,-0.8541245612728333,0.667910447761194,0.9079952941587538,1.0,4/13,13.16%,MACF1;MOV10;MYO9A;MFSD2A
prerank,macrophage chemotaxis (GO:0048246),-0.37915212567520984,-0.8540485978857087,0.6266666666666667,0.9075418677159574,1.0,5/10,38.70%,EDNRB;CKLF;CCL2;CXCL17;CCL5
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3012175116933324,0.8531877782394224,0.648695652173913,0.9122871341083884,1.0,14/66,11.85%,PTEN;CDK6;RGCC;MYO16;DDX3X;LSM10;APPL1;FGF10;CDKN1A;PKD2;KANK2;RBL1;RB1;APC
prerank,mitochondrial protein processing (GO:0034982),0.4093165142025825,0.8531491652599068,0.6070640176600441,0.9116366021925614,1.0,4/11,17.41%,IMMP2L;YME1L1;MIPEP;PMPCB
prerank,regulation of coagulation (GO:0050818),-0.377488304531882,-0.8531137384380029,0.6642066420664207,0.9087969425861245,1.0,5/11,31.68%,CAV1;EPHB2;PROCR;F2R;HRG
prerank,B cell mediated immunity (GO:0019724),0.4069206327950726,0.8524161043949957,0.6012658227848101,0.9123262815815215,1.0,2/10,18.74%,CARD9;CD27
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.35768240039561716,-0.852223240255624,0.6717267552182163,0.9099143742259955,1.0,11/14,51.17%,CSF1;TYROBP;ATP6AP1;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,regulation of cytoplasmic transport (GO:1903649),-0.3649304871232321,-0.8517813664527624,0.6532846715328468,0.9102016396127317,1.0,3/11,14.53%,LRRK2;ATP9A;MAPK3
prerank,positive regulation of TOR signaling (GO:0032008),-0.2826248099663058,-0.8516692888636256,0.739514348785872,0.9098021228373531,1.0,19/40,37.49%,GAS6;FNIP1;CLEC16A;GOLPH3;FLCN;GPR137;SIK3;RRAGB;LAMTOR5;PIH1D1;RRAGC;NCKAP1L;RPTOR;TREM2;HTR6;SLC38A9;WDR59;RRAGD;KLHL22
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.37835444505311927,-0.8515896391666851,0.6414048059149723,0.9093608664504629,1.0,4/10,25.85%,ESR1;PSMC2;PSMC5;TP53
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.36077811553099004,-0.8515556152655437,0.6748582230623819,0.9088275604506169,1.0,7/13,30.32%,CNOT7;CPEB3;TNRC6A;POLR2G;EIF4ENIF1;AGO2;ZFP36
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.33758133285935554,-0.8503927178494062,0.6927272727272727,0.910488564281266,1.0,6/18,19.01%,POR;EDN3;PARK7;SIRT3;AGT;AGTR1
prerank,epithelial tube morphogenesis (GO:0060562),0.3426307599570572,0.8501067969495087,0.6467486818980668,0.9160558670211473,1.0,9/32,11.50%,MEF2C;TBX20;COL4A1;RYR2;FGF10;PRKD2;PKD2;PRKX;PAK1
prerank,regulation of histone methylation (GO:0031060),-0.3521911041142843,-0.8500064124416832,0.6520912547528517,0.9106560852068509,1.0,7/13,31.34%,JARID2;NSD1;NNMT;PIH1D1;AASS;PAF1;TET1
prerank,DNA double-strand break processing (GO:0000729),-0.32661318279136736,-0.8499559950407626,0.7004048582995951,0.91015404392291,1.0,6/18,24.17%,ATM;RAD50;SMARCAD1;RAD52;SLX4;BRCA1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3652859324546738,-0.8490953001085064,0.6836935166994106,0.9112365883153106,1.0,2/14,6.32%,IGF1;TNFRSF1B
prerank,regulation of mRNA stability (GO:0043488),-0.2177931389230957,-0.8490180517880248,0.8461538461538461,0.9107754510894078,1.0,40/145,24.71%,SAMD4A;ROCK2;VIM;THRAP3;NOCT;PRKCD;IGF2BP2;RC3H2;AKT1;PSME2;PUM1;TENT5A;PSMB4;UBB;LARP1;PSMB1;PSMD11;FTO;PSMD8;FXR2;EXOSC5;PSME3;XRN1;ELAVL1;PSMD4;PSMA2;CSDC2;ZFP36L2;E2F1;TENT5C;PSMD3;NUP214;PSMB7;PCBP4;TNFSF13;PSMC2;EXOSC7;SAMD4B;PSMC5;PSMD10
prerank,mRNA modification (GO:0016556),0.3536311363111073,0.8484802760264017,0.6050420168067226,0.9185297867586563,1.0,8/22,19.99%,TRMT61A;CBLL1;TRUB1;TRMT10C;PUS7;NSUN2;ZC3H13;WTAP
prerank,autophagy of nucleus (GO:0044804),-0.34182728355256115,-0.848201139129035,0.6942307692307692,0.9117616755724623,1.0,5/16,24.93%,WIPI2;ULK2;ATG2A;ATG7;ATG12
prerank,regulation of interleukin-10 production (GO:0032653),0.3191967318134898,0.8479504674632484,0.6499102333931778,0.9188320929568018,1.0,4/44,6.03%,TNFRSF21;CD46;TRIB2;IL4
prerank,regulation of urine volume (GO:0035809),-0.38395869602751853,-0.8479434354492179,0.6698473282442748,0.9116474970266799,1.0,2/10,5.58%,NPR3;NPR1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.27511120763391905,-0.8477632409649648,0.7199124726477024,0.9113904585258988,1.0,14/42,23.90%,LARS2;RARS2;KARS1;TARS2;CARS1;QARS1;SARS1;HARS1;MARS2;EARS2;VARS2;FARSA;PPA1;FARSB
prerank,granulocyte chemotaxis (GO:0071621),0.30475469105179237,0.8472647149470636,0.649737302977233,0.9193724827320044,1.0,6/55,7.50%,PIK3CD;CXCR2;CXCL10;PDE4B;CXCL5;PIKFYVE
prerank,N-terminal protein amino acid modification (GO:0031365),0.37493424437465006,0.846974461343421,0.6188524590163934,0.9192141505032322,1.0,5/14,21.24%,METAP2;NAA11;NAA15;METAP1;NTMT1
prerank,myeloid cell differentiation (GO:0030099),-0.2622163949069253,-0.8467555267756464,0.7125890736342043,0.912772875128083,1.0,18/47,27.92%,ZBTB16;RPS14;MFHAS1;RPS19;KIT;SLC25A38;IKZF1;TAL1;HIPK2;ZFPM1;PTPN2;HSPA9;ACIN1;TET2;RASGRP4;ALAS2;CEBPA;HCLS1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.3440743737461183,-0.8465818428631657,0.6799242424242424,0.9124874589698584,1.0,7/15,25.43%,CPEB2;ZC3H12A;MKNK2;VCP;GSTO2;ATF3;ZFAND1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.31657058900697066,-0.8465504670485908,0.6582809224318659,0.9119449185729567,1.0,2/20,1.64%,DAB2;RHOQ
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.37251619676566816,-0.8458506344852764,0.6575342465753424,0.9126662155320737,1.0,5/12,18.44%,SNAP23;STX3;STX1A;SNAP47;STX2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.27928300527088523,0.8458052073253963,0.6896024464831805,0.9206471040365046,1.0,15/94,9.85%,ATP2A3;MAP3K5;FNIP2;CHAC1;CUL3;BCL2L10;ITPR1;CIDEB;SCN2A;DDX3X;CASP9;CDKN1A;STK24;HTRA2;EPHA2
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.31715407769356135,-0.8456596036721786,0.6869918699186992,0.9124490283267886,1.0,10/22,23.23%,SASH1;XDH;MFHAS1;ZC3H12A;RELL1;SPHK1;MAP3K4;GADD45G;VEGFA;GADD45B
prerank,cellular response to hypoxia (GO:0071456),0.2686086553195219,0.8452276484876048,0.7115097159940209,0.9210466798712783,1.0,10/126,4.92%,LIMD1;RORA;RGCC;CPEB1;RBX1;KCND2;FMN2;SCN2A;EPAS1;PSMB11
prerank,response to light stimulus (GO:0009416),0.30295820526452727,0.8451459956472092,0.6588447653429603,0.9204556008229718,1.0,20/55,23.01%,OPN1MW;OPN1MW3;TYR;ERCC4;CCAR2;MAPK10;BRSK1;RRH;OPN3;USP1;CRY1;UVSSA;ERCC8;CPT1B;UBE2B;DDB2;COPS3;UBE2A;DRD2;CIRBP
prerank,mitotic spindle organization (GO:0007052),0.26059018400998757,0.8448464515111013,0.7197724039829303,0.9202502463604744,1.0,21/153,15.10%,DYNLL1;RMDN1;MECP2;NUP43;TNKS;CLASP2;CENPP;PPP1CC;DYNC1I2;NEK6;TUBG2;XPO1;TOGARAM2;SEC13;NUDC;MZT1;KIFC2;LSM14A;RANBP2;CEP126;MAD2L1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.34326963158525564,-0.8447435632984132,0.6792079207920793,0.9137336974876501,1.0,6/16,16.95%,TNKS2;SMG6;NAF1;PINX1;ATM;SMG5
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2831713808856456,-0.8447347934504815,0.7121535181236673,0.9131609440462556,1.0,7/33,13.04%,ESR1;DDX5;AR;KLK2;H3-3A;CARM1;CALR
prerank,cellular response to lipopolysaccharide (GO:0071222),0.27808306303055125,0.8442658517133108,0.7079510703363915,0.9206570693424403,1.0,10/101,6.43%,MEF2C;NR1H3;IL1B;PTPN22;AXL;CXCL10;TNIP2;PDE4B;CXCL5;CACTIN
prerank,regulation of axon extension (GO:0030516),-0.2801514615812179,-0.8440534583669014,0.7127882599580713,0.9138692872142301,1.0,16/37,28.95%,APOE;MACF1;SEMA7A;DIP2B;NTN1;RUFY3;SEMA3G;MAP3K13;MT3;ZFYVE27;DBN1;SIN3A;PTPRS;RTN4R;ABL1;CTTN
prerank,inner dynein arm assembly (GO:0036159),-0.38850405089863466,-0.8435600583059594,0.6880733944954128,0.9141875740613714,1.0,9/10,57.91%,CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3;CFAP73;ZMYND10;DNAAF5
prerank,mitotic sister chromatid cohesion (GO:0007064),0.37257392409895457,0.8433203078128585,0.6428571428571429,0.9217570204038986,1.0,5/16,13.84%,REC8;POGZ;MAU2;RB1;NIPBL
prerank,response to axon injury (GO:0048678),-0.3265579201412554,-0.8431746127663593,0.6787762906309751,0.9143040500995885,1.0,3/18,7.43%,DPYSL3;APOD;P2RX4
prerank,protein modification by small protein conjugation (GO:0032446),-0.19787698596805314,-0.8425895892404209,0.9617486338797814,0.9148228987555995,1.0,79/361,20.63%,RNF220;FBXL7;EYA1;PDZRN3;RNF213;SMURF2;FBXO10;RNF38;ASB2;RNF43;TRIM24;SPSB1;ARRB1;WWP2;HIF3A;RNF139;SMURF1;CDC16;KLHL2;RNF103;AMFR;RTF1;CHFR;MKRN2;DTX3L;HIF1A;KCTD10;RNF135;STX1A;MGRN1;ZNRF3;ARRDC1;TRIM27;USP5;CUL4A;ASB5;MDM2;TRIM63;UBE2Q2;SAE1;FBXW11;TRIM35;BRAP;UBB;RNF181;TRIM39;ATG10;ELOB;UBE2G2;NEDD8;DDB1;DTX1;TRIM17;NUP98;UBA3;WWP1;FBXL2;RNF187;ASB1;RNF40;SPSB4;TPR;UBA7;SPSB2;ANAPC16;ARRDC4;TRIM14;UBE2M;TRIM47;TRIM41;VCP;NUP88;PIAS4;CDC27;RNF144A;URM1;NUP214;CDK5RAP3;TRPM4
prerank,lipid droplet formation (GO:0140042),0.4140544826967478,0.8424542401599829,0.6144329896907217,0.9227162787639608,1.0,2/10,10.56%,CDS2;SQLE
prerank,Golgi ribbon formation (GO:0090161),-0.354864995207819,-0.8422544469139364,0.651685393258427,0.9148371447434364,1.0,4/13,10.98%,MYO18A;GOLPH3;STX6;OPTN
prerank,protein palmitoylation (GO:0018345),0.3319913957660496,0.8422453133469336,0.627254509018036,0.9223738149405458,1.0,8/30,13.53%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC16;ZDHHC17;ZDHHC21;ZDHHC23;HHAT
prerank,positive regulation of lipid catabolic process (GO:0050996),0.36606474051822324,0.8420374803277749,0.6232741617357002,0.9220361885983004,1.0,3/19,7.20%,IL1B;ABCD2;IRS1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.38878423396731154,0.8418961801864999,0.6546610169491526,0.9208521463715532,1.0,2/13,4.10%,IL15RA;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.38878423396731154,0.8418961801864999,0.6546610169491526,0.9208521463715532,1.0,2/13,4.10%,IL15RA;JAK1
prerank,superoxide metabolic process (GO:0006801),0.3303293617583202,0.8402667364182618,0.6303142329020333,0.9231935022769658,1.0,4/29,5.98%,NCF2;NCF1;ATP7A;SOD3
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3955479698144011,0.8401324589478965,0.6073752711496746,0.9227151808711728,1.0,1/11,1.15%,BMP5
prerank,mRNA catabolic process (GO:0006402),-0.2693022133922153,-0.8399251315335441,0.7305122494432071,0.9187134875037717,1.0,14/44,23.10%,DDX5;TUT4;THRAP3;TUT7;ERN1;NUDT12;XRN1;NBDY;PNPT1;LSM5;ZFP36L2;AGO1;NUDT16;DHX34
prerank,membrane raft organization (GO:0031579),0.3802109245228462,0.8398940317562453,0.6280087527352297,0.9224733427252013,1.0,6/15,14.92%,RFTN1;EMP2;PPT1;NPC1;ABCA7;MYADM
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.24337212736551828,-0.8398835883965958,0.7819548872180451,0.9182021871533321,1.0,28/70,28.39%,B2M;TAPBP;SNAP23;LNPEP;PSME2;PSMB4;CALR;CYBA;PSMB1;PSMD11;PSMD8;PDIA3;PSME3;PSMD4;PSMA2;IKBKG;PSMD3;CYBB;PSMB7;VAMP8;PSMC2;PSMC5;TAP2;PSMD10;FCGR1A;PSMD7;TAP1;MFSD6
prerank,negative regulation of translation (GO:0017148),-0.23845417980693054,-0.8396378529370592,0.821917808219178,0.9180404718561623,1.0,21/87,18.48%,DAPK1;SAMD4A;ROCK2;IGFBP5;CNOT7;RNF139;DDX6;CPEB2;IGF2BP2;PUM1;CPEB3;CALR;LARP1;CNOT8;FTO;FXR2;EIF4EBP1;TPR;PAIP2B;EIF4E2;TYMS
prerank,regulation of RNA export from nucleus (GO:0046831),0.3959654220746547,0.8396333335976236,0.6214442013129103,0.9222276198656224,1.0,2/11,7.49%,NCBP2;CPSF6
prerank,presynaptic endocytosis (GO:0140238),0.3513735132902516,0.8396134118547044,0.6428571428571429,0.9215315024660761,1.0,7/24,17.69%,CEL;SNCA;SYT1;SYT2;NLGN3;CDK5;VAMP2
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2923874055500512,-0.8393436305514157,0.720173535791757,0.9180000607672234,1.0,10/31,23.51%,TNKS2;NAF1;PML;ATM;MAPK3;RAD50;MAP3K4;MAP2K7;SLX4;ERCC1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.34974905693521824,0.8389583986677108,0.6097560975609756,0.9220556280892471,1.0,4/21,7.02%,SPRY4;SH3BP1;SPRY2;LZTR1
prerank,cilium-dependent cell motility (GO:0060285),-0.3061811918596961,-0.8388552454379964,0.734225621414914,0.9183132687298323,1.0,11/22,35.79%,EFHC1;EFHC2;DNAH3;DNAH8;DRC1;CCDC65;DNAH2;DNAAF2;TEKT2;CFAP44;DNAH17
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2444639170531792,-0.8387912456773873,0.7738693467336684,0.9178305159959056,1.0,27/72,30.73%,POLR2A;ERCC5;CUL4A;COPS4;POLR2F;UBB;COPS8;DDB1;RPA1;POLR2E;HMGN1;RFC3;TCEA1;RFC1;ERCC1;ERCC2;RPA3;POLR2G;COPS7A;CDK7;ERCC3;COPS2;PRPF19;POLD1;MNAT1;GTF2H3;PCNA
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.29702471832075217,0.8386688252782056,0.6790923824959482,0.9218839403768677,1.0,17/70,13.39%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;WASF2;MYO10;LYN;NCKAP1;DOCK1;ARPC4;PAK1;SRC;ARPC1A
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3555520301350653,0.8386176844138752,0.6477732793522267,0.9212550096320139,1.0,5/18,20.21%,COX18;FASTKD3;COX20;OXA1L;SURF1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2969397047267782,0.8383800201100282,0.6796116504854369,0.9209651560540084,1.0,17/71,13.39%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;WASF2;MYO10;LYN;NCKAP1;DOCK1;ARPC4;PAK1;SRC;ARPC1A
prerank,regulation of cell growth (GO:0001558),0.24964205040197646,0.8380583401815281,0.7641509433962265,0.9208556449954338,1.0,19/204,8.15%,PLCE1;RERG;APBB2;SLC25A33;RASGRP2;SLIT3;BCAR1;SIPA1;PABIR1;CRLF3;NRG3;AKAP6;ROS1;DDX3X;CAPRIN2;SUPV3L1;PPT1;CDKN1A;MTOR
prerank,proteoglycan biosynthetic process (GO:0030166),0.33956664140519704,0.8380006207279147,0.6525911708253359,0.9202417580571509,1.0,2/31,2.35%,NDST3;EXTL3
prerank,protein import into peroxisome membrane (GO:0045046),0.3413740407773119,0.8371227603391633,0.6407185628742516,0.9211787680102,1.0,6/22,15.58%,RAB8B;ABCD2;ATAD1;PEX3;PEX19;PEX12
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.35023926269483385,-0.8371194065922007,0.6685823754789272,0.9203676325319744,1.0,3/13,12.43%,NFAT5;RHOA;RELA
prerank,positive regulation of developmental growth (GO:0048639),0.3097247077609757,0.8370770423125824,0.6970227670753065,0.9205422803323682,1.0,5/49,5.28%,NEDD4L;LIMK1;AGRN;RIMS1;RIMS2
prerank,regulation of nuclear division (GO:0051783),-0.31555332772141537,-0.8368693335896761,0.6752988047808764,0.9201933937109295,1.0,7/20,32.09%,OBSL1;CAV2;CCDC8;CUL9;L3MBTL1;MKI67;CUL7
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.32844478429551016,-0.8367526815626986,0.7,0.9198288789885506,1.0,4/18,11.59%,SMAD3;PDPN;EMILIN1;TGFB1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3164022180610069,-0.8367213517627442,0.6853932584269663,0.9192817253920921,1.0,9/21,20.84%,SAMD4A;CNOT7;TUT4;TUT7;CNOT8;CNOT3;PNLDC1;CNOT11;PAN3
prerank,relaxation of muscle (GO:0090075),0.3784845060853079,0.8366315477084957,0.5991902834008097,0.9206522985452558,1.0,2/13,3.05%,ATP1A2;PIK3CA
prerank,neuron projection fasciculation (GO:0106030),0.4014952711609888,0.8364925196936606,0.6012931034482759,0.9201815905797017,1.0,3/10,9.19%,SEMA5A;CNTN4;ARHGAP35
prerank,mRNA destabilization (GO:0061157),-0.2740259391704742,-0.8359672365542099,0.7255813953488373,0.9200380209576635,1.0,9/38,14.26%,ROCK2;TUT4;MOV10;TUT7;RC3H2;ZC3H12A;PUM1;CPEB3;FTO
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3735794058828245,0.8354628294699938,0.6415478615071283,0.9214208963572034,1.0,3/15,9.02%,SEMA5A;FGF2;PRKD2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.28288417467521987,-0.8347658444452928,0.7278481012658228,0.9216772303173897,1.0,15/33,29.82%,FOXO3;HOXA5;MAPK14;STAT1;STAT3;HIF1A;TAL1;HMGB2;FES;BRD1;RAB7B;NCKAP1L;MTURN;HSPA1B;ACVR2A
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.34469667418101313,-0.8344096764888805,0.6988416988416989,0.9217819183113793,1.0,2/13,7.04%,IRAK2;PIK3AP1
prerank,positive regulation of neuron migration (GO:2001224),0.39941271758777586,0.8343340772480068,0.6363636363636364,0.9228801047776277,1.0,1/11,1.01%,RAPGEF2
prerank,negative regulation of calcium ion transport (GO:0051926),0.3844348387207786,0.8338727525987596,0.6465696465696466,0.9230379033036901,1.0,4/15,15.51%,ATP1A2;STC1;PACSIN3;CBARP
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.27537470686013543,-0.8337864381865249,0.7333333333333333,0.9223546614696558,1.0,15/39,28.74%,ABCA1;STEAP3;RCN3;GOLPH3;TMEM167A;RAB8A;PPY;CANX;TANGO2;TVP23B;LTBP2;RAB3D;ARL4D;PREB;RAB3A
prerank,intracellular cholesterol transport (GO:0032367),-0.34209147054986316,-0.8333190229012122,0.7047619047619048,0.9226470894272709,1.0,3/15,6.78%,ABCA1;LRP6;NPC2
prerank,mitochondrial gene expression (GO:0140053),0.31318053996308326,0.8331148777902602,0.6618705035971223,0.9237798062656917,1.0,16/42,20.03%,SLC25A33;FASTKD2;NOA1;TFAM;GATB;GFM2;PTCD3;IARS2;GATC;MRPS34;MRPS12;MRPS18B;TFB2M;MRPS17;MRPL47;MRPL2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3543060738081613,-0.8330745204188194,0.690978886756238,0.9224939922857045,1.0,4/12,17.71%,ABCA1;ITGB3;PPARA;NFKBIA
prerank,transcription by RNA polymerase I (GO:0006360),-0.2807610449424486,-0.8329614697758317,0.7198364008179959,0.9221197485699388,1.0,14/34,30.61%,TAF1;CAVIN1;TCOF1;POLR2F;MAPK3;POLR2E;UBTF;TTF1;ERCC2;CDK7;ERCC3;POLR1C;MNAT1;GTF2H3
prerank,peptidyl-lysine modification (GO:0018205),-0.23254963416632266,-0.8326959954992117,0.8294797687861272,0.9220329720375261,1.0,24/99,20.63%,EYA1;HDAC4;LOXL1;KAT2B;HDAC9;PLOD2;NNAT;STX1A;SENP3;SAE1;NUP98;PLOD1;P3H4;SIRT7;SIRT2;TPR;PARK7;SIRT3;NUP88;PIAS4;ETFBKMT;NUP214;PLOD3;TRPM4
prerank,hyaluronan catabolic process (GO:0030214),0.3594862751403049,0.8322076152296258,0.6464646464646465,0.9248072205884463,1.0,3/18,4.25%,CEMIP2;HYAL4;FGF2
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.36462952722272135,0.8318347850810445,0.632295719844358,0.9247763794529171,1.0,7/17,13.82%,ROCK1;GGA3;NTRK2;CHRNA7;BIN1;RTN1;ABCA7
prerank,cardiolipin metabolic process (GO:0032048),-0.3566993216468946,-0.8314196814631591,0.6660482374768089,0.9238058014169177,1.0,3/13,15.84%,PLA2G4A;PLA2G6;PLSCR3
prerank,positive regulation of lipid localization (GO:1905954),-0.3696333771340828,-0.8313571669250797,0.7091254752851711,0.9233209776687208,1.0,5/11,30.55%,IKBKE;ZC3H12A;LPL;C3;HILPDA
prerank,regulation of regulated secretory pathway (GO:1903305),0.32566413304837305,0.8310299629414815,0.6673151750972762,0.9255383239851898,1.0,12/34,18.00%,RIMS1;RIMS2;SYN1;VPS18;SYT1;SYT2;RAB5A;PREPL;SYT12;SYT11;SYT13;GSK3B
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3605621543624084,0.8308723870719144,0.6404715127701375,0.9251123021891733,1.0,10/19,23.20%,GNL3L;HNRNPA1;SRC;HNRNPU;HNRNPC;PIF1;TERF1;TINF2;CTC1;EXOSC10
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.24317555973468,-0.830834317949571,0.7732997481108312,0.9236910144290386,1.0,15/70,18.05%,SMAD3;IL6R;TNFRSF1B;IFI27;BAG3;MCL1;TNFRSF1A;CASP8;DAB2IP;P2RX7;TGFB1;BID;RIPK1;PDPK1;DEDD
prerank,positive regulation of immune response (GO:0050778),-0.24483008366702277,-0.8305100815118684,0.7699530516431925,0.9237079966963306,1.0,16/64,28.35%,IL15;IL6ST;LGALS9;IFI35;KARS1;GBP5;CYBA;RSAD2;CD81;XBP1;POLR3D;ITGB2;PLSCR1;EIF2AK4;ITGAM;SPHK2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2908446275673948,0.830464226429564,0.6666666666666666,0.9251653472460766,1.0,8/62,11.47%,LIMD1;NUP43;AJUBA;DND1;POLR2C;NUP35;SEC13;NDC1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.34877875689544935,0.8302424119144711,0.6458752515090543,0.9248452675883575,1.0,2/23,4.25%,PIK3CD;FGF2
prerank,regulation of organelle organization (GO:0033043),-0.23661532903166071,-0.8302374112032231,0.7890818858560794,0.9236284029380514,1.0,26/80,24.09%,CLIC4;DIAPH1;EZR;CAPN2;ARMH3;USP6NL;CLEC16A;GOLPH3;AKAP9;MAVS;VPS35;LMAN1;F11R;SURF4;MAPK3;TBC1D25;SIRT7;STX18;SAR1A;SAR1B;TMED9;TMEM33;STMN3;NEXN;CAPN6;RDX
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3642129793915926,0.8299037876979407,0.6538461538461539,0.9247690599513679,1.0,2/17,6.93%,RAPGEF2;ADCY9
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3816941770025838,0.8298866868812134,0.6377440347071583,0.9240759335991213,1.0,4/12,9.66%,PTPN22;CD300A;LYN;PAX5
prerank,sarcomere organization (GO:0045214),-0.2944800345883137,-0.829636618598183,0.6777777777777778,0.9241127418687176,1.0,13/27,40.63%,ACTN2;CSRP2;MYOM2;KRT19;CAPN3;MYPN;MYLK3;FHOD3;TNNT3;TCAP;OBSCN;MYH6;CSRP1
prerank,response to X-ray (GO:0010165),-0.34098494306452554,-0.8295371128816048,0.6854368932038835,0.9237221114866512,1.0,4/14,20.30%,ANXA1;ATM;XRCC4;IKBIP
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.36045356747707613,-0.8294695394707261,0.6958250497017893,0.9232428068448506,1.0,7/11,35.34%,UBN1;H3-3A;HAT1;ASF1A;IPO4;ATRX;ASF1B
prerank,positive regulation of translation (GO:0045727),0.2759255608274855,0.8293865254845088,0.7099841521394612,0.9242783496274442,1.0,33/94,20.20%,PLD1;FASTKD2;DAZL;RPS6KB2;MRPS27;BOLL;YTHDF3;DDX3X;SOX4;MTOR;EIF3C;EIF6;YTHDF2;FASTKD3;PRKDC;TRMT10C;UPF3B;LARP6;DHX36;RMND1;C1QBP;FMR1;PKM;RPS6KB1;PRR16;NSUN5;HNRNPD;HABP4;POLR2D;EEF2;EIF3E;RBM3;POLDIP3
prerank,regulation of hormone secretion (GO:0046883),-0.3379911075099643,-0.8291365176052611,0.704119850187266,0.9232420548864395,1.0,2/15,3.96%,SNX6;ANXA1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.37831779426364837,0.828805582484548,0.6359832635983264,0.9246569697139674,1.0,4/12,17.68%,HEXIM1;TCERG1;HNRNPU;LARP7
prerank,regulation of complement activation (GO:0030449),0.31853413828812666,0.8286527182835035,0.6441281138790036,0.9241928266039169,1.0,6/40,9.51%,VTN;IL1B;CD46;C7;SUSD4;CR2
prerank,neuron fate commitment (GO:0048663),-0.3406388393223446,-0.8281712950556351,0.6920222634508348,0.9244422027902593,1.0,8/14,44.36%,TGFBR1;ID2;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1
prerank,positive regulation of transport (GO:0051050),0.2762097735353858,0.8279536862581722,0.7041800643086816,0.924793145360052,1.0,8/85,6.30%,NEDD4L;IL15RA;NR1H3;MERTK;IL1B;GPC3;CBLL1;SNCA
prerank,positive regulation of nervous system process (GO:0031646),-0.3266237028129563,-0.8278329802271004,0.7265469061876247,0.9244650869886661,1.0,4/18,9.97%,UNC13B;TNFRSF1B;PARD3;NLGN2
prerank,sensory perception (GO:0007600),0.3078830429486751,0.8266661756079193,0.6765217391304348,0.926479803587014,1.0,11/45,17.78%,ADORA2A;TRPV2;OPRK1;CHRNA7;SCN9A;TMEM150C;ASIC3;CHRNB2;NIPSNAP1;TTC8;GNAL
prerank,copper ion homeostasis (GO:0055070),-0.32353866340357107,-0.8265136516552561,0.7017208413001912,0.9262640265281672,1.0,2/17,5.22%,APP;ATOX1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3258855614736468,-0.8265017216215824,0.7145669291338582,0.9256892862838147,1.0,9/17,34.56%,ATP5PF;DMAC2L;ATP5MF;ATP5MC3;ATP5MC1;ATP5MC2;ATP5F1E;STOML2;ATP5MG
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3643357149459803,-0.8263991286797224,0.700374531835206,0.924699519624502,1.0,2/10,21.34%,CACNA2D4;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3643357149459803,-0.8263991286797224,0.700374531835206,0.924699519624502,1.0,2/10,21.34%,CACNA2D4;TULP1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.26106259375940694,-0.8262428872758877,0.755056179775281,0.9243758711244767,1.0,16/49,23.73%,ADAMTS9;DENND3;STT3B;SIDT2;IDE;DAB2IP;DNASE1L1;UBE2G2;PNPT1;MANBA;RIPK1;NGLY1;DFFB;FBXO17;CHEK2;EXOSC7
prerank,nuclear export (GO:0051168),-0.23763453345630353,-0.8261897548971507,0.8157894736842105,0.9238846045616566,1.0,26/80,30.82%,RANBP3L;ATXN1;SMURF1;CCHCR1;NXF1;TGFB1;RAN;CALR;PKD1;SRSF2;TPR;SRSF6;CHP1;THOC1;NUP214;SRSF5;THOC7;XPO4;SRSF11;NUP155;RANBP17;CSE1L;NUP62;THOC5;XPO5;LSG1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2915545161728604,0.8261714478700751,0.7105691056910569,0.9266621749376295,1.0,17/73,13.39%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;WASF2;MYO10;LYN;NCKAP1;DOCK1;ARPC4;PAK1;SRC;ARPC1A
prerank,membrane depolarization (GO:0051899),0.3255765963180314,0.825762230314815,0.6525735294117647,0.9267316734850538,1.0,9/32,14.69%,CACNA1H;SCN2A;SCN5A;SCN8A;SCN9A;CACNA1A;ATP5IF1;SCN1A;CHRNB2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.36591871884290084,0.8254952536939207,0.6461864406779662,0.9265184202428497,1.0,4/17,7.70%,KCNE4;CACNA2D1;SCN5A;KCNE5
prerank,cAMP biosynthetic process (GO:0006171),0.3898357179868782,0.8253711218785451,0.6247422680412371,0.9260362577241856,1.0,4/10,6.93%,ADCY8;ADCY3;ADCY6;ADCY9
prerank,RNA processing (GO:0006396),0.2526211685413566,0.825352055069154,0.7652050919377652,0.9253537625406943,1.0,45/176,20.43%,RBPMS;APOBEC1;FASTKD2;ELAVL4;CLP1;DHX15;LSM3;NCBP2;ADARB2;SFPQ;HNRNPR;SRRM1;XRN2;RNPS1;CPSF6;TCERG1;RBMS1;SNRNP25;PRPF6;CCAR2;DDX47;SCNM1;HNRNPUL1;PABPC4;DDX23;CELF1;HNRNPU;HNRNPC;KIN;LSM1;SF3B3;SNRPD3;KHSRP;USB1;HNRNPD;LIN28B;FUS;SNRNP48;HNRNPA2B1;RBM3;RNGTT;PPP2R1A;LUC7L3;SRRM4;LSM6
prerank,TOR signaling (GO:0031929),0.3330014118702671,0.8247779199191831,0.6351606805293005,0.9256630900522989,1.0,5/26,8.93%,EIF4EBP2;PRR5L;RPS6KB2;MTOR;NPRL3
prerank,integrated stress response signaling (GO:0140467),-0.33391766413326046,-0.824534486640306,0.6782945736434108,0.9263358574834087,1.0,5/14,30.68%,QRICH1;HSPA5;EIF2AK3;EIF2AK4;CCL2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3252980502344772,0.8245279340625485,0.6765249537892791,0.9254222472337216,1.0,14/30,24.88%,ARV1;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;HMGCR;INSIG1;NSDHL;MVK;FDFT1;ACAA2;CYP51A1;FDPS
prerank,regulation of cilium assembly (GO:1902017),0.2948725627640819,0.824320033636299,0.6903914590747331,0.9250544910399529,1.0,15/62,16.80%,TBC1D1;TBC1D30;IFT20;TESK1;TBC1D2B;ARHGAP35;TBC1D10C;TBC1D9B;CEP97;FUZ;TBC1D19;CEP120;TBC1D10B;KCTD17;HTT
prerank,microtubule anchoring at centrosome (GO:0034454),0.3873853553433295,0.8243104762235027,0.6308724832214765,0.9243582746062545,1.0,5/10,21.22%,HOOK3;KIF3A;DCTN1;CEP19;CCDC68
prerank,mitochondrion distribution (GO:0048311),-0.3581209936682468,-0.8243042712040684,0.7034220532319392,0.9261438957744366,1.0,3/12,15.88%,LRRK2;MEF2A;MSTO1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.34530616903227457,0.8237165541462549,0.6350515463917525,0.9247806906532458,1.0,4/22,9.24%,RAPGEF2;NTRK2;RAP1A;TMEM108
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3414496887030575,-0.8230101756503927,0.7056672760511883,0.9279097492509553,1.0,5/14,22.33%,TNKS2;PINX1;BRCA2;TPP1;ACD
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.27838373681022915,-0.8224871300445318,0.7565217391304347,0.9282726162003949,1.0,10/33,18.15%,ANXA1;CYP1B1;RHOB;PRKCD;RELA;SIRPA;NET1;RIPK1;OSER1;PARK7
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.35119047896076205,-0.8222878690087402,0.7100371747211895,0.9280484266389611,1.0,1/12,0.40%,UNC13B
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.28695310707617144,-0.8222820051622157,0.7568627450980392,0.9274705106128894,1.0,14/30,25.95%,NOS3;ARHGEF2;CFLAR;TNFSF10;ICAM1;CASP8;SERPINE1;RIPK1;GPX1;PARK7;RFFL;BRCA1;BCL2L1;FAS
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3180719211010201,0.8220815905940909,0.6601423487544484,0.9270831678551277,1.0,10/35,14.58%,CDK6;ETS1;FAM210B;ANKRD54;ARNT;LYN;MED1;PRMT1;PRKDC;ABCB10
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2584907996254677,0.8215657407685426,0.7151424287856072,0.9272918024437806,1.0,17/122,9.26%,PDGFRB;PLD1;RGCC;IL1B;FGF2;YTHDF3;IL4;DDX3X;SOX4;KAT7;IRS1;NMD3;MTOR;EIF3C;PRKD2;PDGFB;GCK
prerank,long-term synaptic potentiation (GO:0060291),-0.3128641322713109,-0.82153415888567,0.7437858508604207,0.9281831919361999,1.0,5/21,8.84%,SLC8A3;PRKCZ;PTK2B;PLK2;GRIN2D
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.36216020338563565,-0.8213235645569673,0.7024029574861368,0.9279680234975054,1.0,4/11,12.59%,IGF2BP2;NOVA2;PCBP2;NOVA1
prerank,positive regulation of cellular protein localization (GO:1903829),-0.23516366942140998,-0.8210484330060331,0.804177545691906,0.9278583475696296,1.0,21/69,21.83%,LIMK2;PARP9;YAP1;GPD1L;STX3;TFRC;AKT1;DTX3L;CARD10;TGFB1;HSP90AB1;PRKAA2;TM9SF4;PARK7;LAMTOR5;ORMDL3;VPS28;CDK5RAP3;NUMA1;TYROBP;EIF2AK3
prerank,cellular response to metal ion (GO:0071248),0.2635971642831974,0.8210315134533354,0.7242424242424242,0.9275786737007358,1.0,20/123,11.38%,MEF2C;SLC12A2;RASGRP2;CACNA1H;NCF1;ADCY8;ITPKB;CPNE7;SCN5A;ANK3;SNCA;SYT1;RYR3;PKD2;HPCA;DLG2;CPNE4;BRAF;CHP2;SYT2
prerank,organelle fusion (GO:0048284),0.34045133983329734,0.8207070345957959,0.6493775933609959,0.927419594609484,1.0,7/22,15.81%,PLD6;VPS18;VPS11;STX4;MFF;MFN1;MIEF1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.27090088022596853,0.8206878090330718,0.7484375,0.9267461016078866,1.0,9/95,6.43%,MEF2C;NR1H3;IL1B;AXL;CXCL10;TNIP2;PDE4B;CXCL5;CACTIN
prerank,dendrite self-avoidance (GO:0070593),-0.3194139237572947,-0.8204903270526845,0.7116104868913857,0.9283207541753077,1.0,3/16,10.19%,BSG;PALLD;ROBO4
prerank,negative regulation of catalytic activity (GO:0043086),0.34042967435881416,0.8204343825602571,0.6354581673306773,0.9265047174006695,1.0,5/24,13.42%,NOTCH1;NES;CCAR2;ATP5IF1;PPP1R12A
prerank,respiratory chain complex IV assembly (GO:0008535),0.33591012117855756,0.8197056198394127,0.6456692913385826,0.9271368675275987,1.0,6/21,20.21%,COX18;FASTKD3;COA6;COX20;OXA1L;SURF1
prerank,actin nucleation (GO:0045010),0.34664455328259736,0.8194282457257864,0.641851106639839,0.9269655730706006,1.0,6/21,13.39%,SPIRE1;ARPC5;ARPC5L;LMOD1;ARPC4;ARPC1A
prerank,positive regulation of isotype switching (GO:0045830),-0.335187617510481,-0.8192033847857643,0.6945996275605214,0.9299534261499027,1.0,6/15,22.40%,TFRC;TGFB1;SHLD1;KMT5C;CLCF1;TNFSF13
prerank,protein oxidation (GO:0018158),-0.3562416059769189,-0.8189044919672525,0.6917148362235067,0.9298668258628886,1.0,1/11,1.62%,LOXL1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3110008273787829,-0.8186403843862634,0.7278481012658228,0.9297094215568024,1.0,3/20,13.54%,WNT4;C1QTNF3;PGP
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.23830730813266493,-0.8184346991832568,0.8217054263565892,0.9294870172642412,1.0,21/73,20.59%,HDAC4;DNMT3A;KAT2B;RBBP7;IGF2;BAZ1B;H3-3A;JARID2;TRIM27;POLR2F;TDG;HDAC5;ACTB;PPHLN1;POLR2E;GPX1;EZH2;ZFP57;SMYD5;CTCF;MPHOSPH8
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.3683533209638783,-0.8181299582838258,0.7110694183864915,0.9294547028545537,1.0,5/10,22.98%,LRRK2;TXN;RIPK1;PARK7;STK26
prerank,protein insertion into ER membrane (GO:0045048),-0.2708426276900461,-0.8176481137661887,0.7782608695652173,0.9297465981388868,1.0,16/37,32.57%,APP;TRAM2;EMC2;STX1A;ALDH3A2;VAPA;GET1;SEC61B;EMC6;WDR83OS;CCDC47;UBL4A;TRAM1;HMOX1;GET3;MMGT1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3416677585168994,0.8175680212388344,0.6508264462809917,0.9296267700408489,1.0,4/20,11.62%,NOTCH1;CHD6;RUNX2;EP300
prerank,intracellular sterol transport (GO:0032366),-0.344833433695608,-0.8172707438498273,0.7056603773584905,0.9298450192803267,1.0,3/13,13.55%,ABCA1;NPC2;STARD4
prerank,histone methylation (GO:0016571),-0.2938823682140338,-0.817012399537651,0.744421906693712,0.929706505266854,1.0,9/26,25.80%,SMYD3;CARM1;EHMT1;NSD1;SIRT7;EZH2;SETD6;TRMT112;FBL
prerank,mitochondrion organization (GO:0007005),0.2500005555319277,0.8170078138275516,0.762114537444934,0.9299843375713225,1.0,16/165,8.56%,PID1;HIGD1B;SLC25A33;IMMP2L;AKT3;PLD6;PTCD2;ATP7A;FANCG;ESRRA;SUPV3L1;GABPA;TIMM22;MTFP1;TFAM;RAB38
prerank,mitotic spindle assembly (GO:0090307),-0.2580102063370334,-0.8167082638409525,0.7803203661327232,0.9296162048575748,1.0,18/42,33.68%,RAB11A;RHOA;SMC3;TOGARAM1;SMC1A;CEP192;CHEK2;ABRAXAS2;MISP;ARHGEF10;PIBF1;TPX2;KIFC1;STAG2;KIF4A;GOLGA2;KIF23;PRC1
prerank,regulation of cell cycle phase transition (GO:1901987),-0.22579964539556663,-0.8164128651084632,0.8443271767810027,0.9295429625347682,1.0,29/91,25.85%,TAF1;MN1;CDC16;PSME2;ANAPC4;PSMB4;TRIM39;PSMB1;PSMD11;DDB1;PSMD8;DBF4;PSME3;CDKN1B;TCIM;ANAPC16;PSMD4;FZR1;PSMA2;PSMD3;CDC27;PSMB7;ANAPC5;PSMC2;ERCC2;PSMC5;PSMD10;ERCC3;TP53
prerank,mRNA methylation (GO:0080009),0.3646696944385267,0.8161569241415736,0.6353944562899787,0.9308789924942662,1.0,6/15,19.99%,TRMT61A;CBLL1;TRMT10C;NSUN2;ZC3H13;WTAP
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3665408292868785,0.8161271837550433,0.6560636182902585,0.9302222000573945,1.0,2/17,1.63%,ATP1A2;GPER1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2971372977990308,0.8160152397389191,0.7038327526132404,0.9297277976785271,1.0,11/48,12.70%,FNIP2;BCL2L10;CIDEB;CASP9;CDIP1;HTRA2;EPHA2;DDIT4;HIPK1;EP300;PRKDC
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.30124699745790695,-0.8159313509765378,0.732776617954071,0.9297887260540253,1.0,3/22,7.22%,ROCK2;PTPA;FKBP1A
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.22507193919362806,-0.8155738610205141,0.8428184281842819,0.9298134784783898,1.0,29/94,24.89%,PLCB1;IL1R1;NOD1;IRAK2;MAP3K8;IRAK3;PSME2;RELA;PSMB4;FBXW11;UBB;PSMB1;PSMD11;PSMD8;MAPK3;PSME3;PELI1;NFKBIA;MAP3K3;PSMD4;PSMA2;IKBKG;PSMD3;PSMB7;PSMC2;PSMC5;EGR1;PSMD10;MYD88
prerank,early endosome to late endosome transport (GO:0045022),-0.32030382040825683,-0.8151216446551115,0.7151394422310757,0.9299875902312246,1.0,5/20,14.56%,EEA1;BECN1;RAB7A;WDR81;ANKRD27
prerank,protein polyubiquitination (GO:0000209),-0.1934414718726323,-0.814661137316329,0.9739130434782609,0.9302086661615819,1.0,86/297,25.94%,FBXL7;RNF213;SASH1;HERC6;NPEPPS;SMURF2;FBXO10;RNF146;ZNRF1;TAF1;SPSB1;RNF19A;TNKS2;WWP2;RNF144B;TTC3;SMURF1;CDC16;AMFR;IFI27;UBE2E2;LNPEP;RC3H2;NHLRC3;CHFR;DTX3L;RNF135;TRIM27;PSME2;UBE4B;ANAPC4;RNF125;MDM2;PSMB4;UBE2Q2;FBXW11;UBB;UBE2G2;PSMB1;PSMD11;PSMD8;RNF115;WWP1;FBXL14;ANKIB1;PSME3;RNF187;PELI1;UBE3D;FBXL19;TRAF3IP2;PSMD4;LONRF1;TRIM14;FZR1;PSMA2;FBXO41;RNF217;PSMD3;CDC27;RNF144A;UBE2L6;RFFL;RMND5A;RNF126;PSMB7;ANAPC5;RBBP6;DZIP3;FBXO17;CCNF;DDA1;RNF19B;PSMC2;CBFB;RNF8;TRIM6;RNF216;BRCA1;PSMC5;PSMD10;BFAR;DCAF15;PRKN;UBE2H;CTNNB1
prerank,snRNA processing (GO:0016180),0.3704768872943789,0.8145399825640235,0.6702127659574468,0.9317446524720469,1.0,3/16,14.01%,INTS6L;INTS1;INTS12
prerank,protein-DNA complex assembly (GO:0065004),-0.2172414515610426,-0.8144323371043645,0.8909090909090909,0.9300423818173827,1.0,35/116,25.65%,KAT6B;TCF4;H3-3A;ERCC5;ANP32B;PSME2;CUL4A;PSMB4;UBB;PSMB1;PSMD11;DDB1;PSMD8;RPA1;PSME3;HMGB2;PSMD4;PSMA2;PSMD3;RSF1;PSMB7;NAP1L2;CETN2;MCM8;BRD2;RAD51;PSMC2;ERCC2;ASF1A;CHAF1A;PSMC5;RPA3;PSMD10;CDK7;ERCC3
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.25374705050327656,-0.8143080624224807,0.7799511002444988,0.9296688201870823,1.0,22/52,32.09%,SEC31A;HSPA5;ERN1;ADD1;EXTL2;DNAJB11;DNAJC3;PARP16;PDIA6;PDIA5;GFPT1;TPP1;XBP1;SHC1;ATP6V0D1;EDEM1;PREB;SYVN1;YIF1A;ZBTB17;HYOU1;CUL7
prerank,erythrocyte development (GO:0048821),0.3810300560928264,0.8142945266987434,0.6629955947136564,0.931463557268735,1.0,3/10,14.58%,SH2B3;MED1;ABCB10
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.36704410346047023,-0.8142545698909468,0.7099099099099099,0.9291720171649236,1.0,2/10,6.62%,APPL2;ANO6
prerank,regulation of interleukin-17 production (GO:0032660),-0.28037814817537315,-0.8141345535511105,0.7603305785123967,0.9287994709068222,1.0,6/31,16.55%,IL15;SLC7A5;IL18;TGFB1;SPHK1;TLR4
prerank,mesoderm formation (GO:0001707),0.3608481086803115,0.8137394186344838,0.660455486542443,0.9317948899862738,1.0,3/17,6.96%,TBX20;ITGB1;ITGA8
prerank,snRNA 3'-end processing (GO:0034472),0.3513436219984321,0.8137077937474427,0.6557377049180327,0.93114399299604,1.0,4/19,17.94%,INTS6L;INTS1;INTS12;USB1
prerank,protein import into nucleus (GO:0006606),-0.2390337039612648,-0.8132324335990038,0.8137755102040817,0.9297787800369952,1.0,24/66,29.60%,APPL2;STAT3;AKT1;IPO7;FAM53C;IPO13;RAN;RGPD1;KPNA6;RPL23;NXT2;IPO8;TPR;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;EIF4ENIF1;CSE1L;NUP62;PTTG1IP;TNPO2
prerank,protein localization to mitochondrion (GO:0070585),-0.3589122493504854,-0.8127923000664076,0.7267441860465116,0.9299437304625894,1.0,8/11,34.23%,LRRK2;HK2;AKT1;MAIP1;HK1;ISG15;RALA;PINK1
prerank,negative regulation of catabolic process (GO:0009895),0.30510175020197533,0.812747179447751,0.711645101663586,0.9322101158674199,1.0,4/47,4.06%,CBFA2T3;AGAP2;IL1B;FMN2
prerank,relaxation of cardiac muscle (GO:0055119),0.37240044091788416,0.8124886386107142,0.6443089430894309,0.932028906591784,1.0,2/13,3.05%,ATP1A2;PIK3CA
prerank,retinal metabolic process (GO:0042574),-0.3434152940345994,-0.8118510183261614,0.7222222222222222,0.9309792900530378,1.0,2/12,7.96%,CYP1B1;ABCA4
prerank,hexose metabolic process (GO:0019318),-0.26820687893712036,-0.8115073866187004,0.7704545454545455,0.9310143531991207,1.0,18/39,33.43%,APOD;SORD;FUCA1;SLC35A2;CHST15;AKR1A1;GAA;FPGT;ALDOA;BRAT1;GALT;FUCA2;HK1;GDPGP1;KHK;IRS2;DCXR;CHST1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.3680975083729487,-0.8114736702148585,0.7395437262357415,0.9304898627480674,1.0,1/10,1.69%,TGFA
prerank,neutrophil migration (GO:1990266),0.29044891549578306,0.8111751888069703,0.6923076923076923,0.9337960596563909,1.0,6/58,7.50%,PIK3CD;CXCR2;CXCL10;PDE4B;CXCL5;PIKFYVE
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.23629519895250717,-0.8111683127578596,0.83008356545961,0.9304293121602887,1.0,31/78,28.31%,DAB2;CAV1;LRRK2;SMAD7;TAF1;RNF19A;RNF144B;SH3RF2;BBS7;USP5;DNAJB2;MDM2;ELOB;ANKIB1;SIRT2;BCAP31;FZR1;TRIB1;VCP;RNF217;RNF144A;BAG2;DDA1;RNF19B;PSMD10;RACK1;PRKN;CEBPA;TRIB3;HSPA1B;CLU
prerank,protein localization to chromosome (GO:0034502),-0.2714603041569568,-0.8108076808216662,0.7792792792792793,0.930463953912014,1.0,10/34,22.52%,ESR1;TNKS2;PARP3;PINX1;XRCC4;RPA1;TPP1;CTCF;ACD;MCM8
prerank,negative regulation of cellular protein localization (GO:1903828),-0.2739984970138211,-0.8106254613783651,0.7569892473118279,0.930192412158182,1.0,5/34,9.92%,ROCK2;ACTN2;MFHAS1;CTNNA1;FLCN
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3040373121209234,-0.8105546744116835,0.7240704500978473,0.929738198740001,1.0,4/21,9.01%,MFHAS1;PTPA;FKBP1A;PPP1R16B
prerank,myeloid dendritic cell activation (GO:0001773),-0.351903431780982,-0.8104471706672459,0.699443413729128,0.9293355117379056,1.0,1/12,3.00%,TGFBR2
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.29967813353916567,-0.8103479647611798,0.73828125,0.9289200716216564,1.0,7/21,23.00%,TALDO1;HK2;DERA;PGD;RPIA;PGLS;SHPK
prerank,positive regulation of protein maturation (GO:1903319),-0.35733359495493117,-0.8100391838763135,0.7140186915887851,0.9288621198709531,1.0,1/11,1.79%,CCBE1
prerank,regulation of receptor recycling (GO:0001919),0.3545668083259519,0.809730855341044,0.6826722338204593,0.9356917055139883,1.0,3/16,6.30%,ECE1;AP1AR;SNCA
prerank,piRNA metabolic process (GO:0034587),0.35066440871010074,0.8095231072321152,0.6551020408163265,0.9353731116181395,1.0,3/19,14.98%,PLD6;TDRKH;EXD1
prerank,regulation of autophagosome assembly (GO:2000785),0.30915925647758347,0.8093290446801408,0.6730038022813688,0.9350074956985165,1.0,11/33,14.52%,PIP4K2A;IFT20;FEZ2;PIP4K2C;TBC1D12;PIKFYVE;NPRL3;NPRL2;FEZ1;UBQLN2;RAB5A
prerank,regulation of mast cell activation (GO:0033003),0.3826867030557034,0.809166044199634,0.6866952789699571,0.9345908958936903,1.0,4/10,23.85%,LYN;CD84;TSLP;MILR1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.23979618769624975,-0.8091631513047189,0.8341121495327103,0.929774846803246,1.0,23/62,31.82%,MLLT3;RTF1;POLR2A;POLR2F;EAF1;ELOB;CDK9;POLR2E;TCEA1;ELOC;NELFCD;ELOF1;ERCC2;POLR2G;CDK7;ERCC3;ELP2;CTDP1;MNAT1;SUPT4H1;GTF2H3;PAF1;SSRP1
prerank,negative regulation of kinase activity (GO:0033673),-0.2422954186865912,-0.808429080361331,0.8325581395348837,0.9304343624808225,1.0,25/62,27.97%,PRKAG2;DEPTOR;LRP6;DTNBP1;AKT1;TRIM27;CEP85;QARS1;PPIA;GSKIP;CEACAM1;CDKN1B;PDPK1;PARK7;CHP1;TRIB1;UBASH3B;CDKN1C;INPP5K;PYDC1;GNAQ;PAK2;SFN;TRIB3;PPM1F
prerank,maintenance of protein location in nucleus (GO:0051457),0.3363401834831835,0.8084221010194635,0.6694214876033058,0.9352286285400927,1.0,1/20,1.25%,SYNE1
prerank,T cell proliferation (GO:0042098),-0.3382219545061668,-0.8083738527562188,0.7285429141716567,0.9299455062268194,1.0,7/13,42.31%,CTPS1;LMBR1L;PPP3CB;DOCK8;PIK3CG;TNFRSF4;CRTAM
prerank,regulation of vesicle-mediated transport (GO:0060627),0.26808993432978023,0.8080133381749417,0.7291338582677165,0.935301364346759,1.0,25/91,18.92%,PLD1;SCARB1;RAB8B;RIT2;RIMS2;RAB3B;LGI3;SYT1;AP2S1;HIP1;ABL2;STXBP5L;STX4;DENND10;PACSIN3;SRC;PTPN1;RAB5A;CHMP3;MAPK1;HAP1;VAMP2;CPLX1;STXBP5;RAB33B
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.29697378335755803,-0.8076067037736335,0.7265135699373695,0.930649301936687,1.0,6/23,14.30%,PARP9;PARP14;STAT1;IRGM;NLRC5;HSP90AB1
prerank,apical protein localization (GO:0045176),-0.3634699953430136,-0.8075792079092807,0.720216606498195,0.9301247772124132,1.0,2/10,3.09%,SHROOM2;SHROOM3
prerank,regulation of telomere maintenance (GO:0032204),-0.29031741566041935,-0.8075302768522481,0.7251082251082251,0.9296141012892292,1.0,5/26,16.95%,HDAC8;SMG6;PML;RAD50;SMG5
prerank,negative regulation of hemostasis (GO:1900047),-0.3503923046116373,-0.8071562133626917,0.7321772639691715,0.929683005734353,1.0,3/12,4.57%,APOE;THBD;CD34
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.2986167584866832,-0.8060502778478772,0.7489270386266095,0.9309901692419476,1.0,3/24,6.10%,BMPR2;NIBAN2;ACVRL1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.30151209570013665,-0.8052486588950577,0.7418032786885246,0.9317306566902026,1.0,2/21,7.81%,EPHA7;BIRC3
prerank,neuromuscular junction development (GO:0007528),0.33581950449570286,0.8050319820801335,0.6785009861932939,0.9399789040558928,1.0,5/24,7.88%,CACNB2;DOK7;AGRN;ANK3;PPFIBP2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.34429935825104085,0.804857493471593,0.6491596638655462,0.9395888777810391,1.0,6/18,15.84%,LDLRAP1;SPTBN1;APPL1;ZDHHC2;VTI1B;CDK5
prerank,gluconeogenesis (GO:0006094),0.3002904857019828,0.8048037128748667,0.6960431654676259,0.9389758256157211,1.0,7/39,15.45%,PER2;SLC25A13;GOT1;ALDOC;GPI;CRY1;PCK2
prerank,oligodendrocyte development (GO:0014003),0.3488687380368819,0.8046377409236023,0.6859504132231405,0.9385918705503031,1.0,4/15,10.86%,B4GALT6;TPPP;PLP1;EIF2B3
prerank,peptidyl-lysine methylation (GO:0018022),-0.2928768860699222,-0.8043928797997695,0.7700205338809035,0.9325561456455872,1.0,4/26,10.03%,SMYD3;SETD7;KMT5A;EHMT1
prerank,DNA repair (GO:0006281),-0.1912020105416401,-0.8041555120002779,0.9957983193277311,0.9323855443199844,1.0,90/284,31.01%,EYA1;USP47;ASCC3;PARP9;PDS5B;INO80;HINFP;RAD51B;BAZ1B;TRRAP;ERCC5;DCLRE1C;DTX3L;PARP3;REXO4;MMS19;BRCA2;NABP1;POLH;APEX2;FANCI;ATM;UBB;UVRAG;TDG;XRCC4;FTO;DDB1;INIP;RPA1;KMT5C;ADPRS;RAD50;ASCC1;ACTR8;PARK7;RFC3;BABAM2;VCP;PIAS4;SMC1A;RECQL;RAD52;POLI;UBXN1;POLE2;BABAM1;CETN2;RAD51C;NEIL3;BAP1;SLX4;EXO5;RMI2;RAD51;ERCC1;CHEK2;ERCC2;MSH6;RNF8;ASF1A;BRCA1;RPA3;ALKBH5;PPP5C;CENPX;ACTR5;NUDT1;ERCC3;TP53;POLA1;NEIL1;HUS1;APLF;CDKN2D;ATXN3;POLD1;FANCM;FANCA;ABL1;WDR33;MNAT1;EID3;WRN;GTF2H3;UBE2V1;DOT1L;PCNA;EXO1;HERC2
prerank,positive regulation of cell aging (GO:0090343),-0.3497447154894344,-0.8041004734876317,0.7064393939393939,0.9318898978936415,1.0,2/11,13.90%,B2M;YPEL3
prerank,cholesterol biosynthetic process (GO:0006695),0.31691667056164535,0.8039020855436542,0.7062043795620438,0.9391926706624111,1.0,14/31,24.88%,ARV1;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;HMGCR;INSIG1;NSDHL;MVK;FDFT1;ACAA2;CYP51A1;FDPS
prerank,polyamine metabolic process (GO:0006595),0.36485784685116274,0.8036971925239482,0.6708860759493671,0.9388684469942046,1.0,4/13,16.46%,OAZ2;DHPS;AOC1;HDAC10
prerank,histone H4-K8 acetylation (GO:0043982),0.35039749802517445,0.803671845751412,0.6430020283975659,0.937495261334882,1.0,6/15,19.14%,OGT;KAT7;KANSL3;KANSL1;MCRS1;WDR5
prerank,histone H4-K5 acetylation (GO:0043981),0.35039749802517445,0.803671845751412,0.6430020283975659,0.937495261334882,1.0,6/15,19.14%,OGT;KAT7;KANSL3;KANSL1;MCRS1;WDR5
prerank,regulation of TOR signaling (GO:0032006),0.2831991636158301,0.8036461093576625,0.7429048414023373,0.9368374545332214,1.0,15/67,16.23%,UBR1;PIK3CA;ROS1;AKT1S1;GNA12;NPRL3;DDIT4;DYRK3;SEC13;UBR2;TTI1;NPRL2;PRKAA1;MIOS;TSC1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.23152992026949082,-0.8028841950657947,0.8253164556962025,0.9333534939328493,1.0,23/72,25.28%,MAP3K14;CARD14;BIRC3;AKT1;CARD10;PSME2;RELA;PSMB4;FBXW11;COPS8;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;DICER1;PSMB7;PSMC2;PSMC5;PSMD10;REL
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.24737013135323357,-0.8028637399418491,0.8043478260869565,0.9328053322914421,1.0,13/49,19.93%,F3;LBP;NOD1;LGALS9;STAT3;MAVS;RELA;SERPINE1;TLR4;RIPK1;PARK7;LAMTOR5;SYK
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.3583343600415163,0.8024218851140031,0.6748971193415638,0.9383989781499681,1.0,1/16,1.29%,RORA
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.34445863398291604,0.8023298142564868,0.6507592190889371,0.9378737693658424,1.0,2/17,6.25%,CACNA1H;SCAMP5
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3053357294727451,-0.801949914345244,0.7540983606557377,0.9337892462008198,1.0,6/20,21.78%,ACACA;FAR2;ACSL4;HSD17B8;DGAT2;GCDH
prerank,Golgi to endosome transport (GO:0006895),0.3491267684058941,0.8011092624187355,0.6612903225806451,0.9393825177252323,1.0,3/16,6.21%,CORO7;SORT1;AP1AR
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.27046583912420125,-0.8009989089204718,0.7732181425485961,0.9347505460262702,1.0,8/34,15.74%,PTPRB;PTPN13;PTPRJ;DUSP1;DUSP16;PGP;DUSP7;DUSP10
prerank,aminoglycan biosynthetic process (GO:0006023),0.3002022906486335,0.8007926099745328,0.7107023411371237,0.9392180934045601,1.0,8/49,9.20%,GCNT2;SDC2;SDC3;AGRN;GPC5;GPC3;B3GALT1;B3GNT8
prerank,endosome organization (GO:0007032),-0.2598725423427327,-0.8004873833733493,0.7749469214437368,0.9350186898192737,1.0,10/41,16.20%,EEA1;RAB27A;USP8;ALS2;ALS2CL;CLCN3;SNX10;CORO1C;PHETA1;ARFGEF2
prerank,regulation of T cell differentiation (GO:0045580),0.31017394656227587,0.7996698759468202,0.6986817325800376,0.9406043131203392,1.0,3/33,6.03%,PRDM1;IL2RA;IL4
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3108904443824996,0.7996112434772941,0.6953125,0.9400120755027987,1.0,6/33,11.06%,PTK2;JAM3;RAC3;LYN;EPHA2;SNAI2
prerank,RNA destabilization (GO:0050779),0.3530227814614978,0.7995209319324882,0.6823770491803278,0.9394575191022513,1.0,5/18,13.07%,ROCK1;RBM24;YTHDF3;YTHDF2;CELF1
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.2350953277438148,-0.7993885884121603,0.8291571753986332,0.9362972748888964,1.0,21/68,27.28%,AOX1;PCCA;ENPP1;SLC2A1;PCCB;CUBN;SLC5A6;ALDH1L1;SLC25A19;NNMT;FPGS;SLC52A3;CYB5R3;SLC19A2;SLC52A1;GSTO2;CD320;SLC25A32;PDXK;PNPO;MTRR
prerank,regulation of cellular catabolic process (GO:0031329),-0.2355968060713077,-0.7993394915817142,0.849009900990099,0.9357965328088766,1.0,12/62,16.25%,DAPK1;NUPR1;LRRK2;WDR41;ACER2;PSAP;PIP4K2B;RAB8A;ATM;FBXL2;GPR137;MTMR3
prerank,positive regulation of cellular senescence (GO:2000774),-0.3599294370347673,-0.7988458736820371,0.7315689981096408,0.9360194657332831,1.0,2/10,13.90%,B2M;YPEL3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.35045372429821986,0.7987828537648444,0.6948453608247422,0.9400750130839028,1.0,1/18,1.34%,PIK3R1
prerank,regulation of glucose metabolic process (GO:0010906),0.3097830183819943,0.7980207327619527,0.7010869565217391,0.9407256530573819,1.0,5/34,9.22%,RORA;OGT;IRS1;ZNF692;SDHAF3
prerank,protein neddylation (GO:0045116),0.3624376568737342,0.797699916227094,0.6527472527472528,0.9405449424422365,1.0,6/13,23.43%,RBX1;DCUN1D2;UBE2F;RNF7;DCUN1D4;DCUN1D1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.2777841855004184,-0.7976805830830046,0.7780126849894292,0.9373783489698845,1.0,14/30,28.89%,CXCL12;TPT1;MDM2;SNAI1;THOC1;PSMD10;BCL2L1;RPS3;CD44;TWIST1;CDKN2D;CLU;PTTG1IP;THOC5
prerank,base-excision repair (GO:0006284),-0.2496363684232769,-0.7976243575375377,0.8108747044917257,0.9369033136329175,1.0,16/48,32.01%,USP47;ERCC5;APEX2;TDG;RPA1;ADPRS;RFC3;RFC1;NEIL3;RPA3;NEIL1;NTHL1;POLD1;WRN;PCNA;RFC5
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.31387412935799175,-0.7968150034523714,0.7545126353790613,0.9376441114759723,1.0,4/17,15.72%,CXCL12;ANO6;CREB3;SERPINE1
prerank,lymphocyte mediated immunity (GO:0002449),0.37246648647855707,0.7965272739926869,0.664488017429194,0.94193264151333,1.0,2/12,9.28%,CD46;JAG1
prerank,chromosome organization (GO:0051276),-0.22159947104352054,-0.7964762874505974,0.8724637681159421,0.9375899013061673,1.0,36/99,31.24%,HDAC8;SETD7;TCF7L2;TOP2B;H3-3A;EHMT1;CUL4A;HDAC1;COPS4;UBB;COPS8;EZH1;HDAC5;DDB1;CENPT;HHEX;HMGB2;HMGN1;EZH2;CETN2;TOP2A;SMARCA4;MSH6;SATB1;BRWD1;COPS7A;L3MBTL1;NUP155;COPS2;CENPH;ABL1;NDC80;POLE3;SUPT4H1;DOT1L;CDCA8
prerank,neuromuscular synaptic transmission (GO:0007274),0.34307070333653594,0.7961656142774587,0.6952789699570815,0.9418759387172473,1.0,4/18,8.51%,CHRNA3;ERC2;RIMBP2;SLC5A7
prerank,nucleotide metabolic process (GO:0009117),0.3292142380004545,0.7960336629605832,0.6991869918699187,0.9414110522228266,1.0,9/23,15.63%,AK1;AK8;REXO2;DCK;NMNAT3;DCTD;AK7;AK5;AK4
prerank,amide biosynthetic process (GO:0043604),-0.2536814194766307,-0.7960214288340347,0.8191721132897604,0.9377623075971904,1.0,4/47,2.90%,PAM;PCSK5;SGMS1;SGMS2
prerank,dendritic cell differentiation (GO:0097028),-0.3008706738934806,-0.7957814403680816,0.75,0.9375667560554165,1.0,3/22,5.51%,TGFBR2;GAS6;LGALS9
prerank,ganglioside metabolic process (GO:0001573),-0.2991157255509325,-0.7954174887000787,0.755741127348643,0.9375936024286752,1.0,8/20,21.68%,ST6GALNAC3;HEXA;HEXB;ST8SIA2;ST6GALNAC6;ST3GAL5;NEU3;CLN6
prerank,regulation of neuron death (GO:1901214),0.26326234106088153,0.7952898194333621,0.7411575562700965,0.942072253524826,1.0,14/82,12.16%,MEF2C;MAP3K5;INPP5A;SNCA;CHRNA7;AKT1S1;HTRA2;GRM4;GRIN2B;SARM1;DDIT4;TRIM2;BTBD10;EPHB1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.36969932476640266,0.7948348995641922,0.6578366445916115,0.9421798348698215,1.0,3/11,15.02%,NCBP2;PAPOLA;DHX36
prerank,telomere capping (GO:0016233),0.35287015070178473,0.794728907469091,0.6923076923076923,0.9416685769697459,1.0,5/16,22.11%,DCLRE1B;PRKDC;TERF1;TINF2;CTC1
prerank,negative regulation of endocytosis (GO:0045806),0.3290350151142584,0.7944805146566766,0.6686868686868687,0.9413977961697497,1.0,11/24,23.37%,NR1H3;CD300A;SCAMP5;PACSIN3;ABCA7;SYT11;PRKD1;SNX33;LILRB1;PICALM;ARF6
prerank,sulfur amino acid metabolic process (GO:0000096),0.3241828015122516,0.794017924125204,0.7021696252465484,0.9415361615527716,1.0,3/24,6.61%,CTH;TXN2;MSRA
prerank,macroautophagy (GO:0016236),0.2533979822507283,0.7938580432324163,0.8217522658610272,0.9411219975875615,1.0,36/118,22.98%,DYNLL1;PIP4K2A;ATG16L1;CHMP2B;MTMR14;MVB12A;MTERF3;SRC;VTI1B;UBXN6;PRKAA1;PLEKHM1;VPS33B;MFN1;TOMM40;CHMP3;HDAC10;EI24;PIK3C3;ULK3;SNF8;LIX1L;VTA1;GABARAP;NBR1;PRKAB2;CSNK2A2;TOMM70;VPS37B;GABARAPL2;ATG13;ARL8B;VPS16;VAMP7;VPS36;VDAC1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.37285035352920615,0.7936265898537284,0.6581740976645435,0.9408548736487852,1.0,3/11,11.50%,BCAR1;HPN;PAK1
prerank,entry into host (GO:0044409),-0.3365963867559617,-0.7934634171688794,0.7513711151736746,0.9401558549170811,1.0,7/13,32.50%,CDH1;MET;PPIA;CTNNB1;CXCR4;GRB2;CTNND1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.32896137609349896,0.7930969232719203,0.6885553470919324,0.9411005894251288,1.0,4/22,9.11%,NR1H3;PTPN22;APPL1;LYN
prerank,regulation of astrocyte differentiation (GO:0048710),0.3607256605174851,0.7930448662128247,0.6673553719008265,0.9404971307275155,1.0,2/12,7.30%,NOTCH1;BIN1
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.284476088092721,-0.7913394561841972,0.7584745762711864,0.9430553339355311,1.0,7/26,14.98%,APP;MDM2;SMOC2;SPHK1;MEIS2;TAL1;EIF4EBP1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.34610304007750425,0.7912748769562921,0.692,0.9429461740807847,1.0,3/18,8.10%,LDLRAP1;ADAM19;ACHE
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3206454464442224,0.7912016026914909,0.6881091617933723,0.9423772557998568,1.0,6/26,15.88%,HECW2;CUL3;NEK6;RB1;ANAPC7;NSMCE2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.21821628136736126,-0.7911730694434784,0.8457300275482094,0.9427707871228487,1.0,34/88,33.53%,FBXL7;PSME2;DMAC2;CUL4A;PSMB4;FBXW11;PSMB1;PSMD11;PSMD8;FBXL14;FBXL2;PSME3;PSMD4;PSMA2;PSMD3;PSMB7;CUL5;FBXO17;CCNF;PSMC2;PSMC5;PSMD10;FBXL12;FBXL6;PSMD7;FBXL13;FBXL22;KIF14;FBXO44;FBXO38;PSMD12;PSMB9;FBXL20;FBXO2
prerank,T cell differentiation in thymus (GO:0033077),-0.3228279975890588,-0.7904344101144011,0.7418111753371869,0.9433880964825461,1.0,7/14,34.86%,GLI3;MR1;ZFP36L2;RABL3;ADAM17;FADD;SHH
prerank,myelin assembly (GO:0032288),0.3711988134907747,0.7903864181060059,0.672686230248307,0.9430917869922982,1.0,3/10,8.39%,TPPP;NCMAP;TENM4
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3135161742753874,-0.789590682767912,0.7855670103092783,0.9441249616152301,1.0,5/16,11.77%,LARGE1;ST6GALNAC3;A4GALT;ST8SIA2;ST6GALNAC6
prerank,regulation of establishment of planar polarity (GO:0090175),-0.2199496969394654,-0.7888547644812031,0.8975741239892183,0.9447126808713213,1.0,30/88,24.71%,SMURF2;FZD2;AP2A2;SMURF1;WNT5A;RHOA;FZD4;TIAM1;FZD7;PSME2;PFN1;AP2A1;PSMB4;ARHGEF19;PSMB1;PSMD11;PSMD8;PSME3;WNT11;ROR2;FZD1;PSMD4;PSMA2;PSMD3;PSMB7;VANGL2;AP2M1;PSMC2;PSMC5;PSMD10
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.32992255636232437,-0.7886585886246821,0.7360594795539034,0.9444551271137841,1.0,5/14,29.56%,ETNK2;LPIN3;ETNK1;ETNPPL;CHKA
prerank,anterograde axonal transport (GO:0008089),-0.2603880336122964,-0.7884249481659998,0.8183760683760684,0.9442483797861804,1.0,6/37,10.29%,AP3S1;KIF1B;DTNBP1;AP3B1;RAB21;SPAST
prerank,gonad development (GO:0008406),-0.25874498156559345,-0.7883261300933013,0.8092105263157895,0.9438352647610542,1.0,11/41,26.76%,WNT4;AR;WNT5A;KIT;GATA6;BASP1;NCOA4;CSDE1;COL9A3;ADAM21;BIK
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3241160035985149,-0.7880604157560506,0.7311233885819521,0.9436986595397421,1.0,5/14,22.35%,ANXA1;PRKCZ;IL18;CCL19;RARA
prerank,cellular response to pH (GO:0071467),-0.30579178162831855,-0.7870332854718822,0.752895752895753,0.9447541159174341,1.0,7/17,31.93%,RAB11FIP5;SLC9A1;CHP1;MCOLN1;PKD1L3;HVCN1;KCNK4
prerank,regulation of lymphocyte activation (GO:0051249),0.3699550771726951,0.7862516974932682,0.6856540084388185,0.9497709709368701,1.0,1/12,3.87%,PAG1
prerank,protein localization to chromatin (GO:0071168),-0.30607422961997954,-0.7856095550427253,0.7298387096774194,0.9463780080295484,1.0,5/18,23.55%,ESR1;PPHLN1;MCM8;PIH1D1;SGF29
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.3749463312213183,0.7853458007324189,0.6666666666666666,0.9499529757798234,1.0,3/10,15.92%,CDC42EP1;APC;CDC42EP4
prerank,regulation of pseudopodium assembly (GO:0031272),0.3749463312213183,0.7853458007324189,0.6666666666666666,0.9499529757798234,1.0,3/10,15.92%,CDC42EP1;APC;CDC42EP4
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.3566110160773092,-0.7851952033464888,0.7566539923954373,0.9465060858892298,1.0,4/10,21.78%,IVD;ACADL;ACADS;GCDH
prerank,protein targeting (GO:0006605),-0.2063027691458572,-0.785026354996554,0.9361702127659575,0.9462159054845501,1.0,42/118,29.95%,LAMP2;KIF13B;SDCBP;ZFAND6;NACA;RASSF9;TAOK2;PARD3;AP4M1;RPL11;TOMM7;ZDHHC24;GDAP1;AQP11;TIMM13;BCAP31;HOMER3;TOMM22;MICALL1;SPCS1;AP4E1;HPS4;TIMM8B;TOMM34;TOMM5;SEC61A1;ZDHHC15;TIMM9;VPS37D;AP4B1;LTBP2;TIMM44;ZDHHC7;YIF1B;RABGEF1;RAB3IP;EDEM1;ZDHHC12;TIMM10;SRP14;TSPO;SEC63
prerank,macrophage activation involved in immune response (GO:0002281),0.3653185866347565,0.7849671254808979,0.6724511930585684,0.9499312293387431,1.0,1/13,1.12%,DYSF
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3778402747736004,0.7848729516079188,0.6897374701670644,0.9493978310188156,1.0,2/11,9.67%,UQCRFS1;UQCRC2
prerank,regulation of response to oxidative stress (GO:1902882),-0.3439451572561287,-0.7846991759295536,0.751412429378531,0.9461598010019064,1.0,7/11,41.03%,MCTP1;GGT7;PRKN;PINK1;ALOX5;HEBP2;AIFM2
prerank,response to sterol (GO:0036314),0.36991421650465656,0.7845932184713036,0.7149532710280374,0.9491951349950781,1.0,1/11,1.29%,RORA
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.20810331933426293,-0.7838328355763485,0.9304347826086956,0.9469097573617722,1.0,35/114,25.85%,FOXO3;MAP3K14;TNFRSF11B;TNFRSF1B;PTK2B;STAT1;CARD14;BIRC3;TMSB4X;TNFRSF1A;EIF5A;PSME2;RELA;PSMB4;TNFRSF11A;PSMB1;PSMD11;PSMD8;PSME3;RIPK1;NFKBIA;EDA;PSMD4;PSMA2;EDA2R;PSMD3;PSMB7;EDAR;TNFSF13;PSMC2;PSMC5;PSMD10;TNFSF8;PYDC1;TP53
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.37017957019208864,0.7837794078895826,0.6877729257641921,0.9499200331102244,1.0,1/10,2.89%,EMC7
prerank,mitotic recombination (GO:0006312),-0.3172066960337061,-0.7836484682493047,0.7681992337164751,0.9466076451924235,1.0,7/15,25.37%,TEP1;RAD50;TPRKB;RAD52;RAD51;ERCC1;RAD54B
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3288080003611985,-0.7835520279389372,0.7551789077212806,0.9461817897923188,1.0,3/13,10.94%,GAS6;WNT5A;MAVS
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.2827402282503086,-0.7832939138158201,0.7710843373493976,0.9460228189140149,1.0,11/23,31.02%,LMAN1;SURF4;HSP90B1;NPLOC4;VCP;TMED9;SEC61B;SEC16A;PREB;SYVN1;AUP1
prerank,ncRNA transcription (GO:0098781),-0.3276399742168663,-0.7831369343404493,0.7467889908256881,0.9457075674389732,1.0,3/13,19.54%,CAVIN1;SIRT7;GTF3C1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3132561350265699,-0.7831160292239779,0.7632093933463796,0.945166591834732,1.0,2/17,3.38%,PTPRJ;EZR
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.22751352093508356,-0.7828429184149147,0.8664987405541562,0.945007846525452,1.0,26/67,28.09%,B2M;TAPBP;SNAP23;PSME2;PSMB4;CALR;CYBA;PSMB1;PSMD11;PSMD8;PDIA3;PSME3;PSMD4;PSMA2;IKBKG;PSMD3;CYBB;PSMB7;VAMP8;PSMC2;PSMC5;TAP2;PSMD10;FCGR1A;PSMD7;TAP1
prerank,regulation of lipase activity (GO:0060191),-0.3353587228175577,-0.7828343203975366,0.7555147058823529,0.9444510438435397,1.0,2/13,6.59%,PCSK5;RHOA
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.2565557633914526,-0.782199648582522,0.8171557562076749,0.9448578379541444,1.0,14/38,27.17%,RBBP7;UBN1;CENPC;H3-3A;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;HAT1;ASF1A;CENPX;CENPH
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3644573258779277,0.7821235494112537,0.6868686868686869,0.9521013848891232,1.0,1/12,1.34%,PIK3R1
prerank,negative regulation of coagulation (GO:0050819),-0.3239565882010524,-0.7819900919182655,0.7846153846153846,0.9446036697306925,1.0,3/14,4.57%,APOE;THBD;CD34
prerank,glutamate metabolic process (GO:0006536),0.3316814527134719,0.7811993632757317,0.6873706004140787,0.9530217854964611,1.0,4/19,11.94%,GGT1;GOT1;GAD1;GLS2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.27454376788760854,-0.7811653294303691,0.7631578947368421,0.945331818517067,1.0,7/25,16.15%,FOXO3;MAPK14;STAT1;STAT3;HIF1A;TAL1;HMGB2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.32027398509149685,0.7811164980478178,0.72,0.9524644867132832,1.0,2/24,1.93%,NR1H3;USP25
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.33506138212173614,0.7809726927510378,0.6918367346938775,0.952019320312463,1.0,6/20,9.97%,RGCC;SPDYA;TTBK1;PKD2;PDGFB;CCNYL1
prerank,peptidyl-lysine acetylation (GO:0018394),0.3763798893557718,0.7809506342580096,0.6944444444444444,0.9513634587273017,1.0,3/10,11.62%,KAT7;BLOC1S1;EP300
prerank,nucleotide-excision repair (GO:0006289),-0.2177247069141291,-0.7804905704476297,0.8997214484679665,0.9457859111458858,1.0,32/101,27.15%,POLR2A;ERCC5;MMS19;BRCA2;CUL4A;COPS4;POLR2F;UBB;COPS8;DDB1;RPA1;POLR2E;HMGN1;RFC3;TCEA1;RFC1;CETN2;SLX4;ERCC1;ERCC2;RPA3;POLR2G;COPS7A;CDK7;ERCC3;TP53;POLA1;HUS1;COPS2;ATXN3;PRPF19;POLD1
prerank,tRNA methylation (GO:0030488),0.30081556482049826,0.7803216416755884,0.7281553398058253,0.9517534006132475,1.0,13/34,24.32%,TRMT61A;TRMT5;TRMT1;THUMPD2;TRMT10C;MTO1;NSUN2;METTL6;TRMT1L;DALRD3;GTPBP3;TRMT10A;TRDMT1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.31830988706005026,-0.7802129238731226,0.7609108159392789,0.9456293888551749,1.0,5/15,14.51%,ARPC2;IQGAP2;ARPC1B;TRIM27;WASHC1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.2286167201188837,-0.78010870954472,0.8636363636363636,0.9452204166906347,1.0,21/72,25.65%,ENPP1;EDC3;RNASE4;ERCC5;REXO4;ZC3H12A;CUL4A;DNASE1L1;UBB;DDB1;RPA1;RAD50;SPO11;RFC3;PNRC2;DICER1;RFC1;ERCC1;ERCC2;RPA3;ERCC3
prerank,regulation of cholesterol metabolic process (GO:0090181),0.33052105501211376,0.7799224653859972,0.7029702970297029,0.9517285377798583,1.0,3/20,5.07%,LDLRAP1;ARV1;SREBF2
prerank,regulation of phosphate metabolic process (GO:0019220),0.3406533305578099,0.7795179022747452,0.69,0.9517226450719678,1.0,5/16,14.21%,IL4;MCM7;SMG7;PSEN1;RAD17
prerank,peptidyl-threonine modification (GO:0018210),0.2713401083696611,0.7792838295786604,0.7711038961038961,0.9514492710342604,1.0,15/66,12.70%,GALNTL6;ROCK1;CDC42BPA;STK39;TNKS;TTBK1;GALNT13;GALNT1;MARK2;PRKD2;DYRK3;HIPK1;NLK;GALNT4;PRKDC
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.29696212843744463,-0.7792224235240872,0.803030303030303,0.9459949193016883,1.0,8/20,19.22%,ARRB1;BRD7;DIP2B;TADA2A;MAPK3;PRKAA2;NOS1;PPARGC1A
prerank,skeletal muscle tissue development (GO:0007519),0.3090873382789981,0.7791272463841775,0.7302752293577982,0.950988537088275,1.0,3/32,7.45%,MEF2C;POPDC3;IGSF8
prerank,histone mRNA metabolic process (GO:0008334),-0.27502120592994156,-0.7785078610390517,0.7949790794979079,0.9464986607610116,1.0,10/27,27.77%,TUT4;TUT7;MTPAP;ATM;SNRPF;XRN1;TENT4B;SNRPB;CPSF2;SNRPE
prerank,nucleoside salvage (GO:0043174),0.3718066845393192,0.7782755974426229,0.7052401746724891,0.951762998755817,1.0,3/10,8.20%,TK1;TK2;DCK
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.2971120701555946,-0.7780465353797757,0.7799607072691552,0.9454861121578997,1.0,12/20,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.2971120701555946,-0.7780465353797757,0.7799607072691552,0.9454861121578997,1.0,12/20,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.2971120701555946,-0.7780465353797757,0.7799607072691552,0.9454861121578997,1.0,12/20,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,ion homeostasis (GO:0050801),0.3084158253434256,0.7780081518263898,0.7122040072859745,0.9515338085630202,1.0,2/30,3.51%,NEDD4L;UNC80
prerank,skeletal muscle contraction (GO:0003009),0.3400974054267529,0.778000174036466,0.7060041407867494,0.9508573963714733,1.0,2/19,8.92%,RCSD1;STAC
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.26032451706632814,0.7777771384424181,0.7756714060031595,0.9505381913185875,1.0,15/83,15.98%,CDK6;CUL3;CDK15;CRLF3;DHFR;SPDYA;CDKN1A;NPAT;LATS2;RB1;CDK14;EIF4E;CCNH;CDK5;CCNE1
prerank,mitochondrial transcription (GO:0006390),0.3776249395737871,0.7777054300462375,0.6877828054298643,0.9499810570796469,1.0,2/10,8.23%,SLC25A33;TFAM
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.28082753528251825,-0.7771770065996327,0.7896825396825397,0.9462131567544897,1.0,5/25,13.39%,LRRK2;P2RX4;CMKLR1;CDH13;PLCG2
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.371639651848813,0.7768893819746333,0.6638830897703549,0.9500698260676159,1.0,4/10,10.81%,MYLIP;AP2S1;AP2B1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.371639651848813,0.7768893819746333,0.6638830897703549,0.9500698260676159,1.0,4/10,10.81%,MYLIP;AP2S1;AP2B1;VLDLR
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.29294476501242867,0.7765522311851984,0.7224199288256228,0.9499530464187169,1.0,10/42,19.05%,WAS;FANCB;TIMELESS;CGAS;SHLD3;PPP4C;PARP1;MRNIP;RPA2;FUS
prerank,regulation of gluconeogenesis (GO:0006111),0.31054590380745545,0.7763509609420203,0.7115384615384616,0.9495954951252953,1.0,7/27,13.27%,OGT;SIK1;ZNF692;SDHAF3;GCK;EP300;CRY1
prerank,vacuolar acidification (GO:0007035),-0.28514059217452875,-0.7760432595651144,0.7919191919191919,0.9473660060670186,1.0,9/21,27.55%,ATP6V0A4;ATP6V0A1;TCIRG1;ATP6V0A2;CLN6;CCDC115;CLN5;TMEM199;ATP6V0D1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2720080946252946,-0.7753926078968982,0.8029045643153527,0.947763191776396,1.0,13/30,30.28%,CAV1;PARP14;PRKCZ;PRKCD;SFRP1;PTPN2;SAMSN1;PTPN6;NTF3;SH3BP5;PIBF1;SOCS1;INPP5F
prerank,positive regulation of catabolic process (GO:0009896),0.2707530088595506,0.774339183857534,0.755700325732899,0.9522939943258857,1.0,6/65,6.86%,NEDD4L;HECW2;IL1B;OAZ2;GPC3;HACE1
prerank,regulation of ERAD pathway (GO:1904292),0.3624180627806817,0.774191970783546,0.7245119305856833,0.9518583037620125,1.0,1/11,1.93%,USP25
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3464355219464937,0.7741470990070423,0.7025862068965517,0.9512513306574235,1.0,5/17,13.74%,SPRED1;CADM4;SPRY2;DDIT4;SPRED2
prerank,nucleocytoplasmic transport (GO:0006913),-0.2515710531370606,-0.7737002794674611,0.8233995584988962,0.9497895157338635,1.0,9/40,16.93%,ATXN1;GEMIN7;BACH2;GEMIN5;NUP98;SNRPF;NXT2;SNRPD1;SNRPD2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.2331521896847757,-0.7731977113637788,0.8522727272727273,0.9499878925907367,1.0,17/57,26.24%,FOXN3;RINT1;TAOK2;ATM;TRIM39;CCND1;FZR1;BABAM2;CDK5RAP3;BABAM1;RPS27L;CHEK2;BRCA1;STK33;TP53;ATF2;HUS1
prerank,negative regulation of locomotion (GO:0040013),-0.32692323638221593,-0.7729378823675083,0.758364312267658,0.9498306497889434,1.0,4/12,19.45%,FBLN1;CCDC125;FRMD5;PTPN2
prerank,cytosolic transport (GO:0016482),0.24973054931284003,0.7726675656098817,0.8070444104134763,0.953142618637174,1.0,26/108,15.95%,DENND2A;STX16;CORO7;SORT1;AP1G1;VTI1A;RIC1;EMP2;PIKFYVE;HOOK3;EHD3;TBC1D10C;BAIAP3;AKTIP;ARFRP1;VPS51;PLEKHJ1;GCC2;ANKFY1;VTI1B;DCTN1;RAB5A;PREPL;RHOBTB3;TMEM87B;TBC1D10B
prerank,B cell differentiation (GO:0030183),0.28974074386060866,0.7724032777862441,0.7358834244080146,0.9529098999024718,1.0,3/46,6.03%,ITGA4;ITGB1;IL4
prerank,spinal cord development (GO:0021510),-0.3398812301770925,-0.7710931357328125,0.7615526802218114,0.9520112954401759,1.0,2/12,2.85%,GLI2;VIT
prerank,neuron projection organization (GO:0106027),0.3426817986652187,0.7705638512952004,0.6888412017167382,0.9553667013830144,1.0,7/15,23.39%,ABCD2;CHRNA7;PSEN1;DCTN1;GSK3B;LGMN;ABCD1
prerank,non-motile cilium assembly (GO:1905515),-0.26527145193341445,-0.7703486535374097,0.8195020746887967,0.9525081327584052,1.0,11/30,29.19%,TOGARAM1;TMEM216;VANGL2;TBC1D32;TMEM17;C2CD3;TMEM107;PIBF1;IFT122;DISC1;CCDC13
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3034732447001083,0.7696874239484927,0.720558882235529,0.9561895706231704,1.0,8/31,17.73%,CACNA1H;SCAMP5;SYT1;SYT2;CBARP;SYT12;SYT11;SYT13
prerank,cellular response to decreased oxygen levels (GO:0036294),0.2700507541094366,0.7696106580138947,0.7868284228769498,0.9556299611721941,1.0,7/65,4.85%,RORA;RGCC;CPEB1;KCND2;FMN2;SCN2A;EPAS1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.32602930981803185,0.7694702374732753,0.7134615384615385,0.9552024302125727,1.0,5/23,13.27%,CBFA2T3;SIK1;GCK;EP300;CRY1
prerank,mitochondrion disassembly (GO:0061726),-0.26063691078702356,-0.7694129146187421,0.8264642082429501,0.9533417528443038,1.0,9/34,25.65%,WIPI2;BECN1;ULK2;BNIP3;ATG2A;GABARAPL1;ATG7;ATG12;PRKN
prerank,cell-cell junction maintenance (GO:0045217),0.37198074607412657,0.7693655100436005,0.7033898305084746,0.9547009220256711,1.0,1/11,2.09%,FERMT2
prerank,regulation of mast cell degranulation (GO:0043304),0.3456627560130574,0.769245294581602,0.6761710794297352,0.954211700692407,1.0,4/14,10.09%,CD300A;IL4;LYN;STXBP2
prerank,neurotransmitter uptake (GO:0001504),0.3488174425422583,0.7690576317823573,0.7004310344827587,0.95383555113264,1.0,2/12,3.79%,ATP1A2;SNAP25
prerank,cellular biogenic amine metabolic process (GO:0006576),0.35003849629315653,0.7690515649658789,0.6907894736842105,0.953161573953533,1.0,2/12,3.71%,OAZ2;ATP7A
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3233027062944199,0.7688874375047536,0.7366336633663366,0.9527495274284079,1.0,3/22,2.42%,NOTCH1;ROCK1;PDE9A
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.33932557931033885,0.7686857747826228,0.7327935222672065,0.9523931740778053,1.0,1/16,1.63%,GPER1
prerank,regulation of phosphatase activity (GO:0010921),-0.2819810532579556,-0.7680058605474551,0.8031809145129225,0.9548066641932758,1.0,7/24,23.32%,PTPA;SH3RF2;HSP90B1;TIPRL;CHP1;CDK5RAP3;SH2D4A
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.2991529150622144,-0.7679282179328623,0.7655038759689923,0.9537846713755517,1.0,10/17,33.01%,SOCS2;STAT3;CISH;SMARCA4;BRWD1;IL7;SOCS1;IRS2;STAT5B;IL2RG
prerank,cellular response to interleukin-7 (GO:0098761),-0.2991529150622144,-0.7679282179328623,0.7655038759689923,0.9537846713755517,1.0,10/17,33.01%,SOCS2;STAT3;CISH;SMARCA4;BRWD1;IL7;SOCS1;IRS2;STAT5B;IL2RG
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.33635242481653893,-0.7676555810098109,0.7697974217311234,0.9536178250524406,1.0,5/10,34.57%,JARID2;DNMT1;BRCA1;KDM1A;ATRX
prerank,membrane fusion (GO:0061025),0.2990252879237622,0.7666386754684238,0.7550274223034735,0.9551490536240353,1.0,9/33,17.69%,DYSF;RIMS1;HACE1;UBXN2B;VTI1B;VPS33B;GCA;DNM1;VAMP2
prerank,response to interferon-alpha (GO:0035455),-0.31348401250448465,-0.7665925102704622,0.7641509433962265,0.954584184525436,1.0,4/16,17.49%,GAS6;IFITM3;IFITM2;TPR
prerank,coenzyme A metabolic process (GO:0015936),0.34871095661849943,0.766469313744394,0.721868365180467,0.9547646214833255,1.0,6/14,25.58%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,positive regulation of DNA recombination (GO:0045911),0.3100349088780229,0.7663831111350833,0.7145631067961165,0.9542234571418471,1.0,8/27,19.05%,WAS;FANCB;TIMELESS;SHLD3;KMT5B;PARP1;MRNIP;FUS
prerank,regulation of DNA replication (GO:0006275),-0.24098230840128665,-0.766218013939618,0.8709677419354839,0.954576825913154,1.0,3/49,6.10%,EGFR;GLI2;ACVRL1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3353529039960741,0.7660186646177954,0.7254901960784313,0.954146268504186,1.0,3/18,8.99%,PTPN22;PAG1;MIA3
prerank,amino sugar biosynthetic process (GO:0046349),-0.332882863090371,-0.7659232041366283,0.7773851590106007,0.9544104715067245,1.0,3/12,19.18%,GFPT2;UAP1;GFPT1
prerank,interstrand cross-link repair (GO:0036297),0.27313353121679756,0.7653912213113108,0.75,0.954549300037668,1.0,12/53,17.06%,DCLRE1B;FANCF;FANCG;FANCB;ERCC4;ATR;USP1;FANCE;FANCD2;ATRIP;XRCC3;RPA2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.3477817062710069,-0.7651372237662261,0.7758284600389863,0.9549258328585708,1.0,2/10,7.33%,GHR;STAT3
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.29807401894123525,0.7648484097744614,0.7439252336448599,0.954792259447692,1.0,7/32,16.25%,SLC44A2;ABHD3;ACHE;STARD7;CHKB;LPCAT1;LPIN2
prerank,protein K48-linked ubiquitination (GO:0070936),0.27724150800172576,0.7640938125965586,0.7608695652173914,0.9553714904723083,1.0,9/54,11.87%,NEDD4L;CUL3;RBX1;UBE2E3;HACE1;UBE2E1;UBE2G1;KBTBD7;UBE3A
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.27046163005613966,-0.7635779420070637,0.823045267489712,0.956486506475808,1.0,14/26,36.49%,LRRK2;AKT1;TXN;PPIA;PARK7;PRKN;BAG5;SOD2;HSPB1;PINK1;PYCR1;MAPK7;VNN1;NME5
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.344256457536355,0.7625680520055389,0.7270833333333333,0.9572794821870388,1.0,4/13,17.68%,HEXIM1;TCERG1;HNRNPU;LARP7
prerank,protein trimerization (GO:0070206),-0.3175577966449644,-0.7621584481438904,0.7790262172284644,0.9574598354712055,1.0,4/14,16.56%,SCARA5;CLYBL;DISP1;PNPT1
prerank,protein homotrimerization (GO:0070207),-0.3175577966449644,-0.7621584481438904,0.7790262172284644,0.9574598354712055,1.0,4/14,16.56%,SCARA5;CLYBL;DISP1;PNPT1
prerank,regulation of hemopoiesis (GO:1903706),0.36340414421618633,0.7614257437331563,0.7062780269058296,0.9584736461118785,1.0,1/10,2.51%,PTN
prerank,regulation of pH (GO:0006885),-0.3359240380820885,-0.7613246582293707,0.7576301615798923,0.9580477856821339,1.0,4/11,17.51%,ATP6V0A4;LACC1;CLCN3;SLC9A1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.2899789811161896,-0.7613238929041115,0.8218029350104822,0.9574808847542576,1.0,6/20,16.55%,LBP;PRKCE;IL18;TGFB1;TICAM1;TLR4
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.24427727116400422,-0.7613221205764442,0.8609271523178808,0.9569179677807856,1.0,9/40,17.83%,KMT5A;PRKCD;IER3;MCL1;POLH;FXR2;CDK9;SIRT7;NPAS2
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.2838542797499605,-0.760854425477289,0.8003992015968064,0.9569728330201122,1.0,6/23,22.35%,GAS6;LGALS9;ZC3H12A;TLR4;CD274;RARA
prerank,DNA metabolic process (GO:0006259),-0.18211890852266516,-0.760478940409632,0.9791666666666666,0.9569316796034067,1.0,109/270,37.68%,SP100;TCF7L2;PDS5B;INO80;HINFP;RAD51B;TOP2B;TRRAP;ERCC5;PARP3;REXO4;MMS19;SAMHD1;NT5E;NABP1;POLH;DNASE1L1;ATM;UBB;RAN;UVRAG;GLRX2;TDG;DDB1;INIP;RPA1;KMT5C;ADPRS;RAD50;DBF4;CBS;HMGB2;SIRT7;PARK7;TYMS;RFC3;VCP;SMARCAD1;SMC1A;RECQL;RAD52;POLI;TOP3A;DFFB;POLE2;RFC1;DNMT1;TOP2A;RAD51C;ACD;NEIL3;MCM8;SLX4;RMI2;RAD51;CDC45;ERCC1;MSH6;ASF1A;BRCA1;RPA3;SRPK2;NUDT1;ERCC3;POLA1;NEIL1;HUS1;NTHL1;POLD1;PRIM2;FANCA;TOP1;MCM3;MNAT1;EID3;POLE3;WRN;MCM5;GTF2H3;MCM10;DOT1L;PCNA;EXO1;DMC1;RAD54L;RFC5;FANCL;RAD51AP1;HUS1B;RECQL5;UHRF2;LONP1;CDC34;CHEK1;UHRF1;RAD51D;MGMT;FANCC;TOPBP1;ENDOG;PRIMPOL;CDK1;CDC6;ZRANB3;FEN1;DCTPP1;DNASE2;TICRR;TRIM28
prerank,cellular response to chemical stress (GO:0062197),-0.21326447172362822,-0.7598015487369045,0.9299719887955182,0.9573078923599162,1.0,41/96,30.89%,FOXO1;FOXO3;CAV1;LRRK2;CPEB2;PRDX2;ZC3H12A;SLC25A24;VKORC1L1;TRPV4;ATM;CYBA;PPIA;VRK2;PRKAA2;PNPT1;SIRT2;GPX1;PARK7;STX2;BRF2;MT3;PPARGC1A;NOX1;RAD52;CYBB;TXNRD2;PYCR2;ATG7;ZFAND1;FAS;PRDX1;SOD2;ABL1;HSPA1B;ATP13A2;GSR;NUDT2;KEAP1;AIF1;CHCHD2
prerank,synaptic vesicle recycling (GO:0036465),0.2989332015401338,0.7592343661638814,0.7754318618042226,0.9614066825995625,1.0,7/31,15.84%,CEL;SNCA;SYT1;SYT2;NLGN3;RAB5A;CDK5
prerank,termination of RNA polymerase II transcription (GO:0006369),0.29714139964441655,0.7589763697482989,0.74573055028463,0.9611728351867499,1.0,8/33,19.26%,CLP1;NCBP2;LSM10;PAPOLA;SYMPK;SNRPD3;CPSF7;MED18
prerank,linoleic acid metabolic process (GO:0043651),0.3293474533547387,0.7587935632703231,0.7081545064377682,0.9608109953955114,1.0,1/17,2.03%,FADS2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.23102489875165796,-0.7585698335980233,0.8883495145631068,0.9584940078876121,1.0,18/58,26.98%,POLM;DCLRE1C;NHEJ1;ATM;UVRAG;XRCC4;RAD50;PAXX;HMGB2;CYREN;BABAM2;PIAS4;BABAM1;ERCC1;RNF8;BRCA1;POLA1;PRPF19
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.303340082620791,-0.7581490942400765,0.78515625,0.9584731678752968,1.0,1/18,0.60%,PLCB1
prerank,ceramide biosynthetic process (GO:0046513),-0.25079026322754105,-0.7580203239976624,0.8292682926829268,0.9580839672965671,1.0,9/40,16.94%,SGMS1;SGMS2;ST6GALNAC3;ST8SIA2;DEGS2;ST6GALNAC6;SPTLC2;ST3GAL5;CLN8
prerank,tryptophan metabolic process (GO:0006568),0.35085986723627,0.7579991176235151,0.7088607594936709,0.9614177684567303,1.0,1/11,3.71%,ATP7A
prerank,proteasomal protein catabolic process (GO:0010498),0.22532296593299153,0.7577934668613953,0.8739946380697051,0.961063246260307,1.0,27/201,12.49%,NEDD4L;TNFAIP1;HECW2;BTRC;TRIM9;CUL3;RBX1;PSMB11;SIAH2;UCHL1;SPOPL;FBXO45;ATE1;PSMF1;HACE1;SIAH3;KCTD13;HECW1;UBE2G1;UBXN2B;SOCS6;KBTBD7;TRIM2;SPOP;KCTD5;PSME4;APPBP2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.30866182105963624,0.7573272903369617,0.7585513078470825,0.9611415595789532,1.0,7/27,15.63%,AK1;AK8;RRM1;DCTD;AK7;AK5;AK4
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3370344013357184,-0.7560017027615944,0.789103690685413,0.9603680722005672,1.0,3/11,19.18%,GFPT2;UAP1;GFPT1
prerank,regulation of JUN kinase activity (GO:0043506),0.29758843919286226,0.7559744151429804,0.718978102189781,0.9626944810820247,1.0,8/33,15.59%,MAP3K5;PTPN22;TAOK3;PAK1;TRAF6;DVL2;TRAF2;DVL3
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.34844245963123366,-0.7553682685459072,0.786096256684492,0.9607187315587931,1.0,2/10,6.26%,LRP6;WNT5A
prerank,neuromuscular process controlling balance (GO:0050885),0.34316008454030456,0.7551435014809191,0.7164502164502164,0.9633640377841081,1.0,1/12,3.15%,NRXN1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.31012098751872985,0.7544526952462345,0.7359223300970874,0.9637878411502444,1.0,3/24,6.39%,NCKAP5;FGF13;TPPP
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.2993001808980771,-0.7539928141960544,0.8188824662813102,0.9621702037222576,1.0,3/18,10.03%,SETD7;SETD1B;EHMT1
prerank,regulation of spindle organization (GO:0090224),-0.30158381604714735,-0.7537533330310439,0.7985212569316081,0.9619674541753563,1.0,7/18,28.51%,PARP3;DYNC1H1;NUMA1;GNAI1;TPX2;FSD1;NUP62
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.26830882233435366,0.7535886193121851,0.7610921501706485,0.9645094096155042,1.0,7/53,10.68%,GLMN;RHBDF1;ALAD;DESI1;PSMF1;GNA12;XPO1
prerank,response to organonitrogen compound (GO:0010243),-0.2505731933453288,-0.753420212675139,0.8526077097505669,0.9618676296459016,1.0,14/38,30.30%,RCN3;RNF139;GLRA3;RNF185;IRAK3;VCP;DNAJB12;CCDC47;KYNU;RRAGC;PRKN;TRPM2;SYVN1;MEAK7
prerank,protein hydroxylation (GO:0018126),-0.30533672749000906,-0.7533533701676708,0.7889908256880734,0.9613982053111878,1.0,5/15,20.62%,PLOD2;EGLN3;PLOD1;P3H4;PLOD3
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.3389635349640071,-0.7531947345839723,0.7944444444444444,0.9610312409411084,1.0,6/10,51.17%,TLR4;NCKAP1L;VSIR;IL12A;FOXP3;IL12B
prerank,histone lysine demethylation (GO:0070076),-0.27121560795216776,-0.7529025100874649,0.8329979879275654,0.9608480348498246,1.0,4/25,16.16%,KDM7A;KDM5B;KDM3A;KDM6B
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.2227583898057065,-0.752571845290699,0.918854415274463,0.9607484448849333,1.0,23/64,31.82%,MLLT3;RTF1;POLR2A;POLR2F;EAF1;ELOB;CDK9;POLR2E;TCEA1;ELOC;NELFCD;ELOF1;ERCC2;POLR2G;CDK7;ERCC3;ELP2;CTDP1;MNAT1;SUPT4H1;GTF2H3;PAF1;SSRP1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3093865597565184,0.7519668138053379,0.7665995975855131,0.9664964792081087,1.0,2/27,4.98%,LIMD1;AJUBA
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.2487045927849857,-0.7518063806226528,0.8348837209302326,0.9612081532962746,1.0,14/38,29.11%,NPEPPS;LRRK2;LMAN1;SH3GLB1;TOMM7;SAE1;SREBF1;LEPROT;HPS4;USP36;BAP1;PRKN;FZD5;RHOU
prerank,histone lysine methylation (GO:0034968),-0.259282942575425,-0.7517372334378349,0.8297872340425532,0.9607437709868579,1.0,18/33,40.85%,SMYD3;SETD1B;PRDM5;EZH2;SETDB1;SETD6;WDR5B;TRMT112;RBBP5;DOT1L;WDR82;ASH2L;KDM6A;DYDC2;SETDB2;DPY30;N6AMT1;SMYD2
prerank,positive regulation of intracellular transport (GO:0032388),-0.25174403251720207,-0.7511367924715856,0.8675213675213675,0.9610049682032447,1.0,17/38,27.30%,ACTN2;EHD1;EHD2;RUFY3;TPR;DYNC1H1;STX18;OAZ1;RAB29;NUMA1;RIPOR1;ICE1;STK11;TBC1D20;ZFAND1;SPAG5;B3GAT3
prerank,signal transduction in response to DNA damage (GO:0042770),0.2781500605146361,0.7505777585312563,0.7912280701754386,0.9680205737571627,1.0,7/49,14.26%,MAP3K20;CASP9;RAD1;MYO6;ATR;RAD17;ATRIP
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2985902991794874,0.7505168133923699,0.7440585009140768,0.9674337877057435,1.0,1/33,0.42%,PTEN
prerank,carbohydrate transport (GO:0008643),0.34256639127684707,0.7502254150550277,0.7366167023554604,0.9672260359755043,1.0,3/11,16.93%,SLC5A1;SLC23A2;SLC23A1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3308410831772554,-0.7502183750267356,0.7902350813743219,0.9616478199461723,1.0,1/11,5.85%,WIPI2
prerank,cell cycle G1/S phase transition (GO:0044843),0.26077914570597727,0.749739628687384,0.8177339901477833,0.9673398266492536,1.0,9/61,14.28%,CDK6;CUL3;CRLF3;SPDYA;CDKN1A;LATS2;RB1;EIF4E;CCNH
prerank,negative regulation of cell cycle process (GO:0010948),-0.2235428864473331,-0.7496463578458309,0.8787878787878788,0.9618420496929929,1.0,9/61,10.24%,BMP7;TOM1L2;BMP4;TFDP2;RBBP7;TOM1L1;ZFYVE19;EHMT1;DAB2IP
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3402918694349274,0.7494326477124069,0.718816067653277,0.9671431342351228,1.0,2/13,7.49%,NCBP2;CPSF6
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.3387255721387749,0.7485380512572297,0.7017543859649122,0.9679342729912324,1.0,1/13,1.15%,BMP5
prerank,rRNA catabolic process (GO:0016075),0.3259116878184094,0.7483235095754547,0.7733887733887734,0.9676154960068738,1.0,2/16,10.41%,PELO;TRIR
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.29488481805433314,0.7478377218489222,0.7449908925318761,0.9677155027710275,1.0,2/33,2.01%,TNKS1BP1;DCLRE1B
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.33155779347349584,0.7477846673283258,0.7551867219917012,0.967136834793345,1.0,6/19,12.56%,MTCL1;CRB1;MARK2;DLG2;PARD3B;DLG3
prerank,positive regulation of chromosome organization (GO:2001252),0.33592951207465777,0.7473412174315865,0.7036247334754797,0.9671711755862478,1.0,5/15,17.61%,LIG4;SHCBP1L;PPP1R10;DHX36;DDX11
prerank,rRNA methylation (GO:0031167),0.31569046745650475,0.7463273864317592,0.7428571428571429,0.9681807871672674,1.0,3/22,5.31%,MRM3;FBLL1;NSUN3
prerank,proton transmembrane transport (GO:1902600),0.283899256565796,0.7460507619142005,0.7712177121771218,0.9679324810895834,1.0,3/36,6.15%,ATP1A2;ATP1A4;ATP6V0E2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.2999637871262927,0.7455828998632346,0.7713717693836978,0.9680306642432852,1.0,5/29,8.15%,NR1H3;SCARB1;LDLR;FABP3;MTOR
prerank,carboxylic acid catabolic process (GO:0046395),-0.3193384467792131,-0.7455270899595062,0.7767527675276753,0.9668674677250858,1.0,8/12,53.14%,PON3;BCKDK;IL4I1;AMDHD2;GNPDA1;PON1;ACOT4;RENBP
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.21390595371270743,0.745468406029887,0.9523809523809523,0.9675213528262695,1.0,55/314,16.31%,NEDD4L;TNFAIP1;UBR1;HECW2;BTRC;TRIM9;FAM8A1;CUL3;RBX1;DERL3;PSMB11;SIAH2;FAF2;FOXRED2;UCHL1;SPOPL;FBXO45;PSMF1;UBR3;HACE1;SGTB;UBE2J2;UBE2E1;SIAH3;KCTD13;HECW1;UBE2G1;UBXN2B;PTTG1;KBTBD7;TRIM2;RB1;ERLIN1;UBR2;SPOP;KCTD5;PSME4;RNF121;APPBP2;ANAPC2;RMND5B;ANAPC7;UBQLN2;DNAJC18;SKP1;AMN1;ARMC8;FAF1;MAD2L1;RNF103-CHMP3;ZFAND2A;KCTD17;PSMB5;ERCC8;TMUB2
prerank,nucleic acid metabolic process (GO:0090304),-0.22219600153394153,-0.744434353431107,0.9295039164490861,0.9677667178879444,1.0,12/69,14.80%,RBFOX2;ENPP1;POLR2A;PCBP2;ATXN2;MMS19;NT5E;DNASE1L1;POLR2F;RAN;DDX24;RAD50
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.27659660333342206,-0.744227801950001,0.8132075471698114,0.9674733448526748,1.0,12/22,31.44%,DUSP1;DUSP16;DUSP7;PPM1B;DUSP10;PPM1G;PPP5C;PPM1F;PPP1CA;DUSP8;DUSP4;DUSP18
prerank,microtubule nucleation (GO:0007020),0.3140037197372061,0.7435541936188141,0.7366255144032922,0.9698480233540449,1.0,4/19,10.49%,CCDC57;CLASP2;TPPP;TUBG2
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.32895289155417223,-0.7432651616837617,0.7927927927927928,0.9682215968683255,1.0,5/10,26.73%,PDCD4;MAPK8IP1;DUSP10;HIPK3;AIDA
prerank,mitotic sister chromatid segregation (GO:0000070),-0.20396692443353284,-0.7431072948599705,0.9405099150141643,0.9678362460780534,1.0,37/98,33.68%,RAB11A;PDCD6IP;KMT5A;PDS5B;INO80;PINX1;BECN1;CHMP4B;CHMP4A;NCAPG2;RAN;ZW10;SMC4;CENPK;SMC1A;DSN1;CENPE;RRS1;PIBF1;SPAG5;KIF18B;KIFC1;CHMP5;NUP62;NSL1;NDC80;DCTN2;KIF14;CDCA8;CEP55;SGO1;EML3;KIF23;KIF18A;CSNK2B;CHMP6;PRC1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.2428577525305931,-0.7428013710293072,0.8672768878718535,0.9676731910934128,1.0,11/43,21.71%,FOXN3;RINT1;CHFR;TAOK2;NABP1;ATM;TRIM39;FZR1;BABAM2;CDK5RAP3;BABAM1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.23798978961824097,-0.7422568832420015,0.8864142538975501,0.9678142090474725,1.0,7/48,17.27%,ZMIZ1;KAT2B;BAZ1B;POLR2F;ACTB;ZMIZ2;POLR2E
prerank,nucleotide biosynthetic process (GO:0009165),-0.293977243673202,-0.7421880149457922,0.7948717948717948,0.9673404818907089,1.0,7/18,22.56%,ME1;PRPS2;NMNAT1;PRPS1;PRPS1L1;PNP;RRM2B
prerank,response to hexose (GO:0009746),-0.26437915126010847,-0.7420241889453605,0.8101010101010101,0.9670008329858583,1.0,2/25,3.88%,THBS1;TCF7L2
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.3027682797211373,-0.7415864371745191,0.8020408163265306,0.9669825080339871,1.0,3/15,9.52%,NR3C1;ANXA1;BCL2L11
prerank,regulation of stem cell differentiation (GO:2000736),0.2467221189658056,0.7413150638307733,0.8451816745655608,0.9726536533411515,1.0,23/89,19.86%,NOTCH1;TCF15;PTN;RBM24;PSMB11;PSMF1;MYB;JAG1;TCF12;YTHDF2;PSME4;PRKDC;OCIAD1;HNRNPU;PUS7;KMT2A;PSMB5;NSUN2;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.35207292007119156,0.7410966076421938,0.7404921700223713,0.9723150819276313,1.0,1/10,1.44%,JAM3
prerank,apoptotic DNA fragmentation (GO:0006309),-0.29885168912241833,-0.7405991682490883,0.7839388145315488,0.9676948199810027,1.0,7/16,37.23%,HMGB2;DICER1;DFFB;FOXL2;EXOG;ENDOG;DNASE2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3128761411014135,-0.7402235398970374,0.7866666666666666,0.9676221452618408,1.0,3/13,17.91%,STX7;MR1;CYRIB
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.28539210326639847,0.7395548035641971,0.7912885662431942,0.9741139567087653,1.0,5/36,6.47%,CBX5;PHC3;RYBP;PHC1;CBX3
prerank,negative regulation of hormone secretion (GO:0046888),-0.3407076228990211,-0.7392794488582526,0.7898550724637681,0.9682773724633175,1.0,3/10,14.97%,GJA1;RAB11FIP1;RAB11FIP5
prerank,nuclear membrane reassembly (GO:0031468),0.2661440968010475,0.7386607007380669,0.8197879858657244,0.9748538016530865,1.0,15/54,20.10%,NUP43;PPP2R2A;CHMP2B;ANKLE2;NUP35;UBXN2B;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.2280587630595693,-0.7383290693446553,0.9156908665105387,0.9689396326181996,1.0,17/50,31.12%,CCND2;CCND3;CCNG1;CCND1;ACTB;HSP90AB1;CDKN1B;CDK5RAP3;CDKN1C;CCNF;SERTAD1;CDK7;CDC25A;CDKN2D;MNAT1;CDKN3;CDKN2B
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.29443885944027615,-0.7382792778660576,0.8053949903660886,0.9684548435689879,1.0,10/17,36.49%,P4HB;AKT1;PPIA;BAG5;SOD2;HSPB1;TREM2;MAPK7;VNN1;NME5
prerank,polyol biosynthetic process (GO:0046173),-0.292226483478549,-0.7368523373974215,0.7891682785299806,0.9697007179337478,1.0,5/16,14.32%,CYP27A1;ACER3;IP6K1;ISYNA1;IP6K2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2779401483234808,0.7365246921594085,0.8149466192170819,0.9775216853156021,1.0,14/44,18.08%,ROCK1;PRR5L;RBM24;YTHDF3;NANOS1;TNRC6C;YTHDF2;TNRC6B;CELF1;DHX36;CNOT1;RC3H1;KHSRP;ZC3HAV1
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2596865002640427,-0.7360746498695532,0.855072463768116,0.9700822199893164,1.0,11/26,33.55%,PCBP2;IRAK3;PPM1B;SIRT2;TRIB1;SIGIRR;LYAR;MAPKBP1;TRIM21;RNF26;ITCH
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2858461949571976,0.735346921414945,0.7820738137082601,0.978702558218023,1.0,6/36,9.08%,USP25;RYBP;OGT;ALAD;PSMF1;CCAR2
prerank,positive regulation of sodium ion transport (GO:0010765),0.3338787810736148,0.7351338994501495,0.7246376811594203,0.9783447851261804,1.0,3/12,7.26%,SCN5A;ANK3;PRSS8
prerank,homocysteine metabolic process (GO:0050667),0.3435282706639495,0.7350991803905177,0.758695652173913,0.9777183631619393,1.0,1/11,2.95%,CTH
prerank,regulation of endocytic recycling (GO:2001135),-0.3233257439575632,-0.7349763593980153,0.797270955165692,0.9708766759476771,1.0,4/11,15.60%,ACTN2;EHD1;ATP9A;EHD2
prerank,autophagosome maturation (GO:0097352),-0.2517699064279623,-0.7343553276379453,0.859538784067086,0.971130777684767,1.0,7/32,21.45%,LAMP2;WIPI2;UVRAG;CALM1;GABARAPL1;VCP;VAMP8
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3192715084257008,0.734232250903957,0.7453027139874739,0.9784171092703524,1.0,5/17,9.97%,RGCC;SPDYA;PKD2;PDGFB;CCNYL1
prerank,RNA catabolic process (GO:0006401),0.2693957345498846,0.7338670608689807,0.7732342007434945,0.9783029813642922,1.0,14/46,20.43%,AGO3;SUPV3L1;XRN2;RNASE6;YTHDF2;SND1;PABPC4;RNASEH1;RNH1;CNOT10;DIS3L2;LSM2;HNRNPD;LSM6
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3277325519712819,-0.7338493606589828,0.7974217311233885,0.9712033677717995,1.0,4/10,24.62%,HDAC4;SAE1;PIAS4;PIAS3
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.27779511758652214,-0.7332009837300832,0.8291746641074856,0.9708951290211749,1.0,9/20,36.32%,IVD;BCKDHB;AUH;BCKDK;BCKDHA;ALDH6A1;BCAT1;ACADSB;HSD17B10
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.27779511758652214,-0.7332009837300832,0.8291746641074856,0.9708951290211749,1.0,9/20,36.32%,IVD;BCKDHB;AUH;BCKDK;BCKDHA;ALDH6A1;BCAT1;ACADSB;HSD17B10
prerank,regulation of response to interferon-gamma (GO:0060330),-0.29749289711379284,-0.7319648643600475,0.8022181146025879,0.9719459023012921,1.0,4/14,19.45%,PARP9;STAT1;HSP90AB1;PTPN2
prerank,immunoglobulin mediated immune response (GO:0016064),0.34648920888253637,0.7318184347826031,0.7406639004149378,0.9807160789617984,1.0,1/10,4.99%,CARD9
prerank,regulation of mRNA processing (GO:0050684),0.27784986471952755,0.7318101774044247,0.7919847328244275,0.9800463598242348,1.0,8/32,17.68%,PTCD2;SRPK3;PAPOLA;KHDRBS2;YTHDC1;SAFB2;QKI;LARP7
prerank,electron transport chain (GO:0022900),-0.2920893207714447,-0.7318082327122907,0.8101503759398496,0.9715568158992149,1.0,4/15,19.22%,POR;PDIA5;CYB561;PPARGC1A
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.2503607840432347,-0.7311219328957206,0.8545454545454545,0.9718277156718143,1.0,13/33,29.29%,PTPRJ;EZR;RELA;CEACAM1;RAB29;PTPN2;IKBKG;CD81;DGKZ;RPS3;BCL10;LAPTM5;KCNN4
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2724169279700025,-0.7293225368056422,0.8379446640316206,0.9734301620245784,1.0,12/21,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,protein acylation (GO:0043543),-0.24076209954294786,-0.7287173823368559,0.8871681415929203,0.973609427082081,1.0,13/38,24.92%,GLUL;FOXO1;KAT2B;SELENOK;CLOCK;SPHK1;NAT10;ZDHHC8;ZDHHC15;NAT9;NAA80;ZDHHC7;ING4
prerank,regulation of viral release from host cell (GO:1902186),0.3019911315985381,0.7286916903303019,0.7666666666666667,0.9840951645398424,1.0,3/21,6.20%,MID2;TRIM62;CHMP2B
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.30444739917981434,0.7279648550281019,0.7520661157024794,0.9845301933322727,1.0,2/20,4.20%,CDK6;HOXA9
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.31270159940509373,0.7277585403960566,0.7601547388781431,0.9841728437469892,1.0,2/21,2.53%,MYH9;ADAM19
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.3388455879222574,0.7267450938576818,0.7361963190184049,0.9850189041683901,1.0,2/12,8.18%,IL1B;IL12RB1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.28260768107343287,-0.7263632276719689,0.821917808219178,0.9758912372625693,1.0,13/18,44.83%,RAB11A;RAD51B;CCND1;RAD51C;CDC25A;DTL;CDC25B;CDK1;RCC2;CCNB1;BRD4;CDC25C;VPS4B
prerank,covalent chromatin modification (GO:0016569),-0.3051732144371332,-0.7263537772914789,0.8220640569395018,0.975339392644697,1.0,5/14,22.14%,HDAC1;SIRT7;PARK7;MT3;MBD2
prerank,chemical homeostasis (GO:0048878),0.2521985018272842,0.7260911655573007,0.8677966101694915,0.9852837558441098,1.0,3/61,2.82%,NEDD4L;NR1H3;NR1D2
prerank,zymogen activation (GO:0031638),0.27360420109563327,0.7255130707073502,0.8113553113553114,0.9854655244471539,1.0,3/39,7.59%,GGT1;CIDEB;RIPK2
prerank,tRNA aminoacylation (GO:0043039),-0.23875207513732483,-0.7253795006551887,0.8697478991596639,0.9759715505656015,1.0,11/37,23.90%,LARS2;RARS2;KARS1;CARS1;QARS1;SARS1;HARS1;MARS2;FARSA;PPA1;FARSB
prerank,alanine transport (GO:0032328),0.34669583035902823,0.7252751277479202,0.7466960352422908,0.9851381253153865,1.0,1/10,2.19%,SLC1A4
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.32552619336167155,0.7248614229412901,0.7385892116182573,0.9850750154811712,1.0,6/14,15.63%,AK1;AK8;AK7;AK5;AK3;AK4
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2669334158404664,0.7227114544705586,0.8294010889292196,0.9877064615731438,1.0,14/45,19.76%,GCNT2;GRM5;NANOS1;ZC3H10;YTHDC1;METTL18;EIF4E;PUM3;TSC1;MATR3;RC3H1;METAP1;DDX25;RBM3
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.3185070468986712,-0.722541126748523,0.8067375886524822,0.9788062925324971,1.0,4/11,20.35%,CAV1;HGS;LEPROT;ADIPOR1
prerank,secondary alcohol metabolic process (GO:1902652),-0.23868744376615636,-0.722447923439852,0.9046563192904656,0.9783527072312791,1.0,9/42,21.68%,ABCA1;APOE;CYP27A1;OSBPL1A;STARD3;IDH3G;CLN8;EBP;CLN6
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.22215403439442533,-0.7224448419926468,0.9241706161137441,0.9777930082364735,1.0,17/53,24.71%,PSME2;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;ODC1;OAZ1;PSMD4;PSMA2;PSMD3;BCKDK;PSMB7;AZIN1;PSMC2;PSMC5;PSMD10
prerank,global genome nucleotide-excision repair (GO:0070911),0.2928417205976047,0.7224078379001105,0.7652859960552268,0.9874865409398627,1.0,9/26,20.33%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;XPC;CHD1L;GTF2H4;DDB2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22545534689754954,0.7207041843921328,0.9184549356223176,0.9893788085893097,1.0,6/145,6.74%,DYNLL1;RBX1;MECP2;PSMB11;PRKAR2B;PSMF1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2921328831217021,0.7206152715285572,0.8077669902912621,0.9888248467581813,1.0,7/27,11.62%,PHF20L1;KAT7;MRGBP;TAF6;KAT6A;RUVBL1;EP300
prerank,positive regulation of mRNA processing (GO:0050685),0.30419548321628603,0.7200557795945853,0.7726315789473684,0.9889983947892032,1.0,9/21,27.16%,NCBP2;TRA2A;DAZAP1;DHX36;RBMX;RBM3;CIRBP;LEO1;SNW1
prerank,midbody abscission (GO:0061952),-0.28356512745471324,-0.7199573039096832,0.8299065420560747,0.9801454564006261,1.0,4/17,16.82%,PDCD6IP;CHMP4B;CHMP4A;MITD1
prerank,mRNA stabilization (GO:0048255),0.2750873253485633,0.7199495583770326,0.8080985915492958,0.9884792192651076,1.0,9/40,14.25%,RBM24;ELAVL4;DAZL;BOLL;DND1;AXIN2;HNRNPU;TENT5D;HNRNPC
prerank,organelle fission (GO:0048285),0.2950709109985302,0.7196209283553188,0.7984344422700587,0.9882834486962311,1.0,8/24,17.53%,TMCC1;MTFP1;WASHC5;MFF;PEX19;MTFR1;MIEF1;DNM1
prerank,regulation of synapse organization (GO:0050807),0.29512730335575854,0.7195735507255138,0.7944111776447106,0.9876814851306946,1.0,4/26,9.92%,MEF2C;YWHAZ;IL1RAPL1;CTNNA2
prerank,positive regulation of secretion (GO:0051047),-0.3155421530189657,-0.718273676565346,0.8269230769230769,0.9815179897235006,1.0,4/11,37.94%,NPR1;XBP1;AQP1;SCIN
prerank,membrane repolarization during action potential (GO:0086011),-0.3053333323782713,-0.7178372552752699,0.8388349514563107,0.9814582723829891,1.0,3/13,13.64%,KCNJ2;KCNQ1;ATP1A1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.3472038495881054,0.7173426649095325,0.7635574837310195,0.9902942765108523,1.0,3/10,12.29%,GALNT13;GALNT1;GALNT4
prerank,striated muscle cell development (GO:0055002),0.33304743032704065,0.7172528937691125,0.7545638945233266,0.9897480853198514,1.0,3/14,10.32%,TMOD1;TMOD3;LMOD1
prerank,mammary gland epithelium development (GO:0061180),-0.2959246287480371,-0.7172217571186027,0.8313492063492064,0.981610762868891,1.0,6/14,24.86%,WNT4;AKT1;ID2;CSF1R;AKT2;SCRIB
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.26448539325933396,-0.7171278300090922,0.8678861788617886,0.9811673786851877,1.0,6/27,18.14%,NAAA;ETNK2;PLA2G6;PLA2G15;LPIN3;ETNK1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.21892007003772623,0.7164247852926864,0.9313304721030042,0.9903246933208353,1.0,25/173,14.03%,DYNLL1;CUL3;SPTBN1;COG7;COG1;SPTB;ANK3;VTI1A;SPTA1;GOLT1A;MIA3;DYNC1I2;TMED7;KLHL12;TMED4;COL7A1;SEC13;RANGRF;COPB2;PROC;TRIP11;VTI1B;COG6;DCTN1;ANK2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3289653699509676,0.7163714722232803,0.7828810020876826,0.9897144209149792,1.0,6/13,18.43%,CIDEB;RIPK2;PERP;GRIN2A;ASPH;NLRC4
prerank,response to ethanol (GO:0045471),0.3220504902974801,0.716212336252203,0.7672413793103449,0.9892626124985777,1.0,5/14,22.35%,GRIN2B;CHRNB2;GRIN2A;GRIN1;SOD1
prerank,Fc receptor signaling pathway (GO:0038093),-0.1953636909250427,-0.715660465264595,0.9705882352941176,0.9822653941172903,1.0,39/110,28.98%,PLCG1;VAV2;MAP3K1;NFATC1;PIK3CB;KIT;PSME2;RELA;PSMB4;FBXW11;PLCG2;FER;PSMB1;PSMD11;PSMD8;MAPK3;PSME3;CALM1;PDPK1;PSMD4;PSMA2;IKBKG;SYK;PSMD3;PPP3CB;NFATC2;PSMB7;LCP2;MAP2K7;PSMC2;SHC1;PSMC5;PSMD10;BCL10;PAK2;PSMD7;MAPK9;VAV3;JUN
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.3204824318011654,-0.7151623832791772,0.8289473684210527,0.9822572102464934,1.0,4/10,28.31%,HSP90AB1;NAB2;EGR1;CLU
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.28695636594863333,0.7150744231173457,0.8309859154929577,0.9902486627616965,1.0,8/25,19.22%,SORT1;CHMP2B;MVB12A;DENND10;UBXN6;CHMP3;LEPROTL1;VTA1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3185779762671433,0.7149112923840804,0.7881873727087576,0.9898111394475843,1.0,2/16,7.64%,PTPN22;FGF10
prerank,ncRNA catabolic process (GO:0034661),-0.25430829970777624,-0.7143041486462826,0.8856502242152466,0.9826710659124748,1.0,8/28,25.83%,TUT4;EXOSC5;XRN1;TENT4B;DEDD2;NUDT16;EXOSC7;POP1
prerank,negative regulation of immune system process (GO:0002683),0.3164250851447752,0.7140443710069377,0.7617107942973523,0.9904022016624071,1.0,2/16,9.11%,GPER1;LYN
prerank,alpha-amino acid metabolic process (GO:1901605),0.2624831511730983,0.7138742947393838,0.8384201077199281,0.9899682163651942,1.0,6/45,11.94%,NAALAD2;ATP7A;SLC25A13;GOT1;SRR;GLS2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2992314577515367,0.7132682042506038,0.8104838709677419,0.9901912059376436,1.0,2/22,3.28%,CD46;IL2RA
prerank,magnesium ion transport (GO:0015693),-0.30506017924427725,-0.7130808022752138,0.8454011741682974,0.9834672544883706,1.0,1/12,4.08%,SLC41A1
prerank,regulation of telomerase activity (GO:0051972),-0.22656800400296007,-0.7130291607645469,0.8912037037037037,0.9829640373156201,1.0,14/45,26.85%,KLF4;SMG6;NAF1;PINX1;ATM;HSP90AB1;MAPK3;MAP3K4;ACD;MAP2K7;WRAP53;TP53;CTNNB1;NEK7
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.28294165627077966,0.7129087661682253,0.8095238095238095,0.9893617761428081,1.0,7/32,14.56%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,tRNA export from nucleus (GO:0006409),0.28294165627077966,0.7129087661682253,0.8095238095238095,0.9893617761428081,1.0,7/32,14.56%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,RNA methylation (GO:0001510),0.24968024021313603,0.7122957448955362,0.8508474576271187,0.9895853308862638,1.0,19/60,24.32%,FBLL1;NSUN3;TRMT61A;TRMT5;CBLL1;THUMPD2;RBM15;TRMT10C;MTO1;TFB2M;NSUN2;NSUN5;ZC3H13;WTAP;METTL6;DIMT1;GTPBP3;TRMT10A;TRDMT1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.24282789501923152,-0.7118797393413292,0.8876651982378855,0.9836793572224388,1.0,11/30,31.24%,HSPA5;ENTPD5;ST13;DNAJB5;HSPA13;GAK;HSPA9;DNAJB12;HSPA1B;BAG1;SDF2L1
prerank,regulation of G0 to G1 transition (GO:0070316),0.2730073120419061,0.7110270549826164,0.8450450450450451,0.9907698383877479,1.0,5/38,6.47%,CBX5;PHC3;RYBP;PHC1;CBX3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.31893662320066235,0.7109486557029472,0.7733598409542743,0.9902008345874402,1.0,1/13,1.77%,NR1H3
prerank,positive regulation of natural killer cell activation (GO:0032816),0.33309033170017943,0.7107394843678526,0.8026315789473685,0.989836357322865,1.0,2/13,4.80%,AXL;AP1G1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.2908361038238261,-0.7100418630368707,0.8385214007782101,0.9851970801043992,1.0,6/16,31.20%,CAV1;TRIM27;TRIM14;TRIM6;FUCA2;TRIM21
prerank,gastrulation (GO:0007369),0.3157428288641828,0.7098358560387228,0.7941176470588235,0.9904771266658768,1.0,3/15,15.64%,GPC3;LMBRD1;TASOR
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.2654112556953114,-0.7084417293267031,0.8627049180327869,0.9864019158490422,1.0,8/23,26.75%,CUL4A;COPS4;UBB;COPS8;DDB1;CETN2;COPS7A;COPS2
prerank,telomere maintenance via recombination (GO:0000722),-0.3123056773416587,-0.7084201536436108,0.8460111317254174,0.9858631247234797,1.0,5/11,23.51%,TEP1;RAD50;TPRKB;RAD51;ERCC1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.1924638548880839,-0.708066423992203,0.9798270893371758,0.9856784220236815,1.0,39/109,28.98%,PLCG1;VAV2;MAP3K1;NFATC1;PIK3CB;PSME2;RELA;PSMB4;FBXW11;PLCG2;FER;PSMB1;PSMD11;PSMD8;MAPK3;PSME3;CALM1;PDPK1;PSMD4;PSMA2;IKBKG;SYK;PSMD3;PPP3CB;NFATC2;PSMB7;LCP2;NR4A3;MAP2K7;PSMC2;SHC1;PSMC5;PSMD10;BCL10;PAK2;PSMD7;MAPK9;VAV3;JUN
prerank,endocytic recycling (GO:0032456),0.2576558819328222,0.7072792839609455,0.8271186440677966,0.9934867120460282,1.0,1/50,0.58%,ANKRD50
prerank,regulation of dopamine secretion (GO:0014059),0.2867511134968268,0.7071403929792744,0.7858585858585858,0.9929985044639198,1.0,11/25,24.87%,SNCA;SYT1;SYT2;CHRNB2;SYT12;SYT11;SYT13;SYT3;DRD2;SYT6;SYT10
prerank,regulation of store-operated calcium entry (GO:2001256),0.33381404310081236,0.7071391716786525,0.7692307692307693,0.9923277106544216,1.0,4/10,16.17%,STIM1;CASQ1;SLC8B1;CD84
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.2764920207688467,-0.706947588880444,0.8709055876685935,0.9863526081816849,1.0,2/16,5.34%,KAT2B;NAA35
prerank,respiratory electron transport chain (GO:0022904),0.32242968525607435,0.7060026942038512,0.790356394129979,0.9932098326709543,1.0,6/14,18.71%,UQCRFS1;SLC25A13;ETFB;ETFA;ETFDH;NDUFA5
prerank,axonemal dynein complex assembly (GO:0070286),-0.25069497903926774,-0.7059127915471358,0.877431906614786,0.9869426897818636,1.0,19/27,48.80%,DNAH8;ODAD2;DRC1;ODAD3;DNAL1;CCDC65;DNAAF2;DNAI4;TTC12;CFAP100;DNAH17;CCDC40;DNAAF4;ODAD1;DNAH1;DNAAF3;DNAAF1;DNAI3;CFAP73
prerank,autophagy of peroxisome (GO:0030242),-0.3085779945823999,-0.7058795272155609,0.8221797323135756,0.986421982698966,1.0,2/12,13.31%,ATM;ACBD5
prerank,V(D)J recombination (GO:0033151),0.3291893707843452,0.7058601822637293,0.7644539614561028,0.9927469592622185,1.0,2/11,12.70%,LIG4;PRKDC
prerank,tryptophan catabolic process (GO:0006569),-0.30640043538141565,-0.705616771396185,0.8166351606805293,0.9861541388338791,1.0,10/11,57.19%,AFMID;KYNU;IL4I1;HAAO;KYAT1;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,morphogenesis of an epithelium (GO:0002009),0.2926806227149946,0.7054876626390386,0.8042226487523992,0.9926257159269682,1.0,6/25,12.93%,VCL;TIMELESS;TBX18;AHI1;PRKX;KDM2B
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3179817909267097,0.7051965802516246,0.7736263736263737,0.9923502316418549,1.0,5/15,15.63%,AK1;AK8;AK7;AK5;AK4
prerank,histone monoubiquitination (GO:0010390),0.29915866149360737,0.7045730271329989,0.8109640831758034,0.9925741840329465,1.0,6/24,16.09%,RYBP;UBE2E1;CTR9;KDM2B;SKP1;TRIM37
prerank,regulation of viral transcription (GO:0046782),-0.23238135307150665,-0.7044495560424128,0.9040511727078892,0.9868862224746676,1.0,16/39,31.20%,MDFIC;IFITM3;POLR2A;TRIM27;POLR2F;CDK9;POLR2E;TRIM14;RSF1;NELFCD;TRIM11;POLR2G;CTDP1;SUPT4H1;ZFP36;TRIM21
prerank,regulation of amyloid-beta clearance (GO:1900221),0.3144819476372888,0.704385558186878,0.7929606625258799,0.9921798441099067,1.0,4/16,14.71%,ROCK1;IL4;ABCA7;HMGCR
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.24195829213738865,-0.703765901819172,0.9022403258655805,0.9870849416989609,1.0,12/32,30.61%,TAF1;CAVIN1;POLR2F;MAPK3;POLR2E;UBTF;ERCC2;CDK7;ERCC3;POLR1C;MNAT1;GTF2H3
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.2742571338031273,0.7036257578288855,0.8355899419729207,0.992555896714605,1.0,4/32,7.89%,CAMP;CXCL10;CXCL5;RNASE6
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.31907073286189985,0.7033667101994628,0.7914893617021277,0.9922541320304524,1.0,9/14,26.81%,RNPS1;C1QBP;RBMX;SRSF9;PTBP1;SAP18;SRSF12;SRSF4;SFSWAP
prerank,positive regulation of telomerase activity (GO:0051973),-0.23756591739150967,-0.7032247310361626,0.8937644341801386,0.9871216726056484,1.0,10/33,26.85%,KLF4;NAF1;HSP90AB1;MAPK3;MAP3K4;ACD;MAP2K7;WRAP53;CTNNB1;NEK7
prerank,bicarbonate transport (GO:0015701),-0.25469826507631,-0.7032172093690723,0.8781512605042017,0.9865731749612565,1.0,2/25,3.27%,SLC26A7;SLC4A10
prerank,protein K11-linked ubiquitination (GO:0070979),-0.24715706467602588,-0.7021521278802948,0.8913480885311871,0.9871582581380561,1.0,8/27,25.78%,CDC16;UBE2E2;ANAPC4;FZR1;CDC27;ANAPC5;PRKN;UBE2H
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2621578907307514,-0.7020964774836032,0.8806584362139918,0.98666039034339,1.0,7/23,29.00%,ELOVL7;FAR2;ELOVL1;ACSL4;DGAT2;ACSBG1;ACSF3
prerank,regulation of immune effector process (GO:0002697),0.26867986435315233,0.7018936965104122,0.8274647887323944,0.9936172624186844,1.0,5/41,9.51%,VTN;CD46;C7;SUSD4;CR2
prerank,phagosome-lysosome fusion (GO:0090385),-0.31456300769740997,-0.7018484076910939,0.8497316636851521,0.9863441035960231,1.0,7/10,39.23%,RAB7A;RAB7B;SYT7;RAB20;CLN3;PLA2G5;RAB39A
prerank,fatty acid beta-oxidation (GO:0006635),-0.22384550227160932,-0.70048041135058,0.9447115384615384,0.9872091858950887,1.0,14/51,21.78%,IVD;CPT2;SLC25A17;ACOX1;ECI2;ACADL;AUH;BDH2;ACAD10;ACOX3;ECHDC2;ACADS;DECR1;GCDH
prerank,positive regulation of protein acetylation (GO:1901985),0.3271635858055262,0.7004684731242844,0.7973273942093542,0.9948740379792632,1.0,3/12,14.30%,DDX3X;FAM161A;PRKAA1
prerank,negative regulation of mRNA processing (GO:0050686),0.31575764729949063,0.7004576763639959,0.7914893617021277,0.9942195440777696,1.0,9/15,26.81%,RNPS1;C1QBP;RBMX;SRSF9;PTBP1;SAP18;SRSF12;SRSF4;SFSWAP
prerank,protein targeting to membrane (GO:0006612),0.2307983411025722,0.7002986259932994,0.8954468802698144,0.993754898570555,1.0,17/83,18.15%,ZDHHC14;RAB8B;NCF1;ABCD2;ATAD1;SGTB;PIKFYVE;ZDHHC1;ZDHHC2;ZDHHC21;PEX3;ZDHHC23;PEX19;PEX12;ZDHHC9;CHM;NACAD
prerank,regulation of synapse maturation (GO:0090128),0.32870321592882173,0.6998057602956204,0.7640449438202247,0.9937339094914244,1.0,3/10,13.11%,NRXN1;YWHAZ;ANAPC2
prerank,dopaminergic neuron differentiation (GO:0071542),-0.2697860631223856,-0.6988560755971799,0.8312387791741472,0.9883622126650032,1.0,8/19,34.86%,LRP6;NR4A2;LMX1B;VEGFA;CTNNB1;LMX1A;WNT2;SHH
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.23987028608094457,-0.6987886314144319,0.8941684665226782,0.9878692125454578,1.0,10/29,25.91%,PINX1;PPIA;ANKRD28;HSP90AB1;RPA1;RAD50;RFC1;ACD;WRAP53;NHP2
prerank,histone H4 acetylation (GO:0043967),-0.219813058213154,-0.6977102566046378,0.9291845493562232,0.988436427210471,1.0,16/47,25.98%,LEF1;TRRAP;MEAF6;TRIM16;BRCA2;KANSL2;BEND3;NAA40;CHD5;MORF4L2;HAT1;BRD8;JADE1;ING4;ATF2;EPC1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3228342334239748,0.69665231522843,0.79004329004329,0.9973548933739412,1.0,3/12,8.20%,TK1;TK2;DCK
prerank,regulation of smoothened signaling pathway (GO:0008589),0.25989498906035047,0.6965078616544338,0.8626373626373627,0.9968842926495223,1.0,7/50,6.76%,RORA;BTRC;IFT81;MOSMO;GAS8;GPC3;KCTD6
prerank,regulation of small molecule metabolic process (GO:0062012),0.2830809597053049,0.6963404855464627,0.839622641509434,0.9964394501395009,1.0,2/28,3.04%,RORA;ARV1
prerank,regulation of organelle assembly (GO:1902115),0.23818218498458962,0.6959008837414618,0.8776859504132232,0.996368292696229,1.0,15/72,15.95%,TBC1D1;IFT20;TBC1D12;PIKFYVE;TBC1D2B;NPRL3;TBC1D10C;VPS11;TBC1D9B;NPRL2;TBC1D19;UBQLN2;RAB5A;CEP76;TBC1D10B
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2425552658363439,-0.6958597648488545,0.9223946784922394,0.9897673181847908,1.0,8/29,29.00%,ELOVL7;ACACA;ELOVL1;ACSL4;HSD17B8;GCDH;ACSBG1;ACSF3
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2572256078185252,-0.6958285475816877,0.8864097363083164,0.9892453434323314,1.0,8/24,32.01%,UBB;RPA1;RFC3;RFC1;RPA3;POLD1;PCNA;RFC5
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.314859722535565,-0.6955559177818539,0.8477443609022557,0.9889654128432129,1.0,5/10,25.85%,SP100;HIPK2;RPS27L;ING4;TP53
prerank,mitochondrial fusion (GO:0008053),0.29784228934679013,0.6955494445790952,0.7970085470085471,0.9961657799205241,1.0,4/18,15.81%,PLD6;MFF;MFN1;MIEF1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.268986949124286,-0.6954357587282947,0.8507751937984496,0.9885194567656539,1.0,5/19,22.61%,CUX1;OBSL1;LRP8;DBN1;SS18L1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.23668188032084536,-0.6953010330581338,0.9128540305010894,0.9880834484672486,1.0,16/37,32.01%,ERCC5;CUL4A;UBB;DDB1;RPA1;RFC3;RFC1;ERCC1;ERCC2;RPA3;ERCC3;NTHL1;POLD1;GTF2H3;PCNA;RFC5
prerank,tRNA transport (GO:0051031),0.2691409237260629,0.6949911694660662,0.8439849624060151,0.9962698513346744,1.0,7/35,14.56%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.28025879207971643,-0.6949604341844946,0.8766355140186916,0.9878807974267031,1.0,6/16,29.45%,AMPD3;ATIC;LHPP;ADSS1;PAICS;NUDT2
prerank,regulation of defense response to virus by host (GO:0050691),0.2762816869359615,0.6948033986913433,0.8186915887850468,0.9958415233788604,1.0,6/30,10.05%,PTPN22;IL4;IL12RB1;ZDHHC1;TARBP2;CGAS
prerank,regulation of oxidoreductase activity (GO:0051341),0.3188271986143726,0.6946558170321947,0.8038793103448276,0.9953821622660193,1.0,2/13,10.52%,ATP7A;ABL2
prerank,cilium movement (GO:0003341),0.2538908023533645,0.6932095216838182,0.8556338028169014,0.9966235431376663,1.0,8/47,17.56%,RSPH6A;SPEF1;GAS8;CAMSAP3;CCDC63;ODAD4;CFAP61;DNAH9
prerank,fatty acid transport (GO:0015908),0.3001262882770855,0.6927064508856577,0.795131845841785,0.9965978063522399,1.0,3/17,5.58%,PPARD;SLC27A4;FABP3
prerank,spliceosomal snRNP assembly (GO:0000387),-0.22999119074961424,-0.6923285414027532,0.9330357142857143,0.9899510089441903,1.0,13/38,27.77%,GEMIN7;STRAP;SRSF10;GEMIN5;PRPF3;SNRPF;SNRPD1;SNRPD2;WDR77;PRPF19;SNRPC;SNRPB;SNRPE
prerank,cellular response to tumor necrosis factor (GO:0071356),0.2125567641690301,0.6920970195962556,0.9757142857142858,0.9967357608728643,1.0,12/175,7.97%,LIMS1;PID1;TNFRSF21;GPER1;TRAF5;PSMB11;ACTN4;TNFRSF8;CACTIN;PSMF1;TRAF3;CDIP1
prerank,embryonic axis specification (GO:0000578),-0.2840426555849898,-0.6916685610040113,0.846441947565543,0.9900807275877762,1.0,1/15,0.78%,SMAD6
prerank,positive regulation of rRNA processing (GO:2000234),-0.3145621907093138,-0.6916003562913594,0.8444444444444444,0.9895989553052174,1.0,3/10,24.10%,SIRT7;RIOK2;TRMT112
prerank,regulation of histone acetylation (GO:0035065),-0.23552237192029388,-0.6908842657000986,0.9138276553106213,0.9897331216212718,1.0,11/33,24.17%,ARRB1;BRD7;TADA2A;FLCN;HDAC5;MAPK3;NOS1;PARK7;PPARGC1A;CTBP1;BRCA1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.25322958634550025,0.69068437667799,0.8837209302325582,0.9972672743167765,1.0,14/51,20.10%,NUP43;PPP2R2A;CHMP2B;ANKLE2;NUP35;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,mitotic nuclear membrane organization (GO:0101024),0.25322958634550025,0.69068437667799,0.8837209302325582,0.9972672743167765,1.0,14/51,20.10%,NUP43;PPP2R2A;CHMP2B;ANKLE2;NUP35;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.29028105615507527,0.690252109934912,0.8291746641074856,0.9971419919535788,1.0,3/26,6.30%,NR1H3;PTPN22;DDX3X
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.29303765693066236,0.6898239502523149,0.7894736842105263,0.9963705526676611,1.0,9/21,20.33%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;CHD1L;RPA2;GTF2H4;DDB2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.29303765693066236,0.6898239502523149,0.7894736842105263,0.9963705526676611,1.0,9/21,20.33%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;CHD1L;RPA2;GTF2H4;DDB2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.322947556789973,0.6898120421371196,0.7810526315789473,0.9944118534811143,1.0,4/12,15.88%,CUL3;RB1;ANAPC7;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.322947556789973,0.6898120421371196,0.7810526315789473,0.9944118534811143,1.0,4/12,15.88%,CUL3;RB1;ANAPC7;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.322947556789973,0.6898120421371196,0.7810526315789473,0.9944118534811143,1.0,4/12,15.88%,CUL3;RB1;ANAPC7;NSMCE2
prerank,microtubule polymerization (GO:0046785),0.27348294599340356,0.6896991111052497,0.8148854961832062,0.9939050251091703,1.0,5/28,10.49%,FGF13;CCDC57;CLASP2;TPPP;TUBG2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.2427309400274122,-0.6896202918743441,0.9105145413870246,0.9904570859903064,1.0,9/30,22.76%,NPEPPS;SH3GLB1;TOMM7;SAE1;LEPROT;PDCD5;HPS4;USP36;BAP1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2692755029489088,0.6889599927882529,0.8484251968503937,0.9942566735582992,1.0,10/30,21.36%,ABCD2;SLC27A2;SLC27A4;ACOT2;TECR;ACOX2;ELOVL6;PEX2;ELOVL2;ACSL1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.27838567365791045,-0.6888630759090639,0.8544776119402985,0.9906477009075447,1.0,6/15,30.06%,SNX10;CEP192;C2CD3;PIBF1;SPAG5;DCTN2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.2968212454058304,0.6888302845866179,0.8116504854368932,0.9937577067182307,1.0,5/20,15.12%,GRK3;SNCA;CRY1;APLP1;YWHAB
prerank,pre-miRNA processing (GO:0031054),-0.2863065485904649,-0.6880955926062393,0.8636363636363636,0.9908512671850779,1.0,4/14,20.39%,TUT4;TUT7;AGO1;DICER1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.2851338360935672,-0.6872915143481019,0.8740458015267175,0.9910652568655779,1.0,3/14,13.18%,CARD14;CARD10;COPS8
prerank,translational termination (GO:0006415),-0.1896303288118355,-0.6866536371372622,0.973293768545994,0.9911086806460092,1.0,29/95,29.24%,MRPL33;MRRF;MRPS7;MRPS6;MRPS18A;MRPS24;MRPL52;CHCHD1;MRPL24;MRPL15;MRPL46;MRPL39;MTRF1L;MRPL17;MRPL12;MRPL1;MRPS26;APEH;MTRF1;TRMT112;MRPL35;MRPL4;MRPL21;MRPL54;MRPL34;MRPS2;MRPL50;MRPS23;MRPL49
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.26590967357091244,-0.6866492381622185,0.874,0.9905581244021134,1.0,5/18,29.00%,ELOVL7;ELOVL1;ACSL4;ACSBG1;ACSF3
prerank,DNA geometric change (GO:0032392),-0.2560763067831283,-0.6866185183880449,0.898,0.990031952647151,1.0,5/24,20.33%,ASCC3;ANXA1;RAD50;HMGB2;RECQL
prerank,cobalamin metabolic process (GO:0009235),0.30136030763780397,0.6865842127478474,0.7975708502024291,0.9959953250761944,1.0,3/17,13.84%,MMADHC;MMAB;LMBRD1
prerank,regulation of centriole replication (GO:0046599),-0.2729140522269031,-0.6864873155288925,0.8778004073319755,0.9896201461878139,1.0,6/17,28.51%,KAT2B;PLK2;ALMS1;PLK4;BRCA1;NUP62
prerank,regulation of protein localization to cell surface (GO:2000008),0.2684171093012075,0.6859429878329703,0.8364312267657993,0.9961820551447468,1.0,1/33,0.83%,NEDD4L
prerank,regulation of protein transport (GO:0051223),-0.24670532757952512,-0.6854299043877761,0.8888888888888888,0.9900972672760385,1.0,9/27,22.24%,WWP2;NDEL1;DISP1;RHBDF2;LLGL2;CHP1;ARFIP1;SNX3;LCP1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.30793539986944385,0.6854234779581623,0.8113207547169812,0.9961863450900909,1.0,5/13,26.80%,ALG12;ALG1;ALG11;DPAGT1;MPDU1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.23672798939546216,-0.6852927875179623,0.9316628701594533,0.9896708971069073,1.0,4/34,6.94%,RBP4;LACC1;WNT5A;SLC7A5
prerank,epithelial cell development (GO:0002064),0.2950378132394414,0.6852732579880438,0.8183632734530938,0.9957351499715846,1.0,2/20,5.43%,RILPL2;ROS1
prerank,protein K48-linked deubiquitination (GO:0071108),0.28081218535268004,0.685076945355725,0.8046875,0.9953181132616062,1.0,6/23,17.22%,USP25;OTUD5;OTUB1;USP50;USP33;OTUD7B
prerank,negative regulation of histone modification (GO:0031057),-0.2818133183423769,-0.6845602579549923,0.8634615384615385,0.9898510080329583,1.0,6/14,28.35%,JARID2;CTBP1;BRCA1;AASS;TWIST1;SPHK2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.25498525229173147,0.6843306311137348,0.8409506398537477,0.9955954204122754,1.0,5/42,6.11%,SH2B3;STK39;ACKR3;CXCL10;CXCL5
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.22458219128244142,-0.6838948513579113,0.9279475982532751,0.9899161469431986,1.0,1/41,0.05%,PRKAG2
prerank,regulation of humoral immune response (GO:0002920),0.2569502007806656,0.6833711815410696,0.8689407540394973,0.9961340557561443,1.0,5/44,9.51%,VTN;CD46;C7;SUSD4;CR2
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.2133120899315967,-0.6831252010270463,0.9572446555819477,0.9900946737408141,1.0,30/57,37.12%,DCN;MCU;TNFSF10;BCL2L11;KDR;VPS35;BNIP3;ADCK1;BID;PDCD5;PARK7;BBC3;PPARGC1A;PLAUR;DDHD1;RALBP1;PRKN;TP53;BIK;TREM2;RALA;DNM1L;MIEF2;HRK;PINK1;PPIF;ZNF205;AURKA;HIP1R;BAX
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.3231901221574369,0.6827792756869558,0.7709251101321586,0.9962564883119317,1.0,4/12,18.05%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,translational elongation (GO:0006414),-0.18491678740802406,-0.6825018331123102,0.9826086956521739,0.9901465201390895,1.0,33/101,31.99%,MRPL33;EEF1D;EEF1A1;EEF1B2;MRPS7;MRPS6;MRPS18A;MRPS24;MRPL52;CHCHD1;MRPL24;MRPL15;EEFSEC;MRPL46;MRPL39;MRPL17;MRPL12;MRPL1;MRPS26;MRPL35;GTPBP2;MRPL4;RACK1;MRPL21;MRPL54;MRPL34;MRPS2;MRPL50;MRPS23;MRPL49;EEF1A2;MRPL43;MRPL48
prerank,intraciliary retrograde transport (GO:0035721),0.3191169828864824,0.6818809684932465,0.8371134020618557,0.9967246806852914,1.0,1/12,2.29%,IFT43
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2538922914095109,-0.6806043038011952,0.8951612903225806,0.9913901859530037,1.0,6/23,24.53%,REXO4;DNASE1L1;HMGB2;DICER1;DFFB;FOXL2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.23649254088340682,-0.6798276817847752,0.9106029106029107,0.9915887555988422,1.0,7/29,19.88%,COPZ2;TRAPPC10;COPA;TRAPPC3;NAPA;RAB6A;COPB1
prerank,regulation of mitotic spindle organization (GO:0060236),-0.22883067989695022,-0.6796618804909792,0.9387755102040817,0.9911737897838606,1.0,14/35,32.16%,PDCD6IP;PARP3;CHMP4B;TPR;DYNC1H1;NUMA1;GNAI1;TPX2;FSD1;CHMP5;HSPA1B;NUP62;CCSAP;EML3
prerank,regulation of Golgi organization (GO:1903358),-0.270592216235509,-0.679153112657669,0.881578947368421,0.9911043160319051,1.0,5/17,17.97%,ARMH3;USP6NL;AKAP9;MAPK3;STX18
prerank,neuron maturation (GO:0042551),0.2944367039225441,0.6791252286420357,0.8396793587174348,0.9995457924036343,1.0,4/18,9.40%,SCARF1;B4GALT6;ADGRB3;ACTL6B
prerank,cellular response to misfolded protein (GO:0071218),0.28142122507806366,0.6787304488057462,0.8067729083665338,0.9993801061662753,1.0,6/20,22.19%,CUL3;UGGT2;DNAJC18;TOR1A;STUB1;POMT2
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.2780104227557859,-0.6785252743548281,0.8700787401574803,0.9911293619358973,1.0,12/15,58.60%,KYNU;FAH;HGD;IL4I1;HAAO;KYAT1;AADAT;IDO2;TDO2;IDO1;ACMSD;GSTZ1
prerank,negative regulation of protein secretion (GO:0050709),0.26094365268670594,0.6784105018896858,0.8615664845173042,0.9991237843057064,1.0,4/38,7.20%,NR1H3;IL1B;RHBDF1;IRS1
prerank,positive regulation of RNA splicing (GO:0033120),0.2696541336091286,0.6776989010088645,0.8559837728194726,0.9993545672802963,1.0,6/29,19.76%,PIK3R1;TRA2A;DAZAP1;HABP4;RBMX;RBM3
prerank,glycolipid biosynthetic process (GO:0009247),0.259341964384487,0.6776552639488501,0.8712871287128713,0.9987508820782695,1.0,6/38,11.03%,PIGU;ST8SIA1;PIGO;B4GALT6;PIGZ;DPM3
prerank,miRNA mediated inhibition of translation (GO:0035278),0.31884663328452306,0.6776113268810621,0.7793814432989691,0.9975008637491004,1.0,4/11,18.13%,AGO3;TNRC6C;EIF6;NOTCH4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.31884663328452306,0.6776113268810621,0.7793814432989691,0.9975008637491004,1.0,4/11,18.13%,AGO3;TNRC6C;EIF6;NOTCH4
prerank,response to endoplasmic reticulum stress (GO:0034976),0.2212569429232242,0.6773850168961049,0.9361702127659575,0.9971350180155386,1.0,7/107,6.59%,ATP2A3;MAP3K5;PIK3R1;CHAC1;ITPR1;SCAMP5;ATP2A2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.24309390641043985,0.6772101611575466,0.8939670932358318,0.9967007554320868,1.0,9/54,11.62%,RGCC;TNKS1BP1;CNOT2;SOX4;CDKN1A;CNOT9;CNOT4;PRMT1;EP300
prerank,regulation of transposition (GO:0010528),-0.2791356524017709,-0.6770393698958348,0.8694029850746269,0.9919740835066116,1.0,7/13,42.84%,SIRT7;SMYD5;TDRD9;DDX4;MYBL1;PIWIL4;SPOCD1
prerank,synaptic vesicle endocytosis (GO:0048488),0.26773165446263236,0.6768157900222382,0.8661417322834646,0.9965517929860236,1.0,10/33,20.17%,CEL;SNCA;SYT1;SYT2;NLGN3;CDK5;DNM1;VAMP2;SNAP91;AMPH
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.28525412829237295,0.6765135454653783,0.8123711340206186,0.9962916545449277,1.0,8/22,20.33%,RBX1;GTF2H5;GTF2H1;PARP1;XPC;CHD1L;GTF2H4;DDB2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.288226392251834,-0.6763814484933935,0.8678500986193294,0.9920408229556582,1.0,6/13,19.75%,SEC16B;TMEM30A;TM9SF4;SAR1A;SAR1B;CD81
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.30428540009806376,0.676356262890906,0.8148936170212766,0.9958383952472466,1.0,2/14,4.40%,PPP3CA;PPP2R2A
prerank,response to UV (GO:0009411),0.22761582963847327,0.67579502418896,0.9462025316455697,0.995884201355532,1.0,1/95,0.16%,PTPRK
prerank,recombinational repair (GO:0000725),-0.1952111651884983,-0.6751678723663862,0.9814323607427056,0.9926272989904447,1.0,32/77,35.56%,INO80;RAD51B;SFR1;ERCC5;SAMHD1;BRCA2;NABP1;AP5Z1;RPA1;RAD50;RECQL;RAD52;RAD51C;MCM8;SLX4;RAD51;BRCA1;RPA3;ZSWIM7;RAD54B;HUS1;AP5S1;WRN;HELQ;RMI1;RAD51AP1;ZFYVE26;MORF4L1;HUS1B;RECQL5;RAD51D;NSMCE1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.305447587932555,0.6751371050793732,0.7860082304526749,0.9960608870580936,1.0,4/15,16.08%,RUVBL1;NOP10;CCT7;CCT3
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.255339161262499,-0.6748288907209424,0.8888888888888888,0.9924053233548394,1.0,2/22,3.38%,PTPRJ;EZR
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.2331051053566861,-0.6747552370400081,0.8989247311827957,0.9919239760755382,1.0,7/28,20.68%,OCLN;AKAP9;GIT1;MET;TOGARAM1;FES;NUMA1
prerank,protein heterooligomerization (GO:0051291),0.31015897155964073,0.6742678233671856,0.8008565310492506,0.9964885828009304,1.0,7/17,21.36%,CPSF6;MAT2A;PKD2;GRIN2B;KCNC2;CPSF7;GRIN1
prerank,carbohydrate catabolic process (GO:0016052),-0.22368208564138692,-0.6740505570628039,0.9285714285714286,0.9919850220961368,1.0,12/38,28.40%,HK2;DERA;NAGA;ENO1;MANBA;MAN2C1;MAN2B2;NEU3;ALDOA;LDHA;HK1;ENO3
prerank,RNA stabilization (GO:0043489),-0.2219846476189654,-0.6734497626014072,0.9168490153172867,0.9919853457738937,1.0,9/33,19.79%,THRAP3;NOCT;NAF1;TENT5A;LARP1;ZCCHC17;ELAVL1;E2F1;TENT5C
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.20849777088778892,-0.6732209976358617,0.9484777517564403,0.9916522520285742,1.0,16/50,24.71%,PSME2;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;ODC1;OAZ1;PSMD4;PSMA2;PSMD3;PSMB7;AZIN1;PSMC2;PSMC5;PSMD10
prerank,autophagy of mitochondrion (GO:0000422),-0.22360214340868445,-0.6728564295130638,0.9282608695652174,0.991432664770866,1.0,13/38,35.29%,WIPI2;BECN1;ULK2;BNIP3;ATG2A;GABARAPL1;ATG7;ATG12;PRKN;ATG14;RB1CC1;PINK1;PHB2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.23734079904740957,-0.6724891546817229,0.9004329004329005,0.9912133200170314,1.0,10/25,31.24%,HSPA5;ST13;DNAJB5;HSPA13;GAK;HSPA9;DNAJB12;HSPA1B;BAG1;SDF2L1
prerank,miRNA metabolic process (GO:0010586),-0.25543741938277625,-0.6722892574505647,0.8955512572533849,0.9908262409394916,1.0,5/20,20.39%,TUT4;TUT7;RAN;TENT4B;DICER1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.27006334695082573,-0.6720384500294468,0.875,0.9905099519186523,1.0,3/16,17.91%,STX7;CEACAM1;CYRIB
prerank,CENP-A containing chromatin organization (GO:0061641),-0.23401027293284526,-0.670785805824193,0.9121338912133892,0.9905264026106294,1.0,10/29,27.17%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.23401027293284526,-0.670785805824193,0.9121338912133892,0.9905264026106294,1.0,10/29,27.17%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,phasic smooth muscle contraction (GO:0014821),-0.3004429509170454,-0.670599337209746,0.8568904593639576,0.9901399381885356,1.0,6/10,43.11%,EDN3;EDNRB;GDNF;EDN1;TIFAB;HTR1D
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2752672833430083,0.670573317418023,0.8237623762376237,1.0,1.0,5/25,16.33%,CUL3;UGGT2;ZER1;YME1L1;TOR1A
prerank,nuclear transport (GO:0051169),-0.2691522877421361,-0.6703405552302362,0.8802395209580839,0.9898111742262804,1.0,6/16,32.42%,NUP98;NXT2;PSIP1;NXT1;ANP32A;RBM15B
prerank,vitamin D metabolic process (GO:0042359),-0.2765584075425239,-0.6695060316687919,0.8987108655616943,0.989984422563631,1.0,8/13,50.27%,CUBN;PIAS4;CYP2R1;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.2833853812294265,-0.6693580772852485,0.867513611615245,0.9895564457901741,1.0,5/13,25.05%,SDAD1;RAN;RPS15;NUP88;RRS1
prerank,apoptotic nuclear changes (GO:0030262),0.28127142910591096,0.6689379302828146,0.8514056224899599,1.0,1.0,1/24,1.63%,GPER1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3019316784440439,-0.6684932665637363,0.8854545454545455,0.9897966619018497,1.0,3/11,18.06%,ARRB1;GRK2;ADRB2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3002125527043513,-0.6678537924058153,0.879245283018868,0.9897742191846272,1.0,5/10,33.73%,NAF1;NHP2;RPUSD4;RPUSD2;RPUSD3
prerank,positive regulation of histone acetylation (GO:0035066),0.2720276302258568,0.667687576243747,0.8507157464212679,1.0,1.0,4/23,11.18%,IL1B;RPS6KA4;KAT7;GLYR1
prerank,positive regulation of myelination (GO:0031643),0.3164529342711275,0.6675504590415035,0.8012958963282938,1.0,1.0,3/11,8.39%,TPPP;NCMAP;TENM4
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2257089946562087,0.6662743123534527,0.9367521367521368,1.0,1.0,13/72,13.63%,RGCC;TNKS1BP1;FOXM1;CNOT2;SOX4;CDKN1A;MYO6;CNOT9;CNOT4;PRMT1;EP300;RPS6KA6;CNOT10
prerank,nuclear pore complex assembly (GO:0051292),-0.2958349351747399,-0.6657312690254609,0.8733944954128441,0.99103910336301,1.0,9/10,49.97%,NUP98;TPR;NUP153;NUP107;RTN4;NUP93;AHCTF1;NUP205;TMEM170A
prerank,negative regulation of signaling (GO:0023057),0.2742983499168884,0.665327061309311,0.8703339882121808,1.0,1.0,3/25,6.21%,IL1B;SOCS5;AP1AR
prerank,regulation of type I interferon production (GO:0032479),-0.19102843213725965,-0.664563342757552,0.9896373056994818,0.9915260998051727,1.0,30/84,33.81%,IRF1;IKBKE;PCBP2;NLRC5;RNF135;MAVS;RNF125;LRRFIP1;RELA;POLR2F;POLR3GL;G3BP1;POLR2E;UBA7;NPLOC4;UBE2L6;POLR3D;RNF216;MYD88;ZBP1;CTNNB1;POLA1;TAX1BP1;POLR1C;ISG15;TRIM21;RNF26;PQBP1;ITCH;POLR3A
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.24707719512849727,-0.6644460110475697,0.9067961165048544,0.9910788190761083,1.0,7/23,22.72%,BCL2L11;TIMM13;TOMM22;TIMM8B;MAIP1;TIMM9;NDUFA13
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.30624054845976756,0.6641736267961115,0.8135593220338984,1.0,1.0,6/13,23.59%,SART3;PRPF6;PRPF31;LSM2;AAR2;SRSF12
prerank,glycerophospholipid catabolic process (GO:0046475),-0.23827499076942477,-0.6638091333841035,0.91701244813278,0.9910735046750877,1.0,4/27,13.21%,PLA2G4A;PLA2G6;ABHD16A;PLA2G15
prerank,protein heterotetramerization (GO:0051290),0.315528680212648,0.6633391304876382,0.8078602620087336,1.0,1.0,3/13,9.81%,CPSF6;PKD2;GRIN2B
prerank,cardiocyte differentiation (GO:0035051),-0.2973344399515465,-0.662136292382933,0.8884892086330936,0.9919371827033441,1.0,3/10,16.16%,AKAP13;GATA6;KDM6B
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.31582282966991704,0.6621225910102111,0.8344519015659956,1.0,1.0,2/13,8.96%,YAE1;ISCA1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.29163233603268296,-0.6620665375279878,0.8886827458256029,0.9914450871531048,1.0,5/11,25.85%,SP100;HIPK2;RPS27L;ING4;TP53
prerank,mitotic nuclear division (GO:0140014),0.2311419880243003,0.6613855048623672,0.9077429983525536,1.0,1.0,1/71,0.31%,EPS8
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2319395279465489,0.6611043206947887,0.9011532125205931,1.0,1.0,7/69,12.01%,COX4I2;UQCRFS1;NDUFB2;UQCRC2;COX4I1;COX5A;COA6
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3147976001846155,0.6601382111032652,0.8329853862212944,1.0,1.0,4/12,13.28%,RLIM;YTHDC1;RBM15;HNRNPU
prerank,mitochondrial translational termination (GO:0070126),-0.18241771136469537,-0.6595258442249666,0.9771428571428571,0.9929056924468694,1.0,27/88,29.24%,MRPL33;MRRF;MRPS7;MRPS6;MRPS18A;MRPS24;MRPL52;CHCHD1;MRPL24;MRPL15;MRPL46;MRPL39;MTRF1L;MRPL17;MRPL12;MRPL1;MRPS26;MTRF1;MRPL35;MRPL4;MRPL21;MRPL54;MRPL34;MRPS2;MRPL50;MRPS23;MRPL49
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2706942821435507,0.658693229330809,0.8608349900596421,1.0,1.0,4/25,12.68%,GPER1;CIDEB;MFF;FAM162A
prerank,production of siRNA involved in RNA interference (GO:0030422),0.31021587675931206,0.6586932159934866,0.8100686498855835,1.0,1.0,2/10,11.90%,TARBP2;TSN
prerank,tRNA metabolic process (GO:0006399),0.28522177512419356,0.6581118750102264,0.8395061728395061,1.0,1.0,9/17,26.60%,SSB;DARS2;ADAT1;AARS1;POP7;POP5;DTD1;RPP30;FARS2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.31348707573573625,0.6573398311251702,0.8174097664543525,1.0,1.0,1/10,3.71%,ATP7A
prerank,regulation of cellular response to heat (GO:1900034),-0.1879407431596392,-0.657064545137558,0.9791666666666666,0.994356135092979,1.0,26/77,28.91%,CD34;HSPB8;BAG3;FKBP4;CAMK2A;ATM;DNAJB6;HSP90AB1;RPA1;MAPK3;NUP98;TPR;NUP88;NUP214;BAG2;NUP37;YWHAE;RPA3;DNAJC2;NUP155;BAG5;HSPH1;HSPA1B;RPTOR;NUP62;BAG1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.25579837616153217,-0.6568769159886014,0.887378640776699,0.9939644196190599,1.0,1/17,1.20%,NSA2
prerank,regulation of gene silencing by RNA (GO:0060966),-0.20602182381871692,-0.656797349463783,0.9601873536299765,0.9929483281103146,1.0,17/50,29.08%,H3-3A;POLR2A;PUM1;POLR2F;NUP98;TNRC6A;IPO8;POLR2E;TPR;AGO1;NUP88;NUP214;NUP37;POLR2G;NUP155;NUP62;AGO2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.20602182381871692,-0.656797349463783,0.9601873536299765,0.9929483281103146,1.0,17/50,29.08%,H3-3A;POLR2A;PUM1;POLR2F;NUP98;TNRC6A;IPO8;POLR2E;TPR;AGO1;NUP88;NUP214;NUP37;POLR2G;NUP155;NUP62;AGO2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.21575118210584981,0.6566329631961304,0.946236559139785,1.0,1.0,24/105,21.19%,BTRC;CLEC10A;FFAR2;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;CREBBP;TAB3
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.27193631919320044,-0.6562320844379068,0.8910505836575876,0.9928596014799269,1.0,1/13,5.19%,ADHFE1
prerank,glucose metabolic process (GO:0006006),0.23355046823712655,0.6561635801902242,0.9018302828618968,1.0,1.0,8/58,13.27%,PER2;PPARD;SLC25A13;TFAP2B;GOT1;ALDOC;GPI;CRY1
prerank,cellular response to superoxide (GO:0071451),-0.2993451281927788,-0.656011093181124,0.9032258064516129,0.9925159279209139,1.0,6/10,27.64%,NOS3;PRDX2;ADPRS;MT3;PRDX1;SOD2
prerank,regulation of spindle assembly (GO:0090169),-0.23680275441126025,-0.6552152897944691,0.9294354838709677,0.9925604743632622,1.0,10/25,32.16%,PDCD6IP;CHMP4B;TPR;DYNC1H1;NUMA1;SPAG5;CHMP5;HSPA1B;CCSAP;EML3
prerank,regulation of leukocyte activation (GO:0002694),0.29962880928506086,0.6549504598582035,0.8175965665236051,1.0,1.0,2/14,9.11%,GPER1;LYN
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24290291941135123,0.6545349592107281,0.8931159420289855,1.0,1.0,10/48,11.62%,NOA1;NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;EIF6;NDC1;EP300
prerank,regulation of protein kinase C signaling (GO:0090036),-0.27200214743443923,-0.6545329307065532,0.8893203883495145,0.992527567341517,1.0,5/14,17.25%,ADGRV1;WNT5A;GPD1L;FLT4;WNT11
prerank,protein autoprocessing (GO:0016540),-0.25897829162571473,-0.6544005145161702,0.9040590405904059,0.9921036180454678,1.0,3/17,16.86%,CASP4;AFG3L2;MYRF
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.21955148494230461,-0.6543966915951234,0.9457831325301205,0.9915656710597412,1.0,14/37,33.31%,ENTPD1;SIDT2;DNASE1L1;ENTPD5;PNPT1;ENTPD2;DFFB;NUDT16;EXOSC7;NUDT1;NUDT18;ENTPD3;NUDT5;NUDT9
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3098251212844498,0.6543451356071938,0.8133047210300429,1.0,1.0,4/11,24.17%,CCT7;CCT3;TERF1;DKC1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2545763957004766,-0.6537654986054231,0.9015444015444015,0.9915351841481913,1.0,5/18,29.84%,SIRT7;UBTF;EIF2AK3;LYAR;RASL11A
prerank,spermatid development (GO:0007286),0.2542490869913855,0.6537332030372165,0.8886827458256029,1.0,1.0,6/32,16.21%,PLD6;RSPH1;YTHDC2;SOX30;CCDC63;ACRBP
prerank,positive regulation of defense response to virus by host (GO:0002230),0.27379803782700796,0.6532857546789232,0.8752475247524752,1.0,1.0,5/24,10.05%,PTPN22;IL4;IL12RB1;ZDHHC1;CGAS
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.278604679971057,0.6527971712033624,0.8686868686868687,1.0,1.0,2/18,3.36%,NRXN1;CACNG7
prerank,pseudouridine synthesis (GO:0001522),0.2987746334366694,0.6526609067815211,0.8262806236080178,1.0,1.0,5/13,24.17%,TRUB1;NOP10;PUS7;GAR1;DKC1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.29898240840731927,0.6525080537071374,0.852882703777336,1.0,1.0,3/14,13.82%,ADAM19;PSEN1;ABCA7
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.19062063596700066,-0.6519862595422264,0.9947780678851175,0.9923920398004321,1.0,19/73,24.71%,YAP1;FOXC1;LMO2;GATA2;PSME2;PSMB4;TAL1;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;PSMB7;PSMC2;CBFB;PSMC5;PSMD10
prerank,response to peptide (GO:1901652),-0.22306009792045822,-0.6518293040155014,0.9311111111111111,0.9919763792375963,1.0,9/33,24.44%,ANXA1;STAT2;STAT1;STAT3;MMP2;EIF2B2;ERBIN;GNAI1;EIF2B5
prerank,negative regulation of cilium assembly (GO:1902018),-0.2820831836107833,-0.651497099439981,0.8937728937728938,0.9917118305851549,1.0,3/12,13.57%,LIMK2;YAP1;TCHP
prerank,serine family amino acid catabolic process (GO:0009071),0.3015191881992963,0.6507731729567535,0.842436974789916,1.0,1.0,3/10,15.53%,GCSH;DAO;DLD
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.22176658659091436,-0.6507180445109011,0.9558498896247241,0.9917286900129447,1.0,16/39,32.01%,ERCC5;CUL4A;UBB;DDB1;RPA1;RFC3;RFC1;ERCC1;ERCC2;RPA3;ERCC3;NTHL1;POLD1;GTF2H3;PCNA;RFC5
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.27067388495775757,-0.6498717925952099,0.896414342629482,0.9918232071239024,1.0,1/15,1.42%,STOX2
prerank,ureteric bud morphogenesis (GO:0060675),-0.26073892391365217,-0.6498548130658267,0.8936170212765957,0.9913001899201718,1.0,2/16,6.23%,BMP4;SIX1
prerank,ESCRT III complex disassembly (GO:1904903),0.31539405225975703,0.6497903327044445,0.8126361655773421,1.0,1.0,1/10,6.20%,CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),0.31539405225975703,0.6497903327044445,0.8126361655773421,1.0,1.0,1/10,6.20%,CHMP2B
prerank,establishment of mitotic spindle localization (GO:0040001),0.2645575843225024,0.6494888181660368,0.8580121703853956,1.0,1.0,10/28,18.52%,CLASP2;ITGB1;UBXN2B;NUSAP1;DCTN1;MAD2L1;NDE1;HTT;CENPA;INSC
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.28170356952196635,0.6487317428414486,0.8601941747572815,1.0,1.0,2/18,5.44%,NF1;CD300A
prerank,axonal transport of mitochondrion (GO:0019896),-0.28635524367541487,-0.6487163695404053,0.8800705467372134,0.9916482225166281,1.0,3/11,18.05%,HIF1A;SPAST;ACTR10
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.2780667090312583,-0.648046591592938,0.9068541300527241,0.9916099468077249,1.0,3/13,19.18%,GFPT2;UAP1;GFPT1
prerank,retrograde axonal transport (GO:0008090),0.28184511442372495,0.6471632300109905,0.8562628336755647,1.0,1.0,7/16,22.35%,TMEM108;DLG2;HAP1;DST;KIF1A;NEFL;SOD1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2612914315343067,-0.6465362870479398,0.8956043956043956,0.9921808756955075,1.0,9/16,36.07%,PIGN;PIGL;PIGW;PIGB;PIGC;PIGG;PIGA;DPM2;PIGV
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18860260789373243,0.6451886073495228,0.9922380336351876,1.0,1.0,82/264,25.52%,SRPK3;CLP1;DHX15;LSM3;RBM14;NCBP2;SFPQ;CACTIN;HNRNPR;SART3;SRRM1;PAPOLA;RNPS1;POLR2C;SNRNP25;CRNKL1;TRA2A;PRPF6;PSPC1;CHERP;PCBP1;YTHDC1;CLNS1A;SYMPK;PPIH;SCNM1;HNRNPA1;RBM15;SPEN;HNRNPUL1;DDX46;PRMT7;DDX23;HNRNPU;LSM8;UPF3B;HNRNPC;HNRNPH2;ELAVL2;COIL;PRPF31;SF3B3;SNRPD3;LSM2;RBM19;HNRNPD;CPSF7;FUS;POLR2D;CDK13;SNRNP48;HNRNPA2B1;CWC27;PNN;RBMX;LSM6;SRSF9;PTBP1;PPIL3;PABPC1;DDX42;CWF19L2;DDX1;SMNDC1;SRSF12;HNRNPK;DHX16;EIF4A3;GTF2F2;POLR2L;DHX35;POLR2H;EFTUD2;SRSF4;CTNNBL1;CASC3;POLR2J;SF3B2;SF3B1;CDC40;RSRC1;RBM5
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3094800631334854,0.6451645258052346,0.8283261802575107,1.0,1.0,1/11,6.44%,LPO
prerank,presynapse organization (GO:0099172),0.3104167535964536,0.6451285952612312,0.8456521739130435,1.0,1.0,1/10,2.44%,LRRTM3
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.30415742082791575,0.6449382625443612,0.8507795100222717,1.0,1.0,2/12,7.20%,ABCD2;IRS1
prerank,mRNA metabolic process (GO:0016071),0.21944846176069066,0.6448931857853827,0.9339774557165862,1.0,1.0,20/90,17.31%,DHX15;LSM3;PCBP3;NCBP2;AGO3;LSM10;SFPQ;HNRNPR;CPSF6;TCERG1;SSB;YTHDF2;CELF1;RNH1;CNOT10;DIS3L2;KIN;SNRPD3;LSM2;HSF1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.27344435938920286,-0.6448116035058556,0.9040307101727447,0.9929599818923411,1.0,5/13,26.83%,UPP2;TDG;NT5C;NEIL1;NTHL1
prerank,tetrapyrrole metabolic process (GO:0033013),0.2787113831133058,0.6443519635619653,0.854251012145749,1.0,1.0,3/18,13.84%,MMADHC;MMAB;LMBRD1
prerank,organophosphate biosynthetic process (GO:0090407),0.2460417593600415,0.6441641731908084,0.8874045801526718,1.0,1.0,8/37,17.83%,FGF2;ITPKB;TPK1;GK;IPMK;LPCAT1;IPPK;PIP5K1A
prerank,acetyl-CoA metabolic process (GO:0006084),-0.2631456139418344,-0.6441182428670567,0.909853249475891,0.9929670297208324,1.0,3/15,18.87%,HMGCS2;ACACA;ACACB
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.21528156098297863,0.6437355285997275,0.951734539969834,1.0,1.0,16/87,20.21%,SLC25A33;IMMP2L;COX18;UQCRFS1;NDUFB2;SDHAF3;ACAD9;FASTKD3;NDUFAF3;NDUFS6;COX20;OXA1L;NDUFA5;NDUFC2;NDUFAF2;SURF1
prerank,negative regulation of double-strand break repair (GO:2000780),0.2572563376198683,0.6435826888076395,0.8973384030418251,1.0,1.0,9/30,23.50%,FANCB;AUNIP;CGAS;OTUB1;SHLD3;HSF1;HMGA2;NUDT16L1;FBH1
prerank,establishment of spindle localization (GO:0051293),0.28318081556297614,0.6430893460635727,0.8343949044585988,1.0,1.0,2/14,10.17%,CLASP2;NUSAP1
prerank,vasodilation (GO:0042311),0.2986874107261012,0.6418769669018684,0.851931330472103,1.0,1.0,1/13,1.63%,GPER1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.2225587196755579,-0.6414156372193892,0.9447731755424064,0.9943862954235047,1.0,7/28,21.58%,BAG3;TNFRSF1A;CASP8;DAB2IP;BID;DEDD;DEDD2
prerank,histone H3-K4 trimethylation (GO:0080182),-0.2827679351363707,-0.6411610878307632,0.8920454545454546,0.9940203646472261,1.0,3/11,15.23%,SETD1B;TET3;BEND3
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.19003893332892352,-0.6410920417752408,0.987012987012987,0.9935376729927894,1.0,25/69,31.02%,STT3B;HSPA5;RNF103;AMFR;RNF185;UBXN4;UBE4B;DNAJB2;EDEM2;UBE2G2;ERLIN2;DNAJC10;HSP90B1;NPLOC4;VCP;SEC61B;FBXO17;DNAJB12;EDEM1;SYVN1;TMUB1;ANKZF1;UBE2J1;FBXO44;AUP1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.29157633223110596,0.64056843058568,0.8283261802575107,1.0,1.0,3/14,13.05%,SLC25A33;TFAM;FASTKD1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.25717362999183024,0.6403999609885596,0.881578947368421,1.0,1.0,14/30,23.20%,GNL3L;CDKN1A;ERCC4;HNRNPA1;SRC;HNRNPU;HNRNPC;PIF1;TERF1;TINF2;DACH1;CERS1;CTC1;EXOSC10
prerank,intracellular pH reduction (GO:0051452),0.2528250811652837,0.6400978372415702,0.9143897996357013,1.0,1.0,6/33,10.29%,GPR89A;GPR89B;DMXL1;ATP6V0E2;RAB38;ATP6V1B2
prerank,peptidyl-proline hydroxylation (GO:0019511),0.30565457994487255,0.640097590369121,0.8418803418803419,1.0,1.0,3/11,10.02%,P4HA1;P3H2;P4HTM
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2607767342530306,0.6400496929556657,0.8839458413926499,1.0,1.0,12/28,24.50%,WAS;AUNIP;SETMAR;PRKDC;SHLD3;KMT5B;MRNIP;HSF1;HMGA2;PNKP;NUDT16L1;KDM4D
prerank,positive regulation of histone modification (GO:0031058),-0.21191961914230073,-0.637989017106688,0.9533468559837728,0.9952404267040241,1.0,10/33,24.17%,ARRB1;BRD7;SAP30BP;TADA2A;MAPK3;CDK9;NOS1;PPARGC1A;CTBP1;BRCA1
prerank,response to UV-B (GO:0010224),-0.2769008702657051,-0.6378930806929027,0.8837209302325582,0.9947672496760451,1.0,4/12,23.81%,MFAP4;RELA;CRIP1;STK11
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.2928036410369552,0.6374351671104342,0.8387799564270153,1.0,1.0,3/11,9.61%,TPK1;DCK;DCTD
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.2569113898932325,0.6369323885508456,0.8833652007648184,1.0,1.0,9/25,25.08%,SRRM1;PRPF6;DDX23;LSM1;SF3B3;KHSRP;SMNDC1;SRSF4;SF3B1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.28875869059156356,-0.6366497456017522,0.9054054054054054,0.9950584821134122,1.0,5/10,33.27%,BAG3;SIRT2;JUN;HIF1AN;NCK1
prerank,regulation of centrosome duplication (GO:0010824),-0.22330526133880196,-0.6364185965217813,0.941544885177453,0.9946998031846754,1.0,8/29,27.68%,PDCD6IP;PLK2;CHMP4B;NAT10;ALMS1;CCNF;CENATAC;CHMP5
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.28811028245892684,-0.6363752023537308,0.8976377952755905,0.994199976673906,1.0,3/10,15.71%,DNAJB2;DNAJB6;DNAJA4
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2236440259473047,0.6357355729598054,0.9390862944162437,1.0,1.0,11/63,13.63%,RGCC;TNKS1BP1;CNOT2;SOX4;CDKN1A;CNOT9;CNOT4;PRMT1;EP300;PRKDC;CNOT10
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2814932471053295,0.635636526689694,0.8326446280991735,1.0,1.0,3/16,13.03%,FANCB;CGAS;SHLD3
prerank,histone ubiquitination (GO:0016574),0.27040107110252426,0.6347679717579813,0.8714859437751004,1.0,1.0,7/21,21.96%,PHC1;UBE2E1;UBR2;CTR9;UBE2B;HUWE1;UBE2A
prerank,cellular response to amino acid starvation (GO:0034198),0.2194571720817703,0.6341936680879411,0.9436152570480929,1.0,1.0,13/71,16.73%,MAP3K5;SESN3;ATP6V0E2;CDKN1A;MTOR;NPRL3;ATP6V1B2;SEC13;NPRL2;MIOS;MAPK1;IMPACT;PRKD1
prerank,hexose biosynthetic process (GO:0019319),0.23140243488584125,0.6337886528415461,0.9153439153439153,1.0,1.0,7/42,15.45%,PER2;SLC25A13;GOT1;ALDOC;GPI;CRY1;PCK2
prerank,spindle assembly (GO:0051225),0.22458235409694258,0.6337073839440784,0.9504132231404959,1.0,1.0,9/67,13.81%,STARD9;TNKS;CLASP2;MAPRE2;NEK6;TOGARAM2;MZT1;KIFC2;LSM14A
prerank,isotype switching (GO:0045190),0.2978305660972613,0.6330304628416804,0.860655737704918,1.0,1.0,1/10,6.90%,LIG4
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.2663098145866364,-0.6324992261087787,0.8994614003590664,0.9963414292798362,1.0,3/13,14.54%,SLC4A10;RAB3GAP1;SHISA7
prerank,megakaryocyte differentiation (GO:0030219),0.2909991698611888,0.6323695906736323,0.8855291576673866,1.0,1.0,2/11,9.43%,SH2B3;MED1
prerank,potassium ion export across plasma membrane (GO:0097623),0.29382368300537665,0.631621500075875,0.8571428571428571,1.0,1.0,2/13,7.70%,KCNE4;KCNE5
prerank,negative regulation of ATPase activity (GO:0032780),-0.2531606428531379,-0.6314720286666191,0.9292929292929293,0.9964904092144072,1.0,7/16,38.18%,PXK;IFIT1;PLN;TP53;TNNI3;PPIF;VCPKMT
prerank,autophagosome assembly (GO:0000045),-0.19633958106408542,-0.6305405836028911,0.977116704805492,0.9965610600327289,1.0,15/52,28.60%,WIPI2;SMURF1;IRGM;BECN1;ULK2;RAB7A;ATG2A;GABARAPL1;ATG101;EMC6;ATG7;ATG12;STX17;RAB19;ATG14
prerank,acylglycerol catabolic process (GO:0046464),0.25308102338603444,0.6293747069578256,0.8919925512104283,1.0,1.0,3/30,6.96%,FABP3;LIPC;LIPH
prerank,negative regulation of histone acetylation (GO:0035067),0.2983883297936803,0.6279881138786912,0.8836206896551724,1.0,1.0,2/11,12.85%,SNCA;SET
prerank,peptide hormone secretion (GO:0030072),-0.2219521263489648,-0.6277406405946186,0.9480249480249481,0.9978606332065612,1.0,2/26,4.34%,ANXA1;LTBP4
prerank,glycerolipid catabolic process (GO:0046503),-0.2439228540262942,-0.6264893885753355,0.9377510040160643,0.9981202795231158,1.0,1/19,1.12%,PLA2G4A
prerank,acyl-CoA metabolic process (GO:0006637),0.2428624316243936,0.626245153922537,0.9027522935779817,1.0,1.0,8/35,15.91%,ACSF2;BAAT;ACOT12;HMGCS1;ACOT2;GLYAT;MLYCD;ACOT7
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.28225917564674263,0.6260552913061924,0.8763102725366876,1.0,1.0,2/14,7.49%,NCBP2;CPSF6
prerank,maturation of SSU-rRNA (GO:0030490),-0.2090008960111897,-0.6260031468961162,0.9539748953974896,0.9978933780777293,1.0,5/34,12.39%,RPS14;RPS19;RPS8;RPS16;UTP6
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.23520309539902962,-0.6257951268164533,0.9329388560157791,0.9974903168958503,1.0,6/22,22.86%,PWP1;UBTF;EIF2AK3;LYAR;PIH1D1;SMARCA4
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.23793592611887934,0.625762863042252,0.9131238447319778,1.0,1.0,9/41,11.62%,NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;EIF6;NDC1;EP300
prerank,methylguanosine-cap decapping (GO:0110156),-0.28385806810082137,-0.6231342036961066,0.9163498098859315,0.9986654691298371,1.0,2/10,20.18%,EDC3;PNRC2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2727378657141233,-0.6230638291092547,0.9005736137667304,0.9981707229233341,1.0,4/11,27.45%,KAT2B;CCNF;BRCA1;CENATAC
prerank,regulation of defense response to virus (GO:0050688),-0.2547621441830478,-0.6227518140797922,0.907103825136612,0.9978406452475207,1.0,7/14,33.55%,PCBP2;PPM1B;ELMOD2;RNF216;RNF26;IFNLR1;ITCH
prerank,indolalkylamine catabolic process (GO:0046218),-0.27672609792911973,-0.6225305116652519,0.9022556390977443,0.9974426659883515,1.0,9/10,57.19%,KYNU;IL4I1;HAAO;KYAT1;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,defense response to fungus (GO:0050832),0.27751152153366826,0.6219763077179326,0.890020366598778,1.0,1.0,3/17,15.54%,CARD9;RARRES2;FAM3A
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2717159858229444,0.6219413073102638,0.8882113821138211,1.0,1.0,4/19,11.62%,CDIP1;DDIT4;HIPK1;EP300
prerank,aerobic electron transport chain (GO:0019646),0.21960375180188996,0.621732914166545,0.9550748752079867,1.0,1.0,6/68,11.86%,COX4I2;UQCRFS1;NDUFB2;UQCRC2;COX4I1;COX5A
prerank,positive regulation of interferon-beta production (GO:0032728),-0.211980882135198,-0.6213793906805146,0.9598214285714286,0.9976195822415611,1.0,4/33,10.94%,IRF1;OAS2;RNF135;MAVS
prerank,nucleus organization (GO:0006997),0.22889295675278842,0.6206268667817679,0.9376114081996435,1.0,1.0,9/47,17.70%,SYNE1;CHMP2B;BIN1;NUP35;NDC1;CHMP3;TOR1A;WDR73;NUP133
prerank,determination of left/right symmetry (GO:0007368),0.2405940291145345,0.6205248779648871,0.9115523465703971,1.0,1.0,3/36,10.35%,NOTCH1;PKD2;CITED2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.27814683032598936,0.6201632078727757,0.8813905930470347,1.0,1.0,7/15,22.32%,NANOS1;TNRC6C;TNRC6B;DHX36;CNOT1;ZFP36L1;PABPC1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.27814683032598936,0.6201632078727757,0.8813905930470347,1.0,1.0,7/15,22.32%,NANOS1;TNRC6C;TNRC6B;DHX36;CNOT1;ZFP36L1;PABPC1
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.2850337253024776,-0.6201588908129392,0.9201596806387226,0.997822027090624,1.0,3/10,24.86%,LGALS9;CD274;SCRIB
prerank,phospholipid catabolic process (GO:0009395),-0.2238071046466835,-0.6200316995324355,0.9477911646586346,0.9973720920870024,1.0,12/24,41.10%,PLA2G4A;SMPDL3A;ENPP2;GDPD3;PLBD2;PLA2G4F;SMPD1;ANGPTL3;ABHD12;GDE1;PLBD1;PNPLA6
prerank,regulation of chromosome organization (GO:0033044),0.2605060775485145,0.6200252192208658,0.9090909090909091,1.0,1.0,7/22,18.75%,LIG4;WAPL;SETMAR;RB1;SHCBP1L;PIF1;HNRNPD
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.17668671842764408,-0.6199887689145307,0.9920844327176781,0.9968611004197702,1.0,23/80,28.90%,CAV1;ANGPT1;LRRK2;SMAD7;FKBP1A;BIRC3;PHF23;FANCI;UBB;SPHK1;SPSB4;ARRDC4;CDK5RAP3;FAM107A;BRCA1;PSMD10;CENPX;BCL10;FANCM;TRIB3;PTTG1IP;RPS2;LAPTM5
prerank,mRNA processing (GO:0006397),0.18114473388943922,0.6198356609330542,1.0,1.0,1.0,89/287,25.18%,CLP1;DHX15;LSM3;RBM14;NCBP2;SFPQ;CACTIN;HNRNPR;SART3;SRRM1;PAPOLA;RNPS1;CPSF6;TCERG1;POLR2C;SNRNP25;CRNKL1;TRA2A;PRPF6;RNMT;PSPC1;CHERP;PCBP1;YTHDC1;SYMPK;PPIH;RPRD1B;HNRNPA1;RBM15;SPEN;HNRNPUL1;DDX46;DDX23;CELF1;HNRNPU;LSM8;UPF3B;GTF2H5;HNRNPC;CCNH;HNRNPH2;ELAVL2;KIN;GTF2H1;PRPF31;SF3B3;ZC3H11A;SNRPD3;LSM2;RBM19;HNRNPD;CPSF7;FUS;POLR2D;GTF2H4;SNRNP48;HNRNPA2B1;CWC27;PNN;RBMX;RNGTT;POLDIP3;SRRM4;LSM6;SRSF9;PTBP1;PPIL3;PABPC1;DDX42;CWF19L2;AKAP8L;SMNDC1;THOC2;SRSF12;HNRNPK;DHX16;EIF4A3;GTF2F2;POLR2L;DHX35;POLR2H;EFTUD2;SRSF4;CTNNBL1;CASC3;POLR2J;SF3B2;SF3B1;CDC40
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.2866285597373772,0.619424047166736,0.8639455782312925,1.0,1.0,3/12,13.97%,ADSL;PPAT;IMPDH2
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.2776006857892917,-0.619404527812364,0.8957952468007313,0.9966916146628788,1.0,6/10,39.62%,VEGFA;CTNNB1;DISC1;KDM1A;CX3CL1;CX3CR1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.2669565103432935,-0.6186454862137278,0.9239130434782609,0.9966488334873069,1.0,1/12,2.35%,HDAC8
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.3091514098655972,0.6185967845516844,0.8732718894009217,1.0,1.0,2/10,12.85%,SNCA;SET
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.2940370978151624,0.6183934395146281,0.8435374149659864,1.0,1.0,4/13,18.05%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.29090087337499426,0.6176529274101636,0.9154334038054969,1.0,1.0,2/11,12.28%,AKAP6;RNF207
prerank,"DNA-templated transcription, termination (GO:0006353)",0.21357309363308505,0.6173609099906153,0.9496527777777778,1.0,1.0,16/68,19.26%,CLP1;NCBP2;LSM10;PAPOLA;TBP;POLR1E;SYMPK;POLR1A;GTF2H5;CCNH;GTF2H1;SNRPD3;POLR1B;CPSF7;GTF2H4;MED18
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2481117151013859,0.6172001780281478,0.9023904382470119,1.0,1.0,3/25,6.30%,TFAP2B;ANK3;SNCA
prerank,nuclear body organization (GO:0030575),0.2872845468517705,0.6161873835395345,0.8650963597430407,1.0,1.0,3/12,13.01%,ETS1;DYRK3;USP50
prerank,protein localization to synapse (GO:0035418),0.28486671385344675,0.61598372526458,0.8768267223382046,1.0,1.0,2/12,12.66%,NRXN1;NPHS1
prerank,maturation of LSU-rRNA (GO:0000470),-0.2186620396912205,-0.6155781950642836,0.9494736842105264,0.9979899598982434,1.0,9/26,31.88%,NSA2;RPL7;RPL10A;MRPL1;FTSJ3;NHP2;MAK16;RPF1;URB1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.1823490385137805,0.6154702782246841,0.9973082099596231,1.0,1.0,76/241,25.71%,CLP1;DHX15;LSM3;RBM14;NCBP2;SFPQ;CACTIN;HNRNPR;SART3;SRRM1;PAPOLA;RNPS1;POLR2C;SNRNP25;CRNKL1;TRA2A;PRPF6;PSPC1;CHERP;PCBP1;YTHDC1;SYMPK;PPIH;HNRNPA1;RBM15;SPEN;HNRNPUL1;DDX46;DDX23;HNRNPU;LSM8;UPF3B;HNRNPC;HNRNPH2;ELAVL2;PRPF31;SF3B3;SNRPD3;LSM2;RBM19;HNRNPD;CPSF7;FUS;POLR2D;SNRNP48;HNRNPA2B1;CWC27;PNN;RBMX;LSM6;SRSF9;PTBP1;PPIL3;PABPC1;DDX42;CWF19L2;SMNDC1;SRSF12;HNRNPK;DHX16;EIF4A3;GTF2F2;POLR2L;DHX35;POLR2H;EFTUD2;SRSF4;CTNNBL1;CASC3;POLR2J;SF3B2;SF3B1;CDC40;RSRC1;RBM5;ZCRB1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.24785296119340078,0.6150136865862845,0.8955512572533849,1.0,1.0,6/25,19.13%,HEXIM1;TCERG1;HNRNPU;EAF2;LARP7;CDK13
prerank,positive regulation of type I interferon production (GO:0032481),-0.18069332545127242,-0.6146337464529781,0.9923469387755102,0.998045497551626,1.0,12/73,17.27%,IRF1;STAT1;OAS2;RNF135;MAVS;LRRFIP1;RELA;POLR2F;POLR3GL;G3BP1;TLR4;POLR2E
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.24930408836073825,-0.6133770093049575,0.9154135338345865,0.9982290853122681,1.0,2/15,9.97%,USP46;NLGN2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.22680452820568012,-0.6133582065475467,0.9536679536679536,0.9977085495296008,1.0,4/23,14.04%,CCDC186;KIF1B;CCDC88C;TUBA1B
prerank,establishment of spindle orientation (GO:0051294),-0.21528825522342204,-0.613098491008026,0.9558232931726908,0.997309993020663,1.0,9/28,28.82%,GJA1;NDEL1;FBXW11;ZW10;LLGL2;NUMA1;PAFAH1B1;MISP;NDC80
prerank,response to histamine (GO:0034776),0.29008798476606945,0.6128210078193703,0.8704883227176221,1.0,1.0,5/10,22.22%,GABRG2;AOC1;GABRB3;GABRB2;DRD2
prerank,negative regulation of phosphatase activity (GO:0010923),-0.22056878639192953,-0.6126032294640072,0.9489795918367347,0.997059397134181,1.0,3/25,7.47%,PTPA;FKBP1A;SH3RF2
prerank,insulin secretion (GO:0030073),0.26230737886650407,0.6125009234218536,0.8934426229508197,1.0,1.0,3/19,8.60%,RIMS2;MAFA;RAB11FIP2
prerank,response to amino acid starvation (GO:1990928),0.21151340744540267,0.6124428481027012,0.9573770491803278,1.0,1.0,13/72,16.73%,MAP3K5;SESN3;ATP6V0E2;CDKN1A;MTOR;NPRL3;ATP6V1B2;SEC13;NPRL2;MIOS;MAPK1;IMPACT;PRKD1
prerank,synaptic vesicle membrane organization (GO:0048499),0.2654123452520608,0.6118050270853784,0.9015748031496063,1.0,1.0,4/17,11.29%,SNAP25;SYNGR1;STX4;SYP
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.23576681332812885,-0.6113931476305934,0.9274509803921569,0.9972401457089789,1.0,11/18,48.23%,SPEF2;ROPN1L;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4;NPHP3;OFD1;DNAAF1;ADCY10
prerank,RNA splicing (GO:0008380),0.19790861759498693,0.6112016468904101,0.9797507788161994,1.0,1.0,33/95,25.97%,DHX15;NCBP2;SFPQ;SRRM1;RNPS1;TCERG1;SNRNP25;PRPF6;CCAR2;DDX47;SCNM1;DDX23;HNRNPC;LSM1;SF3B3;SNRPD3;KHSRP;USB1;FUS;SNRNP48;PPP2R1A;LUC7L3;LSM6;PTBP1;NOL3;SMNDC1;DHX16;SRSF4;SF3B2;SF3B1;RSRC1;ZCRB1;TARDBP
prerank,purine-containing compound salvage (GO:0043101),0.28216138713323935,0.6111236499533218,0.8843813387423936,1.0,1.0,2/12,8.20%,ADK;DCK
prerank,quinone biosynthetic process (GO:1901663),0.27651752350564834,0.6108750490875913,0.8812095032397408,1.0,1.0,4/14,20.49%,COQ2;COQ8A;PDSS1;FDXR
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.26765522664604285,0.610683019095227,0.8755555555555555,1.0,1.0,3/16,9.39%,MEIOB;ERCC4;HFM1
prerank,regulation of phospholipase activity (GO:0010517),-0.27446256229780874,-0.6102306215705008,0.9284332688588007,0.9973618691003501,1.0,1/10,3.02%,FGFR2
prerank,chromosome condensation (GO:0030261),0.22872710837170532,0.6100372577228507,0.9439252336448598,1.0,1.0,13/36,26.86%,GPER1;NUSAP1;RB1;SET;NCAPD3;SMC2;CSNK2A2;AKAP8L;NCAPH;BANF2;BANF1;CSNK2A1;NCAPD2
prerank,negative regulation of transferase activity (GO:0051348),-0.21891480725480902,-0.6098474368566205,0.9432048681541582,0.9970629400496379,1.0,13/28,31.53%,SMAD7;DTX3L;PINX1;EIF4A2;CDKN1B;PARK7;CDKN1C;INPP5K;TP53;BAG5;ABL1;ZFP36;IRS2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.1892914702414384,-0.6090218037848677,0.9800498753117207,0.9969845701848177,1.0,13/51,22.47%,TNKS2;SMG6;NAF1;PINX1;ATM;MAPK3;XRN1;MAP3K4;SMG5;NAT10;TENT4B;ACD;MAP2K7
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.2621361758307545,-0.6089135605178456,0.8966789667896679,0.9965152792900589,1.0,2/11,13.32%,MFHAS1;CYBA
prerank,snRNA metabolic process (GO:0016073),0.2701953390149617,0.6083452861265086,0.8920570264765784,1.0,1.0,3/17,14.01%,RBM7;INTS1;INTS12
prerank,protein K63-linked deubiquitination (GO:0070536),0.23738338416114016,0.6077035751694065,0.9205426356589147,1.0,1.0,5/31,17.22%,USP25;OTUD5;USP50;USP33;OTUD7B
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.22950411432313111,-0.6073379721718876,0.9377431906614786,0.9968612884875482,1.0,6/20,26.43%,AMPD3;ATIC;LHPP;ADSS1;NT5C2;PAICS
prerank,telomere maintenance (GO:0000723),0.2229624984836428,0.6061764715793063,0.9411764705882353,1.0,1.0,13/50,17.43%,DCLRE1B;ERCC4;ATR;PRKDC;BLM;XRCC3;NSMCE2;PARP1;PTGES3;SMC6;RPA2;TERF1;APEX1
prerank,telomere maintenance via telomerase (GO:0007004),-0.21042940118215045,-0.6061648015886107,0.9551282051282052,0.9969935588015598,1.0,9/28,25.91%,PINX1;ANKRD28;HSP90AB1;RPA1;RAD50;RFC1;ACD;WRAP53;NHP2
prerank,organophosphate catabolic process (GO:0046434),-0.2697308407933264,-0.6057056831832575,0.9382022471910112,0.996706871320281,1.0,7/11,47.98%,ENPP2;PLBD2;ANGPTL3;ABHD12;PLBD1;PDXP;PON1
prerank,regulation of protein neddylation (GO:2000434),0.28504493720860624,0.6052229656012599,0.8766816143497758,1.0,1.0,5/10,24.24%,EPAS1;DCUN1D2;DCUN1D4;DCUN1D1;RPL5
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.28175373851010777,0.6050312471339612,0.8634361233480177,1.0,1.0,4/11,17.61%,MTOR;IPPK;NOL11;DDX11
prerank,mismatch repair (GO:0006298),-0.2120251130075786,-0.6047702201674915,0.9536290322580645,0.9967046826219533,1.0,9/27,30.97%,TDG;RPA1;ERCC1;MSH6;RPA3;POLD1;ABL1;PCNA;EXO1
prerank,histone exchange (GO:0043486),-0.20141596394727054,-0.6045041159657618,0.9576837416481069,0.9963290952558045,1.0,12/37,27.17%,RBBP7;CENPC;ANP32E;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;RNF8;CENPX;CENPH
prerank,fatty acid biosynthetic process (GO:0006633),-0.1775170982641605,-0.6038856903925471,0.9901477832512315,0.9961768807747494,1.0,13/63,23.82%,ELOVL7;HACD4;HACD3;GPX4;ACACA;PTGS2;EPHX2;ELOVL1;ALOX12;HSD17B8;XBP1;LPL;OXSM
prerank,DNA duplex unwinding (GO:0032508),-0.19243240873335896,-0.6035763524504841,0.9752252252252253,0.9958327080872946,1.0,13/50,23.71%,ASCC3;ANXA1;SSBP1;CUL4A;UBB;DDB1;RPA1;RAD50;MCMDC2;RECQL;CETN2;RAD51;ERCC2
prerank,chromatin remodeling at centromere (GO:0031055),-0.20813067952304798,-0.6034845898396025,0.9640591966173362,0.9953571452273063,1.0,10/31,27.17%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,lipoprotein localization (GO:0044872),-0.2641645203417512,-0.6028761823664335,0.9176029962546817,0.9951365947676487,1.0,2/11,12.72%,PRKCB;UNC119B
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.20560873607024935,-0.6026596395466094,0.9710467706013363,0.9947250521174157,1.0,9/32,26.85%,TNKS2;NAF1;ATM;MAPK3;MAP3K4;ACD;MAP2K7;CTNNB1;NEK7
prerank,oligodendrocyte differentiation (GO:0048709),-0.22860853412027116,-0.6001123765288936,0.949317738791423,0.9955497608030984,1.0,7/19,28.49%,SLC8A3;SOX13;MYRF;EIF2B2;EIF2B5;EIF2B4;SOX10
prerank,regulation of chromosome segregation (GO:0051983),-0.23380333415004273,-0.5990243149897564,0.944015444015444,0.9955918197642436,1.0,11/16,50.84%,PUM1;NUMA1;RMI2;MKI67;CDC6;BUB1;IHO1;KIF2C;AURKB;PUM2;HORMAD1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.20018196977517602,0.5987602363241574,0.9735202492211839,1.0,1.0,5/86,6.74%,LIMD1;RBX1;EPAS1;PSMB11;PSMF1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.26236052798868276,0.598288855789157,0.8810483870967742,1.0,1.0,6/18,24.17%,RUVBL1;NOP10;CCT7;CCT3;EXOSC10;DKC1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.24797775263480204,0.5974538881575482,0.9106463878326996,1.0,1.0,1/24,1.19%,NOTCH1
prerank,tyrosine metabolic process (GO:0006570),0.2793941129088642,0.5973002966795935,0.875,1.0,1.0,2/11,19.04%,TYR;THAP4
prerank,regulation of mitochondrion organization (GO:0010821),0.21892622603030854,0.5961919461219395,0.9524647887323944,1.0,1.0,5/47,12.39%,PID1;SREBF2;HTRA2;EP300;MFF
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.23600629174492163,-0.596045763817968,0.9317343173431735,0.9965949301034938,1.0,5/16,26.88%,CEBPG;ULBP1;RAET1E;TUBB4B;LYST
prerank,transcription preinitiation complex assembly (GO:0070897),0.2768782030176637,0.5943794213246686,0.8752598752598753,1.0,1.0,5/12,22.70%,TBP;POLR1E;TAF7L;DR1;TAF7
prerank,regulation of viral life cycle (GO:1903900),0.2546375254963737,0.5943779461096547,0.9186295503211992,1.0,1.0,2/21,5.49%,AXL;TRIM62
prerank,cellular response to DNA damage stimulus (GO:0006974),0.16992191130987738,0.5943288267370814,1.0,1.0,1.0,70/336,17.61%,FNIP2;CBX5;RBM24;BCL2L10;FMN2;CIDEB;SPDYA;FANCF;FANCG;NUPR2;FBXO45;CBX3;TAOK3;CASP9;NCOA6;CDKN1A;ERCC4;RAD1;UBA1;SLF2;HTRA2;CBX1;LYN;MSH3;OARD1;CSNK1E;MBD4;TIMELESS;EPHA2;CGAS;ATR;SUSD6;ZDHHC16;BRSK1;AKTIP;MCM7;ETAA1;UBA6;OTUB1;PAK1;APC;PSME4;PRKDC;PARP4;CRY1;PSEN1;TANK;MUTYH;NIPBL;RAD17;ATRIP;KMT5B;BLM;PWWP3A;SUV39H1;TDP1;XRCC3;KIN;GTF2H1;PARP1;XPC;ERCC8;SMC6;MRNIP;CHD1L;FMR1;SUMO1;MASTL;APEX1;DDX11
prerank,regulation of microtubule polymerization (GO:0031113),0.2283586873014528,0.5936306115986302,0.944043321299639,1.0,1.0,7/40,13.86%,MAP2;NAV3;SNCA;CAMSAP3;PAK1;TUBB4A;DCTN1
prerank,kinetochore organization (GO:0051383),-0.2499481646534818,-0.5935406475540277,0.9255533199195171,0.9973113401045195,1.0,8/13,36.29%,CENPC;CENPT;CENPE;CENPH;NDC80;CENPF;DLGAP5;NUF2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.24867145376001343,-0.5928640523228018,0.9209486166007905,0.997102230726616,1.0,4/12,25.85%,CCND1;RPS27L;PLK5;TP53
prerank,ribosomal large subunit assembly (GO:0000027),0.24243092714267628,0.5924963504707867,0.9007936507936508,1.0,1.0,5/24,16.43%,FASTKD2;RSL24D1;BRIX1;RPF2;MRPL20
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.26447435611387055,-0.5902660284473137,0.9373913043478261,0.9978293874510427,1.0,5/11,29.36%,TIMM13;TIMM8B;TIMM9;NDUFA13;TIMM10
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2038277241865099,-0.5902535864916634,0.9453441295546559,0.9973120983526028,1.0,11/30,30.61%,CAVIN1;POLR2F;POLR2E;UBTF;TTF1;ERCC2;CDK7;ERCC3;POLR1C;MNAT1;GTF2H3
prerank,negative regulation of cell communication (GO:0010648),0.2546102869827458,0.5898072727751604,0.9207317073170732,1.0,1.0,2/21,5.24%,IL1B;SOCS5
prerank,mitochondrial fission (GO:0000266),0.25846522046810183,0.5892025440070436,0.8912579957356077,1.0,1.0,5/16,17.53%,MTFP1;MFF;MTFR1;MIEF1;DNM1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.26392549200544585,0.5891180393806419,0.8952569169960475,1.0,1.0,5/16,17.81%,RBM24;DND1;DHX36;RC3H1;KHSRP
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.25772253295056213,0.5889372389299802,0.9164835164835164,1.0,1.0,3/15,13.01%,DDX3X;CPTP;USP50
prerank,body fluid secretion (GO:0007589),-0.23817582475875115,-0.5886417573774867,0.9548736462093863,0.9975505731940284,1.0,2/15,6.82%,NPR1;SLC22A4
prerank,negative regulation of protein transport (GO:0051224),0.24502718754873315,0.5869488056081099,0.9195402298850575,1.0,1.0,5/25,14.71%,RHBDF1;NDFIP2;CSK;ERP29;HMGCR
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.22636740103550754,-0.5867280556241675,0.9631147540983607,0.9974085520975716,1.0,5/19,24.60%,POLR2A;POLR2F;POLR2E;ACD;POLR2G
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.22636740103550754,-0.5867280556241675,0.9631147540983607,0.9974085520975716,1.0,5/19,24.60%,POLR2A;POLR2F;POLR2E;ACD;POLR2G
prerank,lipid droplet organization (GO:0034389),0.25285897588741757,0.5867008009261356,0.9129554655870445,1.0,1.0,3/22,10.56%,CDS2;FAF2;SQLE
prerank,sensory perception of pain (GO:0019233),-0.219540800886414,-0.5862769403950289,0.948,0.997080930134799,1.0,11/21,38.55%,P2RX4;P2RX7;RETREG1;PTGES;TRPA1;CCR2;CCL2;KCNK4;OPRL1;ALOXE3;PROK2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.23532372700270532,-0.5848540679235524,0.9521072796934866,0.9972163907567174,1.0,7/15,32.06%,RAB3GAP1;RAB3GAP2;SPCS1;SEC61A1;EDEM1;SRP14;SPCS2
prerank,7-methylguanosine RNA capping (GO:0009452),0.22512291947392563,0.5846497641560486,0.9500959692898272,1.0,1.0,13/31,24.91%,NCBP2;POLR2C;RNMT;GTF2H5;CCNH;GTF2H1;POLR2D;GTF2H4;RNGTT;GTF2F2;POLR2L;POLR2H;POLR2J
prerank,7-methylguanosine mRNA capping (GO:0006370),0.22512291947392563,0.5846497641560486,0.9500959692898272,1.0,1.0,13/31,24.91%,NCBP2;POLR2C;RNMT;GTF2H5;CCNH;GTF2H1;POLR2D;GTF2H4;RNGTT;GTF2F2;POLR2L;POLR2H;POLR2J
prerank,lipoprotein transport (GO:0042953),-0.2647152626637146,-0.5844720354358772,0.94106463878327,0.9968774890751037,1.0,2/10,12.72%,PRKCB;UNC119B
prerank,rRNA modification (GO:0000154),0.2475779469919253,0.5844567435985079,0.9133064516129032,1.0,1.0,9/21,24.17%,FBLL1;NSUN3;NOP10;TFB2M;GAR1;DIMT1;TSR3;THUMPD1;DKC1
prerank,DNA modification (GO:0006304),-0.21524141670099883,-0.5841331681626217,0.951417004048583,0.9965049615697282,1.0,7/22,26.83%,PARP3;TDG;EXOSC5;ACD;NEIL3;NEIL1;NTHL1
prerank,protein monoubiquitination (GO:0006513),0.22472552903257523,0.5832476195604985,0.9502762430939227,1.0,1.0,6/36,15.58%,CUL3;RBX1;UBE2E1;KLHL12;CTR9;PEX12
prerank,intracellular protein transmembrane transport (GO:0065002),0.21747106389561208,0.5831901361924219,0.9634369287020109,1.0,1.0,20/42,28.06%,PEX7;PEX1;GRPEL2;TOMM40L;TIMM23;TOMM40;PEX12;PEX2;SEC61A2;TOMM70;DNAJC19;PEX5;PAM16;PEX6;TIMM17A;ZFAND2B;DNLZ;TIMM17B;SEC62;CHCHD4
prerank,phagosome maturation (GO:0090382),0.22705924092193802,0.5827743634430721,0.9542124542124543,1.0,1.0,6/35,10.29%,MREG;ATP6V0E2;PIKFYVE;CORO1A;RAB38;ATP6V1B2
prerank,cellular response to lectin (GO:1990858),0.19163846967896497,0.5824004654240743,0.9861111111111112,1.0,1.0,23/104,21.19%,BTRC;CLEC10A;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;CREBBP;TAB3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.19163846967896497,0.5824004654240743,0.9861111111111112,1.0,1.0,23/104,21.19%,BTRC;CLEC10A;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;CREBBP;TAB3
prerank,DNA-dependent DNA replication (GO:0006261),-0.1528174096972317,-0.5817739755760419,1.0,0.9970984246921054,1.0,51/128,36.85%,BAZ1A;SSBP1;PSME2;PSMB4;UBB;CDK2AP1;PSMB1;PSMD11;PSMD8;RPA1;DBF4;PSME3;SIRT7;PSMD4;PSMA2;MCMDC2;RFC3;TEFM;PSMD3;RECQL;PSMB7;POLE2;RFC1;MCM8;RAD51;CDC45;PSMC2;PSMC5;RPA3;PSMD10;SRPK2;POLA1;POLD1;PSMD7;PRIM2;MCM3;POLE3;WRN;MCM5;MCM10;RFC5;PSMD12;PSMB9;PSMA8;RECQL5;CDC34;TWNK;TOPBP1;PRIMPOL;CDC6;GINS2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.23736270688523364,-0.5817625256633709,0.9453860640301318,0.9965821970509695,1.0,6/15,31.02%,HSP90B1;NPLOC4;VCP;SEC61B;SYVN1;AUP1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.24966255825402692,0.5814611146802406,0.9156862745098039,1.0,1.0,7/22,19.86%,PSMB11;PSME4;PSMB5;PSMA1;PSMB8;PSMA5;PSMB2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.27432090785719465,0.5793478077962534,0.8893617021276595,1.0,1.0,4/11,24.17%,FBLL1;LARP7;EXOSC10;DKC1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.24708464024820317,0.5787155829786318,0.9001996007984032,1.0,1.0,4/20,19.88%,PSMG3;PTGES3;PSMG2;HOPX
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.23047350306185638,0.5784203227408702,0.9323770491803278,1.0,1.0,6/29,11.01%,WDR46;RRP36;TBL3;NOP14;TSR2;UTP4
prerank,negative regulation of interferon-beta production (GO:0032688),-0.26150615486021556,-0.5778434940748863,0.9338103756708408,0.9977622944350709,1.0,4/10,26.07%,PPM1B;SIRPA;REL;PTPRS
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.21442554563241167,-0.5772108629807668,0.9645669291338582,0.997519290753082,1.0,2/23,8.51%,LGALS9;PIK3R6
prerank,regulation of exit from mitosis (GO:0007096),0.21856874649410202,0.5771628098351036,0.9545454545454546,1.0,1.0,6/38,15.10%,RGCC;UBE2E1;CDC14B;ANAPC2;ANAPC7;MAD2L1
prerank,histone H2A monoubiquitination (GO:0035518),0.25928648101331414,0.575510688528931,0.9078694817658349,1.0,1.0,5/17,16.09%,RYBP;KDM2B;SKP1;BMI1;TRIM37
prerank,stress granule assembly (GO:0034063),0.2466420979261747,0.5749564453547045,0.8800813008130082,1.0,1.0,6/20,17.42%,YTHDF3;DDX3X;YTHDF2;LSM14A;PRRC2C;OGFOD1
prerank,positive regulation of chromatin organization (GO:1905269),-0.24823926102893085,-0.5745660511076506,0.952286282306163,0.9981396174630492,1.0,4/12,22.33%,H3-3A;TAL1;SIN3A;ACD
prerank,regulation of immunoglobulin production (GO:0002637),-0.21294248964821755,-0.5744742097024577,0.9734693877551021,0.997657214365293,1.0,4/23,22.38%,RBP4;EPHB2;XBP1;CLCF1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.2623367992242531,-0.5742862886741169,0.9392857142857143,0.997213257312884,1.0,5/10,30.28%,PARP14;PTPN2;PIBF1;SOCS1;INPP5F
prerank,double-strand break repair via homologous recombination (GO:0000724),0.1895993788079245,0.5742563429166287,0.993798449612403,1.0,1.0,21/95,17.06%,FANCB;GINS4;SFPQ;MCM6;MEIOB;REC8;ERCC4;PALB2;AUNIP;MCM7;MCM2;REV3L;NIPBL;SEM1;BLM;XRCC3;NSMCE2;PARP1;RNF138;SMC6;RPA2
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.19420898540586456,-0.5707906627029684,0.9658119658119658,0.9981227381982316,1.0,10/29,27.39%,THRAP3;NOCT;TENT5A;LARP1;ELAVL1;E2F1;TENT5C;DHX34;EIF4ENIF1;GDNF
prerank,L-serine metabolic process (GO:0006563),-0.25304279167499033,-0.5707814097342748,0.927063339731286,0.9976061104641838,1.0,3/10,19.56%,CBS;SERINC3;SERINC5
prerank,ubiquinone biosynthetic process (GO:0006744),0.25666024164363754,0.5706371201264253,0.9291845493562232,1.0,1.0,4/15,20.49%,COQ2;COQ8A;PDSS1;FDXR
prerank,ubiquinone metabolic process (GO:0006743),0.25523117605374424,0.5701007341345679,0.9182795698924732,1.0,1.0,4/15,20.49%,COQ2;COQ8A;PDSS1;FDXR
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.24591531427769858,0.5699157915686547,0.9134020618556701,1.0,1.0,4/16,13.89%,ACKR3;CCAR2;SNAI2;SFRP2
prerank,protein sumoylation (GO:0016925),-0.17752098579909004,-0.5683788117630716,0.9908256880733946,0.9980586720752606,1.0,12/49,25.93%,EYA1;STX1A;SAE1;NUP98;TPR;NUP88;PIAS4;NUP214;TRPM4;NUP37;PIAS3;NUP155
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2444241930879418,-0.5680031993680847,0.9339622641509434,0.9976917404863587,1.0,3/12,18.28%,PRPS2;PRPS1;PRPS1L1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.19870191125645173,-0.5678952767185769,0.9727463312368972,0.9972081652754025,1.0,20/29,49.41%,STX7;CYRIB;TYROBP;RAET1E;ITGAM;PVR;FADD;NOS2;SLAMF6;CD226;IL12A;CRTAM;STAP1;IL23A;KLRD1;CD160;SPI1;LAMP1;KLRK1;IL23R
prerank,positive regulation by host of viral transcription (GO:0043923),-0.23315120155644822,-0.567660095076154,0.957169459962756,0.9967757194667056,1.0,5/15,28.98%,LEF1;SMARCA4;TAF11;CTDP1;JUN
prerank,reticulophagy (GO:0061709),-0.2386616434059799,-0.5661278466209385,0.9473684210526315,0.9968316947550029,1.0,3/12,16.45%,ULK2;RETREG1;ATG2A
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.25495655410275136,0.5660814495005194,0.9393939393939394,1.0,1.0,2/14,7.20%,ABCD2;IRS1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2101375714069151,-0.5655160375378981,0.9737903225806451,0.9965562658750954,1.0,8/23,28.82%,GJA1;NDEL1;FBXW11;ZW10;NUMA1;PAFAH1B1;MISP;NDC80
prerank,microtubule-based transport (GO:0099111),-0.2447147374891675,-0.5627031964305091,0.9581749049429658,0.9971131249893679,1.0,8/12,39.68%,SPEF2;ROPN1L;SPAG17;DYNC1I1;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,B cell activation involved in immune response (GO:0002312),-0.23370930258868627,-0.5626475039638209,0.9566074950690335,0.9966084572687649,1.0,3/13,23.82%,CD180;MSH6;RNF8
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.21874050451875474,0.5622838835576851,0.9375,1.0,1.0,7/32,15.98%,CDK15;DHFR;NPAT;RB1;CDK14;CDK5;CCNE1
prerank,centromere complex assembly (GO:0034508),-0.1894316982465594,-0.5600737730961417,0.9889380530973452,0.9970555956559413,1.0,12/36,28.92%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPE;CENPU;CENPX;CENPH;CENPF
prerank,RNA biosynthetic process (GO:0032774),-0.1883002975584559,-0.5592308595021125,0.9898580121703854,0.9968455934169922,1.0,9/31,27.72%,POLR2A;TBPL1;BRF2;RSF1;TTF1;TAF5;POLA1;NAT14;PRIM2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.23232370357909382,0.5591000638623683,0.9484126984126984,1.0,1.0,4/25,10.64%,ADK;ADSL;DCK;PPAT
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.23912427722574958,0.5589859861387654,0.950920245398773,1.0,1.0,3/17,13.54%,ALG12;ALG1;DHDDS
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.15663481910105567,-0.5587096001450549,1.0,0.9965273856711444,1.0,21/84,24.71%,CDC16;PSME2;ANAPC4;PSMB4;UBB;PSMB1;PSMD11;PSMD8;PSME3;ANAPC16;PSMD4;FZR1;PSMA2;PSMD3;CDC27;PSMB7;ANAPC5;ECRG4;PSMC2;PSMC5;PSMD10
prerank,mitotic metaphase plate congression (GO:0007080),0.19936316527540082,0.5563246333831002,0.9770318021201413,1.0,1.0,4/51,6.20%,RMDN1;CUL3;CHAMP1;CHMP2B
prerank,negative regulation by host of viral transcription (GO:0043922),-0.24033974301471084,-0.5562969292764849,0.9673704414587332,0.9968834689707347,1.0,8/12,52.81%,HDAC1;INPP5K;JUN;CCL5;CCL4;CCL3;POU2F3;REST
prerank,protein K63-linked ubiquitination (GO:0070534),-0.18085242521881173,-0.555878374270799,0.9957627118644068,0.996511705186199,1.0,17/41,33.55%,WWP2;UBE2E2;RNF135;TRIM27;RNF115;PELI1;TRAF3IP2;RNF126;RNF8;BFAR;PRKN;PRPF19;NEDD4;UBE2V1;TRIM21;RNF152;ITCH
prerank,synaptic vesicle exocytosis (GO:0016079),0.21109982347322243,0.5543155085889501,0.9694244604316546,1.0,1.0,7/40,11.38%,SNAP25;RIMS1;RIMS2;SNCA;SYT1;STX4;SYT2
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2094160983915319,-0.5529233089035422,0.9727626459143969,0.9970416779639691,1.0,2/20,12.16%,AKR1B1;STARD3
prerank,microtubule depolymerization (GO:0007019),0.23982324202222907,0.5523721393550104,0.9411764705882353,1.0,1.0,1/17,3.37%,NCKAP5
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.23957641285824152,0.5516226372291284,0.9301848049281314,1.0,1.0,1/16,4.80%,AP1G1
prerank,histone H2B ubiquitination (GO:0033523),-0.24667639733357782,-0.5505607533081458,0.9455535390199638,0.9973379254188259,1.0,4/10,30.79%,DTX3L;RNF40;RNF8;PAF1
prerank,receptor recycling (GO:0001881),-0.2501675009531773,-0.5499392165929701,0.9592592592592593,0.997038212923084,1.0,3/10,17.96%,PHETA1;ARFGEF2;REP15
prerank,tRNA modification (GO:0006400),0.19033270108703332,0.5485853699800357,0.9898132427843803,1.0,1.0,18/62,24.32%,TRMT61A;TRMT5;TRUB1;SSB;TRMT1;THUMPD2;PUS7;ELP5;MTO1;NSUN2;AARS1;ALKBH1;METTL6;THUMPD1;GTPBP3;TRMT10A;TRMT9B;TRDMT1
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.21402937602078373,-0.548474376628268,0.9631147540983607,0.9970023807391013,1.0,6/17,26.83%,ERCC5;TDG;ACD;NEIL3;NEIL1;NTHL1
prerank,long-term memory (GO:0007616),-0.2101813975371654,-0.5484479304560309,0.9716446124763705,0.9964934431105664,1.0,1/19,1.96%,APOE
prerank,protein localization to kinetochore (GO:0034501),-0.22546908327358453,-0.5483769202655769,0.9533980582524272,0.996005240030634,1.0,3/14,15.46%,ZW10;IK;CENPT
prerank,regulation of cellular response to stress (GO:0080135),0.1771605625291199,0.5483605239705376,0.998533724340176,1.0,1.0,26/115,18.00%,ADCY8;CORO2B;NUP43;AJUBA;CASP9;AKT1S1;MTOR;NUP35;CCAR2;NEK6;ATR;DYRK3;DNAJC7;SEC13;NUAK1;NDC1;EP300;RANBP2;RSL1D1;CAMK2G;PTGES3;MAPK1;RPA2;HSF1;NUP133;GSK3B
prerank,protein methylation (GO:0006479),0.20867747697853817,0.5476411797551501,0.9711711711711711,1.0,1.0,12/40,21.24%,METTL21A;EEF1AKMT1;PRMT1;METTL22;PRMT3;PRMT7;SETD3;FAM98A;SNRPD3;NSD3;ATPSCKMT;NTMT1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.24614695228166278,0.5471013282620307,0.9405940594059405,1.0,1.0,3/16,15.35%,PPT1;PPT2;MLYCD
prerank,phagolysosome assembly (GO:0001845),0.2569363823523505,0.5466514366718572,0.9346846846846847,1.0,1.0,2/12,8.41%,PIKFYVE;CORO1A
prerank,RNA modification (GO:0009451),0.19921193601788423,0.5466229744813449,0.9826989619377162,1.0,1.0,12/54,17.96%,NSUN3;TRMT61A;TRUB1;SSB;TRMT1;RBM15;NOP10;PUS7;ELP5;NSUN2;NSUN5;AARS1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.21482688368572686,0.5456338404495781,0.9609665427509294,1.0,1.0,7/34,15.15%,GRAMD4;CD300A;CACTIN;LYN;SARM1;LRRC14;NFKBIL1
prerank,ERAD pathway (GO:0036503),0.18665513276225953,0.5449065045036053,0.9952755905511811,1.0,1.0,16/83,16.33%,FAM8A1;DERL3;FAF2;FOXRED2;UGGT2;SGTB;UBE2J2;ERLIN1;GET4;RNF121;UBXN6;UBQLN2;DNAJC18;RNF103-CHMP3;TMUB2;TOR1A
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.2345499640702871,-0.5439466924190947,0.9541984732824428,0.996896260167071,1.0,5/12,30.18%,ACO1;IDH3G;ASS1;SIRT4;IDH3B
prerank,meiosis I (GO:0007127),0.22262746952410378,0.5431447575367023,0.9609856262833676,1.0,1.0,4/23,15.66%,MEIOB;BRDT;PTTG1;SLC25A31
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.2589850486025857,0.5426304004406314,0.9168399168399168,1.0,1.0,4/10,23.89%,LYN;MAPK1;NBR1;GREM1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.228344804463205,0.5410558870495926,0.9519230769230769,1.0,1.0,8/21,25.65%,NES;TOX;SMARCD3;NAP1L1;FZD9;DRD2;FZD3;DISP3
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.24803816937660855,0.5396030713025819,0.9368635437881874,1.0,1.0,14/14,75.22%,CLP1;TSEN15;DDX1;FAM98B;CPSF4;RTRAF;CSTF2;RTCB;TSEN54;TRPT1;ZBTB8OS;CPSF1;TSEN34;TSEN2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.20068426552125962,-0.5367408778448434,0.9826589595375722,0.9985310287775256,1.0,5/22,22.50%,TOM1L1;RNF115;VPS28;RNF126;VPS37D
prerank,mitochondrial translation (GO:0032543),0.17618619089747706,0.5365381607581824,0.9939301972685888,1.0,1.0,28/104,21.59%,FASTKD2;NOA1;MRPS27;MTIF2;MRPL55;MRPL58;GATB;GFM2;MRPS30;PTCD3;IARS2;GFM1;GATC;MRPL20;MRPS18C;MRPS33;MRPS34;MRPS12;MRPS18B;OXA1L;MRPS17;MRPL47;MRPL40;MRPL2;MRPL37;MRPL11;TSFM;MRPS15
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.22512638285621378,-0.5357153802564864,0.9652014652014652,0.9983123404401316,1.0,1/12,6.61%,PRKCB
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2159799543249692,0.5353083783066485,0.9613152804642167,1.0,1.0,10/29,20.33%,RBX1;GTF2H5;CCNH;GTF2H1;PARP1;XPC;CHD1L;RPA2;GTF2H4;DDB2
prerank,positive regulation of histone deacetylation (GO:0031065),0.24344416676886294,0.534969205801911,0.9501039501039501,1.0,1.0,5/12,22.92%,PRKD2;NIPBL;PRKD1;AKAP8;AKAP8L
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.23031377753347987,0.5349187430599027,0.947261663286004,1.0,1.0,1/17,4.80%,AP1G1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.15854448693067166,-0.534531750062005,0.9950124688279302,0.9981405511502338,1.0,16/69,26.26%,POLR2A;NABP1;POLR2F;INTS11;POU2F1;CDK9;RPRD2;POLR2E;POU2F2;TAF5;ICE1;INTS5;POLR2G;CDK7;SNAPC4;TAF11
prerank,tRNA wobble base modification (GO:0002097),-0.22161256032499596,-0.5344263473198481,0.9781746031746031,0.9976498770513752,1.0,6/14,36.29%,ELP3;URM1;KTI12;ADAT2;CTU2;CTU1
prerank,snRNA transcription (GO:0009301),-0.15743566804579984,-0.5342839228672422,0.9950738916256158,0.9971769765795735,1.0,16/70,26.26%,POLR2A;NABP1;POLR2F;INTS11;POU2F1;CDK9;RPRD2;POLR2E;POU2F2;TAF5;ICE1;INTS5;POLR2G;CDK7;SNAPC4;TAF11
prerank,telomere organization (GO:0032200),0.20470033016537043,0.533953709833241,0.9875222816399287,1.0,1.0,10/43,17.43%,DCLRE1B;ERCC4;ATR;PRKDC;BLM;PARP1;PTGES3;RPA2;TERF1;APEX1
prerank,glycolytic process (GO:0006096),0.21327159450003247,0.5335509386530453,0.9667318982387475,1.0,1.0,9/28,24.37%,GCK;ALDOC;GPI;PFKM;PKM;ENO2;PGM1;PFKFB2;PGK1
prerank,negative regulation of DNA recombination (GO:0045910),-0.17016435244423306,-0.5328857840304098,0.9976689976689976,0.9970894590370285,1.0,11/43,24.60%,POLR2A;PARP3;POLR2F;SHLD1;POLR2E;ACD;RMI2;KLHL15;MSH6;PARPBP;POLR2G
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.20421522962644,-0.5320190278541505,0.966,0.9968030690964608,1.0,11/18,52.85%,BID;TMEM14A;ZNF205;HIP1R;BAX;SLC25A5;GSK3A;BOK;MPV17L;TMEM102;MUL1
prerank,outer dynein arm assembly (GO:0036158),0.2329713101889636,0.5308892382005238,0.9469214437367304,1.0,1.0,14/14,76.72%,CCDC63;ODAD4;DNAH5;LRRC49;DNAAF5;ZMYND10;DNAAF1;ODAD1;DNAAF4;DNAH17;DNAL1;ODAD3;ODAD2;DNAH8
prerank,organelle disassembly (GO:1903008),0.20980974458323504,0.5300402730903162,0.9668508287292817,1.0,1.0,6/33,14.05%,PELO;MTIF2;UFM1;DYRK3;GFM2;ATG2B
prerank,regulation of T cell activation (GO:0050863),0.20067265632927078,0.5281515805813437,0.9773519163763066,1.0,1.0,2/42,3.87%,PTPN22;PAG1
prerank,regulation of interferon-beta production (GO:0032648),-0.16646849426820523,-0.5263894848416503,0.9909297052154195,0.9977762294095016,1.0,11/46,26.07%,IRF1;OAS2;RNF135;MAVS;PPM1B;SIRPA;TLR4;POLR3D;RNF216;REL;PTPRS
prerank,DNA catabolic process (GO:0006308),-0.23060360966106194,-0.5260635623380041,0.9766187050359713,0.9973455951842355,1.0,3/11,21.23%,REXO4;DNASE1L1;DFFB
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2235276613222011,0.5255937901078653,0.9486652977412731,1.0,1.0,1/17,2.62%,IL1B
prerank,positive regulation of telomere capping (GO:1904355),-0.20869021902034762,-0.5253003914062121,0.9739478957915831,0.9970549214459565,1.0,5/17,26.85%,TNKS2;MAPK3;MAP3K4;MAP2K7;NEK7
prerank,dendritic cell chemotaxis (GO:0002407),-0.21611435827799177,-0.5250514199017875,0.97678916827853,0.996612473963781,1.0,8/14,42.44%,TRPM4;CCL19;TRPM2;CCR2;CXCR4;PIK3CG;CCL5;CCR1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.23298783104503756,0.5221160226386339,0.9434782608695652,1.0,1.0,1/17,2.89%,EMC7
prerank,microglial cell activation (GO:0001774),-0.19471215028451663,-0.5220543481172998,0.9789272030651341,0.9968553130476954,1.0,1/21,2.11%,APP
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.1939447386271733,-0.5216972686673683,0.9807321772639692,0.9964317657320244,1.0,9/22,34.32%,MMS19;ISCA2;CIAPIN1;NUBP1;HSPA9;CIAO2B;IBA57;NUBP2;CIAO2A
prerank,glucose catabolic process to pyruvate (GO:0061718),0.21195900565514122,0.5210058649042062,0.9669902912621359,1.0,1.0,6/24,18.63%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,canonical glycolysis (GO:0061621),0.21195900565514122,0.5210058649042062,0.9669902912621359,1.0,1.0,6/24,18.63%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,"phototransduction, visible light (GO:0007603)",-0.21317872511412594,-0.5186799013409765,0.9904580152671756,0.9967019514429463,1.0,3/14,26.06%,ABCA4;RP1;GNAQ
prerank,DNA replication checkpoint signaling (GO:0000076),0.23431908080617836,0.5140792261583247,0.9501084598698482,1.0,1.0,16/16,76.59%,TIMELESS;RAD17;TIPIN;DNA2;RAD9A;NAE1;CLSPN;ORC1;RAD9B;CDT1;TICRR;CDC6;TOPBP1;HUS1B;HUS1;CDC45
prerank,male meiosis I (GO:0007141),0.22427324668801402,0.5128887538197396,0.9642857142857143,1.0,1.0,16/16,77.60%,BRDT;SLC25A31;FOXJ3;ING2;FOXJ2;ZSCAN21;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;MYBL1;DDX4;TDRD9;SYCP3;HSF2BP
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.19115613088473654,-0.5119045330417341,0.9880715705765407,0.9977822047676631,1.0,3/21,13.57%,RAB11A;RAD51B;CCND1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.2014894480897067,-0.5113711330766283,0.9808795411089866,0.9974063415249554,1.0,6/17,31.02%,HSP90B1;NPLOC4;VCP;SEC61B;SYVN1;AUP1
prerank,transcription by RNA polymerase III (GO:0006383),-0.18417605647923935,-0.5113218054333467,0.9959183673469387,0.9969015689448508,1.0,7/27,26.26%,IVNS1ABP;POLR3GL;GTF3C2;GTF3C5;GTF3C1;ICE1;SNAPC4
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.2393314612583627,0.5109786611230848,0.9573560767590619,1.0,1.0,1/11,6.95%,LIPC
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.17583037897352266,0.5098923378596061,0.9967159277504105,1.0,1.0,17/70,19.86%,TCF15;PSMB11;N4BP2L2;PSMF1;MYB;TCF12;YTHDF2;PSME4;PRKDC;PUS7;KMT2A;PSMB5;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.23543445504771476,0.5098402764688706,0.9634408602150538,1.0,1.0,15/15,76.48%,FANCD2;RAD17;MDC1;MUS81;TIPIN;RAD9A;MRE11;EME2;RAD9B;EME1;NEK11;HUS1B;HUS1;ATF2;CHEK2
prerank,iron-sulfur cluster assembly (GO:0016226),-0.18536045080961655,-0.5096025389980441,0.9961240310077519,0.9967432533388453,1.0,11/24,39.43%,MMS19;ISCA2;CIAPIN1;NUBP1;HSPA9;CIAO2B;IBA57;NUBP2;CIAO2A;GLRX3;NFS1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2445061241758954,0.5085048479911153,0.9290322580645162,1.0,1.0,3/10,14.24%,VPS9D1;ATP5F1A;ATP5PO
prerank,phosphate ion transmembrane transport (GO:0035435),-0.21526941395248003,-0.5078925568747434,0.9813084112149533,0.9966062453681821,1.0,4/12,27.90%,SLC20A2;SLC37A1;SLC37A2;SLC25A11
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.20499280902198017,0.507630786535495,0.9749518304431599,1.0,1.0,6/25,18.63%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,regulation of DNA recombination (GO:0000018),0.19493485214992964,0.5073518832042424,0.9794776119402985,1.0,1.0,6/32,17.06%,IL4;MSH3;KPNA1;PPP4C;BLM;RPA2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.23539011989203468,0.507023698900326,0.954248366013072,1.0,1.0,12/12,76.48%,SETMAR;RAD17;NAE1;CLSPN;ORC1;TICRR;CDC6;TOPBP1;HUS1B;HUS1;STK33;CHEK2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.1835881500088052,-0.5067651511586531,0.9776422764227642,0.9963248586843931,1.0,8/24,28.31%,CXCL12;TPT1;SNAI1;TAF9B;BCL2L1;CD44;CDKN2D;CLU
prerank,pyruvate metabolic process (GO:0006090),0.1823182293917596,0.5060568455378782,0.9930191972076788,1.0,1.0,10/52,16.88%,SLC16A3;GCK;ALDOC;PDHX;SRR;GPI;PFKM;PCK2;DLD;PKM
prerank,nucleosome disassembly (GO:0006337),0.22876925788159558,0.505252187878417,0.9585062240663901,1.0,1.0,4/14,19.38%,SET;SMARCD3;NFE2;SMARCD1
prerank,chromatin disassembly (GO:0031498),0.22876925788159558,0.505252187878417,0.9585062240663901,1.0,1.0,4/14,19.38%,SET;SMARCD3;NFE2;SMARCD1
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.17205423879339934,-0.5041717963880805,0.9956521739130435,0.9963417836914735,1.0,11/35,32.01%,TDG;RPA1;ADPRS;RFC3;RFC1;RPA3;NEIL1;NTHL1;POLD1;PCNA;RFC5
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.22684006837925685,0.503795741837811,0.9661733615221987,1.0,1.0,2/15,10.42%,CUL3;DYRK3
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.21815670851325053,0.5031056424448981,0.9498069498069498,1.0,1.0,6/17,23.94%,CHAMP1;RB1;CENPA;SPDL1;MTBP;ZWILCH
prerank,replication fork processing (GO:0031297),-0.16440462201277967,-0.5011911211929466,0.9932735426008968,0.9964083368679106,1.0,21/38,47.06%,SAMHD1;BRCA2;CDK9;THOC1;RAD51;CENPX;FANCM;WRN;PCNA;FAM111A;ATRX;PRIMPOL;ZRANB3;ALYREF;NUCKS1;EME1;GEN1;TONSL;RTEL1;CENPS;MMS22L
prerank,synaptic vesicle transport (GO:0048489),-0.22299946316922903,-0.500634302271415,0.9814471243042672,0.9959985830475866,1.0,2/11,16.11%,RAB27A;SYNJ1
prerank,vesicle transport along microtubule (GO:0047496),0.20589115320250911,0.5005296364680695,0.9715447154471545,1.0,1.0,8/23,19.16%,KIF3A;TRAK1;TRAK2;RAB1A;NDE1;HTT;HAP1;KIF1A
prerank,peptidyl-lysine trimethylation (GO:0018023),0.20398474005122186,0.4993841535780803,0.974308300395257,1.0,1.0,9/26,19.73%,OGT;CTR9;SETD3;KMT5B;SUV39H1;KMT2A;KMT2D;SETD5;ATPSCKMT
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.1692382942140511,-0.49860289442584893,0.997716894977169,0.9959016372524641,1.0,9/35,26.85%,TNKS2;NAF1;ATM;MAPK3;MAP3K4;ACD;MAP2K7;CTNNB1;NEK7
prerank,rRNA 3'-end processing (GO:0031125),-0.22264131509875032,-0.496892816737481,0.977818853974122,0.9957261625422226,1.0,4/10,39.16%,ERI3;EXOSC7;RPS21;ERI1
prerank,histone H3-K4 methylation (GO:0051568),0.20011943775924718,0.49607483877668085,0.9809523809523809,1.0,1.0,7/26,19.14%,OGT;KMT2B;SETMAR;CTR9;KMT2A;KMT2D;WDR5
prerank,nuclear envelope organization (GO:0006998),0.2104163331439653,0.49525424118894856,0.9578544061302682,1.0,1.0,5/20,22.76%,TOR1B;EMD;TOR1A;LEMD3;SUN2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.1821338104671794,-0.4947725721838894,0.9917184265010351,0.9955884518175192,1.0,1/27,1.24%,LPAR1
prerank,steroid hormone biosynthetic process (GO:0120178),0.19977127848906379,0.4924036813881086,0.9780876494023905,1.0,1.0,5/29,13.32%,MED1;DHCR7;STAR;SRD5A1;CYP11B1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.21212525463572132,0.4911812929136143,0.9574468085106383,1.0,1.0,2/19,7.59%,DDX3X;RIPK2
prerank,DNA packaging (GO:0006323),-0.19323286992499306,-0.4889921782188778,0.9886792452830189,0.996106014125155,1.0,10/16,49.58%,AIFM1;HAT1;CHAF1A;TP53;NAA10;RBBP4;CHAF1B;NOC2L;M1AP;H1-0
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.20723797522872173,0.4887677279895732,0.9705882352941176,1.0,1.0,11/22,28.56%,MED13;MED1;MED4;DHX36;MED30;MED16;MED14;PSMC3;SUB1;PSMC4;MED17
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.23164967388123417,0.48673183789267194,0.9466950959488273,1.0,1.0,3/10,24.17%,CCT7;CCT3;DKC1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.21252813779199364,0.4865963045535386,0.967741935483871,1.0,1.0,2/19,8.20%,ADK;DCK
prerank,autophagosome organization (GO:1905037),0.17876897494222455,0.4859402364461226,0.9963636363636363,1.0,1.0,18/50,24.89%,ATG16L1;ATP2A2;TP53INP2;UBXN2B;ATG2B;UBQLN2;VMP1;RAB1A;PIK3C3;ULK3;RAB1B;GABARAP;GABARAPL2;ATG13;ATG9A;TMEM41B;ATG16L2;UBXN2A
prerank,modulation by host of symbiont process (GO:0051851),-0.1688622188833424,-0.48558562170636155,0.9938650306748467,0.996170208568903,1.0,14/31,41.46%,LEF1;SAP30BP;HDAC1;SMARCA4;INPP5K;TAF11;CTDP1;JUN;AQP1;CCL5;CX3CR1;NUCKS1;SAP30;CCL4
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.2268405930712161,0.48496076603738647,0.9789915966386554,1.0,1.0,6/11,28.68%,UGGT2;TOR1A;POMT2;DERL1;BAG6;UGGT1
prerank,DNA replication (GO:0006260),0.15986971991123858,0.4849057879028948,1.0,1.0,1.0,20/105,17.51%,KAT7;MCM6;RBMS1;RAD1;WRNIP1;TIMELESS;ATR;MCM7;MCM2;SET;REV3L;RAD17;ATRIP;BLM;ORC4;KIN;PIF1;NAP1L1;RPA2;RHNO1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.21886278629451217,0.4846845215783233,0.9629629629629629,1.0,1.0,4/16,14.32%,MCM6;MCM7;MCM2;BLM
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.17898492534575394,0.48397800146748027,0.992619926199262,1.0,1.0,6/40,14.32%,MSH3;TIMELESS;ATR;ETAA1;SETMAR;BLM
prerank,mRNA transport (GO:0051028),0.160279165202749,0.4836452962348241,1.0,1.0,1.0,29/101,25.18%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;KIF5C;UPF3B;EIF4E;RANBP2;ZC3H11A;FMR1;NUP133;HNRNPA2B1;DDX25;POLDIP3;SRSF9;ZFP36L1;THOC2;SEH1L;EIF4A3;RAE1;SRSF4;CASC3;CDC40
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.21535945674236937,0.48214498712316456,0.9713024282560706,1.0,1.0,5/16,23.01%,TRA2A;DAZAP1;RBMX;RBM3;CIRBP
prerank,mitotic chromosome condensation (GO:0007076),0.1913354494525413,0.4816149659591813,0.9842829076620825,1.0,1.0,10/26,26.86%,NUSAP1;RB1;SET;NCAPD3;SMC2;CSNK2A2;AKAP8L;NCAPH;CSNK2A1;NCAPD2
prerank,synaptic vesicle localization (GO:0097479),0.22643708700122173,0.4811432940090995,0.9642857142857143,1.0,1.0,4/13,16.33%,KIF5C;SYNDIG1;CDK5;TOR1A
prerank,t-circle formation (GO:0090656),0.2309526383342915,0.4799081496386564,0.9557522123893806,1.0,1.0,3/10,17.26%,BLM;XRCC3;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.2309526383342915,0.4799081496386564,0.9557522123893806,1.0,1.0,3/10,17.26%,BLM;XRCC3;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.2309526383342915,0.4799081496386564,0.9557522123893806,1.0,1.0,3/10,17.26%,BLM;XRCC3;TERF1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.2060770258206916,0.4792313773109249,0.98068669527897,1.0,1.0,1/19,3.24%,UGP2
prerank,protein targeting to mitochondrion (GO:0006626),0.17348726675024054,0.47848875179222305,0.9963570127504554,1.0,1.0,18/52,26.75%,IMMP2L;TIMM22;GRPEL2;TOMM40L;MFF;TIMM23;TOMM40;MIPEP;PMPCB;TOMM70;PITRM1;AGK;DNAJC19;PAM16;TIMM17A;DNLZ;HSP90AA1;TIMM17B
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.21105791134741858,0.47619356148262315,0.9660297239915074,1.0,1.0,1/13,3.69%,DERL3
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.23171323229377766,0.47555899782821937,0.9748858447488584,1.0,1.0,3/10,20.85%,LYN;CD24;LILRB1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.20417548216735437,0.474852077810922,0.9905660377358491,1.0,1.0,6/19,22.98%,SREBF2;HTRA2;CAMKK2;HTT;CSNK2A2;VDAC1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.19951991428798124,0.47469958374545307,0.9766990291262136,1.0,1.0,2/22,7.63%,KAT7;TCERG1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.20834871018193207,0.4744469604499817,0.9840319361277445,1.0,1.0,6/18,22.97%,PCID2;ZC3H11A;NUP133;DDX25;POLDIP3;THOC2
prerank,negative regulation of defense response to virus (GO:0050687),0.22706885165934126,0.47395714496804925,0.9594017094017094,1.0,1.0,3/10,16.99%,TARBP2;C1QBP;TRAF3IP1
prerank,negative regulation of viral release from host cell (GO:1902187),0.21363608306313703,0.4738170527958047,0.9647577092511013,1.0,1.0,1/13,3.31%,MID2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.18661774663403843,0.4715353216472497,0.9942528735632183,1.0,1.0,2/29,5.68%,LIMK1;MAGEC2
prerank,tRNA wobble uridine modification (GO:0002098),-0.19219629698610827,-0.4711046426531387,0.9904030710172744,0.9977627545523241,1.0,6/14,36.29%,ELP1;ELP3;URM1;KTI12;CTU2;CTU1
prerank,mRNA export from nucleus (GO:0006406),0.15457676111906957,0.470669507933898,1.0,1.0,1.0,21/102,20.86%,NUP43;NCBP2;SRRM1;RNPS1;PCID2;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;UPF3B;EIF4E;RANBP2;ZC3H11A;NUP133;POLR2D;HNRNPA2B1;DDX25;POLDIP3;SRSF9
prerank,neuromuscular process (GO:0050905),0.2074112631245753,0.4663043842262214,0.9700214132762313,1.0,1.0,1/16,3.15%,NRXN1
prerank,cellular response to UV-A (GO:0071492),-0.20350089927080092,-0.46550017480303285,0.9832089552238806,0.9980113142595504,1.0,2/11,15.44%,PPID;MMP2
prerank,nuclear pore organization (GO:0006999),0.21094015896850404,0.46536757640985016,0.9746835443037974,1.0,1.0,3/14,17.70%,NUP35;NDC1;NUP133
prerank,RNA 3'-end processing (GO:0031123),0.16327487103540042,0.46260778260986607,1.0,1.0,1.0,8/69,11.42%,CLP1;NCBP2;SUPV3L1;SRRM1;PAPOLA;RNPS1;SYMPK;RPRD1B
prerank,regulation of histone deacetylation (GO:0031063),-0.1948553025506492,-0.4618907840951785,0.9903288201160542,0.9979392526083648,1.0,3/13,28.35%,SAP30BP;CTBP1;SPHK2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.19829322205011407,0.4593680248528942,0.9705263157894737,1.0,1.0,6/19,19.24%,MTOR;MAF1;DHX36;CHD8;POLR3F;TENM1
prerank,phosphate ion transport (GO:0006817),-0.1828462439004045,-0.45759109045510704,0.9920792079207921,0.9979581027946088,1.0,1/16,4.14%,SLC20A2
prerank,aerobic respiration (GO:0009060),0.19144220833999492,0.45067104692320664,0.9876796714579056,1.0,1.0,5/20,20.21%,BLOC1S1;UQCRC2;MTFR1;OXA1L;SURF1
prerank,protein-DNA complex disassembly (GO:0032986),-0.18047224130134787,-0.4493569044606868,0.9941747572815534,0.9982998152290368,1.0,6/16,36.43%,SMARCC1;RPL23;SMARCA4;SMARCD2;MYC;GRWD1
prerank,DNA recombination (GO:0006310),0.17469634491357008,0.4477894432514995,0.9906890130353817,1.0,1.0,8/37,17.51%,SUPV3L1;LIG4;MSH3;TSN;BLM;XRCC3;HDAC10;RHNO1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.17692856713539806,-0.44514674328784465,0.9959677419354839,0.9981942541038566,1.0,6/16,34.13%,DDX5;SRSF6;PUF60;HNRNPM;PQBP1;CELF4
prerank,protein localization to condensed chromosome (GO:1903083),0.20431819926041253,0.44486516505418267,0.9896265560165975,1.0,1.0,1/12,5.19%,CHAMP1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.17353745115396915,0.44341480617582607,0.9846743295019157,1.0,1.0,4/31,12.82%,LSS;STAR;PRLR;SRD5A1
prerank,aminoglycan metabolic process (GO:0006022),0.21684554070168824,0.4419249685528152,0.9800884955752213,1.0,1.0,10/10,78.33%,B3GALT6;CHST9;B3GAT1;B3GAT2;B4GALT7;XYLT2;GAL3ST3;B3GAT3;XYLT1;CLN6
prerank,nuclear membrane disassembly (GO:0051081),0.1930172891552634,0.4416370990582547,0.9770833333333333,1.0,1.0,5/14,26.40%,NEK6;DCTN1;NEK9;AKAP8L;VRK1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.16178672283130213,-0.4401933889677409,0.9941060903732809,0.9981562585480926,1.0,11/22,43.08%,ERI3;FTSJ3;EXOSC7;RRS1;ABT1;URB1;RPS21;RPP40;ERI1;KRI1;UTP20
prerank,regulation of catecholamine secretion (GO:0050433),0.17314558738656058,0.4399974695199044,0.9838383838383838,1.0,1.0,11/29,24.87%,SNCA;SYT1;SYT2;CHRNB2;SYT12;SYT11;SYT13;SYT3;DRD2;SYT6;SYT10
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.18524755203749704,0.4397662670766125,0.9938524590163934,1.0,1.0,3/20,11.90%,AGO3;TARBP2;TSN
prerank,RNA export from nucleus (GO:0006405),0.1458637140701154,0.4380170650327741,1.0,1.0,1.0,14/100,14.56%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;HNRNPA1;UPF3B;EIF4E;RANBP2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.20709984928555647,0.43713557203758596,0.980561555075594,1.0,1.0,1/10,6.30%,SNCA
prerank,DNA replication initiation (GO:0006270),0.16886070726402475,0.4360299768246168,0.998211091234347,1.0,1.0,7/37,17.07%,MCM6;MCM7;MCM2;PRIM1;ORC4;RPA2;POLE4
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.19874761166118163,0.4325449458666982,0.989648033126294,1.0,1.0,1/15,4.81%,CLP1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.17651299355874112,0.4325417808999591,0.9922779922779923,1.0,1.0,9/25,26.09%,KAT7;CCAR2;EAF2;SETD5;CCNK;TSFM;CCNT2;WDR43;LDB1
prerank,tRNA processing (GO:0008033),0.15297896272549766,0.431976710315239,0.9982668977469671,1.0,1.0,18/61,24.32%,CLP1;TRMT61A;TRUB1;SSB;TRMT1;ADAT1;TRMT10C;ELP5;NSUN2;AARS1;POP7;POP5;TSEN15;DDX1;THUMPD1;TRMT10A;TRMT9B;TRDMT1
prerank,C4-dicarboxylate transport (GO:0015740),0.18984418608736142,0.43127448375203964,0.993801652892562,1.0,1.0,1/14,5.46%,SLC25A13
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.14291292214534088,0.42768192026997676,1.0,1.0,1.0,26/96,25.18%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;UPF3B;EIF4E;RANBP2;ZC3H11A;NUP133;HNRNPA2B1;DDX25;POLDIP3;SRSF9;THOC2;SEH1L;EIF4A3;RAE1;SRSF4;CASC3;CDC40
prerank,tRNA 5'-leader removal (GO:0001682),-0.17972112144109087,-0.42465222294503613,0.9944341372912802,0.9988180427305984,1.0,6/13,37.73%,PRORP;RPP38;POP1;RPP25L;RPP21;RPP40
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.19085384071822625,0.4225906641777295,0.9847826086956522,1.0,1.0,5/13,22.99%,PCID2;MAD2L1;XRCC3;DYNC1LI1;CDK5RAP2
prerank,pre-replicative complex assembly (GO:0036388),0.1468903379309358,0.42162998266156043,1.0,1.0,1.0,14/64,19.95%,PSMB11;PSMF1;MCM6;MCM7;MCM2;PSME4;ORC4;PSMB5;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;ORC6
prerank,mitochondrial translational elongation (GO:0070125),0.14242454198526325,0.42046529350200645,1.0,1.0,1.0,29/88,25.61%,MRPS27;MRPL55;MRPL58;GFM2;MRPS30;PTCD3;GFM1;MRPL20;MRPS18C;MRPS33;MRPS34;MRPS12;MRPS18B;OXA1L;MRPS17;MRPL47;MRPL40;MRPL2;MRPL37;MRPL11;TSFM;MRPS15;MRPL42;DAP3;MRPS11;MRPL14;MRPL32;MRPS16;MRPL41
prerank,regulation of interferon-alpha production (GO:0032647),0.17798346025558914,0.4195543003932315,0.9923664122137404,1.0,1.0,2/23,7.59%,DDX3X;RIPK2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.17950452223104782,0.418182300683119,0.9878048780487805,0.9996167708802293,1.0,5/19,19.22%,CHMP2B;CEP97;HNRNPU;CHMP3;DRG1
prerank,regulation of centrosome cycle (GO:0046605),-0.15555710411343107,-0.41560623811702574,0.9960707269155207,0.998877740779745,1.0,2/21,10.71%,PDCD6IP;CHMP4B
prerank,lipid biosynthetic process (GO:0008610),0.14058620527663007,0.41338918987728035,1.0,0.999614974773096,1.0,12/77,15.35%,LIPC;LIPH;LSS;STAR;PRLR;SRD5A1;PRKAA1;OLAH;HMGCR;PDSS1;LPCAT1;MLYCD
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.18542551713442473,-0.41330134980241656,0.9941747572815534,0.9985004118215528,1.0,2/10,22.85%,NAF1;PIH1D1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.1270081082007929,-0.413269073688048,1.0,0.997996740247757,1.0,2/53,3.96%,CALCRL;ANXA1
prerank,mRNA 3'-end processing (GO:0031124),0.1387487865929889,0.4000368744860325,1.0,1.0,1.0,25/78,26.69%,CLP1;NCBP2;SRRM1;PAPOLA;RNPS1;CPSF6;SYMPK;RPRD1B;UPF3B;ZC3H11A;CPSF7;POLR2D;POLDIP3;SRSF9;PABPC1;THOC2;EIF4A3;TUT1;SRSF4;CASC3;CDC40;LEO1;PAPOLG;TENT2;SRSF3
prerank,RNA transport (GO:0050658),0.13261403085771753,0.38522308321879173,1.0,1.0,1.0,20/71,25.18%,RFTN1;NCBP2;SRRM1;RNPS1;KIF5C;HNRNPA1;UPF3B;EIF4E;ZC3H11A;FMR1;HNRNPA2B1;POLDIP3;SRSF9;ZFP36L1;THOC2;EIF4A3;RAE1;SRSF4;CASC3;CDC40
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.17231427140153907,0.36894705367336866,0.9962121212121212,1.0,1.0,4/13,19.43%,PTPN1;ABCA7;DDRGK1;PPP1R15A
prerank,androgen metabolic process (GO:0008209),0.15954108292292335,0.36310112582274434,1.0,1.0,1.0,3/18,19.52%,MED1;SRD5A1;HSD17B4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.1688947467520241,0.35610868025366,0.9978540772532188,1.0,1.0,10/10,83.12%,APC;KNSTRN;CDC42;RACGAP1;ECT2;NEK2;CCNB1;RCC2;SPAG5;SIRT2
prerank,ncRNA metabolic process (GO:0034660),0.13039920746456718,0.3421323345961302,1.0,1.0,1.0,5/37,17.81%,PLD6;TARBP2;TDRKH;EXD1;KHSRP
prerank,tRNA 5'-end processing (GO:0099116),0.14863923125535622,0.3350029434276384,0.9957805907172996,1.0,1.0,4/15,21.95%,SSB;TRMT10C;POP7;POP5
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.14282126938288647,0.3055637125128639,1.0,0.9998901364064371,1.0,14/14,85.73%,WDR12;RPF2;DDX18;NOL9;PES1;ZNHIT6;ZNHIT3;BOP1;NIFK;RPL35;RPL7L1;URB1;FTSJ3;RPL7
